1	nature	NN	O	nature	nn	2	SENT_1	[p1l21t97r112b118],
2	publishing	NN	O	publishing	_	0	SENT_1	[p1l121t94r269b125],
3	group	NN	O	group	nn	5	SENT_1	[p1l278t101r362b125],
4	R	NN	O	r	nn	5	SENT_1	[p1l1948t81r1974b118],
5	E	NN	O	e	dep	2	SENT_1	[p1l1983t81r2003b118],
6	VI	NNP	O	VI	nn	8	SENT_1	[p1l2010t81r2056b118],
7	E	NNP	O	E	nn	8	SENT_1	[p1l2068t81r2088b118],
8	W	NNP	O	W	dep	2	SENT_1	[p1l2096t81r2138b118],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_2	[p1l27t210r733b306],
2	Treatment	NN	O	treatment	_	0	SENT_2	[p1l753t214r1198b286],
3	of	IN	O	of	_	0	SENT_2	[p1l1222t209r1310b286],
4	Acute	JJ	O	acute	amod	6	SENT_2	[p1l1326t214r1572b286],
5	Heart	NNP	O	Heart	nn	6	SENT_2	[p1l1600t214r1831b286],
6	Failure	NN	O	failure	prep_of	2	SENT_2	[p1l27t322r324b398],
7	:	:	O	:	_	0	SENT_2	[p1l27t322r324b398],
8	Current	JJ	DATE	current	amod	9	SENT_2	[p1l349t325r670b398],
9	Treatment	NN	O	treatment	dep	2	SENT_2	[p1l686t326r1130b398],
10	and	CC	O	and	_	0	SENT_2	[p1l1154t322r1310b398],
11	NewTargets	NNS	O	newtarget	conj_and	9	SENT_2	[p1l1342t326r1855b418],

1	IP6ss1	NN	O	ip6ss1	_	0	SENT_3	[p1l20t465r165b514],
2	,	,	O	,	_	0	SENT_3	[p1l20t465r165b514],
3	A	DT	O	a	det	5	SENT_3	[p1l177t472r210b506],
4	Link	NN	O	link	nn	5	SENT_3	[p1l221t465r330b506],
5	‘	NN	O	‘	appos	1	SENT_3	[p1l221t465r330b506],
6	and	CC	O	and	_	0	SENT_3	[p1l344t470r420b507],
7	M	NN	O	m	nn	8	SENT_3	[p1l429t473r472b506],
8	Bohml	NN	O	bohml	appos	1	SENT_3	[p1l483t465r623b507],

1	Acute	JJ	O	acute	amod	3	SENT_4	[p1l20t591r121b620],
2	heart	NN	O	heart	nn	3	SENT_4	[p1l131t589r224b620],
3	failure	NN	O	failure	nsubjpass	8	SENT_4	[p1l232t589r345b620],
4	(	CD	NUMBER	(	num	6	SENT_4	[p1l355t590r449b624],
5	AHF	NN	ORGANIZATION	ahf	nn	6	SENT_4	[p1l355t590r449b624],
6	)	NN	O	)	dep	3	SENT_4	[p1l355t590r449b624],
7	is	VBZ	O	be	auxpass	8	SENT_4	[p1l461t590r485b620],
8	defined	VBN	O	define	_	0	SENT_4	[p1l494t589r628b620],
9	as	IN	O	as	_	0	SENT_4	[p1l638t598r674b620],
10	the	DT	O	the	det	12	SENT_4	[p1l682t589r740b620],
11	rapid	JJ	O	rapid	amod	12	SENT_4	[p1l750t589r840b627],
12	onset	NN	O	onset	prep_as	8	SENT_4	[p1l850t593r947b620],
13	of	IN	O	of	_	0	SENT_4	[p1l956t589r998b624],
14	,	,	O	,	_	0	SENT_4	[p1l956t589r998b624],
15	or	CC	O	or	dep	16	SENT_4	[p1l1007t598r1044b620],
16	changes	NNS	O	change	dep	12	SENT_4	[p1l1052t589r1198b628],
17	in	IN	O	in	prep	16	SENT_4	[p1l1209t590r1249b624],
18	,	,	O	,	_	0	SENT_4	[p1l1209t590r1249b624],
19	the	DT	O	the	det	20	SENT_4	[p1l1257t589r1315b620],
20	symptoms	NNS	O	symptom	prep_of	12	SENT_4	[p1l1324t594r1508b628],
21	and	CC	O	and	_	0	SENT_4	[p1l1517t589r1583b620],
22	signs	NNS	O	sign	prep_of	12	SENT_4	[p1l1593t590r1682b628],
23	of	IN	O	of	_	0	SENT_4	[p1l1691t589r1728b620],
24	heart	NN	O	heart	nn	25	SENT_4	[p1l1736t589r1828b620],
25	failure	NN	O	failure	prep_of	20	SENT_4	[p1l1836t589r1949b620],
26	(	CD	NUMBER	(	num	28	SENT_4	[p1l1959t590r2039b624],
27	HF	NN	O	hf	nn	28	SENT_4	[p1l1959t590r2039b624],
28	)	NN	O	)	dep	25	SENT_4	[p1l1959t590r2039b624],
29	.	.	O	.	_	0	SENT_4	[p1l1959t590r2039b624],

1	It	PRP	O	it	nsubj	5	SENT_5	[p1l2049t591r2071b620],
2	is	VBZ	O	be	cop	5	SENT_5	[p1l21t643r46b673],
3	a	DT	O	a	det	5	SENT_5	[p1l55t651r72b673],
4	life-threatening	JJ	O	life-threatening	amod	5	SENT_5	[p1l84t642r359b682],
5	situation	NN	O	situation	_	0	SENT_5	[p1l369t643r524b673],
6	in	IN	O	in	_	0	SENT_5	[p1l535t643r564b673],
7	which	WDT	O	which	rel	15	SENT_5	[p1l574t642r678b673],
8	diagnosis	NN	O	diagnosis	nsubj	15	SENT_5	[p1l689t642r857b682],
9	and	CC	O	and	_	0	SENT_5	[p1l866t642r931b673],
10	initiation	NN	O	initiation	conj_and	8	SENT_5	[p1l942t643r1100b673],
11	of	IN	O	of	_	0	SENT_5	[p1l1110t642r1146b673],
12	therapy	NN	O	therapy	prep_of	8	SENT_5	[p1l1152t642r1291b682],
13	are	VBP	O	be	cop	15	SENT_5	[p1l1299t651r1353b673],
14	crucia	JJ	O	crucia	amod	15	SENT_5	[p1l1362t642r1557b673],
15	|	NN	O	|	rcmod	5	SENT_5	[p1l1362t642r1557b673],
16	.	.	O	.	_	0	SENT_5	[p1l1362t642r1557b673],

1	The	DT	O	the	det	3	SENT_6	[p1l1362t642r1557b673],
2	treatment	NN	O	treatment	nn	3	SENT_6	[p1l1565t647r1743b673],
3	aims	NNS	O	aim	nsubj	4	SENT_6	[p1l1752t643r1833b673],
4	are	VBP	O	be	_	0	SENT_6	[p1l1842t651r1897b673],
5	to	TO	O	to	aux	6	SENT_6	[p1l1905t647r1941b673],
6	stabilize	VB	O	stabilize	xcomp	4	SENT_6	[p1l1950t642r2095b673],
7	the	DT	O	the	det	8	SENT_6	[p1l20t696r78b727],
8	patient	NN	O	patient	dobj	6	SENT_6	[p1l88t697r222b734],
9	,	,	O	,	_	0	SENT_6	[p1l88t697r222b734],
10	improve	VB	O	improve	dep	6	SENT_6	[p1l232t697r378b734],
11	clinical	JJ	O	clinical	amod	12	SENT_6	[p1l387t696r507b727],
12	symptoms	NNS	O	symptom	dobj	10	SENT_6	[p1l517t700r711b735],
13	,	,	O	,	_	0	SENT_6	[p1l517t700r711b735],
14	and	CC	O	and	_	0	SENT_6	[p1l720t696r785b727],
15	increase	VBP	O	increase	dep	6	SENT_6	[p1l796t697r940b727],
16	long-term	JJ	O	long-term	amod	18	SENT_6	[p1l950t696r1125b735],
17	survival	NN	O	survival	nn	18	SENT_6	[p1l1135t696r1271b727],
18	rates	NNS	O	rate	dobj	15	SENT_6	[p1l1283t700r1376b727],
19	.	.	O	.	_	0	SENT_6	[p1l1283t700r1376b727],

1	Few	JJ	O	few	amod	2	SENT_7	[p1l1387t698r1455b727],
2	treatments	NNS	O	treatment	nsubjpass	5	SENT_7	[p1l1463t700r1658b727],
3	have	VBP	O	have	aux	5	SENT_7	[p1l1668t696r1751b727],
4	been	VBN	O	be	auxpass	5	SENT_7	[p1l1761t696r1846b727],
5	investigated	VBN	O	investigate	dep	13	SENT_7	[p1l1858t696r2074b735],
6	in	IN	O	in	_	0	SENT_7	[p1l2085t697r2115b726],
7	clinical	JJ	O	clinical	amod	10	SENT_7	[p1l20t749r140b780],
8	tria	NN	O	trium	nn	10	SENT_7	[p1l150t749r323b780],
9	|	CD	NUMBER	|	num	10	SENT_7	[p1l150t749r323b780],
10	s.	NN	O	s.	prep_in	5	SENT_7	[p1l150t749r323b780],
11	This	DT	O	this	det	12	SENT_7	[p1l150t749r323b780],
12	review	NN	O	review	nsubj	13	SENT_7	[p1l333t750r450b780],
13	summarizes	VBZ	O	summarize	_	0	SENT_7	[p1l458t750r669b780],
14	the	DT	O	the	det	15	SENT_7	[p1l677t749r735b780],
15	principles	NNS	O	principle	dobj	13	SENT_7	[p1l745t749r917b787],
16	of	IN	O	of	_	0	SENT_7	[p1l926t749r962b780],
17	pharmacologic	JJ	O	pharmacologic	amod	18	SENT_7	[p1l970t749r1234b788],
18	treatment	NN	O	treatment	prep_of	15	SENT_7	[p1l1242t753r1429b784],
19	,	,	O	,	_	0	SENT_7	[p1l1242t753r1429b784],
20	the	DT	O	the	det	23	SENT_7	[p1l1437t749r1495b780],
21	underlying	VBG	O	underlie	amod	23	SENT_7	[p1l1505t749r1697b788],
22	clinical	JJ	O	clinical	amod	23	SENT_7	[p1l1707t749r1827b780],
23	trials	NNS	O	trial	appos	15	SENT_7	[p1l1836t749r1932b784],
24	,	,	O	,	_	0	SENT_7	[p1l1836t749r1932b784],
25	and	CC	O	and	_	0	SENT_7	[p1l1941t749r2006b780],
26	new	JJ	O	new	amod	28	SENT_7	[p1l2018t758r2091b780],
27	pharmacologic	JJ	O	pharmacologic	amod	28	SENT_7	[p1l11t820r560b900],
28	targets	NNS	O	target	dobj	13	SENT_7	[p1l577t828r855b900],
29	.	.	O	.	_	0	SENT_7	[p1l577t828r855b900],

1	Acute	JJ	O	acute	amod	3	SENT_8	[p1l8t1036r211b1095],
2	heart	NN	O	heart	nn	3	SENT_8	[p1l237t1032r418b1095],
3	failure	NN	O	failure	nsubjpass	8	SENT_8	[p1l443t1032r665b1095],
4	(	CD	NUMBER	(	num	6	SENT_8	[p1l695t1033r920b1108],
5	AHF	NN	ORGANIZATION	ahf	nn	6	SENT_8	[p1l695t1033r920b1108],
6	)	NN	O	)	dep	3	SENT_8	[p1l695t1033r920b1108],
7	is	VBZ	O	be	auxpass	8	SENT_8	[p1l950t1038r1001b1095],
8	defined	VBN	O	define	_	0	SENT_8	[p1l1029t1032r1293b1095],
9	as	IN	O	as	_	0	SENT_8	[p1l1319t1055r1384b1095],
10	the	DT	O	the	det	12	SENT_8	[p1l1410t1032r1519b1095],
11	rapid	JJ	O	rapid	amod	12	SENT_8	[p1l1545t1032r1728b1115],
12	onset	NN	O	onset	prep_as	8	SENT_8	[p1l1753t1044r1939b1095],
13	of	IN	O	of	_	0	SENT_8	[p1l1965t1032r2048b1104],
14	,	,	O	,	_	0	SENT_8	[p1l1965t1032r2048b1104],
15	or	CC	O	or	dep	16	SENT_8	[p1l2077t1055r2150b1095],
16	changes	NNS	O	change	dep	12	SENT_8	[p1l9t1134r266b1219],
17	in	IN	O	in	prep	16	SENT_8	[p1l284t1141r364b1207],
18	,	,	O	,	_	0	SENT_8	[p1l284t1141r364b1207],
19	the	DT	O	the	det	20	SENT_8	[p1l382t1134r484b1198],
20	symptoms	NNS	O	symptom	appos	16	SENT_8	[p1l502t1146r839b1219],
21	and	CC	O	and	_	0	SENT_8	[p1l857t1134r979b1198],
22	signs	NNS	O	sign	appos	16	SENT_8	[p1l996t1141r1157b1219],
23	of	IN	O	of	_	0	SENT_8	[p1l1175t1134r1247b1198],
24	heart	NN	O	heart	nn	25	SENT_8	[p1l1253t1134r1423b1198],
25	failure	NN	O	failure	prep_of	20	SENT_8	[p1l1439t1134r1644b1198],
26	(	CD	NUMBER	(	num	27	SENT_8	[p1l1665t1126r1866b1211],
27	HF	NN	O	hf	dep	16	SENT_8	[p1l1665t1126r1866b1211],
28	)	CD	NUMBER	)	num	29	SENT_8	[p1l1665t1126r1866b1211],
29	.1	CD	NUMBER	.1	prep_of	12	SENT_8	[p1l1665t1126r1866b1211],
30	Because	IN	O	because	mark	50	SENT_8	[p1l1888t1140r2149b1198],
31	of	IN	O	of	_	0	SENT_8	[p1l9t1238r81b1301],
32	the	DT	O	the	det	35	SENT_8	[p1l88t1238r190b1301],
33	poor	JJ	O	poor	amod	35	SENT_8	[p1l207t1260r366b1321],
34	clinical	JJ	O	clinical	amod	35	SENT_8	[p1l383t1238r616b1301],
35	outcome	NN	O	outcome	prep_of	50	SENT_8	[p1l633t1250r918b1301],
36	and	CC	O	and	_	0	SENT_8	[p1l937t1238r1059b1301],
37	the	DT	O	the	det	40	SENT_8	[p1l1075t1238r1177b1301],
38	relevant	JJ	O	relevant	amod	40	SENT_8	[p1l1195t1238r1456b1301],
39	associated	VBN	O	associate	amod	40	SENT_8	[p1l1473t1238r1805b1301],
40	morbidity	NN	O	morbidity	conj_and	35	SENT_8	[p1l1821t1238r2153b1322],
41	and	CC	O	and	_	0	SENT_8	[p1l9t1341r130b1404],
42	mortality	NN	O	mortality	conj_and	35	SENT_8	[p1l145t1341r454b1425],
43	,	,	O	,	_	0	SENT_8	[p1l145t1341r454b1425],
44	it	PRP	O	it	nsubj	50	SENT_8	[p1l472t1347r516b1404],
45	remains	VBZ	O	remain	cop	50	SENT_8	[p1l531t1347r788b1404],
46	a	DT	O	a	det	50	SENT_8	[p1l806t1364r840b1404],
47	major	JJ	O	major	amod	50	SENT_8	[p1l855t1347r1047b1425],
48	public	JJ	O	public	amod	50	SENT_8	[p1l1062t1341r1262b1424],
49	health	NN	O	health	nn	50	SENT_8	[p1l1277t1341r1477b1404],
50	issue	NN	O	issue	advcl	8	SENT_8	[p1l1494t1347r1648b1404],
51	with	IN	O	with	_	0	SENT_8	[p1l1663t1341r1808b1404],
52	a	DT	O	a	det	55	SENT_8	[p1l1825t1364r1859b1404],
53	substantial	JJ	O	substantial	amod	55	SENT_8	[p1l1875t1341r2145b1404, p1l8t1444r112b1507],
54	socioeconomic	JJ	O	socioeconomic	amod	55	SENT_8	[p1l132t1450r633b1507],
55	burden	NN	O	burden	prep_with	50	SENT_8	[p1l651t1444r908b1507],
56	.	.	O	.	_	0	SENT_8	[p1l651t1444r908b1507],

1	AHF	NN	ORGANIZATION	ahf	nsubj	5	SENT_9	[p1l930t1448r1096b1506],
2	is	VBZ	O	be	cop	5	SENT_9	[p1l1117t1450r1166b1507],
3	a	DT	O	a	det	5	SENT_9	[p1l1187t1467r1222b1507],
4	life-threatening	JJ	O	life-threatening	amod	5	SENT_9	[p1l1240t1444r1756b1528],
5	situation	NN	O	situation	_	0	SENT_9	[p1l1775t1450r2063b1507],
6	in	IN	O	in	_	0	SENT_9	[p1l2083t1450r2148b1506],
7	which	WDT	O	which	rel	15	SENT_9	[p1l7t1547r213b1610],
8	diagnosis	NN	O	diagnosis	nsubj	18	SENT_9	[p1l234t1547r547b1631],
9	and	CC	O	and	_	0	SENT_9	[p1l568t1547r693b1610],
10	initiation	NN	O	initiation	conj_and	8	SENT_9	[p1l712t1553r1019b1610],
11	of	IN	O	of	_	0	SENT_9	[p1l1040t1547r1113b1610],
12	appropriate	JJ	O	appropriate	amod	13	SENT_9	[p1l1124t1553r1509b1630],
13	therapy	NN	O	therapy	prep_of	8	SENT_9	[p1l1528t1547r1785b1631],
14	are	VBP	O	be	cop	15	SENT_9	[p1l1802t1570r1901b1610],
15	crucial	JJ	O	crucial	rcmod	5	SENT_9	[p1l1922t1547r2148b1610],
16	and	CC	O	and	_	0	SENT_9	[p1l9t1650r136b1713],
17	often	RB	O	often	advmod	15	SENT_9	[p1l157t1650r329b1713],
18	have	VBP	O	have	rcmod	5	SENT_9	[p1l349t1650r504b1713],
19	to	TO	O	to	aux	21	SENT_9	[p1l524t1662r591b1713],
20	be	VB	O	be	auxpass	21	SENT_9	[p1l610t1650r691b1713],
21	carried	VBN	O	carry	xcomp	18	SENT_9	[p1l712t1650r953b1713],
22	out	RP	O	out	prt	21	SENT_9	[p1l973t1662r1084b1713],
23	in	IN	O	in	_	0	SENT_9	[p1l1104t1656r1170b1712],
24	parallel	NN	O	parallel	prep_in	21	SENT_9	[p1l1190t1650r1456b1733],
25	.	.	O	.	_	0	SENT_9	[p1l1190t1650r1456b1733],

1	Besides	IN	O	besides	_	0	SENT_10	[p1l1481t1650r1733b1713],
2	prompt	JJ	O	prompt	amod	3	SENT_10	[p1l1753t1662r2010b1733],
3	initiation	NN	O	initiation	prep_besides	10	SENT_10	[p1l2030t1656r2146b1712, p1l8t1759r226b1816],
4	of	IN	O	of	_	0	SENT_10	[p1l246t1753r320b1816],
5	therapy	NN	O	therapy	prep_of	3	SENT_10	[p1l329t1753r593b1837],
6	,	,	O	,	_	0	SENT_10	[p1l329t1753r593b1837],
7	emphasis	NN	O	emphasis	nsubjpass	10	SENT_10	[p1l615t1753r925b1836],
8	must	MD	O	must	aux	10	SENT_10	[p1l945t1765r1113b1816],
9	be	VB	O	be	auxpass	10	SENT_10	[p1l1130t1753r1209b1816],
10	placed	VBN	O	place	_	0	SENT_10	[p1l1228t1753r1446b1836],
11	on	IN	O	on	_	0	SENT_10	[p1l1466t1776r1551b1816],
12	assessment	NN	O	assessment	prep_on	10	SENT_10	[p1l1572t1765r1941b1816],
13	of	IN	O	of	_	0	SENT_10	[p1l1961t1753r2034b1816],
14	the	DT	O	the	det	17	SENT_10	[p1l2044t1753r2148b1816],
15	potential	JJ	O	potential	amod	17	SENT_10	[p1l7t1856r300b1939],
16	underlying	VBG	O	underlie	amod	17	SENT_10	[p1l317t1856r678b1940],
17	cause	NN	O	cause	prep_of	12	SENT_10	[p1l694t1879r871b1919],
18	of	IN	O	of	_	0	SENT_10	[p1l889t1856r961b1919],
19	AHF	NN	ORGANIZATION	ahf	prep_of	17	SENT_10	[p1l968t1860r1132b1918],
20	because	IN	O	because	mark	33	SENT_10	[p1l1149t1856r1406b1919],
21	correction	NN	O	correction	nsubj	33	SENT_10	[p1l1425t1862r1763b1919],
22	of	IN	O	of	_	0	SENT_10	[p1l1781t1856r1853b1919],
23	the	DT	O	the	det	25	SENT_10	[p1l1860t1856r1963b1919],
24	latter	JJ	O	latter	amod	25	SENT_10	[p1l1979t1856r2148b1919],
25	(	NN	O	(	prep_of	21	SENT_10	[p1l12t1959r161b2043],
26	e.g.	FW	O	e.g.	dep	25	SENT_10	[p1l12t1959r161b2043],
27	,	,	O	,	_	0	SENT_10	[p1l12t1959r161b2043],
28	acute	JJ	O	acute	amod	31	SENT_10	[p1l184t1971r355b2022],
29	coronary	JJ	O	coronary	amod	31	SENT_10	[p1l375t1982r676b2043],
30	syndrome	NN	O	syndrome	nn	31	SENT_10	[p1l693t1959r1048b2043],
31	)	NN	O	)	appos	25	SENT_10	[p1l693t1959r1048b2043],
32	might	MD	O	might	aux	33	SENT_10	[p1l1071t1959r1269b2043],
33	be	VB	O	be	advcl	10	SENT_10	[p1l1285t1959r1363b2022],
34	of	IN	O	of	_	0	SENT_10	[p1l1383t1959r1456b2022],
35	predominant	JJ	O	predominant	amod	36	SENT_10	[p1l1464t1959r1899b2042],
36	importance	NN	O	importance	prep_of	33	SENT_10	[p1l1918t1965r2146b2042, p1l8t2074r183b2125],
37	for	IN	O	for	_	0	SENT_10	[p1l200t2062r294b2125],
38	the	DT	O	the	det	39	SENT_10	[p1l310t2062r413b2125],
39	patient	NN	O	patient	poss	41	SENT_10	[p1l430t2062r696b2145],
40	’s	POS	O	’s	_	0	SENT_10	[p1l430t2062r696b2145],
41	outcome	NN	O	outcome	prep_for	36	SENT_10	[p1l714t2074r1016b2125],
42	.	.	O	.	_	0	SENT_10	[p1l714t2074r1016b2125],

1	The	DT	O	the	det	3	SENT_11	[p1l1037t2062r1160b2125],
2	main	JJ	O	main	amod	3	SENT_11	[p1l1178t2068r1348b2125],
3	principles	NNS	O	principle	nsubj	11	SENT_11	[p1l1364t2062r1688b2145],
4	of	IN	O	of	_	0	SENT_11	[p1l1707t2062r1779b2125],
5	pharmacological	JJ	O	pharmacological	amod	6	SENT_11	[p1l1786t2062r2148b2145, p1l7t2165r224b2249],
6	treatment	NN	O	treatment	prep_of	3	SENT_11	[p1l240t2177r564b2228],
7	of	IN	O	of	_	0	SENT_11	[p1l581t2165r653b2228],
8	AHF	NNP	ORGANIZATION	AHF	prep_of	6	SENT_11	[p1l661t2169r826b2227],
9	are	VBP	O	be	cop	11	SENT_11	[p1l845t2188r942b2228],
10	a	DT	O	a	det	11	SENT_11	[p1l962t2188r996b2228],
11	reduction	NN	O	reduction	_	0	SENT_11	[p1l1013t2165r1333b2228],
12	of	IN	O	of	_	0	SENT_11	[p1l1352t2165r1424b2228],
13	preload	NN	O	preload	prep_of	11	SENT_11	[p1l1431t2165r1683b2248],
14	and	CC	O	and	_	0	SENT_11	[p1l1700t2165r1823b2228],
15	afterload	NN	O	afterload	prep_of	11	SENT_11	[p1l1841t2165r2148b2237],
16	,	,	O	,	_	0	SENT_11	[p1l1841t2165r2148b2237],
17	an	DT	O	a	det	18	SENT_11	[p1l9t2291r86b2331],
18	increase	NN	O	increase	conj_and	11	SENT_11	[p1l103t2274r363b2331],
19	in	IN	O	in	_	0	SENT_11	[p1l379t2274r443b2330],
20	myocardial	JJ	O	myocardial	amod	21	SENT_11	[p1l459t2268r821b2352],
21	contractility	NN	O	contractility	prep_in	18	SENT_11	[p1l837t2268r1233b2352],
22	,	,	O	,	_	0	SENT_11	[p1l837t2268r1233b2352],
23	and	CC	O	and	_	0	SENT_11	[p1l1252t2268r1373b2331],
24	a	DT	O	a	det	25	SENT_11	[p1l1389t2291r1423b2331],
25	blockade	NN	O	blockade	conj_and	11	SENT_11	[p1l1436t2268r1726b2331],
26	of	IN	O	of	_	0	SENT_11	[p1l1743t2268r1813b2331],
27	neurohormonal	JJ	O	neurohormonal	amod	28	SENT_11	[p1l1821t2268r2146b2331, p1l8t2371r216b2434],
28	activation	NN	O	activation	prep_of	25	SENT_11	[p1l233t2377r562b2434],
29	.	.	O	.	_	0	SENT_11	[p1l233t2377r562b2434],

1	The	DT	O	the	det	2	SENT_12	[p1l582t2371r703b2434],
2	aims	NNS	O	aim	nsubj	7	SENT_12	[p1l721t2377r870b2434],
3	of	IN	O	of	_	0	SENT_12	[p1l888t2371r959b2434],
4	the	DT	O	the	det	6	SENT_12	[p1l965t2371r1066b2434],
5	treating	VBG	O	treat	amod	6	SENT_12	[p1l1081t2377r1332b2455],
6	physicians	NNS	O	physician	prep_of	2	SENT_12	[p1l1346t2371r1680b2455],
7	are	VBP	O	be	_	0	SENT_12	[p1l1698t2394r1793b2434],
8	to	TO	O	to	aux	9	SENT_12	[p1l1809t2383r1872b2434],
9	stabilize	VB	O	stabilize	xcomp	7	SENT_12	[p1l1891t2371r2147b2434],
10	the	DT	O	the	det	11	SENT_12	[p1l8t2474r111b2537],
11	patient	NN	O	patient	poss	14	SENT_12	[p1l130t2474r396b2557],
12	’s	POS	O	’s	_	0	SENT_12	[p1l130t2474r396b2557],
13	hemodynamic	JJ	O	hemodynamic	amod	14	SENT_12	[p1l415t2474r896b2558],
14	situation	NN	O	situation	dobj	9	SENT_12	[p1l917t2480r1219b2546],
15	;	:	O	;	_	0	SENT_12	[p1l917t2480r1219b2546],
16	improve	VB	O	improve	dep	9	SENT_12	[p1l1240t2480r1514b2557],
17	clinical	JJ	O	clinical	amod	18	SENT_12	[p1l1534t2474r1769b2537],
18	symptoms	NNS	O	symptom	dobj	16	SENT_12	[p1l1789t2486r2147b2558],
19	,	,	O	,	_	0	SENT_12	[p1l1789t2486r2147b2558],
20	particularly	RB	O	particularly	advmod	18	SENT_12	[p1l7t2577r389b2661],
21	dyspnea	NN	O	dyspnea	dep	18	SENT_12	[p1l403t2577r686b2661],
22	;	:	O	;	_	0	SENT_12	[p1l403t2577r686b2661],
23	and	CC	O	and	_	0	SENT_12	[p1l706t2577r828b2640],
24	increase	VB	O	increase	dep	9	SENT_12	[p1l844t2583r1109b2640],
25	the	DT	O	the	det	26	SENT_12	[p1l1125t2577r1227b2640],
26	likelihood	NN	O	likelihood	dobj	24	SENT_12	[p1l1243t2577r1576b2640],
27	of	IN	O	of	_	0	SENT_12	[p1l1592t2577r1664b2640],
28	long-term	JJ	O	long-term	amod	29	SENT_12	[p1l1670t2577r2001b2661],
29	survival	NN	O	survival	prep_of	26	SENT_12	[p1l2020t2600r2146b2640, p1l6t2680r174b2743],
30	.	.	O	.	_	0	SENT_12	[p1l2020t2600r2146b2640, p1l6t2680r174b2743],

1	Despite	IN	O	despite	_	0	SENT_13	[p1l194t2685r439b2763],
2	strong	JJ	O	strong	amod	3	SENT_13	[p1l457t2692r663b2764],
3	attempts	NNS	O	attempt	prep_despite	17	SENT_13	[p1l679t2692r972b2763],
4	,	,	O	,	_	0	SENT_13	[p1l679t2692r972b2763],
5	development	NN	O	development	appos	3	SENT_13	[p1l992t2680r1416b2763],
6	of	IN	O	of	_	0	SENT_13	[p1l1432t2680r1503b2743],
7	new	JJ	O	new	amod	9	SENT_13	[p1l1511t2703r1649b2743],
8	pharmacologic	JJ	O	pharmacologic	amod	9	SENT_13	[p1l1662t2680r2151b2764],
9	agents	NNS	O	agent	prep_of	5	SENT_13	[p1l9t2795r214b2867],
10	for	IN	O	for	_	0	SENT_13	[p1l234t2783r328b2846],
11	AHF	NN	ORGANIZATION	ahf	nn	12	SENT_13	[p1l344t2787r509b2845],
12	fulﬁlling	NN	O	fulﬁlling	prep_for	9	SENT_13	[p1l528t2783r810b2867],
13	these	DT	O	these	det	14	SENT_13	[p1l826t2783r995b2846],
14	prospects	NNS	O	prospects	nsubj	17	SENT_13	[p1l1013t2795r1327b2866],
15	remains	VBZ	O	remain	cop	17	SENT_13	[p1l1347t2789r1610b2846],
16	a	DT	O	a	det	17	SENT_13	[p1l1630t2806r1664b2846],
17	challenge	NN	O	challenge	_	0	SENT_13	[p1l1682t2783r2006b2867],
18	,	,	O	,	_	0	SENT_13	[p1l1682t2783r2006b2867],
19	and	CC	O	and	_	0	SENT_13	[p1l2027t2783r2150b2846],
20	only	RB	O	only	advmod	22	SENT_13	[p1l9t2886r160b2970],
21	little	JJ	O	little	amod	22	SENT_13	[p1l176t2886r327b2949],
22	progress	NN	O	progress	nsubjpass	25	SENT_13	[p1l347t2908r633b2970],
23	has	VBZ	O	have	aux	25	SENT_13	[p1l654t2886r767b2949],
24	been	VBN	O	be	auxpass	25	SENT_13	[p1l786t2886r951b2949],
25	made	VBN	O	make	conj_and	17	SENT_13	[p1l972t2886r1160b2949],
26	in	IN	O	in	_	0	SENT_13	[p1l1181t2892r1248b2948],
27	recent	JJ	DURATION	recent	amod	28	SENT_13	[p1l1270t2898r1480b2949],
28	decades	NNS	DURATION	decade	prep_in	25	SENT_13	[p1l1500t2886r1783b2949],
29	.	.	O	.	_	0	SENT_13	[p1l1500t2886r1783b2949],

1	Few	JJ	O	few	amod	2	SENT_14	[p1l1808t2891r1948b2949],
2	treatments	NNS	O	treatment	nsubjpass	6	SENT_14	[p1l1965t2898r2147b2949, p1l8t3001r206b3052],
3	have	VBP	O	have	aux	6	SENT_14	[p1l223t2989r372b3052],
4	been	VBN	O	be	auxpass	6	SENT_14	[p1l387t2989r545b3052],
5	adequately	RB	O	adequately	advmod	6	SENT_14	[p1l562t2989r913b3073],
6	investigated	VBN	O	investigate	_	0	SENT_14	[p1l926t2989r1313b3073],
7	in	IN	O	in	_	0	SENT_14	[p1l1329t2995r1393b3051],
8	prospective	JJ	O	prospective	amod	10	SENT_14	[p1l1409t2995r1782b3072],
9	clinical	JJ	O	clinical	amod	10	SENT_14	[p1l1800t2989r2031b3052],
10	trials	NNS	O	trial	prep_in	6	SENT_14	[p1l2046t2995r2147b3052, p1l9t3092r108b3164],
11	,	,	O	,	_	0	SENT_14	[p1l2046t2995r2147b3052, p1l9t3092r108b3164],
12	and	CC	O	and	_	0	SENT_14	[p1l127t3092r249b3155],
13	the	DT	O	the	det	14	SENT_14	[p1l263t3092r365b3155],
14	results	NNS	O	result	nsubj	34	SENT_14	[p1l382t3092r589b3155],
15	of	IN	O	of	_	0	SENT_14	[p1l607t3092r678b3155],
16	most	JJS	O	most	prep_of	14	SENT_14	[p1l685t3104r848b3155],
17	of	IN	O	of	_	0	SENT_14	[p1l864t3092r936b3155],
18	the	DT	O	the	prep_of	16	SENT_14	[p1l942t3092r1044b3155],
19	adequately	RB	O	adequately	advmod	20	SENT_14	[p1l1062t3092r1411b3176],
20	designed	VBN	O	design	dep	18	SENT_14	[p1l1425t3092r1713b3176],
21	and	CC	O	and	_	0	SENT_14	[p1l1730t3092r1852b3155],
22	powered	VBN	O	power	dep	18	SENT_14	[p1l1866t3092r2149b3175],
23	studies	NNS	O	study	dobj	22	SENT_14	[p1l9t3195r235b3258],
24	investigating	VBG	O	investigate	xcomp	22	SENT_14	[p1l253t3201r672b3279],
25	new	JJ	O	new	amod	26	SENT_14	[p1l688t3218r827b3258],
26	agents	NNS	O	agent	dobj	24	SENT_14	[p1l843t3207r1047b3279],
27	in	IN	O	in	_	0	SENT_14	[p1l1066t3201r1131b3257],
28	addition	NN	O	addition	prep_in	24	SENT_14	[p1l1149t3195r1425b3258],
29	to	TO	O	to	_	0	SENT_14	[p1l1442t3207r1506b3258],
30	standard	JJ	O	standard	amod	31	SENT_14	[p1l1526t3195r1813b3258],
31	treatment	NN	O	treatment	prep_to	24	SENT_14	[p1l1828t3207r2152b3258],
32	have	VBP	O	have	aux	34	SENT_14	[p1l8t3298r161b3361],
33	been	VBN	O	be	cop	34	SENT_14	[p1l180t3298r342b3361],
34	disappointing	JJ	O	disappointing	conj_and	6	SENT_14	[p1l363t3298r841b3382],
35	.	.	O	.	_	0	SENT_14	[p1l363t3298r841b3382],

1	This	DT	O	this	det	2	SENT_15	[p1l865t3298r1007b3361],
2	review	NN	O	review	nsubj	3	SENT_15	[p1l1028t3304r1252b3361],
3	summarizes	VBZ	O	summarize	_	0	SENT_15	[p1l1270t3304r1675b3361],
4	the	DT	O	the	det	5	SENT_15	[p1l1695t3298r1800b3361],
5	principles	NNS	O	principle	dobj	3	SENT_15	[p1l1820t3298r2150b3381],
6	of	IN	O	of	_	0	SENT_15	[p1l9t3401r81b3464],
7	current	JJ	DATE	current	amod	9	SENT_15	[p1l90t3413r333b3464],
8	pharmacologic	JJ	O	pharmacologic	amod	9	SENT_15	[p1l348t3401r844b3485],
9	treatment	NN	O	treatment	prep_of	5	SENT_15	[p1l860t3413r1199b3473],
10	,	,	O	,	_	0	SENT_15	[p1l860t3413r1199b3473],
11	the	DT	O	the	det	14	SENT_15	[p1l1217t3401r1321b3464],
12	underlying	VBG	O	underlie	amod	14	SENT_15	[p1l1338t3401r1701b3485],
13	clinical	JJ	O	clinical	amod	14	SENT_15	[p1l1718t3401r1952b3464],
14	trials	NNS	O	trial	prep_of	5	SENT_15	[p1l1968t3401r2148b3473],
15	,	,	O	,	_	0	SENT_15	[p1l1968t3401r2148b3473],
16	and	CC	O	and	_	0	SENT_15	[p1l9t3504r133b3567],
17	new	JJ	O	new	amod	19	SENT_15	[p1l149t3527r289b3567],
18	pharmacologic	JJ	O	pharmacologic	amod	19	SENT_15	[p1l302t3504r798b3588],
19	targets	NNS	O	target	prep_of	5	SENT_15	[p1l814t3516r1032b3588],
20	that	WDT	O	that	nsubjpass	23	SENT_15	[p1l1049t3504r1178b3567],
21	are	VBP	O	be	aux	23	SENT_15	[p1l1196t3527r1293b3567],
22	being	VBG	O	be	auxpass	23	SENT_15	[p1l1308t3504r1494b3588],
23	developed	VBN	O	develop	rcmod	19	SENT_15	[p1l1511t3504r1848b3587],
24	for	IN	O	for	_	0	SENT_15	[p1l1865t3504r1959b3567],
25	AHF	NN	O	ahf	prep_for	23	SENT_15	[p1l1975t3508r2146b3567],
26	.	.	O	.	_	0	SENT_15	[p1l1975t3508r2146b3567],

1	CURRENT	JJ	DATE	current	amod	2	SENT_16	[p1l9t3720r350b3775],
2	TREATMENT	NN	O	treatment	_	0	SENT_16	[p1l363t3720r801b3774],

1	General	NNP	O	General	nn	3	SENT_17	[p2l9t30r278b87],
2	aspects	NNS	O	aspect	nn	3	SENT_17	[p2l297t37r558b102],
3	AHF	NN	ORGANIZATION	ahf	nsubj	7	SENT_17	[p2l8t132r188b191],
4	remains	VBZ	O	remain	cop	7	SENT_17	[p2l228t135r533b192],
5	a	DT	O	a	det	7	SENT_17	[p2l573t151r608b192],
6	disease	NN	O	disease	nn	7	SENT_17	[p2l646t128r918b192],
7	entity	NN	O	entity	_	0	SENT_17	[p2l958t135r1181b213],
8	with	IN	O	with	_	0	SENT_17	[p2l1214t128r1383b192],
9	a	DT	O	a	det	11	SENT_17	[p2l1423t151r1458b192],
10	poor	JJ	O	poor	amod	11	SENT_17	[p2l1494t150r1676b212],
11	prognosis	NN	O	prognosis	prep_with	7	SENT_17	[p2l1711t135r2110b213],
12	.	.	O	.	_	0	SENT_17	[p2l1711t135r2110b213],

1	In-hospital	JJ	O	in-hospital	amod	2	SENT_18	[p2l9t232r460b315],
2	mortality	NN	O	mortality	nsubj	7	SENT_18	[p2l507t232r889b316],
3	of	IN	O	of	_	0	SENT_18	[p2l934t232r1016b295],
4	AHF	NN	ORGANIZATION	ahf	nn	5	SENT_18	[p2l1054t236r1238b294],
5	patients	NNS	O	patient	prep_of	2	SENT_18	[p2l1286t238r1607b315],
6	is	VBZ	O	be	cop	7	SENT_18	[p2l1657t238r1714b295],
7	~	NN	O	~	_	0	SENT_18	[p2l1766t237r1958b304],
8	4	CD	PERCENT	4	number	9	SENT_18	[p2l1766t237r1958b304],
9	%	NN	PERCENT	%	amod	7	SENT_18	[p2l1766t237r1958b304],
10	,	,	O	,	_	0	SENT_18	[p2l1766t237r1958b304],
11	and	CC	O	and	_	0	SENT_18	[p2l2008t232r2150b295],
12	rehospitalization	NN	O	rehospitalization	nsubj	15	SENT_18	[p2l10t335r605b418],
13	or	CC	O	or	_	0	SENT_18	[p2l631t358r705b398],
14	death	NN	O	death	conj_or	12	SENT_18	[p2l729t335r923b398],
15	occurs	VBZ	O	occur	conj_and	7	SENT_18	[p2l949t358r1178b398],
16	in	IN	O	in	_	0	SENT_18	[p2l1204t341r1272b397],
17	~	NN	O	~	prep_in	15	SENT_18	[p2l1300t340r1494b400],
18	40	CD	PERCENT	40	number	19	SENT_18	[p2l1300t340r1494b400],
19	%	NN	PERCENT	%	amod	17	SENT_18	[p2l1300t340r1494b400],
20	of	IN	O	of	_	0	SENT_18	[p2l1522t335r1597b398],
21	patients	NNS	O	patient	prep_of	17	SENT_18	[p2l1612t341r1890b418],
22	within	IN	O	within	_	0	SENT_18	[p2l1914t335r2144b398],
23	12	CD	DURATION	12	num	24	SENT_18	[p2l16t444r90b499],
24	months	NNS	NUMBER	month	prep_within	21	SENT_18	[p2l122t437r398b500],
25	after	IN	O	after	_	0	SENT_18	[p2l429t437r592b500],
26	discharge	NN	O	discharge	nn	27	SENT_18	[p2l621t429r1025b521],
27	.3	NN	NUMBER	.3	prep_after	15	SENT_18	[p2l621t429r1025b521],
28	Despite	IN	O	despite	_	0	SENT_18	[p2l1056t442r1332b520],
29	this	DT	O	this	prep_despite	7	SENT_18	[p2l1361t437r1517b509],
30	,	,	O	,	_	0	SENT_18	[p2l1361t437r1517b509],
31	evidence	NN	O	evidence	nsubj	39	SENT_18	[p2l1549t437r1870b500],
32	for	IN	O	for	_	0	SENT_18	[p2l1900t437r2004b500],
33	the	DT	O	the	det	34	SENT_18	[p2l2031t437r2145b500],
34	treatment	NN	O	treatment	prep_for	31	SENT_18	[p2l8t552r357b603],
35	of	IN	O	of	_	0	SENT_18	[p2l382t540r457b603],
36	AHF	NN	O	ahf	prep_of	34	SENT_18	[p2l472t544r643b602],
37	is	VBZ	O	be	aux	39	SENT_18	[p2l670t546r721b603],
38	largely	RB	O	largely	advmod	39	SENT_18	[p2l746t540r984b624],
39	lacking	VBG	O	lack	ccomp	7	SENT_18	[p2l1005t540r1280b624],
40	.	.	O	.	_	0	SENT_18	[p2l1005t540r1280b624],

1	This	DT	O	this	nsubj	4	SENT_19	[p2l1308t540r1454b603],
2	is	VBZ	O	be	cop	4	SENT_19	[p2l1481t546r1532b603],
3	partly	RB	O	partly	advmod	4	SENT_19	[p2l1557t540r1770b624],
4	due	JJ	O	due	_	0	SENT_19	[p2l1793t540r1918b603],
5	to	TO	O	to	_	0	SENT_19	[p2l1943t552r2010b603],
6	the	DT	O	the	det	8	SENT_19	[p2l2036t540r2146b603],
7	acute	JJ	O	acute	amod	8	SENT_19	[p2l10t655r192b706],
8	situation	NN	O	situation	prep_to	4	SENT_19	[p2l216t649r541b715],
9	,	,	O	,	_	0	SENT_19	[p2l216t649r541b715],
10	in	IN	O	in	_	0	SENT_19	[p2l565t649r633b705],
11	which	WDT	O	which	rel	18	SENT_19	[p2l654t643r867b706],
12	the	DT	O	the	det	13	SENT_19	[p2l889t643r997b706],
13	application	NN	O	application	nsubj	18	SENT_19	[p2l1021t643r1411b726],
14	of	IN	O	of	_	0	SENT_19	[p2l1434t643r1509b706],
15	standardized	JJ	O	standardized	amod	16	SENT_19	[p2l1524t643r1975b706],
16	procedures	NNS	O	procedure	prep_of	13	SENT_19	[p2l1996t665r2143b726, p2l10t746r270b809],
17	is	VBZ	O	be	cop	18	SENT_19	[p2l293t752r343b809],
18	difﬁcult	NN	O	difﬁcult	rcmod	8	SENT_19	[p2l367t746r650b809],
19	.	.	O	.	_	0	SENT_19	[p2l367t746r650b809],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_20	[p2l675t746r1138b818],
2	,	,	O	,	_	0	SENT_20	[p2l675t746r1138b818],
3	many	JJ	O	many	nsubj	13	SENT_20	[p2l1161t769r1354b830],
4	of	IN	O	of	_	0	SENT_20	[p2l1373t746r1447b809],
5	the	DT	O	the	det	6	SENT_20	[p2l1459t746r1565b809],
6	trials	NNS	O	trial	prep_of	3	SENT_20	[p2l1587t746r1760b809],
7	conducted	VBN	O	conduct	partmod	6	SENT_20	[p2l1783t746r2145b809],
8	in	IN	O	in	_	0	SENT_20	[p2l9t855r77b911],
9	patients	NNS	O	patient	prep_in	7	SENT_20	[p2l98t855r375b932],
10	with	IN	O	with	_	0	SENT_20	[p2l396t849r552b912],
11	AHF	NN	ORGANIZATION	ahf	prep_with	9	SENT_20	[p2l574t853r743b911],
12	have	VBP	O	have	aux	13	SENT_20	[p2l766t849r924b912],
13	remained	VBN	O	remain	_	0	SENT_20	[p2l947t849r1279b912],
14	neutral	JJ	O	neutral	acomp	13	SENT_20	[p2l1301t849r1552b912],
15	or	CC	O	or	_	0	SENT_20	[p2l1575t872r1647b912],
16	negative	JJ	O	negative	acomp	13	SENT_20	[p2l1669t855r1975b933],
17	.	.	O	.	_	0	SENT_20	[p2l1669t855r1975b933],

1	One	CD	NUMBER	one	num	2	SENT_21	[p2l2002t853r2147b912],
2	reason	NN	O	reason	nsubj	6	SENT_21	[p2l10t975r242b1015],
3	may	MD	O	may	aux	6	SENT_21	[p2l267t975r418b1036],
4	be	VB	O	be	cop	6	SENT_21	[p2l438t952r519b1015],
5	the	DT	O	the	det	6	SENT_21	[p2l543t952r653b1015],
6	difﬁculty	NN	O	difﬁculty	_	0	SENT_21	[p2l680t952r999b1036],
7	of	IN	O	of	_	0	SENT_21	[p2l1021t952r1096b1015],
8	selecting	VBG	O	select	prepc_of	6	SENT_21	[p2l1113t952r1425b1036],
9	an	DT	O	a	det	11	SENT_21	[p2l1450t975r1531b1015],
10	appropriate	JJ	O	appropriate	amod	11	SENT_21	[p2l1558t958r1967b1035],
11	subgroup	NN	O	subgroup	dobj	8	SENT_21	[p2l1994t952r2142b1015, p2l9t1077r217b1139],
12	of	IN	O	of	_	0	SENT_21	[p2l245t1055r321b1118],
13	patients	NNS	O	patient	prep_of	11	SENT_21	[p2l335t1061r618b1138],
14	because	IN	O	because	_	0	SENT_21	[p2l642t1055r921b1118],
15	of	IN	O	of	_	0	SENT_21	[p2l948t1055r1024b1118],
16	the	DT	O	the	det	18	SENT_21	[p2l1039t1055r1149b1118],
17	wide	JJ	O	wide	amod	18	SENT_21	[p2l1173t1055r1341b1118],
18	heterogeneity	NN	O	heterogeneity	prep_because_of	8	SENT_21	[p2l1367t1055r1858b1139],
19	of	IN	O	of	_	0	SENT_21	[p2l1881t1055r1957b1118],
20	AHF	NN	ORGANIZATION	ahf	nn	21	SENT_21	[p2l1972t1059r2144b1117],
21	syndromes	NNS	O	syndrome	prep_of	18	SENT_21	[p2l10t1158r430b1242],
22	.	.	O	.	_	0	SENT_21	[p2l10t1158r430b1242],

1	Another	DT	O	another	det	2	SENT_22	[p2l462t1158r772b1221],
2	challenge	NN	O	challenge	nsubj	4	SENT_22	[p2l801t1158r1147b1242],
3	is	VBZ	O	be	cop	4	SENT_22	[p2l1178t1164r1231b1221],
4	selection	NN	O	selection	_	0	SENT_22	[p2l1263t1158r1589b1221],
5	of	IN	O	of	_	0	SENT_22	[p2l1620t1158r1697b1221],
6	appropriate	JJ	O	appropriate	amod	8	SENT_22	[p2l1718t1164r2144b1241],
7	end	NN	O	end	nn	8	SENT_22	[p2l10t1261r139b1324],
8	points	NNS	O	point	prep_of	4	SENT_22	[p2l163t1267r402b1344],
9	.	.	O	.	_	0	SENT_22	[p2l163t1267r402b1344],

1	More	JJR	O	more	nsubj	16	SENT_23	[p2l430t1266r617b1324],
2	than	IN	O	than	prep	1	SENT_23	[p2l642t1261r801b1324],
3	in	IN	O	in	pcomp	2	SENT_23	[p2l827t1267r895b1323],
4	other	JJ	O	other	amod	6	SENT_23	[p2l921t1261r1109b1324],
5	disease	NN	O	disease	nn	6	SENT_23	[p2l1134t1261r1384b1324],
6	entities	NNS	O	entity	pobj	3	SENT_23	[p2l1410t1267r1686b1333],
7	,	,	O	,	_	0	SENT_23	[p2l1410t1267r1686b1333],
8	an	DT	O	a	det	9	SENT_23	[p2l1714t1284r1796b1324],
9	improvement	NN	O	improvement	appos	6	SENT_23	[p2l1821t1267r2143b1344, p2l9t1376r189b1427],
10	of	IN	O	of	_	0	SENT_23	[p2l211t1364r286b1427],
11	surrogate	JJ	O	surrogate	amod	12	SENT_23	[p2l300t1376r628b1448],
12	markers	NNS	O	marker	prep_of	9	SENT_23	[p2l651t1364r935b1427],
13	does	VBZ	O	do	aux	16	SENT_23	[p2l960t1364r1116b1427],
14	not	RB	O	not	neg	16	SENT_23	[p2l1140t1376r1256b1427],
15	necessarily	RB	O	necessarily	advmod	16	SENT_23	[p2l1278t1364r1664b1448],
16	translate	VB	O	translate	_	0	SENT_23	[p2l1682t1364r1983b1427],
17	into	IN	O	into	_	0	SENT_23	[p2l2006t1370r2143b1427],
18	a	DT	O	a	det	20	SENT_23	[p2l10t1490r45b1530],
19	clinical	JJ	O	clinical	amod	20	SENT_23	[p2l70t1467r329b1530],
20	beneﬁt	NN	O	beneﬁt	prep_into	16	SENT_23	[p2l353t1467r617b1530],
21	.	.	O	.	_	0	SENT_23	[p2l353t1467r617b1530],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_24	[p2l647t1467r1129b1539],
2	,	,	O	,	_	0	SENT_24	[p2l647t1467r1129b1539],
3	it	PRP	O	it	nsubj	6	SENT_24	[p2l1157t1473r1205b1530],
4	might	MD	O	might	aux	6	SENT_24	[p2l1229t1467r1442b1551],
5	seem	VB	O	seem	cop	6	SENT_24	[p2l1468t1490r1647b1530],
6	unrealistic	JJ	O	unrealistic	_	0	SENT_24	[p2l1672t1467r2052b1530],
7	to	TO	O	to	aux	8	SENT_24	[p2l2077t1479r2145b1530],
8	expect	VB	O	expect	xcomp	6	SENT_24	[p2l10t1582r243b1653],
9	a	DT	O	a	det	10	SENT_24	[p2l268t1593r303b1633],
10	drug	NN	O	drug	dobj	8	SENT_24	[p2l329t1570r498b1654],
11	that	WDT	O	that	nsubjpass	13	SENT_24	[p2l522t1570r662b1633],
12	is	VBZ	O	be	auxpass	13	SENT_24	[p2l687t1576r740b1633],
13	administered	VBN	O	administer	rcmod	10	SENT_24	[p2l767t1570r1244b1633],
14	only	RB	O	only	advmod	13	SENT_24	[p2l1270t1570r1428b1654],
15	over	IN	O	over	_	0	SENT_24	[p2l1451t1593r1606b1633],
16	a	DT	DURATION	a	det	18	SENT_24	[p2l1631t1593r1666b1633],
17	few	JJ	DURATION	few	amod	18	SENT_24	[p2l1691t1570r1817b1633],
18	hours	NNS	DURATION	hour	prep_over	13	SENT_24	[p2l1839t1570r2043b1633],
19	or	CC	O	or	_	0	SENT_24	[p2l2071t1593r2145b1633],
20	days	NNS	DURATION	day	conj_or	18	SENT_24	[p2l10t1673r162b1757],
21	to	TO	O	to	aux	22	SENT_24	[p2l185t1685r253b1736],
22	reduce	VB	O	reduce	xcomp	13	SENT_24	[p2l278t1673r512b1736],
23	hard	JJ	O	hard	amod	26	SENT_24	[p2l535t1673r697b1736],
24	clinical	JJ	O	clinical	amod	26	SENT_24	[p2l720t1673r974b1736],
25	end	NN	O	end	nn	26	SENT_24	[p2l997t1673r1126b1736],
26	points	NNS	O	point	dobj	22	SENT_24	[p2l1147t1679r1385b1756],
27	.	.	O	.	_	0	SENT_24	[p2l1147t1679r1385b1756],

1	Another	DT	O	another	det	3	SENT_25	[p2l1411t1673r1708b1736],
2	major	JJ	O	major	amod	3	SENT_25	[p2l1730t1679r1937b1757],
3	point	NN	O	point	nsubj	7	SENT_25	[p2l1959t1679r2147b1756],
4	might	MD	O	might	aux	7	SENT_25	[p2l9t1776r217b1860],
5	be	VB	O	be	cop	7	SENT_25	[p2l236t1776r317b1839],
6	the	DT	O	the	det	7	SENT_25	[p2l339t1776r447b1839],
7	drugs	NNS	O	drug	_	0	SENT_25	[p2l471t1776r667b1860],
8	themselves	PRP	O	themselves	dep	7	SENT_25	[p2l689t1776r1091b1839],
9	:	:	O	:	_	0	SENT_25	[p2l689t1776r1091b1839],
10	an	DT	O	a	det	13	SENT_25	[p2l1118t1799r1199b1839],
11	ideal	JJ	O	ideal	amod	13	SENT_25	[p2l1222t1776r1389b1839],
12	pharmacologic	JJ	O	pharmacologic	amod	13	SENT_25	[p2l1410t1776r1936b1860],
13	agent	NN	O	agent	nsubj	14	SENT_25	[p2l1960t1788r2146b1860],
14	reduces	VBZ	O	reduce	parataxis	7	SENT_25	[p2l10t1879r274b1942],
15	preload	NN	O	preload	dobj	14	SENT_25	[p2l296t1879r579b1962],
16	,	,	O	,	_	0	SENT_25	[p2l296t1879r579b1962],
17	leading	VBG	O	lead	partmod	14	SENT_25	[p2l603t1879r861b1963],
18	to	TO	O	to	_	0	SENT_25	[p2l881t1891r947b1942],
19	venous	JJ	O	venous	amod	20	SENT_25	[p2l969t1902r1215b1942],
20	dilation	NN	O	dilation	prep_to	17	SENT_25	[p2l1239t1879r1510b1942],
21	and	CC	O	and	_	0	SENT_25	[p2l1533t1879r1661b1942],
22	decongestion	NN	O	decongestion	conj_and	20	SENT_25	[p2l1684t1879r2147b1963],
23	without	IN	O	without	_	0	SENT_25	[p2l8t1982r293b2045],
24	having	VBG	O	have	prepc_without	17	SENT_25	[p2l319t1982r566b2066],
25	a	DT	O	a	det	27	SENT_25	[p2l593t2005r628b2045],
26	major	JJ	O	major	amod	27	SENT_25	[p2l655t1988r869b2066],
27	impact	NN	O	impact	dobj	24	SENT_25	[p2l896t1988r1148b2065],
28	on	IN	O	on	_	0	SENT_25	[p2l1175t2005r1264b2045],
29	the	DT	O	the	det	32	SENT_25	[p2l1292t1982r1404b2045],
30	arterial	JJ	O	arterial	amod	32	SENT_25	[p2l1433t1982r1698b2045],
31	blood	NN	O	blood	nn	32	SENT_25	[p2l1723t1982r1935b2045],
32	pressure	NN	O	pressure	prep_on	27	SENT_25	[p2l1961t2004r2142b2065, p2l10t2108r173b2157],
33	,	,	O	,	_	0	SENT_25	[p2l1961t2004r2142b2065, p2l10t2108r173b2157],
34	thus	RB	O	thus	advmod	24	SENT_25	[p2l198t2085r347b2148],
35	maintaining	VBG	O	maintain	dep	24	SENT_25	[p2l371t2091r804b2169],
36	cardiac	JJ	O	cardiac	amod	37	SENT_25	[p2l827t2085r1080b2148],
37	output	NN	O	output	dobj	35	SENT_25	[p2l1104t2097r1336b2168],
38	and	CC	O	and	_	0	SENT_25	[p2l1360t2085r1489b2148],
39	vital-organ	JJ	O	vital-organ	amod	40	SENT_25	[p2l1509t2085r1901b2169],
40	perfusion	NN	O	perfusion	dobj	35	SENT_25	[p2l1923t2085r2143b2168, p2l10t2194r178b2251],
41	.	.	O	.	_	0	SENT_25	[p2l1923t2085r2143b2168, p2l10t2194r178b2251],

1	These	DT	O	these	det	2	SENT_26	[p2l209t2188r413b2251],
2	expectations	NNS	O	expectation	nsubjpass	4	SENT_26	[p2l441t2194r899b2271],
3	are	VBP	O	be	auxpass	4	SENT_26	[p2l927t2211r1033b2251],
4	diﬂicult	VBN	O	diﬂicult	_	0	SENT_26	[p2l1062t2188r1344b2251],
5	to	TO	O	to	_	0	SENT_26	[p2l1369t2200r1438b2251],
6	fulﬁll	NN	O	fulﬁll	prep_to	4	SENT_26	[p2l1467t2188r1680b2251],
7	.	.	O	.	_	0	SENT_26	[p2l1467t2188r1680b2251],

1	Beyond	IN	O	beyond	_	0	SENT_27	[p2l1711t2188r1987b2272],
2	this	DT	O	this	det	3	SENT_27	[p2l2013t2188r2145b2251],
3	background	NN	O	background	prep_beyond	13	SENT_27	[p2l7t2291r458b2375],
4	,	,	O	,	_	0	SENT_27	[p2l7t2291r458b2375],
5	guideline	NN	O	guideline	nn	6	SENT_27	[p2l485t2291r817b2375],
6	recommendations	NNS	O	recommendation	nsubj	13	SENT_27	[p2l843t2291r1493b2354],
7	in	IN	O	in	_	0	SENT_27	[p2l1520t2297r1588b2353],
8	AHF	NNP	O	AHF	prep_in	6	SENT_27	[p2l1613t2295r1786b2353],
9	are	VBP	O	be	cop	13	SENT_27	[p2l1813t2314r1917b2354],
10	much	JJ	O	much	advmod	13	SENT_27	[p2l1943t2291r2144b2354],
11	less	JJR	O	less	amod	13	SENT_27	[p2l8t2394r134b2457],
12	evidence	NN	O	evidence	nn	13	SENT_27	[p2l161t2394r720b2457],
13	—	NN	O	—	_	0	SENT_27	[p2l161t2394r720b2457],
14	based	VBN	O	base	prep	13	SENT_27	[p2l161t2394r720b2457],
15	than	IN	O	than	pcomp	14	SENT_27	[p2l745t2394r907b2457],
16	those	DT	O	those	pobj	15	SENT_27	[p2l932t2394r1125b2457],
17	in	IN	O	in	_	0	SENT_27	[p2l1152t2400r1221b2457],
18	chronic	JJ	O	chronic	amod	22	SENT_27	[p2l1248t2394r1521b2457],
19	HF	NN	O	hf	nn	22	SENT_27	[p2l1548t2399r1658b2457],
20	(	NN	O	(	nn	22	SENT_27	[p2l1689t2395r1941b2471],
21	CHF	NN	O	chf	nn	22	SENT_27	[p2l1689t2395r1941b2471],
22	)	NN	O	)	prep_in	16	SENT_27	[p2l1689t2395r1941b2471],
23	;	:	O	;	_	0	SENT_27	[p2l1689t2395r1941b2471],
24	most	RBS	O	most	advmod	25	SENT_27	[p2l1969t2406r2147b2457],
25	recommendations	NNS	O	recommendation	nsubj	26	SENT_27	[p2l10t2496r657b2560],
26	refer	VBP	O	refer	parataxis	13	SENT_27	[p2l684t2496r849b2560],
27	to	TO	O	to	_	0	SENT_27	[p2l872t2508r940b2560],
28	smaller	JJR	O	smaller	prep_to	26	SENT_27	[p2l968t2496r1242b2568],
29	,	,	O	,	_	0	SENT_27	[p2l968t2496r1242b2568],
30	nonrandomized	JJ	O	nonrandomized	amod	31	SENT_27	[p2l1269t2496r1844b2560],
31	trials	NNS	O	trial	conj_or	28	SENT_27	[p2l1867t2496r2047b2560],
32	or	CC	O	or	_	0	SENT_27	[p2l2074t2519r2148b2560],
33	expert	NN	O	expert	nn	34	SENT_27	[p2l10t2612r236b2683],
34	consensus	NN	O	consensus	conj_or	28	SENT_27	[p2l260t2623r640b2663],
35	.	.	O	.	_	0	SENT_27	[p2l260t2623r640b2663],

1	Recommendations	NNS	O	recommendation	nsubj	5	SENT_28	[p2l669t2600r1339b2663],
2	on	IN	O	on	_	0	SENT_28	[p2l1366t2623r1454b2663],
3	general	JJ	O	general	amod	4	SENT_28	[p2l1480t2600r1740b2684],
4	treatments	NNS	O	treatment	prep_on	1	SENT_28	[p2l1764t2612r2146b2663],
5	have	VBP	O	have	_	0	SENT_28	[p2l8t2703r166b2766],
6	stronger	JJR	O	stronger	amod	7	SENT_28	[p2l190t2715r479b2787],
7	impact	NN	O	impact	dobj	5	SENT_28	[p2l500t2709r740b2786],
8	than	IN	O	than	_	0	SENT_28	[p2l761t2703r918b2766],
9	speciﬁc	JJ	O	speciﬁc	amod	10	SENT_28	[p2l941t2703r1198b2786],
10	therapies	NNS	O	therapy	prep_than	5	SENT_28	[p2l1220t2703r1555b2786],
11	.	.	O	.	_	0	SENT_28	[p2l1220t2703r1555b2786],

1	There	EX	O	there	expl	2	SENT_29	[p2l1581t2703r1775b2766],
2	is	VBZ	O	be	_	0	SENT_29	[p2l1798t2709r1849b2766],
3	no	DT	O	no	det	5	SENT_29	[p2l1872t2726r1958b2766],
4	clear	JJ	O	clear	amod	5	SENT_29	[p2l1983t2703r2147b2766],
5	class	NN	O	class	nsubj	2	SENT_29	[p2l10t2805r169b2869],
6	I	CD	NUMBER	i	num	7	SENT_29	[p2l195t2810r218b2868],
7	recommendation	NN	O	recommendation	npadvmod	8	SENT_29	[p2l245t2805r853b2869],
8	other	JJ	O	other	advmod	5	SENT_29	[p2l878t2805r1065b2869],
9	than	IN	O	than	_	0	SENT_29	[p2l1087t2805r1246b2869],
10	treatment	NN	O	treatment	prep_than	8	SENT_29	[p2l1269t2817r1615b2869],
11	with	IN	O	with	_	0	SENT_29	[p2l1637t2805r1794b2869],
12	diuretics	NNS	O	diuretic	prep_with	5	SENT_29	[p2l1819t2805r2144b2877],
13	,	,	O	,	_	0	SENT_29	[p2l1819t2805r2144b2877],

1	application	NN	O	application	_	0	SENT_30	[p2l10t2909r401b2992],
2	of	IN	O	of	_	0	SENT_30	[p2l424t2909r499b2972],
3	oxygen	NN	O	oxygen	prep_of	1	SENT_30	[p2l513t2932r761b2993],
4	in	IN	O	in	_	0	SENT_30	[p2l784t2915r851b2971],
5	hypoxic	JJ	O	hypoxic	amod	6	SENT_30	[p2l874t2909r1151b2993],
6	patients	NNS	O	patient	prep_in	3	SENT_30	[p2l1172t2915r1469b2992],
7	,	,	O	,	_	0	SENT_30	[p2l1172t2915r1469b2992],
8	and	CC	O	and	_	0	SENT_30	[p2l1495t2909r1623b2972],
9	prophylaxis	NN	O	prophylaxis	prep_of	1	SENT_30	[p2l1643t2909r2054b2993],
10	of	IN	O	of	_	0	SENT_30	[p2l2079t2909r2153b2972],
11	thromboembolism	NN	O	thromboembolism	prep_of	9	SENT_30	[p2l8t3011r678b3074],
12	.	.	O	.	_	0	SENT_30	[p2l8t3011r678b3074],

1	The	DT	O	the	det	3	SENT_31	[p2l703t3011r828b3074],
2	recommended	VBN	O	recommend	amod	3	SENT_31	[p2l851t3011r1353b3074],
3	interventions	NNS	O	intervention	_	0	SENT_31	[p2l1374t3017r1835b3074],
4	for	IN	O	for	_	0	SENT_31	[p2l1858t3011r1957b3074],
5	AHF	NN	O	ahf	prep_for	3	SENT_31	[p2l1977t3015r2145b3073],

1	comprise	VBP	O	comprise	_	0	SENT_32	[p2l10t3120r336b3197],
2	application	NN	O	application	dobj	1	SENT_32	[p2l363t3114r761b3197],
3	of	IN	O	of	_	0	SENT_32	[p2l787t3114r863b3177],
4	oxygen	NN	O	oxygen	prep_of	2	SENT_32	[p2l880t3137r1152b3198],
5	,	,	O	,	_	0	SENT_32	[p2l880t3137r1152b3198],
6	diuretics	NNS	O	diuretic	conj_and	4	SENT_32	[p2l1180t3114r1510b3186],
7	,	,	O	,	_	0	SENT_32	[p2l1180t3114r1510b3186],
8	and	CC	O	and	_	0	SENT_32	[p2l1538t3114r1668b3177],
9	vasodilators	NNS	O	vasodilator	prep_of	2	SENT_32	[p2l1690t3114r2143b3177],
10	.	.	O	.	_	0	SENT_32	[p2l1690t3114r2143b3177],

1	The	DT	O	the	det	2	SENT_33	[p2l9t3217r139b3280],
2	use	NN	O	use	nsubj	10	SENT_33	[p2l168t3240r285b3280],
3	of	IN	O	of	_	0	SENT_33	[p2l315t3217r392b3280],
4	opiates	NNS	O	opiate	prep_of	2	SENT_33	[p2l412t3223r666b3300],
5	and	CC	O	and	_	0	SENT_33	[p2l697t3217r830b3280],
6	positive	JJ	O	positive	amod	7	SENT_33	[p2l856t3223r1144b3300],
7	inotropes	NNS	O	inotrope	prep_of	2	SENT_33	[p2l1173t3223r1522b3300],
8	is	VBZ	O	be	cop	10	SENT_33	[p2l1551t3223r1604b3280],
9	less	RBR	O	less	advmod	10	SENT_33	[p2l1633t3217r1760b3280],
10	evidencebased	JJ	O	evidencebased	_	0	SENT_33	[p2l1790t3217r2141b3280, p2l7t3319r209b3382],
11	and	CC	O	and	_	0	SENT_33	[p2l233t3319r361b3382],
12	in	IN	O	in	conj_and	10	SENT_33	[p2l385t3325r453b3381],
13	the	DT	O	the	det	15	SENT_33	[p2l476t3319r585b3382],
14	latter	JJ	O	latter	amod	15	SENT_33	[p2l608t3319r792b3382],
15	case	NN	O	case	pobj	12	SENT_33	[p2l815t3342r958b3382],
16	affected	VBN	O	affect	partmod	15	SENT_33	[p2l984t3319r1255b3382],
17	by	IN	O	by	_	0	SENT_33	[p2l1277t3319r1362b3403],
18	safety	NN	O	safety	nn	19	SENT_33	[p2l1384t3319r1586b3403],
19	issues	NNS	O	issue	agent	16	SENT_33	[p2l1607t3311r1859b3382],
20	.1	CD	NUMBER	.1	tmod	16	SENT_33	[p2l1607t3311r1859b3382],

1	‘	NN	O	‘	nn	4	SENT_34	[p2l21t3489r295b3516],
2	Universitétsk	NN	O	universitétsk	nn	4	SENT_34	[p2l21t3489r295b3516],
3	|	NN	O	|	nn	4	SENT_34	[p2l21t3489r295b3516],
4	inikum	NN	O	inikum	_	0	SENT_34	[p2l21t3489r295b3516],
5	des	FW	PERSON	des	nn	6	SENT_34	[p2l303t3492r347b3516],
6	Saarlandes	FW	PERSON	saarlandes	dep	4	SENT_34	[p2l354t3492r500b3519],
7	,	,	O	,	_	0	SENT_34	[p2l354t3492r500b3519],
8	Klinik	NNP	O	Klinik	nn	12	SENT_34	[p2l508t3492r577b3516],
9	fur	NN	O	fur	nn	12	SENT_34	[p2l583t3492r619b3516],
10	Innere	NNP	PERSON	Innere	nn	12	SENT_34	[p2l627t3494r707b3516],
11	Medizin	NNP	PERSON	Medizin	nn	12	SENT_34	[p2l715t3492r815b3516],
12	III	NNP	PERSON	III	appos	6	SENT_34	[p2l825t3494r851b3519],
13	,	,	O	,	_	0	SENT_34	[p2l825t3494r851b3519],
14	Kardiologie	NNP	PERSON	Kardiologie	appos	6	SENT_34	[p2l859t3492r1011b3522],
15	,	,	O	,	_	0	SENT_34	[p2l859t3492r1011b3522],
16	Angiologie	NNP	PERSON	Angiologie	nn	19	SENT_34	[p2l1018t3492r1160b3522],
17	und	NN	O	und	nn	19	SENT_34	[p2l1168t3492r1216b3516],
18	lnternistische	NN	O	lnternistische	nn	19	SENT_34	[p2l1225t3493r1398b3516],
19	lntensivmedizin	NN	O	lntensivmedizin	appos	6	SENT_34	[p2l1406t3492r1617b3519],
20	,	,	O	,	_	0	SENT_34	[p2l1406t3492r1617b3519],
21	Homburg/Saar	NN	O	homburg/saar	appos	6	SENT_34	[p2l1625t3492r1820b3522],
22	,	,	O	,	_	0	SENT_34	[p2l1625t3492r1820b3522],
23	Germany	NNP	LOCATION	Germany	appos	6	SENT_34	[p2l1827t3493r1949b3522],
24	.	.	O	.	_	0	SENT_34	[p2l1827t3493r1949b3522],

1	Correspondence	NN	O	correspondence	_	0	SENT_35	[p2l20t3530r256b3559],
2	:	:	O	:	_	0	SENT_35	[p2l20t3530r256b3559],
3	J	NNP	PERSON	J	nn	4	SENT_35	[p2l20t3530r256b3559],
4	Poss	NNP	PERSON	Poss	dep	1	SENT_35	[p2l266t3531r320b3553],
5	(	CD	NUMBER	(	num	6	SENT_35	[p2l328t3530r615b3559],
6	Janine.poess@uks.eu	NN	O	janine.poess@uks.eu	dep	4	SENT_35	[p2l328t3530r615b3559],
7	)	CD	NUMBER	)	dep	4	SENT_35	[p2l328t3530r615b3559],
8	Received	VBN	O	receive	dep	4	SENT_35	[p2l21t3571r130b3594],
9	3	CD	DATE	3	dobj	8	SENT_35	[p2l139t3573r151b3594],
10	June	NNP	DATE	June	tmod	9	SENT_35	[p2l158t3572r216b3594],
11	201	CD	NUMBER	201	num	10	SENT_35	[p2l224t3573r262b3594],
12	3	CD	NUMBER	3	dep	9	SENT_35	[p2l270t3573r288b3598],
13	;	:	O	;	_	0	SENT_35	[p2l270t3573r288b3598],
14	accepted	VBN	O	accept	dep	8	SENT_35	[p2l296t3571r409b3600],
15	7	CD	DATE	7	dobj	14	SENT_35	[p2l418t3573r430b3594],
16	July	NNP	DATE	July	tmod	14	SENT_35	[p2l437t3571r484b3601],
17	201	CD	NUMBER	201	num	16	SENT_35	[p2l491t3573r530b3594],
18	3	CD	NUMBER	3	dobj	8	SENT_35	[p2l537t3573r556b3598],
19	;	:	O	;	_	0	SENT_35	[p2l537t3573r556b3598],
20	advance	NN	O	advance	dep	1	SENT_35	[p2l563t3571r666b3594],
21	online	NN	O	online	prep	20	SENT_35	[p2l674t3571r750b3594],
22	publication	NN	O	publication	dep	21	SENT_35	[p2l759t3571r897b3600],
23	11	CD	DATE	11	num	22	SENT_35	[p2l908t3573r929b3594],
24	September	NNP	DATE	September	dep	20	SENT_35	[p2l941t3571r1079b3600],
25	201	CD	NUMBER	201	number	26	SENT_35	[p2l1086t3573r1124b3594],
26	3	CD	NUMBER	3	dep	24	SENT_35	[p2l1132t3573r1150b3594],
27	.	.	O	.	_	0	SENT_35	[p2l1132t3573r1150b3594],

1	doi	FW	O	doi	nn	2	SENT_36	[p2l1158t3571r1211b3594],
2	:1	FW	O	:1	dep	11	SENT_36	[p2l1158t3571r1211b3594],
3	0.1	CD	NUMBER	0.1	num	4	SENT_36	[p2l1219t3573r1247b3594],
4	O38/c	NN	O	o38/c	dep	2	SENT_36	[p2l1254t3571r1402b3600],
5	|	CD	NUMBER	|	num	6	SENT_36	[p2l1254t3571r1402b3600],
6	pt	NN	O	pt	dep	11	SENT_36	[p2l1254t3571r1402b3600],
7	.201	CD	NUMBER	.201	num	11	SENT_36	[p2l1254t3571r1402b3600],
8	3.1	CD	NUMBER	3.1	num	11	SENT_36	[p2l1410t3573r1438b3594],
9	36	CD	NUMBER	36	num	11	SENT_36	[p2l1446t3573r1474b3594],
10	CLINICAL	NNP	O	CLINICAL	nn	11	SENT_36	[p2l20t3614r140b3635],
11	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	19	SENT_36	[p2l149t3614r373b3635],
12	&	CC	O	&	_	0	SENT_36	[p2l380t3614r600b3635],
13	THERAPEUT	NNP	O	THERAPEUT	conj_and	11	SENT_36	[p2l380t3614r600b3635],
14	|	CD	NUMBER	|	num	17	SENT_36	[p2l380t3614r600b3635],
15	CS	NNP	O	CS	nn	17	SENT_36	[p2l380t3614r600b3635],
16	[	CD	NUMBER	[	num	17	SENT_36	[p2l610t3612r728b3642],
17	VOLUME	NNP	O	VOLUME	dep	11	SENT_36	[p2l610t3612r728b3642],
18	94	CD	NUMBER	94	num	19	SENT_36	[p2l736t3614r765b3635],
19	NUMBER	NN	O	number	dep	24	SENT_36	[p2l774t3614r881b3635],
20	4	CD	NUMBER	4	number	21	SENT_36	[p2l889t3612r914b3642],
21	|	CD	NUMBER	|	dep	19	SENT_36	[p2l889t3612r914b3642],
22	OCTOBER	NNP	DATE	OCTOBER	dep	21	SENT_36	[p2l924t3614r1043b3635],
23	2013	CD	DATE	2013	num	24	SENT_36	[p2l1052t3614r1109b3635],
24	499	CD	NUMBER	499	_	0	SENT_36	[p2l2092t3614r2139b3635],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_37	[p2l19t3717r209b3754],

1	Monitoring	VBG	O	monitor	partmod	15	SENT_38	[p3l10t131r399b204],
2	Because	IN	O	because	mark	7	SENT_38	[p3l9t233r284b291],
3	AHF	NN	ORGANIZATION	ahf	nsubj	7	SENT_38	[p3l305t232r474b290],
4	is	VBZ	O	be	cop	7	SENT_38	[p3l498t234r548b291],
5	a	DT	O	a	det	7	SENT_38	[p3l572t251r606b291],
6	life-threatening	JJ	O	life-threatening	amod	7	SENT_38	[p3l626t228r1163b312],
7	condition	NN	O	condition	advcl	1	SENT_38	[p3l1184t228r1533b300],
8	,	,	O	,	_	0	SENT_38	[p3l1184t228r1533b300],
9	close	JJ	O	close	amod	10	SENT_38	[p3l1558t228r1725b291],
10	monitoring	NN	O	monitoring	nsubjpass	21	SENT_38	[p3l1748t234r2143b312],
11	of	IN	O	of	_	0	SENT_38	[p3l9t331r82b394],
12	vital	JJ	O	vital	amod	13	SENT_38	[p3l90t331r237b394],
13	function	NN	O	function	prep_of	10	SENT_38	[p3l256t331r544b394],
14	is	VBZ	O	be	cop	15	SENT_38	[p3l565t337r614b394],
15	crucial	JJ	O	crucial	_	0	SENT_38	[p3l635t331r864b394],
16	during	IN	O	during	_	0	SENT_38	[p3l883t331r1111b415],
17	evaluation	NN	O	evaluation	prep_during	15	SENT_38	[p3l1130t331r1480b394],
18	and	CC	O	and	_	0	SENT_38	[p3l1501t331r1626b394],
19	is	VBZ	O	be	auxpass	21	SENT_38	[p3l1645t337r1694b394],
20	often	RB	O	often	advmod	21	SENT_38	[p3l1715t331r1886b394],
21	carried	VBN	O	carry	conj_and	15	SENT_38	[p3l1906t331r2145b394],
22	out	RP	O	out	prt	21	SENT_38	[p3l9t446r118b497],
23	in	IN	O	in	_	0	SENT_38	[p3l136t440r201b496],
24	parallel	NN	O	parallel	prep_in	21	SENT_38	[p3l219t434r467b517],
25	with	IN	O	with	_	0	SENT_38	[p3l484t434r633b497],
26	the	DT	O	the	det	28	SENT_38	[p3l651t434r756b497],
27	initial	JJ	O	initial	amod	28	SENT_38	[p3l775t434r969b497],
28	treatment	NN	O	treatment	prep_with	21	SENT_38	[p3l987t446r1330b497],
29	.	.	O	.	_	0	SENT_38	[p3l987t446r1330b497],

1	According	VBG	O	accord	_	0	SENT_39	[p3l1351t434r1703b518],
2	to	TO	O	to	prepc_according_to	25	SENT_39	[p3l1719t446r1784b497],
3	the	DT	O	the	det	4	SENT_39	[p3l1803t434r1907b497],
4	guidelines	NNS	O	guideline	pobj	25	SENT_39	[p3l1927t434r2138b518, p3l7t537r178b609],
5	,	,	O	,	_	0	SENT_39	[p3l1927t434r2138b518, p3l7t537r178b609],
6	blood	NN	O	blood	nn	7	SENT_39	[p3l197t537r393b600],
7	pressure	NN	O	pressure	nsubjpass	25	SENT_39	[p3l410t559r705b620],
8	,	,	O	,	_	0	SENT_39	[p3l410t559r705b620],
9	heart	NN	O	heart	nn	10	SENT_39	[p3l725t537r899b600],
10	rate	NN	O	rate	conj_and	7	SENT_39	[p3l917t549r1058b609],
11	,	,	O	,	_	0	SENT_39	[p3l917t549r1058b609],
12	peripheral	JJ	O	peripheral	amod	18	SENT_39	[p3l1078t537r1424b620],
13	blood	NN	O	blood	nn	18	SENT_39	[p3l1440t537r1636b600],
14	oxygen	NN	O	oxygen	nn	18	SENT_39	[p3l1654t560r1892b621],
15	saturation	NN	O	saturation	nn	18	SENT_39	[p3l1912t549r2139b600, p3l8t645r146b702],
16	(	CD	NUMBER	(	num	18	SENT_39	[p3l171t640r424b730],
17	SpO2	NN	O	spo2	nn	18	SENT_39	[p3l171t640r424b730],
18	)	NN	O	)	nsubjpass	25	SENT_39	[p3l171t640r424b730],
19	,	,	O	,	_	0	SENT_39	[p3l171t640r424b730],
20	and	CC	O	and	_	0	SENT_39	[p3l449t639r575b702],
21	urine	NN	O	urine	nn	22	SENT_39	[p3l597t645r779b702],
22	output	NN	O	output	nsubjpass	25	SENT_39	[p3l802t651r1029b722],
23	should	MD	O	should	aux	25	SENT_39	[p3l1051t639r1282b702],
24	be	VB	O	be	auxpass	25	SENT_39	[p3l1301t639r1381b702],
25	monitored	VBN	O	monitor	_	0	SENT_39	[p3l1403t639r1768b702],
26	frequently	RB	O	frequently	advmod	25	SENT_39	[p3l1789t639r2144b723],
27	until	IN	O	until	mark	31	SENT_39	[p3l8t742r170b805],
28	the	DT	O	the	det	29	SENT_39	[p3l190t742r297b805],
29	patient	NN	O	patient	nsubjpass	31	SENT_39	[p3l318t748r558b825],
30	is	VBZ	O	be	auxpass	31	SENT_39	[p3l579t748r629b805],
31	stabilized	VBN	O	stabilize	advcl	25	SENT_39	[p3l654t742r991b805],
32	.	.	O	.	_	0	SENT_39	[p3l654t742r991b805],

1	If	IN	O	if	mark	4	SENT_40	[p3l1017t742r1076b804],
2	vasoactive	JJ	O	vasoactive	amod	3	SENT_40	[p3l1086t748r1441b805],
3	drugs	NNS	O	drug	nsubj	4	SENT_40	[p3l1464t742r1656b826],
4	(	VBP	O	(	advcl	19	SENT_40	[p3l1683t742r2139b819],
5	vasodilators	NNS	O	vasodilator	nsubjpass	13	SENT_40	[p3l1683t742r2139b819],
6	,	,	O	,	_	0	SENT_40	[p3l1683t742r2139b819],
7	inotropes	NNS	O	inotrope	nsubjpass	13	SENT_40	[p3l9t851r342b928],
8	,	,	O	,	_	0	SENT_40	[p3l9t851r342b928],
9	and	CC	O	and	_	0	SENT_40	[p3l364t845r487b908],
10	Vasopressors	NNP	O	Vasopressors	nn	11	SENT_40	[p3l503t845r951b928],
11	)	NN	O	)	conj_and	5	SENT_40	[p3l503t845r951b928],
12	are	VBP	O	be	auxpass	13	SENT_40	[p3l975t868r1072b908],
13	used	VBN	O	use	ccomp	4	SENT_40	[p3l1091t845r1262b917],
14	,	,	O	,	_	0	SENT_40	[p3l1091t845r1262b917],
15	continuous	JJ	O	continuous	amod	17	SENT_40	[p3l1284t851r1656b908],
16	electrocardiogram	NN	O	electrocardiogram	nn	17	SENT_40	[p3l1677t845r2140b908, p3l8t971r188b1032],
17	monitoring	NN	O	monitoring	nsubjpass	19	SENT_40	[p3l210t954r606b1032],
18	is	VBZ	O	be	auxpass	19	SENT_40	[p3l627t954r677b1011],
19	required	VBN	O	require	_	0	SENT_40	[p3l701t948r994b1031],
20	and	CC	O	and	_	0	SENT_40	[p3l1017t948r1144b1011],
21	intra-arterial	JJ	O	intra-arterial	amod	24	SENT_40	[p3l1166t948r1612b1011],
22	blood	NN	O	blood	nn	24	SENT_40	[p3l1631t948r1833b1011],
23	pressure	NN	O	pressure	nn	24	SENT_40	[p3l1853t970r2141b1031],
24	monitoring	NN	O	monitoring	nsubjpass	27	SENT_40	[p3l8t1057r403b1135],
25	might	MD	O	might	aux	27	SENT_40	[p3l424t1051r628b1135],
26	be	VB	O	be	auxpass	27	SENT_40	[p3l648t1051r728b1114],
27	considered	VBN	O	consider	conj_and	19	SENT_40	[p3l750t1051r1141b1114],
28	.	.	O	.	_	0	SENT_40	[p3l750t1051r1141b1114],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_41	[p3l1168t1051r1629b1123],
2	,	,	O	,	_	0	SENT_41	[p3l1168t1051r1629b1123],
3	renal	JJ	O	renal	amod	4	SENT_41	[p3l1653t1051r1826b1114],
4	function	NN	O	function	nsubjpass	13	SENT_41	[p3l1847t1051r2142b1114],
5	(	CD	NUMBER	(	num	7	SENT_41	[p3l12t1155r338b1230],
6	retention	NN	O	retention	nn	7	SENT_41	[p3l12t1155r338b1230],
7	parameters	NNS	O	parameter	dep	4	SENT_41	[p3l356t1155r750b1237],
8	)	CD	NUMBER	)	dep	4	SENT_41	[p3l356t1155r750b1237],
9	and	CC	O	and	_	0	SENT_41	[p3l773t1154r896b1217],
10	electrolytes	NNS	O	electrolyte	conj_and	8	SENT_41	[p3l914t1154r1284b1238],
11	should	MD	O	should	aux	13	SENT_41	[p3l1304t1154r1527b1217],
12	be	VB	O	be	auxpass	13	SENT_41	[p3l1543t1154r1620b1217],
13	monitored	VBN	O	monitor	_	0	SENT_41	[p3l1639t1154r1989b1217],
14	frequently	RB	O	frequently	advmod	13	SENT_41	[p3l2023t1154r2137b1217, p3l9t1257r271b1341],
15	.	.	O	.	_	0	SENT_41	[p3l2023t1154r2137b1217, p3l9t1257r271b1341],

1	Risk	NN	O	risk	nn	2	SENT_42	[p3l296t1257r445b1320],
2	evaluation	NN	O	evaluation	nsubj	4	SENT_42	[p3l463t1257r814b1320],
3	is	VBZ	O	be	cop	4	SENT_42	[p3l836t1263r885b1320],
4	essential	JJ	O	essential	_	0	SENT_42	[p3l908t1257r1193b1320],
5	in	IN	O	in	_	0	SENT_42	[p3l1215t1263r1280b1319],
6	this	DT	O	this	det	7	SENT_42	[p3l1301t1257r1423b1320],
7	phase	NN	O	phase	prep_in	4	SENT_42	[p3l1445t1257r1655b1340],
8	;	:	O	;	_	0	SENT_42	[p3l1445t1257r1655b1340],
9	some	DT	O	some	det	10	SENT_42	[p3l1679t1280r1855b1320],
10	patients	NNS	O	patient	nsubj	12	SENT_42	[p3l1875t1263r2141b1340],
11	may	MD	O	may	aux	12	SENT_42	[p3l8t1383r151b1444],
12	need	VB	O	need	parataxis	4	SENT_42	[p3l167t1360r327b1423],
13	to	TO	O	to	aux	15	SENT_42	[p3l344t1372r408b1423],
14	be	VB	O	be	auxpass	15	SENT_42	[p3l426t1360r504b1423],
15	transferred	VBN	O	transfer	xcomp	12	SENT_42	[p3l522t1360r891b1423],
16	to	TO	O	to	_	0	SENT_42	[p3l908t1372r972b1423],
17	the	DT	O	the	det	22	SENT_42	[p3l991t1360r1095b1423],
18	intensive	JJ	O	intensive	amod	22	SENT_42	[p3l1114t1366r1409b1423],
19	or	CC	O	or	_	0	SENT_42	[p3l1429t1383r1499b1423],
20	coronary	JJ	O	coronary	conj_or	18	SENT_42	[p3l1517t1383r1820b1444],
21	care	NN	O	care	nn	22	SENT_42	[p3l1836t1383r1969b1423],
22	unit	NN	O	unit	prep_to	15	SENT_42	[p3l1988t1366r2138b1423],
23	.	.	O	.	_	0	SENT_42	[p3l1988t1366r2138b1423],

1	Acute	JJ	O	acute	amod	2	SENT_43	[p3l8t1575r206b1630],
2	management	NN	O	management	nsubj	25	SENT_43	[p3l225t1580r686b1646],
3	and	CC	O	and	_	0	SENT_43	[p3l703t1572r831b1630],
4	differential	JJ	O	differential	amod	5	SENT_43	[p3l851t1572r1237b1630],
5	therapy	NN	O	therapy	conj_and	2	SENT_43	[p3l1255t1573r1528b1646],
6	of	IN	O	of	_	0	SENT_43	[p3l1543t1572r1614b1630],
7	AHF	NNP	O	AHF	prep_of	2	SENT_43	[p3l1627t1575r1770b1629],
8	According	VBG	O	accord	_	0	SENT_43	[p3l8t1670r358b1754],
9	to	TO	O	to	prepc_according_to	25	SENT_43	[p3l375t1682r439b1733],
10	the	DT	O	the	det	13	SENT_43	[p3l459t1670r563b1733],
11	current	JJ	DATE	current	amod	13	SENT_43	[p3l583t1682r829b1733],
12	European	JJ	ORGANIZATION	european	amod	13	SENT_43	[p3l848t1675r1171b1753],
13	Society	NNP	ORGANIZATION	Society	pobj	25	SENT_43	[p3l1192t1674r1434b1754],
14	of	IN	ORGANIZATION	of	_	0	SENT_43	[p3l1451t1670r1523b1733],
15	Cardiology	NNP	ORGANIZATION	Cardiology	nn	16	SENT_43	[p3l1534t1670r1911b1754],
16	guidelines	NNS	O	guideline	prep_of	13	SENT_43	[p3l1927t1670r2137b1754, p3l7t1764r211b1844],
17	,1	CD	NUMBER	,1	dep	16	SENT_43	[p3l1927t1670r2137b1754, p3l7t1764r211b1844],
18	all	DT	O	all	det	19	SENT_43	[p3l239t1772r317b1835],
19	patients	NNS	O	patient	dep	17	SENT_43	[p3l338t1778r607b1855],
20	with	IN	O	with	_	0	SENT_43	[p3l628t1772r781b1835],
21	acute	JJ	O	acute	amod	23	SENT_43	[p3l804t1784r981b1835],
22	pulmonary	JJ	O	pulmonary	amod	23	SENT_43	[p3l1003t1772r1388b1856],
23	edema	NN	O	edema	prep_with	19	SENT_43	[p3l1407t1772r1632b1835],
24	should	MD	O	should	aux	25	SENT_43	[p3l1654t1772r1884b1835],
25	receive	VB	O	receive	_	0	SENT_43	[p3l1906t1778r2142b1835],
26	an	DT	O	a	det	28	SENT_43	[p3l9t1898r89b1938],
27	intravenous	JJ	O	intravenous	amod	28	SENT_43	[p3l112t1881r515b1938],
28	bolus	NN	O	bolus	dobj	25	SENT_43	[p3l536t1875r720b1938],
29	of	IN	O	of	_	0	SENT_43	[p3l744t1875r818b1938],
30	loop	NN	O	loop	nn	32	SENT_43	[p3l829t1875r981b1958],
31	diuretic	JJ	O	diuretic	amod	32	SENT_43	[p3l1005t1875r1269b1938],
32	(	NN	O	(	prep_of	28	SENT_43	[p3l1295t1875r1588b1951],
33	2.5-fold	JJ	O	2.5-fold	amod	32	SENT_43	[p3l1295t1875r1588b1951],
34	preexisting	VBG	O	preexist	dep	33	SENT_43	[p3l1608t1881r1988b1959],
35	oral	JJ	O	oral	amod	37	SENT_43	[p3l2010t1875r2142b1938],
36	dose	NN	O	dose	nn	37	SENT_43	[p3l9t1977r218b2054],
37	)	NN	O	)	dobj	34	SENT_43	[p3l9t1977r218b2054],
38	.	.	O	.	_	0	SENT_43	[p3l9t1977r218b2054],

1	Hypoxemic	JJ	O	hypoxemic	amod	2	SENT_44	[p3l248t1982r657b2061],
2	patients	NNS	O	patient	nsubj	26	SENT_44	[p3l682t1983r963b2060],
3	(	IN	O	(	_	0	SENT_44	[p3l993t1978r1221b2068],
4	SpO2	NN	O	spo2	prep_(	2	SENT_44	[p3l993t1978r1221b2068],
5	:	:	O	:	_	0	SENT_44	[p3l993t1978r1221b2068],
6	<	JJR	O	<	dep	2	SENT_44	[p3l1253t1982r1468b2049],
7	90	CD	PERCENT	90	number	8	SENT_44	[p3l1253t1982r1468b2049],
8	%	NN	PERCENT	%	amod	6	SENT_44	[p3l1253t1982r1468b2049],
9	;	:	O	;	_	0	SENT_44	[p3l1253t1982r1468b2049],
10	partial	JJ	O	partial	amod	11	SENT_44	[p3l1494t1977r1728b2060],
11	pressure	NN	O	pressure	dep	2	SENT_44	[p3l1752t1999r2049b2060],
12	of	IN	O	of	_	0	SENT_44	[p3l2076t1977r2152b2040],
13	oxygen	NN	O	oxygen	prep_of	11	SENT_44	[p3l9t2102r261b2163],
14	in	IN	O	in	_	0	SENT_44	[p3l289t2085r357b2141],
15	arterial	JJ	O	arterial	amod	16	SENT_44	[p3l385t2079r642b2142],
16	blood	NN	O	blood	prep_in	13	SENT_44	[p3l666t2079r891b2151],
17	,	,	O	,	_	0	SENT_44	[p3l666t2079r891b2151],
18	PaO2	NN	O	pao2	appos	16	SENT_44	[p3l921t2083r1120b2170],
19	:	:	O	:	_	0	SENT_44	[p3l921t2083r1120b2170],
20	<	JJR	O	<	dep	2	SENT_44	[p3l1153t2085r1280b2142],
21	60	CD	NUMBER	60	num	23	SENT_44	[p3l1153t2085r1280b2142],
22	mm	NN	O	mm	nn	23	SENT_44	[p3l1298t2102r1440b2141],
23	Hg	NN	O	hg	dep	20	SENT_44	[p3l1468t2080r1597b2163],
24	)	CD	NUMBER	)	dep	2	SENT_44	[p3l1468t2080r1597b2163],
25	should	MD	O	should	aux	26	SENT_44	[p3l1629t2079r1869b2142],
26	receive	VB	O	receive	_	0	SENT_44	[p3l1896t2085r2142b2142],
27	oxygen	NN	O	oxygen	dobj	26	SENT_44	[p3l9t2205r268b2266],
28	.	.	O	.	_	0	SENT_44	[p3l9t2205r268b2266],

1	In	IN	O	in	_	0	SENT_45	[p3l293t2187r364b2244],
2	severely	RB	O	severely	advmod	3	SENT_45	[p3l386t2182r658b2266],
3	anxious	JJ	O	anxious	amod	6	SENT_45	[p3l677t2188r940b2245],
4	or	CC	O	or	_	0	SENT_45	[p3l963t2205r1035b2245],
5	distressed	JJ	O	distressed	conj_or	3	SENT_45	[p3l1055t2182r1392b2245],
6	patients	NNS	O	patient	prep_in	10	SENT_45	[p3l1412t2188r1699b2265],
7	,	,	O	,	_	0	SENT_45	[p3l1412t2188r1699b2265],
8	an	DT	O	a	det	9	SENT_45	[p3l1723t2205r1803b2245],
9	i.v.	NN	O	i.v.	nsubj	10	SENT_45	[p3l1824t2188r1912b2245],
10	opiate	VBP	O	opiate	_	0	SENT_45	[p3l1937t2188r2142b2265],
11	(	NN	O	(	nsubjpass	20	SENT_45	[p3l12t2285r105b2362],
12	in	IN	O	in	_	0	SENT_45	[p3l12t2285r105b2362],
13	combination	NN	O	combination	prep_in	11	SENT_45	[p3l125t2285r558b2349],
14	with	IN	O	with	_	0	SENT_45	[p3l577t2285r729b2348],
15	an	DT	O	a	det	17	SENT_45	[p3l750t2308r829b2348],
16	antiemetic	JJ	O	antiemetic	amod	17	SENT_45	[p3l850t2286r1232b2362],
17	)	NN	O	)	prep_with	13	SENT_45	[p3l850t2286r1232b2362],
18	should	MD	O	should	aux	20	SENT_45	[p3l1258t2285r1487b2348],
19	be	VB	O	be	auxpass	20	SENT_45	[p3l1505t2285r1584b2348],
20	considered	VBN	O	consider	ccomp	10	SENT_45	[p3l1605t2285r1991b2348],
21	.	.	O	.	_	0	SENT_45	[p3l1605t2285r1991b2348],

1	The	DT	O	the	det	3	SENT_46	[p3l2015t2285r2139b2348],
2	subsequent	JJ	O	subsequent	amod	3	SENT_46	[p3l9t2388r392b2471],
3	therapy	NN	O	therapy	nsubj	4	SENT_46	[p3l410t2388r671b2472],
4	differs	VBZ	O	differ	_	0	SENT_46	[p3l688t2388r898b2451],
5	according	VBG	O	accord	_	0	SENT_46	[p3l920t2388r1256b2472],
6	to	TO	O	to	prepc_according_to	4	SENT_46	[p3l1274t2400r1339b2451],
7	the	DT	O	the	det	10	SENT_46	[p3l1360t2388r1466b2451],
8	systolic	JJ	O	systolic	amod	10	SENT_46	[p3l1487t2388r1735b2472],
9	blood	NN	O	blood	nn	10	SENT_46	[p3l1753t2388r1951b2451],
10	pressure	NN	O	pressure	pobj	4	SENT_46	[p3l1969t2410r2137b2471, p3l9t2514r149b2554],
11	(	CD	NUMBER	(	num	12	SENT_46	[p3l174t2492r353b2567],
12	SBP	NN	O	sbp	dep	10	SENT_46	[p3l174t2492r353b2567],
13	;	:	O	;	_	0	SENT_46	[p3l174t2492r353b2567],
14	Figure	NNP	O	Figure	dep	10	SENT_46	[p3l378t2496r608b2574],
15	1	CD	NUMBER	1	number	16	SENT_46	[p3l634t2492r715b2568],
16	)	CD	NUMBER	)	dep	14	SENT_46	[p3l634t2492r715b2568],
17	.	.	O	.	_	0	SENT_46	[p3l634t2492r715b2568],

1	1	LS	NUMBER	1	_	0	SENT_47	[p3l64t2705r112b2761],
2	.	.	O	.	_	0	SENT_47	[p3l64t2705r112b2761],

1	In	IN	O	in	_	0	SENT_48	[p3l162t2703r233b2760],
2	hypotensive	JJ	O	hypotensive	amod	4	SENT_48	[p3l254t2698r663b2782],
3	(	NN	O	(	nn	4	SENT_48	[p3l688t2699r849b2774],
4	SBP	NN	O	sbp	prep_in	48	SENT_48	[p3l688t2699r849b2774],
5	<	JJR	O	<	dep	10	SENT_48	[p3l874t2705r995b2761],
6	85	CD	NUMBER	85	num	7	SENT_48	[p3l874t2705r995b2761],
7	mm	NN	O	mm	dep	5	SENT_48	[p3l1013t2721r1151b2760],
8	Hg	NN	O	hg	dep	10	SENT_48	[p3l1172t2698r1298b2782],
9	)	CD	NUMBER	)	num	8	SENT_48	[p3l1172t2698r1298b2782],
10	patients	NNS	O	patient	dep	21	SENT_48	[p3l1322t2704r1591b2781],
11	or	CC	O	or	_	0	SENT_48	[p3l1614t2721r1686b2761],
12	patients	NNS	O	patient	conj_or	10	SENT_48	[p3l1705t2704r1974b2781],
13	with	IN	O	with	_	0	SENT_48	[p3l160t2801r313b2864],
14	clinical	JJ	O	clinical	amod	15	SENT_48	[p3l335t2801r579b2864],
15	signs	NNS	O	sign	prep_with	10	SENT_48	[p3l601t2807r769b2885],
16	of	IN	O	of	_	0	SENT_48	[p3l793t2801r866b2864],
17	cardiogenic	JJ	O	cardiogenic	amod	18	SENT_48	[p3l879t2801r1275b2885],
18	shock	NN	O	shock	prep_of	15	SENT_48	[p3l1298t2801r1497b2864],
19	(	CD	NUMBER	(	num	21	SENT_48	[p3l1519t2801r1690b2877],
20	cold	JJ	O	cold	amod	21	SENT_48	[p3l1519t2801r1690b2877],
21	skin	NN	O	skin	dep	4	SENT_48	[p3l1711t2801r1869b2873],
22	,	,	O	,	_	0	SENT_48	[p3l1711t2801r1869b2873],
23	low	JJ	O	low	amod	25	SENT_48	[p3l1891t2801r2015b2864],
24	pulse	NN	O	pulse	nn	25	SENT_48	[p3l161t2905r339b2988],
25	volume	NN	O	volume	conj_and	21	SENT_48	[p3l358t2905r631b2977],
26	,	,	O	,	_	0	SENT_48	[p3l358t2905r631b2977],
27	poor	JJ	O	poor	amod	29	SENT_48	[p3l653t2927r817b2988],
28	urine	NN	O	urine	nn	29	SENT_48	[p3l838t2911r1019b2968],
29	output	NN	O	output	conj_and	21	SENT_48	[p3l1041t2917r1283b2988],
30	,	,	O	,	_	0	SENT_48	[p3l1041t2917r1283b2988],
31	confusion	NN	O	confusion	conj_and	21	SENT_48	[p3l1308t2905r1665b2977],
32	,	,	O	,	_	0	SENT_48	[p3l1308t2905r1665b2977],
33	and	CC	O	and	_	0	SENT_48	[p3l1689t2905r1815b2968],
34	myocardial	JJ	O	myocardial	amod	36	SENT_48	[p3l1835t2928r2116b2989, p3l162t3008r288b3071],
35	ischemia	NN	O	ischemia	nn	36	SENT_48	[p3l309t3008r659b3084],
36	)	NN	O	)	conj_and	21	SENT_48	[p3l309t3008r659b3084],
37	,	,	O	,	_	0	SENT_48	[p3l309t3008r659b3084],
38	a	DT	O	a	det	40	SENT_48	[p3l683t3031r717b3071],
39	nonvasodilating	JJ	O	nonvasodilating	amod	40	SENT_48	[p3l738t3008r1290b3092],
40	inotrope	NN	O	inotrope	nsubjpass	48	SENT_48	[p3l1310t3014r1620b3091],
41	,	,	O	,	_	0	SENT_48	[p3l1310t3014r1620b3091],
42	e.g.	FW	O	e.g.	appos	40	SENT_48	[p3l1644t3031r1774b3092],
43	,	,	O	,	_	0	SENT_48	[p3l1644t3031r1774b3092],
44	dobutamine	NN	O	dobutamine	appos	42	SENT_48	[p3l1797t3008r1999b3071, p3l161t3117r417b3183],
45	,	,	O	,	_	0	SENT_48	[p3l1797t3008r1999b3071, p3l161t3117r417b3183],
46	should	MD	O	should	aux	48	SENT_48	[p3l441t3111r671b3174],
47	be	VB	O	be	auxpass	48	SENT_48	[p3l690t3111r769b3174],
48	considered	VBN	O	consider	_	0	SENT_48	[p3l792t3111r1180b3174],
49	.	.	O	.	_	0	SENT_48	[p3l792t3111r1180b3174],

1	Restoration	NN	O	restoration	nsubj	8	SENT_49	[p3l1205t3116r1600b3174],
2	of	IN	O	of	_	0	SENT_49	[p3l1622t3111r1696b3174],
3	an	DT	O	a	det	6	SENT_49	[p3l1709t3134r1788b3174],
4	adequate	JJ	O	adequate	amod	6	SENT_49	[p3l1811t3111r2115b3194],
5	volume	NN	O	volume	nn	6	SENT_49	[p3l159t3213r414b3276],
6	state	NN	O	state	prep_of	1	SENT_49	[p3l437t3225r589b3276],
7	is	VBZ	O	be	cop	8	SENT_49	[p3l611t3219r661b3276],
8	essential	JJ	O	essential	_	0	SENT_49	[p3l684t3213r988b3276],
9	.	.	O	.	_	0	SENT_49	[p3l684t3213r988b3276],

1	2	LS	NUMBER	2	_	0	SENT_50	[p3l58t3323r112b3379],
2	.	.	O	.	_	0	SENT_50	[p3l58t3323r112b3379],

1	In	IN	O	in	_	0	SENT_51	[p3l162t3321r233b3378],
2	patients	NNS	O	patient	prep_in	17	SENT_51	[p3l254t3322r522b3399],
3	with	IN	O	with	_	0	SENT_51	[p3l543t3316r696b3379],
4	an	DT	O	a	det	5	SENT_51	[p3l718t3339r797b3379],
5	SBP	NN	O	sbp	prep_with	2	SENT_51	[p3l820t3320r953b3379],
6	between	IN	O	between	_	0	SENT_51	[p3l973t3316r1259b3379],
7	85	CD	NUMBER	85	num	11	SENT_51	[p3l1282t3323r1357b3379],
8	and	CC	NUMBER	and	_	0	SENT_51	[p3l1382t3316r1508b3379],
9	110	CD	NUMBER	110	num	11	SENT_51	[p3l1535t3323r1648b3379],
10	mm	NN	O	mm	nn	11	SENT_51	[p3l1664t3339r1802b3378],
11	Hg	NN	O	hg	prep_between	5	SENT_51	[p3l1824t3321r1942b3400],
12	,	,	O	,	_	0	SENT_51	[p3l1824t3321r1942b3400],
13	no	DT	O	no	det	15	SENT_51	[p3l1965t3339r2051b3379],
14	additional	JJ	O	additional	amod	15	SENT_51	[p3l163t3419r510b3482],
15	therapy	NN	O	therapy	nsubjpass	17	SENT_51	[p3l530t3419r792b3503],
16	is	VBZ	O	be	auxpass	17	SENT_51	[p3l810t3425r860b3482],
17	required	VBN	O	require	_	0	SENT_51	[p3l882t3419r1188b3502],
18	.	.	O	.	_	0	SENT_51	[p3l882t3419r1188b3502],

1	3	LS	NUMBER	3	_	0	SENT_52	[p3l59t3529r112b3585],
2	.	.	O	.	_	0	SENT_52	[p3l59t3529r112b3585],

1	In	IN	O	in	dep	6	SENT_53	[p3l162t3527r233b3584],
2	patients	NNS	O	patient	pobj	1	SENT_53	[p3l254t3528r522b3605],
3	with	IN	O	with	_	0	SENT_53	[p3l543t3522r696b3585],
4	an	DT	O	a	det	5	SENT_53	[p3l718t3545r797b3585],
5	SBP	NN	O	sbp	prep_with	2	SENT_53	[p3l820t3526r953b3585],
6	>	JJR	O	>	_	0	SENT_53	[p3l978t3529r1142b3585],
7	110	CD	NUMBER	110	num	9	SENT_53	[p3l978t3529r1142b3585],
8	mm	NN	O	mm	nn	9	SENT_53	[p3l1158t3545r1296b3584],
9	Hg	NN	O	hg	dep	6	SENT_53	[p3l1318t3527r1436b3606],
10	,	,	O	,	_	0	SENT_53	[p3l1318t3527r1436b3606],
11	a	DT	O	a	det	12	SENT_53	[p3l1460t3545r1495b3585],
12	vasodilator	NN	O	vasodilator	appos	9	SENT_53	[p3l1512t3522r1907b3594],
13	,	,	O	,	_	0	SENT_53	[p3l1512t3522r1907b3594],
14	e.g.	FW	O	e.g.	dep	9	SENT_53	[p3l1931t3545r2061b3606],
15	,	,	O	,	_	0	SENT_53	[p3l1931t3545r2061b3606],

1	nitroglycerin	NN	O	nitroglycerin	nsubjpass	5	SENT_54	[p3l162t3625r624b3709],
2	,	,	O	,	_	0	SENT_54	[p3l162t3625r624b3709],
3	should	MD	O	should	aux	5	SENT_54	[p3l649t3625r879b3688],
4	be	VB	O	be	auxpass	5	SENT_54	[p3l897t3625r977b3688],
5	considered	VBN	O	consider	_	0	SENT_54	[p3l999t3625r1388b3688],
6	.	.	O	.	_	0	SENT_54	[p3l999t3625r1388b3688],

1	After	IN	O	after	_	0	SENT_55	[p4l81t68r255b131],
2	these	DT	O	these	det	3	SENT_55	[p4l273t68r446b131],
3	measures	NNS	O	measure	prep_after	8	SENT_55	[p4l465t91r797b140],
4	,	,	O	,	_	0	SENT_55	[p4l465t91r797b140],
5	the	DT	O	the	det	6	SENT_55	[p4l818t68r923b131],
6	physician	NN	O	physician	nsubj	8	SENT_55	[p4l942t68r1262b152],
7	should	MD	O	should	aux	8	SENT_55	[p4l1283t68r1510b131],
8	assess	VB	O	assess	_	0	SENT_55	[p4l1530t91r1723b131],
9	whether	IN	O	whether	complm	12	SENT_55	[p4l1741t68r2020b131],
10	the	DT	O	the	det	11	SENT_55	[p4l2038t68r2143b131],
11	patient	NN	O	patient	nsubj	12	SENT_55	[p4l7t177r246b254],
12	responds	VBZ	O	respond	ccomp	8	SENT_55	[p4l266t171r573b254],
13	adequately	RB	O	adequately	advmod	12	SENT_55	[p4l596t171r964b255],
14	to	TO	O	to	_	0	SENT_55	[p4l981t183r1047b234],
15	the	DT	O	the	det	17	SENT_55	[p4l1068t171r1174b234],
16	initiated	VBN	O	initiate	amod	17	SENT_55	[p4l1195t171r1480b234],
17	therapy	NN	O	therapy	prep_to	12	SENT_55	[p4l1499t171r1768b255],
18	.	.	O	.	_	0	SENT_55	[p4l1499t171r1768b255],

1	Criteria	NNS	O	criterion	nsubj	5	SENT_56	[p4l1793t175r2058b234],
2	of	IN	O	of	_	0	SENT_56	[p4l2078t171r2152b234],
3	response	NN	O	response	prep_of	1	SENT_56	[p4l9t296r308b357],
4	are	VBP	O	be	cop	5	SENT_56	[p4l332t297r432b337],
5	establishment	NN	O	establishment	ccomp	36	SENT_56	[p4l455t274r929b337],
6	of	IN	O	of	_	0	SENT_56	[p4l951t274r1024b337],
7	adequate	JJ	O	adequate	amod	8	SENT_56	[p4l1038t274r1342b357],
8	diuresis	NN	O	diuresis	prep_of	5	SENT_56	[p4l1366t274r1647b346],
9	,	,	O	,	_	0	SENT_56	[p4l1366t274r1647b346],
10	an	DT	O	a	det	11	SENT_56	[p4l1672t297r1752b337],
11	increase	NN	O	increase	nsubj	36	SENT_56	[p4l1775t280r2052b337],
12	in	IN	O	in	_	0	SENT_56	[p4l2075t280r2142b336],
13	oxygen	NN	O	oxygen	nn	14	SENT_56	[p4l9t400r258b461],
14	saturation	NN	O	saturation	prep_in	11	SENT_56	[p4l282t383r654b449],
15	,	,	O	,	_	0	SENT_56	[p4l282t383r654b449],
16	a	DT	O	a	det	17	SENT_56	[p4l680t400r715b440],
17	reduction	NN	O	reduction	conj_and	11	SENT_56	[p4l738t377r1078b440],
18	in	IN	O	in	_	0	SENT_56	[p4l1103t383r1170b439],
19	heart	NN	O	heart	nn	22	SENT_56	[p4l1193t377r1375b440],
20	and	CC	O	and	_	0	SENT_56	[p4l1398t377r1527b440],
21	respiratory	JJ	O	respiratory	conj_and	19	SENT_56	[p4l1550t383r1938b461],
22	rates	NNS	O	rate	prep_in	17	SENT_56	[p4l1958t389r2140b449],
23	,	,	O	,	_	0	SENT_56	[p4l1958t389r2140b449],
24	an	DT	O	a	det	25	SENT_56	[p4l9t503r92b543],
25	increase	NN	O	increase	conj_and	11	SENT_56	[p4l118t486r408b543],
26	in	IN	O	in	_	0	SENT_56	[p4l434t486r503b542],
27	peripheral	JJ	O	peripheral	amod	29	SENT_56	[p4l528t480r899b563],
28	blood	NN	O	blood	nn	29	SENT_56	[p4l922t480r1130b543],
29	ﬂow	NN	O	ﬂow	prep_in	25	SENT_56	[p4l1155t480r1317b552],
30	,	,	O	,	_	0	SENT_56	[p4l1155t480r1317b552],
31	and	CC	O	and	_	0	SENT_56	[p4l1345t480r1476b543],
32	a	DT	O	a	det	33	SENT_56	[p4l1502t503r1537b543],
33	decrease	NN	O	decrease	conj_and	11	SENT_56	[p4l1563t480r1865b543],
34	in	IN	O	in	_	0	SENT_56	[p4l1892t486r1960b542],
35	lung	NN	O	lung	prep_in	33	SENT_56	[p4l1985t480r2144b564],
36	crackles	VBZ	O	crackle	_	0	SENT_56	[p4l9t583r306b646],
37	.	.	O	.	_	0	SENT_56	[p4l9t583r306b646],

1	If	IN	O	if	mark	5	SENT_57	[p4l333t583r393b645],
2	these	DT	O	these	det	3	SENT_57	[p4l406t583r585b646],
3	criteria	NNS	O	criterion	nsubjpass	5	SENT_57	[p4l610t589r861b646],
4	are	VBP	O	be	auxpass	5	SENT_57	[p4l884t606r986b646],
5	met	VBN	O	meet	advcl	12	SENT_57	[p4l1010t595r1161b655],
6	,	,	O	,	_	0	SENT_57	[p4l1010t595r1161b655],
7	the	DT	O	the	det	9	SENT_57	[p4l1185t583r1294b646],
8	initiated	VBN	O	initiate	amod	9	SENT_57	[p4l1318t583r1610b646],
9	therapy	NN	O	therapy	nsubjpass	12	SENT_57	[p4l1631t583r1900b667],
10	can	MD	O	can	aux	12	SENT_57	[p4l1921t606r2040b646],
11	be	VB	O	be	auxpass	12	SENT_57	[p4l2062t583r2143b646],
12	continued	VBN	O	continue	_	0	SENT_57	[p4l9t686r379b749],
13	.	.	O	.	_	0	SENT_57	[p4l9t686r379b749],

1	If	IN	O	if	mark	7	SENT_58	[p4l407t686r467b748],
2	the	DT	O	the	det	3	SENT_58	[p4l480t686r588b749],
3	patient	NN	O	patient	poss	5	SENT_58	[p4l611t686r896b769],
4	’s	POS	O	’s	_	0	SENT_58	[p4l611t686r896b769],
5	response	NN	O	response	nsubj	7	SENT_58	[p4l920t708r1227b769],
6	is	VBZ	O	be	cop	7	SENT_58	[p4l1251t692r1302b749],
7	insuﬂicient	JJ	O	insuﬂicient	advcl	14	SENT_58	[p4l1327t686r1735b758],
8	,	,	O	,	_	0	SENT_58	[p4l1327t686r1735b758],
9	the	DT	O	the	det	11	SENT_58	[p4l1759t686r1868b749],
10	clinical	JJ	O	clinical	amod	11	SENT_58	[p4l1893t686r2144b749],
11	status	NN	O	status	nsubjpass	14	SENT_58	[p4l9t800r201b851],
12	must	MD	O	must	aux	14	SENT_58	[p4l223t800r393b851],
13	be	VB	O	be	auxpass	14	SENT_58	[p4l411t788r490b851],
14	reevaluated	VBN	O	reevaluate	_	0	SENT_58	[p4l513t788r920b851],
15	.	.	O	.	_	0	SENT_58	[p4l513t788r920b851],

1	In	IN	O	in	_	0	SENT_59	[p4l162t1000r233b1057],
2	hypotensive	JJ	O	hypotensive	amod	3	SENT_59	[p4l254t995r663b1079],
3	patients	NNS	O	patient	prep_in	14	SENT_59	[p4l684t1001r971b1078],
4	,	,	O	,	_	0	SENT_59	[p4l684t1001r971b1078],
5	a	DT	O	a	det	10	SENT_59	[p4l995t1018r1029b1058],
6	preexisting	VBG	O	preexist	amod	10	SENT_59	[p4l1049t1001r1429b1079],
7	Vasodilatory	JJ	O	vasodilatory	amod	10	SENT_59	[p4l1446t995r1874b1079],
8	and	CC	O	and	_	0	SENT_59	[p4l1893t995r2018b1058],
9	[	JJ	O	[	amod	10	SENT_59	[p4l165t1098r534b1182],
10	3-blocking	NN	O	3-blocking	appos	3	SENT_59	[p4l165t1098r534b1182],
11	therapy	NN	O	therapy	nsubjpass	14	SENT_59	[p4l552t1098r815b1182],
12	should	MD	O	should	aux	14	SENT_59	[p4l833t1098r1064b1161],
13	be	VB	O	be	auxpass	14	SENT_59	[p4l1082t1098r1161b1161],
14	stopped	VBN	O	stop	_	0	SENT_59	[p4l1184t1098r1470b1181],
15	,	,	O	,	_	0	SENT_59	[p4l1184t1098r1470b1181],
16	and	CC	O	and	_	0	SENT_59	[p4l1494t1098r1620b1161],
17	therapy	NN	O	therapy	nsubjpass	26	SENT_59	[p4l1640t1098r1902b1182],
18	with	IN	O	with	_	0	SENT_59	[p4l1918t1098r2070b1161],
19	a	DT	O	a	det	21	SENT_59	[p4l163t1224r197b1264],
20	nonvasodilating	JJ	O	nonvasodilating	amod	21	SENT_59	[p4l217t1201r770b1285],
21	inotrope	NN	O	inotrope	prep_with	17	SENT_59	[p4l790t1207r1082b1284],
22	or	CC	O	or	_	0	SENT_59	[p4l1105t1224r1176b1264],
23	Vasopressor	NN	O	vasopressor	conj_or	21	SENT_59	[p4l1194t1223r1598b1284],
24	should	MD	O	should	aux	26	SENT_59	[p4l1619t1201r1849b1264],
25	be	VB	O	be	auxpass	26	SENT_59	[p4l1868t1201r1947b1264],
26	considered	VBN	O	consider	conj_and	14	SENT_59	[p4l1969t1224r2119b1264, p4l163t1304r425b1367],
27	.	.	O	.	_	0	SENT_59	[p4l1969t1224r2119b1264, p4l163t1304r425b1367],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_60	[p4l450t1304r909b1376],
2	,	,	O	,	_	0	SENT_60	[p4l450t1304r909b1376],
3	the	DT	O	the	det	4	SENT_60	[p4l931t1304r1037b1367],
4	guidelines	NNS	O	guideline	nsubj	5	SENT_60	[p4l1059t1304r1406b1388],
5	recommend	VBP	O	recommend	_	0	SENT_60	[p4l1429t1304r1844b1367],
6	consideration	NN	O	consideration	dobj	5	SENT_60	[p4l1865t1304r2115b1367, p4l162t1413r403b1470],
7	of	IN	O	of	_	0	SENT_60	[p4l426t1407r499b1470],
8	right-heart	JJ	O	right-heart	amod	9	SENT_60	[p4l511t1407r886b1491],
9	catheterization	NN	O	catheterization	prep_of	6	SENT_60	[p4l907t1407r1416b1470],
10	and	CC	O	and	_	0	SENT_60	[p4l1438t1407r1564b1470],
11	the	DT	O	the	det	12	SENT_60	[p4l1584t1407r1690b1470],
12	initiation	NN	O	initiation	dobj	5	SENT_60	[p4l1712t1413r2027b1470],
13	of	IN	O	of	_	0	SENT_60	[p4l2049t1407r2123b1470],
14	mechanical	JJ	O	mechanical	amod	15	SENT_60	[p4l161t1510r553b1573],
15	support	NN	O	support	prep_of	12	SENT_60	[p4l574t1522r855b1593],
16	.	.	O	.	_	0	SENT_60	[p4l574t1522r855b1593],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_61	[p4l880t1515r1148b1573],
2	with	IN	O	with	_	0	SENT_61	[p4l1169t1510r1322b1573],
3	persistently	RB	O	persistently	advmod	4	SENT_61	[p4l1341t1510r1739b1594],
4	low	JJ	O	low	amod	6	SENT_61	[p4l1755t1510r1879b1573],
5	blood	NN	O	blood	nn	6	SENT_61	[p4l1896t1510r2095b1573],
6	pressure	NN	O	pressure	prep_with	1	SENT_61	[p4l161t1635r446b1696],
7	should	MD	O	should	aux	9	SENT_61	[p4l468t1613r699b1676],
8	be	VB	O	be	auxpass	9	SENT_61	[p4l717t1613r796b1676],
9	scrutinized	VBN	O	scrutinize	dep	14	SENT_61	[p4l819t1613r1201b1676],
10	for	IN	O	for	_	0	SENT_61	[p4l1222t1613r1319b1676],
11	underlying	VBG	O	underlie	amod	13	SENT_61	[p4l1339t1613r1715b1697],
12	reversible	JJ	O	reversible	amod	13	SENT_61	[p4l1735t1613r2063b1676],
13	causes	NNS	O	cause	prep_for	9	SENT_61	[p4l162t1739r377b1779],
14	(	VBP	O	(	_	0	SENT_61	[p4l402t1717r559b1800],
15	e.g.	FW	O	e.g.	dobj	14	SENT_61	[p4l402t1717r559b1800],
16	,	,	O	,	_	0	SENT_61	[p4l402t1717r559b1800],
17	pulmonary	JJ	O	pulmonary	amod	18	SENT_61	[p4l581t1716r966b1800],
18	embolism	NN	O	embolism	dobj	14	SENT_61	[p4l985t1716r1340b1788],
19	,	,	O	,	_	0	SENT_61	[p4l985t1716r1340b1788],
20	acute	JJ	O	acute	amod	22	SENT_61	[p4l1364t1728r1542b1779],
21	mechanical	JJ	O	mechanical	amod	22	SENT_61	[p4l1563t1716r1954b1779],
22	problems	NNS	O	problem	dobj	14	SENT_61	[p4l161t1818r498b1901],
23	,	,	O	,	_	0	SENT_61	[p4l161t1818r498b1901],
24	and	CC	O	and	_	0	SENT_61	[p4l522t1818r648b1881],
25	severe	JJ	O	severe	amod	28	SENT_61	[p4l670t1841r878b1881],
26	valvular	JJ	O	valvular	amod	28	SENT_61	[p4l897t1818r1174b1881],
27	disease	NN	O	disease	nn	28	SENT_61	[p4l1196t1810r1561b1895],
28	)	NN	O	)	dobj	14	SENT_61	[p4l1196t1810r1561b1895],
29	.45	CD	NUMBER	.45	nsubj	14	SENT_61	[p4l1196t1810r1561b1895],

1	.	.	O	.	_	0	SENT_62	[p4l101t1975r112b1985],

1	In	IN	O	in	_	0	SENT_63	[p4l162t1927r233b1984],
2	hypoxemic	JJ	O	hypoxemic	amod	3	SENT_63	[p4l254t1922r631b2006],
3	patients	NNS	O	patient	prep_in	4	SENT_63	[p4l651t1928r920b2005],
4	(	VBP	O	(	_	0	SENT_63	[p4l946t1923r1148b2013],
5	SpO2	NN	O	spo2	dep	6	SENT_63	[p4l946t1923r1148b2013],
6	<	JJR	O	<	dobj	4	SENT_63	[p4l1173t1922r1388b1998],
7	90	CD	PERCENT	90	num	8	SENT_63	[p4l1173t1922r1388b1998],
8	%	NN	PERCENT	%	nsubj	4	SENT_63	[p4l1173t1922r1388b1998],
9	)	CD	NUMBER	)	dep	8	SENT_63	[p4l1173t1922r1388b1998],
10	without	IN	O	without	_	0	SENT_63	[p4l1412t1922r1680b1985],
11	contraindications	NNS	O	contraindication	prep_without	9	SENT_63	[p4l1701t1928r2015b1985, p4l162t2025r470b2088],

1	who	WP	O	who	nsubj	4	SENT_64	[p4l491t2025r637b2088],
2	are	VBP	O	be	aux	4	SENT_64	[p4l661t2048r761b2088],
3	not	RB	O	not	neg	4	SENT_64	[p4l782t2037r896b2088],
4	responding	VBG	O	respond	_	0	SENT_64	[p4l916t2025r1305b2109],
5	to	TO	O	to	_	0	SENT_64	[p4l1323t2037r1389b2088],
6	oxygen	NN	O	oxygen	nn	7	SENT_64	[p4l1413t2048r1655b2109],
7	therapy	NN	O	therapy	prep_to	4	SENT_64	[p4l1676t2025r1946b2109],
8	,	,	O	,	_	0	SENT_64	[p4l1676t2025r1946b2109],

1	noninvasive	JJ	O	noninvasive	amod	2	SENT_65	[p4l163t2331r573b2388],
2	ventilation	NN	O	ventilation	nsubj	5	SENT_65	[p4l592t2325r961b2388],
3	might	MD	O	might	aux	5	SENT_65	[p4l983t2325r1186b2409],
4	be	VB	O	be	cop	5	SENT_65	[p4l1204t2325r1283b2388],
5	necessary	JJ	O	necessary	_	0	SENT_65	[p4l1305t2348r1644b2409],
6	.	.	O	.	_	0	SENT_65	[p4l1305t2348r1644b2409],

1	Main	NNP	O	Main	nn	2	SENT_66	[p4l1668t2330r1848b2388],
2	indications	NNS	O	indication	nsubj	11	SENT_66	[p4l164t2427r542b2490],
3	for	IN	O	for	_	0	SENT_66	[p4l564t2427r661b2490],
4	endotracheal	JJ	O	endotracheal	amod	5	SENT_66	[p4l683t2427r1127b2490],
5	intubation	NN	O	intubation	prep_for	2	SENT_66	[p4l1148t2427r1505b2490],
6	and	CC	O	and	_	0	SENT_66	[p4l1527t2427r1653b2490],
7	mechanical	JJ	O	mechanical	amod	8	SENT_66	[p4l1673t2427r2064b2490],
8	ventilation	NN	O	ventilation	conj_and	5	SENT_66	[p4l161t2530r530b2593],
9	are	VBP	O	be	cop	11	SENT_66	[p4l553t2553r652b2593],
10	respiratory	JJ	O	respiratory	amod	11	SENT_66	[p4l675t2536r1052b2614],
11	failure	NN	O	failure	_	0	SENT_66	[p4l1069t2530r1304b2602],
12	,	,	O	,	_	0	SENT_66	[p4l1069t2530r1304b2602],
13	increasing	VBG	O	increase	amod	14	SENT_66	[p4l1327t2536r1679b2614],
14	confusion	NN	O	confusion	conj_and	11	SENT_66	[p4l1700t2530r2057b2602],
15	,	,	O	,	_	0	SENT_66	[p4l1700t2530r2057b2602],
16	and	CC	O	and	_	0	SENT_66	[p4l164t2633r290b2696],
17	insuﬂicient	JJ	O	insuﬂicient	amod	18	SENT_66	[p4l311t2633r692b2696],
18	cooperation	NN	O	cooperation	conj_and	11	SENT_66	[p4l714t2639r1141b2716],
19	.	.	O	.	_	0	SENT_66	[p4l714t2639r1141b2716],

1	.	.	O	.	_	0	SENT_67	[p4l103t2789r113b2799],

1	In	IN	O	in	_	0	SENT_68	[p4l164t2741r235b2798],
2	oligo/anuric	JJ	O	oligo/anuric	amod	3	SENT_68	[p4l257t2736r675b2820],
3	patients	NNS	O	patient	prep_in	32	SENT_68	[p4l695t2742r964b2819],
4	(	CD	NUMBER	(	num	6	SENT_68	[p4l989t2737r1197b2812],
5	urine	NN	O	urine	nn	6	SENT_68	[p4l989t2737r1197b2812],
6	output	NN	O	output	dep	7	SENT_68	[p4l1219t2748r1445b2819],
7	<	JJR	O	<	nsubjpass	32	SENT_68	[p4l1468t2743r1591b2799],
8	20	CD	NUMBER	20	num	10	SENT_68	[p4l1468t2743r1591b2799],
9	ml/h	NN	O	ml/h	nn	10	SENT_68	[p4l1606t2736r1818b2812],
10	)	NN	O	)	dep	7	SENT_68	[p4l1606t2736r1818b2812],
11	,	,	O	,	_	0	SENT_68	[p4l1606t2736r1818b2812],
12	an	DT	O	a	det	13	SENT_68	[p4l1843t2759r1922b2799],
13	increase	NN	O	increase	nsubjpass	32	SENT_68	[p4l164t2844r441b2902],
14	in	IN	O	in	_	0	SENT_68	[p4l463t2844r529b2901],
15	the	DT	O	the	det	16	SENT_68	[p4l550t2838r656b2902],
16	dose	NN	O	dose	prep_in	13	SENT_68	[p4l679t2838r832b2902],
17	of	IN	O	of	_	0	SENT_68	[p4l855t2838r929b2902],
18	diuretic	JJ	O	diuretic	prep_of	16	SENT_68	[p4l941t2838r1222b2910],
19	,	,	O	,	_	0	SENT_68	[p4l941t2838r1222b2910],
20	a	DT	O	a	det	21	SENT_68	[p4l1246t2861r1280b2902],
21	combination	NN	O	combination	conj_or	7	SENT_68	[p4l1302t2838r1736b2902],
22	of	IN	O	of	_	0	SENT_68	[p4l1758t2838r1832b2902],
23	diuretics	NNS	O	diuretic	prep_of	21	SENT_68	[p4l1845t2838r1981b2902, p4l164t2948r364b3014],
24	,	,	O	,	_	0	SENT_68	[p4l1845t2838r1981b2902, p4l164t2948r364b3014],
25	or	CC	O	or	_	0	SENT_68	[p4l387t2965r459b3005],
26	initiation	NN	O	initiation	conj_or	7	SENT_68	[p4l480t2948r795b3005],
27	of	IN	O	of	_	0	SENT_68	[p4l817t2942r891b3005],
28	low-dose	JJ	O	low-dose	amod	29	SENT_68	[p4l901t2942r1212b3005],
29	dopamine	NN	O	dopamine	prep_of	26	SENT_68	[p4l1234t2942r1579b3025],
30	should	MD	O	should	aux	32	SENT_68	[p4l1601t2942r1831b3005],
31	be	VB	O	be	auxpass	32	SENT_68	[p4l1850t2942r1929b3005],
32	considered	VBN	O	consider	_	0	SENT_68	[p4l164t3045r553b3108],
33	.	.	O	.	_	0	SENT_68	[p4l164t3045r553b3108],

1	Beyond	IN	O	beyond	_	0	SENT_69	[p4l578t3045r839b3129],
2	this	DT	O	this	prep_beyond	7	SENT_69	[p4l859t3045r1001b3117],
3	,	,	O	,	_	0	SENT_69	[p4l859t3045r1001b3117],
4	the	DT	O	the	det	5	SENT_69	[p4l1024t3045r1130b3108],
5	physician	NN	O	physician	nsubj	7	SENT_69	[p4l1150t3045r1475b3129],
6	might	MD	O	might	aux	7	SENT_69	[p4l1497t3045r1700b3129],
7	consider	VB	O	consider	_	0	SENT_69	[p4l1721t3045r2013b3108],
8	right	JJ	O	right	amod	11	SENT_69	[p4l164t3148r539b3232],
9	—	JJ	O	—	amod	11	SENT_69	[p4l164t3148r539b3232],
10	heart	NN	O	heart	nn	11	SENT_69	[p4l164t3148r539b3232],
11	catheterization	NN	O	catheterization	dobj	7	SENT_69	[p4l559t3148r1069b3211],
12	and	CC	O	and	_	0	SENT_69	[p4l1091t3148r1217b3211],
13	ultraﬁltration	NN	O	ultraﬁltration	dobj	7	SENT_69	[p4l1237t3148r1716b3211],
14	.	.	O	.	_	0	SENT_69	[p4l1237t3148r1716b3211],

1	HF	NN	O	hf	_	0	SENT_70	[p5l10t80r94b130],
2	with	IN	O	with	_	0	SENT_70	[p5l129t77r258b131],
3	preserved	JJ	O	preserved	amod	5	SENT_70	[p5l293t77r598b145],
4	ejection	NN	O	ejection	nn	5	SENT_70	[p5l632t79r871b145],
5	fraction	NN	O	fraction	prep_with	1	SENT_70	[p5l910t76r1163b131],
6	.	.	O	.	_	0	SENT_70	[p5l910t76r1163b131],

1	The	DT	O	the	det	3	SENT_71	[p5l1219t68r1344b131],
2	European	JJ	ORGANIZATION	european	amod	3	SENT_71	[p5l1397t73r1727b151],
3	Society	NNP	ORGANIZATION	Society	nsubj	9	SENT_71	[p5l1782t72r2030b152],
4	of	IN	ORGANIZATION	of	_	0	SENT_71	[p5l2079t68r2153b131],
5	Cardiology	NNP	ORGANIZATION	Cardiology	nn	6	SENT_71	[p5l12t171r397b255],
6	guidelines	NNS	O	guideline	prep_of	3	SENT_71	[p5l429t171r776b255],
7	do	VBP	O	do	aux	9	SENT_71	[p5l813t171r897b234],
8	not	RB	O	not	neg	9	SENT_71	[p5l933t183r1047b234],
9	give	VB	O	give	_	0	SENT_71	[p5l1081t177r1216b255],
10	differential	JJ	O	differential	amod	11	SENT_71	[p5l1253t171r1626b234],
11	recommendations	NNS	O	recommendation	dobj	9	SENT_71	[p5l1661t171r2141b234, p5l9t280r177b337],
12	for	IN	O	for	_	0	SENT_71	[p5l211t274r309b337],
13	the	DT	O	the	det	16	SENT_71	[p5l341t274r447b337],
14	initial	JJ	O	initial	amod	16	SENT_71	[p5l481t274r681b337],
15	treatment	NN	O	treatment	nn	16	SENT_71	[p5l713t286r1048b337],
16	approach	NN	O	approach	prep_for	9	SENT_71	[p5l1082t274r1398b357],
17	for	IN	O	for	_	0	SENT_71	[p5l1431t274r1529b337],
18	patients	NNS	O	patient	prep_for	16	SENT_71	[p5l1560t280r1829b357],
19	presenting	VBG	O	present	partmod	18	SENT_71	[p5l1863t286r2141b357, p5l10t383r118b461],
20	with	IN	O	with	_	0	SENT_71	[p5l142t377r295b440],
21	preserved	JJ	O	preserved	amod	26	SENT_71	[p5l321t377r656b460],
22	ejection	NN	O	ejection	nn	26	SENT_71	[p5l683t383r953b461],
23	fraction	NN	O	fraction	nn	26	SENT_71	[p5l979t377r1249b440],
24	(	CD	NUMBER	(	num	26	SENT_71	[p5l1280t377r1579b460],
25	HFpEF	NN	O	hfpef	nn	26	SENT_71	[p5l1280t377r1579b460],
26	)	NN	O	)	prep_with	19	SENT_71	[p5l1280t377r1579b460],
27	and	CC	O	and	_	0	SENT_71	[p5l1611t377r1737b440],
28	pulmonary	JJ	O	pulmonary	amod	29	SENT_71	[p5l1762t377r2147b461],
29	congestion	NN	O	congestion	prep_with	19	SENT_71	[p5l11t484r408b564],
30	/	:	O	/	punct	31	SENT_71	[p5l11t484r408b564],
31	edema	NN	O	edema	dep	29	SENT_71	[p5l413t480r653b543],
32	.	.	O	.	_	0	SENT_71	[p5l413t480r653b543],

1	However	RB	O	however	advmod	10	SENT_72	[p5l679t485r998b552],
2	,	,	O	,	_	0	SENT_72	[p5l679t485r998b552],
3	some	DT	O	some	det	4	SENT_72	[p5l1022t503r1199b543],
4	aspects	NNS	O	aspect	nsubjpass	10	SENT_72	[p5l1222t492r1464b563],
5	that	WDT	O	that	nsubjpass	8	SENT_72	[p5l1485t480r1619b543],
6	should	MD	O	should	aux	8	SENT_72	[p5l1641t480r1870b543],
7	be	VB	O	be	auxpass	8	SENT_72	[p5l1889t480r1968b543],
8	considered	VBN	O	consider	rcmod	4	SENT_72	[p5l1991t503r2141b543, p5l11t582r258b645],
9	are	VBP	O	be	auxpass	10	SENT_72	[p5l292t605r392b645],
10	mentioned	VBN	O	mention	_	0	SENT_72	[p5l426t574r843b645],
11	}	CD	NUMBER	}	dobj	10	SENT_72	[p5l426t574r843b645],
12	In	IN	O	in	_	0	SENT_72	[p5l882t587r953b644],
13	HFpEF	NN	O	hfpef	nn	14	SENT_72	[p5l987t587r1232b665],
14	patients	NNS	O	patient	prep_in	19	SENT_72	[p5l1265t588r1553b665],
15	,	,	O	,	_	0	SENT_72	[p5l1265t588r1553b665],
16	diuretic	JJ	O	diuretic	amod	17	SENT_72	[p5l1589t582r1853b645],
17	therapy	NN	O	therapy	nsubjpass	19	SENT_72	[p5l1885t582r2147b666],
18	is	VBZ	O	be	auxpass	19	SENT_72	[p5l10t691r60b748],
19	used	VBN	O	use	dep	10	SENT_72	[p5l96t685r254b748],
20	to	TO	O	to	aux	21	SENT_72	[p5l287t697r352b748],
21	relieve	VB	O	relieve	xcomp	19	SENT_72	[p5l389t685r610b748],
22	congestion	NN	O	congestion	dobj	21	SENT_72	[p5l646t691r1016b769],
23	and	CC	O	and	_	0	SENT_72	[p5l1052t685r1178b748],
24	dyspnea	NN	O	dyspnea	dobj	21	SENT_72	[p5l1213t685r1508b769],
25	,	,	O	,	_	0	SENT_72	[p5l1213t685r1508b769],
26	as	RB	O	as	advmod	28	SENT_72	[p5l1545t708r1610b748],
27	is	VBZ	O	be	auxpass	28	SENT_72	[p5l1645t691r1695b748],
28	done	VBN	O	do	dep	10	SENT_72	[p5l1732t685r1899b748],
29	in	IN	O	in	_	0	SENT_72	[p5l1934t691r2001b747],
30	HF	NN	O	hf	nn	31	SENT_72	[p5l2036t690r2143b747],
31	patients	NNS	O	patient	prep_in	28	SENT_72	[p5l9t794r278b871],
32	with	IN	O	with	_	0	SENT_72	[p5l313t788r465b851],
33	reduced	VBN	O	reduce	amod	34	SENT_72	[p5l502t788r776b851],
34	EF	NN	O	ef	prep_with	28	SENT_72	[p5l811t793r901b850],
35	(	CD	NUMBER	(	num	37	SENT_72	[p5l942t789r1248b865],
36	HFrEF	NN	O	hfref	nn	37	SENT_72	[p5l942t789r1248b865],
37	)	NN	O	)	nsubjpass	28	SENT_72	[p5l942t789r1248b865],
38	.	.	O	.	_	0	SENT_72	[p5l942t789r1248b865],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_73	[p5l1288t788r1747b860],
2	,	,	O	,	_	0	SENT_73	[p5l1288t788r1747b860],
3	in	IN	O	in	_	0	SENT_73	[p5l1785t794r1851b850],
4	HFpEF	NN	O	hfpef	prep_in	10	SENT_73	[p5l1888t793r2142b871],
5	,	,	O	,	_	0	SENT_73	[p5l1888t793r2142b871],
6	special	JJ	O	special	amod	7	SENT_73	[p5l11t891r242b974],
7	emphasis	NN	O	emphasis	nsubjpass	10	SENT_73	[p5l275t891r591b974],
8	should	MD	O	should	aux	10	SENT_73	[p5l626t891r856b954],
9	be	VB	O	be	auxpass	10	SENT_73	[p5l886t891r965b954],
10	placed	VBN	O	place	_	0	SENT_73	[p5l998t891r1220b974],
11	on	IN	O	on	_	0	SENT_73	[p5l1254t914r1339b954],
12	adequate	JJ	O	adequate	amod	13	SENT_73	[p5l1374t891r1678b974],
13	treatment	NN	O	treatment	prep_on	10	SENT_73	[p5l1711t903r2046b954],
14	of	IN	O	of	_	0	SENT_73	[p5l2079t891r2153b954],
15	hypertension	NN	O	hypertension	prep_of	13	SENT_73	[p5l9t994r460b1078],
16	and	CC	O	and	_	0	SENT_73	[p5l485t994r612b1057],
17	on	IN	O	on	_	0	SENT_73	[p5l635t1017r721b1057],
18	the	DT	O	the	det	19	SENT_73	[p5l745t994r851b1057],
19	control	NN	O	control	prep_on	10	SENT_73	[p5l876t994r1121b1057],
20	of	IN	O	of	_	0	SENT_73	[p5l1145t994r1219b1057],
21	ventricular	JJ	O	ventricular	amod	22	SENT_73	[p5l1231t994r1610b1057],
22	rate	NN	O	rate	prep_of	19	SENT_73	[p5l1633t1006r1760b1057],
23	in	IN	O	in	_	0	SENT_73	[p5l1785t1000r1851b1056],
24	patients	NNS	O	patient	prep_in	10	SENT_73	[p5l1874t1000r2143b1077],
25	with	IN	O	with	_	0	SENT_73	[p5l9t1097r161b1160],
26	atrial	JJ	O	atrial	amod	27	SENT_73	[p5l198t1097r373b1160],
27	ﬁbrillation	NN	O	ﬁbrillation	prep_with	24	SENT_73	[p5l407t1097r786b1160],
28	.	.	O	.	_	0	SENT_73	[p5l407t1097r786b1160],

1	Calcium	NN	O	calcium	nn	4	SENT_74	[p5l826t1097r1418b1160],
2	—	NN	O	—	nn	4	SENT_74	[p5l826t1097r1418b1160],
3	channel	NN	O	channel	nn	4	SENT_74	[p5l826t1097r1418b1160],
4	blockers	NNS	O	blocker	nsubj	5	SENT_74	[p5l1451t1097r1736b1160],
5	(	VBP	O	(	ccomp	12	SENT_74	[p5l1776t1098r1933b1181],
6	e.g.	FW	O	e.g.	dobj	5	SENT_74	[p5l1776t1098r1933b1181],
7	,	,	O	,	_	0	SENT_74	[p5l1776t1098r1933b1181],
8	verapamil	NN	O	verapamil	nn	9	SENT_74	[p5l1968t1120r2141b1160, p5l9t1200r231b1283],
9	)	NN	O	)	nsubj	12	SENT_74	[p5l1968t1120r2141b1160, p5l9t1200r231b1283],
10	may	MD	O	may	aux	12	SENT_74	[p5l256t1223r402b1284],
11	be	VB	O	be	cop	12	SENT_74	[p5l417t1200r496b1263],
12	useful	JJ	O	useful	_	0	SENT_74	[p5l517t1200r723b1263],
13	for	IN	O	for	_	0	SENT_74	[p5l743t1200r840b1263],
14	ventricular	JJ	O	ventricular	amod	16	SENT_74	[p5l857t1200r1236b1263],
15	rate	NN	O	rate	nn	16	SENT_74	[p5l1255t1212r1382b1263],
16	control	NN	O	control	prep_for	12	SENT_74	[p5l1403t1200r1647b1263],
17	in	IN	O	in	_	0	SENT_74	[p5l1668t1206r1734b1262],
18	atrial	JJ	O	atrial	amod	19	SENT_74	[p5l1755t1200r1930b1263],
19	ﬁbrillation	NN	O	ﬁbrillation	prep_in	16	SENT_74	[p5l1950t1200r2141b1263, p5l9t1303r223b1375],
20	,	,	O	,	_	0	SENT_74	[p5l1950t1200r2141b1263, p5l9t1303r223b1375],
21	to	TO	O	to	aux	22	SENT_74	[p5l247t1315r313b1366],
22	treat	VB	O	treat	xcomp	12	SENT_74	[p5l337t1315r493b1366],
23	hypertension	NN	O	hypertension	nn	27	SENT_74	[p5l514t1303r965b1387],
24	and	CC	O	and	_	0	SENT_74	[p5l990t1303r1115b1366],
25	myocardial	JJ	O	myocardial	conj_and	23	SENT_74	[p5l1138t1303r1522b1387],
26	ischemia	NN	O	ischemia	nn	27	SENT_74	[p5l1544t1303r1847b1366],
27	(	NN	O	(	dobj	22	SENT_74	[p5l1873t1304r1966b1379],
28	in	IN	O	in	_	0	SENT_74	[p5l1873t1304r1966b1379],
29	contrast	NN	O	contrast	prep_in	27	SENT_74	[p5l1991t1326r2141b1366, p5l9t1418r162b1469],
30	to	TO	O	to	_	0	SENT_74	[p5l182t1418r247b1469],
31	HFrEF	NN	O	hfref	nn	32	SENT_74	[p5l271t1411r503b1468],
32	patients	NNS	O	patient	prep_to	22	SENT_74	[p5l525t1412r813b1489],
33	,	,	O	,	_	0	SENT_74	[p5l525t1412r813b1489],
34	in	IN	O	in	_	0	SENT_74	[p5l837t1412r903b1468],
35	whom	WP	O	whom	rel	43	SENT_74	[p5l923t1406r1141b1469],
36	the	DT	O	the	det	39	SENT_74	[p5l1162t1406r1268b1469],
37	negative	JJ	O	negative	amod	39	SENT_74	[p5l1290t1412r1572b1490],
38	inotropic	JJ	O	inotropic	amod	39	SENT_74	[p5l1595t1412r1909b1489],
39	effects	NNS	O	effect	nsubj	43	SENT_74	[p5l1931t1406r2143b1469],
40	may	MD	O	may	aux	43	SENT_74	[p5l10t1533r156b1594],
41	be	VB	O	be	cop	43	SENT_74	[p5l175t1510r254b1573],
42	dangerous	JJ	O	dangerous	amod	43	SENT_74	[p5l278t1510r677b1594],
43	)	NN	O	)	rcmod	32	SENT_74	[p5l278t1510r677b1594],
44	.	.	O	.	_	0	SENT_74	[p5l278t1510r677b1594],

1	Of	IN	O	of	_	0	SENT_75	[p5l85t1613r183b1676],
2	note	NN	O	note	prep_of	14	SENT_75	[p5l201t1625r376b1685],
3	,	,	O	,	_	0	SENT_75	[p5l201t1625r376b1685],
4	in	IN	O	in	_	0	SENT_75	[p5l406t1619r475b1675],
5	contrast	NN	O	contrast	prep_in	14	SENT_75	[p5l503t1625r795b1676],
6	to	TO	O	to	_	0	SENT_75	[p5l821t1625r889b1676],
7	HFrEF	NN	O	hfref	prep_to	5	SENT_75	[p5l919t1618r1172b1685],
8	,	,	O	,	_	0	SENT_75	[p5l919t1618r1172b1685],
9	no	DT	O	no	det	10	SENT_75	[p5l1201t1636r1291b1676],
10	treatment	NN	O	treatment	nsubjpass	14	SENT_75	[p5l1318t1625r1672b1676],
11	has	VBZ	O	have	aux	14	SENT_75	[p5l1698t1613r1815b1676],
12	yet	RB	O	yet	advmod	14	SENT_75	[p5l1841t1625r1947b1697],
13	been	VBN	O	be	auxpass	14	SENT_75	[p5l1971t1613r2143b1676],
14	shown	VBN	O	show	_	0	SENT_75	[p5l11t1716r242b1779],
15	to	TO	O	to	aux	16	SENT_75	[p5l267t1728r335b1779],
16	reduce	VB	O	reduce	xcomp	14	SENT_75	[p5l363t1716r600b1779],
17	morbidity	NN	O	morbidity	dobj	16	SENT_75	[p5l626t1716r988b1800],
18	and	CC	O	and	_	0	SENT_75	[p5l1011t1716r1142b1779],
19	mortality	NN	O	mortality	dobj	16	SENT_75	[p5l1166t1716r1504b1800],
20	in	IN	O	in	_	0	SENT_75	[p5l1527t1722r1595b1778],
21	HFpEF	NN	O	hfpef	prep_in	16	SENT_75	[p5l1622t1721r1886b1799],
22	.	.	O	.	_	0	SENT_75	[p5l1622t1721r1886b1799],

1	In	IN	O	in	_	0	SENT_76	[p5l1915t1721r1988b1778],
2	stable	JJ	O	stable	amod	4	SENT_76	[p5l2016t1728r2140b1779, p5l8t1819r115b1882],
3	HFpEF	NN	O	hfpef	nn	4	SENT_76	[p5l149t1824r408b1902],
4	patients	NNS	O	patient	prep_in	10	SENT_76	[p5l440t1825r754b1902],
5	,	,	O	,	_	0	SENT_76	[p5l440t1825r754b1902],
6	none	NN	O	none	nsubj	10	SENT_76	[p5l788t1842r969b1882],
7	of	IN	O	of	_	0	SENT_76	[p5l1002t1819r1080b1882],
8	three	CD	NUMBER	three	prep_of	6	SENT_76	[p5l1102t1819r1290b1882],
9	key	JJ	O	key	amod	8	SENT_76	[p5l1321t1819r1449b1903],
10	randomized	VBN	O	randomize	_	0	SENT_76	[p5l1478t1819r1924b1882],
11	trials	NNS	O	trial	nsubj	17	SENT_76	[p5l1954t1819r2141b1882],
12	with	IN	O	with	_	0	SENT_76	[p5l9t1922r168b1985],
13	hard	JJ	O	hard	amod	16	SENT_76	[p5l192t1922r357b1985],
14	clinical	JJ	O	clinical	amod	16	SENT_76	[p5l382t1922r640b1985],
15	end	NN	O	end	nn	16	SENT_76	[p5l666t1922r797b1985],
16	points	NNS	O	point	prep_with	11	SENT_76	[p5l821t1928r1043b2005],
17	investigating	VBG	O	investigate	dep	10	SENT_76	[p5l1070t1928r1529b2006],
18	the	DT	O	the	det	19	SENT_76	[p5l1553t1922r1663b1985],
19	effects	NNS	O	effect	dobj	17	SENT_76	[p5l1690t1922r1912b1985],
20	of	IN	O	of	_	0	SENT_76	[p5l1939t1922r2016b1985],
21	the	DT	O	the	det	27	SENT_76	[p5l2031t1922r2142b1985],
22	angiotensin-converting	JJ	O	angiotensin-converting	amod	27	SENT_76	[p5l11t2031r837b2109],
23	enzyme	NN	O	enzyme	nn	27	SENT_76	[p5l860t2047r1130b2109],
24	(	CD	NUMBER	(	num	27	SENT_76	[p5l1158t2026r1375b2102],
25	ACE	NN	O	ace	nn	27	SENT_76	[p5l1158t2026r1375b2102],
26	)	NN	O	)	nn	27	SENT_76	[p5l1158t2026r1375b2102],
27	inhibitor	NN	O	inhibitor	prep_of	19	SENT_76	[p5l1404t2025r1716b2088],
28	perindopril	NN	O	perindopril	nn	30	SENT_76	[p5l1738t2025r2144b2108],
29	(	CD	NUMBER	(	num	30	SENT_76	[p5l14t2128r457b2211],
30	Perindopril	NNP	O	Perindopril	dep	27	SENT_76	[p5l14t2128r457b2211],
31	for	IN	O	for	_	0	SENT_76	[p5l484t2128r586b2191],
32	Elderly	NNP	O	Elderly	nn	33	SENT_76	[p5l611t2128r871b2212],
33	People	NNS	O	people	prep_for	30	SENT_76	[p5l895t2128r1131b2211],
34	with	IN	O	with	_	0	SENT_76	[p5l1157t2128r1317b2191],
35	Chronic	JJ	O	chronic	amod	38	SENT_76	[p5l1345t2128r1639b2191],
36	Heart	NNP	O	Heart	nn	38	SENT_76	[p5l1667t2133r1870b2191],
37	Failure	NN	O	failure	nn	38	SENT_76	[p5l1897t2128r2144b2191],
38	trial	NN	O	trial	prep_with	10	SENT_76	[p5l9t2231r171b2303],
39	,	,	O	,	_	0	SENT_76	[p5l9t2231r171b2303],
40	PEP	NN	O	pep	dobj	10	SENT_76	[p5l198t2232r582b2308],
41	.	.	O	.	_	0	SENT_76	[p5l198t2232r582b2308],

1	—	NN	O	—	_	0	SENT_77	[p5l198t2232r582b2308],
2	.	.	O	.	_	0	SENT_77	[p5l198t2232r582b2308],

1	CHF	NN	O	chf	_	0	SENT_78	[p5l198t2232r582b2308],
2	)	CD	NUMBER	)	nsubj	7	SENT_78	[p5l198t2232r582b2308],
3	or	CC	O	or	_	0	SENT_78	[p5l611t2254r683b2294],
4	the	DT	O	the	det	6	SENT_78	[p5l705t2231r814b2294],
5	angiotensin-receptor	NN	O	angiotensin-receptor	nn	6	SENT_78	[p5l838t2237r1572b2315],
6	blockers	NNS	O	blocker	conj_or	2	SENT_78	[p5l1592t2231r1885b2294],
7	candesartan	VBP	O	candesartan	rcmod	1	SENT_78	[p5l1910t2231r2141b2294, p5l11t2346r218b2397],
8	(	CD	NUMBER	(	num	9	SENT_78	[p5l242t2334r699b2411],
9	Candesartan	NNP	O	Candesartan	dobj	7	SENT_78	[p5l242t2334r699b2411],
10	in	IN	O	in	_	0	SENT_78	[p5l720t2340r786b2397],
11	Heart	NNP	O	Heart	nn	12	SENT_78	[p5l807t2339r999b2397],
12	Failure	NN	O	failure	prep_in	9	SENT_78	[p5l1020t2334r1269b2397],
13	:	:	O	:	_	0	SENT_78	[p5l1020t2334r1269b2397],
14	Assessment	NNP	O	Assessment	dep	9	SENT_78	[p5l1291t2338r1687b2398],
15	of	IN	O	of	_	0	SENT_78	[p5l1707t2334r1780b2397],
16	Reduction	NNP	O	Reduction	prep_of	14	SENT_78	[p5l1792t2334r2143b2397],
17	in	IN	O	in	_	0	SENT_78	[p5l11t2443r79b2499],
18	Mortality	NNP	O	Mortality	prep_in	7	SENT_78	[p5l105t2437r446b2521],
19	and	CC	O	and	_	0	SENT_78	[p5l469t2437r600b2500],
20	Morbidity	NNP	O	Morbidity	nn	22	SENT_78	[p5l625t2437r990b2521],
21	(	CD	NUMBER	(	num	22	SENT_78	[p5l1016t2437r1785b2514],
22	CHARM	NN	O	charm	prep_in	7	SENT_78	[p5l1016t2437r1785b2514],
23	)	SYM	O	)	dep	25	SENT_78	[p5l1016t2437r1785b2514],
24	-	:	O	-	_	0	SENT_78	[p5l1016t2437r1785b2514],
25	Preserved	VBN	O	preserve	dep	1	SENT_78	[p5l1016t2437r1785b2514],
26	trial	NN	O	trial	nn	27	SENT_78	[p5l1809t2437r1983b2513],
27	)	NN	O	)	dobj	25	SENT_78	[p5l1809t2437r1983b2513],
28	and	CC	O	and	_	0	SENT_78	[p5l2014t2437r2145b2500],
29	irbesartan	NN	O	irbesartan	nn	31	SENT_78	[p5l10t2540r360b2603],
30	(	CD	NUMBER	(	num	31	SENT_78	[p5l385t2540r766b2617],
31	Irbesartan	NNP	O	Irbesartan	dobj	25	SENT_78	[p5l385t2540r766b2617],
32	in	IN	O	in	_	0	SENT_78	[p5l788t2546r854b2602],
33	Heart	NNP	O	Heart	nn	34	SENT_78	[p5l876t2545r1072b2603],
34	Failure	NN	O	failure	prep_in	25	SENT_78	[p5l1093t2540r1329b2603],
35	with	IN	O	with	_	0	SENT_78	[p5l1349t2540r1503b2603],
36	Preserved	VBN	O	preserve	prepc_with	25	SENT_78	[p5l1525t2540r1865b2603],
37	Systolic	JJ	O	systolic	amod	39	SENT_78	[p5l1886t2540r2146b2624],
38	Function	NN	O	function	nn	39	SENT_78	[p5l11t2648r344b2706],
39	trial	NN	O	trial	nsubj	41	SENT_78	[p5l375t2643r529b2706],
40	(	CD	NUMBER	(	dep	39	SENT_78	[p5l564t2644r1035b2720],
41	I	PRP	O	I	xcomp	36	SENT_78	[p5l564t2644r1035b2720],
42	.	.	O	.	_	0	SENT_78	[p5l564t2644r1035b2720],

1	—	NN	O	—	_	0	SENT_79	[p5l564t2644r1035b2720],
2	.	.	O	.	_	0	SENT_79	[p5l564t2644r1035b2720],

1	Preserve	VB	O	preserve	_	0	SENT_80	[p5l564t2644r1035b2720],
2	)	NN	O	)	nn	3	SENT_80	[p5l564t2644r1035b2720],
3	)	NN	O	)	nsubj	4	SENT_80	[p5l564t2644r1035b2720],
4	showed	VBD	O	show	ccomp	1	SENT_80	[p5l1073t2643r1348b2706],
5	any	DT	O	any	det	6	SENT_80	[p5l1379t2666r1507b2727],
6	reduction	NN	O	reduction	nsubj	11	SENT_80	[p5l1536t2643r1894b2706],
7	in	IN	O	in	_	0	SENT_80	[p5l1927t2649r1997b2705],
8	the	DT	O	the	det	10	SENT_80	[p5l2028t2643r2141b2706],
9	primary	JJ	O	primary	amod	10	SENT_80	[p5l9t2752r307b2830],
10	outcomes	NNS	O	outcome	prep_in	6	SENT_80	[p5l332t2758r676b2809],
11	(	VBP	O	(	ccomp	4	SENT_80	[p5l709t2747r1108b2829],
12	composite	NN	O	composite	dobj	11	SENT_80	[p5l709t2747r1108b2829],
13	of	IN	O	of	_	0	SENT_80	[p5l1137t2746r1214b2809],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_80	[p5l1232t2746r1760b2809],
15	death	NN	O	death	prep_of	12	SENT_80	[p5l1788t2746r1986b2809],
16	and	CC	O	and	_	0	SENT_80	[p5l2015t2746r2146b2809],
17	rehospitalization	NN	O	rehospitalization	conj_and	12	SENT_80	[p5l11t2840r759b2931],
18	)	CD	NUMBER	)	number	19	SENT_80	[p5l11t2840r759b2931],
19	.6	CD	NUMBER	.6	dep	17	SENT_80	[p5l11t2840r759b2931],
20	‘	NN	O	‘	dep	19	SENT_80	[p5l11t2840r759b2931],
21	8	CD	NUMBER	8	num	20	SENT_80	[p5l11t2840r759b2931],
22	In	IN	O	in	_	0	SENT_80	[p5l785t2853r858b2910],
23	the	DT	O	the	det	25	SENT_80	[p5l882t2848r992b2911],
24	recently	RB	DATE	recently	advmod	25	SENT_80	[p5l1017t2848r1302b2932],
25	published	VBN	O	publish	prep_in	11	SENT_80	[p5l1321t2848r1670b2931],
26	randomized	VBN	O	randomize	dep	25	SENT_80	[p5l1694t2848r2141b2920],
27	,	,	O	,	_	0	SENT_80	[p5l1694t2848r2141b2920],
28	controlled	VBN	O	control	dep	26	SENT_80	[p5l11t2951r369b3014],
29	Aldosterone	NN	O	aldosterone	nn	31	SENT_80	[p5l391t2951r819b3014],
30	Receptor	NN	O	receptor	nn	31	SENT_80	[p5l844t2956r1157b3034],
31	Blockade	NN	O	blockade	dobj	28	SENT_80	[p5l1180t2951r1498b3014],
32	in	IN	O	in	_	0	SENT_80	[p5l1522t2957r1590b3013],
33	Diastolic	JJ	O	diastolic	amod	36	SENT_80	[p5l1614t2951r1924b3014],
34	Heart	NNP	O	Heart	nn	36	SENT_80	[p5l1948t2956r2146b3014],
35	FailureALDO-DHF	NN	O	failurealdo-dhf	nn	36	SENT_80	[p5l11t3053r711b3117],
36	trial	NN	O	trial	prep_in	31	SENT_80	[p5l737t3053r902b3125],
37	,	,	O	,	_	0	SENT_80	[p5l737t3053r902b3125],
38	treatment	NN	O	treatment	dobj	26	SENT_80	[p5l928t3065r1277b3117],
39	with	IN	O	with	_	0	SENT_80	[p5l1299t3053r1457b3117],
40	the	DT	O	the	det	41	SENT_80	[p5l1481t3053r1591b3117],
41	mineralocorticoid-receptor	NN	O	mineralocorticoid-receptor	prep_with	38	SENT_80	[p5l1617t3053r2140b3117, p5l11t3157r495b3240],

1	antagonist	NN	O	antagonist	nn	2	SENT_81	[p5l521t3163r891b3241],
2	spironolactone	NN	O	spironolactone	nsubj	40	SENT_81	[p5l917t3157r1448b3240],
3	improved	VBD	O	improve	_	0	SENT_81	[p5l1474t3157r1817b3240],
4	diastolic	JJ	O	diastolic	amod	6	SENT_81	[p5l1843t3157r2142b3220],
5	dysfunction	NN	O	dysfunction	nn	6	SENT_81	[p5l11t3260r423b3344],
6	(	NN	O	(	dobj	3	SENT_81	[p5l448t3261r540b3336],
7	as	IN	O	as	mark	37	SENT_81	[p5l448t3261r540b3336],
8	assessed	VBN	O	assess	csubj	37	SENT_81	[p5l563t3260r847b3323],
9	by	IN	O	by	_	0	SENT_81	[p5l865t3260r950b3344],
10	echocardiography	NN	O	echocardiography	nn	11	SENT_81	[p5l968t3260r1615b3344],
11	)	NN	O	)	prep_by	8	SENT_81	[p5l968t3260r1615b3344],
12	without	IN	O	without	_	0	SENT_81	[p5l1639t3260r1909b3323],
13	affecting	VBG	O	affect	prepc_without	8	SENT_81	[p5l1930t3260r2141b3323, p5l11t3369r122b3447],
14	exercise	NN	O	exercise	nn	15	SENT_81	[p5l147t3369r428b3426],
15	capacity	NN	O	capacity	dobj	13	SENT_81	[p5l455t3369r758b3447],
16	,	,	O	,	_	0	SENT_81	[p5l455t3369r758b3447],
17	symptoms	NNS	O	symptom	conj_or	15	SENT_81	[p5l786t3375r1170b3447],
18	,	,	O	,	_	0	SENT_81	[p5l786t3375r1170b3447],
19	or	CC	O	or	_	0	SENT_81	[p5l1198t3386r1273b3426],
20	quality	NN	O	quality	conj_or	15	SENT_81	[p5l1298t3363r1546b3447],
21	of	IN	O	of	_	0	SENT_81	[p5l1568t3363r1644b3426],
22	life	NN	O	life	prep_of	20	SENT_81	[p5l1659t3363r1768b3426],
23	in	IN	O	in	_	0	SENT_81	[p5l1794t3369r1863b3425],
24	HFpEF	NN	O	hfpef	nn	25	SENT_81	[p5l1889t3368r2143b3446],
25	patients	NNS	O	patient	prep_in	22	SENT_81	[p5l9t3457r341b3548],
26	.9	CD	NUMBER	.9	tmod	13	SENT_81	[p5l9t3457r341b3548],
27	The	DT	O	the	det	29	SENT_81	[p5l366t3465r493b3528],
28	clinical	JJ	O	clinical	amod	29	SENT_81	[p5l519t3465r772b3528],
29	signiﬁcance	NN	O	signiﬁcance	nsubj	33	SENT_81	[p5l797t3465r1213b3549],
30	of	IN	O	of	_	0	SENT_81	[p5l1238t3465r1313b3528],
31	the	DT	O	the	prep_of	29	SENT_81	[p5l1327t3465r1437b3528],
32	observed	VBN	O	observe	partmod	31	SENT_81	[p5l1462t3465r1782b3528],
33	improved	VBD	O	improve	rcmod	26	SENT_81	[p5l1806t3465r2146b3548],
34	diastolic	JJ	O	diastolic	amod	35	SENT_81	[p5l11t3568r291b3631],
35	dysfunction	NN	O	dysfunction	dobj	33	SENT_81	[p5l312t3568r714b3652],
36	remains	VBZ	O	remain	cop	37	SENT_81	[p5l735t3574r1003b3631],
37	unclear	JJ	O	unclear	advcl	3	SENT_81	[p5l1024t3568r1274b3631],
38	and	CC	O	and	_	0	SENT_81	[p5l1294t3568r1419b3631],
39	will	MD	O	will	aux	40	SENT_81	[p5l1436t3568r1560b3631],
40	need	VB	O	need	conj_and	3	SENT_81	[p5l1580t3568r1742b3631],
41	to	TO	O	to	aux	43	SENT_81	[p5l1760t3580r1825b3631],
42	be	VB	O	be	auxpass	43	SENT_81	[p5l1844t3568r1922b3631],
43	investigated	VBN	O	investigate	xcomp	40	SENT_81	[p5l1943t3574r2140b3631, p5l9t3671r245b3755],
44	in	IN	O	in	_	0	SENT_81	[p5l267t3677r334b3733],
45	further	JJ	O	further	amod	46	SENT_81	[p5l356t3671r602b3734],
46	trials	NNS	O	trial	prep_in	43	SENT_81	[p5l622t3671r813b3734],
47	.	.	O	.	_	0	SENT_81	[p5l622t3671r813b3734],

1	AHF	NN	ORGANIZATION	ahf	_	0	SENT_82	[p6l6t102r138b152],
2	in	IN	O	in	_	0	SENT_82	[p6l152t101r206b152],
3	patients	NNS	O	patient	prep_in	1	SENT_82	[p6l223t101r475b167],
4	with	IN	O	with	_	0	SENT_82	[p6l495t99r625b153],
5	HF	NN	O	hf	prep_with	3	SENT_82	[p6l645t102r730b152],
6	due	JJ	O	due	_	0	SENT_82	[p6l744t99r856b153],
7	to	TO	O	to	_	0	SENT_82	[p6l876t106r935b153],
8	acute	JJ	O	acute	amod	10	SENT_82	[p6l954t106r1122b153],
9	coronary	JJ	O	coronary	amod	10	SENT_82	[p6l1140t115r1418b168],
10	syndrome	NN	O	syndrome	prep_due_to	1	SENT_82	[p6l1431t99r1748b168],
11	.	.	O	.	_	0	SENT_82	[p6l1431t99r1748b168],

1	In	IN	O	in	_	0	SENT_83	[p6l1778t95r1849b152],
2	patients	NNS	O	patient	prep_in	10	SENT_83	[p6l1874t96r2143b173],
3	with	IN	O	with	_	0	SENT_83	[p6l9t193r161b256],
4	AHF	NN	ORGANIZATION	ahf	prep_with	2	SENT_83	[p6l188t197r365b265],
5	,	,	O	,	_	0	SENT_83	[p6l188t197r365b265],
6	special	JJ	O	special	amod	7	SENT_83	[p6l396t193r626b276],
7	emphasis	NN	O	emphasis	nsubjpass	10	SENT_83	[p6l654t193r969b276],
8	must	MD	O	must	aux	10	SENT_83	[p6l997t205r1167b256],
9	be	VB	O	be	auxpass	10	SENT_83	[p6l1192t193r1271b256],
10	placed	VBN	O	place	_	0	SENT_83	[p6l1298t193r1521b276],
11	on	IN	O	on	_	0	SENT_83	[p6l1548t216r1634b256],
12	the	DT	O	the	det	13	SENT_83	[p6l1661t193r1767b256],
13	identiﬁcation	NN	O	identiﬁcation	prep_on	10	SENT_83	[p6l1795t193r2141b256, p6l9t302r146b359],
14	of	IN	O	of	_	0	SENT_83	[p6l175t296r249b359],
15	the	DT	O	the	det	17	SENT_83	[p6l266t296r372b359],
16	underlying	VBG	O	underlie	amod	17	SENT_83	[p6l400t296r776b380],
17	cause	NN	O	cause	prep_of	13	SENT_83	[p6l803t319r986b359],
18	because	IN	O	because	mark	20	SENT_83	[p6l1012t296r1279b359],
19	this	DT	O	this	nsubj	20	SENT_83	[p6l1307t296r1431b359],
20	determines	VBZ	O	determine	advcl	10	SENT_83	[p6l1460t296r1841b359],
21	the	DT	O	the	det	24	SENT_83	[p6l1869t296r1975b359],
22	speciﬁc	NN	O	speciﬁc	nn	24	SENT_83	[p6l2004t318r2141b379, p6l11t399r149b462],
23	treatment	NN	O	treatment	nn	24	SENT_83	[p6l193t411r529b462],
24	measures	NNS	O	measure	dobj	20	SENT_83	[p6l573t422r907b462],
25	.	.	O	.	_	0	SENT_83	[p6l573t422r907b462],

1	Acute	JJ	O	acute	amod	3	SENT_84	[p6l955t403r1154b462],
2	coronary	JJ	O	coronary	amod	3	SENT_84	[p6l1200t422r1511b483],
3	syndromes	NNS	O	syndrome	nsubj	5	SENT_84	[p6l1554t399r1925b483],
4	often	RB	O	often	advmod	5	SENT_84	[p6l1971t399r2144b462],
5	represent	VBP	O	represent	_	0	SENT_84	[p6l11t514r328b585],
6	the	DT	O	the	det	7	SENT_84	[p6l347t502r453b565],
7	cause	NN	O	cause	dobj	5	SENT_84	[p6l474t525r657b565],
8	or	CC	O	or	_	0	SENT_84	[p6l679t525r750b565],
9	the	DT	O	the	det	10	SENT_84	[p6l769t502r875b565],
10	precipitant	NN	O	precipitant	dobj	5	SENT_84	[p6l894t508r1266b585],
11	of	IN	O	of	_	0	SENT_84	[p6l1286t502r1360b565],
12	AHF	NN	O	ahf	prep_of	10	SENT_84	[p6l1370t506r1545b565],
13	.	.	O	.	_	0	SENT_84	[p6l1370t506r1545b565],

1	In	IN	O	in	_	0	SENT_85	[p6l1569t507r1640b564],
2	these	DT	O	these	det	3	SENT_85	[p6l1660t502r1835b565],
3	patients	NNS	O	patient	prep_in	10	SENT_85	[p6l1855t508r2142b585],
4	,	,	O	,	_	0	SENT_85	[p6l1855t508r2142b585],
5	revascularization	NN	O	revascularization	nsubj	10	SENT_85	[p6l11t605r596b668],
6	is	VBZ	O	be	cop	10	SENT_85	[p6l639t611r689b668],
7	the	DT	O	the	det	10	SENT_85	[p6l732t605r838b668],
8	most	RBS	O	most	advmod	9	SENT_85	[p6l881t617r1051b668],
9	important	JJ	O	important	amod	10	SENT_85	[p6l1093t611r1440b688],
10	therapy	NN	O	therapy	_	0	SENT_85	[p6l1481t605r1750b689],
11	.	.	O	.	_	0	SENT_85	[p6l1481t605r1750b689],

1	Therefore	RB	O	therefore	advmod	5	SENT_86	[p6l1796t605r2142b677],
2	,	,	O	,	_	0	SENT_86	[p6l1796t605r2142b677],
3	patients	NNS	O	patient	nsubj	5	SENT_86	[p6l9t715r278b792],
4	should	MD	O	should	aux	5	SENT_86	[p6l313t709r543b772],
5	undergo	VB	O	undergo	_	0	SENT_86	[p6l576t709r861b793],
6	coronary	JJ	O	coronary	amod	7	SENT_86	[p6l896t732r1207b793],
7	angiography	NN	O	angiography	dobj	5	SENT_86	[p6l1238t709r1666b793],
8	and	CC	O	and	_	0	SENT_86	[p6l1697t709r1823b772],
9	revascularization	NN	O	revascularization	dobj	5	SENT_86	[p6l1855t732r2140b772, p6l9t839r334b902],
10	as	IN	O	as	_	0	SENT_86	[p6l368t862r431b902],
11	appropriate	JJ	O	appropriate	prep_as	5	SENT_86	[p6l465t845r874b922],
12	.	.	O	.	_	0	SENT_86	[p6l465t845r874b922],

1	According	VBG	O	accord	_	0	SENT_87	[p6l909t839r1268b923],
2	to	TO	O	to	pcomp	1	SENT_87	[p6l1298t851r1363b902],
3	the	DT	O	the	det	5	SENT_87	[p6l1396t839r1502b902],
4	European	JJ	ORGANIZATION	european	amod	5	SENT_87	[p6l1534t844r1865b922],
5	Society	NNP	ORGANIZATION	Society	pobj	2	SENT_87	[p6l1899t843r2147b923],
6	of	IN	ORGANIZATION	of	_	0	SENT_87	[p6l11t942r85b1005],
7	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	5	SENT_87	[p6l111t942r495b1026],
8	and	CC	O	and	_	0	SENT_87	[p6l527t942r653b1005],
9	updated	VBN	O	update	conj_and	1	SENT_87	[p6l686t942r965b1025],
10	American	NNP	ORGANIZATION	American	nn	11	SENT_87	[p6l997t946r1338b1005],
11	College	NNP	ORGANIZATION	College	dobj	9	SENT_87	[p6l1373t942r1627b1026],
12	of	IN	ORGANIZATION	of	_	0	SENT_87	[p6l1662t942r1736b1005],
13	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	11	SENT_87	[p6l1762t942r2147b1026],

1	VOLUME	NN	O	volume	nn	3	SENT_88	[p6l537t1160r761b1202],
2	94	CD	NUMBER	94	num	3	SENT_88	[p6l778t1161r837b1202],
3	NUMBER	NN	O	number	_	0	SENT_88	[p6l856t1160r1079b1202],
4	4	CD	NUMBER	4	number	5	SENT_88	[p6l1094t1156r1147b1217],
5	|	CD	NUMBER	|	num	6	SENT_88	[p6l1094t1156r1147b1217],
6	OCTOBER	NNP	DATE	OCTOBER	dep	3	SENT_88	[p6l1167t1160r1414b1202],
7	2013	CD	DATE	2013	num	8	SENT_88	[p6l1432t1161r1550b1202],
8	|	CD	NUMBER	|	dep	6	SENT_88	[p6l1571t1156r1576b1217],
9	www.nature.com/cpt	JJ	O	www.nature.com/cpt	amod	10	SENT_88	[p6l1594t1160r2144b1213],
10	REVIEW	NNP	O	REVIEW	dep	3	SENT_88	[p6l1948t1292r2138b1329],

1	Intravenous	JJ	O	intravenous	amod	2	SENT_89	[p6l219t1882r547b1930],
2	bolus	NN	O	bolus	_	0	SENT_89	[p6l571t1882r721b1930],
3	of	IN	O	of	_	0	SENT_89	[p6l245t1963r297b2011],
4	loop	NN	O	loop	prep_of	2	SENT_89	[p6l320t1963r437b2024],
5	diuretic	JJ	O	diuretic	amod	6	SENT_89	[p6l459t1950r684b2011],
6	‘	NN	O	‘	dep	2	SENT_89	[p6l459t1950r684b2011],

1	_	NN	O	_	_	0	SENT_90	[p6l569t2280r576b2287],
2	2	CD	NUMBER	2	dep	1	SENT_90	[p6l617t2266r640b2299],
3	Yes	UH	O	yes	dep	7	SENT_90	[p6l1077t2217r1177b2266],
4	3	CD	NUMBER	3	num	7	SENT_90	[p6l1969t2251r1991b2282],
5	Hypoxemia	NN	O	hypoxemia	nn	7	SENT_90	[p6l299t2280r615b2341],
6	Til	NN	O	til	nn	7	SENT_90	[p6l1035t2277r1269b2319],
7	OXY9e	NN	O	oxy9e	rcmod	2	SENT_90	[p6l1746t2265r1964b2329],
8	“	CD	NUMBER	“	dep	1	SENT_90	[p6l1746t2265r1964b2329],

1	1	CD	NUMBER	1	_	0	SENT_91	[p6l457t2512r494b2642],
2	No	DT	O	no	det	4	SENT_91	[p6l533t2517r609b2566],
3	_	NN	O	_	nn	4	SENT_91	[p6l660t2585r664b2587],
4	T	NN	O	t	dep	1	SENT_91	[p6l702t2585r705b2586],
5	I	PRP	O	I	dep	1	SENT_91	[p6l1857t2460r1873b2601],

1	_	RB	O	_	_	0	SENT_92	[p6l463t2845r469b2852],
2	_	CD	NUMBER	_	nsubj	11	SENT_92	[p6l618t2845r625b2852],
3	Yes	UH	O	yes	dep	6	SENT_92	[p6l1077t2789r1177b2837],
4	_	CD	NUMBER	_	num	6	SENT_92	[p6l1738t2839r1744b2846],
5	_	CD	NUMBER	_	num	6	SENT_92	[p6l1864t2839r1871b2846],
6	_	NN	O	_	rcmod	2	SENT_92	[p6l2029t2839r2035b2846],
7	4	CD	NUMBER	4	num	10	SENT_92	[p6l2130t2823r2153b2854],
8	Severe	JJ	O	severe	amod	10	SENT_92	[p6l137t2843r334b2893],
9	anxiety/distress	NN	O	anxiety/distress	nn	10	SENT_92	[p6l356t2843r801b2906],
10	T	NN	O	t	dep	2	SENT_92	[p6l1018t2860r1269b2892],
11	Consider	VB	O	consider	ccomp	1	SENT_92	[p6l1584t2838r1842b2888],
12	l.V.	NNP	O	l.V.	nsubj	13	SENT_92	[p6l1864t2852r1933b2887],
13	opiate	VB	O	opiate	ccomp	11	SENT_92	[p6l1954t2842r2127b2900],

1	N	NN	O	n	_	0	SENT_93	[p6l533t3001r1873b3157],
2	4	CD	NUMBER	4	num	3	SENT_93	[p6l457t3089r494b3204],
3	|	NN	O	|	dep	1	SENT_93	[p6l1853t3012r1856b3130],

1	Measure	NN	O	measure	_	0	SENT_94	[p6l7t3300r253b3348],
2	systolic	JJ	O	systolic	amod	4	SENT_94	[p6l275t3300r485b3361],
3	blood	NN	O	blood	nn	4	SENT_94	[p6l508t3300r659b3348],
4	pressure	NN	O	pressure	dep	1	SENT_94	[p6l684t3311r931b3361],

1	SBP	NN	O	sbp	dep	15	SENT_95	[p6l431t3513r479b3532],
2	<	JJR	O	<	dep	1	SENT_95	[p6l487t3513r528b3532],
3	85	CD	NUMBER	85	num	5	SENT_95	[p6l487t3513r528b3532],
4	mm	NN	O	mm	nn	5	SENT_95	[p6l537t3518r576b3532],
5	Hg	NN	O	hg	dep	2	SENT_95	[p6l586t3513r615b3537],
6	or	CC	O	or	_	0	SENT_95	[p6l624t3518r645b3532],
7	shock5	NN	O	shock5	dep	2	SENT_95	[p6l653t3507r726b3532],
8	i	FW	O	i	nn	7	SENT_95	[p6l876t3507r880b3537],
9	)	FW	O	)	nn	7	SENT_95	[p6l876t3507r880b3537],
10	*	FW	O	*	dep	7	SENT_95	[p6l876t3507r880b3537],
11	SBP	NN	O	sbp	dep	15	SENT_95	[p6l971t3513r1019b3532],
12	35-110	CD	NUMBER	35-110	num	11	SENT_95	[p6l1028t3513r1110b3532],
13	mm	NN	O	mm	nn	15	SENT_95	[p6l1119t3518r1158b3532],
14	Hg	NN	O	hg	nn	15	SENT_95	[p6l1168t3513r1197b3537],
15	SBP	NN	O	sbp	_	0	SENT_95	[p6l1496t3513r1544b3532],
16	>	JJR	O	>	dep	15	SENT_95	[p6l1552t3513r1607b3532],
17	110	CD	NUMBER	110	num	19	SENT_95	[p6l1552t3513r1607b3532],
18	mm	NN	O	mm	nn	19	SENT_95	[p6l1616t3518r1654b3532],
19	Hg	NN	O	hg	dep	16	SENT_95	[p6l1664t3513r1694b3537],

1	1	CD	NUMBER	1	num	2	SENT_96	[p6l572t3561r584b3609],
2	ll	NN	O	ll	_	0	SENT_96	[p6l1076t3561r1090b3609],
3	1	CD	NUMBER	1	dep	2	SENT_96	[p6l1584t3561r1600b3609],

1	No	DT	O	no	det	2	SENT_97	[p6l942t3633r971b3652],
2	additional	JJ	O	additional	_	0	SENT_97	[p6l980t3633r1084b3652],
3	there	EX	O	there	dep	2	SENT_97	[p6l1093t3633r1149b3652],
4	until	IN	O	until	prep	3	SENT_97	[p6l1184t3633r1227b3652],

1	Add	VB	O	add	_	0	SENT_98	[p6l413t3655r456b3674],
2	nonvasodilating	JJ	O	nonvasodilating	amod	4	SENT_98	[p6l466t3655r636b3679],
3	inotropes	NNS	O	inotrope	nn	4	SENT_98	[p6l645t3648r743b3679],
4	response	NN	O	response	dobj	1	SENT_98	[p6l973t3668r1074b3687],
5	asse	NN	O	asse	nsubj	7	SENT_98	[p6l1082t3668r1134b3682],
6	7	CD	NUMBER	7	num	5	SENT_98	[p6l1188t3657r1196b3669],
7	Consider	VB	O	consider	dep	1	SENT_98	[p6l1412t3654r1511b3674],
8	vasodilator	NN	O	vasodilator	nn	9	SENT_98	[p6l1518t3655r1638b3674],
9	(	NN	O	(	nsubj	10	SENT_98	[p6l1646t3654r1700b3679],
10	e.g.	FW	O	e.g.	xcomp	7	SENT_98	[p6l1646t3654r1700b3679],
11	,	,	O	,	_	0	SENT_98	[p6l1646t3654r1700b3679],
12	NTG8	NN	O	ntg8	nn	13	SENT_98	[p6l1710t3648r1777b3679],
13	)	NN	O	)	appos	10	SENT_98	[p6l1710t3648r1777b3679],

1	Yes	UH	O	yes	_	0	SENT_99	[p7l1313t102r1351b121],

1	Adequate	JJ	O	adequate	amod	2	SENT_100	[p7l974t126r1079b150],
2	response	NN	O	response	_	0	SENT_100	[p7l1089t131r1189b150],
3	to	TO	O	to	_	0	SENT_100	[p7l1003t157r1024b175],
4	treatment	NN	O	treatment	prep_to	2	SENT_100	[p7l1031t150r1159b175],
5	?	.	O	?	_	0	SENT_100	[p7l1031t150r1159b175],

1	9	CD	NUMBER	9	_	0	SENT_101	[p7l1031t150r1159b175],

1	-2	CD	NUMBER	-2	_	0	SENT_102	[p7l1295t140r1392b154],
2	:	:	O	:	_	0	SENT_102	[p7l1295t140r1392b154],
3	Continue	VB	O	continue	dep	1	SENT_102	[p7l1459t135r1557b155],
4	present	JJ	DATE	present	amod	6	SENT_102	[p7l1566t137r1648b159],
5	treatment	NN	O	treatment	nn	6	SENT_102	[p7l1655t130r1779b155],
6	”	NN	O	”	dobj	3	SENT_102	[p7l1655t130r1779b155],

1	1No	NN	O	1no	_	0	SENT_103	[p7l1080t200r1169b248],

1	Re-evaluation	NN	O	re-evaluation	_	0	SENT_104	[p7l859t284r1009b303],
2	of	IN	O	of	_	0	SENT_104	[p7l1018t284r1038b303],
3	patient	NN	O	patient	prep_of	1	SENT_104	[p7l1046t284r1136b308],
4	’s	POS	O	’s	possessive	3	SENT_104	[p7l1046t284r1136b308],
5	clinical	JJ	O	clinical	amod	6	SENT_104	[p7l1144t284r1217b303],
6	status	NN	O	status	dep	1	SENT_104	[p7l1226t278r1308b303],
7	"	''	O	"	punct	6	SENT_104	[p7l1226t278r1308b303],

1	SBP	NN	O	sbp	_	0	SENT_105	[p7l417t507r465b526],
2	<	JJR	O	<	dep	1	SENT_105	[p7l473t508r514b526],
3	85	CD	NUMBER	85	num	5	SENT_105	[p7l473t508r514b526],
4	mm	NN	O	mm	nn	5	SENT_105	[p7l523t512r562b526],
5	Hg	NN	O	hg	dep	2	SENT_105	[p7l572t501r625b531],
6	?	.	O	?	_	0	SENT_105	[p7l572t501r625b531],

1	5	CD	NUMBER	5	_	0	SENT_106	[p7l572t501r625b531],

1	1	CD	NUMBER	1	_	0	SENT_107	[p7l512t593r524b653],
2	Yes	UH	O	yes	dep	1	SENT_107	[p7l545t616r584b635],

1	o	NN	O	o	nn	6	SENT_108	[p7l275t673r284b682],
2	Stop	NN	O	stop	nn	6	SENT_108	[p7l295t668r345b692],
3	vasodilator	NN	O	vasodilator	nn	6	SENT_108	[p7l352t669r473b687],
4	o	NN	O	o	nn	6	SENT_108	[p7l275t713r284b721],
5	Stop	NN	O	stop	nn	6	SENT_108	[p7l295t708r345b732],
6	ﬂ-blocker	NN	O	ﬂ-blocker	_	0	SENT_108	[p7l354t708r454b733],
7	if	IN	O	if	advmod	8	SENT_108	[p7l462t708r473b727],
8	hypoperfused	VBN	O	hypoperfuse	partmod	6	SENT_108	[p7l481t708r629b732],
9	o	NN	O	o	dobj	8	SENT_108	[p7l275t753r284b762],
10	Consider	VB	O	consider	dep	8	SENT_108	[p7l295t748r394b767],
11	nonvasodilating	JJ	O	nonvasodilating	amod	12	SENT_108	[p7l402t749r572b772],
12	inotrope	NN	O	inotrope	nsubj	16	SENT_108	[p7l582t749r670b772],
13	or	CC	O	or	_	0	SENT_108	[p7l294t783r316b797],
14	vasopressors	NNS	O	vasopressor	nn	15	SENT_108	[p7l323t772r467b802],
15	o	NN	O	o	conj_or	12	SENT_108	[p7l275t821r284b830],
16	Consider	VB	O	consider	ccomp	10	SENT_108	[p7l295t815r394b834],
17	right-heart	JJ	O	right-heart	amod	18	SENT_108	[p7l402t815r516b839],
18	catheterization	NN	O	catheterization	dobj	16	SENT_108	[p7l524t809r704b834],
19	”	SYM	O	”	dep	18	SENT_108	[p7l524t809r704b834],
20	-	:	O	-	_	0	SENT_108	[p7l275t858r284b867],
21	Consid	JJ	O	consid	dep	6	SENT_108	[p7l295t853r370b872],
22	echanical	JJ	O	echanical	amod	24	SENT_108	[p7l422t853r526b872],
23	circulatory	JJ	O	circulatory	amod	24	SENT_108	[p7l535t853r649b877],
24	suppor	NN	O	suppor	dep	21	SENT_108	[p7l294t888r370b907],

1	SpO2	NN	O	spo2	_	0	SENT_109	[p7l1029t507r1086b534],
2	<	JJR	O	<	dep	1	SENT_109	[p7l1094t508r1157b526],
3	90	CD	PERCENT	90	num	4	SENT_109	[p7l1094t508r1157b526],
4	%	NN	PERCENT	%	dep	1	SENT_109	[p7l1094t508r1157b526],

1	-	:	O	-	_	0	SENT_110	[p7l958t673r967b682],
2	Oxygens	NNS	O	oxygen	dep	4	SENT_110	[p7l979t662r1073b692],
3	-	:	O	-	_	0	SENT_110	[p7l958t713r966b721],
4	Consider	VB	O	consider	_	0	SENT_110	[p7l979t708r1078b727],
5	NlV	NN	O	nlv	nn	6	SENT_110	[p7l1086t702r1145b726],
6	‘	NN	O	‘	dobj	4	SENT_110	[p7l1086t702r1145b726],
7	5	CD	NUMBER	5	nsubj	9	SENT_110	[p7l1086t702r1145b726],
8	o	NN	O	o	dep	7	SENT_110	[p7l958t753r967b762],
9	Consider	VB	O	consider	dep	4	SENT_110	[p7l979t748r1078b767],
10	E	NN	O	e	nn	13	SENT_110	[p7l1087t748r1132b767],
11	‘	CD	NUMBER	‘	num	13	SENT_110	[p7l1087t748r1132b767],
12	l'	NN	O	l'	nn	13	SENT_110	[p7l1087t748r1132b767],
13	l'	NN	O	l'	dobj	9	SENT_110	[p7l1087t748r1132b767],
14	and	CC	O	and	_	0	SENT_110	[p7l1140t748r1180b767],
15	invasive	JJ	O	invasive	amod	17	SENT_110	[p7l979t778r1066b797],
16	ventilation	NN	O	ventilation	nn	17	SENT_110	[p7l1074t772r1203b797],
17	”	NN	O	”	dobj	9	SENT_110	[p7l1074t772r1203b797],

1	_	NN	O	_	nn	3	SENT_111	[p7l1496t533r1500b534],
2	Urine	NN	O	urine	nn	3	SENT_111	[p7l1525t507r1582b526],
3	output	NN	O	output	_	0	SENT_111	[p7l1590t509r1659b531],
4	<	JJR	O	<	dep	3	SENT_111	[p7l1667t508r1707b526],
5	20	CD	NUMBER	20	num	6	SENT_111	[p7l1667t508r1707b526],
6	ml/hm	NN	O	ml/hm	dep	3	SENT_111	[p7l1716t501r1780b526],

1	1	CD	NUMBER	1	_	0	SENT_112	[p7l1648t593r1660b653],
2	Yes	UH	O	yes	dep	1	SENT_112	[p7l1682t616r1720b635],

1	-	:	O	-	_	0	SENT_113	[p7l1409t673r1418b682],
2	Bladder	NN	O	bladder	nn	3	SENT_113	[p7l1431t668r1516b687],
3	catheterization	NN	O	catheterization	_	0	SENT_113	[p7l1523t668r1684b687],
4	to	TO	O	to	aux	5	SENT_113	[p7l1692t669r1712b687],
5	confirm	VB	O	confirm	infmod	3	SENT_113	[p7l1721t668r1801b687],
6	-	:	O	-	_	0	SENT_113	[p7l1409t714r1418b722],
7	Increase	NN	O	increase	nn	8	SENT_113	[p7l1431t708r1524b727],
8	dose	NN	O	dose	dobj	5	SENT_113	[p7l1533t708r1586b727],
9	of	IN	O	of	_	0	SENT_113	[p7l1594t708r1614b727],
10	diuretic	JJ	O	diuretic	prep_of	8	SENT_113	[p7l1622t708r1701b727],
11	or	CC	O	or	_	0	SENT_113	[p7l1709t713r1731b727],
12	use	VB	O	use	dep	13	SENT_113	[p7l1739t713r1777b727],
13	combination	NN	O	combination	conj_or	10	SENT_113	[p7l1430t738r1563b757],
14	of	IN	O	of	_	0	SENT_113	[p7l1572t738r1592b757],
15	diuretics	NNS	O	diuretic	prep_of	8	SENT_113	[p7l1599t732r1710b757],
16	"	``	O	"	punct	8	SENT_113	[p7l1599t732r1710b757],
17	-	:	O	-	_	0	SENT_113	[p7l1409t783r1418b792],
18	Consider	VB	O	consider	parataxis	23	SENT_113	[p7l1430t778r1530b797],
19	low-dose	JJ	O	low-dose	amod	20	SENT_113	[p7l1538t778r1635b797],
20	dopamine	NN	O	dopamine	dobj	18	SENT_113	[p7l1644t772r1771b802],
21	“	SYM	O	“	dep	20	SENT_113	[p7l1644t772r1771b802],
22	-	:	O	-	_	0	SENT_113	[p7l1409t825r1418b834],
23	Consider	VB	O	consider	dep	8	SENT_113	[p7l1430t820r1530b839],
24	right-heart	JJ	O	right-heart	amod	26	SENT_113	[p7l1538t820r1651b844],
25	catheterization	NN	O	catheterization	nn	26	SENT_113	[p7l1659t814r1840b839],
26	”	NN	O	”	iobj	23	SENT_113	[p7l1659t814r1840b839],
27	o	NN	O	o	dobj	23	SENT_113	[p7l1409t866r1418b875],
28	Consider	VB	O	consider	dep	27	SENT_113	[p7l1430t860r1530b880],
29	ultrafiltrationlg	NN	O	ultrafiltrationlg	nsubj	23	SENT_113	[p7l1538t854r1690b880],

1	I	PRP	O	I	nsubj	2	SENT_114	[p7l1080t593r1092b653],
2	Yes	UH	O	yes	_	0	SENT_114	[p7l1118t616r1156b635],

1	Figure	NNP	O	Figure	nn	4	SENT_115	[p7l21t986r111b1016],
2	1	CD	NUMBER	1	num	1	SENT_115	[p7l121t988r131b1009],
3	Differential	JJ	O	differential	amod	4	SENT_115	[p7l154t985r298b1010],
4	therapy	NN	O	therapy	nsubj	21	SENT_115	[p7l307t986r410b1016],
5	in	IN	O	in	_	0	SENT_115	[p7l418t987r439b1009],
6	patients	NNS	O	patient	prep_in	4	SENT_115	[p7l449t987r555b1016],
7	with	IN	O	with	_	0	SENT_115	[p7l563t986r620b1010],
8	acute	JJ	O	acute	amod	10	SENT_115	[p7l629t990r701b1010],
9	heart	NN	O	heart	nn	10	SENT_115	[p7l710t986r779b1010],
10	failure	NN	O	failure	prep_with	6	SENT_115	[p7l786t985r868b1010],
11	and	CC	O	and	_	0	SENT_115	[p7l876t986r925b1010],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_115	[p7l935t986r1081b1016],
13	edema	NN	O	edema	conj_and	10	SENT_115	[p7l1088t986r1178b1010],
14	according	VBG	O	accord	_	0	SENT_115	[p7l1187t986r1317b1016],
15	to	TO	O	to	prepc_according_to	21	SENT_115	[p7l1326t989r1352b1010],
16	the	DT	O	the	det	20	SENT_115	[p7l1360t986r1403b1010],
17	current	JJ	DATE	current	amod	18	SENT_115	[p7l1411t989r1507b1010],
18	European	JJ	ORGANIZATION	european	amod	20	SENT_115	[p7l1515t987r1640b1016],
19	Society	NNP	ORGANIZATION	Society	nn	20	SENT_115	[p7l1650t987r1746b1016],
20	ofCardio	NNP	O	ofCardio	pobj	21	SENT_115	[p7l1753t985r1931b1016],
21	|	VBD	O	|	_	0	SENT_115	[p7l1753t985r1931b1016],
22	ogy	NN	O	ogy	nn	23	SENT_115	[p7l1753t985r1931b1016],
23	guidelines	NNS	O	guideline	dobj	21	SENT_115	[p7l1938t982r2090b1016],
24	.	.	O	.	_	0	SENT_115	[p7l1938t982r2090b1016],

1	‘	NN	O	‘	nn	2	SENT_116	[p7l1938t982r2090b1016],
2	NTG	NNP	O	NTG	_	0	SENT_116	[p7l22t1027r82b1054],
3	,	,	O	,	_	0	SENT_116	[p7l22t1027r82b1054],
4	nitroglycerin	NN	O	nitroglycerin	appos	2	SENT_116	[p7l91t1026r266b1057],
5	;	:	O	;	_	0	SENT_116	[p7l91t1026r266b1057],
6	SBP	NNP	O	SBP	dep	2	SENT_116	[p7l274t1027r324b1054],
7	,	,	O	,	_	0	SENT_116	[p7l274t1027r324b1054],
8	systolic	JJ	O	systolic	amod	10	SENT_116	[p7l332t1026r428b1057],
9	blood	NN	O	blood	nn	10	SENT_116	[p7l437t1026r512b1051],
10	pressure	NN	O	pressure	appos	6	SENT_116	[p7l522t1033r640b1057],
11	;	:	O	;	_	0	SENT_116	[p7l522t1033r640b1057],
12	SPO2	NN	O	spo2	dep	2	SENT_116	[p7l648t1027r720b1061],
13	,	,	O	,	_	0	SENT_116	[p7l648t1027r720b1061],
14	saturation	NN	O	saturation	appos	12	SENT_116	[p7l728t1028r861b1051],
15	of	IN	O	of	_	0	SENT_116	[p7l870t1026r897b1051],
16	peripheral	JJ	O	peripheral	amod	17	SENT_116	[p7l904t1026r1038b1057],
17	oxygen	NN	O	oxygen	prep_of	14	SENT_116	[p7l1047t1034r1151b1057],
18	.	.	O	.	_	0	SENT_116	[p7l1047t1034r1151b1057],

1	and	CC	O	and	cc	13	SENT_117	[p7l21t1128r82b1159],
2	American	JJ	ORGANIZATION	american	amod	6	SENT_117	[p7l91t1130r255b1159],
3	Heart	NNP	ORGANIZATION	Heart	nn	6	SENT_117	[p7l265t1130r359b1159],
4	Association	NNP	ORGANIZATION	Association	nn	6	SENT_117	[p7l367t1130r561b1159],
5	HF	NN	O	hf	nn	6	SENT_117	[p7l571t1130r622b1158],
6	guidelines	NNS	O	guideline	nsubjpass	13	SENT_117	[p7l632t1128r809b1169],
7	,	,	O	,	_	0	SENT_117	[p7l632t1128r809b1169],
8	revasculariza	NN	O	revasculariza	nn	10	SENT_117	[p7l819t1128r1048b1159],
9	—	NN	O	—	nn	10	SENT_117	[p7l819t1128r1048b1159],
10	tion	NN	O	tion	appos	6	SENT_117	[p7l20t1181r86b1209],
11	should	MD	O	should	aux	13	SENT_117	[p7l99t1178r210b1209],
12	be	VB	O	be	auxpass	13	SENT_117	[p7l220t1178r258b1209],
13	performed	VBN	O	perform	_	0	SENT_117	[p7l269t1178r446b1219],
14	as	IN	O	as	_	0	SENT_117	[p7l458t1189r489b1209],
15	an	DT	O	a	det	17	SENT_117	[p7l501t1189r540b1209],
16	urgent	JJ	O	urgent	amod	17	SENT_117	[p7l551t1184r733b1219],
17	—	NN	O	—	prep_as	13	SENT_117	[p7l551t1184r733b1219],
18	or	CC	O	or	_	0	SENT_117	[p7l551t1184r733b1219],
19	even	RB	O	even	advmod	20	SENT_117	[p7l745t1189r820b1209],
20	emergencyprocedure	NN	O	emergencyprocedure	conj_or	17	SENT_117	[p7l832t1189r1049b1219, p7l20t1228r188b1269],
21	in	IN	O	in	_	0	SENT_117	[p7l202t1231r234b1258],
22	patients	NNS	O	patient	prep_in	13	SENT_117	[p7l247t1231r377b1269],
23	presenting	VBG	O	present	partmod	22	SENT_117	[p7l390t1231r564b1269],
24	with	IN	O	with	_	0	SENT_117	[p7l576t1228r650b1259],
25	hemodynamic	JJ	O	hemodynamic	amod	26	SENT_117	[p7l662t1228r901b1269],
26	instability	NN	O	instability	prep_with	23	SENT_117	[p7l914t1228r1048b1259, p7l21t1281r63b1319],
27	or	CC	O	or	_	0	SENT_117	[p7l80t1289r114b1309],
28	cardiogenic	JJ	O	cardiogenic	amod	29	SENT_117	[p7l132t1278r324b1319],
29	shock	NN	O	shock	conj_or	26	SENT_117	[p7l342t1278r445b1309],
30	.	.	O	.	_	0	SENT_117	[p7l342t1278r445b1309],

1	Immediate	NNP	O	Immediate	nsubjpass	6	SENT_118	[p7l464t1278r643b1309],
2	percutaneous	JJ	O	percutaneous	amod	4	SENT_118	[p7l660t1284r883b1319],
3	coronary	JJ	O	coronary	amod	4	SENT_118	[p7l901t1289r1051b1319],
4	intervention	NN	O	intervention	dep	1	SENT_118	[p7l21t1331r225b1359],
5	is	VBZ	O	be	auxpass	6	SENT_118	[p7l247t1331r271b1359],
6	recommended	VBN	O	recommend	_	0	SENT_118	[p7l293t1328r533b1359],
7	in	IN	O	in	_	0	SENT_118	[p7l555t1331r587b1358],
8	patients	NNS	O	patient	prep_in	6	SENT_118	[p7l608t1331r738b1369],
9	with	IN	O	with	_	0	SENT_118	[p7l759t1328r833b1359],
10	ST-segment	NN	O	st-segment	nn	11	SENT_118	[p7l855t1329r1050b1369],
11	elevation	NN	O	elevation	nn	16	SENT_118	[p7l21t1378r169b1409],
12	myocardial	JJ	O	myocardial	amod	16	SENT_118	[p7l192t1378r378b1419],
13	infarction	NN	O	infarction	dep	12	SENT_118	[p7l401t1378r563b1409],
14	(	CD	NUMBER	(	num	13	SENT_118	[p7l588t1378r742b1415],
15	STEMI	NN	O	stemus	nn	16	SENT_118	[p7l588t1378r742b1415],
16	)	NN	O	)	prep_with	8	SENT_118	[p7l588t1378r742b1415],
17	.	.	O	.	_	0	SENT_118	[p7l588t1378r742b1415],

1	In	IN	O	in	dep	107	SENT_119	[p7l767t1380r801b1409],
2	patients	NNS	O	patient	dep	107	SENT_119	[p7l824t1381r953b1419],
3	with	IN	O	with	dep	107	SENT_119	[p7l976t1378r1050b1409],
4	STEMI	NN	O	stemus	dep	107	SENT_119	[p7l21t1429r138b1459],
5	or	CC	O	or	dep	107	SENT_119	[p7l155t1439r189b1459],
6	new	JJ	O	new	dep	107	SENT_119	[p7l204t1439r273b1459],
7	left	JJ	O	left	dep	107	SENT_119	[p7l287t1428r339b1459],
8	bundle	JJ	O	bundle	dep	107	SENT_119	[p7l353t1428r467b1459],
9	branch	NN	O	branch	dep	107	SENT_119	[p7l482t1428r598b1459],
10	block	NN	O	block	dep	107	SENT_119	[p7l612t1428r711b1463],
11	,	,	O	,	_	0	SENT_119	[p7l612t1428r711b1463],
12	ﬁbrinolytic	JJ	O	ﬁbrinolytic	dep	107	SENT_119	[p7l727t1428r910b1469],
13	therapy	NN	O	therapy	dep	107	SENT_119	[p7l925t1428r1051b1469],
14	is	VBZ	O	be	dep	107	SENT_119	[p7l21t1481r45b1509],
15	recommended	VBN	O	recommend	dep	107	SENT_119	[p7l68t1478r308b1509],
16	if	IN	O	if	dep	107	SENT_119	[p7l330t1478r356b1508],
17	timely	JJ	O	timely	dep	107	SENT_119	[p7l374t1478r479b1519],
18	primary	JJ	O	primary	dep	107	SENT_119	[p7l499t1481r636b1519],
19	percutaneous	JJ	O	percutaneous	dep	107	SENT_119	[p7l656t1484r878b1519],
20	coronary	JJ	O	coronary	dep	107	SENT_119	[p7l901t1489r1051b1519],
21	intervention	NN	O	intervention	dep	107	SENT_119	[p7l1111t1131r1315b1159],
22	can	MD	O	can	dep	107	SENT_119	[p7l1328t1134r1441b1159],
23	not	RB	O	not	dep	107	SENT_119	[p7l1328t1134r1441b1159],
24	be	VB	O	be	dep	107	SENT_119	[p7l1452t1128r1491b1159],
25	performed	VBN	O	perform	dep	107	SENT_119	[p7l1503t1124r1754b1169],
26	.1	CD	NUMBER	.1	dep	107	SENT_119	[p7l1503t1124r1754b1169],
27	°	CD	NUMBER	°	dep	107	SENT_119	[p7l1503t1124r1754b1169],
28	>	JJR	O	>	dep	107	SENT_119	[p7l1503t1124r1754b1169],
29	“	CD	NUMBER	“	dep	107	SENT_119	[p7l1503t1124r1754b1169],
30	In	IN	O	in	dep	107	SENT_119	[p7l1769t1131r1803b1158],
31	patients	NNS	O	patient	dep	107	SENT_119	[p7l1816t1131r1945b1169],
32	with	IN	O	with	dep	107	SENT_119	[p7l1957t1128r2031b1159],
33	an	DT	O	a	dep	107	SENT_119	[p7l2044t1139r2083b1159],
34	EF	NN	O	ef	dep	107	SENT_119	[p7l2095t1130r2139b1158],
35	340	CD	PERCENT	340	dep	107	SENT_119	[p7l1112t1181r1213b1213],
36	%	NN	PERCENT	%	dep	107	SENT_119	[p7l1112t1181r1213b1213],
37	,	,	O	,	_	0	SENT_119	[p7l1112t1181r1213b1213],
38	mineralocorticoid	NN	O	mineralocorticoid	dep	107	SENT_119	[p7l1231t1178r1531b1209],
39	receptor	NN	O	receptor	dep	107	SENT_119	[p7l1548t1184r1685b1219],
40	antagonist	NN	O	antagonist	dep	107	SENT_119	[p7l1702t1181r1873b1219],
41	treatment	NN	O	treatment	dep	107	SENT_119	[p7l1889t1184r2050b1209],
42	with	IN	O	with	dep	107	SENT_119	[p7l2066t1178r2140b1209],
43	eplerenone	NN	O	eplerenone	dep	107	SENT_119	[p7l1111t1228r1292b1269],
44	and	CC	O	and	dep	107	SENT_119	[p7l1305t1228r1374b1263],
45	,	,	O	,	_	0	SENT_119	[p7l1305t1228r1374b1263],
46	after	IN	O	after	dep	107	SENT_119	[p7l1388t1228r1461b1259],
47	stabilization	NN	O	stabilization	dep	107	SENT_119	[p7l1473t1228r1682b1263],
48	,	,	O	,	_	0	SENT_119	[p7l1473t1228r1682b1263],
49	with	IN	O	with	dep	107	SENT_119	[p7l1694t1228r1768b1259],
50	an	DT	O	a	dep	107	SENT_119	[p7l1781t1239r1819b1259],
51	ACE	NN	O	ace	dep	107	SENT_119	[p7l1831t1230r1908b1259],
52	inhibitor	NN	O	inhibitor	dep	107	SENT_119	[p7l1921t1228r2067b1259],
53	and	CC	O	and	dep	107	SENT_119	[p7l2079t1228r2140b1259],
54	[	NN	O	[	dep	107	SENT_119	[p7l1112t1278r1269b1319],
55	5-blocker	NN	O	5-blocker	dep	107	SENT_119	[p7l1112t1278r1269b1319],
56	should	MD	O	should	dep	107	SENT_119	[p7l1282t1278r1393b1309],
57	be	VB	O	be	dep	107	SENT_119	[p7l1404t1278r1443b1309],
58	started	VBN	O	start	dep	107	SENT_119	[p7l1456t1278r1756b1319],
59	—	RB	O	—	dep	107	SENT_119	[p7l1456t1278r1756b1319],
60	provided	VBN	O	provide	dep	107	SENT_119	[p7l1456t1278r1756b1319],
61	heart	NN	O	heart	dep	107	SENT_119	[p7l1768t1278r1854b1309],
62	rate	NN	O	rate	dep	107	SENT_119	[p7l1866t1284r1936b1313],
63	,	,	O	,	_	0	SENT_119	[p7l1866t1284r1936b1313],
64	blood	NN	O	blood	dep	107	SENT_119	[p7l1949t1278r2045b1309],
65	pressure	NN	O	pressure	dep	107	SENT_119	[p7l2057t1289r2138b1319, p7l1111t1339r1187b1363],
66	,	,	O	,	_	0	SENT_119	[p7l2057t1289r2138b1319, p7l1111t1339r1187b1363],
67	renal	JJ	O	renal	dep	107	SENT_119	[p7l1200t1328r1283b1359],
68	function	NN	O	function	dep	107	SENT_119	[p7l1294t1328r1444b1363],
69	,	,	O	,	_	0	SENT_119	[p7l1294t1328r1444b1363],
70	and	CC	O	and	dep	107	SENT_119	[p7l1457t1328r1518b1359],
71	potassium	NN	O	potassium	dep	107	SENT_119	[p7l1528t1331r1699b1369],
72	levels	NNS	O	level	dep	107	SENT_119	[p7l1710t1328r1799b1359],
73	permit	VBP	O	permit	dep	107	SENT_119	[p7l1811t1331r1995b1369],
74	—	RB	O	—	dep	107	SENT_119	[p7l1811t1331r1995b1369],
75	in	IN	O	in	dep	107	SENT_119	[p7l1811t1331r1995b1369],
76	order	NN	O	order	dep	107	SENT_119	[p7l2007t1328r2096b1359],
77	to	TO	O	to	dep	107	SENT_119	[p7l2107t1334r2139b1359],
78	reduce	VB	O	reduce	dep	107	SENT_119	[p7l1111t1378r1220b1409],
79	cardiovascular	JJ	O	cardiovascular	dep	107	SENT_119	[p7l1233t1378r1473b1409],
80	morbidity	NN	O	morbidity	dep	107	SENT_119	[p7l1484t1378r1651b1419],
81	and	CC	O	and	dep	107	SENT_119	[p7l1662t1378r1723b1409],
82	mortality	NN	O	mortality	dep	107	SENT_119	[p7l1734t1374r1993b1419],
83	.1	CD	NUMBER	.1	dep	107	SENT_119	[p7l1734t1374r1993b1419],
84	’	CD	NUMBER	’	dep	107	SENT_119	[p7l1734t1374r1993b1419],
85	12	CD	NUMBER	12	dep	107	SENT_119	[p7l1734t1374r1993b1419],
86	‘	NN	O	‘	dep	107	SENT_119	[p7l1734t1374r1993b1419],
87	14	CD	NUMBER	14	dep	107	SENT_119	[p7l1734t1374r1993b1419],
88	Of	IN	O	of	dep	107	SENT_119	[p7l2005t1378r2051b1409],
89	note	NN	O	note	dep	107	SENT_119	[p7l2058t1384r2139b1413],
90	,	,	O	,	_	0	SENT_119	[p7l2058t1384r2139b1413],
91	hemodynamic	JJ	O	hemodynamic	dep	107	SENT_119	[p7l1110t1428r1349b1469],
92	instability	NN	O	instability	dep	107	SENT_119	[p7l1370t1428r1535b1469],
93	may	MD	O	may	dep	107	SENT_119	[p7l1555t1439r1626b1469],
94	also	RB	O	also	dep	107	SENT_119	[p7l1646t1428r1709b1459],
95	be	VB	O	be	dep	107	SENT_119	[p7l1731t1428r1769b1459],
96	caused	VBN	O	cause	dep	107	SENT_119	[p7l1791t1428r1902b1459],
97	by	IN	O	by	dep	107	SENT_119	[p7l1923t1428r1963b1469],
98	mechanical	JJ	O	mechanical	dep	107	SENT_119	[p7l1983t1428r2138b1459, p7l1111t1478r1156b1509],
99	complications	NNS	O	complication	dep	107	SENT_119	[p7l1172t1478r1402b1519],
100	of	IN	O	of	dep	107	SENT_119	[p7l1419t1478r1455b1509],
101	myocardial	JJ	O	myocardial	dep	107	SENT_119	[p7l1466t1478r1651b1519],
102	infarction	NN	O	infarction	dep	107	SENT_119	[p7l1667t1478r1830b1509],
103	(	CD	NUMBER	(	dep	107	SENT_119	[p7l1848t1478r1923b1519],
104	e.g.	FW	O	e.g.	dep	107	SENT_119	[p7l1848t1478r1923b1519],
105	,	,	O	,	_	0	SENT_119	[p7l1848t1478r1923b1519],
106	mitral	JJ	O	mitral	dep	107	SENT_119	[p7l1940t1478r2041b1509],
107	valve	NN	O	valve	_	0	SENT_119	[p7l2055t1478r2139b1509],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_120	[p7l21t1584r140b1605],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	_	0	SENT_120	[p7l149t1584r374b1605],
3	&	CC	O	&	_	0	SENT_120	[p7l381t1584r601b1605],
4	THERAPEUTlCS	NNP	O	THERAPEUTlCS	nn	6	SENT_120	[p7l381t1584r601b1605],
5	|	NNP	O	|	nn	6	SENT_120	[p7l611t1582r613b1612],
6	VOLUME	NNP	O	VOLUME	conj_and	2	SENT_120	[p7l621t1584r729b1605],
7	94	CD	NUMBER	94	num	8	SENT_120	[p7l737t1584r765b1605],
8	NUMBER	NN	O	number	dep	2	SENT_120	[p7l774t1584r882b1605],
9	4	CD	NUMBER	4	number	10	SENT_120	[p7l889t1582r915b1612],
10	]	CD	NUMBER	]	num	11	SENT_120	[p7l889t1582r915b1612],
11	OCTOBER	NNP	DATE	OCTOBER	dep	8	SENT_120	[p7l924t1584r1044b1605],
12	2013	CD	DATE	2013	num	13	SENT_120	[p7l1052t1584r1109b1605],
13	501	CD	NUMBER	501	dep	2	SENT_120	[p7l2093t1584r2136b1605],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_121	[p7l19t1687r209b1724],

1	papillary	JJ	O	papillary	amod	4	SENT_122	[p7l6t1896r314b1980],
2	muscle	NN	O	muscle	nn	4	SENT_122	[p7l331t1896r570b1959],
3	rupture	NN	O	rupture	nn	4	SENT_122	[p7l590t1896r897b1979],
4	)	NN	O	)	_	0	SENT_122	[p7l590t1896r897b1979],
5	,	,	O	,	_	0	SENT_122	[p7l590t1896r897b1979],
6	which	WDT	O	which	nsubj	16	SENT_122	[p7l916t1896r1127b1959],
7	may	MD	O	may	aux	9	SENT_122	[p7l1146t1919r1294b1980],
8	be	VB	O	be	auxpass	9	SENT_122	[p7l1308t1896r1388b1959],
9	identiﬁed	VBN	O	identiﬁed	rcmod	4	SENT_122	[p7l1408t1896r1737b1959],
10	by	IN	O	by	_	0	SENT_122	[p7l1754t1896r1838b1980],
11	echocar	NN	O	echocar	nn	13	SENT_122	[p7l1855t1896r2148b1959],
12	—	NN	O	—	nn	13	SENT_122	[p7l1855t1896r2148b1959],
13	diography	NN	O	diography	agent	9	SENT_122	[p7l8t1999r359b2083],
14	and	CC	O	and	_	0	SENT_122	[p7l380t1999r507b2062],
15	may	MD	O	may	aux	16	SENT_122	[p7l529t2022r676b2083],
16	require	VB	O	require	rcmod	4	SENT_122	[p7l696t2005r942b2082],
17	urgent	JJ	O	urgent	amod	19	SENT_122	[p7l965t2011r1189b2083],
18	surgical	JJ	O	surgical	amod	19	SENT_122	[p7l1213t1999r1479b2083],
19	correction	NN	O	correction	dobj	16	SENT_122	[p7l1503t2005r1874b2062],
20	.	.	O	.	_	0	SENT_122	[p7l1503t2005r1874b2062],

1	Individual	JJ	O	individual	amod	2	SENT_123	[p7l10t2212r358b2270],
2	therapies	NNS	O	therapy	_	0	SENT_123	[p7l377t2213r706b2285],
3	Oxygen	NN	O	oxygen	dep	2	SENT_123	[p7l8t2321r252b2389],
4	.	.	O	.	_	0	SENT_123	[p7l8t2321r252b2389],

1	Oxygen	NN	O	oxygen	nsubjpass	4	SENT_124	[p7l288t2314r550b2395],
2	should	MD	O	should	aux	4	SENT_124	[p7l582t2310r811b2374],
3	be	VB	O	be	auxpass	4	SENT_124	[p7l840t2310r919b2374],
4	applied	VBN	O	apply	dep	25	SENT_124	[p7l952t2310r1200b2394],
5	to	TO	O	to	_	0	SENT_124	[p7l1230t2322r1295b2374],
6	hypoxic	JJ	O	hypoxic	amod	7	SENT_124	[p7l1327t2310r1596b2395],
7	patients	NNS	O	patient	prep_to	4	SENT_124	[p7l1626t2316r1893b2394],
8	(	IN	O	(	_	0	SENT_124	[p7l1929t2311r2148b2402],
9	SpO2	NN	O	spo2	prep_(	7	SENT_124	[p7l1929t2311r2148b2402],
10	:	:	O	:	_	0	SENT_124	[p7l1929t2311r2148b2402],
11	<	JJR	O	<	dep	7	SENT_124	[p7l10t2420r197b2480],
12	90	CD	PERCENT	90	num	13	SENT_124	[p7l10t2420r197b2480],
13	%	NN	PERCENT	%	dep	11	SENT_124	[p7l10t2420r197b2480],
14	or	CC	O	or	_	0	SENT_124	[p7l230t2438r302b2479],
15	PaO2	NN	O	pao2	dep	11	SENT_124	[p7l332t2419r523b2507],
16	:	:	O	:	_	0	SENT_124	[p7l332t2419r523b2507],
17	<	JJR	O	<	dep	7	SENT_124	[p7l559t2421r681b2479],
18	60	CD	NUMBER	60	num	20	SENT_124	[p7l559t2421r681b2479],
19	mm	NN	O	mm	nn	20	SENT_124	[p7l696t2438r834b2478],
20	Hg	NN	O	hg	dep	17	SENT_124	[p7l865t2416r991b2500],
21	)	RB	O	)	advmod	7	SENT_124	[p7l865t2416r991b2500],
22	because	IN	O	because	_	0	SENT_124	[p7l1023t2415r1289b2479],
23	hypoxemia	NN	O	hypoxemia	prep_because	4	SENT_124	[p7l1318t2415r1697b2500],
24	is	VBZ	O	be	auxpass	25	SENT_124	[p7l1726t2421r1775b2479],
25	associated	VBN	O	associate	_	0	SENT_124	[p7l1807t2415r2152b2479],
26	with	IN	O	with	_	0	SENT_124	[p7l6t2519r158b2582],
27	an	DT	O	a	det	29	SENT_124	[p7l192t2542r272b2582],
28	increased	VBN	O	increase	amod	29	SENT_124	[p7l305t2519r628b2582],
29	risk	NN	O	risk	prep_with	25	SENT_124	[p7l661t2519r789b2582],
30	of	IN	O	of	_	0	SENT_124	[p7l820t2519r894b2582],
31	mortality	NN	O	mortality	nn	34	SENT_124	[p7l917t2519r1237b2603],
32	(	CD	NUMBER	(	num	34	SENT_124	[p7l1270t2519r1885b2595],
33	recommendation	NN	O	recommendation	nn	34	SENT_124	[p7l1270t2519r1885b2595],
34	class	NN	O	class	prep_of	29	SENT_124	[p7l1919t2519r2072b2582],
35	I	CD	NUMBER	i	nsubjpass	25	SENT_124	[p7l2107t2524r2149b2591],
36	,	,	O	,	_	0	SENT_124	[p7l2107t2524r2149b2591],
37	evidence	NN	O	evidence	nn	38	SENT_124	[p7l8t2622r305b2685],
38	level	NN	O	level	appos	35	SENT_124	[p7l328t2622r482b2685],
39	C	NN	O	c	nn	40	SENT_124	[p7l507t2623r605b2699],
40	)	NN	O	)	dep	38	SENT_124	[p7l507t2623r605b2699],
41	.	.	O	.	_	0	SENT_124	[p7l507t2623r605b2699],

1	However	RB	O	however	advmod	7	SENT_125	[p7l633t2627r950b2694],
2	,	,	O	,	_	0	SENT_125	[p7l633t2627r950b2694],
3	it	PRP	O	it	nsubj	7	SENT_125	[p7l976t2628r1021b2685],
4	should	MD	O	should	aux	7	SENT_125	[p7l1045t2622r1274b2685],
5	not	RB	O	not	neg	7	SENT_125	[p7l1297t2634r1410b2685],
6	be	VB	O	be	cop	7	SENT_125	[p7l1431t2622r1510b2685],
7	unselectively	JJ	O	unselectively	_	0	SENT_125	[p7l1534t2622r1974b2706],
8	used	VBN	O	use	dep	7	SENT_125	[p7l1994t2622r2152b2685],
9	in	IN	O	in	_	0	SENT_125	[p7l8t2732r74b2788],
10	nonhypoxemic	JJ	O	nonhypoxemic	amod	11	SENT_125	[p7l121t2726r632b2810],
11	patients	NNS	O	patient	prep_in	8	SENT_125	[p7l678t2732r945b2809],
12	because	IN	O	because	mark	15	SENT_125	[p7l990t2726r1256b2789],
13	it	PRP	O	it	nsubj	15	SENT_125	[p7l1304t2732r1349b2789],
14	may	MD	O	may	aux	15	SENT_125	[p7l1395t2749r1541b2810],
15	exert	VB	O	exert	advcl	7	SENT_125	[p7l1585t2738r1753b2789],
16	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_125	[p7l1800t2726r2152b2810],
17	hemodynamic	JJ	O	hemodynamic	amod	18	SENT_125	[p7l7t2829r499b2913],
18	effects	NNS	O	effect	dobj	15	SENT_125	[p7l520t2829r749b2901],
19	,	,	O	,	_	0	SENT_125	[p7l520t2829r749b2901],
20	such	JJ	O	such	_	0	SENT_125	[p7l773t2829r927b2892],
21	as	IN	O	as	_	0	SENT_125	[p7l949t2852r1012b2892],
22	vasoconstriction	NN	O	vasoconstriction	prep_such_as	18	SENT_125	[p7l1031t2835r1598b2892],
23	and	CC	O	and	_	0	SENT_125	[p7l1620t2829r1746b2892],
24	a	DT	O	a	det	25	SENT_125	[p7l1766t2852r1801b2892],
25	reduction	NN	O	reduction	prep_such_as	18	SENT_125	[p7l1821t2829r2151b2892],
26	in	IN	O	in	_	0	SENT_125	[p7l8t2938r74b2994],
27	cardiac	JJ	O	cardiac	amod	28	SENT_125	[p7l99t2932r342b2995],
28	output	NN	O	output	prep_in	25	SENT_125	[p7l366t2944r607b3015],
29	,	,	O	,	_	0	SENT_125	[p7l366t2944r607b3015],
30	which	WDT	O	which	nsubj	33	SENT_125	[p7l632t2932r841b2995],
31	might	MD	O	might	aux	33	SENT_125	[p7l864t2932r1067b3016],
32	be	VB	O	be	cop	33	SENT_125	[p7l1088t2932r1168b2995],
33	deleterious	JJ	O	deleterious	rcmod	28	SENT_125	[p7l1193t2932r1565b2995],
34	for	IN	O	for	_	0	SENT_125	[p7l1589t2932r1686b2995],
35	patients	NNS	O	patient	prep_for	33	SENT_125	[p7l1709t2938r1976b3015],
36	with	IN	O	with	_	0	SENT_125	[p7l1999t2932r2151b2995],
37	AHE15	NN	O	ahe15	prep_with	35	SENT_125	[p7l7t3027r246b3099],

1	Diuretics	NNS	O	diuretic	_	0	SENT_126	[p7l7t3254r291b3306],
2	.	.	O	.	_	0	SENT_126	[p7l7t3254r291b3306],

1	Loop	NNP	O	Loop	nsubj	2	SENT_127	[p7l314t3248r490b3326],
2	diuretics	VBZ	O	diuretic	_	0	SENT_127	[p7l512t3243r808b3306],
3	(	CD	NUMBER	(	num	5	SENT_127	[p7l833t3243r977b3320],
4	i.v.	NN	O	i.v.	nn	5	SENT_127	[p7l833t3243r977b3320],
5	)	NN	O	)	nsubjpass	8	SENT_127	[p7l833t3243r977b3320],
6	should	MD	O	should	aux	8	SENT_127	[p7l1003t3243r1234b3306],
7	be	VB	O	be	auxpass	8	SENT_127	[p7l1252t3243r1331b3306],
8	applied	VBN	O	apply	ccomp	2	SENT_127	[p7l1353t3243r1603b3326],
9	to	TO	O	to	_	0	SENT_127	[p7l1622t3255r1688b3306],
10	patients	NNS	O	patient	prep_to	8	SENT_127	[p7l1708t3249r1978b3326],
11	with	IN	O	with	_	0	SENT_127	[p7l1998t3243r2151b3306],
12	signs	NNS	O	sign	prep_with	10	SENT_127	[p7l8t3353r178b3431],
13	of	IN	O	of	_	0	SENT_127	[p7l207t3347r281b3410],
14	pulmonary	JJ	O	pulmonary	amod	15	SENT_127	[p7l299t3347r686b3431],
15	congestion	NN	O	congestion	prep_of	12	SENT_127	[p7l711t3353r1082b3431],
16	or	CC	O	or	_	0	SENT_127	[p7l1111t3370r1183b3410],
17	edema	NN	O	edema	conj_or	15	SENT_127	[p7l1211t3347r1437b3410],
18	in	IN	O	in	mark	21	SENT_127	[p7l1464t3353r1531b3409],
19	order	NN	O	order	dep	21	SENT_127	[p7l1560t3347r1746b3410],
20	to	TO	O	to	aux	21	SENT_127	[p7l1772t3359r1838b3410],
21	improve	VB	O	improve	dep	8	SENT_127	[p7l1867t3353r2151b3430],
22	symptoms	NNS	O	symptom	dobj	21	SENT_127	[p7l8t3462r360b3534],
23	and	CC	O	and	_	0	SENT_127	[p7l386t3450r513b3513],
24	to	TO	O	to	aux	25	SENT_127	[p7l535t3462r601b3513],
25	reduce	VB	O	reduce	conj_and	21	SENT_127	[p7l627t3450r856b3513],
26	congestion	NN	O	congestion	nn	28	SENT_127	[p7l881t3456r1252b3534],
27	(	NN	O	(	nn	28	SENT_127	[p7l1281t3450r1901b3527],
28	recommendation	NN	O	recommendation	dobj	25	SENT_127	[p7l1281t3450r1901b3527],
29	class	NN	O	class	dep	28	SENT_127	[p7l1926t3450r2080b3513],
30	I	CD	NUMBER	i	num	29	SENT_127	[p7l2106t3455r2149b3522],
31	,	,	O	,	_	0	SENT_127	[p7l2106t3455r2149b3522],
32	evidence	NN	O	evidence	nn	34	SENT_127	[p7l8t3552r308b3616],
33	level	NN	O	level	nn	34	SENT_127	[p7l329t3552r485b3616],
34	B	NN	O	b	appos	28	SENT_127	[p7l507t3544r630b3630],
35	)	CD	NUMBER	)	number	36	SENT_127	[p7l507t3544r630b3630],
36	.1	CD	NUMBER	.1	dep	34	SENT_127	[p7l507t3544r630b3630],
37	Although	IN	O	although	mark	42	SENT_127	[p7l656t3552r984b3637],
38	loop	NN	O	loop	nn	39	SENT_127	[p7l1005t3552r1157b3636],
39	diuretics	NNS	O	diuretic	nsubj	42	SENT_127	[p7l1181t3552r1477b3616],
40	are	VBP	O	be	cop	42	SENT_127	[p7l1501t3575r1601b3616],
41	essential	JJ	O	essential	amod	42	SENT_127	[p7l1624t3552r1915b3616],
42	agents	NNS	O	agent	dep	8	SENT_127	[p7l1937t3564r2150b3637],
43	in	IN	O	in	_	0	SENT_127	[p7l8t3661r74b3718],
44	the	DT	O	the	det	45	SENT_127	[p7l110t3655r216b3719],
45	treatment	NN	O	treatment	prep_in	42	SENT_127	[p7l252t3667r589b3719],
46	of	IN	O	of	_	0	SENT_127	[p7l625t3655r699b3719],
47	AHF	NNP	ORGANIZATION	AHF	prep_of	45	SENT_127	[p7l724t3659r902b3727],
48	,	,	O	,	_	0	SENT_127	[p7l724t3659r902b3727],
49	smaller	JJR	O	smaller	amod	50	SENT_127	[p7l941t3655r1192b3719],
50	studies	NNS	O	study	appos	47	SENT_127	[p7l1228t3655r1464b3719],
51	associated	VBN	O	associate	partmod	50	SENT_127	[p7l1502t3655r1850b3719],
52	diuretic	JJ	O	diuretic	amod	53	SENT_127	[p7l1886t3655r2151b3719],
53	therapy	NN	O	therapy	dobj	51	SENT_127	[p8l7t23r270b107],
54	with	IN	O	with	_	0	SENT_127	[p8l302t23r455b86],
55	adverse	JJ	O	adverse	amod	56	SENT_127	[p8l492t23r749b86],
56	events	NNS	O	event	prep_with	51	SENT_127	[p8l787t35r1019b95],
57	,	,	O	,	_	0	SENT_127	[p8l787t35r1019b95],
58	including	VBG	O	include	_	0	SENT_127	[p8l1058t23r1385b107],
59	electrolyte	NN	O	electrolyte	nn	60	SENT_127	[p8l1422t23r1776b107],
60	disorders	NNS	O	disorder	prep_including	51	SENT_127	[p8l1814t23r2149b95],
61	,	,	O	,	_	0	SENT_127	[p8l1814t23r2149b95],
62	neurohormonal	JJ	O	neurohormonal	amod	63	SENT_127	[p8l7t126r553b189],
63	activation	NN	O	activation	appos	60	SENT_127	[p8l590t132r946b198],
64	,	,	O	,	_	0	SENT_127	[p8l590t132r946b198],
65	renal	JJ	O	renal	amod	66	SENT_127	[p8l985t126r1158b189],
66	dysfunction	NN	O	dysfunction	conj_and	63	SENT_127	[p8l1195t126r1623b210],
67	,	,	O	,	_	0	SENT_127	[p8l1195t126r1623b210],
68	and	CC	O	and	_	0	SENT_127	[p8l1663t126r1790b189],
69	increased	VBD	O	increase	amod	70	SENT_127	[p8l1826t126r2152b189],
70	mortality	NN	O	mortality	conj_and	63	SENT_127	[p8l7t220r403b313],
71	.	.	O	.	_	0	SENT_127	[p8l7t220r403b313],

1	”	NN	O	”	npadvmod	20	SENT_128	[p8l7t220r403b313],
2	Of	IN	O	of	_	0	SENT_128	[p8l460t228r555b292],
3	note	NN	O	note	prep_of	20	SENT_128	[p8l602t240r769b301],
4	,	,	O	,	_	0	SENT_128	[p8l602t240r769b301],
5	no	DT	O	no	det	13	SENT_128	[p8l826t251r912b292],
6	well-controlled	JJ	O	well-controlled	amod	13	SENT_128	[p8l968t228r1509b301],
7	,	,	O	,	_	0	SENT_128	[p8l968t228r1509b301],
8	large-scale	JJ	O	large-scale	amod	13	SENT_128	[p8l1566t228r1946b313],
9	,	,	O	,	_	0	SENT_128	[p8l1566t228r1946b313],
10	prospective	JJ	O	prospective	amod	13	SENT_128	[p8l2003t251r2148b312, p8l8t338r299b415],
11	,	,	O	,	_	0	SENT_128	[p8l2003t251r2148b312, p8l8t338r299b415],
12	randomized	JJ	O	randomized	amod	13	SENT_128	[p8l332t332r749b395],
13	study	NN	O	study	nsubj	20	SENT_128	[p8l779t332r966b416],
14	with	IN	O	with	_	0	SENT_128	[p8l991t332r1145b395],
15	hard	JJ	O	hard	amod	18	SENT_128	[p8l1174t332r1333b395],
16	clinical	JJ	O	clinical	amod	18	SENT_128	[p8l1363t332r1609b395],
17	end	NN	O	end	nn	18	SENT_128	[p8l1639t332r1766b395],
18	points	NNS	O	point	prep_with	13	SENT_128	[p8l1794t338r2008b415],
19	has	VBZ	O	have	aux	20	SENT_128	[p8l2038t332r2150b395],
20	proven	VBN	O	prove	_	0	SENT_128	[p8l6t457r246b518],
21	the	DT	O	the	det	22	SENT_128	[p8l268t435r375b498],
22	safety	NN	O	safety	dobj	20	SENT_128	[p8l400t435r597b519],
23	and	CC	O	and	_	0	SENT_128	[p8l618t435r745b498],
24	efficacy	NN	O	efficacy	dobj	20	SENT_128	[p8l767t435r1026b519],
25	of	IN	O	of	_	0	SENT_128	[p8l1046t435r1120b498],
26	these	DT	O	these	det	27	SENT_128	[p8l1133t435r1309b498],
27	agents	NNS	O	agent	prep_of	22	SENT_128	[p8l1334t447r1565b519],
28	.	.	O	.	_	0	SENT_128	[p8l1334t447r1565b519],

1	Furthermore	RB	O	furthermore	advmod	16	SENT_129	[p8l82t538r567b610],
2	,	,	O	,	_	0	SENT_129	[p8l82t538r567b610],
3	the	DT	O	the	det	5	SENT_129	[p8l593t538r705b601],
4	optimal	JJ	O	optimal	amod	5	SENT_129	[p8l732t538r1010b621],
5	dose	NN	O	dose	nsubj	16	SENT_129	[p8l1037t538r1198b601],
6	and	CC	O	and	_	0	SENT_129	[p8l1226t538r1357b601],
7	the	DT	O	the	det	8	SENT_129	[p8l1381t538r1493b601],
8	route	NN	O	route	nsubj	16	SENT_129	[p8l1519t550r1706b601],
9	of	IN	O	of	_	0	SENT_129	[p8l1733t538r1810b601],
10	administration	NN	O	administration	nn	13	SENT_129	[p8l1827t538r2148b601, p8l7t647r252b704],
11	(	CD	NUMBER	(	num	13	SENT_129	[p8l281t642r434b718],
12	i.v.	NN	O	i.v.	nn	13	SENT_129	[p8l281t642r434b718],
13	)	NN	O	)	prep_of	8	SENT_129	[p8l281t642r434b718],
14	of	IN	O	of	_	0	SENT_129	[p8l465t641r542b704],
15	diuretics	NNS	O	diuretic	prep_of	8	SENT_129	[p8l558t641r869b704],
16	are	VBP	O	be	_	0	SENT_129	[p8l896t664r1000b704],
17	still	RB	O	still	advmod	16	SENT_129	[p8l1027t641r1156b704],
18	under	IN	O	under	_	0	SENT_129	[p8l1181t641r1396b704],
19	debate	NN	O	debate	prep_under	16	SENT_129	[p8l1421t641r1670b704],
20	.	.	O	.	_	0	SENT_129	[p8l1421t641r1670b704],

1	The	DT	O	the	det	5	SENT_130	[p8l1699t641r1828b704],
2	Diuretic	JJ	O	diuretic	amod	5	SENT_130	[p8l1854t646r2151b704],
3	Optimization	NN	O	optimization	nn	5	SENT_130	[p8l9t748r502b827],
4	Strategies	NNS	O	strategy	nn	5	SENT_130	[p8l531t748r880b828],
5	Evaluation	NN	O	evaluation	_	0	SENT_130	[p8l909t744r1300b807],
6	in	IN	O	in	_	0	SENT_130	[p8l1328t750r1398b806],
7	Acute	JJ	O	acute	amod	9	SENT_130	[p8l1426t748r1637b807],
8	Heart	NNP	O	Heart	nn	9	SENT_130	[p8l1666t749r1872b807],
9	Failure	NN	O	failure	prep_in	5	SENT_130	[p8l1900t744r2151b807],
10	(	CD	NUMBER	(	num	13	SENT_130	[p8l11t847r283b924],
11	DOSE	NN	O	dose	nn	13	SENT_130	[p8l11t847r283b924],
12	)	NN	O	)	nn	13	SENT_130	[p8l11t847r283b924],
13	trial	NN	O	trial	dep	5	SENT_130	[p8l311t847r456b910],
14	compared	VBN	O	compare	partmod	5	SENT_130	[p8l481t847r830b930],
15	low	JJ	O	low	acomp	14	SENT_130	[p8l853t847r1005b910],
16	-	:	O	-	_	0	SENT_130	[p8l853t847r1005b910],
17	(	NN	O	(	nsubj	18	SENT_130	[p8l1036t847r1453b931],
18	preexisting	VBG	O	preexist	dep	5	SENT_130	[p8l1036t847r1453b931],
19	oral	JJ	O	oral	amod	21	SENT_130	[p8l1476t847r1611b910],
20	dose	NN	O	dose	nn	21	SENT_130	[p8l1635t847r1820b924],
21	)	NN	O	)	dobj	18	SENT_130	[p8l1635t847r1820b924],
22	vs.	FW	O	vs.	prep	21	SENT_130	[p8l1845t870r1935b910],
23	highdose	FW	O	highdose	nn	24	SENT_130	[p8l1961t847r2147b931, p8l8t950r169b1013],
24	(	FW	O	(	amod	27	SENT_130	[p8l199t950r508b1026],
25	2.5	CD	NUMBER	2.5	number	26	SENT_130	[p8l199t950r508b1026],
26	—	CD	NUMBER	—	num	27	SENT_130	[p8l199t950r508b1026],
27	fold	NN	O	fold	pobj	22	SENT_130	[p8l199t950r508b1026],
28	oral	JJ	O	oral	amod	32	SENT_130	[p8l533t950r671b1013],
29	dose	NN	O	dose	nn	32	SENT_130	[p8l696t950r885b1026],
30	)	NN	O	)	nn	32	SENT_130	[p8l696t950r885b1026],
31	furosemide	NN	O	furosemide	nn	32	SENT_130	[p8l915t950r1323b1013],
32	therapy	NN	O	therapy	dep	27	SENT_130	[p8l1348t950r1632b1034],
33	,	,	O	,	_	0	SENT_130	[p8l1348t950r1632b1034],
34	in	IN	O	in	_	0	SENT_130	[p8l1660t956r1729b1012],
35	addition	NN	O	addition	_	0	SENT_130	[p8l1755t950r2057b1013],
36	to	TO	O	to	_	0	SENT_130	[p8l2082t962r2150b1013],
37	studying	VBG	O	study	dep	5	SENT_130	[p8l9t1052r320b1137],
38	bolus	NN	O	bolus	dobj	37	SENT_130	[p8l343t1052r537b1116],
39	vs.	CC	O	vs.	prep	38	SENT_130	[p8l561t1075r653b1116],
40	continuous	JJ	O	continuous	amod	42	SENT_130	[p8l683t1059r1087b1116],
41	i.v.	NN	O	i.v.	nn	42	SENT_130	[p8l1114t1059r1209b1116],
42	infusion	NN	O	infusion	dep	39	SENT_130	[p8l1239t1044r1627b1116],
43	.	.	O	.	_	0	SENT_130	[p8l1239t1044r1627b1116],

1	”	NN	O	”	ccomp	5	SENT_131	[p8l1239t1044r1627b1116],
2	Overall	RB	O	overall	advmod	1	SENT_131	[p8l1655t1052r1940b1125],
3	,	,	O	,	_	0	SENT_131	[p8l1655t1052r1940b1125],
4	there	EX	O	there	expl	5	SENT_131	[p8l1967t1052r2151b1116],
5	were	VBD	O	be	_	0	SENT_131	[p8l6t1179r167b1219],
6	no	DT	O	no	det	7	SENT_131	[p8l189t1179r275b1219],
7	differences	NNS	O	difference	nsubj	5	SENT_131	[p8l298t1156r669b1219],
8	with	IN	O	with	_	0	SENT_131	[p8l689t1156r843b1219],
9	respect	NN	O	respect	nn	41	SENT_131	[p8l864t1168r1109b1239],
10	to	TO	O	to	dep	41	SENT_131	[p8l1129t1168r1195b1219],
11	the	DT	O	the	det	13	SENT_131	[p8l1216t1156r1323b1219],
12	application	NN	O	application	nn	13	SENT_131	[p8l1346t1156r1728b1239],
13	route	NN	O	route	pobj	10	SENT_131	[p8l1750t1168r1928b1219],
14	or	CC	O	or	_	0	SENT_131	[p8l1951t1179r2023b1219],
15	the	DT	O	the	det	16	SENT_131	[p8l2042t1156r2149b1219],
16	dosage	NN	O	dosage	pobj	10	SENT_131	[p8l8t1259r246b1343],
17	of	IN	O	of	_	0	SENT_131	[p8l271t1259r347b1322],
18	the	DT	O	the	det	29	SENT_131	[p8l361t1259r470b1322],
19	diuretic	JJ	O	diuretic	amod	29	SENT_131	[p8l495t1259r768b1322],
20	on	IN	O	on	_	0	SENT_131	[p8l792t1282r880b1322],
21	the	DT	O	the	det	24	SENT_131	[p8l904t1259r1012b1322],
22	coprimary	JJ	O	coprimary	amod	24	SENT_131	[p8l1038t1265r1409b1343],
23	end	NN	O	end	nn	24	SENT_131	[p8l1431t1259r1559b1322],
24	points	NNS	O	point	prep_on	19	SENT_131	[p8l1582t1265r1801b1342],
25	(	CD	NUMBER	(	num	26	SENT_131	[p8l1830t1259r2150b1342],
26	patients	NNS	O	patient	dep	24	SENT_131	[p8l1830t1259r2150b1342],
27	’	CD	NUMBER	’	num	29	SENT_131	[p8l1830t1259r2150b1342],
28	global	JJ	O	global	amod	29	SENT_131	[p8l7t1362r214b1446],
29	assessment	NN	O	assessment	prep_of	16	SENT_131	[p8l235t1374r610b1425],
30	of	IN	O	of	_	0	SENT_131	[p8l631t1362r704b1425],
31	symptoms	NNS	O	symptom	prep_of	16	SENT_131	[p8l716t1374r1064b1446],
32	and	CC	O	and	_	0	SENT_131	[p8l1086t1362r1212b1425],
33	change	VB	O	change	dep	41	SENT_131	[p8l1232t1362r1468b1446],
34	in	IN	O	in	_	0	SENT_131	[p8l1489t1368r1555b1424],
35	serum	NN	O	serum	nn	36	SENT_131	[p8l1578t1385r1790b1425],
36	creatinine	NN	O	creatinine	prep_in	33	SENT_131	[p8l1811t1368r2150b1425],
37	from	IN	O	from	_	0	SENT_131	[p8l7t1465r182b1528],
38	baseline	NN	O	baseline	prep_from	36	SENT_131	[p8l206t1465r498b1528],
39	to	TO	O	to	_	0	SENT_131	[p8l522t1477r591b1528],
40	72	CD	NUMBER	72	prep_to	33	SENT_131	[p8l619t1472r698b1528],
41	h	NN	O	h	prep_with	7	SENT_131	[p8l715t1465r779b1537],
42	;	:	O	;	_	0	SENT_131	[p8l715t1465r779b1537],
43	Figure	NN	O	figure	dep	41	SENT_131	[p8l807t1470r1049b1548],
44	2	CD	NUMBER	2	num	45	SENT_131	[p8l1074t1466r1163b1542],
45	)	NN	O	)	dep	43	SENT_131	[p8l1074t1466r1163b1542],
46	.	.	O	.	_	0	SENT_131	[p8l1074t1466r1163b1542],

1	High-dose	JJ	O	high-dose	amod	2	SENT_132	[p8l1193t1465r1570b1549],
2	therapy	NN	O	therapy	nsubj	3	SENT_132	[p8l1595t1465r1870b1549],
3	led	VBD	O	lead	_	0	SENT_132	[p8l1890t1465r1998b1528],
4	to	TO	O	to	_	0	SENT_132	[p8l2022t1477r2090b1528],
5	a	DT	O	a	det	7	SENT_132	[p8l2117t1488r2153b1528],
6	faster	RBR	O	faster	advmod	7	SENT_132	[p8l7t1568r198b1631],
7	relief	NN	O	relief	prep_to	3	SENT_132	[p8l219t1568r402b1631],
8	of	IN	O	of	_	0	SENT_132	[p8l415t1568r490b1631],
9	dyspnea	NN	O	dyspnea	prep_of	7	SENT_132	[p8l503t1568r786b1652],
10	and	CC	O	and	_	0	SENT_132	[p8l808t1568r935b1631],
11	a	DT	O	a	det	13	SENT_132	[p8l957t1591r992b1631],
12	greater	JJR	O	greater	amod	13	SENT_132	[p8l1013t1580r1254b1652],
13	loss	NN	O	loss	prep_to	3	SENT_132	[p8l1274t1568r1402b1631],
14	of	IN	O	of	_	0	SENT_132	[p8l1425t1568r1500b1631],
15	ﬂuid	NN	O	ﬂuid	prep_of	13	SENT_132	[p8l1512t1568r1671b1631],
16	and	CC	O	and	_	0	SENT_132	[p8l1693t1568r1820b1631],
17	weight	NN	O	weight	prep_of	13	SENT_132	[p8l1839t1568r2072b1652],
18	at	IN	O	at	_	0	SENT_132	[p8l2094t1580r2154b1631],
19	the	DT	O	the	det	20	SENT_132	[p8l7t1671r117b1734],
20	cost	NN	O	cost	prep_at	3	SENT_132	[p8l142t1683r282b1734],
21	of	IN	O	of	_	0	SENT_132	[p8l307t1671r383b1734],
22	a	DT	O	a	det	27	SENT_132	[p8l399t1694r434b1734],
23	more	RBR	O	more	advmod	24	SENT_132	[p8l458t1694r641b1734],
24	pronounced	JJ	O	pronounced	amod	27	SENT_132	[p8l665t1671r1118b1754],
25	,	,	O	,	_	0	SENT_132	[p8l665t1671r1118b1754],
26	transient	JJ	O	transient	amod	27	SENT_132	[p8l1143t1677r1461b1734],
27	worsening	NN	O	worsening	prep_of	20	SENT_132	[p8l1483t1677r1856b1755],
28	of	IN	O	of	_	0	SENT_132	[p8l1880t1671r1956b1734],
29	renal	JJ	O	renal	amod	30	SENT_132	[p8l1971t1671r2150b1734],
30	function	NN	O	function	prep_of	27	SENT_132	[p8l7t1774r325b1838],
31	.	.	O	.	_	0	SENT_132	[p8l7t1774r325b1838],

1	In	IN	O	in	_	0	SENT_133	[p8l82t1883r155b1940],
2	patients	NNS	O	patient	prep_in	17	SENT_133	[p8l178t1884r455b1961],
3	with	IN	O	with	_	0	SENT_133	[p8l478t1878r635b1941],
4	resistant	JJ	O	resistant	amod	6	SENT_133	[p8l659t1884r956b1941],
5	peripheral	JJ	O	peripheral	amod	6	SENT_133	[p8l977t1878r1344b1961],
6	edema	NN	O	edema	prep_with	2	SENT_133	[p8l1367t1878r1617b1950],
7	,	,	O	,	_	0	SENT_133	[p8l1367t1878r1617b1950],
8	a	DT	O	a	det	9	SENT_133	[p8l1643t1901r1678b1941],
9	combination	NN	O	combination	nsubj	17	SENT_133	[p8l1701t1878r2150b1941],
10	of	IN	O	of	_	0	SENT_133	[p8l8t1981r83b2044],
11	loop	NN	O	loop	nn	14	SENT_133	[p8l95t1981r249b2064],
12	and	CC	O	and	_	0	SENT_133	[p8l274t1981r402b2044],
13	thiazide	JJ	O	thiazide	conj_and	11	SENT_133	[p8l423t1981r701b2044],
14	diuretics	NNS	O	diuretic	prep_of	9	SENT_133	[p8l725t1981r1025b2044],
15	is	VBZ	O	be	cop	17	SENT_133	[p8l1049t1987r1099b2044],
16	more	RBR	O	more	advmod	17	SENT_133	[p8l1123t2004r1303b2044],
17	efficient	JJ	O	efficient	ccomp	33	SENT_133	[p8l1327t1981r1602b2044],
18	than	IN	O	than	_	0	SENT_133	[p8l1623t1981r1780b2044],
19	high-dose	JJ	O	high-dose	amod	20	SENT_133	[p8l1802t1981r2151b2065],
20	monotherapy	NN	O	monotherapy	prep_than	17	SENT_133	[p8l7t2083r465b2168],
21	with	IN	O	with	_	0	SENT_133	[p8l479t2083r629b2147],
22	a	DT	O	a	det	23	SENT_133	[p8l650t2106r684b2147],
23	loop	NN	O	loop	prep_with	20	SENT_133	[p8l701t2083r850b2167],
24	diuretic	JJ	O	diuretic	amod	23	SENT_133	[p8l872t2075r1285b2147],
25	.18	CD	NUMBER	.18	number	26	SENT_133	[p8l872t2075r1285b2147],
26	’19	CD	NUMBER	’19	dep	24	SENT_133	[p8l872t2075r1285b2147],
27	However	RB	O	however	advmod	17	SENT_133	[p8l1306t2089r1620b2156],
28	,	,	O	,	_	0	SENT_133	[p8l1306t2089r1620b2156],
29	patients	NNS	O	patient	nsubjpass	33	SENT_133	[p8l1640t2090r1905b2167],
30	should	MD	O	should	aux	33	SENT_133	[p8l1926t2083r2153b2147],
31	be	VB	O	be	auxpass	33	SENT_133	[p8l6t2187r87b2250],
32	closely	RB	O	closely	advmod	33	SENT_133	[p8l113t2187r354b2271],
33	monitored	VBN	O	monitor	_	0	SENT_133	[p8l376t2187r753b2250],
34	in	IN	O	in	mark	37	SENT_133	[p8l777t2193r846b2249],
35	order	NN	O	order	dep	37	SENT_133	[p8l871t2187r1064b2250],
36	to	TO	O	to	aux	37	SENT_133	[p8l1087t2199r1155b2250],
37	avoid	VB	O	avoid	purpcl	33	SENT_133	[p8l1182t2187r1373b2250],
38	hypokalemia	NN	O	hypokalemia	dobj	37	SENT_133	[p8l1396t2187r1876b2271],
39	,	,	O	,	_	0	SENT_133	[p8l1396t2187r1876b2271],
40	hypov	NN	O	hypov	nn	42	SENT_133	[p8l1902t2187r2149b2271],
41	—	NN	O	—	nn	42	SENT_133	[p8l1902t2187r2149b2271],
42	olemia	NN	O	olemia	dobj	37	SENT_133	[p8l8t2290r258b2362],
43	,	,	O	,	_	0	SENT_133	[p8l8t2290r258b2362],
44	and	CC	O	and	_	0	SENT_133	[p8l283t2290r411b2353],
45	renal	JJ	O	renal	amod	46	SENT_133	[p8l433t2290r606b2353],
46	dysfunction	NN	O	dysfunction	conj_and	38	SENT_133	[p8l629t2290r1058b2374],
47	.	.	O	.	_	0	SENT_133	[p8l629t2290r1058b2374],

1	A	DT	O	a	det	6	SENT_134	[p8l1083t2294r1140b2352],
2	combined	JJ	O	combined	amod	6	SENT_134	[p8l1163t2290r1508b2353],
3	diuretic	JJ	O	diuretic	amod	6	SENT_134	[p8l1531t2290r1797b2353],
4	and	CC	O	and	_	0	SENT_134	[p8l1820t2290r1948b2353],
5	vasodilatory	JJ	O	vasodilatory	conj_and	3	SENT_134	[p8l1966t2313r2149b2353, p8l8t2393r287b2477],
6	therapy	NN	O	therapy	nsubj	7	SENT_134	[p8l306t2393r576b2477],
7	seems	VBZ	O	seem	_	0	SENT_134	[p8l597t2416r806b2456],
8	to	TO	O	to	aux	10	SENT_134	[p8l830t2405r898b2456],
9	be	VB	O	be	cop	10	SENT_134	[p8l920t2393r1002b2456],
10	superior	JJ	O	superior	xcomp	7	SENT_134	[p8l1027t2399r1322b2476],
11	to	TO	O	to	_	0	SENT_134	[p8l1344t2405r1412b2456],
12	a	DT	O	a	det	13	SENT_134	[p8l1438t2416r1473b2456],
13	monotherapy	NN	O	monotherapy	prep_to	10	SENT_134	[p8l1495t2393r1975b2477],
14	with	IN	O	with	_	0	SENT_134	[p8l1993t2393r2150b2456],
15	respect	NN	O	respect	prep_with	13	SENT_134	[p8l8t2507r252b2579],
16	to	TO	O	to	_	0	SENT_134	[p8l271t2507r337b2559],
17	organ	NN	O	organ	nn	19	SENT_134	[p8l361t2518r556b2580],
18	protection	NN	O	protection	nn	19	SENT_134	[p8l577t2487r1090b2579],
19	.2	NN	NUMBER	.2	prep_to	10	SENT_134	[p8l577t2487r1090b2579],
20	°	CD	NUMBER	°	number	21	SENT_134	[p8l577t2487r1090b2579],
21	’21	CD	NUMBER	’21	num	19	SENT_134	[p8l577t2487r1090b2579],

1	Opiates	NNS	O	opiate	_	0	SENT_135	[p8l8t2714r248b2780],
2	.	.	O	.	_	0	SENT_135	[p8l8t2714r248b2780],

1	Opiates	NNS	O	opiate	nsubj	5	SENT_136	[p8l284t2707r534b2786],
2	reduce	VBP	O	reduce	_	0	SENT_136	[p8l567t2703r789b2766],
3	anxiety	NN	O	anxiety	dobj	2	SENT_136	[p8l821t2709r1065b2787],
4	and	CC	O	and	_	0	SENT_136	[p8l1093t2703r1217b2766],
5	relieve	VB	O	relieve	conj_and	2	SENT_136	[p8l1248t2703r1462b2766],
6	respiratory	JJ	O	respiratory	amod	7	SENT_136	[p8l1494t2709r1860b2787],
7	distress	NN	O	distress	dobj	5	SENT_136	[p8l1888t2703r2148b2766],
8	.	.	O	.	_	0	SENT_136	[p8l1888t2703r2148b2766],

1	Beyond	IN	O	beyond	_	0	SENT_137	[p8l8t2806r264b2890],
2	this	DT	O	this	prep_beyond	5	SENT_137	[p8l281t2806r419b2878],
3	,	,	O	,	_	0	SENT_137	[p8l281t2806r419b2878],
4	opiates	NNS	O	opiate	nsubj	9	SENT_137	[p8l441t2812r670b2889],
5	reduce	VBP	O	reduce	_	0	SENT_137	[p8l691t2806r913b2869],
6	preload	NN	O	preload	dobj	5	SENT_137	[p8l931t2806r1184b2889],
7	and	CC	O	and	_	0	SENT_137	[p8l1204t2806r1327b2869],
8	may	MD	O	may	aux	9	SENT_137	[p8l1345t2829r1490b2890],
9	reduce	VB	O	reduce	conj_and	5	SENT_137	[p8l1506t2806r1728b2869],
10	sympathetic	JJ	O	sympathetic	amod	11	SENT_137	[p8l1749t2806r2152b2890],
11	drive	NN	O	drive	dobj	9	SENT_137	[p8l8t2909r191b2972],
12	.	.	O	.	_	0	SENT_137	[p8l8t2909r191b2972],

1	Therefore	RB	O	therefore	advmod	5	SENT_138	[p8l230t2909r567b2981],
2	,	,	O	,	_	0	SENT_138	[p8l230t2909r567b2981],
3	the	DT	O	the	det	4	SENT_138	[p8l605t2909r708b2972],
4	guidelines	NNS	O	guideline	nsubj	5	SENT_138	[p8l745t2909r1082b2993],
5	recommend	VBP	O	recommend	_	0	SENT_138	[p8l1120t2909r1526b2972],
6	the	DT	O	the	det	7	SENT_138	[p8l1561t2909r1665b2972],
7	use	NN	O	use	nsubj	11	SENT_138	[p8l1702t2932r1810b2972],
8	of	IN	O	of	_	0	SENT_138	[p8l1848t2909r1920b2972],
9	an	DT	O	a	det	10	SENT_138	[p8l1948t2932r2027b2972],
10	i.v.	NN	O	i.v.	prep_of	7	SENT_138	[p8l2063t2915r2148b2972],
11	opiate	VB	O	opiate	ccomp	5	SENT_138	[p8l8t3018r207b3095],
12	in	IN	O	in	_	0	SENT_138	[p8l235t3018r300b3074],
13	anxious	JJ	O	anxious	amod	15	SENT_138	[p8l328t3018r602b3084],
14	,	,	O	,	_	0	SENT_138	[p8l328t3018r602b3084],
15	restless	JJ	O	restless	prep_in	11	SENT_138	[p8l631t3012r883b3084],
16	,	,	O	,	_	0	SENT_138	[p8l631t3012r883b3084],
17	or	CC	O	or	_	0	SENT_138	[p8l912t3035r983b3075],
18	distressed	JJ	O	distressed	amod	19	SENT_138	[p8l1009t3012r1336b3075],
19	patients	NNS	O	patient	prep_in	11	SENT_138	[p8l1361t3018r1622b3095],
20	(	CD	NUMBER	(	num	23	SENT_138	[p8l1654t3012r2148b3088, p8l7t3121r141b3178],
21	recommendation	NN	O	recommendation	nn	23	SENT_138	[p8l1654t3012r2148b3088, p8l7t3121r141b3178],
22	class	NN	O	class	nn	23	SENT_138	[p8l168t3115r317b3178],
23	Ila	NN	O	ilum	dep	19	SENT_138	[p8l345t3120r450b3187],
24	,	,	O	,	_	0	SENT_138	[p8l345t3120r450b3187],
25	evidence	NN	O	evidence	nn	28	SENT_138	[p8l480t3115r771b3178],
26	level	NN	O	level	nn	28	SENT_138	[p8l796t3115r947b3178],
27	B	NN	O	b	nn	28	SENT_138	[p8l974t3116r1064b3192],
28	)	NN	O	)	appos	23	SENT_138	[p8l974t3116r1064b3192],
29	.	.	O	.	_	0	SENT_138	[p8l974t3116r1064b3192],

1	If	IN	O	if	mark	2	SENT_139	[p8l1095t3115r1152b3177],
2	administered	VBN	O	administer	advcl	7	SENT_139	[p8l1171t3115r1625b3187],
3	,	,	O	,	_	0	SENT_139	[p8l1171t3115r1625b3187],
4	they	PRP	O	they	nsubjpass	7	SENT_139	[p8l1653t3115r1800b3199],
5	should	MD	O	should	aux	7	SENT_139	[p8l1824t3115r2049b3178],
6	be	VB	O	be	auxpass	7	SENT_139	[p8l2073t3115r2151b3178],
7	combined	VBN	O	combine	_	0	SENT_139	[p8l8t3218r342b3281],
8	with	IN	O	with	_	0	SENT_139	[p8l357t3218r507b3281],
9	an	DT	O	a	det	10	SENT_139	[p8l525t3241r604b3281],
10	antiemetic	JJ	O	antiemetic	prep_with	7	SENT_139	[p8l623t3224r986b3281],
11	.	.	O	.	_	0	SENT_139	[p8l623t3224r986b3281],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_140	[p8l1008t3218r1454b3290],
2	,	,	O	,	_	0	SENT_140	[p8l1008t3218r1454b3290],
3	opiates	NNS	O	opiate	nsubj	5	SENT_140	[p8l1475t3224r1704b3301],
4	may	MD	O	may	aux	5	SENT_140	[p8l1722t3241r1867b3302],
5	increase	VB	O	increase	_	0	SENT_140	[p8l1881t3224r2151b3281],
6	the	DT	O	the	det	7	SENT_140	[p8l7t3321r110b3384],
7	risk	NN	O	risk	dobj	5	SENT_140	[p8l135t3321r261b3384],
8	for	IN	O	for	_	0	SENT_140	[p8l281t3321r376b3384],
9	invasive	JJ	O	invasive	amod	10	SENT_140	[p8l400t3327r664b3384],
10	ventilation	NN	O	ventilation	prep_for	5	SENT_140	[p8l685t3321r1044b3384],
11	because	IN	O	because	mark	13	SENT_140	[p8l1066t3321r1326b3384],
12	they	PRP	O	they	nsubj	13	SENT_140	[p8l1350t3321r1497b3405],
13	depress	VBP	O	depress	advcl	5	SENT_140	[p8l1518t3321r1764b3404],
14	respiratory	JJ	O	respiratory	amod	15	SENT_140	[p8l1788t3327r2154b3405],
15	drive	NN	O	drive	dobj	13	SENT_140	[p8l8t3424r191b3487],
16	.	.	O	.	_	0	SENT_140	[p8l8t3424r191b3487],

1	Regular	JJ	O	regular	amod	2	SENT_141	[p8l223t3424r481b3508],
2	monitoring	NN	O	monitoring	nsubj	14	SENT_141	[p8l508t3430r891b3508],
3	of	IN	O	of	_	0	SENT_141	[p8l918t3424r991b3487],
4	alertness	NN	O	alertness	prep_of	2	SENT_141	[p8l1010t3424r1299b3487],
5	and	CC	O	and	_	0	SENT_141	[p8l1329t3424r1453b3487],
6	ventilatory	JJ	O	ventilatory	amod	7	SENT_141	[p8l1477t3424r1842b3508],
7	function	NN	O	function	nsubj	14	SENT_141	[p8l1866t3424r2151b3487],
8	(	CD	NUMBER	(	num	9	SENT_141	[p8l11t3527r216b3604],
9	effort	NN	O	effort	dep	7	SENT_141	[p8l11t3527r216b3604],
10	and	CC	O	and	_	0	SENT_141	[p8l237t3527r360b3590],
11	frequency	NN	O	frequency	nn	12	SENT_141	[p8l381t3527r737b3611],
12	)	NN	O	)	dep	7	SENT_141	[p8l381t3527r737b3611],
13	is	VBZ	O	be	cop	14	SENT_141	[p8l763t3533r811b3590],
14	crucial	JJ	O	crucial	_	0	SENT_141	[p8l834t3527r1073b3590],
15	.	.	O	.	_	0	SENT_141	[p8l834t3527r1073b3590],

1	Vasodilators	NNS	O	vasodilator	_	0	SENT_142	[p9l11t77r407b131],
2	.	.	O	.	_	0	SENT_142	[p9l11t77r407b131],

1	Vasodilators	NNS	O	vasodilator	nsubj	2	SENT_143	[p9l444t68r875b131],
2	reduce	VBP	O	reduce	_	0	SENT_143	[p9l912t68r1143b131],
3	pulmonary	JJ	O	pulmonary	amod	6	SENT_143	[p9l1178t68r1569b152],
4	capillary	JJ	O	capillary	amod	6	SENT_143	[p9l1602t68r1902b152],
5	wedge	NN	O	wedge	nn	6	SENT_143	[p9l1933t68r2151b152],
6	pressure	NN	O	pressure	dobj	2	SENT_143	[p9l6t193r296b254],
7	and	CC	O	and	_	0	SENT_143	[p9l347t171r475b234],
8	systemic	JJ	O	systemic	amod	10	SENT_143	[p9l525t177r821b255],
9	Vascular	JJ	O	vascular	amod	10	SENT_143	[p9l868t171r1157b234],
10	resistance	NN	O	resistance	conj_and	6	SENT_143	[p9l1207t177r1564b243],
11	,	,	O	,	_	0	SENT_143	[p9l1207t177r1564b243],
12	thereby	RB	O	thereby	advmod	10	SENT_143	[p9l1615t171r1879b255],
13	reduc502	NN	O	reduc502	dep	10	SENT_143	[p9l1926t171r2148b234, p9l8t391r104b433],

1	a	DT	O	a	det	2	SENT_144	[p9l33t464r77b513],
2	Bolus	NNP	O	Bolus	_	0	SENT_144	[p9l721t477r868b522],
3	vs.	CC	O	vs.	dep	2	SENT_144	[p9l887t488r958b522],
4	continuous	JJ	O	continuous	amod	5	SENT_144	[p9l978t477r1268b522],
5	infusion	NN	O	infusion	dep	3	SENT_144	[p9l1290t476r1493b522],

1	100	CD	NUMBER	100	num	2	SENT_145	[p9l140t563r234b607],
2	AUC	NN	O	auc	dep	13	SENT_145	[p9l331t574r453b621],
3	with	IN	O	with	_	0	SENT_145	[p9l473t575r577b620],
4	bolus	NN	O	bolus	nn	5	SENT_145	[p9l601t575r741b621],
5	infusions	NNS	O	infusion	prep_with	2	SENT_145	[p9l763t575r1010b629],
6	,	,	O	,	_	0	SENT_145	[p9l763t575r1010b629],
7	4,263	CD	NUMBER	4,263	num	9	SENT_145	[p9l1033t576r1182b629],
8	:	:	O	:	_	0	SENT_145	[p9l1201t580r1234b620],
9	1,440	CD	NUMBER	1,440	appos	5	SENT_145	[p9l1257t576r1402b629],
10	I	PRP	O	I	dep	13	SENT_145	[p9l1748t573r1806b628],
11	Continuous	JJ	O	continuous	amod	13	SENT_145	[p9l1831t574r2134b621],
12	90	CD	NUMBER	90	tmod	11	SENT_145	[p9l170t678r234b723],
13	AUC	NN	O	auc	dep	21	SENT_145	[p9l331t644r453b691],
14	with	IN	O	with	_	0	SENT_145	[p9l473t645r577b690],
15	continuous	JJ	O	continuous	amod	16	SENT_145	[p9l599t645r890b691],
16	infusions	NNS	O	infusion	prep_with	13	SENT_145	[p9l912t645r1158b699],
17	,	,	O	,	_	0	SENT_145	[p9l912t645r1158b699],
18	4,373	CD	NUMBER	4,373	appos	16	SENT_145	[p9l1181t646r1331b699],
19	i	FW	O	i	dep	18	SENT_145	[p9l1350t650r1382b690],
20	1,404	CD	NUMBER	1,404	num	21	SENT_145	[p9l1405t646r1550b699],
21	Bolus	NN	O	bolus	_	0	SENT_145	[p9l1833t667r1979b712],

1	P	NN	O	p	_	0	SENT_146	[p9l335t714r376b758],
2	=	JJ	O	=	amod	1	SENT_146	[p9l390t734r422b751],
3	0.47	CD	NUMBER	0.47	tmod	2	SENT_146	[p9l442t715r557b759],

1	9	CD	NUMBER	9	num	4	SENT_147	[p9l52t932r86b980],
2	O	NN	O	o	nn	4	SENT_147	[p9l52t986r86b1016],
3	U	NN	O	u	nn	4	SENT_147	[p9l52t1019r86b1047],
4	(	NN	O	(	_	0	SENT_147	[p9l52t1049r86b1077],
5	D	NN	O	d	dep	4	SENT_147	[p9l52t1049r86b1077],
6	3	CD	NUMBER	3	num	5	SENT_147	[p9l40t1098r87b1176],
7	:	:	O	:	_	0	SENT_147	[p9l40t1098r87b1176],
8	’	CD	NUMBER	’	num	9	SENT_147	[p9l40t1098r87b1176],
9	>	JJR	O	>	dep	4	SENT_147	[p9l41t1172r86b1211],
10	To	TO	O	to	infmod	9	SENT_147	[p9l41t1229r86b1271],
11	.	.	O	.	_	0	SENT_147	[p9l41t1275r86b1304],

1	Q	NNP	O	Q	_	0	SENT_148	[p9l41t1275r86b1304],
2	2	CD	NUMBER	2	number	3	SENT_148	[p9l41t1309r86b1351],
3	(	CD	NUMBER	(	dep	1	SENT_148	[p9l40t1358r87b1399],
4	5	CD	NUMBER	5	dep	3	SENT_148	[p9l40t1358r87b1399],

1	Hours	NNS	DURATION	hour	_	0	SENT_149	[p9l1096t1892r1252b1937],
2	b	NN	O	b	nn	3	SENT_149	[p9l29t1970r75b2035],
3	Low-dose	NN	O	low-dose	dep	1	SENT_149	[p9l677t2007r933b2053],
4	vs.	CC	O	vs.	prep	3	SENT_149	[p9l952t2018r1024b2053],
5	high-dose	JJ	O	high-dose	amod	6	SENT_149	[p9l1045t2007r1306b2065],
6	strategy	NN	O	strategy	dep	4	SENT_149	[p9l1327t2010r1540b2065],

1	100	CD	NUMBER	100	num	2	SENT_150	[p9l137t2085r230b2130],
2	AUC	NN	O	auc	_	0	SENT_150	[p9l331t2098r453b2145],
3	with	IN	O	with	_	0	SENT_150	[p9l473t2099r577b2144],
4	low-dose	JJ	O	low-dose	amod	5	SENT_150	[p9l601t2099r838b2145],
5	strategy	NN	O	strategy	prep_with	2	SENT_150	[p9l858t2102r1078b2157],
6	,	,	O	,	_	0	SENT_150	[p9l858t2102r1078b2157],
7	4,171	CD	NUMBER	4,171	appos	5	SENT_150	[p9l1101t2100r1241b2153],
8	i	FW	O	i	dep	2	SENT_150	[p9l1269t2104r1302b2144],
9	1,436	CD	NUMBER	1,436	dep	8	SENT_150	[p9l1325t2100r1469b2153],
10	!	.	O	!	_	0	SENT_150	[p9l1745t2093r1803b2150],

1	High-dose	JJ	O	high-dose	amod	3	SENT_151	[p9l1825t2099r2096b2157],
2	90	CD	NUMBER	90	tmod	1	SENT_151	[p9l167t2201r230b2246],
3	AUC	NN	O	auc	_	0	SENT_151	[p9l331t2168r453b2214],
4	with	IN	O	with	_	0	SENT_151	[p9l473t2169r577b2214],
5	high-dose	JJ	O	high-dose	amod	6	SENT_151	[p9l601t2169r862b2227],
6	strategy	NN	O	strategy	prep_with	3	SENT_151	[p9l883t2172r1103b2227],
7	,	,	O	,	_	0	SENT_151	[p9l883t2172r1103b2227],
8	4,430	CD	NUMBER	4,430	appos	6	SENT_151	[p9l1126t2170r1275b2222],
9	i	FW	O	i	dep	3	SENT_151	[p9l1293t2173r1327b2213],
10	1,401	CD	NUMBER	1,401	num	12	SENT_151	[p9l1349t2170r1484b2222],
11	B	NN	O	b	nn	12	SENT_151	[p9l1745t2184r1803b2242],
12	LOW_dOSe	NN	O	low_dose	dep	9	SENT_151	[p9l1825t2190r2081b2236],

1	P	NN	O	p	_	0	SENT_152	[p9l335t2238r422b2282],
2	:	:	O	:	_	0	SENT_152	[p9l335t2238r422b2282],
3	0.06	CD	NUMBER	0.06	dep	1	SENT_152	[p9l442t2239r556b2283],

1	Global	JJ	O	global	amod	2	SENT_153	[p9l37t2752r83b2921],
2	VAS	NNP	O	VAS	_	0	SENT_153	[p9l37t2620r83b2733],
3	score	NN	NUMBER	score	dep	2	SENT_153	[p9l49t2454r83b2599],

1	0.15	CD	NUMBER	0.15	num	2	SENT_154	[p10l251t76r366b120],
2	E	NN	O	e	_	0	SENT_154	[p10l393t105r397b106],

1	E	NN	O	e	_	0	SENT_155	[p10l140t418r199b511],
2	-	:	O	-	_	0	SENT_155	[p10l140t418r199b511],
3	,	,	O	,	_	0	SENT_155	[p10l140t418r199b511],
4	P	NN	O	p	dep	14	SENT_155	[p10l796t454r836b499],
5	=	JJ	O	=	rcmod	4	SENT_155	[p10l851t474r882b492],
6	0.45	CD	NUMBER	0.45	num	7	SENT_155	[p10l903t455r1017b500],
7	P	NN	O	p	dep	5	SENT_155	[p10l1524t454r1564b499],
8	=	JJ	O	=	dep	5	SENT_155	[p10l1579t474r1610b492],
9	0.21	CD	NUMBER	0.21	number	10	SENT_155	[p10l1631t455r1736b500],
10	15	CD	NUMBER	15	dep	8	SENT_155	[p10l140t516r198b580],
11	,	,	O	,	_	0	SENT_155	[p10l140t516r198b580],
12	0.10	CD	NUMBER	0.10	number	13	SENT_155	[p10l251t527r366b571],
13	G	NN	O	g	amod	14	SENT_155	[p10l153t603r186b632],
14	)	NNS	O	)	dep	1	SENT_155	[p10l153t603r186b632],
15	I	PRP	O	I	nsubj	19	SENT_155	[p10l772t531r784b631],
16	l	NN	O	l	nn	17	SENT_155	[p10l1018t531r1030b631],
17	l	NN	O	l	tmod	19	SENT_155	[p10l1505t531r1517b606],
18	I	PRP	O	I	nsubj	19	SENT_155	[p10l1747t531r1759b606],
19	—	VBP	O	—	rcmod	14	SENT_155	[p10l141t638r186b712],
20	§	CD	NUMBER	§	number	21	SENT_155	[p10l141t638r186b712],
21	0.08	CD	NUMBER	0.08	dobj	19	SENT_155	[p10l1697t645r1811b690],
22	*	NN	O	*	dep	21	SENT_155	[p10l144t730r186b811],
23	5	CD	NUMBER	5	num	22	SENT_155	[p10l144t730r186b811],
24	;	:	O	;	_	0	SENT_155	[p10l144t730r186b811],
25	0.07	CD	NUMBER	0.07	num	28	SENT_155	[p10l975t738r1090b782],
26	E	NN	O	e	nn	28	SENT_155	[p10l152t813r186b862],
27	E	NN	O	e	nn	28	SENT_155	[p10l141t884r186b924],
28	(	NN	O	(	dep	21	SENT_155	[p10l153t947r186b977],
29	D	NN	O	d	dep	28	SENT_155	[p10l153t947r186b977],
30	0.05	CD	NUMBER	0.05	num	29	SENT_155	[p10l714t903r828b947],

1	.	.	O	.	_	0	SENT_156	[p10l141t1084r186b1110],

1	C	NN	O	c	nn	2	SENT_157	[p10l141t1084r186b1110],
2	O	NN	O	o	_	0	SENT_157	[p10l140t1116r187b1155],

1	o.	NN	O	o.	nn	2	SENT_158	[p10l251t1430r366b1474],
2	oo	NN	O	oo	nsubj	3	SENT_158	[p10l251t1430r366b1474],
3	is	VBZ	O	be	_	0	SENT_158	[p10l713t1444r720b1446],

1	9o	NN	O	9o	nsubj	4	SENT_159	[p10l668t1488r813b1585],
2	\	SYM	O	\	dep	4	SENT_159	[p10l668t1488r813b1585],
3	°	CD	NUMBER	°	num	4	SENT_159	[p10l668t1488r813b1585],
4	9	CD	NUMBER	9	_	0	SENT_159	[p10l668t1488r813b1585],
5	.	.	O	.	_	0	SENT_159	[p10l890t1488r1059b1592],

1	(	NN	O	(	dep	6	SENT_160	[p10l890t1488r1059b1592],
2	\	CD	NUMBER	\	num	1	SENT_160	[p10l890t1488r1059b1592],
3	\	CD	NUMBER	\	num	4	SENT_160	[p10l890t1488r1059b1592],
4	>	JJR	O	>	dep	1	SENT_160	[p10l890t1488r1059b1592],
5	°	CD	NUMBER	°	dep	6	SENT_160	[p10l890t1488r1059b1592],
6	°	NN	O	°	dep	10	SENT_160	[p10l890t1488r1059b1592],
7	6	CD	NUMBER	6	dep	6	SENT_160	[p10l890t1488r1059b1592],
8	,	,	O	,	_	0	SENT_160	[p10l1399t1489r1532b1574],
9	<	JJR	O	<	appos	7	SENT_160	[p10l1399t1489r1532b1574],
10	>	JJR	O	>	_	0	SENT_160	[p10l1399t1489r1532b1574],
11	°	CD	NUMBER	°	nsubj	12	SENT_160	[p10l1399t1489r1532b1574],
12	‘	NN	O	‘	rcmod	10	SENT_160	[p10l1399t1489r1532b1574],
13	*	CD	NUMBER	*	number	14	SENT_160	[p10l1399t1489r1532b1574],
14	’	CD	NUMBER	’	num	20	SENT_160	[p10l1399t1489r1532b1574],
15	e	LS	O	e	dep	20	SENT_160	[p10l1399t1489r1532b1574],
16	,	,	O	,	_	0	SENT_160	[p10l1639t1489r1772b1574],
17	e	LS	O	e	dep	20	SENT_160	[p10l1639t1489r1772b1574],
18	,	,	O	,	_	0	SENT_160	[p10l1639t1489r1772b1574],
19	°	CD	NUMBER	°	number	20	SENT_160	[p10l1639t1489r1772b1574],
20	9	CD	NUMBER	9	dobj	12	SENT_160	[p10l1639t1489r1772b1574],
21	"	``	O	"	prep	20	SENT_160	[p10l1639t1489r1772b1574],
22	’	NN	O	’	dep	21	SENT_160	[p10l1639t1489r1772b1574],

1	Figure	NN	O	figure	dep	24	SENT_161	[p10l10t1791r197b1854],
2	2	CD	NUMBER	2	num	3	SENT_161	[p10l213t1794r245b1839],
3	Results	NNS	O	result	npadvmod	1	SENT_161	[p10l286t1790r477b1840],
4	of	IN	O	of	_	0	SENT_161	[p10l494t1790r551b1840],
5	the	DT	O	the	det	9	SENT_161	[p10l561t1790r652b1840],
6	Diuretic	JJ	O	diuretic	amod	9	SENT_161	[p10l671t1792r884b1840],
7	Optimization	NN	O	optimization	nn	9	SENT_161	[p10l900t1792r1260b1853],
8	Strategies	NNS	O	strategy	nn	9	SENT_161	[p10l1279t1792r1551b1854],
9	Evaluation	NN	O	evaluation	prep_of	1	SENT_161	[p10l1570t1790r1855b1840],
10	in	IN	O	in	_	0	SENT_161	[p10l1875t1793r1920b1840],
11	Acute	JJ	O	acute	amod	13	SENT_161	[p10l8t1879r167b1927],
12	Heart	NNP	O	Heart	nn	13	SENT_161	[p10l186t1879r335b1927],
13	Failure	NN	O	failure	prep_in	9	SENT_161	[p10l354t1877r532b1927],
14	(	CD	NUMBER	(	num	17	SENT_161	[p10l550t1878r737b1934],
15	DOSE	NN	O	dose	nn	17	SENT_161	[p10l550t1878r737b1934],
16	)	NN	O	)	nn	17	SENT_161	[p10l550t1878r737b1934],
17	trial	NN	O	trial	dep	1	SENT_161	[p10l754t1877r857b1927],
18	showing	VBG	O	show	partmod	17	SENT_161	[p10l876t1877r1110b1940],
19	no	DT	O	no	det	20	SENT_161	[p10l1131t1892r1199b1927],
20	influence	NN	O	influence	dobj	18	SENT_161	[p10l1217t1876r1470b1927],
21	of	IN	O	of	_	0	SENT_161	[p10l1486t1876r1544b1927],
22	diuretic	JJ	O	diuretic	amod	23	SENT_161	[p10l1555t1877r1765b1927],
23	strategies	NNS	O	strategy	prep_of	20	SENT_161	[p10l1781t1879r2046b1940],
24	(	VBP	O	(	_	0	SENT_161	[p10l10t1963r338b2019],
25	continuous	JJ	O	continuous	dobj	24	SENT_161	[p10l10t1963r338b2019],
26	vs.	CC	O	vs.	prep	25	SENT_161	[p10l354t1977r422b2012],
27	bolus	NN	O	bolus	dep	26	SENT_161	[p10l441t1962r602b2019],
28	,	,	O	,	_	0	SENT_161	[p10l441t1962r602b2019],
29	a	DT	O	a	conj_and	25	SENT_161	[p10l618t1976r668b2019],
30	;	:	O	;	_	0	SENT_161	[p10l618t1976r668b2019],
31	and	CC	O	and	_	0	SENT_161	[p10l684t1962r785b2012],
32	high	JJ	O	high	amod	34	SENT_161	[p10l806t1962r1084b2025],
33	—	NN	O	—	nn	34	SENT_161	[p10l806t1962r1084b2025],
34	dose	NN	O	dose	conj_and	25	SENT_161	[p10l806t1962r1084b2025],
35	vs.	CC	O	vs.	prep	34	SENT_161	[p10l1099t1977r1168b2012],
36	|	NN	O	|	nn	37	SENT_161	[p10l1186t1962r1451b2019],
37	ow	NN	O	ow	dep	35	SENT_161	[p10l1186t1962r1451b2019],
38	—	CD	NUMBER	—	num	39	SENT_161	[p10l1186t1962r1451b2019],
39	dose	NN	O	dose	nsubj	24	SENT_161	[p10l1186t1962r1451b2019],
40	,	,	O	,	_	0	SENT_161	[p10l1186t1962r1451b2019],
41	b	NN	O	b	nn	42	SENT_161	[p10l1468t1962r1520b2019],
42	)	NN	O	)	appos	39	SENT_161	[p10l1468t1962r1520b2019],
43	on	IN	O	on	_	0	SENT_161	[p10l1539t1977r1606b2012],
44	the	DT	O	the	det	45	SENT_161	[p10l1624t1962r1715b2012],
45	severity	NN	O	severity	prep_on	42	SENT_161	[p10l1731t1964r1946b2026],
46	of	IN	O	of	_	0	SENT_161	[p10l1961t1961r2018b2012],
47	dyspnea	NN	O	dyspnea	prep_of	45	SENT_161	[p10l8t2048r239b2112],
48	and	CC	O	and	_	0	SENT_161	[p10l257t2048r359b2098],
49	on	IN	O	on	_	0	SENT_161	[p10l378t2063r445b2098],
50	the	DT	O	the	det	51	SENT_161	[p10l463t2048r553b2098],
51	change	NN	O	change	prep_on	42	SENT_161	[p10l570t2048r774b2112],
52	in	IN	O	in	_	0	SENT_161	[p10l792t2051r837b2098],
53	serum	NN	O	serum	prep_in	51	SENT_161	[p10l856t2063r1024b2098],
54	creatinine	NN	O	creatinine	nn	57	SENT_161	[p10l1043t2051r1317b2098],
55	(	CD	NUMBER	(	num	57	SENT_161	[p10l1335t2041r1463b2106],
56	c	NN	O	c	nn	57	SENT_161	[p10l1335t2041r1463b2106],
57	)	NN	O	)	dep	42	SENT_161	[p10l1335t2041r1463b2106],
58	.	.	O	.	_	0	SENT_161	[p10l1335t2041r1463b2106],

1	l7	NN	O	l7	nn	2	SENT_162	[p10l1335t2041r1463b2106],
2	AUC	NN	O	auc	_	0	SENT_162	[p10l1479t2050r1611b2106],
3	,	,	O	,	_	0	SENT_162	[p10l1479t2050r1611b2106],
4	area	NN	O	area	appos	2	SENT_162	[p10l1627t2063r1741b2098],
5	under	IN	O	under	_	0	SENT_162	[p10l1761t2048r1924b2098],
6	the	DT	O	the	det	7	SENT_162	[p10l1938t2048r2028b2098],
7	curve	NN	O	curve	prep_under	4	SENT_162	[p10l8t2136r305b2192],
8	;	:	O	;	_	0	SENT_162	[p10l8t2136r305b2192],
9	VAS	NNP	O	VAS	dep	2	SENT_162	[p10l8t2136r305b2192],
10	,	,	O	,	_	0	SENT_162	[p10l8t2136r305b2192],
11	visual	JJ	O	visual	amod	13	SENT_162	[p10l320t2135r474b2185],
12	analog	NN	O	analog	nn	13	SENT_162	[p10l493t2135r679b2198],
13	scale	NN	O	scale	appos	9	SENT_162	[p10l698t2135r845b2185],
14	.	.	O	.	_	0	SENT_162	[p10l698t2135r845b2185],

1	ing	VBG	O	ing	_	0	SENT_163	[p10l8t2360r118b2438],
2	preload	NN	O	preload	dobj	1	SENT_163	[p10l143t2354r407b2437],
3	and	CC	O	and	_	0	SENT_163	[p10l435t2354r562b2417],
4	afterload	NN	O	afterload	dobj	1	SENT_163	[p10l590t2354r897b2417],
5	and	CC	O	and	_	0	SENT_163	[p10l925t2354r1052b2417],
6	increasing	VBG	O	increase	conj_and	1	SENT_163	[p10l1080t2360r1437b2438],
7	stroke	NN	O	stroke	nn	8	SENT_163	[p10l1465t2354r1674b2417],
8	Volume	NN	O	volume	dobj	6	SENT_163	[p10l1700t2354r1976b2417],
9	.	.	O	.	_	0	SENT_163	[p10l1700t2354r1976b2417],

1	This	DT	O	this	nsubj	2	SENT_164	[p10l2007t2354r2151b2417],
2	leads	VBZ	O	lead	_	0	SENT_164	[p10l7t2457r180b2520],
3	to	TO	O	to	_	0	SENT_164	[p10l212t2469r279b2520],
4	a	DT	O	a	det	5	SENT_164	[p10l313t2480r348b2520],
5	reduction	NN	O	reduction	prep_to	2	SENT_164	[p10l379t2457r716b2520],
6	of	IN	O	of	_	0	SENT_164	[p10l749t2457r823b2520],
7	Ventricular	JJ	O	ventricular	amod	9	SENT_164	[p10l843t2457r1228b2520],
8	ﬁlling	NN	O	ﬁlling	nn	9	SENT_164	[p10l1259t2457r1461b2541],
9	pressures	NNS	O	pressure	prep_of	5	SENT_164	[p10l1490t2479r1831b2540],
10	,	,	O	,	_	0	SENT_164	[p10l1490t2479r1831b2540],
11	myocardial	JJ	O	myocardial	amod	13	SENT_164	[p10l1864t2480r2149b2541, p10l9t2560r136b2623],
12	wall	NN	O	wall	nn	13	SENT_164	[p10l158t2560r300b2623],
13	stress	NN	O	stress	prep_of	5	SENT_164	[p10l325t2572r530b2632],
14	,	,	O	,	_	0	SENT_164	[p10l325t2572r530b2632],
15	and	CC	O	and	_	0	SENT_164	[p10l557t2560r684b2623],
16	myocardial	JJ	O	myocardial	amod	18	SENT_164	[p10l707t2560r1097b2644],
17	oxygen	NN	O	oxygen	nn	18	SENT_164	[p10l1121t2583r1367b2644],
18	consumption	NN	O	consumption	conj_and	9	SENT_164	[p10l1391t2566r1868b2643],
19	.	.	O	.	_	0	SENT_164	[p10l1391t2566r1868b2643],

1	Table	NNP	O	Table	_	0	SENT_165	[p10l1895t2561r2090b2623],
2	1	CD	NUMBER	1	dep	1	SENT_165	[p10l2118t2567r2146b2622],

1	VOLUME	NN	O	volume	nn	3	SENT_166	[p10l537t2779r762b2821],
2	94	CD	NUMBER	94	num	3	SENT_166	[p10l780t2780r839b2821],
3	NUMBER	NN	O	number	_	0	SENT_166	[p10l858t2779r1082b2821],
4	4	CD	NUMBER	4	number	5	SENT_166	[p10l1097t2775r1150b2836],
5	|	CD	NUMBER	|	num	6	SENT_166	[p10l1097t2775r1150b2836],
6	OCTOBER	NNP	DATE	OCTOBER	dep	3	SENT_166	[p10l1170t2779r1419b2821],
7	2013	CD	DATE	2013	num	8	SENT_166	[p10l1436t2780r1555b2821],
8	|	CD	NUMBER	|	dep	6	SENT_166	[p10l1577t2775r1581b2836],
9	www.nature.com/cpt	JJ	O	www.nature.com/cpt	amod	10	SENT_166	[p10l1600t2779r2152b2833],
10	REVIEW	NNP	O	REVIEW	dep	3	SENT_166	[p10l1948t2911r2138b2948],

1	Table	NNP	O	Table	dep	13	SENT_167	[p10l8t3121r187b3177],
2	1	CD	NUMBER	1	num	3	SENT_167	[p10l207t3126r230b3176],
3	Characteristics	NNS	O	characteristic	dep	1	SENT_167	[p10l283t3121r772b3177],
4	and	CC	O	and	_	0	SENT_167	[p10l788t3121r911b3177],
5	dosage	NN	O	dosage	conj_and	1	SENT_167	[p10l929t3121r1170b3192],
6	of	IN	O	of	_	0	SENT_167	[p10l1186t3120r1254b3177],
7	the	DT	O	the	det	9	SENT_167	[p10l1265t3121r1374b3177],
8	different	JJ	O	different	amod	9	SENT_167	[p10l1390t3120r1681b3177],
9	vasodilators	NNS	O	vasodilator	prep_of	5	SENT_167	[p10l1695t3121r2105b3177],
10	Vasodilator	NNP	O	Vasodilator	nn	11	SENT_167	[p10l8t3247r346b3297],
11	Dosing	NNP	O	Dosing	dep	13	SENT_167	[p10l662t3248r865b3310],
12	Important	JJ	O	important	amod	13	SENT_167	[p10l1437t3249r1736b3310],
13	facts	NNS	O	fact	dep	16	SENT_167	[p10l1750t3246r1890b3297],
14	Nitroglycerin	NNP	O	Nitroglycerin	nn	15	SENT_167	[p10l12t3366r377b3431],
15	Start	NNP	O	Start	dep	13	SENT_167	[p10l660t3368r793b3417],
16	with	IN	O	with	_	0	SENT_167	[p10l807t3366r930b3417],
17	10-20	CD	NUMBER	10-20	num	19	SENT_167	[p10l953t3370r1121b3417],
18	pg/min	NN	O	pg/min	nn	19	SENT_167	[p10l1139t3368r1342b3430],
19	Tolerance	NN	O	tolerance	pobj	16	SENT_167	[p10l1431t3366r1707b3417],
20	on	IN	O	on	dep	19	SENT_167	[p10l1724t3381r1793b3417],
21	continuous	JJ	O	continuous	pobj	20	SENT_167	[p10l1812t3369r2132b3417],
22	and	CC	O	and	_	0	SENT_167	[p10l659t3446r763b3497],
23	increase	VB	O	increase	dep	19	SENT_167	[p10l783t3449r1015b3497],
24	up	RP	O	up	prt	23	SENT_167	[p10l1033t3461r1104b3509],
25	to	TO	O	to	aux	26	SENT_167	[p10l1118t3454r1176b3497],
26	use	VB	O	use	xcomp	23	SENT_167	[p10l1436t3461r1530b3497],
27	200	CD	NUMBER	200	nsubj	28	SENT_167	[p10l660t3531r762b3578],
28	pg/min	JJ	O	pg/min	xcomp	26	SENT_167	[p10l780t3529r984b3591],

1	Isosorbide	NNP	O	Isosorbide	nn	3	SENT_168	[p11l12t24r304b75],
2	dinitrate	NNP	O	dinitrate	nn	3	SENT_168	[p11l320t24r561b75],
3	Start	NNP	O	Start	_	0	SENT_168	[p11l660t26r793b75],
4	with	IN	O	with	dep	3	SENT_168	[p11l807t24r930b75],
5	1	CD	NUMBER	1	num	6	SENT_168	[p11l953t28r968b74],
6	mg/h	NN	O	mg/h	pobj	4	SENT_168	[p11l995t24r1144b88],
7	and	CC	O	and	_	0	SENT_168	[p11l1163t24r1267b75],
8	Tolerance	NN	O	tolerance	pobj	4	SENT_168	[p11l1432t24r1707b75],
9	on	IN	O	on	_	0	SENT_168	[p11l1724t39r1793b75],
10	continuous	JJ	O	continuous	amod	11	SENT_168	[p11l1812t27r2132b75],
11	increase	NN	O	increase	prep_on	8	SENT_168	[p11l661t108r892b156],
12	up	IN	O	up	amod	8	SENT_168	[p11l911t120r982b168],
13	to	TO	O	to	aux	14	SENT_168	[p11l996t113r1053b156],
14	10mg/h	VB	O	10mg/h	xcomp	12	SENT_168	[p11l1075t105r1301b169],
15	use	NN	O	use	dobj	14	SENT_168	[p11l1437t120r1530b156],

1	Nitroprusside	NNP	O	Nitroprusside	nn	2	SENT_169	[p11l12t225r395b288],
2	Start	NNP	O	Start	_	0	SENT_169	[p11l660t227r793b275],
3	with	IN	O	with	_	0	SENT_169	[p11l807t225r930b275],
4	0.3	CD	NUMBER	0.3	num	5	SENT_169	[p11l948t228r1027b275],
5	ug	NN	O	ug	prep_with	2	SENT_169	[p11l1048t227r1144b289],
6	/	:	O	/	punct	7	SENT_169	[p11l1048t227r1144b289],
7	kg	NN	O	kg	dep	5	SENT_169	[p11l1148t225r1239b289],
8	/	:	O	/	punct	7	SENT_169	[p11l1148t225r1239b289],
9	min	NN	DURATION	min	nn	10	SENT_169	[p11l1243t227r1346b275],
10	Light	NN	O	light	dep	5	SENT_169	[p11l1437t225r1579b289],
11	sensitive	JJ	O	sensitive	amod	10	SENT_169	[p11l1595t227r1854b283],
12	,	,	O	,	_	0	SENT_169	[p11l1595t227r1854b283],

1	and	CC	O	and	advmod	2	SENT_170	[p11l659t306r763b357],
2	increase	VB	O	increase	_	0	SENT_170	[p11l783t309r1015b357],
3	up	RP	O	up	prt	2	SENT_170	[p11l1033t321r1104b369],
4	to	TO	O	to	_	0	SENT_170	[p11l1119t314r1176b357],
5	isocyanate	NN	O	isocyanate	nn	6	SENT_170	[p11l1436t308r1738b370],
6	toxicity	NN	O	toxicity	prep_to	2	SENT_170	[p11l1753t308r1962b370],
7	5	CD	NUMBER	5	num	8	SENT_170	[p11l660t391r688b438],
8	ug/kg/min	NN	O	ug/kg/min	nsubj	2	SENT_170	[p11l709t387r1008b451],

1	Modified	VBN	O	modify	_	0	SENT_171	[p11l11t506r262b558],
2	from	IN	O	from	_	0	SENT_171	[p11l279t506r411b557],
3	ref	NN	O	ref	prep_from	1	SENT_171	[p11l432t506r514b558],
4	.	.	O	.	_	0	SENT_171	[p11l432t506r514b558],

1	1	LS	NUMBER	1	_	0	SENT_172	[p11l535t511r575b557],
2	.	.	O	.	_	0	SENT_172	[p11l535t511r575b557],

1	summarizes	VBZ	O	summarize	_	0	SENT_173	[p11l10t720r425b777],
2	the	DT	O	the	det	3	SENT_173	[p11l445t714r552b777],
3	characteristics	NNS	O	characteristic	dobj	1	SENT_173	[p11l573t714r1068b777],
4	of	IN	O	of	_	0	SENT_173	[p11l1089t714r1163b777],
5	different	JJ	O	different	amod	7	SENT_173	[p11l1175t714r1467b777],
6	vasodilating	NN	O	vasodilating	nn	7	SENT_173	[p11l1483t714r1908b798],
7	agents	NNS	O	agent	prep_of	3	SENT_173	[p11l1928t726r2142b798],
8	according	VBG	O	accord	_	0	SENT_173	[p11l10t817r351b901],
9	to	TO	O	to	prepc_according_to	1	SENT_173	[p11l373t829r439b880],
10	the	DT	O	the	det	12	SENT_173	[p11l464t817r571b880],
11	current	JJ	DATE	current	amod	12	SENT_173	[p11l596t829r851b880],
12	guidelines	NNS	O	guideline	pobj	1	SENT_173	[p11l874t817r1243b901],
13	.	.	O	.	_	0	SENT_173	[p11l874t817r1243b901],

1	Nitrates	NNS	MISC	nitrate	nsubjpass	4	SENT_174	[p11l82t925r369b983],
2	may	MD	O	may	aux	4	SENT_174	[p11l396t943r548b1004],
3	be	VB	O	be	auxpass	4	SENT_174	[p11l569t920r651b983],
4	administered	VBN	O	administer	_	0	SENT_174	[p11l679t920r1157b983],
5	orally	RB	O	orally	dep	4	SENT_174	[p11l1183t920r1401b1004],
6	,	,	O	,	_	0	SENT_174	[p11l1183t920r1401b1004],
7	sublingually	RB	O	sublingually	dep	4	SENT_174	[p11l1430t920r1884b1004],
8	,	,	O	,	_	0	SENT_174	[p11l1430t920r1884b1004],
9	or	CC	O	or	_	0	SENT_174	[p11l1913t943r1988b983],
10	as	IN	O	as	conj_or	7	SENT_174	[p11l2014t943r2081b983],
11	a	DT	O	a	det	13	SENT_174	[p11l2108t943r2144b983],
12	continuous	JJ	O	continuous	amod	13	SENT_174	[p11l10t1029r411b1086],
13	infusion	NN	O	infusion	pobj	10	SENT_174	[p11l438t1023r754b1086],
14	.	.	O	.	_	0	SENT_174	[p11l438t1023r754b1086],

1	To	TO	O	to	aux	2	SENT_175	[p11l783t1026r869b1086],
2	avoid	VB	O	avoid	purpcl	15	SENT_175	[p11l897t1023r1090b1086],
3	hypotension	NN	O	hypotension	dobj	2	SENT_175	[p11l1113t1023r1579b1107],
4	,	,	O	,	_	0	SENT_175	[p11l1113t1023r1579b1107],
5	low	JJ	O	low	amod	6	SENT_175	[p11l1605t1023r1733b1086],
6	increase	NN	O	increase	nsubjpass	15	SENT_175	[p11l1757t1029r2048b1086],
7	in	IN	O	in	_	0	SENT_175	[p11l2075t1029r2144b1085],
8	dosage	NN	O	dosage	nn	13	SENT_175	[p11l10t1127r242b1211],
9	and	CC	O	and	_	0	SENT_175	[p11l265t1127r391b1190],
10	frequent	JJ	O	frequent	conj_and	8	SENT_175	[p11l412t1127r704b1210],
11	blood	NN	O	blood	nn	13	SENT_175	[p11l722t1127r923b1190],
12	pressure	NN	O	pressure	nn	13	SENT_175	[p11l943t1149r1229b1210],
13	measurements	NNS	O	measurement	prep_in	6	SENT_175	[p11l1251t1139r1750b1190],
14	are	VBP	O	be	auxpass	15	SENT_175	[p11l1774t1150r1874b1190],
15	recommended	VBN	O	recommend	_	0	SENT_175	[p11l1896t1150r2139b1190, p11l9t1230r312b1293],
16	.	.	O	.	_	0	SENT_175	[p11l1896t1150r2139b1190, p11l9t1230r312b1293],

1	Tachyphylaxis	NNP	PERSON	Tachyphylaxis	nsubj	3	SENT_176	[p11l339t1230r838b1314],
2	usually	RB	O	usually	advmod	3	SENT_176	[p11l862t1230r1115b1314],
3	occurs	VBZ	O	occur	_	0	SENT_176	[p11l1136t1253r1365b1293],
4	after	IN	O	after	_	0	SENT_176	[p11l1391t1230r1547b1293],
5	24-28	CD	NUMBER	24-28	num	6	SENT_176	[p11l1570t1237r1780b1293],
6	h	NN	O	h	prep_after	3	SENT_176	[p11l1798t1230r1861b1302],
7	,	,	O	,	_	0	SENT_176	[p11l1798t1230r1861b1302],
8	leading	VBG	O	lead	xcomp	3	SENT_176	[p11l1885t1230r2145b1314],
9	to	TO	O	to	_	0	SENT_176	[p11l9t1345r76b1396],
10	an	DT	O	a	det	11	SENT_176	[p11l103t1356r184b1396],
11	increase	NN	O	increase	prep_to	8	SENT_176	[p11l209t1339r496b1396],
12	in	IN	O	in	_	0	SENT_176	[p11l522t1339r589b1395],
13	dosage	NN	O	dosage	prep_in	11	SENT_176	[p11l615t1333r871b1417],
14	.	.	O	.	_	0	SENT_176	[p11l615t1333r871b1417],

1	The	DT	O	the	det	2	SENT_177	[p11l899t1333r1025b1396],
2	guidelines	NNS	O	guideline	nsubj	3	SENT_177	[p11l1050t1333r1410b1417],
3	recommend	VBP	O	recommend	_	0	SENT_177	[p11l1436t1333r1861b1396],
4	that	IN	O	that	complm	8	SENT_177	[p11l1884t1333r2022b1396],
5	i.v.	NN	O	i.v.	nn	6	SENT_177	[p11l2046t1339r2139b1396],
6	nitrates	NNS	O	nitrate	nsubjpass	8	SENT_177	[p11l9t1442r266b1499],
7	be	VB	O	be	auxpass	8	SENT_177	[p11l287t1436r365b1499],
8	considered	VBN	O	consider	ccomp	3	SENT_177	[p11l388t1436r764b1499],
9	in	IN	O	in	_	0	SENT_177	[p11l785t1442r851b1498],
10	patients	NNS	O	patient	prep_in	8	SENT_177	[p11l872t1442r1143b1519],
11	with	IN	O	with	_	0	SENT_177	[p11l1164t1436r1317b1499],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_177	[p11l1337t1436r1723b1520],
13	congestion	NN	O	congestion	prep_with	10	SENT_177	[p11l1742t1440r2142b1520],
14	/	:	O	/	punct	19	SENT_177	[p11l1742t1440r2142b1520],
15	edema	NN	O	edema	dep	19	SENT_177	[p11l10t1539r240b1602],
16	and	CC	O	and	_	0	SENT_177	[p11l265t1539r393b1602],
17	an	DT	O	a	det	18	SENT_177	[p11l418t1562r499b1602],
18	SBP	NN	O	sbp	conj_and	15	SENT_177	[p11l525t1543r661b1602],
19	>	JJR	O	>	dep	13	SENT_177	[p11l690t1546r858b1602],
20	110	CD	NUMBER	110	num	22	SENT_177	[p11l690t1546r858b1602],
21	mm	NN	O	mm	nn	22	SENT_177	[p11l876t1562r1016b1601],
22	Hg	NN	O	hg	tmod	8	SENT_177	[p11l1041t1544r1144b1623],
23	who	WP	O	who	nsubj	26	SENT_177	[p11l1166t1539r1315b1602],
24	do	VBP	O	do	aux	26	SENT_177	[p11l1342t1539r1427b1602],
25	not	RB	O	not	neg	26	SENT_177	[p11l1453t1551r1570b1602],
26	have	VB	O	have	rcmod	22	SENT_177	[p11l1593t1539r1752b1602],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_177	[p11l1778t1539r2144b1623],
28	mitral	NN	O	mitral	dobj	26	SENT_177	[p11l9t1642r223b1705],
29	or	CC	O	or	_	0	SENT_177	[p11l246t1665r318b1705],
30	aortic	JJ	O	aortic	amod	31	SENT_177	[p11l341t1648r542b1705],
31	stenosis	NN	O	stenosis	conj_or	28	SENT_177	[p11l566t1648r838b1705],
32	(	CD	NUMBER	(	num	35	SENT_177	[p11l865t1642r1496b1719],
33	recommendation	NN	O	recommendation	nn	35	SENT_177	[p11l865t1642r1496b1719],
34	class	NN	O	class	nn	35	SENT_177	[p11l1520t1642r1677b1705],
35	Ila	NN	O	ilum	dep	22	SENT_177	[p11l1702t1647r1813b1714],
36	,	,	O	,	_	0	SENT_177	[p11l1702t1647r1813b1714],
37	evidence	NN	O	evidence	nn	40	SENT_177	[p11l1838t1642r2144b1705],
38	level	NN	O	level	nn	40	SENT_177	[p11l8t1745r170b1809],
39	B	NN	O	b	nn	40	SENT_177	[p11l196t1746r292b1822],
40	)	NN	O	)	dep	3	SENT_177	[p11l196t1746r292b1822],
41	.	.	O	.	_	0	SENT_177	[p11l196t1746r292b1822],

1	However	RB	O	however	advmod	7	SENT_178	[p11l322t1750r653b1817],
2	,	,	O	,	_	0	SENT_178	[p11l322t1750r653b1817],
3	until	IN	O	until	advmod	7	SENT_178	[p11l680t1745r848b1808],
4	now	RB	DATE	now	advmod	3	SENT_178	[p11l873t1768r1035b1817],
5	,	,	O	,	_	0	SENT_178	[p11l873t1768r1035b1817],
6	there	EX	O	there	expl	7	SENT_178	[p11l1061t1745r1243b1808],
7	is	VBZ	O	be	_	0	SENT_178	[p11l1269t1751r1321b1808],
8	no	DT	O	no	det	9	SENT_178	[p11l1347t1768r1435b1809],
9	evidence	NN	O	evidence	nsubj	7	SENT_178	[p11l1462t1745r1774b1808],
10	that	IN	O	that	complm	13	SENT_178	[p11l1798t1745r1938b1809],
11	these	DT	O	these	det	12	SENT_178	[p11l1961t1745r2144b1808],
12	agents	NNS	O	agent	nsubj	13	SENT_178	[p11l10t1861r229b1933],
13	improve	VBP	O	improve	ccomp	7	SENT_178	[p11l254t1855r544b1932],
14	symptoms	NNS	O	symptom	dobj	13	SENT_178	[p11l569t1861r928b1933],
15	or	CC	O	or	cc	14	SENT_178	[p11l953t1872r1026b1912],
16	even	RB	O	even	advmod	14	SENT_178	[p11l1050t1872r1210b1912],
17	outcomes	NNS	O	outcome	dep	14	SENT_178	[p11l1235t1861r1571b1912],
18	in	IN	O	in	_	0	SENT_178	[p11l1596t1855r1664b1911],
19	AHF	NNP	O	AHF	prep_in	17	SENT_178	[p11l1687t1841r1933b1912],
20	.22	CD	NUMBER	.22	num	19	SENT_178	[p11l1687t1841r1933b1912],

1	Sodium	NN	O	sodium	nn	2	SENT_179	[p11l84t1952r350b2015],
2	nitroprusside	NN	O	nitroprusside	nsubjpass	5	SENT_179	[p11l372t1952r829b2035],
3	may	MD	O	may	aux	5	SENT_179	[p11l851t1975r997b2036],
4	be	VB	O	be	auxpass	5	SENT_179	[p11l1013t1952r1092b2015],
5	considered	VBN	O	consider	_	0	SENT_179	[p11l1114t1952r1488b2015],
6	as	IN	O	as	_	0	SENT_179	[p11l1509t1975r1573b2015],
7	an	DT	O	a	det	8	SENT_179	[p11l1596t1975r1675b2015],
8	alternative	NN	O	alternative	prep_as	5	SENT_179	[p11l1698t1952r2055b2015],
9	to	TO	O	to	_	0	SENT_179	[p11l2076t1964r2142b2015],
10	nitrates	NNS	O	nitrate	prep_to	5	SENT_179	[p11l9t2081r257b2138],
11	in	IN	O	in	_	0	SENT_179	[p11l277t2081r342b2137],
12	patients	NNS	O	patient	prep_in	10	SENT_179	[p11l360t2081r622b2158],
13	with	IN	O	with	_	0	SENT_179	[p11l640t2075r790b2138],
14	pulmonary	JJ	O	pulmonary	amod	15	SENT_179	[p11l808t2075r1183b2159],
15	congestion	NN	O	congestion	prep_with	12	SENT_179	[p11l1200t2079r1587b2159],
16	/	:	O	/	punct	17	SENT_179	[p11l1200t2079r1587b2159],
17	edema	NN	O	edema	dep	15	SENT_179	[p11l1592t2075r1827b2147],
18	;	:	O	;	_	0	SENT_179	[p11l1592t2075r1827b2147],
19	however	RB	O	however	advmod	25	SENT_179	[p11l1847t2075r2142b2147],
20	,	,	O	,	_	0	SENT_179	[p11l1847t2075r2142b2147],
21	the	DT	O	the	det	23	SENT_179	[p11l9t2178r115b2241],
22	recommendation	NN	O	recommendation	nn	23	SENT_179	[p11l137t2178r728b2241],
23	level	NN	O	level	nsubj	25	SENT_179	[p11l749t2178r903b2241],
24	is	VBZ	O	be	cop	25	SENT_179	[p11l925t2184r974b2241],
25	lower	JJR	O	lower	parataxis	5	SENT_179	[p11l996t2178r1186b2241],
26	(	NN	O	(	nn	29	SENT_179	[p11l1211t2178r1828b2255],
27	recommendation	NN	O	recommendation	nn	29	SENT_179	[p11l1211t2178r1828b2255],
28	class	NN	O	class	nn	29	SENT_179	[p11l1850t2178r2004b2241],
29	Ilb	NN	O	ilb	tmod	25	SENT_179	[p11l2027t2178r2141b2250],
30	,	,	O	,	_	0	SENT_179	[p11l2027t2178r2141b2250],
31	evidence	NN	O	evidence	nn	34	SENT_179	[p11l10t2281r302b2344],
32	level	NN	O	level	nn	34	SENT_179	[p11l320t2281r472b2344],
33	B	NN	O	b	nn	34	SENT_179	[p11l491t2281r582b2358],
34	)	NN	O	)	appos	29	SENT_179	[p11l491t2281r582b2358],
35	.	.	O	.	_	0	SENT_179	[p11l491t2281r582b2358],

1	Because	IN	O	because	_	0	SENT_180	[p11l605t2286r872b2344],
2	of	IN	O	of	prepc_because_of	15	SENT_180	[p11l892t2281r964b2344],
3	the	DT	O	the	det	5	SENT_180	[p11l973t2281r1077b2344],
4	high	JJ	O	high	amod	5	SENT_180	[p11l1096t2281r1246b2365],
5	potency	NN	O	potency	pobj	15	SENT_180	[p11l1265t2293r1536b2365],
6	of	IN	O	of	_	0	SENT_180	[p11l1552t2281r1624b2344],
7	this	DT	O	this	det	8	SENT_180	[p11l1633t2281r1755b2344],
8	drug	NN	O	drug	prep_of	5	SENT_180	[p11l1776t2281r1950b2365],
9	,	,	O	,	_	0	SENT_180	[p11l1776t2281r1950b2365],
10	invasive	JJ	O	invasive	amod	13	SENT_180	[p11l1971t2287r2140b2344, p11l10t2390r136b2447],
11	blood	NN	O	blood	nn	13	SENT_180	[p11l155t2384r355b2447],
12	pressure	NN	O	pressure	nn	13	SENT_180	[p11l374t2406r659b2467],
13	control	NN	O	control	nsubjpass	15	SENT_180	[p11l682t2384r926b2447],
14	is	VBZ	O	be	auxpass	15	SENT_180	[p11l947t2390r997b2447],
15	required	VBN	O	require	_	0	SENT_180	[p11l1019t2384r1325b2467],
16	.	.	O	.	_	0	SENT_180	[p11l1019t2384r1325b2467],

1	Nesiritide	NNP	MISC	Nesiritide	nsubj	15	SENT_181	[p11l82t2487r426b2559],
2	,	,	O	,	_	0	SENT_181	[p11l82t2487r426b2559],
3	a	DT	O	a	det	6	SENT_181	[p11l447t2510r481b2550],
4	recombinant	JJ	O	recombinant	amod	6	SENT_181	[p11l499t2487r923b2550],
5	human	JJ	O	human	amod	6	SENT_181	[p11l940t2487r1177b2550],
6	brain	NN	O	brain	appos	1	SENT_181	[p11l1194t2487r1369b2550],
7	natriuretic	JJ	O	natriuretic	amod	8	SENT_181	[p11l1388t2493r1737b2550],
8	peptide	NN	O	peptide	dep	6	SENT_181	[p11l1755t2487r2021b2570],
9	,	,	O	,	_	0	SENT_181	[p11l1755t2487r2021b2570],
10	is	VBZ	O	be	cop	15	SENT_181	[p11l2041t2493r2090b2550],
11	a	DT	O	a	det	15	SENT_181	[p11l2110t2510r2144b2550],
12	venous	JJ	O	venous	amod	15	SENT_181	[p11l7t2612r244b2652],
13	and	CC	O	and	_	0	SENT_181	[p11l264t2589r389b2652],
14	arterial	JJ	O	arterial	conj_and	12	SENT_181	[p11l407t2589r646b2652],
15	vasodilator	NN	O	vasodilator	_	0	SENT_181	[p11l662t2589r1037b2652],
16	with	IN	O	with	_	0	SENT_181	[p11l1053t2589r1203b2652],
17	modest	JJ	O	modest	prep_with	15	SENT_181	[p11l1222t2589r1470b2652],
18	diuretic	JJ	O	diuretic	amod	17	SENT_181	[p11l1489t2589r1746b2652],
19	and	CC	O	and	_	0	SENT_181	[p11l1766t2589r1890b2652],
20	natriuretic	JJ	O	natriuretic	amod	17	SENT_181	[p11l1908t2595r2140b2652, p11l10t2698r158b2755],

1	effects	NNS	O	effect	_	0	SENT_182	[p11l178t2692r403b2755],
2	.	.	O	.	_	0	SENT_182	[p11l178t2692r403b2755],

1	Nesiritide	NNP	MISC	Nesiritide	nsubjpass	4	SENT_183	[p11l425t2692r757b2755],
2	has	VBZ	O	have	aux	4	SENT_183	[p11l776t2692r886b2755],
3	been	VBN	O	be	auxpass	4	SENT_183	[p11l905t2692r1067b2755],
4	used	VBN	O	use	ccomp	60	SENT_183	[p11l1086t2692r1243b2755],
5	for	IN	O	for	_	0	SENT_183	[p11l1261t2692r1357b2755],
6	a	DT	O	a	det	8	SENT_183	[p11l1376t2715r1411b2755],
7	longer	JJR	O	longer	amod	8	SENT_183	[p11l1428t2692r1643b2776],
8	time	NN	O	time	prep_for	4	SENT_183	[p11l1661t2698r1813b2755],
9	in	IN	O	in	_	0	SENT_183	[p11l1833t2698r1899b2754],
10	the	DT	O	the	det	15	SENT_183	[p11l1917t2692r2023b2755],
11	US	NNP	LOCATION	US	nn	15	SENT_183	[p11l2043t2696r2141b2755],
12	Acute	JJ	O	acute	amod	15	SENT_183	[p11l9t2799r203b2858],
13	Decompensated	JJ	O	decompensated	amod	15	SENT_183	[p11l223t2795r765b2878],
14	Heart	NNP	O	Heart	nn	15	SENT_183	[p11l784t2800r974b2858],
15	Failure	NN	O	failure	prep_in	8	SENT_183	[p11l993t2795r1221b2858],
16	National	NNP	O	National	nn	17	SENT_183	[p11l1240t2795r1530b2858],
17	(	NNP	O	(	nsubj	18	SENT_183	[p11l1552t2796r1933b2871],
18	ADHERE	VBP	O	adhere	rcmod	15	SENT_183	[p11l1552t2796r1933b2871],
19	)	NN	O	)	nn	20	SENT_183	[p11l1552t2796r1933b2871],
20	registry	NN	O	registry	dobj	18	SENT_183	[p11l1957t2801r2139b2879, p11l9t2889r174b2981],
21	.23	CD	NUMBER	.23	num	20	SENT_183	[p11l1957t2801r2139b2879, p11l9t2889r174b2981],
22	The	DT	O	the	det	23	SENT_183	[p11l195t2897r317b2960],
23	Vasodilatation	NN	O	vasodilatation	nsubj	30	SENT_183	[p11l335t2897r813b2960],
24	in	IN	O	in	_	0	SENT_183	[p11l832t2903r896b2959],
25	Management	NN	O	management	prep_in	23	SENT_183	[p11l915t2902r1351b2981],
26	of	IN	O	of	_	0	SENT_183	[p11l1369t2897r1441b2960],
27	Acute	JJ	O	acute	amod	28	SENT_183	[p11l1450t2901r1642b2960],
28	CHF	NN	O	chf	prep_of	25	SENT_183	[p11l1662t2901r1821b2960],
29	(	CD	NUMBER	(	num	30	SENT_183	[p11l1845t2898r2137b2974],
30	VMAC	NN	O	vmac	dep	18	SENT_183	[p11l1845t2898r2137b2974],
31	)	CD	NUMBER	)	num	32	SENT_183	[p11l1845t2898r2137b2974],
32	trial	NN	O	trial	nsubj	33	SENT_183	[p11l9t3000r146b3063],
33	showed	VBD	O	show	rcmod	30	SENT_183	[p11l165t3000r418b3063],
34	an	DT	O	a	det	35	SENT_183	[p11l437t3023r515b3063],
35	improvement	NN	O	improvement	dobj	33	SENT_183	[p11l535t3006r988b3083],
36	of	IN	O	of	_	0	SENT_183	[p11l1006t3000r1079b3063],
37	dyspnea	NN	O	dyspnea	prep_of	35	SENT_183	[p11l1089t3000r1362b3084],
38	and	CC	O	and	_	0	SENT_183	[p11l1381t3000r1505b3063],
39	a	DT	O	a	det	40	SENT_183	[p11l1524t3023r1558b3063],
40	reduction	NN	O	reduction	prep_of	35	SENT_183	[p11l1576t3000r1901b3063],
41	in	IN	O	in	_	0	SENT_183	[p11l1920t3006r1985b3062],
42	pulmonary	JJ	O	pulmonary	amod	44	SENT_183	[p11l2004t3000r2138b3083, p11l9t3125r272b3186],
43	artery	NN	O	artery	nn	44	SENT_183	[p11l288t3114r486b3186],
44	pressure	NN	O	pressure	prep_in	33	SENT_183	[p11l500t3124r774b3185],
45	induced	VBN	O	induce	partmod	44	SENT_183	[p11l793t3102r1060b3165],
46	by	IN	O	by	_	0	SENT_183	[p11l1076t3102r1158b3186],
47	nesiritide	NN	O	nesiritide	nn	48	SENT_183	[p11l1172t3102r1481b3165],
48	treatment	NN	O	treatment	agent	45	SENT_183	[p11l1499t3094r1899b3165],
49	.24	CD	NUMBER	.24	dep	30	SENT_183	[p11l1499t3094r1899b3165],
50	On	IN	O	on	dep	49	SENT_183	[p11l1918t3106r2022b3165],
51	the	DT	O	the	det	52	SENT_183	[p11l2040t3102r2143b3165],
52	basis	NN	O	basis	pobj	50	SENT_183	[p11l8t3205r174b3268],
53	of	IN	O	of	_	0	SENT_183	[p11l197t3205r271b3268],
54	these	DT	O	these	det	55	SENT_183	[p11l283t3205r458b3268],
55	data	NNS	O	datum	prep_of	52	SENT_183	[p11l482t3205r643b3277],
56	,	,	O	,	_	0	SENT_183	[p11l482t3205r643b3277],
57	the	DT	O	the	det	58	SENT_183	[p11l665t3205r772b3268],
58	drug	NN	O	drug	nsubjpass	60	SENT_183	[p11l795t3205r958b3289],
59	was	VBD	O	be	auxpass	60	SENT_183	[p11l976t3228r1103b3268],
60	approved	VBN	O	approve	_	0	SENT_183	[p11l1126t3205r1444b3288],
61	by	IN	O	by	_	0	SENT_183	[p11l1463t3205r1548b3289],
62	the	DT	O	the	det	64	SENT_183	[p11l1565t3205r1672b3268],
63	US	NNP	ORGANIZATION	US	nn	64	SENT_183	[p11l1695t3209r1794b3268],
64	Food	NNP	ORGANIZATION	Food	agent	60	SENT_183	[p11l1818t3205r1995b3268],
65	and	CC	ORGANIZATION	and	_	0	SENT_183	[p11l2017t3205r2143b3268],
66	Drug	NNP	ORGANIZATION	Drug	nn	67	SENT_183	[p11l10t3313r191b3392],
67	Administration	NNP	ORGANIZATION	Administration	conj_and	64	SENT_183	[p11l210t3308r759b3371],
68	.	.	O	.	_	0	SENT_183	[p11l210t3308r759b3371],

1	Due	JJ	O	due	_	0	SENT_184	[p11l784t3313r927b3371],
2	to	TO	O	to	_	0	SENT_184	[p11l948t3320r1014b3371],
3	the	DT	O	the	det	5	SENT_184	[p11l1037t3308r1143b3371],
4	missing	JJ	O	missing	amod	5	SENT_184	[p11l1165t3314r1431b3392],
5	evidence	NN	O	evidence	prep_due_to	18	SENT_184	[p11l1452t3308r1751b3371],
6	in	IN	O	in	_	0	SENT_184	[p11l1774t3314r1840b3370],
7	terms	NNS	O	term	prep_in	5	SENT_184	[p11l1861t3320r2055b3371],
8	of	IN	O	of	_	0	SENT_184	[p11l2079t3308r2153b3371],
9	hard	JJ	O	hard	amod	12	SENT_184	[p11l8t3411r162b3474],
10	clinical	JJ	O	clinical	amod	12	SENT_184	[p11l180t3411r415b3474],
11	end	NN	O	end	nn	12	SENT_184	[p11l433t3411r556b3474],
12	points	NNS	O	point	prep_of	7	SENT_184	[p11l572t3417r795b3494],
13	,	,	O	,	_	0	SENT_184	[p11l572t3417r795b3494],
14	the	DT	O	the	det	17	SENT_184	[p11l814t3411r917b3474],
15	European	JJ	ORGANIZATION	european	amod	17	SENT_184	[p11l936t3416r1256b3494],
16	Medicines	NNP	ORGANIZATION	Medicines	nn	17	SENT_184	[p11l1275t3411r1614b3474],
17	Agency	NNP	ORGANIZATION	Agency	nsubj	18	SENT_184	[p11l1633t3415r1885b3495],
18	refused	VBD	O	refuse	_	0	SENT_184	[p11l1900t3411r2143b3474],
19	its	PRP$	O	its	poss	20	SENT_184	[p11l10t3520r84b3577],
20	approval	NN	O	approval	dobj	18	SENT_184	[p11l104t3514r394b3597],
21	for	IN	O	for	_	0	SENT_184	[p11l413t3514r509b3577],
22	Europe	NNP	LOCATION	Europe	prep_for	18	SENT_184	[p11l527t3519r785b3597],
23	.	.	O	.	_	0	SENT_184	[p11l527t3519r785b3597],

1	Subsequently	RB	O	subsequently	dep	4	SENT_185	[p11l808t3514r1265b3598],
2	,	,	O	,	_	0	SENT_185	[p11l808t3514r1265b3598],
3	the	DT	O	the	dep	4	SENT_185	[p11l1285t3514r1390b3577],
4	randomized	VBN	O	randomize	_	0	SENT_185	[p11l1410t3514r1834b3586],
5	,	,	O	,	_	0	SENT_185	[p11l1410t3514r1834b3586],
6	placebocontrolled	JJ	O	placebocontrolled	amod	8	SENT_185	[p11l1854t3514r2140b3597, p11l10t3617r356b3680],
7	Acute	JJ	O	acute	amod	8	SENT_185	[p11l376t3621r573b3680],
8	Study	NN	O	study	nsubjpass	22	SENT_185	[p11l596t3617r789b3701],
9	of	IN	O	of	_	0	SENT_185	[p11l808t3617r881b3680],
10	Clinical	JJ	O	clinical	amod	11	SENT_185	[p11l894t3617r1158b3680],
11	Effectiveness	NN	O	effectiveness	prep_of	8	SENT_185	[p11l1178t3617r1613b3680],
12	of	IN	O	of	_	0	SENT_185	[p11l1636t3617r1709b3680],
13	Nesiritide	NNP	O	Nesiritide	prep_of	11	SENT_185	[p11l1720t3617r2054b3680],
14	in	IN	O	in	_	0	SENT_185	[p11l2076t3623r2142b3679],
15	Decompensated	NNP	O	Decompensated	nn	16	SENT_185	[p11l10t3720r565b3803],
16	Heart	NNP	O	Heart	prep_in	13	SENT_185	[p11l586t3725r781b3783],
17	Failure	NN	O	failure	nn	20	SENT_185	[p11l803t3720r1038b3783],
18	(	CD	NUMBER	(	num	20	SENT_185	[p11l1063t3721r1591b3797],
19	ASCEND-HF	NN	O	ascend-hf	nn	20	SENT_185	[p11l1063t3721r1591b3797],
20	)	NN	O	)	dep	16	SENT_185	[p11l1063t3721r1591b3797],
21	was	VBD	O	be	auxpass	22	SENT_185	[p11l1615t3743r1742b3783],
22	conducted	VBN	O	conduct	dep	4	SENT_185	[p11l1765t3720r2141b3792],
23	,	,	O	,	_	0	SENT_185	[p11l1765t3720r2141b3792],

1	which	WDT	O	which	nsubj	2	SENT_186	[p12l8t17r211b80],
2	randomized	VBD	O	randomize	_	0	SENT_186	[p12l230t17r632b80],
3	7,141	CD	NUMBER	7,141	num	5	SENT_186	[p12l652t24r820b89],
4	AHF	NN	ORGANIZATION	ahf	nn	5	SENT_186	[p12l845t21r1008b79],
5	patients	NNS	O	patient	dobj	2	SENT_186	[p12l1027t23r1287b100],
6	to	TO	O	to	_	0	SENT_186	[p12l1306t29r1370b80],
7	either	CC	O	either	preconj	8	SENT_186	[p12l1391t17r1581b80],
8	nesiritide	NN	O	nesiritide	prep_to	2	SENT_186	[p12l1599t17r1909b80],
9	or	CC	O	or	_	0	SENT_186	[p12l1929t40r1999b80],
10	placebo	NN	O	placebo	prep_to	2	SENT_186	[p12l2016t17r2141b100, p12l10t120r180b183],
11	.	.	O	.	_	0	SENT_186	[p12l2016t17r2141b100, p12l10t120r180b183],

1	Treatment	NN	O	treatment	nsubj	15	SENT_187	[p12l203t123r553b183],
2	with	IN	O	with	_	0	SENT_187	[p12l571t120r722b183],
3	nesiritide	NN	O	nesiritide	prep_with	1	SENT_187	[p12l742t120r1060b183],
4	did	VBD	O	do	aux	6	SENT_187	[p12l1081t120r1191b183],
5	not	RB	O	not	neg	6	SENT_187	[p12l1210t132r1323b183],
6	lead	VB	O	lead	ccomp	40	SENT_187	[p12l1341t120r1480b183],
7	to	TO	O	to	_	0	SENT_187	[p12l1499t132r1564b183],
8	an	DT	O	a	det	9	SENT_187	[p12l1587t143r1666b183],
9	improvement	NN	O	improvement	prep_to	6	SENT_187	[p12l1686t126r2144b203],
10	of	IN	O	of	_	0	SENT_187	[p12l10t223r82b286],
11	dyspnea	NN	O	dyspnea	prep_of	9	SENT_187	[p12l92t223r363b307],
12	and	CC	O	and	_	0	SENT_187	[p12l381t223r504b286],
13	did	VBD	O	do	aux	15	SENT_187	[p12l523t223r630b286],
14	not	RB	O	not	neg	15	SENT_187	[p12l648t235r759b286],
15	affect	VB	O	affect	conj_and	6	SENT_187	[p12l778t223r954b286],
16	the	DT	O	the	det	19	SENT_187	[p12l971t223r1074b286],
17	composite	JJ	O	composite	amod	19	SENT_187	[p12l1094t229r1434b306],
18	end	NN	O	end	nn	19	SENT_187	[p12l1454t223r1576b286],
19	point	NN	O	point	dobj	15	SENT_187	[p12l1593t229r1770b306],
20	of	IN	O	of	_	0	SENT_187	[p12l1788t223r1860b286],
21	rehospi	NN	O	rehospus	nn	23	SENT_187	[p12l1870t223r2141b306],
22	—	NN	O	—	nn	23	SENT_187	[p12l1870t223r2141b306],
23	talization	NN	O	talization	prep_of	19	SENT_187	[p12l9t325r315b388],
24	for	IN	O	for	_	0	SENT_187	[p12l333t325r427b388],
25	HF	NN	O	hf	prep_for	23	SENT_187	[p12l445t330r548b387],
26	or	CC	O	or	_	0	SENT_187	[p12l568t348r638b388],
27	death	NN	O	death	conj_or	25	SENT_187	[p12l656t325r836b388],
28	within	IN	O	within	_	0	SENT_187	[p12l853t325r1067b388],
29	30	CD	DURATION	30	num	30	SENT_187	[p12l1087t332r1161b388],
30	days	NNS	NUMBER	day	prep_within	15	SENT_187	[p12l1181t317r1403b409],
31	.25	CD	NUMBER	.25	dobj	6	SENT_187	[p12l1181t317r1403b409],
32	However	RB	O	however	advmod	6	SENT_187	[p12l1424t330r1730b397],
33	,	,	O	,	_	0	SENT_187	[p12l1424t330r1730b397],
34	a	DT	O	a	det	36	SENT_187	[p12l1751t348r1785b388],
35	signiﬁcant	JJ	O	signiﬁcant	amod	36	SENT_187	[p12l1803t325r2143b409],
36	increase	NN	O	increase	nsubjpass	40	SENT_187	[p12l10t434r292b491],
37	of	IN	O	of	_	0	SENT_187	[p12l317t428r392b491],
38	hypotension	NN	O	hypotension	prep_of	36	SENT_187	[p12l404t428r836b512],
39	was	VBD	O	be	auxpass	40	SENT_187	[p12l858t451r986b491],
40	observed	VBN	O	observe	_	0	SENT_187	[p12l1010t428r1326b491],
41	in	IN	O	in	_	0	SENT_187	[p12l1348t434r1416b490],
42	the	DT	O	the	det	44	SENT_187	[p12l1438t428r1547b491],
43	nesiritide	NN	O	nesiritide	nn	44	SENT_187	[p12l1570t428r1897b491],
44	group	NN	O	group	prep_in	40	SENT_187	[p12l1921t450r2140b512],
45	.	.	O	.	_	0	SENT_187	[p12l1921t450r2140b512],

1	The	DT	O	the	det	6	SENT_188	[p12l9t531r134b594],
2	ongoing	JJ	O	ongoing	amod	6	SENT_188	[p12l154t537r431b615],
3	Renal	JJ	O	renal	amod	6	SENT_188	[p12l450t531r642b594],
4	Optimization	NN	O	optimization	nn	6	SENT_188	[p12l663t535r1119b614],
5	Strategies	NNS	O	strategy	nn	6	SENT_188	[p12l1139t535r1460b615],
6	Evaluation	NN	O	evaluation	nsubj	16	SENT_188	[p12l1480t531r1841b594],
7	in	IN	O	in	_	0	SENT_188	[p12l1861t537r1927b593],
8	Acute	JJ	O	acute	amod	10	SENT_188	[p12l1946t535r2143b594],
9	Heart	NNP	O	Heart	nn	10	SENT_188	[p12l10t639r206b697],
10	Failure	NN	O	failure	prep_in	6	SENT_188	[p12l229t634r464b697],
11	(	CD	NUMBER	(	num	12	SENT_188	[p12l491t635r953b710],
12	ROSE-AHF	NN	O	rose-ahf	dep	10	SENT_188	[p12l491t635r953b710],
13	)	CD	NUMBER	)	num	14	SENT_188	[p12l491t635r953b710],
14	study	NN	O	study	dep	12	SENT_188	[p12l980t634r1168b718],
15	will	MD	O	will	aux	16	SENT_188	[p12l1185t634r1312b697],
16	determine	VB	O	determine	_	0	SENT_188	[p12l1335t634r1688b697],
17	the	DT	O	the	det	18	SENT_188	[p12l1710t634r1817b697],
18	effects	NNS	O	effect	dobj	16	SENT_188	[p12l1841t634r2054b697],
19	of	IN	O	of	_	0	SENT_188	[p12l2078t634r2152b697],
20	low	JJ	O	low	amod	23	SENT_188	[p12l8t737r319b801],
21	—	NN	O	—	nn	23	SENT_188	[p12l8t737r319b801],
22	dose	NN	O	dose	nn	23	SENT_188	[p12l8t737r319b801],
23	nesiritide	NN	O	nesiritide	prep_of	18	SENT_188	[p12l342t737r663b800],
24	(	CD	NUMBER	(	number	25	SENT_188	[p12l689t737r1011b813],
25	one-half	NN	O	one-half	num	27	SENT_188	[p12l689t737r1011b813],
26	the	DT	O	the	det	27	SENT_188	[p12l1022t737r1129b800],
27	dose	NN	O	dose	dep	23	SENT_188	[p12l1152t737r1306b800],
28	tested	VBN	O	test	partmod	23	SENT_188	[p12l1328t737r1528b800],
29	in	IN	O	in	_	0	SENT_188	[p12l1550t743r1616b800],
30	ASCEND-HF	NN	O	ascend-hf	prep_in	28	SENT_188	[p12l1638t738r2139b814],
31	)	CD	NUMBER	)	num	30	SENT_188	[p12l1638t738r2139b814],
32	or	CC	O	or	_	0	SENT_188	[p12l10t863r80b903],
33	low	JJ	O	low	amod	36	SENT_188	[p12l96t840r396b903],
34	—	NN	O	—	nn	36	SENT_188	[p12l96t840r396b903],
35	dose	NN	O	dose	nn	36	SENT_188	[p12l96t840r396b903],
36	dopamine	NN	O	dopamine	conj_or	30	SENT_188	[p12l415t840r748b923],
37	in	IN	O	in	_	0	SENT_188	[p12l768t846r832b902],
38	patients	NNS	O	patient	prep_in	28	SENT_188	[p12l850t846r1109b923],
39	with	IN	O	with	_	0	SENT_188	[p12l1126t840r1274b903],
40	congestive	JJ	O	congestive	amod	41	SENT_188	[p12l1293t846r1635b924],
41	HF	NN	O	hf	prep_with	38	SENT_188	[p12l1654t845r1758b902],
42	and	CC	O	and	_	0	SENT_188	[p12l1779t840r1901b903],
43	kidney	NN	O	kidney	nn	44	SENT_188	[p12l1917t840r2146b924],
44	dysfunction	NN	O	dysfunction	prep_in	28	SENT_188	[p12l10t943r414b1027],
45	(	CD	NUMBER	(	num	47	SENT_188	[p12l438t943r1008b1020],
46	NCT01132846	NN	O	nct01132846	nn	47	SENT_188	[p12l438t943r1008b1020],
47	)	NN	O	)	dep	44	SENT_188	[p12l438t943r1008b1020],
48	.	.	O	.	_	0	SENT_188	[p12l438t943r1008b1020],

1	Inotropes	NNS	O	inotrope	_	0	SENT_189	[p12l9t1162r313b1227],
2	.	.	O	.	_	0	SENT_189	[p12l9t1162r313b1227],

1	Despite	IN	O	despite	_	0	SENT_190	[p12l369t1155r625b1233],
2	their	PRP$	O	they	poss	4	SENT_190	[p12l678t1150r841b1213],
3	beneﬁcial	JJ	O	beneﬁcial	amod	4	SENT_190	[p12l890t1150r1220b1213],
4	effects	NNS	O	effect	prep_despite	18	SENT_190	[p12l1274t1150r1485b1213],
5	on	IN	O	on	_	0	SENT_190	[p12l1539t1173r1625b1213],
6	hemodynam	NN	O	hemodynam	nn	8	SENT_190	[p12l1677t1150r2140b1234],
7	—	CD	NUMBER	—	num	8	SENT_190	[p12l1677t1150r2140b1234],
8	ics	NNS	O	ic	prep_on	4	SENT_190	[p12l10t1259r96b1316],
9	and	CC	O	and	_	0	SENT_190	[p12l128t1253r254b1316],
10	organ	NN	O	organ	nn	11	SENT_190	[p12l284t1276r479b1337],
11	perfusion	NN	O	perfusion	conj_and	4	SENT_190	[p12l508t1253r838b1336],
12	in	IN	O	in	_	0	SENT_190	[p12l868t1259r935b1315],
13	the	DT	O	the	det	15	SENT_190	[p12l964t1253r1070b1316],
14	acute	JJ	O	acute	amod	15	SENT_190	[p12l1102t1265r1279b1316],
15	phase	NN	O	phase	prep_in	11	SENT_190	[p12l1309t1253r1521b1336],
16	,	,	O	,	_	0	SENT_190	[p12l1309t1253r1521b1336],
17	inotropes	NNS	O	inotrope	nsubj	24	SENT_190	[p12l1553t1259r1877b1336],
18	lead	VBP	O	lead	_	0	SENT_190	[p12l1907t1253r2048b1316],
19	to	TO	O	to	_	0	SENT_190	[p12l2076t1265r2142b1316],
20	myocardial	JJ	O	myocardial	amod	21	SENT_190	[p12l8t1356r393b1440],
21	ischemia	NN	O	ischemia	prep_to	18	SENT_190	[p12l428t1356r731b1419],
22	and	CC	O	and	_	0	SENT_190	[p12l766t1356r893b1419],
23	are	VBP	O	be	cop	24	SENT_190	[p12l928t1379r1028b1419],
24	proarrhythmogenic	JJ	O	proarrhythmogenic	conj_and	18	SENT_190	[p12l1062t1356r1754b1440],
25	.	.	O	.	_	0	SENT_190	[p12l1062t1356r1754b1440],

1	Increasing	VBG	O	increase	amod	2	SENT_191	[p12l1793t1361r2151b1440],
2	evidence	NN	O	evidence	nsubj	3	SENT_191	[p12l9t1459r309b1522],
3	suggests	VBZ	O	suggest	ccomp	24	SENT_191	[p12l340t1471r619b1543],
4	that	IN	O	that	complm	10	SENT_191	[p12l649t1459r782b1522],
5	the	DT	O	the	det	6	SENT_191	[p12l810t1459r917b1522],
6	use	NN	O	use	nsubjpass	10	SENT_191	[p12l947t1482r1058b1522],
7	of	IN	O	of	_	0	SENT_191	[p12l1089t1459r1163b1522],
8	inotropes	NNS	O	inotrope	prep_of	6	SENT_191	[p12l1183t1465r1508b1542],
9	is	VBZ	O	be	auxpass	10	SENT_191	[p12l1539t1465r1589b1522],
10	associated	VBN	O	associate	ccomp	3	SENT_191	[p12l1620t1459r1969b1522],
11	with	IN	O	with	_	0	SENT_191	[p12l1996t1459r2149b1522],
12	an	DT	O	a	det	14	SENT_191	[p12l9t1584r89b1625],
13	increased	VBN	O	increase	amod	14	SENT_191	[p12l123t1561r449b1625],
14	risk	NN	O	risk	prep_with	10	SENT_191	[p12l482t1561r611b1625],
15	for	IN	O	for	_	0	SENT_191	[p12l642t1561r739b1625],
16	mortality	NN	O	mortality	prep_for	14	SENT_191	[p12l772t1553r1244b1646],
17	.26	CD	NUMBER	.26	num	18	SENT_191	[p12l772t1553r1244b1646],
18	’27	CD	NUMBER	’27	tmod	14	SENT_191	[p12l772t1553r1244b1646],
19	Therefore	RB	O	therefore	advmod	18	SENT_191	[p12l1278t1561r1625b1634],
20	,	,	O	,	_	0	SENT_191	[p12l1278t1561r1625b1634],
21	the	DT	O	the	det	22	SENT_191	[p12l1659t1561r1766b1625],
22	guidelines	NNS	O	guideline	nsubj	24	SENT_191	[p12l1800t1561r2148b1646],
23	clearly	RB	O	clearly	advmod	24	SENT_191	[p12l9t1665r234b1749],
24	discourage	VBP	O	discourage	_	0	SENT_191	[p12l259t1665r627b1749],
25	the	DT	O	the	det	26	SENT_191	[p12l654t1665r761b1728],
26	use	NN	O	use	dobj	24	SENT_191	[p12l789t1688r900b1728],
27	of	IN	O	of	_	0	SENT_191	[p12l928t1665r1002b1728],
28	inotropes	NNS	O	inotrope	prep_of	26	SENT_191	[p12l1021t1671r1346b1748],
29	in	IN	O	in	_	0	SENT_191	[p12l1374t1671r1441b1727],
30	stable	JJ	O	stable	amod	31	SENT_191	[p12l1469t1665r1662b1728],
31	patients	NNS	O	patient	prep_in	28	SENT_191	[p12l1689t1671r1959b1748],
32	(	CD	NUMBER	(	num	34	SENT_191	[p12l1991t1666r2146b1741, p12l9t1768r496b1831],
33	recommendation	NN	O	recommendation	nn	34	SENT_191	[p12l1991t1666r2146b1741, p12l9t1768r496b1831],
34	class	NN	O	class	dep	47	SENT_191	[p12l530t1768r684b1831],
35	III	CD	NUMBER	iii	dep	34	SENT_191	[p12l720t1773r822b1840],
36	,	,	O	,	_	0	SENT_191	[p12l720t1773r822b1840],
37	evidence	NN	O	evidence	nn	40	SENT_191	[p12l858t1768r1158b1831],
38	level	NN	O	level	nn	40	SENT_191	[p12l1190t1768r1346b1831],
39	B	NN	O	b	nn	40	SENT_191	[p12l1379t1769r1451b1845],
40	)	NN	O	)	dep	34	SENT_191	[p12l1379t1769r1451b1845],
41	and	CC	O	and	_	0	SENT_191	[p12l1490t1768r1617b1831],
42	state	NN	O	state	dep	34	SENT_191	[p12l1650t1780r1803b1831],
43	that	IN	O	that	dep	47	SENT_191	[p12l1836t1768r1970b1831],
44	they	PRP	O	they	nsubjpass	47	SENT_191	[p12l2001t1768r2152b1852],
45	should	MD	O	should	aux	47	SENT_191	[p12l9t1871r240b1934],
46	be	VB	O	be	auxpass	47	SENT_191	[p12l260t1871r340b1934],
47	used	VBN	O	use	dep	24	SENT_191	[p12l363t1871r522b1934],
48	only	RB	O	only	advmod	53	SENT_191	[p12l545t1871r696b1955],
49	if	IN	O	if	dep	53	SENT_191	[p12l715t1871r770b1933],
50	the	DT	O	the	det	51	SENT_191	[p12l782t1871r889b1934],
51	patient	NN	O	patient	nsubj	53	SENT_191	[p12l911t1877r1151b1954],
52	is	VBZ	O	be	cop	53	SENT_191	[p12l1173t1877r1223b1934],
53	hypotensive	JJ	O	hypotensive	ccomp	47	SENT_191	[p12l1246t1871r1657b1955],
54	(	CD	NUMBER	(	num	55	SENT_191	[p12l1684t1872r1844b1947],
55	SBP	NN	O	sbp	npadvmod	56	SENT_191	[p12l1684t1872r1844b1947],
56	<	JJR	O	<	dep	60	SENT_191	[p12l1871t1878r1993b1934],
57	85	CD	NUMBER	85	num	59	SENT_191	[p12l1871t1878r1993b1934],
58	mm	NN	O	mm	nn	59	SENT_191	[p12l2010t1894r2149b1933],
59	Hg	NN	O	hg	nsubj	60	SENT_191	[p12l9t1975r157b2058],
60	)	CD	NUMBER	)	dep	53	SENT_191	[p12l9t1975r157b2058],
61	,	,	O	,	_	0	SENT_191	[p12l9t1975r157b2058],
62	hypoperfused	VBN	O	hypoperfuse	partmod	60	SENT_191	[p12l201t1974r692b2058],
63	,	,	O	,	_	0	SENT_191	[p12l201t1974r692b2058],
64	or	CC	O	or	dep	65	SENT_191	[p12l738t1997r810b2037],
65	in	IN	O	in	dep	60	SENT_191	[p12l852t1980r919b2036],
66	shock	NN	O	shock	nn	69	SENT_191	[p12l963t1974r1163b2037],
67	(	CD	NUMBER	(	num	69	SENT_191	[p12l1206t1975r1422b2051],
68	IIaB	NN	O	iiab	nn	69	SENT_191	[p12l1206t1975r1422b2051],
69	)	NN	O	)	pobj	65	SENT_191	[p12l1206t1975r1422b2051],
70	.	.	O	.	_	0	SENT_191	[p12l1206t1975r1422b2051],

1	Because	IN	O	because	mark	7	SENT_192	[p12l1508t1979r1782b2037],
2	of	IN	O	of	prep	7	SENT_192	[p12l1826t1974r1900b2037],
3	to	TO	O	to	pcomp	2	SENT_192	[p12l1932t1986r1998b2037],
4	the	DT	O	the	det	6	SENT_192	[p12l2042t1974r2148b2037],
5	above	JJ	O	above	amod	6	SENT_192	[p12l9t2077r614b2140],
6	—	NN	O	—	pobj	3	SENT_192	[p12l9t2077r614b2140],
7	mentioned	VBD	O	mention	advcl	14	SENT_192	[p12l9t2077r614b2140],
8	safety	NN	O	safety	nn	9	SENT_192	[p12l638t2077r835b2161],
9	concerns	NNS	O	concern	dobj	7	SENT_192	[p12l857t2100r1182b2149],
10	,	,	O	,	_	0	SENT_192	[p12l857t2100r1182b2149],
11	they	PRP	O	they	nsubjpass	14	SENT_192	[p12l1207t2077r1357b2161],
12	should	MD	O	should	aux	14	SENT_192	[p12l1379t2077r1610b2140],
13	be	VB	O	be	auxpass	14	SENT_192	[p12l1632t2077r1711b2140],
14	used	VBN	O	use	_	0	SENT_192	[p12l1736t2077r1894b2140],
15	only	RB	O	only	advmod	14	SENT_192	[p12l1918t2077r2069b2161],
16	at	IN	O	at	_	0	SENT_192	[p12l2091t2089r2150b2140],
17	the	DT	O	the	det	20	SENT_192	[p12l7t2180r114b2243],
18	lowest	JJS	O	lowest	amod	20	SENT_192	[p12l136t2180r353b2243],
19	possible	JJ	O	possible	amod	20	SENT_192	[p12l374t2180r650b2263],
20	dose	NN	O	dose	prep_at	14	SENT_192	[p12l675t2180r829b2243],
21	and	CC	O	and	cc	14	SENT_192	[p12l854t2180r980b2243],
22	only	RB	O	only	advmod	14	SENT_192	[p12l1003t2180r1155b2264],
23	for	IN	O	for	dep	14	SENT_192	[p12l1174t2180r1272b2243],
24	as	RB	O	as	advmod	25	SENT_192	[p12l1295t2203r1359b2243],
25	long	JJ	O	long	pobj	23	SENT_192	[p12l1382t2180r1534b2264],
26	as	RB	O	as	advmod	27	SENT_192	[p12l1557t2203r1621b2243],
27	necessary	JJ	O	necessary	amod	25	SENT_192	[p12l1645t2203r1985b2264],
28	.	.	O	.	_	0	SENT_192	[p12l1645t2203r1985b2264],

1	Dobutamine	NN	O	dobutamine	nsubj	3	SENT_193	[p12l82t2283r537b2346],
2	predominantly	RB	O	predominantly	advmod	3	SENT_193	[p12l567t2283r1108b2367],
3	stimulates	VBZ	O	stimulate	_	0	SENT_193	[p12l1135t2283r1499b2346],
4	[	CD	NUMBER	[	num	5	SENT_193	[p12l1534t2283r1985b2367],
5	31-receptors	NNS	O	31-receptor	dobj	3	SENT_193	[p12l1534t2283r1985b2367],
6	and	CC	O	and	_	0	SENT_193	[p12l2017t2283r2148b2346],
7	increases	VBZ	O	increase	conj_and	3	SENT_193	[p12l8t2392r312b2449],
8	cardiac	JJ	O	cardiac	amod	9	SENT_193	[p12l335t2386r575b2449],
9	output	NN	O	output	dobj	7	SENT_193	[p12l597t2398r820b2469],
10	without	IN	O	without	_	0	SENT_193	[p12l838t2386r1102b2449],
11	signiﬁcantly	JJ	O	signiﬁcantly	prep_without	7	SENT_193	[p12l1123t2386r1535b2470],
12	affecting	VBG	O	affect	partmod	11	SENT_193	[p12l1554t2386r1842b2470],
13	systemic	JJ	O	systemic	amod	15	SENT_193	[p12l1863t2392r2150b2470],
14	vascular	JJ	O	vascular	amod	15	SENT_193	[p12l6t2489r297b2552],
15	resistance	NN	O	resistance	dobj	12	SENT_193	[p12l321t2495r680b2552],
16	.	.	O	.	_	0	SENT_193	[p12l321t2495r680b2552],

1	According	VBG	O	accord	_	0	SENT_194	[p12l707t2489r1075b2573],
2	to	TO	O	to	prepc_according_to	10	SENT_194	[p12l1097t2501r1164b2552],
3	the	DT	O	the	det	4	SENT_194	[p12l1189t2489r1298b2552],
4	guidelines	NNS	O	guideline	pobj	10	SENT_194	[p12l1323t2489r1698b2573],
5	,	,	O	,	_	0	SENT_194	[p12l1323t2489r1698b2573],
6	dobutamine	NN	O	dobutamine	nsubj	10	SENT_194	[p12l1725t2489r2149b2552],
7	should	MD	O	should	aux	10	SENT_194	[p12l9t2592r233b2655],
8	be	VB	O	be	cop	10	SENT_194	[p12l248t2592r326b2655],
9	the	DT	O	the	det	10	SENT_194	[p12l344t2592r448b2655],
10	inotrope	NN	O	inotrope	_	0	SENT_194	[p12l467t2598r750b2675],
11	of	IN	O	of	_	0	SENT_194	[p12l770t2592r842b2655],
12	choice	NN	O	choice	prep_of	10	SENT_194	[p12l851t2592r1062b2655],
13	if	IN	O	if	mark	17	SENT_194	[p12l1081t2592r1134b2654],
14	inotropic	JJ	O	inotropic	amod	15	SENT_194	[p12l1143t2598r1447b2675],
15	support	NN	O	support	nsubj	17	SENT_194	[p12l1466t2604r1724b2675],
16	is	VBZ	O	be	cop	17	SENT_194	[p12l1741t2598r1790b2655],
17	inevitable	JJ	O	inevitable	advcl	10	SENT_194	[p12l1809t2592r2145b2655],
18	.	.	O	.	_	0	SENT_194	[p12l1809t2592r2145b2655],

1	Of	IN	O	of	_	0	SENT_195	[p12l9t2695r102b2758],
2	note	NN	O	note	prep_of	16	SENT_195	[p12l110t2707r269b2767],
3	,	,	O	,	_	0	SENT_195	[p12l110t2707r269b2767],
4	the	DT	O	the	det	7	SENT_195	[p12l288t2695r390b2758],
5	potential	JJ	O	potential	amod	7	SENT_195	[p12l407t2695r699b2778],
6	harmful	JJ	O	harmful	amod	7	SENT_195	[p12l715t2695r983b2758],
7	effects	NNS	O	effect	nsubjpass	16	SENT_195	[p12l1000t2695r1203b2758],
8	of	IN	O	of	_	0	SENT_195	[p12l1222t2695r1294b2758],
9	inotropes	NNS	O	inotrope	prep_of	7	SENT_195	[p12l1302t2701r1612b2778],
10	in	IN	O	in	_	0	SENT_195	[p12l1631t2701r1695b2757],
11	the	DT	O	the	det	13	SENT_195	[p12l1712t2695r1814b2758],
12	long	JJ	O	long	amod	13	SENT_195	[p12l1831t2695r1976b2779],
13	term	NN	O	term	prep_in	9	SENT_195	[p12l1992t2707r2149b2758],
14	should	MD	O	should	aux	16	SENT_195	[p12l9t2798r235b2861],
15	be	VB	O	be	auxpass	16	SENT_195	[p12l250t2798r329b2861],
16	kept	VBN	O	keep	_	0	SENT_195	[p12l346t2798r492b2881],
17	in	IN	O	in	_	0	SENT_195	[p12l509t2804r575b2860],
18	mind	NN	O	mind	prep_in	16	SENT_195	[p12l594t2798r789b2861],
19	.	.	O	.	_	0	SENT_195	[p12l594t2798r789b2861],

1	In	IN	O	in	_	0	SENT_196	[p12l811t2803r881b2860],
2	an	DT	O	a	det	3	SENT_196	[p12l900t2821r979b2861],
3	analysis	NN	O	analysis	prep_in	28	SENT_196	[p12l999t2798r1257b2882],
4	of	IN	O	of	_	0	SENT_196	[p12l1277t2798r1350b2861],
5	the	DT	O	the	det	10	SENT_196	[p12l1358t2798r1462b2861],
6	Flolan	NNP	MISC	Flolan	nn	10	SENT_196	[p12l1482t2798r1690b2861],
7	International	NNP	MISC	International	nn	10	SENT_196	[p12l1710t2798r2147b2861],
8	Randomized	NNP	MISC	Randomized	nn	10	SENT_196	[p12l9t2901r435b2964],
9	Survival	NNP	MISC	Survival	nn	10	SENT_196	[p12l454t2901r724b2964],
10	Trial	NNP	MISC	Trial	prep_of	3	SENT_196	[p12l742t2901r897b2964],
11	(	CD	NUMBER	(	num	12	SENT_196	[p12l918t2901r1202b2978],
12	FIRST	NNP	ORDINAL	FIRST	tmod	10	SENT_196	[p12l918t2901r1202b2978],
13	)	CD	NUMBER	)	num	12	SENT_196	[p12l918t2901r1202b2978],
14	,	,	O	,	_	0	SENT_196	[p12l918t2901r1202b2978],
15	which	WDT	O	which	nsubj	16	SENT_196	[p12l1221t2901r1425b2964],
16	included	VBD	O	include	rcmod	12	SENT_196	[p12l1443t2901r1733b2964],
17	471	CD	NUMBER	471	num	18	SENT_196	[p12l1749t2908r1862b2964],
18	patients	NNS	O	patient	dobj	16	SENT_196	[p12l1886t2907r2146b2984],
19	with	IN	O	with	_	0	SENT_196	[p12l7t3003r161b3067],
20	advanced	JJ	O	advanced	amod	21	SENT_196	[p12l185t3003r512b3067],
21	HF	NN	O	hf	prep_with	16	SENT_196	[p12l534t3008r651b3075],
22	,	,	O	,	_	0	SENT_196	[p12l534t3008r651b3075],
23	the	DT	O	the	det	24	SENT_196	[p12l675t3003r782b3067],
24	use	NN	O	use	nsubjpass	28	SENT_196	[p12l805t3026r917b3067],
25	of	IN	O	of	_	0	SENT_196	[p12l941t3003r1015b3067],
26	dobutamine	NN	O	dobutamine	prep_of	24	SENT_196	[p12l1029t3003r1449b3067],
27	was	VBD	O	be	auxpass	28	SENT_196	[p12l1469t3026r1598b3067],
28	associated	VBN	O	associate	_	0	SENT_196	[p12l1621t3003r1973b3067],
29	with	IN	O	with	_	0	SENT_196	[p12l1993t3003r2147b3067],
30	a	DT	O	a	det	32	SENT_196	[p12l9t3129r44b3170],
31	higher	JJR	O	higher	amod	32	SENT_196	[p12l63t3106r285b3191],
32	risk	NN	O	risk	prep_with	28	SENT_196	[p12l305t3106r434b3170],
33	for	IN	O	for	_	0	SENT_196	[p12l452t3106r548b3170],
34	mortality	NN	O	mortality	prep_for	32	SENT_196	[p12l569t3106r888b3191],
35	even	RB	O	even	advmod	28	SENT_196	[p12l907t3129r1062b3170],
36	after	IN	O	after	_	0	SENT_196	[p12l1085t3106r1236b3170],
37	multivariate	JJ	O	multivariate	amod	38	SENT_196	[p12l1256t3106r1667b3170],
38	adjustment	NN	O	adjustment	prep_after	28	SENT_196	[p12l1689t3098r2149b3191],
39	.	.	O	.	_	0	SENT_196	[p12l1689t3098r2149b3191],

1	”	NN	O	”	nsubj	16	SENT_197	[p12l1689t3098r2149b3191],
2	These	DT	O	these	det	3	SENT_197	[p12l8t3210r198b3273],
3	data	NNS	O	datum	nsubj	4	SENT_197	[p12l217t3210r357b3273],
4	imply	VBP	O	imply	rcmod	1	SENT_197	[p12l374t3210r566b3294],
5	that	IN	O	that	complm	10	SENT_197	[p12l580t3210r709b3273],
6	continuous	JJ	O	continuous	amod	8	SENT_197	[p12l728t3216r1098b3273],
7	inotrope	NN	O	inotrope	nn	8	SENT_197	[p12l1117t3216r1400b3293],
8	use	NN	O	use	nsubj	10	SENT_197	[p12l1419t3233r1527b3273],
9	might	MD	O	might	aux	10	SENT_197	[p12l1545t3210r1743b3294],
10	exert	VB	O	exert	ccomp	4	SENT_197	[p12l1761t3222r1925b3273],
11	harmful	JJ	O	harmful	amod	12	SENT_197	[p12l1941t3210r2147b3273, p12l8t3313r97b3376],
12	effects	NNS	O	effect	dobj	10	SENT_197	[p12l115t3313r320b3376],
13	and	CC	O	and	_	0	SENT_197	[p12l341t3313r464b3376],
14	thus	RB	O	thus	advmod	15	SENT_197	[p12l480t3313r622b3376],
15	strongly	RB	O	strongly	conj_and	12	SENT_197	[p12l642t3313r912b3397],
16	suggest	VBP	O	suggest	_	0	SENT_197	[p12l928t3325r1169b3397],
17	their	PRP$	O	they	poss	18	SENT_197	[p12l1185t3313r1344b3376],
18	use	NN	O	use	dobj	16	SENT_197	[p12l1361t3336r1469b3376],
19	in	IN	O	in	_	0	SENT_197	[p12l1488t3319r1553b3375],
20	a	DT	O	a	det	22	SENT_197	[p12l1572t3336r1606b3376],
21	restrictive	JJ	O	restrictive	amod	22	SENT_197	[p12l1624t3319r1951b3376],
22	manner	NN	O	manner	prep_in	16	SENT_197	[p12l1970t3336r2145b3376, p12l8t3438r130b3487],
23	,	,	O	,	_	0	SENT_197	[p12l1970t3336r2145b3376, p12l8t3438r130b3487],
24	which	WDT	O	which	nsubjpass	27	SENT_197	[p12l150t3415r357b3479],
25	is	VBZ	O	be	auxpass	27	SENT_197	[p12l376t3422r426b3479],
26	also	RB	O	also	advmod	27	SENT_197	[p12l447t3415r575b3479],
27	reﬂected	VBN	O	reﬂected	rcmod	22	SENT_197	[p12l597t3415r885b3479],
28	in	IN	O	in	_	0	SENT_197	[p12l904t3422r970b3478],
29	the	DT	O	the	det	32	SENT_197	[p12l989t3415r1093b3479],
30	current	JJ	DATE	current	amod	32	SENT_197	[p12l1114t3427r1362b3479],
31	recommendations	NNS	O	recommendation	nn	32	SENT_197	[p12l1381t3407r2038b3479],
32	.1	NN	NUMBER	.1	prep_in	27	SENT_197	[p12l1381t3407r2038b3479],

1	Levosimendan	NNP	PERSON	Levosimendan	nsubj	2	SENT_198	[p13l83t23r588b86],
2	exerts	VBZ	O	exert	ccomp	30	SENT_198	[p13l610t35r810b86],
3	positive	JJ	O	positive	amod	5	SENT_198	[p13l832t29r1099b106],
4	inotropic	JJ	O	inotropic	amod	5	SENT_198	[p13l1121t29r1436b106],
5	effects	NNS	O	effect	dobj	2	SENT_198	[p13l1459t23r1671b86],
6	by	IN	O	by	_	0	SENT_198	[p13l1692t23r1776b107],
7	binding	VBG	O	bind	prepc_by	2	SENT_198	[p13l1793t23r2062b107],
8	to	TO	O	to	_	0	SENT_198	[p13l2082t35r2148b86],
9	cardiac	JJ	O	cardiac	amod	11	SENT_198	[p13l9t126r248b189],
10	troponin	NN	O	troponin	nn	11	SENT_198	[p13l266t132r565b209],
11	C	NN	O	c	prep_to	7	SENT_198	[p13l585t130r655b198],
12	,	,	O	,	_	0	SENT_198	[p13l585t130r655b198],
13	thereby	RB	O	thereby	advmod	7	SENT_198	[p13l675t126r930b210],
14	increasing	VBG	O	increase	dep	7	SENT_198	[p13l945t132r1291b210],
15	the	DT	O	the	det	16	SENT_198	[p13l1307t126r1411b189],
16	susceptibility	NN	O	susceptibility	dobj	14	SENT_198	[p13l1432t126r1873b210],
17	of	IN	O	of	_	0	SENT_198	[p13l1890t126r1963b189],
18	myoﬁlaments	NNS	O	myoﬁlaments	prep_of	16	SENT_198	[p13l1972t149r2145b210, p13l8t228r311b292],
19	to	TO	O	to	aux	20	SENT_198	[p13l329t240r393b292],
20	ca1cium	VB	O	ca1cium	xcomp	14	SENT_198	[p13l414t220r825b292],
21	.28	CD	NUMBER	.28	number	22	SENT_198	[p13l414t220r825b292],
22	’29	CD	NUMBER	’29	dobj	20	SENT_198	[p13l414t220r825b292],
23	Furthermore	RB	O	furthermore	advmod	20	SENT_198	[p13l845t228r1289b301],
24	,	,	O	,	_	0	SENT_198	[p13l845t228r1289b301],
25	it	PRP	O	it	nsubj	26	SENT_198	[p13l1310t235r1354b292],
26	has	VBZ	O	have	dep	20	SENT_198	[p13l1370t228r1479b292],
27	vasodilatory	JJ	O	vasodilatory	amod	28	SENT_198	[p13l1496t228r1909b313],
28	effects	NNS	O	effect	dobj	26	SENT_198	[p13l1925t228r2148b301],
29	,	,	O	,	_	0	SENT_198	[p13l1925t228r2148b301],
30	brought	VBD	O	bring	_	0	SENT_198	[p13l6t332r272b416],
31	about	RB	O	about	advmod	33	SENT_198	[p13l290t332r477b395],
32	byvia	JJ	O	byvia	amod	33	SENT_198	[p13l493t332r671b416],
33	adenosine	NN	O	adenosine	iobj	30	SENT_198	[p13l690t332r1024b395],
34	triphosphate	NN	O	triphosphate	nn	35	SENT_198	[p13l1042t332r1860b415],
35	—	NN	O	—	dobj	30	SENT_198	[p13l1042t332r1860b415],
36	dependent	JJ	O	dependent	amod	37	SENT_198	[p13l1042t332r1860b415],
37	opening	NN	O	opening	nsubj	30	SENT_198	[p13l1878t338r2151b416],
38	of	IN	O	of	_	0	SENT_198	[p13l9t435r84b499],
39	potassium	NN	O	potassium	nn	40	SENT_198	[p13l96t442r455b519],
40	channels30	NN	O	channels30	prep_of	37	SENT_198	[p13l478t427r844b499],
41	and	CC	O	and	_	0	SENT_198	[p13l868t435r996b499],
42	phosphodiesterase	NN	O	phosphodiesterase	nn	43	SENT_198	[p13l1017t435r1664b519],
43	inhibition	NN	O	inhibition	prep_of	37	SENT_198	[p13l1687t435r2051b499],
44	.	.	O	.	_	0	SENT_198	[p13l1687t435r2051b499],

1	In	IN	O	in	_	0	SENT_199	[p13l2078t441r2150b498],
2	contrast	NN	O	contrast	prep_in	8	SENT_199	[p13l9t551r290b602],
3	to	TO	O	to	_	0	SENT_199	[p13l311t551r378b602],
4	other	JJ	O	other	amod	5	SENT_199	[p13l402t539r587b602],
5	inotropes	NNS	O	inotrope	prep_to	2	SENT_199	[p13l609t545r957b622],
6	,	,	O	,	_	0	SENT_199	[p13l609t545r957b622],
7	levosimendan	NN	O	levosimendan	nsubj	8	SENT_199	[p13l981t539r1469b602],
8	acts	VBZ	O	act	_	0	SENT_199	[p13l1492t551r1623b602],
9	independently	RB	O	independently	advmod	8	SENT_199	[p13l1646t539r2153b623],
10	of	IN	O	of	_	0	SENT_199	[p13l9t642r82b705],
11	[	CD	NUMBER	[	number	12	SENT_199	[p13l96t642r541b726],
12	3	CD	NUMBER	3	num	15	SENT_199	[p13l96t642r541b726],
13	—	NN	O	—	nn	15	SENT_199	[p13l96t642r541b726],
14	adrenergic	JJ	O	adrenergic	amod	15	SENT_199	[p13l96t642r541b726],
15	receptors	NNS	O	receptor	prep_of	8	SENT_199	[p13l561t654r888b725],
16	.	.	O	.	_	0	SENT_199	[p13l561t654r888b725],

1	In	IN	O	in	_	0	SENT_200	[p13l912t647r982b704],
2	preclinical	JJ	O	preclinical	amod	3	SENT_200	[p13l1001t642r1356b725],
3	studies	NNS	O	study	prep_in	8	SENT_200	[p13l1377t642r1627b714],
4	,	,	O	,	_	0	SENT_200	[p13l1377t642r1627b714],
5	treatment	NN	O	treatment	nsubj	8	SENT_200	[p13l1648t654r1981b705],
6	with	IN	O	with	_	0	SENT_200	[p13l1998t642r2149b705],
7	levosimendan	NN	O	levosimendan	prep_with	5	SENT_200	[p13l7t744r487b808],
8	reduced	VBD	O	reduce	_	0	SENT_200	[p13l509t744r784b808],
9	myocardial	JJ	O	myocardial	amod	11	SENT_200	[p13l805t744r1189b829],
10	infarct	NN	O	infarct	nn	11	SENT_200	[p13l1211t744r1435b808],
11	size	NN	O	size	iobj	8	SENT_200	[p13l1457t736r1658b808],
12	.31	CD	NUMBER	.31	num	14	SENT_200	[p13l1457t736r1658b808],
13	Clinical	JJ	O	clinical	amod	14	SENT_200	[p13l1686t744r1952b808],
14	studies	NNS	O	study	dobj	8	SENT_200	[p13l1974t744r2145b808, p13l8t854r94b911],
15	showed	VBD	O	show	partmod	14	SENT_200	[p13l115t848r369b911],
16	that	IN	O	that	complm	18	SENT_200	[p13l386t848r518b911],
17	levosimendan	NN	O	levosimendan	nsubj	22	SENT_200	[p13l534t848r1006b911],
18	increased	VBD	O	increase	ccomp	15	SENT_200	[p13l1026t848r1345b911],
19	cardiac	JJ	O	cardiac	amod	20	SENT_200	[p13l1364t848r1604b911],
20	output	NN	O	output	dobj	18	SENT_200	[p13l1624t860r1863b931],
21	,	,	O	,	_	0	SENT_200	[p13l1624t860r1863b931],
22	lowered	VBD	O	lower	conj_and	18	SENT_200	[p13l1882t848r2150b911],
23	pulmonary	JJ	O	pulmonary	amod	26	SENT_200	[p13l7t952r383b1036],
24	capillary	JJ	O	capillary	amod	26	SENT_200	[p13l399t952r687b1036],
25	wedge	NN	O	wedge	nn	26	SENT_200	[p13l701t952r911b1036],
26	pressure	NN	O	pressure	dobj	22	SENT_200	[p13l929t974r1224b1035],
27	,	,	O	,	_	0	SENT_200	[p13l929t974r1224b1035],
28	and	CC	O	and	_	0	SENT_200	[p13l1246t952r1369b1015],
29	reduced	VBD	O	reduce	conj_and	18	SENT_200	[p13l1387t952r1655b1015],
30	all-cause	JJ	O	all-cause	amod	31	SENT_200	[p13l1674t952r1962b1015],
31	morta1ity	NN	O	morta1ity	iobj	29	SENT_200	[p13l1981t975r2146b1015, p13l7t1046r358b1139],
32	.32	CD	NUMBER	.32	dobj	29	SENT_200	[p13l1981t975r2146b1015, p13l7t1046r358b1139],
33	"	``	O	"	punct	32	SENT_200	[p13l1981t975r2146b1015, p13l7t1046r358b1139],
34	34	CD	NUMBER	34	dep	32	SENT_200	[p13l1981t975r2146b1015, p13l7t1046r358b1139],
35	In	IN	O	in	_	0	SENT_200	[p13l380t1060r452b1117],
36	the	DT	O	the	det	42	SENT_200	[p13l475t1054r582b1118],
37	Levosimendan	NNP	O	Levosimendan	nn	42	SENT_200	[p13l606t1054r1118b1118],
38	Infusion	NNP	O	Infusion	nn	42	SENT_200	[p13l1142t1054r1434b1118],
39	Versus	NNP	O	Versus	nn	42	SENT_200	[p13l1456t1060r1685b1118],
40	Dobutamine	NNP	O	Dobutamine	nn	42	SENT_200	[p13l1709t1054r2150b1118],
41	(	CD	NUMBER	(	num	42	SENT_200	[p13l12t1158r268b1235],
42	LIDO	NNP	ORGANIZATION	LIDO	prep_in	47	SENT_200	[p13l12t1158r268b1235],
43	)	CD	NUMBER	)	num	44	SENT_200	[p13l12t1158r268b1235],
44	trial	NN	O	trial	dep	42	SENT_200	[p13l294t1158r453b1230],
45	,	,	O	,	_	0	SENT_200	[p13l294t1158r453b1230],
46	levosimendan	NN	O	levosimendan	nsubjpass	55	SENT_200	[p13l476t1158r961b1221],
47	led	VBD	O	lead	rcmod	14	SENT_200	[p13l982t1158r1086b1221],
48	to	TO	O	to	_	0	SENT_200	[p13l1107t1170r1173b1221],
49	an	DT	O	a	det	52	SENT_200	[p13l1198t1181r1279b1221],
50	increased	VBN	O	increase	amod	52	SENT_200	[p13l1301t1158r1630b1221],
51	hemodynamic	JJ	O	hemodynamic	amod	52	SENT_200	[p13l1650t1158r2150b1242],
52	improvement	NN	O	improvement	prep_to	47	SENT_200	[p13l8t1267r459b1344],
53	and	CC	O	and	_	0	SENT_200	[p13l477t1261r600b1324],
54	was	VBD	O	be	auxpass	55	SENT_200	[p13l616t1284r740b1324],
55	associated	VBN	O	associate	conj_and	47	SENT_200	[p13l760t1261r1097b1324],
56	with	IN	O	with	_	0	SENT_200	[p13l1113t1261r1262b1324],
57	a	DT	O	a	det	59	SENT_200	[p13l1281t1284r1316b1324],
58	lower	JJR	O	lower	amod	59	SENT_200	[p13l1332t1261r1518b1324],
59	risk	NN	O	risk	prep_with	55	SENT_200	[p13l1535t1261r1661b1324],
60	of	IN	O	of	_	0	SENT_200	[p13l1677t1261r1749b1324],
61	mortality	NN	O	mortality	prep_of	59	SENT_200	[p13l1758t1261r2071b1345],
62	as	IN	O	as	prep	55	SENT_200	[p13l2087t1284r2150b1324],
63	compared	VBN	O	compare	_	0	SENT_200	[p13l9t1363r340b1447],
64	with	IN	O	with	prepc_compared_with	55	SENT_200	[p13l356t1363r504b1427],
65	dobutamine	NN	O	dobutamine	pobj	55	SENT_200	[p13l523t1355r1000b1427],
66	.35	CD	NUMBER	.35	num	65	SENT_200	[p13l523t1355r1000b1427],
67	However	RB	O	however	advmod	55	SENT_200	[p13l1021t1369r1329b1436],
68	,	,	O	,	_	0	SENT_200	[p13l1021t1369r1329b1436],
69	in	IN	O	in	_	0	SENT_200	[p13l1350t1370r1415b1426],
70	the	DT	O	the	det	71	SENT_200	[p13l1432t1363r1535b1427],
71	large	JJ	O	large	prep_in	55	SENT_200	[p13l1553t1363r1728b1448],
72	,	,	O	,	_	0	SENT_200	[p13l1553t1363r1728b1448],
73	randomized	VBN	O	randomize	partmod	71	SENT_200	[p13l1749t1363r2150b1427],
74	Of	IN	O	of	_	0	SENT_200	[p13l10t1466r106b1529],
75	Patients	NNS	O	patient	prep_of	73	SENT_200	[p13l120t1471r393b1529],
76	With	IN	O	with	_	0	SENT_200	[p13l415t1466r592b1529],
77	Acute	JJ	O	acute	amod	79	SENT_200	[p13l613t1470r816b1529],
78	Heart	NNP	O	Heart	nn	79	SENT_200	[p13l840t1471r1038b1529],
79	Failure	NN	O	failure	prep_with	75	SENT_200	[p13l1060t1466r1299b1529],
80	In	IN	O	in	_	0	SENT_200	[p13l1323t1471r1395b1528],
81	Need	VBN	O	need	prepc_in	73	SENT_200	[p13l1416t1466r1600b1529],
82	Of	IN	O	of	_	0	SENT_200	[p13l1623t1466r1719b1529],
83	Intravenous	JJ	O	intravenous	prep_of	81	SENT_200	[p13l1733t1471r2148b1529],

1	Inotropic	NNP	O	Inotropic	nn	2	SENT_201	[p13l9t1574r319b1652],
2	Support	NN	O	support	nsubj	3	SENT_201	[p13l339t1573r606b1652],
3	SURVIVE	VB	O	survive	ccomp	23	SENT_201	[p13l625t1573r966b1632],
4	trial	NN	O	trial	dobj	3	SENT_201	[p13l984t1569r1137b1641],
5	,	,	O	,	_	0	SENT_201	[p13l984t1569r1137b1641],
6	which	WDT	O	which	nsubj	7	SENT_201	[p13l1156t1569r1361b1632],
7	included	VBD	O	include	rcmod	4	SENT_201	[p13l1380t1569r1671b1632],
8	1,327	CD	NUMBER	1,327	num	9	SENT_201	[p13l1695t1576r1866b1641],
9	patients	NNS	O	patient	dobj	7	SENT_201	[p13l1884t1575r2146b1652],
10	hospitalized	VBN	O	hospitalize	partmod	9	SENT_201	[p13l7t1672r419b1755],
11	with	IN	O	with	_	0	SENT_201	[p13l439t1672r591b1735],
12	acute	JJ	O	acute	amod	14	SENT_201	[p13l613t1684r790b1735],
13	decompensated	JJ	O	decompensated	amod	14	SENT_201	[p13l813t1672r1345b1755],
14	HF	NN	O	hf	prep_with	10	SENT_201	[p13l1366t1677r1472b1734],
15	requiring	VBG	O	require	partmod	14	SENT_201	[p13l1495t1678r1814b1756],
16	inotropic	JJ	O	inotropic	amod	17	SENT_201	[p13l1835t1678r2147b1755],
17	support	NN	O	support	dobj	15	SENT_201	[p13l9t1787r285b1858],
18	,	,	O	,	_	0	SENT_201	[p13l9t1787r285b1858],
19	levosimendan	NN	O	levosimendan	nn	20	SENT_201	[p13l305t1775r775b1838],
20	treatment	NN	O	treatment	nsubj	23	SENT_201	[p13l793t1787r1122b1838],
21	did	VBD	O	do	aux	23	SENT_201	[p13l1141t1775r1250b1838],
22	not	RB	O	not	neg	23	SENT_201	[p13l1268t1787r1380b1838],
23	improve	VB	O	improve	_	0	SENT_201	[p13l1398t1781r1675b1858],
24	180-day	JJ	DURATION	180-day	amod	25	SENT_201	[p13l1701t1775r1966b1859],
25	mortality	NN	O	mortality	dobj	23	SENT_201	[p13l1981t1798r2146b1838, p13l7t1877r187b1962],
26	or	CC	O	or	_	0	SENT_201	[p13l208t1900r281b1941],
27	any	DT	O	any	det	31	SENT_201	[p13l304t1900r427b1962],
28	other	JJ	O	other	amod	31	SENT_201	[p13l448t1877r633b1941],
29	secondary	JJ	O	secondary	amod	31	SENT_201	[p13l656t1877r1016b1962],
30	clinical	JJ	O	clinical	amod	31	SENT_201	[p13l1036t1877r1287b1941],
31	outcome	NN	O	outcome	dobj	23	SENT_201	[p13l1310t1869r1695b1941],
32	.	.	O	.	_	0	SENT_201	[p13l1310t1869r1695b1941],

1	“	NN	O	“	npadvmod	19	SENT_202	[p13l1310t1869r1695b1941],
2	In	IN	O	in	_	0	SENT_202	[p13l1719t1883r1791b1940],
3	the	DT	O	the	det	5	SENT_202	[p13l1814t1877r1922b1941],
4	initial	JJ	O	initial	amod	5	SENT_202	[p13l1945t1877r2150b1941],
5	phase	NN	O	phase	prep_in	19	SENT_202	[p13l7t1981r200b2064],
6	of	IN	O	of	_	0	SENT_202	[p13l220t1981r293b2044],
7	levosimendan	NN	O	levosimendan	nn	8	SENT_202	[p13l301t1981r775b2044],
8	treatment	NN	O	treatment	prep_of	5	SENT_202	[p13l794t1993r1142b2053],
9	,	,	O	,	_	0	SENT_202	[p13l794t1993r1142b2053],
10	a	DT	O	a	det	12	SENT_202	[p13l1164t2004r1198b2044],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_202	[p13l1217t1981r1568b2065],
12	increase	NN	O	increase	nsubjpass	19	SENT_202	[p13l1586t1987r1860b2044],
13	in	IN	O	in	_	0	SENT_202	[p13l1880t1987r1946b2043],
14	treatment	NN	O	treatment	nn	17	SENT_202	[p13l1964t1993r2144b2044, p13l8t2096r530b2168],
15	—	CD	NUMBER	—	num	17	SENT_202	[p13l1964t1993r2144b2044, p13l8t2096r530b2168],
16	emergent	NN	O	emergent	nn	17	SENT_202	[p13l1964t1993r2144b2044, p13l8t2096r530b2168],
17	hypotension	NN	O	hypotension	prep_in	12	SENT_202	[p13l547t2084r963b2168],
18	was	VBD	O	be	auxpass	19	SENT_202	[p13l981t2107r1105b2147],
19	observed	VBN	O	observe	_	0	SENT_202	[p13l1125t2084r1444b2147],
20	.	.	O	.	_	0	SENT_202	[p13l1125t2084r1444b2147],

1	A	DT	O	a	nsubjpass	47	SENT_203	[p13l1465t2088r1523b2146],
2	randomized	VBN	O	randomize	csubj	15	SENT_203	[p13l1541t2084r1949b2147],
3	study	NN	O	study	dobj	2	SENT_203	[p13l1968t2084r2151b2168],
4	including	VBG	O	include	_	0	SENT_203	[p13l8t2187r324b2271],
5	60	CD	NUMBER	60	num	6	SENT_203	[p13l341t2193r416b2250],
6	patients	NNS	O	patient	prep_including	3	SENT_203	[p13l435t2193r695b2270],
7	with	IN	O	with	_	0	SENT_203	[p13l712t2187r860b2250],
8	acute	JJ	O	acute	amod	10	SENT_203	[p13l880t2199r1051b2250],
9	decompensated	JJ	O	decompensated	amod	10	SENT_203	[p13l1071t2187r1588b2270],
10	HF	NN	O	hf	prep_with	6	SENT_203	[p13l1606t2192r1710b2249],
11	on	IN	O	on	_	0	SENT_203	[p13l1731t2210r1814b2250],
12	[	NN	O	[	nn	14	SENT_203	[p13l1837t2187r2151b2271],
13	3-blocker	NN	O	3-blocker	nn	14	SENT_203	[p13l1837t2187r2151b2271],
14	treatment	NN	O	treatment	prep_on	10	SENT_203	[p13l7t2302r340b2353],
15	showed	VBD	O	show	dep	1	SENT_203	[p13l359t2290r615b2353],
16	that	IN	O	that	complm	21	SENT_203	[p13l633t2290r766b2353],
17	levosimendan	NN	O	levosimendan	nsubj	21	SENT_203	[p13l783t2290r1258b2353],
18	was	VBD	O	be	cop	21	SENT_203	[p13l1276t2313r1401b2353],
19	at	IN	O	at	advmod	21	SENT_203	[p13l1423t2302r1481b2353],
20	least	JJS	O	least	pobj	19	SENT_203	[p13l1499t2290r1650b2353],
21	comparable	JJ	O	comparable	ccomp	15	SENT_203	[p13l1669t2290r2065b2373],
22	to	TO	O	to	_	0	SENT_203	[p13l2083t2302r2149b2353],
23	dobutamine	NN	O	dobutamine	prep_to	21	SENT_203	[p13l9t2393r420b2456],
24	with	IN	O	with	_	0	SENT_203	[p13l438t2393r590b2456],
25	respect	NN	O	respect	prep_with	23	SENT_203	[p13l610t2405r851b2476],
26	to	TO	O	to	_	0	SENT_203	[p13l868t2405r934b2456],
27	hemodynamic	JJ	O	hemodynamic	amod	30	SENT_203	[p13l954t2393r1446b2477],
28	and	CC	O	and	_	0	SENT_203	[p13l1466t2393r1592b2456],
29	neurohormonal	JJ	O	neurohormonal	conj_and	27	SENT_203	[p13l1610t2393r2150b2456],
30	improvement	NN	O	improvement	prep_to	21	SENT_203	[p13l9t2502r495b2579],
31	,	,	O	,	_	0	SENT_203	[p13l9t2502r495b2579],
32	at	IN	O	at	_	0	SENT_203	[p13l520t2508r580b2559],
33	the	DT	O	the	det	34	SENT_203	[p13l601t2496r708b2559],
34	cost	NN	O	cost	prep_at	21	SENT_203	[p13l732t2508r869b2559],
35	of	IN	O	of	_	0	SENT_203	[p13l891t2496r965b2559],
36	higher	JJR	O	higher	amod	37	SENT_203	[p13l977t2496r1204b2580],
37	rates	NNS	O	rate	prep_of	34	SENT_203	[p13l1226t2508r1386b2559],
38	of	IN	O	of	_	0	SENT_203	[p13l1410t2496r1484b2559],
39	hypotension	NN	O	hypotension	prep_of	37	SENT_203	[p13l1496t2496r1927b2580],
40	in	IN	O	in	_	0	SENT_203	[p13l1950t2502r2017b2558],
41	the	DT	O	the	det	45	SENT_203	[p13l2039t2496r2147b2559],
42	levosimendan	NN	O	levosimendan	nn	45	SENT_203	[p13l7t2598r479b2662],
43	group	NN	O	group	nn	45	SENT_203	[p13l498t2590r774b2683],
44	.36	CD	NUMBER	.36	num	45	SENT_203	[p13l498t2590r774b2683],
45	Levosimendan	NN	O	levosimendan	prep_in	39	SENT_203	[p13l794t2598r1290b2662],
46	is	VBZ	O	be	auxpass	47	SENT_203	[p13l1309t2605r1358b2662],
47	approved	VBN	O	approve	_	0	SENT_203	[p13l1379t2598r1692b2682],
48	in	IN	O	in	_	0	SENT_203	[p13l1711t2605r1776b2661],
49	the	DT	O	the	det	51	SENT_203	[p13l1794t2598r1899b2662],
50	United	NNP	LOCATION	United	nn	51	SENT_203	[p13l1919t2598r2151b2662],
51	States	NNPS	LOCATION	States	prep_in	47	SENT_203	[p13l9t2706r204b2765],
52	and	CC	O	and	_	0	SENT_203	[p13l227t2702r356b2765],
53	in	IN	O	in	_	0	SENT_203	[p13l377t2708r444b2764],
54	many	JJ	O	many	amod	56	SENT_203	[p13l467t2725r662b2786],
55	European	JJ	MISC	european	amod	56	SENT_203	[p13l681t2707r1016b2785],
56	countries	NNS	O	country	prep_in	47	SENT_203	[p13l1040t2708r1378b2765],
57	.	.	O	.	_	0	SENT_203	[p13l1040t2708r1378b2765],

1	According	VBG	O	accord	_	0	SENT_204	[p13l1403t2702r1767b2786],
2	to	TO	O	to	prepc_according_to	14	SENT_204	[p13l1787t2714r1853b2765],
3	the	DT	O	the	det	5	SENT_204	[p13l1876t2702r1984b2765],
4	current	JJ	DATE	current	amod	5	SENT_204	[p13l2007t2725r2146b2765, p13l9t2817r145b2868],
5	guidelines	NNS	O	guideline	pobj	14	SENT_204	[p13l166t2805r531b2889],
6	,	,	O	,	_	0	SENT_204	[p13l166t2805r531b2889],
7	the	DT	O	the	det	8	SENT_204	[p13l554t2805r660b2868],
8	efficacy	NN	O	efficacy	nsubj	14	SENT_204	[p13l683t2805r940b2889],
9	and	CC	O	and	_	0	SENT_204	[p13l959t2805r1085b2868],
10	safety	NN	O	safety	conj_and	8	SENT_204	[p13l1107t2805r1302b2889],
11	of	IN	O	of	_	0	SENT_204	[p13l1322t2805r1395b2868],
12	levosimendan	NN	O	levosimendan	prep_of	8	SENT_204	[p13l1406t2805r1885b2868],
13	remain	VBP	O	remain	cop	14	SENT_204	[p13l1907t2811r2149b2868],
14	unclear	JJ	O	unclear	_	0	SENT_204	[p13l8t2908r270b2971],
15	.	.	O	.	_	0	SENT_204	[p13l8t2908r270b2971],

1	The	DT	O	the	det	3	SENT_205	[p13l294t2908r419b2971],
2	European	JJ	ORGANIZATION	european	amod	3	SENT_205	[p13l440t2913r769b2991],
3	Society	NNP	ORGANIZATION	Society	nsubj	7	SENT_205	[p13l790t2912r1037b2992],
4	of	IN	ORGANIZATION	of	_	0	SENT_205	[p13l1054t2908r1128b2971],
5	Cardiology	NNP	ORGANIZATION	Cardiology	nn	6	SENT_205	[p13l1140t2908r1523b2992],
6	guidelines	NNS	O	guideline	prep_of	3	SENT_205	[p13l1539t2908r1884b2992],
7	recommend	VBP	O	recommend	_	0	SENT_205	[p13l1905t2931r2146b2971, p13l8t3011r203b3074],
8	use	NN	O	use	dobj	7	SENT_205	[p13l221t3034r331b3074],
9	with	IN	O	with	_	0	SENT_205	[p13l349t3011r500b3074],
10	a	DT	O	a	det	16	SENT_205	[p13l520t3034r554b3074],
11	relatively	RB	O	relatively	advmod	12	SENT_205	[p13l573t3011r879b3095],
12	weak	JJ	O	weak	amod	16	SENT_205	[p13l893t3011r1069b3074],
13	(	CD	NUMBER	(	num	16	SENT_205	[p13l1089t3011r1698b3087],
14	recommendation	NN	O	recommendation	nn	16	SENT_205	[p13l1089t3011r1698b3087],
15	class	NN	O	class	nn	16	SENT_205	[p13l1718t3011r1869b3074],
16	IIb	NN	O	iib	prep_with	8	SENT_205	[p13l1891t3011r2002b3083],
17	,	,	O	,	_	0	SENT_205	[p13l1891t3011r2002b3083],
18	evidence	NN	O	evidence	nn	20	SENT_205	[p13l2024t3017r2147b3074, p13l9t3114r210b3177],
19	level	NN	O	level	nn	20	SENT_205	[p13l231t3114r388b3177],
20	C	NN	O	c	appos	16	SENT_205	[p13l412t3115r491b3191],
21	)	CD	NUMBER	)	num	22	SENT_205	[p13l412t3115r491b3191],
22	indication	NN	O	indication	dep	20	SENT_205	[p13l518t3114r871b3177],
23	in	IN	O	in	_	0	SENT_205	[p13l894t3120r961b3176],
24	patients	NNS	O	patient	prep_in	7	SENT_205	[p13l983t3120r1255b3197],
25	with	IN	O	with	_	0	SENT_205	[p13l1277t3114r1432b3177],
26	shock	NN	O	shock	prep_with	24	SENT_205	[p13l1456t3114r1673b3186],
27	,	,	O	,	_	0	SENT_205	[p13l1456t3114r1673b3186],
28	hypotension	NN	O	hypotension	conj_or	26	SENT_205	[p13l1696t3114r2145b3198],
29	,	,	O	,	_	0	SENT_205	[p13l1696t3114r2145b3198],
30	or	CC	O	or	_	0	SENT_205	[p13l9t3240r80b3280],
31	hypoperfusion	NN	O	hypoperfusion	conj_or	26	SENT_205	[p13l99t3217r598b3301],
32	and	CC	O	and	_	0	SENT_205	[p13l620t3217r745b3280],
33	state	NN	O	state	conj_and	26	SENT_205	[p13l766t3229r917b3280],
34	that	WDT	O	that	dobj	38	SENT_205	[p13l937t3217r1070b3280],
35	levosimendan	NN	O	levosimendan	nsubjpass	38	SENT_205	[p13l1089t3217r1564b3280],
36	might	MD	O	might	aux	38	SENT_205	[p13l1585t3217r1788b3301],
37	be	VB	O	be	auxpass	38	SENT_205	[p13l1805t3217r1885b3280],
38	used	VBN	O	use	rcmod	24	SENT_205	[p13l1905t3217r2063b3280],
39	to	TO	O	to	aux	40	SENT_205	[p13l2082t3229r2147b3280],
40	counteract	VB	O	counteract	xcomp	38	SENT_205	[p13l9t3332r370b3383],
41	the	DT	O	the	det	42	SENT_205	[p13l389t3320r494b3383],
42	effects	NNS	O	effect	dobj	40	SENT_205	[p13l516t3320r726b3383],
43	of	IN	O	of	_	0	SENT_205	[p13l748t3320r822b3383],
44	a	DT	O	a	det	45	SENT_205	[p13l833t3343r868b3383],
45	[	NN	O	[	prep_of	42	SENT_205	[p13l891t3320r1224b3404],
46	3	CD	NUMBER	3	num	48	SENT_205	[p13l891t3320r1224b3404],
47	—	NN	O	—	nn	48	SENT_205	[p13l891t3320r1224b3404],
48	blocker	NN	O	blocker	dep	45	SENT_205	[p13l891t3320r1224b3404],
49	.	.	O	.	_	0	SENT_205	[p13l891t3320r1224b3404],

1	Phosphodiesterase	NN	O	phosphodiesterase	nsubj	4	SENT_206	[p13l83t3423r728b3506],
2	III	CD	NUMBER	iii	num	3	SENT_206	[p13l752t3428r835b3485],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_206	[p13l859t3423r1195b3486],
4	exert	VBP	O	exert	_	0	SENT_206	[p13l1219t3435r1391b3486],
5	positive	JJ	O	positive	amod	6	SENT_206	[p13l1411t3429r1680b3506],
6	inotrope	NN	O	inotrope	dobj	4	SENT_206	[p13l1703t3429r1999b3506],
7	and	CC	O	and	_	0	SENT_206	[p13l2022t3423r2150b3486],
8	vasodilatory	JJ	O	vasodilatory	amod	9	SENT_206	[p13l6t3526r444b3610],
9	effects	NNS	O	effect	dobj	4	SENT_206	[p13l465t3526r700b3589],
10	.	.	O	.	_	0	SENT_206	[p13l465t3526r700b3589],

1	They	PRP	O	they	nsubj	8	SENT_207	[p13l727t3526r900b3610],
2	act	VBP	O	act	_	0	SENT_207	[p13l920t3538r1021b3589],
3	on	IN	O	on	_	0	SENT_207	[p13l1044t3549r1132b3589],
4	an	DT	O	a	det	6	SENT_207	[p13l1156t3549r1238b3589],
5	intracellular	JJ	O	intracellular	amod	6	SENT_207	[p13l1261t3526r1689b3589],
6	level	NN	O	level	prep_on	2	SENT_207	[p13l1710t3526r1868b3589],
7	and	CC	O	and	_	0	SENT_207	[p13l1892t3526r2022b3589],
8	are	VBP	O	be	conj_and	2	SENT_207	[p13l2045t3549r2147b3589],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_208	[p13l21t3675r140b3696],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_208	[p13l149t3675r374b3696],
3	&	CC	O	&	_	0	SENT_208	[p13l381t3675r601b3696],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_208	[p13l381t3675r601b3696],
5	|	CD	NUMBER	|	num	6	SENT_208	[p13l381t3675r601b3696],
6	CS	NNP	O	CS	conj_and	2	SENT_208	[p13l381t3675r601b3696],
7	|	NNP	O	|	nn	8	SENT_208	[p13l611t3673r613b3703],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_208	[p13l621t3675r729b3696],
9	94	CD	NUMBER	94	num	10	SENT_208	[p13l737t3675r765b3696],
10	NUMBER	NN	O	number	dep	12	SENT_208	[p13l774t3675r882b3696],
11	4	CD	NUMBER	4	num	12	SENT_208	[p13l889t3673r915b3703],
12	]	CD	NUMBER	]	dep	15	SENT_208	[p13l889t3673r915b3703],
13	OCTOBER	NNP	DATE	OCTOBER	dep	12	SENT_208	[p13l924t3675r1044b3696],
14	2013	CD	DATE	2013	num	15	SENT_208	[p13l1052t3675r1109b3696],
15	503	CD	NUMBER	503	_	0	SENT_208	[p13l2093t3675r2139b3696],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_209	[p14l19t44r209b81],

1	therefore	RB	O	therefore	advmod	2	SENT_210	[p14l7t253r305b316],
2	independent	JJ	O	independent	_	0	SENT_210	[p14l324t253r743b336],
3	of	IN	O	of	_	0	SENT_210	[p14l761t253r833b316],
4	downregulation	NN	O	downregulation	prep_of	2	SENT_210	[p14l843t253r1368b337],
5	of	IN	O	of	_	0	SENT_210	[p14l1387t253r1459b316],
6	adrenoreceptors	NNS	O	adrenoreceptor	prep_of	4	SENT_210	[p14l1469t253r2003b336],
7	or	CC	O	or	_	0	SENT_210	[p14l2023t276r2093b316],
8	a	DT	O	a	det	12	SENT_210	[p14l2111t276r2145b316],
9	concomitant	JJ	O	concomitant	amod	12	SENT_210	[p14l8t362r424b419],
10	[	NN	O	[	nn	12	SENT_210	[p14l445t356r758b440],
11	3-blocker	NN	O	3-blocker	nn	12	SENT_210	[p14l445t356r758b440],
12	therapy	NN	O	therapy	conj_or	6	SENT_210	[p14l774t356r1033b440],
13	.	.	O	.	_	0	SENT_210	[p14l774t356r1033b440],

1	Application	NN	O	application	nsubjpass	4	SENT_211	[p14l1053t356r1439b439],
2	should	MD	O	should	aux	4	SENT_211	[p14l1458t356r1681b419],
3	be	VB	O	be	auxpass	4	SENT_211	[p14l1696t356r1773b419],
4	performed	VBN	O	perform	_	0	SENT_211	[p14l1791t356r2145b439],
5	continuously	RB	O	continuously	advmod	4	SENT_211	[p14l8t459r448b543],
6	with	IN	O	with	_	0	SENT_211	[p14l462t459r613b522],
7	a	DT	O	a	det	9	SENT_211	[p14l633t482r667b522],
8	slow	JJ	O	slow	amod	9	SENT_211	[p14l687t459r838b522],
9	increase	NN	O	increase	prep_with	4	SENT_211	[p14l855t465r1128b522],
10	in	IN	O	in	_	0	SENT_211	[p14l1148t465r1213b521],
11	dosage	NN	O	dosage	prep_in	9	SENT_211	[p14l1233t459r1477b543],
12	.	.	O	.	_	0	SENT_211	[p14l1233t459r1477b543],

1	In	IN	O	in	_	0	SENT_212	[p14l1501t464r1571b521],
2	the	DT	O	the	det	3	SENT_212	[p14l1589t459r1694b522],
3	Outcomes	NNS	O	outcome	prep_in	23	SENT_212	[p14l1715t463r2059b522],
4	of	IN	O	of	_	0	SENT_212	[p14l2080t459r2153b522],
5	a	DT	O	a	det	7	SENT_212	[p14l8t585r42b625],
6	Prospective	JJ	O	prospective	amod	7	SENT_212	[p14l61t567r442b645],
7	Trial	NN	O	trial	prep_of	3	SENT_212	[p14l461t562r615b625],
8	of	IN	O	of	_	0	SENT_212	[p14l634t562r705b625],
9	Intravenous	JJ	O	intravenous	amod	10	SENT_212	[p14l715t567r1109b625],
10	Milrinone	NN	O	milrinone	prep_of	7	SENT_212	[p14l1128t562r1464b625],
11	for	IN	O	for	_	0	SENT_212	[p14l1483t562r1577b625],
12	Exacerbations	NNS	O	exacerbation	prep_for	10	SENT_212	[p14l1595t562r2060b625],
13	of	IN	O	of	_	0	SENT_212	[p14l2080t562r2152b625],
14	Chronic	JJ	O	chronic	amod	17	SENT_212	[p14l9t665r287b728],
15	Heart	NNP	O	Heart	nn	17	SENT_212	[p14l309t670r503b728],
16	FailureOPTIME-CHF	NNP	O	FailureOPTIME-CHF	nn	17	SENT_212	[p14l524t665r1275b728],
17	study	NN	O	study	prep_of	12	SENT_212	[p14l1298t665r1491b749],
18	,	,	O	,	_	0	SENT_212	[p14l1298t665r1491b749],
19	patients	NNS	O	patient	nsubjpass	23	SENT_212	[p14l1513t671r1780b748],
20	with	IN	O	with	_	0	SENT_212	[p14l1801t665r1953b728],
21	AHF	NN	ORGANIZATION	ahf	prep_with	19	SENT_212	[p14l1973t669r2141b727],
22	were	VBD	O	be	auxpass	23	SENT_212	[p14l6t791r163b831],
23	treated	VBN	O	treat	_	0	SENT_212	[p14l181t768r414b831],
24	with	IN	O	with	_	0	SENT_212	[p14l430t768r580b831],
25	milrinone	NN	O	milrinone	prep_with	23	SENT_212	[p14l599t768r932b831],
26	or	CC	O	or	_	0	SENT_212	[p14l953t791r1023b831],
27	placebo	NN	O	placebo	prep_with	23	SENT_212	[p14l1040t768r1311b851],
28	.	.	O	.	_	0	SENT_212	[p14l1040t768r1311b851],

1	Milrinone	NN	O	milrinone	nn	2	SENT_213	[p14l1333t768r1673b831],
2	treatment	NN	O	treatment	nsubj	5	SENT_213	[p14l1691t780r2019b831],
3	did	VBD	O	do	aux	5	SENT_213	[p14l2038t768r2146b831],
4	not	RB	O	not	neg	5	SENT_213	[p14l7t883r121b934],
5	improve	VB	O	improve	_	0	SENT_213	[p14l142t877r424b954],
6	duration	NN	O	duration	dobj	5	SENT_213	[p14l447t871r741b934],
7	of	IN	O	of	_	0	SENT_213	[p14l764t871r837b934],
8	hospitalization	NN	O	hospitalization	prep_of	6	SENT_213	[p14l849t871r1355b954],
9	or	CC	O	or	_	0	SENT_213	[p14l1377t894r1449b934],
10	mortality	NN	O	mortality	prep_of	6	SENT_213	[p14l1470t871r1797b955],
11	.	.	O	.	_	0	SENT_213	[p14l1470t871r1797b955],

1	However	RB	O	however	advmod	15	SENT_214	[p14l1823t876r2142b943],
2	,	,	O	,	_	0	SENT_214	[p14l1823t876r2142b943],
3	increases	VBZ	O	increase	csubjpass	15	SENT_214	[p14l8t980r322b1037],
4	in	IN	O	in	_	0	SENT_214	[p14l346t980r413b1036],
5	both	CC	O	both	preconj	9	SENT_214	[p14l434t974r597b1037],
6	atrial	JJ	O	atrial	amod	9	SENT_214	[p14l620t974r798b1037],
7	and	CC	O	and	_	0	SENT_214	[p14l822t974r950b1037],
8	ventricular	JJ	O	ventricular	amod	9	SENT_214	[p14l969t974r1355b1037],
9	tachyarrhythmias	NNS	O	tachyarrhythmia	prep_in	3	SENT_214	[p14l1376t974r1990b1058],
10	and	CC	O	and	_	0	SENT_214	[p14l2015t974r2143b1037],
11	prolonged	JJ	O	prolonged	amod	13	SENT_214	[p14l6t1077r361b1161],
12	hypotensive	JJ	O	hypotensive	amod	13	SENT_214	[p14l382t1077r796b1161],
13	episodes	NNS	O	episode	conj_and	9	SENT_214	[p14l820t1077r1113b1160],
14	were	VBD	O	be	auxpass	15	SENT_214	[p14l1135t1100r1298b1140],
15	observed	VBN	O	observe	_	0	SENT_214	[p14l1321t1077r1650b1140],
16	.	.	O	.	_	0	SENT_214	[p14l1321t1077r1650b1140],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_215	[p14l1676t1077r2141b1149],
2	,	,	O	,	_	0	SENT_215	[p14l1676t1077r2141b1149],
3	there	EX	O	there	expl	4	SENT_215	[p14l7t1179r183b1242],
4	was	VBD	O	be	_	0	SENT_215	[p14l203t1202r331b1242],
5	even	RB	O	even	advmod	4	SENT_215	[p14l355t1202r513b1242],
6	an	DT	O	a	det	8	SENT_215	[p14l536t1202r617b1242],
7	numerical	JJ	O	numerical	amod	8	SENT_215	[p14l639t1179r992b1242],
8	increase	NN	O	increase	nsubj	4	SENT_215	[p14l1014t1185r1294b1242],
9	in	IN	O	in	_	0	SENT_215	[p14l1317t1185r1385b1241],
10	the	DT	O	the	det	11	SENT_215	[p14l1406t1179r1514b1242],
11	number	NN	O	number	prep_in	8	SENT_215	[p14l1536t1179r1812b1242],
12	of	IN	O	of	_	0	SENT_215	[p14l1834t1179r1909b1242],
13	deaths	NNS	O	death	prep_of	11	SENT_215	[p14l1922t1179r2143b1242],
14	in	IN	O	in	_	0	SENT_215	[p14l8t1287r76b1343],
15	the	DT	O	the	det	17	SENT_215	[p14l99t1281r208b1344],
16	milrinone	JJ	O	milrinone	amod	17	SENT_215	[p14l231t1281r582b1344],
17	group	NN	O	group	prep_in	13	SENT_215	[p14l606t1273r895b1365],
18	.37	CD	NUMBER	.37	num	17	SENT_215	[p14l606t1273r895b1365],
19	The	DT	O	the	det	20	SENT_215	[p14l918t1281r1046b1344],
20	guidelines	NNS	O	guideline	nsubj	21	SENT_215	[p14l1071t1281r1427b1365],
21	suggest	VBP	O	suggest	rcmod	17	SENT_215	[p14l1452t1293r1707b1365],
22	considering	VBG	O	consider	xcomp	21	SENT_215	[p14l1731t1281r2145b1365],
23	the	DT	O	the	det	24	SENT_215	[p14l7t1384r114b1447],
24	use	NN	O	use	dobj	22	SENT_215	[p14l137t1407r249b1447],
25	of	IN	O	of	_	0	SENT_215	[p14l273t1384r348b1447],
26	phosphodiesterase	NN	O	phosphodiesterase	nn	28	SENT_215	[p14l360t1384r1006b1467],
27	III	CD	NUMBER	iii	num	28	SENT_215	[p14l1029t1389r1113b1446],
28	inhibitors	NNS	O	inhibitor	prep_of	24	SENT_215	[p14l1137t1384r1474b1447],
29	as	IN	O	as	_	0	SENT_215	[p14l1498t1407r1563b1447],
30	an	DT	O	a	det	31	SENT_215	[p14l1588t1407r1668b1447],
31	alternative	NN	O	alternative	prep_as	22	SENT_215	[p14l1692t1384r2055b1447],
32	to	TO	O	to	_	0	SENT_215	[p14l2077t1396r2144b1447],
33	levosimendan	NN	O	levosimendan	nn	34	SENT_215	[p14l6t1487r473b1550],
34	treatment	NN	O	treatment	prep_to	31	SENT_215	[p14l491t1499r818b1550],
35	with	IN	O	with	_	0	SENT_215	[p14l834t1487r983b1551],
36	the	DT	O	the	det	38	SENT_215	[p14l1001t1487r1105b1550],
37	same	JJ	O	same	amod	38	SENT_215	[p14l1125t1510r1293b1550],
38	level	NN	O	level	prep_with	22	SENT_215	[p14l1311t1487r1462b1550],
39	of	IN	O	of	_	0	SENT_215	[p14l1480t1487r1553b1551],
40	evidence	NN	O	evidence	nn	44	SENT_215	[p14l1563t1487r1854b1550],
41	(	CD	NUMBER	(	num	44	SENT_215	[p14l1877t1488r2141b1563, p14l7t1590r377b1653],
42	recommendation	NN	O	recommendation	nn	44	SENT_215	[p14l1877t1488r2141b1563, p14l7t1590r377b1653],
43	class	NN	O	class	nn	44	SENT_215	[p14l398t1590r550b1653],
44	IIb	NN	O	iib	prep_of	38	SENT_215	[p14l573t1590r685b1662],
45	,	,	O	,	_	0	SENT_215	[p14l573t1590r685b1662],
46	evidence	NN	O	evidence	nn	49	SENT_215	[p14l708t1590r1004b1653],
47	level	NN	O	level	nn	49	SENT_215	[p14l1024t1590r1177b1653],
48	C	NN	O	c	nn	49	SENT_215	[p14l1198t1590r1296b1667],
49	)	NN	O	)	appos	38	SENT_215	[p14l1198t1590r1296b1667],
50	.	.	O	.	_	0	SENT_215	[p14l1198t1590r1296b1667],

1	Cardiac	JJ	O	cardiac	amod	2	SENT_216	[p14l82t1693r346b1756],
2	glycosides	NNS	O	glycoside	_	0	SENT_216	[p14l366t1693r730b1777],
3	,	,	O	,	_	0	SENT_216	[p14l366t1693r730b1777],
4	which	WDT	O	which	nsubjpass	13	SENT_216	[p14l750t1693r959b1756],
5	exert	VBP	O	exert	rcmod	2	SENT_216	[p14l980t1705r1148b1756],
6	positive	JJ	O	positive	amod	8	SENT_216	[p14l1167t1699r1432b1776],
7	inotrope	JJ	O	inotrope	amod	8	SENT_216	[p14l1453t1699r1744b1776],
8	effects	NNS	O	effect	dobj	5	SENT_216	[p14l1765t1693r1995b1765],
9	,	,	O	,	_	0	SENT_216	[p14l1765t1693r1995b1765],
10	and	CC	O	and	_	0	SENT_216	[p14l2018t1693r2143b1756],
11	may	MD	O	may	aux	13	SENT_216	[p14l7t1819r152b1880],
12	be	VB	O	be	auxpass	13	SENT_216	[p14l166t1796r244b1859],
13	indicated	VBN	O	indicate	conj_and	5	SENT_216	[p14l264t1796r576b1859],
14	in	IN	O	in	_	0	SENT_216	[p14l595t1802r660b1858],
15	patients	NNS	O	patient	prep_in	13	SENT_216	[p14l679t1802r944b1879],
16	with	IN	O	with	_	0	SENT_216	[p14l962t1796r1113b1859],
17	AHF	NN	ORGANIZATION	ahf	prep_with	2	SENT_216	[p14l1131t1800r1296b1858],
18	and	CC	O	and	_	0	SENT_216	[p14l1318t1796r1442b1859],
19	fast	JJ	O	fast	amod	21	SENT_216	[p14l1461t1796r1577b1859],
20	atrial	JJ	O	atrial	amod	21	SENT_216	[p14l1596t1796r1769b1859],
21	ﬁbrillation	NN	O	ﬁbrillation	prep_with	2	SENT_216	[p14l1787t1796r2143b1859],
22	in	IN	O	in	_	0	SENT_216	[p14l8t1905r72b1962],
23	order	NN	O	order	prep_in	2	SENT_216	[p14l92t1899r272b1962],
24	to	TO	O	to	aux	25	SENT_216	[p14l289t1911r353b1962],
25	slow	VB	O	slow	infmod	23	SENT_216	[p14l375t1899r524b1962],
26	down	RP	O	down	prt	25	SENT_216	[p14l541t1899r727b1962],
27	the	DT	O	the	det	28	SENT_216	[p14l745t1899r848b1962],
28	rate	NN	O	rate	dobj	25	SENT_216	[p14l868t1911r991b1962],
29	of	IN	O	of	_	0	SENT_216	[p14l1011t1899r1083b1962],
30	ventricular	JJ	O	ventricular	amod	40	SENT_216	[p14l1091t1899r1458b1962],
31	stimulation	NN	O	stimulation	dep	30	SENT_216	[p14l1477t1899r1856b1962],
32	(	CD	NUMBER	(	num	31	SENT_216	[p14l1879t1900r2140b1976, p14l7t2002r378b2065],
33	recommendation	NN	O	recommendation	nn	40	SENT_216	[p14l1879t1900r2140b1976, p14l7t2002r378b2065],
34	class	NN	O	class	nn	40	SENT_216	[p14l399t2002r552b2065],
35	IIb	NN	O	iib	nn	40	SENT_216	[p14l574t2002r687b2074],
36	,	,	O	,	_	0	SENT_216	[p14l574t2002r687b2074],
37	evidence	NN	O	evidence	dep	40	SENT_216	[p14l710t2002r1006b2065],
38	level	NN	O	level	nn	40	SENT_216	[p14l1026t2002r1180b2065],
39	C	NN	O	c	nn	40	SENT_216	[p14l1201t2002r1299b2079],
40	)	NN	O	)	prep_of	28	SENT_216	[p14l1201t2002r1299b2079],
41	.	.	O	.	_	0	SENT_216	[p14l1201t2002r1299b2079],

1	However	RB	O	however	advmod	16	SENT_217	[p14l1323t2007r1640b2074],
2	,	,	O	,	_	0	SENT_217	[p14l1323t2007r1640b2074],
3	in	IN	O	in	_	0	SENT_217	[p14l1663t2008r1729b2064],
4	cardiogenic	JJ	O	cardiogenic	amod	5	SENT_217	[p14l1750t2002r2144b2086],
5	shock	NN	O	shock	prep_in	16	SENT_217	[p14l8t2105r211b2168],
6	due	JJ	O	due	_	0	SENT_217	[p14l231t2105r355b2168],
7	to	TO	O	to	_	0	SENT_217	[p14l377t2117r443b2168],
8	myocardial	JJ	O	myocardial	amod	9	SENT_217	[p14l468t2105r857b2189],
9	infarction	NN	O	infarction	prep_due_to	5	SENT_217	[p14l879t2105r1240b2177],
10	,	,	O	,	_	0	SENT_217	[p14l879t2105r1240b2177],
11	cardiac	JJ	O	cardiac	amod	12	SENT_217	[p14l1265t2105r1513b2168],
12	glycosides	NNS	O	glycoside	nsubjpass	16	SENT_217	[p14l1536t2105r1887b2189],
13	should	MD	O	should	aux	16	SENT_217	[p14l1912t2105r2145b2168],
14	not	RB	O	not	neg	16	SENT_217	[p14l7t2220r119b2271],
15	be	VB	O	be	auxpass	16	SENT_217	[p14l136t2208r214b2271],
16	used	VBN	O	use	_	0	SENT_217	[p14l234t2208r389b2271],
17	because	IN	O	because	_	0	SENT_217	[p14l406t2208r669b2271],
18	of	IN	O	of	_	0	SENT_217	[p14l689t2208r762b2271],
19	the	DT	O	the	det	21	SENT_217	[p14l771t2208r875b2271],
20	increased	VBN	O	increase	amod	21	SENT_217	[p14l896t2208r1214b2271],
21	risk	NN	O	risk	prep_because_of	16	SENT_217	[p14l1233t2208r1360b2271],
22	of	IN	O	of	_	0	SENT_217	[p14l1377t2208r1449b2271],
23	myocardial	JJ	O	myocardial	amod	24	SENT_217	[p14l1459t2208r1836b2292],
24	reinfarction	NN	O	reinfarction	prep_of	21	SENT_217	[p14l1856t2208r2142b2271, p14l7t2316r144b2373],
25	and	CC	O	and	_	0	SENT_217	[p14l166t2310r293b2373],
26	the	DT	O	the	det	28	SENT_217	[p14l312t2310r418b2373],
27	increased	VBN	O	increase	amod	28	SENT_217	[p14l440t2310r765b2373],
28	incidence	NN	O	incidence	conj_and	21	SENT_217	[p14l786t2310r1115b2373],
29	of	IN	O	of	_	0	SENT_217	[p14l1137t2310r1211b2373],
30	ventricular	JJ	O	ventricular	amod	31	SENT_217	[p14l1220t2310r1600b2373],
31	arrhythmias	NNS	O	arrhythmia	prep_of	28	SENT_217	[p14l1620t2302r2119b2394],
32	.38	CD	NUMBER	.38	dep	31	SENT_217	[p14l1620t2302r2119b2394],

1	Vasopressors	NNP	O	Vasopressors	_	0	SENT_218	[p14l11t2529r406b2594],
2	.	.	O	.	_	0	SENT_218	[p14l11t2529r406b2594],

1	According	VBG	O	accord	_	0	SENT_219	[p14l435t2517r784b2601],
2	to	TO	O	to	prepc_according_to	8	SENT_219	[p14l808t2529r873b2580],
3	the	DT	O	the	det	4	SENT_219	[p14l900t2517r1004b2580],
4	guidelines	NNS	O	guideline	pobj	8	SENT_219	[p14l1031t2517r1385b2601],
5	,	,	O	,	_	0	SENT_219	[p14l1031t2517r1385b2601],
6	vasopressors	NNS	O	vasopressor	nsubjpass	8	SENT_219	[p14l1411t2539r1830b2600],
7	are	VBP	O	be	auxpass	8	SENT_219	[p14l1859t2540r1956b2580],
8	indicated	VBN	O	indicate	_	0	SENT_219	[p14l1984t2517r2141b2580, p14l8t2620r181b2683],
9	in	IN	O	in	_	0	SENT_219	[p14l206t2626r272b2682],
10	patients	NNS	O	patient	prep_in	8	SENT_219	[p14l297t2626r557b2703],
11	with	IN	O	with	_	0	SENT_219	[p14l582t2620r731b2683],
12	shock	NN	O	shock	prep_with	10	SENT_219	[p14l757t2620r952b2683],
13	despite	IN	O	despite	_	0	SENT_219	[p14l975t2620r1205b2703],
14	treatment	NN	O	treatment	prep_despite	8	SENT_219	[p14l1231t2632r1556b2683],
15	with	IN	O	with	_	0	SENT_219	[p14l1579t2620r1728b2683],
16	an	DT	O	a	det	21	SENT_219	[p14l1755t2643r1833b2683],
17	inotrope	JJ	O	inotrope	amod	21	SENT_219	[p14l1860t2626r2144b2703],
18	(	NN	O	(	nn	21	SENT_219	[p14l11t2723r611b2800],
19	recommendation	NN	O	recommendation	nn	21	SENT_219	[p14l11t2723r611b2800],
20	class	NN	O	class	nn	21	SENT_219	[p14l637t2723r786b2786],
21	IIb	NN	O	iib	prep_with	8	SENT_219	[p14l812t2723r922b2795],
22	,	,	O	,	_	0	SENT_219	[p14l812t2723r922b2795],
23	evidence	NN	O	evidence	nn	26	SENT_219	[p14l950t2723r1240b2786],
24	level	NN	O	level	nn	26	SENT_219	[p14l1264t2723r1414b2786],
25	C	NN	O	c	nn	26	SENT_219	[p14l1440t2724r1536b2799],
26	)	NN	O	)	appos	21	SENT_219	[p14l1440t2724r1536b2799],
27	.	.	O	.	_	0	SENT_219	[p14l1440t2724r1536b2799],

1	They	PRP	O	they	nsubjpass	3	SENT_220	[p14l1564t2723r1731b2807],
2	are	VBP	O	be	auxpass	3	SENT_220	[p14l1753t2746r1851b2786],
3	given	VBN	O	give	_	0	SENT_220	[p14l1876t2729r2054b2807],
4	to	TO	O	to	aux	5	SENT_220	[p14l2078t2735r2143b2786],
5	raise	VB	O	raise	ccomp	3	SENT_220	[p14l8t2832r160b2889],
6	blood	NN	O	blood	nn	7	SENT_220	[p14l178t2826r373b2889],
7	pressure	NN	O	pressure	dobj	5	SENT_220	[p14l390t2848r666b2909],
8	and	CC	O	and	_	0	SENT_220	[p14l688t2826r811b2889],
9	to	TO	O	to	aux	10	SENT_220	[p14l829t2838r894b2889],
10	redistribute	VB	O	redistribute	conj_and	5	SENT_220	[p14l915t2826r1297b2889],
11	blood	NN	O	blood	nn	12	SENT_220	[p14l1316t2826r1510b2889],
12	volume	NN	O	volume	dobj	10	SENT_220	[p14l1527t2826r1775b2889],
13	to	TO	O	to	_	0	SENT_220	[p14l1795t2838r1859b2889],
14	the	DT	O	the	det	16	SENT_220	[p14l1880t2826r1983b2889],
15	vital	JJ	O	vital	amod	16	SENT_220	[p14l2001t2826r2145b2889],
16	organs	NNS	O	organ	prep_to	10	SENT_220	[p14l8t2952r243b3013],
17	.	.	O	.	_	0	SENT_220	[p14l8t2952r243b3013],

1	However	RB	O	however	advmod	4	SENT_221	[p14l265t2934r576b3001],
2	,	,	O	,	_	0	SENT_221	[p14l265t2934r576b3001],
3	this	DT	O	this	nsubj	4	SENT_221	[p14l595t2929r715b2992],
4	occurs	VBZ	O	occur	_	0	SENT_221	[p14l736t2952r952b2992],
5	at	IN	O	at	_	0	SENT_221	[p14l973t2941r1031b2992],
6	the	DT	O	the	det	7	SENT_221	[p14l1047t2929r1151b2992],
7	cost	NN	O	cost	prep_at	4	SENT_221	[p14l1171t2941r1302b2992],
8	of	IN	O	of	_	0	SENT_221	[p14l1320t2929r1393b2992],
9	an	DT	O	a	det	11	SENT_221	[p14l1403t2952r1482b2992],
10	increased	VBN	O	increase	amod	11	SENT_221	[p14l1501t2929r1816b2992],
11	afterload	NN	O	afterload	prep_of	7	SENT_221	[p14l1834t2929r2141b2992],
12	.	.	O	.	_	0	SENT_221	[p14l1834t2929r2141b2992],

1	Therefore	RB	O	therefore	advmod	7	SENT_222	[p14l7t3032r343b3104],
2	,	,	O	,	_	0	SENT_222	[p14l7t3032r343b3104],
3	vasopressors	NNS	O	vasopressor	nsubjpass	7	SENT_222	[p14l361t3054r780b3115],
4	should	MD	O	should	aux	7	SENT_222	[p14l801t3032r1025b3095],
5	only	RB	O	only	advmod	7	SENT_222	[p14l1043t3032r1190b3116],
6	be	VB	O	be	auxpass	7	SENT_222	[p14l1203t3032r1281b3095],
7	used	VBN	O	use	_	0	SENT_222	[p14l1300t3032r1454b3095],
8	only	RB	O	only	advmod	7	SENT_222	[p14l1473t3032r1620b3116],
9	in	IN	O	in	_	0	SENT_222	[p14l1635t3038r1700b3094],
10	patients	NNS	O	patient	prep_in	7	SENT_222	[p14l1718t3038r1978b3115],
11	with	IN	O	with	_	0	SENT_222	[p14l1995t3032r2144b3095],
12	persistent	JJ	O	persistent	amod	13	SENT_222	[p14l6t3141r328b3218],
13	hypoperfusion	NN	O	hypoperfusion	prep_with	10	SENT_222	[p14l361t3135r848b3219],
14	despite	IN	O	despite	_	0	SENT_222	[p14l884t3135r1114b3218],
15	adequate	JJ	O	adequate	amod	18	SENT_222	[p14l1150t3135r1445b3218],
16	cardiac	JJ	O	cardiac	amod	18	SENT_222	[p14l1481t3135r1718b3198],
17	ﬁlling	NN	O	ﬁlling	nn	18	SENT_222	[p14l1752t3135r1945b3219],
18	pressures	NNS	O	pressure	prep_despite	7	SENT_222	[p14l1977t3157r2141b3218, p14l8t3261r190b3301],
19	.	.	O	.	_	0	SENT_222	[p14l1977t3157r2141b3218, p14l8t3261r190b3301],

1	A	DT	O	a	det	2	SENT_223	[p14l214t3242r271b3300],
2	combination	NN	O	combination	nsubj	8	SENT_223	[p14l293t3238r715b3301],
3	of	IN	O	of	_	0	SENT_223	[p14l737t3238r810b3301],
4	positive	JJ	O	positive	amod	6	SENT_223	[p14l820t3244r1078b3321],
5	inotrope	NN	O	inotrope	nn	6	SENT_223	[p14l1099t3244r1383b3321],
6	agents	NNS	O	agent	prep_of	2	SENT_223	[p14l1405t3250r1611b3322],
7	is	VBZ	O	be	cop	8	SENT_223	[p14l1634t3244r1683b3301],
8	reasonable	JJ	O	reasonable	_	0	SENT_223	[p14l1705t3238r2057b3301],
9	in	IN	O	in	mark	12	SENT_223	[p14l2078t3244r2144b3300],
10	order	NN	O	order	dep	12	SENT_223	[p14l8t3341r188b3404],
11	to	TO	O	to	aux	12	SENT_223	[p14l207t3353r272b3404],
12	keep	VB	O	keep	purpcl	8	SENT_223	[p14l292t3341r446b3424],
13	the	DT	O	the	det	15	SENT_223	[p14l467t3341r571b3404],
14	vasopressor	NN	O	vasopressor	nn	15	SENT_223	[p14l589t3363r981b3424],
15	dose	NN	O	dose	dobj	12	SENT_223	[p14l1001t3341r1151b3404],
16	as	RB	O	as	advmod	17	SENT_223	[p14l1174t3364r1236b3404],
17	low	JJ	O	low	advmod	12	SENT_223	[p14l1257t3341r1379b3404],
18	as	IN	O	as	_	0	SENT_223	[p14l1397t3364r1460b3404],
19	possible	JJ	O	possible	prep_as	17	SENT_223	[p14l1480t3341r1762b3424],
20	.	.	O	.	_	0	SENT_223	[p14l1480t3341r1762b3424],

1	Dopamine	NN	O	dopamine	nsubj	2	SENT_224	[p14l81t3449r457b3527],
2	has	VBZ	O	have	_	0	SENT_224	[p14l482t3444r597b3507],
3	differential	JJ	O	differential	amod	4	SENT_224	[p14l624t3444r1011b3507],
4	effects	NNS	O	effect	dobj	2	SENT_224	[p14l1037t3444r1256b3507],
5	according	VBG	O	accord	_	0	SENT_224	[p14l1284t3444r1634b3528],
6	to	TO	O	to	prepc_according_to	2	SENT_224	[p14l1657t3456r1724b3507],
7	the	DT	O	the	det	9	SENT_224	[p14l1751t3444r1860b3507],
8	applied	VBN	O	apply	amod	9	SENT_224	[p14l1887t3444r2146b3527],
9	dose	NN	O	dose	pobj	2	SENT_224	[p14l8t3547r186b3610],
10	.	.	O	.	_	0	SENT_224	[p14l8t3547r186b3610],

1	At	IN	O	at	_	0	SENT_225	[p14l217t3551r300b3610],
2	low	JJ	O	low	amod	3	SENT_225	[p14l325t3547r454b3610],
3	dosages	NNS	O	dosage	prep_at	6	SENT_225	[p14l479t3547r774b3631],
4	,	,	O	,	_	0	SENT_225	[p14l479t3547r774b3631],
5	it	PRP	O	it	nsubj	6	SENT_225	[p14l804t3553r851b3610],
6	stimulates	VBZ	O	stimulate	_	0	SENT_225	[p14l879t3547r1240b3610],
7	dopaminergic	JJ	O	dopaminergic	amod	8	SENT_225	[p14l1269t3547r1767b3631],
8	receptors	NNS	O	receptor	dobj	6	SENT_225	[p14l1795t3559r2143b3630],
9	,	,	O	,	_	0	SENT_225	[p14l1795t3559r2143b3630],
10	thereby	RB	O	thereby	advmod	6	SENT_225	[p14l7t3650r267b3734],
11	increasing	VBG	O	increase	xcomp	6	SENT_225	[p14l286t3656r640b3734],
12	renal	JJ	O	renal	amod	14	SENT_225	[p14l660t3650r833b3713],
13	blood	NN	O	blood	nn	14	SENT_225	[p14l852t3650r1053b3713],
14	ﬂow	NN	O	ﬂow	dobj	11	SENT_225	[p14l1074t3650r1222b3713],
15	and	CC	O	and	_	0	SENT_225	[p14l1242t3650r1369b3713],
16	diuresis	NN	O	diuresis	dobj	11	SENT_225	[p14l1391t3650r1654b3713],
17	without	IN	O	without	_	0	SENT_225	[p14l1675t3650r1944b3713],
18	causing	VBG	O	cause	prepc_without	11	SENT_225	[p14l1966t3673r2141b3713, p15l8t26r116b104],

1	vasoconstriction	NN	O	vasoconstriction	nn	3	SENT_226	[p15l133t12r863b83],
2	.39	CD	NUMBER	.39	num	3	SENT_226	[p15l133t12r863b83],
3	’	NN	O	’	ccomp	11	SENT_226	[p15l133t12r863b83],
4	4	CD	NUMBER	4	number	5	SENT_226	[p15l133t12r863b83],
5	°	CD	NUMBER	°	dep	3	SENT_226	[p15l133t12r863b83],
6	Pathophysiologically	NNP	O	Pathophysiologically	dep	5	SENT_226	[p15l887t20r1601b104],
7	and	CC	O	and	cc	3	SENT_226	[p15l1620t20r1746b83],
8	pharmacologically	RB	O	pharmacologically	advmod	3	SENT_226	[p15l1767t20r2142b103, p15l6t123r300b207],
9	,	,	O	,	_	0	SENT_226	[p15l1767t20r2142b103, p15l6t123r300b207],
10	this	DT	O	this	nsubj	11	SENT_226	[p15l323t123r446b186],
11	makes	VBZ	O	make	_	0	SENT_226	[p15l468t123r682b186],
12	it	PRP	O	it	nsubj	15	SENT_226	[p15l705t129r750b186],
13	an	DT	O	a	det	15	SENT_226	[p15l771t146r850b186],
14	attractive	JJ	O	attractive	amod	15	SENT_226	[p15l873t129r1186b186],
15	drug	NN	O	drug	xcomp	11	SENT_226	[p15l1209t123r1370b207],
16	for	IN	O	for	_	0	SENT_226	[p15l1390t123r1486b186],
17	patients	NNS	O	patient	prep_for	15	SENT_226	[p15l1506t129r1772b206],
18	with	IN	O	with	_	0	SENT_226	[p15l1793t123r1944b186],
19	AHF	NN	O	ahf	prep_with	17	SENT_226	[p15l1965t127r2140b186],
20	.	.	O	.	_	0	SENT_226	[p15l1965t127r2140b186],

1	However	RB	O	however	advmod	9	SENT_227	[p15l8t231r334b298],
2	,	,	O	,	_	0	SENT_227	[p15l8t231r334b298],
3	until	IN	O	until	prep	9	SENT_227	[p15l358t226r522b289],
4	now	RB	DATE	now	pobj	3	SENT_227	[p15l545t249r705b298],
5	,	,	O	,	_	0	SENT_227	[p15l545t249r705b298],
6	few	JJ	O	few	amod	7	SENT_227	[p15l729t226r852b289],
7	data	NNS	O	datum	nsubj	9	SENT_227	[p15l873t226r1020b289],
8	were	VBD	O	be	cop	9	SENT_227	[p15l1040t249r1204b289],
9	available	JJ	O	available	_	0	SENT_227	[p15l1228t226r1528b289],
10	investigating	VBG	O	investigate	dep	9	SENT_227	[p15l1551t232r1997b310],
11	this	DT	O	this	det	13	SENT_227	[p15l2018t226r2144b289],
12	interesting	JJ	O	interesting	amod	13	SENT_227	[p15l8t335r384b413],
13	issue	NN	O	issue	dobj	10	SENT_227	[p15l408t335r594b392],
14	.	.	O	.	_	0	SENT_227	[p15l408t335r594b392],

1	In	IN	O	in	_	0	SENT_228	[p15l623t334r695b391],
2	the	DT	O	the	det	3	SENT_228	[p15l719t329r828b392],
3	Dopamine	NN	O	dopamine	prep_in	34	SENT_228	[p15l854t334r1228b412],
4	in	IN	O	in	_	0	SENT_228	[p15l1253t335r1321b391],
5	Acute	JJ	O	acute	amod	10	SENT_228	[p15l1345t333r1550b392],
6	Decompensated	JJ	O	decompensated	amod	10	SENT_228	[p15l1576t329r2145b412],
7	Heart	NNP	O	Heart	nn	10	SENT_228	[p15l8t437r210b495],
8	Failure	NN	O	failure	nn	10	SENT_228	[p15l235t432r479b495],
9	(	CD	NUMBER	(	num	10	SENT_228	[p15l509t432r896b509],
10	DAD-HF	NN	O	dad-hf	prep_in	3	SENT_228	[p15l509t432r896b509],
11	)	CD	NUMBER	)	num	12	SENT_228	[p15l509t432r896b509],
12	trial	NN	O	trial	dep	10	SENT_228	[p15l926t432r1090b504],
13	,	,	O	,	_	0	SENT_228	[p15l926t432r1090b504],
14	the	DT	O	the	det	15	SENT_228	[p15l1117t432r1227b495],
15	combination	NN	O	combination	nsubj	34	SENT_228	[p15l1254t432r1705b495],
16	of	IN	O	of	_	0	SENT_228	[p15l1732t432r1808b495],
17	low-dose	JJ	O	low-dose	amod	22	SENT_228	[p15l1823t432r2145b496],
18	furosemide	NN	O	furosemide	nn	22	SENT_228	[p15l7t535r392b598],
19	(	NN	O	(	nn	22	SENT_228	[p15l415t536r477b611],
20	5	CD	NUMBER	5	num	22	SENT_228	[p15l415t536r477b611],
21	mg/h	NN	O	mg/h	nn	22	SENT_228	[p15l492t535r698b619],
22	)	NN	O	)	prep_of	15	SENT_228	[p15l492t535r698b619],
23	and	CC	O	and	_	0	SENT_228	[p15l722t535r848b598],
24	low-dose	JJ	O	low-dose	amod	29	SENT_228	[p15l865t535r1173b598],
25	dopamine	NN	O	dopamine	nn	29	SENT_228	[p15l1193t535r1535b618],
26	(	NN	O	(	nn	29	SENT_228	[p15l1558t536r1620b611],
27	5	CD	NUMBER	5	num	29	SENT_228	[p15l1558t536r1620b611],
28	pg/kg/min	NN	O	pg/kg/min	nn	29	SENT_228	[p15l1645t535r2026b619],
29	)	NN	O	)	conj_and	22	SENT_228	[p15l1645t535r2026b619],
30	for	IN	O	for	_	0	SENT_228	[p15l2050t535r2146b598],
31	8	CD	NUMBER	8	num	32	SENT_228	[p15l9t645r44b701],
32	h	NN	O	h	prep_for	29	SENT_228	[p15l60t638r104b700],
33	was	VBD	O	be	cop	34	SENT_228	[p15l125t661r253b701],
34	superior	JJ	O	superior	_	0	SENT_228	[p15l279t644r571b721],
35	to	TO	O	to	_	0	SENT_228	[p15l591t650r658b701],
36	high	JJ	O	high	amod	39	SENT_228	[p15l682t638r1032b722],
37	—	NN	O	—	nn	39	SENT_228	[p15l682t638r1032b722],
38	dose	NN	O	dose	nn	39	SENT_228	[p15l682t638r1032b722],
39	furosemide	NN	O	furosemide	prep_to	34	SENT_228	[p15l1055t638r1452b701],
40	(	CD	NUMBER	(	number	41	SENT_228	[p15l1479t638r1585b715],
41	20	CD	NUMBER	20	num	43	SENT_228	[p15l1479t638r1585b715],
42	mg/h	NN	O	mg/h	nn	43	SENT_228	[p15l1601t638r1813b722],
43	)	NN	O	)	dobj	56	SENT_228	[p15l1601t638r1813b722],
44	with	IN	O	with	_	0	SENT_228	[p15l1838t638r1994b701],
45	rerespect	NN	O	rerespect	prep_with	43	SENT_228	[p15l2017t661r2141b701, p15l8t752r223b823],
46	to	TO	O	to	_	0	SENT_228	[p15l244t752r311b803],
47	renal	JJ	O	renal	amod	49	SENT_228	[p15l336t740r510b803],
48	function	NN	O	function	nn	49	SENT_228	[p15l532t740r830b803],
49	proﬁle	NN	O	proﬁle	prep_to	45	SENT_228	[p15l852t740r1077b823],
50	and	CC	O	and	_	0	SENT_228	[p15l1101t740r1229b803],
51	potassium	NN	O	potassium	nn	52	SENT_228	[p15l1250t746r1609b823],
52	homeostasis/11	NN	O	homeostasis/11	conj_and	49	SENT_228	[p15l1631t732r2140b803],
53	However	RB	O	however	advmod	56	SENT_228	[p15l8t848r323b915],
54	,	,	O	,	_	0	SENT_228	[p15l8t848r323b915],
55	there	EX	O	there	expl	56	SENT_228	[p15l343t843r514b906],
56	was	VBD	O	be	rcmod	39	SENT_228	[p15l532t866r657b906],
57	no	DT	O	no	det	58	SENT_228	[p15l677t866r762b906],
58	improvement	NN	O	improvement	nsubj	56	SENT_228	[p15l783t849r1240b926],
59	in	IN	O	in	_	0	SENT_228	[p15l1258t849r1324b905],
60	dyspnea	NN	O	dyspnea	prep_in	58	SENT_228	[p15l1344t843r1620b927],
61	or	CC	O	or	_	0	SENT_228	[p15l1639t866r1710b906],
62	hard	JJ	O	hard	amod	65	SENT_228	[p15l1727t843r1883b906],
63	clinical	JJ	O	clinical	amod	65	SENT_228	[p15l1902t843r2143b906],
64	end	NN	O	end	nn	65	SENT_228	[p15l8t945r133b1008],
65	points	NNS	O	point	conj_or	60	SENT_228	[p15l150t951r377b1028],
66	,	,	O	,	_	0	SENT_228	[p15l150t951r377b1028],
67	such	JJ	O	such	_	0	SENT_228	[p15l399t945r551b1008],
68	as	IN	O	as	_	0	SENT_228	[p15l572t968r635b1008],
69	60-day	JJ	DURATION	60-day	amod	70	SENT_228	[p15l656t945r887b1029],
70	mortality	NN	O	mortality	prep_such_as	39	SENT_228	[p15l903t945r1219b1029],
71	or	CC	O	or	_	0	SENT_228	[p15l1236t968r1307b1008],
72	rehospitalization	NN	O	rehospitalization	nn	73	SENT_228	[p15l1325t945r1889b1028],
73	rates	NNS	O	rate	prep_such_as	39	SENT_228	[p15l1909t937r2140b1008],
74	.	.	O	.	_	0	SENT_228	[p15l1909t937r2140b1008],

1	“	RB	O	“	advmod	14	SENT_229	[p15l1909t937r2140b1008],
2	As	IN	O	as	_	0	SENT_229	[p15l7t1052r90b1111],
3	a	DT	O	a	det	4	SENT_229	[p15l111t1071r144b1111],
4	limitation	NN	O	limitation	prep_as	14	SENT_229	[p15l160t1048r502b1120],
5	,	,	O	,	_	0	SENT_229	[p15l160t1048r502b1120],
6	the	DT	O	the	det	7	SENT_229	[p15l521t1048r624b1111],
7	doses	NNS	O	dose	nsubj	14	SENT_229	[p15l643t1048r821b1111],
8	chosen	VBN	O	choose	partmod	7	SENT_229	[p15l841t1048r1070b1111],
9	for	IN	O	for	_	0	SENT_229	[p15l1089t1048r1182b1111],
10	furosemide	NN	O	furosemide	prep_for	8	SENT_229	[p15l1200t1048r1573b1111],
11	were	VBD	O	be	cop	14	SENT_229	[p15l1590t1071r1745b1111],
12	higher	JJR	O	higher	dep	13	SENT_229	[p15l1763t1048r1978b1132],
13	than	IN	O	than	advmod	14	SENT_229	[p15l1994t1048r2143b1111],
14	usual	JJ	O	usual	_	0	SENT_229	[p15l7t1151r201b1223],
15	,	,	O	,	_	0	SENT_229	[p15l7t1151r201b1223],
16	and	CC	O	and	_	0	SENT_229	[p15l223t1151r348b1214],
17	dopamine	NN	O	dopamine	nsubjpass	19	SENT_229	[p15l367t1151r707b1234],
18	was	VBD	O	be	auxpass	19	SENT_229	[p15l724t1174r849b1214],
19	used	VBN	O	use	conj_and	14	SENT_229	[p15l869t1151r1025b1214],
20	at	IN	O	at	_	0	SENT_229	[p15l1044t1163r1103b1214],
21	a	DT	O	a	det	25	SENT_229	[p15l1122t1174r1156b1214],
22	dose	NN	O	dose	nn	25	SENT_229	[p15l1175t1151r1327b1214],
23	(	NN	O	(	nn	25	SENT_229	[p15l1350t1151r1411b1228],
24	5	CD	NUMBER	5	num	25	SENT_229	[p15l1350t1151r1411b1228],
25	pg	NN	O	pg	prep_at	19	SENT_229	[p15l1436t1155r1540b1235],
26	/	:	O	/	punct	27	SENT_229	[p15l1436t1155r1540b1235],
27	kg	NN	O	kg	dep	25	SENT_229	[p15l1543t1151r1650b1235],
28	/	:	O	/	punct	27	SENT_229	[p15l1543t1151r1650b1235],
29	min	NN	DURATION	min	nn	30	SENT_229	[p15l1654t1152r1815b1227],
30	)	NN	O	)	dobj	19	SENT_229	[p15l1654t1152r1815b1227],
31	with	IN	O	with	_	0	SENT_229	[p15l1837t1151r1988b1214],
32	predominant	JJ	O	predominant	amod	34	SENT_229	[p15l2006t1173r2141b1234, p15l8t1254r333b1317],
33	inotropic	JJ	O	inotropic	amod	34	SENT_229	[p15l351t1260r654b1337],
34	effects	NNS	O	effect	prep_with	30	SENT_229	[p15l673t1254r895b1326],
35	,	,	O	,	_	0	SENT_229	[p15l673t1254r895b1326],
36	according	VBG	O	accord	conj_and	14	SENT_229	[p15l916t1254r1243b1338],
37	to	TO	O	to	pcomp	36	SENT_229	[p15l1259t1266r1323b1317],
38	the	DT	O	the	det	39	SENT_229	[p15l1342t1254r1445b1317],
39	majority	NN	O	majority	pobj	37	SENT_229	[p15l1463t1260r1746b1338],
40	of	IN	O	of	_	0	SENT_229	[p15l1762t1254r1834b1317],
41	the	DT	O	the	det	43	SENT_229	[p15l1842t1254r1945b1317],
42	available	JJ	O	available	amod	43	SENT_229	[p15l1965t1254r2141b1317, p15l8t1357r141b1420],
43	literature	NN	O	literature	prep_of	39	SENT_229	[p15l162t1357r486b1420],
44	.	.	O	.	_	0	SENT_229	[p15l162t1357r486b1420],

1	The	DT	O	the	nsubj	2	SENT_230	[p15l510t1357r635b1420],
2	follow	VBP	O	follow	dep	12	SENT_230	[p15l657t1357r984b1440],
3	—	CD	NUMBER	—	dobj	2	SENT_230	[p15l657t1357r984b1440],
4	up	IN	O	up	_	0	SENT_230	[p15l657t1357r984b1440],
5	DAD-HF	NN	O	dad-hf	nn	7	SENT_230	[p15l1008t1361r1327b1419],
6	II	CD	NUMBER	ii	num	7	SENT_230	[p15l1350t1362r1403b1419],
7	trial	NN	O	trial	prep_up	2	SENT_230	[p15l1425t1357r1565b1420],
8	(	CD	NUMBER	(	num	10	SENT_230	[p15l1589t1358r2139b1434],
9	NCTO1060293	NN	O	ncto1060293	nn	10	SENT_230	[p15l1589t1358r2139b1434],
10	)	NN	O	)	nsubjpass	12	SENT_230	[p15l1589t1358r2139b1434],
11	was	VBD	O	be	auxpass	12	SENT_230	[p15l6t1483r132b1523],
12	designed	VBN	O	design	_	0	SENT_230	[p15l155t1460r459b1544],
13	to	TO	O	to	aux	14	SENT_230	[p15l479t1472r545b1523],
14	compare	VB	O	compare	xcomp	12	SENT_230	[p15l569t1482r864b1543],
15	low-dose	JJ	O	low-dose	amod	16	SENT_230	[p15l885t1460r1195b1523],
16	dopamine	NN	O	dopamine	dobj	14	SENT_230	[p15l1218t1460r1580b1543],
17	,	,	O	,	_	0	SENT_230	[p15l1218t1460r1580b1543],
18	high	JJ	O	high	amod	21	SENT_230	[p15l1603t1460r1946b1544],
19	—	NN	O	—	nn	21	SENT_230	[p15l1603t1460r1946b1544],
20	dose	NN	O	dose	nn	21	SENT_230	[p15l1603t1460r1946b1544],
21	furosemide	NN	O	furosemide	dobj	14	SENT_230	[p15l1968t1460r2141b1523, p15l8t1562r266b1634],
22	,	,	O	,	_	0	SENT_230	[p15l1968t1460r2141b1523, p15l8t1562r266b1634],
23	and	CC	O	and	_	0	SENT_230	[p15l290t1562r416b1626],
24	the	DT	O	the	det	25	SENT_230	[p15l436t1562r542b1626],
25	combination	NN	O	combination	dobj	14	SENT_230	[p15l565t1562r998b1626],
26	of	IN	O	of	_	0	SENT_230	[p15l1020t1562r1094b1626],
27	low-dose	JJ	O	low-dose	amod	28	SENT_230	[p15l1105t1562r1415b1626],
28	furosemide	NN	O	furosemide	prep_of	25	SENT_230	[p15l1437t1562r1824b1626],
29	and	CC	O	and	_	0	SENT_230	[p15l1847t1562r1973b1626],
30	lowdose	NN	O	lowdose	nn	31	SENT_230	[p15l1993t1562r2141b1626, p15l8t1666r161b1729],
31	dopamine	NN	O	dopamine	prep_of	25	SENT_230	[p15l181t1666r522b1749],
32	on	IN	O	on	_	0	SENT_230	[p15l542t1689r628b1729],
33	clinical	JJ	O	clinical	amod	34	SENT_230	[p15l648t1666r889b1729],
34	outcomes	NNS	O	outcome	prep_on	14	SENT_230	[p15l908t1678r1232b1729],
35	of	IN	O	of	_	0	SENT_230	[p15l1253t1666r1326b1729],
36	AHF	NN	ORGANIZATION	ahf	nn	37	SENT_230	[p15l1335t1670r1501b1728],
37	patients	NNS	O	patient	prep_of	34	SENT_230	[p15l1521t1672r1803b1749],
38	.	.	O	.	_	0	SENT_230	[p15l1521t1672r1803b1749],

1	However	RB	O	however	advmod	10	SENT_231	[p15l1827t1671r2142b1738],
2	,	,	O	,	_	0	SENT_231	[p15l1827t1671r2142b1738],
3	the	DT	O	the	det	5	SENT_231	[p15l7t1768r115b1831],
4	recruitment	NN	O	recruitment	nn	5	SENT_231	[p15l139t1774r555b1831],
5	status	NN	O	status	nsubj	10	SENT_231	[p15l578t1780r773b1831],
6	of	IN	O	of	_	0	SENT_231	[p15l798t1768r873b1831],
7	this	DT	O	this	det	8	SENT_231	[p15l885t1768r1012b1831],
8	trial	NN	O	trial	prep_of	5	SENT_231	[p15l1034t1768r1178b1831],
9	is	VBZ	O	be	cop	10	SENT_231	[p15l1200t1774r1251b1831],
10	unknown	JJ	O	unknown	_	0	SENT_231	[p15l1275t1768r1628b1831],
11	.	.	O	.	_	0	SENT_231	[p15l1275t1768r1628b1831],

1	As	IN	O	as	mark	2	SENT_232	[p15l1653t1772r1741b1831],
2	mentioned	VBN	O	mention	advcl	9	SENT_232	[p15l1765t1768r2145b1831],
3	above	IN	O	above	prep	2	SENT_232	[p15l8t1871r228b1943],
4	,	,	O	,	_	0	SENT_232	[p15l8t1871r228b1943],
5	the	DT	O	the	det	7	SENT_232	[p15l253t1871r362b1934],
6	ROSE-AHF	NN	MISC	rose-ahf	nn	7	SENT_232	[p15l388t1875r802b1934],
7	trial	NN	O	trial	nsubj	9	SENT_232	[p15l827t1871r972b1934],
8	will	MD	O	will	aux	9	SENT_232	[p15l994t1871r1124b1934],
9	compare	VB	O	compare	_	0	SENT_232	[p15l1149t1893r1451b1954],
10	the	DT	O	the	det	11	SENT_232	[p15l1475t1871r1584b1934],
11	effects	NNS	O	effect	dobj	9	SENT_232	[p15l1610t1871r1828b1934],
12	of	IN	O	of	_	0	SENT_232	[p15l1854t1871r1929b1934],
13	nesir	NN	O	nesir	nn	15	SENT_232	[p15l1944t1877r2141b1934],
14	—	NN	O	—	nn	15	SENT_232	[p15l1944t1877r2141b1934],
15	itide	NN	O	itide	prep_of	11	SENT_232	[p15l8t1974r169b2046],
16	,	,	O	,	_	0	SENT_232	[p15l8t1974r169b2046],
17	low-dose	JJ	O	low-dose	amod	19	SENT_232	[p15l189t1974r490b2037],
18	dopamine	NN	O	dopamine	nn	19	SENT_232	[p15l509t1974r844b2057],
19	(	NN	O	(	dobj	9	SENT_232	[p15l867t1975r927b2050],
20	2	CD	NUMBER	2	num	21	SENT_232	[p15l867t1975r927b2050],
21	ug	NN	O	ug	dep	19	SENT_232	[p15l951t1978r1053b2058],
22	/	:	O	/	punct	23	SENT_232	[p15l951t1978r1053b2058],
23	kg	NN	O	kg	dep	21	SENT_232	[p15l1056t1974r1162b2058],
24	/	:	O	/	punct	23	SENT_232	[p15l1056t1974r1162b2058],
25	min	NN	DURATION	min	nn	26	SENT_232	[p15l1166t1974r1346b2051],
26	)	NN	O	)	dep	19	SENT_232	[p15l1166t1974r1346b2051],
27	,	,	O	,	_	0	SENT_232	[p15l1166t1974r1346b2051],
28	and	CC	O	and	_	0	SENT_232	[p15l1367t1974r1490b2037],
29	placebo	NN	O	placebo	dobj	9	SENT_232	[p15l1507t1974r1761b2057],
30	in	IN	O	in	_	0	SENT_232	[p15l1781t1980r1846b2036],
31	addition	NN	O	addition	prep_in	29	SENT_232	[p15l1865t1974r2144b2037],
32	to	TO	O	to	_	0	SENT_232	[p15l7t2089r73b2140],
33	standard	JJ	O	standard	amod	35	SENT_232	[p15l97t2077r395b2140],
34	diuretic	JJ	O	diuretic	amod	35	SENT_232	[p15l416t2077r679b2140],
35	therapy	NN	O	therapy	prep_to	9	SENT_232	[p15l700t2077r962b2161],
36	in	IN	O	in	_	0	SENT_232	[p15l981t2083r1047b2139],
37	AHF	NN	ORGANIZATION	ahf	nn	38	SENT_232	[p15l1068t2081r1236b2139],
38	patients	NNS	O	patient	prep_in	35	SENT_232	[p15l1259t2083r1544b2160],
39	.	.	O	.	_	0	SENT_232	[p15l1259t2083r1544b2160],

1	According	VBG	O	accord	_	0	SENT_233	[p15l1568t2077r1928b2161],
2	to	TO	O	to	pcomp	1	SENT_233	[p15l1947t2089r2013b2140],
3	the	DT	O	the	det	5	SENT_233	[p15l2035t2077r2142b2140],
4	current	JJ	DATE	current	amod	5	SENT_233	[p15l8t2192r258b2243],
5	guidelines	NNS	O	guideline	pobj	2	SENT_233	[p15l278t2180r641b2264],
6	,	,	O	,	_	0	SENT_233	[p15l278t2180r641b2264],
7	the	DT	O	the	det	8	SENT_233	[p15l663t2180r768b2243],
8	use	NN	O	use	appos	5	SENT_233	[p15l790t2203r900b2243],
9	of	IN	O	of	_	0	SENT_233	[p15l923t2180r996b2243],
10	dopamine	NN	O	dopamine	prep_of	8	SENT_233	[p15l1009t2180r1351b2263],
11	remains	VBZ	O	remain	cop	13	SENT_233	[p15l1373t2186r1643b2243],
12	a	DT	O	a	det	13	SENT_233	[p15l1666t2203r1700b2243],
13	case-by-case	JJ	O	case-by-case	dep	10	SENT_233	[p15l1722t2180r2144b2264],

1	504	CD	NUMBER	504	num	2	SENT_234	[p15l8t2400r105b2442],
2	decision	NN	O	decision	_	0	SENT_234	[p15l9t2482r285b2545],
3	(	CD	NUMBER	(	num	6	SENT_234	[p15l308t2482r911b2559],
4	recommendation	NN	O	recommendation	nn	6	SENT_234	[p15l308t2482r911b2559],
5	class	NN	O	class	nn	6	SENT_234	[p15l931t2482r1081b2545],
6	Ilb	NN	O	ilb	dep	2	SENT_234	[p15l1101t2482r1212b2554],
7	,	,	O	,	_	0	SENT_234	[p15l1101t2482r1212b2554],
8	evidence	NN	O	evidence	nn	11	SENT_234	[p15l1233t2482r1525b2545],
9	level	NN	O	level	nn	11	SENT_234	[p15l1543t2482r1695b2545],
10	C	NN	O	c	nn	11	SENT_234	[p15l1714t2483r1791b2559],
11	)	NN	O	)	appos	6	SENT_234	[p15l1714t2483r1791b2559],
12	due	JJ	O	due	_	0	SENT_234	[p15l1815t2482r1935b2545],
13	to	TO	O	to	_	0	SENT_234	[p15l1954t2494r2018b2545],
14	the	DT	O	the	det	15	SENT_234	[p15l2038t2482r2142b2545],
15	gap	NN	O	gap	prep_due_to	11	SENT_234	[p15l8t2607r126b2669],
16	of	IN	O	of	_	0	SENT_234	[p15l150t2585r224b2648],
17	evidence	NN	O	evidence	prep_of	15	SENT_234	[p15l237t2585r552b2648],
18	.	.	O	.	_	0	SENT_234	[p15l237t2585r552b2648],

1	In	IN	O	in	_	0	SENT_235	[p15l578t2590r649b2647],
2	large	JJ	O	large	amod	3	SENT_235	[p15l670t2585r835b2669],
3	doses	NNS	O	dose	prep_in	6	SENT_235	[p15l858t2585r1062b2657],
4	,	,	O	,	_	0	SENT_235	[p15l858t2585r1062b2657],
5	dopamine	NN	O	dopamine	nsubj	6	SENT_235	[p15l1087t2585r1433b2668],
6	exerts	VBZ	O	exert	_	0	SENT_235	[p15l1455t2597r1655b2648],
7	inotropic	JJ	O	inotropic	amod	10	SENT_235	[p15l1678t2591r1993b2668],
8	and	CC	O	and	_	0	SENT_235	[p15l2016t2585r2143b2648],
9	vasopressor	NN	O	vasopressor	amod	10	SENT_235	[p15l6t2710r411b2771],
10	activities	NNS	O	activity	dobj	6	SENT_235	[p15l433t2694r750b2751],
11	.	.	O	.	_	0	SENT_235	[p15l433t2694r750b2751],

1	Beyond	IN	O	beyond	_	0	SENT_236	[p15l776t2688r1039b2772],
2	this	DT	O	this	prep_beyond	5	SENT_236	[p15l1059t2688r1202b2760],
3	,	,	O	,	_	0	SENT_236	[p15l1059t2688r1202b2760],
4	dopamine	NN	O	dopamine	nsubj	9	SENT_236	[p15l1227t2688r1573b2771],
5	depresses	VBZ	O	depress	_	0	SENT_236	[p15l1596t2688r1918b2771],
6	ventilation	NN	O	ventilation	dobj	5	SENT_236	[p15l1938t2694r2137b2751, p15l7t2791r204b2854],
7	and	CC	O	and	_	0	SENT_236	[p15l227t2791r353b2854],
8	might	MD	O	might	aux	9	SENT_236	[p15l375t2791r579b2875],
9	cause	VB	O	cause	conj_and	5	SENT_236	[p15l601t2814r785b2854],
10	hypoxemia	NN	O	hypoxemia	dobj	9	SENT_236	[p15l806t2791r1188b2875],
11	by	IN	O	by	_	0	SENT_236	[p15l1207t2791r1291b2875],
12	attenuating	VBG	O	attenuate	amod	14	SENT_236	[p15l1311t2797r1698b2875],
13	chemoreﬂex	NN	O	chemoreﬂex	nn	14	SENT_236	[p15l1719t2791r2142b2854],
14	responses	NNS	O	response	prep_by	9	SENT_236	[p15l9t2915r347b2976],
15	,	,	O	,	_	0	SENT_236	[p15l9t2915r347b2976],
16	especially	RB	O	especially	advmod	17	SENT_236	[p15l369t2893r690b2977],
17	when	WRB	O	when	advmod	28	SENT_236	[p15l704t2893r887b2956],
18	used	VBN	O	use	partmod	28	SENT_236	[p15l906t2893r1060b2956],
19	in	IN	O	in	_	0	SENT_236	[p15l1079t2899r1143b2955],
20	hypoxic	JJ	O	hypoxic	amod	21	SENT_236	[p15l1162t2893r1424b2977],
21	patients/12	NN	O	patients/12	prep_in	18	SENT_236	[p15l1442t2885r1784b2976],
22	Therefore	RB	O	therefore	advmod	18	SENT_236	[p15l1803t2893r2140b2965],
23	,	,	O	,	_	0	SENT_236	[p15l1803t2893r2140b2965],
24	oxygen	NN	O	oxygen	nn	25	SENT_236	[p15l9t3019r249b3080],
25	saturation	NN	O	saturation	nsubjpass	28	SENT_236	[p15l271t3002r610b3059],
26	should	MD	O	should	aux	28	SENT_236	[p15l632t2996r860b3059],
27	be	VB	O	be	auxpass	28	SENT_236	[p15l878t2996r957b3059],
28	monitored	VBN	O	monitor	dep	14	SENT_236	[p15l977t2996r1351b3059],
29	.	.	O	.	_	0	SENT_236	[p15l977t2996r1351b3059],

1	NEW	JJ	O	new	amod	2	SENT_237	[p15l12t3211r175b3265],
2	TARGETS	NNS	O	target	_	0	SENT_237	[p15l188t3211r511b3266],
3	IN	IN	O	in	_	0	SENT_237	[p15l532t3211r601b3265],
4	SYSTOLIC	NN	O	systolic	nn	5	SENT_237	[p15l623t3210r966b3266],
5	HF	NNS	O	hf	prep_in	2	SENT_237	[p15l987t3211r1076b3265],

1	Vasopressin	NNP	O	Vasopressin	_	0	SENT_238	[p15l7t3312r451b3384],
2	-	:	O	-	_	0	SENT_238	[p15l7t3312r451b3384],
3	receptor	NN	O	receptor	nn	4	SENT_238	[p15l469t3319r762b3384],
4	antagonists	NNS	O	antagonist	dep	1	SENT_238	[p15l777t3312r1187b3385],

1	Elevation	NN	O	elevation	nsubjpass	5	SENT_239	[p16l8t19r323b82],
2	of	IN	O	of	_	0	SENT_239	[p16l344t19r416b82],
3	vasopressin	NN	O	vasopressin	prep_of	1	SENT_239	[p16l424t25r814b102],
4	is	VBZ	O	be	auxpass	5	SENT_239	[p16l833t25r882b82],
5	thought	VBN	O	think	_	0	SENT_239	[p16l902t19r1169b103],
6	to	TO	O	to	aux	7	SENT_239	[p16l1186t31r1251b82],
7	represent	VB	O	represent	xcomp	5	SENT_239	[p16l1272t31r1584b102],
8	one	CD	NUMBER	one	dobj	7	SENT_239	[p16l1603t42r1723b82],
9	of	IN	O	of	_	0	SENT_239	[p16l1743t19r1816b82],
10	the	DT	O	the	det	12	SENT_239	[p16l1825t19r1929b82],
11	maladaptive	JJ	O	maladaptive	amod	12	SENT_239	[p16l1949t19r2139b82, p16l9t122r256b205],
12	responses	NNS	O	response	prep_of	8	SENT_239	[p16l277t144r607b205],
13	in	IN	O	in	_	0	SENT_239	[p16l628t128r695b184],
14	patients	NNS	O	patient	prep_in	7	SENT_239	[p16l714t128r983b205],
15	with	IN	O	with	_	0	SENT_239	[p16l1002t122r1155b185],
16	AHF	NN	O	ahf	prep_with	14	SENT_239	[p16l1174t126r1350b185],
17	.	.	O	.	_	0	SENT_239	[p16l1174t126r1350b185],

1	Tolvaptan	NNP	MISC	Tolvaptan	nsubj	7	SENT_240	[p16l1373t122r1710b205],
2	is	VBZ	O	be	cop	7	SENT_240	[p16l1731t128r1781b185],
3	a	DT	O	a	det	7	SENT_240	[p16l1803t145r1837b185],
4	selective	JJ	O	selective	amod	7	SENT_240	[p16l1857t122r2143b185],
5	vasopressin	NN	O	vasopressin	nn	7	SENT_240	[p16l6t231r403b308],
6	V2-receptor	NN	O	v2-receptor	nn	7	SENT_240	[p16l425t230r843b308],
7	antagonist	NN	O	antagonist	_	0	SENT_240	[p16l865t231r1219b309],
8	which	WDT	O	which	dobj	10	SENT_240	[p16l1239t225r1448b288],
9	that	WDT	O	that	nsubj	10	SENT_240	[p16l1470t225r1604b288],
10	acts	VBZ	O	act	rcmod	7	SENT_240	[p16l1626t237r1753b288],
11	on	IN	O	on	_	0	SENT_240	[p16l1777t248r1863b288],
12	the	DT	O	the	det	14	SENT_240	[p16l1885t225r1991b288],
13	distal	JJ	O	distal	amod	14	SENT_240	[p16l2015t225r2138b288, p16l7t328r92b391],
14	nephron	NN	O	nephron	prep_on	10	SENT_240	[p16l114t328r425b411],
15	,	,	O	,	_	0	SENT_240	[p16l114t328r425b411],
16	causing	VBG	O	cause	xcomp	10	SENT_240	[p16l450t334r709b412],
17	loss	NN	O	loss	dobj	16	SENT_240	[p16l729t328r855b391],
18	of	IN	O	of	_	0	SENT_240	[p16l879t328r953b391],
19	electrolyte-free	JJ	O	electrolyte-free	amod	20	SENT_240	[p16l967t328r1483b412],
20	water	NN	O	water	prep_of	17	SENT_240	[p16l1504t340r1704b391],
21	.	.	O	.	_	0	SENT_240	[p16l1504t340r1704b391],

1	In	IN	O	in	_	0	SENT_241	[p16l1730t333r1801b390],
2	the	DT	O	the	prep_in	18	SENT_241	[p16l1823t328r1929b391],
3	randomized	VBN	O	randomize	partmod	2	SENT_241	[p16l1953t328r2138b391, p16l9t431r278b503],
4	,	,	O	,	_	0	SENT_241	[p16l1953t328r2138b391, p16l9t431r278b503],
5	placebo-controlled	JJ	O	placebo-controlled	amod	7	SENT_241	[p16l301t431r951b514],
6	Endovascular	JJ	O	endovascular	amod	7	SENT_241	[p16l973t431r1440b494],
7	Valve	NN	O	valve	nsubjpass	18	SENT_241	[p16l1460t431r1645b494],
8	Edge	NNP	O	Edge	dep	7	SENT_241	[p16l1668t431r2140b515],
9	—	CD	NUMBER	—	num	14	SENT_241	[p16l1668t431r2140b515],
10	to-Edge	JJ	MISC	to-edge	amod	14	SENT_241	[p16l1668t431r2140b515],
11	Repair	JJ	MISC	repair	amod	14	SENT_241	[p16l9t539r240b617],
12	study	NN	O	study	nn	14	SENT_241	[p16l263t534r454b618],
13	EVEREST	NN	O	everest	nn	14	SENT_241	[p16l474t537r832b597],
14	trial	NN	O	trial	dep	7	SENT_241	[p16l855t534r1017b606],
15	,	,	O	,	_	0	SENT_241	[p16l855t534r1017b606],
16	tolvaptan	NN	O	tolvaptan	appos	14	SENT_241	[p16l1041t534r1369b617],
17	was	VBD	O	be	auxpass	18	SENT_241	[p16l1391t557r1520b597],
18	given	VBN	O	give	_	0	SENT_241	[p16l1544t540r1731b618],
19	in	IN	O	in	_	0	SENT_241	[p16l1755t540r1823b596],
20	addition	NN	O	addition	prep_in	18	SENT_241	[p16l1847t534r2142b597],
21	to	TO	O	to	_	0	SENT_241	[p16l7t649r75b700],
22	standard	JJ	O	standard	amod	23	SENT_241	[p16l102t637r410b700],
23	treatment	NN	O	treatment	prep_to	18	SENT_241	[p16l433t649r780b700],
24	to	TO	O	to	_	0	SENT_241	[p16l802t649r870b700],
25	patients	NNS	O	patient	prep_to	18	SENT_241	[p16l895t643r1174b720],
26	with	IN	O	with	_	0	SENT_241	[p16l1197t637r1355b700],
27	acute	JJ	O	acute	amod	29	SENT_241	[p16l1380t649r1563b700],
28	decompensated	JJ	O	decompensated	amod	29	SENT_241	[p16l1589t637r2142b720],
29	HF	NN	O	hf	prep_with	25	SENT_241	[p16l9t745r126b803],
30	.	.	O	.	_	0	SENT_241	[p16l9t745r126b803],

1	Tolvaptan	NNP	O	Tolvaptan	nsubj	10	SENT_242	[p16l154t740r502b823],
2	reduced	VBD	O	reduce	_	0	SENT_242	[p16l526t740r809b803],
3	many	JJ	O	many	amod	4	SENT_242	[p16l831t763r1029b824],
4	signs	NNS	O	sign	dobj	2	SENT_242	[p16l1050t746r1224b824],
5	and	CC	O	and	_	0	SENT_242	[p16l1249t740r1379b803],
6	symptoms	NNS	O	symptom	conj_and	4	SENT_242	[p16l1403t752r1763b824],
7	of	IN	O	of	_	0	SENT_242	[p16l1788t740r1864b803],
8	HF	NN	O	hf	prep_of	4	SENT_242	[p16l1879t745r1987b802],
9	and	CC	O	and	_	0	SENT_242	[p16l2013t740r2143b803],
10	improved	VBD	O	improve	conj_and	2	SENT_242	[p16l8t843r340b926],
11	hyponatremia	NN	O	hyponatremia	dobj	10	SENT_242	[p16l361t843r845b927],
12	without	IN	O	without	_	0	SENT_242	[p16l865t843r1135b906],
13	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_242	[p16l1157t843r1515b927],
14	adverse	JJ	O	adverse	amod	15	SENT_242	[p16l1537t843r1793b906],
15	effects	NNS	O	effect	prep_without	10	SENT_242	[p16l1817t843r2030b906],
16	on	IN	O	on	_	0	SENT_242	[p16l2054t866r2141b906],
17	blood	NN	O	blood	nn	18	SENT_242	[p16l6t945r212b1008],
18	pressure	NN	O	pressure	prep_on	10	SENT_242	[p16l234t967r529b1028],
19	or	CC	O	or	_	0	SENT_242	[p16l553t968r627b1008],
20	renal	JJ	O	renal	amod	21	SENT_242	[p16l651t945r827b1008],
21	function	NN	O	function	prep_on	10	SENT_242	[p16l851t937r1318b1008],
22	.43	CD	NUMBER	.43	num	21	SENT_242	[p16l851t937r1318b1008],
23	*	CD	NUMBER	*	num	24	SENT_242	[p16l851t937r1318b1008],
24	44	CD	NUMBER	44	dobj	2	SENT_242	[p16l851t937r1318b1008],
25	However	RB	O	however	advmod	2	SENT_242	[p16l1342t950r1671b1017],
26	,	,	O	,	_	0	SENT_242	[p16l1342t950r1671b1017],
27	there	EX	O	there	expl	28	SENT_242	[p16l1696t945r1875b1008],
28	was	VBD	O	be	ccomp	2	SENT_242	[p16l1898t968r2028b1008],
29	no	DT	O	no	det	31	SENT_242	[p16l2052t968r2141b1008],
30	signiﬁcant	JJ	O	signiﬁcant	amod	31	SENT_242	[p16l9t1048r369b1132],
31	beneﬁt	NN	O	beneﬁt	nsubj	28	SENT_242	[p16l389t1048r628b1111],
32	with	IN	O	with	_	0	SENT_242	[p16l648t1048r803b1111],
33	respect	NN	O	respect	prep_with	31	SENT_242	[p16l826t1060r1073b1131],
34	to	TO	O	to	_	0	SENT_242	[p16l1093t1060r1160b1111],
35	mortality	NN	O	mortality	prep_to	28	SENT_242	[p16l1184t1048r1511b1132],
36	or	CC	O	or	_	0	SENT_242	[p16l1531t1071r1604b1111],
37	hospitalization	NN	O	hospitalization	prep_to	28	SENT_242	[p16l1624t1048r2140b1131],
38	rate	NN	O	rate	nn	40	SENT_242	[p16l9t1142r216b1213],
39	.45	CD	NUMBER	.45	num	40	SENT_242	[p16l9t1142r216b1213],
40	Currently	NNP	DATE	Currently	dep	35	SENT_242	[p16l238t1150r581b1234],
41	,	,	O	,	_	0	SENT_242	[p16l238t1150r581b1234],
42	according	VBG	O	accord	_	0	SENT_242	[p16l604t1150r942b1234],
43	to	TO	O	to	prepc_according_to	28	SENT_242	[p16l960t1162r1025b1213],
44	the	DT	O	the	det	45	SENT_242	[p16l1046t1150r1152b1213],
45	guidelines	NNS	O	guideline	pobj	28	SENT_242	[p16l1173t1150r1539b1234],
46	,	,	O	,	_	0	SENT_242	[p16l1173t1150r1539b1234],
47	tolvaptan	NN	O	tolvaptan	nsubjpass	50	SENT_242	[p16l1561t1150r1880b1233],
48	may	MD	O	may	aux	50	SENT_242	[p16l1900t1173r2047b1234],
49	be	VB	O	be	auxpass	50	SENT_242	[p16l2062t1150r2141b1213],
50	used	VBN	O	use	ccomp	2	SENT_242	[p16l8t1252r167b1315],
51	for	IN	O	for	_	0	SENT_242	[p16l188t1252r286b1315],
52	the	DT	O	the	det	53	SENT_242	[p16l307t1252r414b1315],
53	treatment	NN	O	treatment	prep_for	50	SENT_242	[p16l436t1264r773b1315],
54	of	IN	O	of	_	0	SENT_242	[p16l795t1252r869b1315],
55	severe	JJ	O	severe	amod	56	SENT_242	[p16l883t1275r1093b1315],
56	hyponatremia	NN	O	hyponatremia	prep_of	53	SENT_242	[p16l1115t1244r1678b1336],
57	.45	CD	NUMBER	.45	num	61	SENT_242	[p16l1115t1244r1678b1336],
58	Main	NNP	O	Main	nn	61	SENT_242	[p16l1702t1257r1882b1315],
59	known	JJ	O	known	amod	61	SENT_242	[p16l1903t1252r2142b1315],
60	side	NN	O	side	nn	61	SENT_242	[p16l9t1355r141b1418],
61	effects	NNS	O	effect	nsubj	63	SENT_242	[p16l163t1355r375b1418],
62	are	VBP	O	be	cop	63	SENT_242	[p16l398t1378r498b1418],
63	thirst	NN	O	thirst	rcmod	56	SENT_242	[p16l519t1355r703b1418],
64	and	CC	O	and	_	0	SENT_242	[p16l723t1355r849b1418],
65	dehydration	NN	O	dehydration	conj_and	63	SENT_242	[p16l871t1355r1302b1439],
66	.	.	O	.	_	0	SENT_242	[p16l871t1355r1302b1439],

1	The	DT	O	the	det	3	SENT_243	[p16l7t1568r134b1625],
2	adenosine	NN	O	adenosine	nn	3	SENT_243	[p16l150t1567r511b1625],
3	A1	NN	O	a1	_	0	SENT_243	[p16l527t1570r608b1624],
4	-	:	O	-	_	0	SENT_243	[p16l623t1575r943b1640],
5	receptor	NN	O	receptor	nn	8	SENT_243	[p16l623t1575r943b1640],
6	antagonist	NN	O	antagonist	nn	8	SENT_243	[p16l959t1568r1334b1641],
7	rolofylline	NN	O	rolofylline	nn	8	SENT_243	[p16l1353t1567r1708b1641],
8	Adenosine	NNP	LOCATION	Adenosine	nsubjpass	10	SENT_243	[p16l7t1665r366b1728],
9	is	VBZ	O	be	auxpass	10	SENT_243	[p16l387t1671r436b1728],
10	thought	VBN	O	think	dep	3	SENT_243	[p16l456t1665r722b1749],
11	to	TO	O	to	aux	15	SENT_243	[p16l741t1677r805b1728],
12	be	VB	O	be	cop	15	SENT_243	[p16l825t1665r903b1728],
13	an	DT	O	a	det	15	SENT_243	[p16l925t1688r1004b1728],
14	important	JJ	O	important	amod	15	SENT_243	[p16l1024t1671r1364b1748],
15	mediator	NN	O	mediator	xcomp	10	SENT_243	[p16l1383t1665r1688b1728],
16	of	IN	O	of	_	0	SENT_243	[p16l1708t1665r1781b1728],
17	worsening	VBG	O	worsen	amod	19	SENT_243	[p16l1790t1671r2142b1749],
18	renal	JJ	O	renal	amod	19	SENT_243	[p16l9t1767r174b1830],
19	function	NN	O	function	prep_of	15	SENT_243	[p16l192t1767r475b1830],
20	and	CC	O	and	_	0	SENT_243	[p16l494t1767r617b1830],
21	diuretic	JJ	O	diuretic	amod	22	SENT_243	[p16l634t1767r888b1830],
22	resistance	NN	O	resistance	conj_and	19	SENT_243	[p16l907t1773r1228b1830],
23	in	IN	O	in	_	0	SENT_243	[p16l1246t1773r1311b1829],
24	HF	NN	O	hf	prep_in	22	SENT_243	[p16l1330t1772r1442b1830],
25	.	.	O	.	_	0	SENT_243	[p16l1330t1772r1442b1830],

1	Via	NNP	O	Via	_	0	SENT_244	[p16l1461t1772r1575b1830],
2	stimulation	NN	O	stimulation	dep	1	SENT_244	[p16l1593t1767r1970b1830],
3	of	IN	O	of	_	0	SENT_244	[p16l1989t1767r2061b1830],
4	its	PRP$	O	its	prep_of	2	SENT_244	[p16l2069t1773r2142b1830],

1	A1	NN	O	a1	dep	125	SENT_245	[p16l7t1874r98b1932],
2	receptor	NN	O	receptor	dep	125	SENT_245	[p16l124t1882r409b1953],
3	,	,	O	,	_	0	SENT_245	[p16l124t1882r409b1953],
4	adenosine	NN	LOCATION	adenosine	dep	125	SENT_245	[p16l431t1870r765b1933],
5	reduces	VBZ	O	reduce	dep	125	SENT_245	[p16l785t1870r1037b1933],
6	the	DT	O	the	dep	125	SENT_245	[p16l1056t1870r1159b1933],
7	glomerular	JJ	O	glomerular	dep	125	SENT_245	[p16l1179t1870r1549b1954],
8	ﬁltration	NN	O	ﬁltration	dep	125	SENT_245	[p16l1567t1870r1856b1933],
9	rate	NN	O	rate	dep	125	SENT_245	[p16l1876t1882r1998b1933],
10	and	CC	O	and	dep	125	SENT_245	[p16l2019t1870r2143b1933],
11	stimulates	VBZ	O	stimulate	dep	125	SENT_245	[p16l9t1972r343b2035],
12	renin	NN	O	renin	dep	125	SENT_245	[p16l364t1978r541b2035],
13	release	NN	O	release	dep	125	SENT_245	[p16l561t1964r954b2035],
14	.46	CD	NUMBER	.46	dep	125	SENT_245	[p16l561t1964r954b2035],
15	‘	CD	NUMBER	‘	dep	125	SENT_245	[p16l561t1964r954b2035],
16	48	CD	NUMBER	48	dep	125	SENT_245	[p16l561t1964r954b2035],
17	In	IN	O	in	dep	125	SENT_245	[p16l976t1977r1046b2034],
18	a	DT	O	a	dep	125	SENT_245	[p16l1067t1995r1101b2035],
19	phase	NN	O	phase	dep	125	SENT_245	[p16l1119t1972r1309b2055],
20	II	CD	NUMBER	ii	dep	125	SENT_245	[p16l1330t1977r1382b2034],
21	study	NN	O	study	dep	125	SENT_245	[p16l1404t1972r1593b2056],
22	,	,	O	,	_	0	SENT_245	[p16l1404t1972r1593b2056],
23	the	DT	O	the	dep	125	SENT_245	[p16l1614t1972r1718b2035],
24	A1	NN	O	a1	dep	125	SENT_245	[p16l1738t1976r2143b2055],
25	—	NN	O	—	dep	125	SENT_245	[p16l1738t1976r2143b2055],
26	receptor	NN	O	receptor	dep	125	SENT_245	[p16l1738t1976r2143b2055],
27	antagonist	NN	O	antagonist	dep	125	SENT_245	[p16l9t2081r370b2159],
28	rolofylline	NN	O	rolofylline	dep	125	SENT_245	[p16l394t2075r753b2159],
29	led	VBD	O	lead	dep	125	SENT_245	[p16l777t2075r882b2138],
30	to	TO	O	to	dep	125	SENT_245	[p16l905t2087r971b2138],
31	a	DT	O	a	dep	125	SENT_245	[p16l999t2098r1034b2138],
32	greater	JJR	O	greater	dep	125	SENT_245	[p16l1057t2087r1299b2159],
33	relief	NN	O	relief	dep	125	SENT_245	[p16l1323t2075r1506b2138],
34	of	IN	O	of	dep	125	SENT_245	[p16l1522t2075r1597b2138],
35	dyspnea	NN	O	dyspnea	dep	125	SENT_245	[p16l1613t2075r1897b2159],
36	and	CC	O	and	dep	125	SENT_245	[p16l1921t2075r2049b2138],
37	to	TO	O	to	dep	125	SENT_245	[p16l2072t2087r2139b2138],
38	less	JJR	O	less	dep	125	SENT_245	[p16l7t2178r125b2241],
39	worsening	NN	O	worsening	dep	125	SENT_245	[p16l147t2184r507b2262],
40	of	IN	O	of	dep	125	SENT_245	[p16l528t2178r603b2241],
41	renal	JJ	O	renal	dep	125	SENT_245	[p16l615t2178r787b2241],
42	function	NN	O	function	dep	125	SENT_245	[p16l808t2178r1120b2250],
43	,	,	O	,	_	0	SENT_245	[p16l808t2178r1120b2250],
44	as	IN	O	as	dep	125	SENT_245	[p16l1144t2201r1209b2241],
45	compared	VBN	O	compare	dep	125	SENT_245	[p16l1232t2178r1576b2261],
46	with	IN	O	with	dep	125	SENT_245	[p16l1595t2178r1749b2241],
47	placebo	NN	O	placebo	dep	125	SENT_245	[p16l1769t2178r2049b2261],
48	,	,	O	,	_	0	SENT_245	[p16l1769t2178r2049b2261],
49	in	IN	O	in	dep	125	SENT_245	[p16l2073t2184r2140b2240],
50	patients	NNS	O	patient	dep	125	SENT_245	[p16l7t2286r279b2363],
51	with	IN	O	with	dep	125	SENT_245	[p16l301t2280r456b2343],
52	AHE49	NN	O	ahe49	dep	125	SENT_245	[p16l479t2272r721b2343],
53	However	RB	O	however	dep	125	SENT_245	[p16l746t2285r1069b2352],
54	,	,	O	,	_	0	SENT_245	[p16l746t2285r1069b2352],
55	the	DT	O	the	dep	125	SENT_245	[p16l1093t2280r1201b2343],
56	randomized	VBN	O	randomize	dep	125	SENT_245	[p16l1225t2280r1661b2352],
57	,	,	O	,	_	0	SENT_245	[p16l1225t2280r1661b2352],
58	placebocontrolled	JJ	O	placebocontrolled	dep	125	SENT_245	[p16l1685t2280r2140b2363, p16l7t2383r234b2446],
59	Placebo-Controlled	NNP	O	Placebo-Controlled	dep	125	SENT_245	[p16l256t2383r930b2446],
60	Randomized	NNP	O	Randomized	dep	125	SENT_245	[p16l951t2383r1391b2446],
61	Study	NNP	O	Study	dep	125	SENT_245	[p16l1414t2383r1609b2467],
62	of	IN	O	of	dep	125	SENT_245	[p16l1628t2383r1703b2446],
63	the	DT	O	the	dep	125	SENT_245	[p16l1714t2383r1821b2446],
64	Selective	JJ	O	selective	dep	125	SENT_245	[p16l1845t2383r2140b2446],
65	A	DT	O	a	dep	125	SENT_245	[p16l7t2486r164b2563],
66	(	NN	O	(	dep	125	SENT_245	[p16l7t2486r164b2563],
67	1	CD	NUMBER	1	dep	125	SENT_245	[p16l7t2486r164b2563],
68	)	CD	NUMBER	)	dep	125	SENT_245	[p16l7t2486r164b2563],
69	Adenosine	NNP	O	Adenosine	dep	125	SENT_245	[p16l192t2486r565b2549],
70	Receptor	NN	O	receptor	dep	125	SENT_245	[p16l591t2491r902b2569],
71	Antagonist	NN	O	antagonist	dep	125	SENT_245	[p16l925t2490r1310b2570],
72	Rolofylline	NN	O	rolofylline	dep	125	SENT_245	[p16l1335t2486r1717b2570],
73	for	IN	O	for	dep	125	SENT_245	[p16l1742t2486r1841b2549],
74	Patients	NNS	O	patient	dep	125	SENT_245	[p16l1866t2491r2139b2549],
75	Hospitalized	VBD	O	hospitalize	dep	125	SENT_245	[p16l9t2589r455b2672],
76	With	IN	O	with	dep	125	SENT_245	[p16l480t2589r658b2652],
77	Acute	JJ	O	acute	dep	125	SENT_245	[p16l685t2593r890b2652],
78	Decompensated	JJ	O	decompensated	dep	125	SENT_245	[p16l918t2589r1488b2672],
79	Heart	NNP	O	Heart	dep	125	SENT_245	[p16l1515t2594r1716b2652],
80	Failure	NN	O	failure	dep	125	SENT_245	[p16l1743t2589r1985b2652],
81	and	CC	O	and	dep	125	SENT_245	[p16l2014t2589r2143b2652],
82	Volume	NN	O	volume	dep	125	SENT_245	[p16l7t2692r268b2755],
83	Overload	NN	O	overload	dep	125	SENT_245	[p16l290t2692r601b2755],
84	to	TO	O	to	dep	125	SENT_245	[p16l620t2704r684b2755],
85	Assess	VB	O	assess	dep	125	SENT_245	[p16l705t2696r917b2755],
86	Treatment	NN	O	treatment	dep	125	SENT_245	[p16l938t2695r1283b2755],
87	Effect	NN	O	effect	dep	125	SENT_245	[p16l1302t2692r1492b2755],
88	on	IN	O	on	dep	125	SENT_245	[p16l1512t2715r1596b2755],
89	Congestion	NN	O	congestion	dep	125	SENT_245	[p16l1618t2696r1999b2776],
90	and	CC	O	and	dep	125	SENT_245	[p16l2020t2692r2144b2755],
91	Renal	JJ	O	renal	dep	125	SENT_245	[p16l9t2795r193b2858],
92	FunctionPROTECT	NN	O	functionprotect	dep	125	SENT_245	[p16l210t2798r864b2858],
93	study	NN	O	study	dep	125	SENT_245	[p16l882t2795r1059b2879],
94	could	MD	O	could	dep	125	SENT_245	[p16l1073t2795r1253b2858],
95	not	RB	O	not	dep	125	SENT_245	[p16l1269t2807r1378b2858],
96	show	VB	O	show	dep	125	SENT_245	[p16l1395t2795r1564b2858],
97	a	DT	O	a	dep	125	SENT_245	[p16l1579t2818r1613b2858],
98	reduction	NN	O	reduction	dep	125	SENT_245	[p16l1629t2795r1942b2858],
99	in	IN	O	in	dep	125	SENT_245	[p16l1959t2801r2023b2857],
100	the	DT	O	the	dep	125	SENT_245	[p16l2039t2795r2141b2858],
101	primary	JJ	O	primary	dep	125	SENT_245	[p16l7t2904r282b2982],
102	end	NN	O	end	dep	125	SENT_245	[p16l299t2898r423b2961],
103	point	NN	O	point	dep	125	SENT_245	[p16l441t2904r618b2981],
104	(	CD	NUMBER	(	dep	125	SENT_245	[p16l640t2898r978b2982],
105	mortality	NN	O	mortality	dep	125	SENT_245	[p16l640t2898r978b2982],
106	or	CC	O	or	dep	125	SENT_245	[p16l995t2921r1065b2961],
107	rehospitalization	NN	O	rehospitalization	dep	125	SENT_245	[p16l1084t2898r1638b2981],
108	due	JJ	O	due	dep	125	SENT_245	[p16l1659t2898r1779b2961],
109	to	TO	O	to	dep	125	SENT_245	[p16l1798t2910r1863b2961],
110	renal	JJ	O	renal	dep	125	SENT_245	[p16l1884t2898r2050b2961],
111	or	CC	O	or	dep	125	SENT_245	[p16l2071t2921r2141b2961],
112	cardiovascular	JJ	O	cardiovascular	dep	125	SENT_245	[p16l9t3001r487b3064],
113	causes	NNS	O	cause	dep	125	SENT_245	[p16l504t3002r736b3077],
114	)	VBP	O	)	dep	125	SENT_245	[p16l504t3002r736b3077],
115	in	IN	O	in	dep	125	SENT_245	[p16l758t3007r822b3063],
116	patients	NNS	O	patient	dep	125	SENT_245	[p16l839t3007r1097b3084],
117	with	IN	O	with	dep	125	SENT_245	[p16l1114t3001r1262b3064],
118	AHF	NN	ORGANIZATION	ahf	dep	125	SENT_245	[p16l1278t3005r1442b3063],
119	and	CC	O	and	dep	125	SENT_245	[p16l1462t3001r1585b3064],
120	impaired	JJ	O	impaired	dep	125	SENT_245	[p16l1602t3001r1900b3084],
121	kidney	NN	O	kidney	dep	125	SENT_245	[p16l1915t3001r2145b3085],
122	function	NN	O	function	dep	125	SENT_245	[p16l8t3103r297b3166],
123	treated	VBN	O	treat	dep	125	SENT_245	[p16l317t3103r552b3166],
124	with	IN	O	with	dep	125	SENT_245	[p16l570t3103r722b3166],
125	rolofylline	NN	O	rolofylline	_	0	SENT_245	[p16l743t3095r1170b3187],
126	.	.	O	.	_	0	SENT_245	[p16l743t3095r1170b3187],

1	”	NN	O	”	ccomp	10	SENT_246	[p16l743t3095r1170b3187],
2	Notably	RB	O	notably	advmod	1	SENT_246	[p16l1191t3103r1469b3187],
3	,	,	O	,	_	0	SENT_246	[p16l1191t3103r1469b3187],
4	~	NN	O	~	nsubj	10	SENT_246	[p16l1494t3109r1643b3168],
5	1	CD	PERCENT	1	number	6	SENT_246	[p16l1494t3109r1643b3168],
6	%	NN	PERCENT	%	amod	4	SENT_246	[p16l1494t3109r1643b3168],
7	of	IN	O	of	_	0	SENT_246	[p16l1666t3103r1740b3166],
8	the	DT	O	the	det	9	SENT_246	[p16l1750t3103r1856b3166],
9	patients	NNS	O	patient	prep_of	4	SENT_246	[p16l1875t3109r2141b3186],
10	suffered	VBD	O	suffer	_	0	SENT_246	[p16l9t3206r281b3269],
11	from	IN	O	from	_	0	SENT_246	[p16l302t3206r470b3269],
12	seizures	NNS	O	seizure	prep_from	10	SENT_246	[p16l493t3212r881b3269],
13	—	VBP	O	—	dep	12	SENT_246	[p16l493t3212r881b3269],
14	a	DT	O	a	det	17	SENT_246	[p16l493t3212r881b3269],
15	known	JJ	O	known	amod	17	SENT_246	[p16l900t3206r1138b3269],
16	adverse	JJ	O	adverse	amod	17	SENT_246	[p16l1161t3206r1416b3269],
17	effect	NN	O	effect	dobj	13	SENT_246	[p16l1438t3206r1620b3269],
18	of	IN	O	of	_	0	SENT_246	[p16l1642t3206r1716b3269],
19	A1	NN	O	a1	nn	22	SENT_246	[p16l1727t3210r2144b3289],
20	—	NN	O	—	nn	22	SENT_246	[p16l1727t3210r2144b3289],
21	receptor	NN	O	receptor	nn	22	SENT_246	[p16l1727t3210r2144b3289],
22	antagonists	NNS	O	antagonist	prep_of	17	SENT_246	[p16l9t3315r380b3393],
23	owing	VBG	O	owe	partmod	12	SENT_246	[p16l400t3315r604b3393],
24	to	TO	O	to	_	0	SENT_246	[p16l621t3321r685b3372],
25	inhibition	NN	O	inhibition	prep_to	23	SENT_246	[p16l706t3309r1035b3372],
26	of	IN	O	of	_	0	SENT_246	[p16l1054t3309r1127b3372],
27	central	JJ	O	central	amod	29	SENT_246	[p16l1137t3309r1363b3372],
28	A1	NN	O	a1	nn	29	SENT_246	[p16l1380t3313r1471b3371],
29	receptors	NNS	O	receptor	prep_of	25	SENT_246	[p16l1497t3321r1815b3392],
30	.	.	O	.	_	0	SENT_246	[p16l1497t3321r1815b3392],

1	Soluble	JJ	O	soluble	amod	4	SENT_247	[p16l9t3522r270b3579],
2	guanylate	NN	O	guanylate	nn	4	SENT_247	[p16l287t3522r634b3595],
3	cyclase	NN	O	cyclase	nn	4	SENT_247	[p16l651t3521r898b3595],
4	activators	NNS	O	activator	_	0	SENT_247	[p16l914t3522r1258b3579],

1	Activation	NN	O	activation	nsubj	9	SENT_248	[p17l7t23r373b82],
2	of	IN	O	of	_	0	SENT_248	[p17l398t19r473b82],
3	soluble	JJ	O	soluble	amod	5	SENT_248	[p17l489t19r733b82],
4	guanylate	NN	O	guanylate	nn	5	SENT_248	[p17l757t19r1091b103],
5	cyclase	NN	O	cyclase	prep_of	1	SENT_248	[p17l1116t19r1359b103],
6	is	VBZ	O	be	cop	9	SENT_248	[p17l1383t25r1434b82],
7	the	DT	O	the	det	9	SENT_248	[p17l1458t19r1566b82],
8	essential	JJ	O	essential	amod	9	SENT_248	[p17l1591t19r1888b82],
9	step	NN	O	step	_	0	SENT_248	[p17l1912t31r2048b102],
10	in	IN	O	in	_	0	SENT_248	[p17l2074t25r2141b81],
11	nitric	JJ	O	nitric	amod	13	SENT_248	[p17l8t128r191b185],
12	oXide	NN	O	oxide	nn	13	SENT_248	[p17l212t122r759b185],
13	—	NN	O	—	prep_in	9	SENT_248	[p17l212t122r759b185],
14	mediated	VBD	O	mediate	partmod	13	SENT_248	[p17l212t122r759b185],
15	vasodilation	NN	O	vasodilation	dobj	14	SENT_248	[p17l775t122r1209b185],
16	.	.	O	.	_	0	SENT_248	[p17l775t122r1209b185],

1	In	IN	O	in	_	0	SENT_249	[p17l1233t127r1304b184],
2	AHF	NN	ORGANIZATION	ahf	nn	3	SENT_249	[p17l1324t126r1490b184],
3	patients	NNS	O	patient	prep_in	8	SENT_249	[p17l1511t128r1796b205],
4	,	,	O	,	_	0	SENT_249	[p17l1511t128r1796b205],
5	this	DT	O	this	det	6	SENT_249	[p17l1817t122r1940b185],
6	pathway	NN	O	pathway	nsubjpass	8	SENT_249	[p17l1960t122r2139b205, p17l7t248r142b309],
7	is	VBZ	O	be	auxpass	8	SENT_249	[p17l159t231r208b288],
8	thought	VBN	O	think	_	0	SENT_249	[p17l228t225r497b309],
9	to	TO	O	to	aux	11	SENT_249	[p17l516t237r581b288],
10	be	VB	O	be	auxpass	11	SENT_249	[p17l600t225r679b288],
11	compromised	VBN	O	compromise	xcomp	8	SENT_249	[p17l700t225r1182b308],
12	.	.	O	.	_	0	SENT_249	[p17l700t225r1182b308],

1	Cinaciguat	NNP	O	Cinaciguat	nsubj	4	SENT_250	[p17l1207t229r1574b309],
2	is	VBZ	O	be	cop	4	SENT_250	[p17l1592t231r1642b288],
3	an	DT	O	a	det	4	SENT_250	[p17l1664t248r1743b288],
4	activator	NN	O	activator	_	0	SENT_250	[p17l1764t231r2058b288],
5	of	IN	O	of	_	0	SENT_250	[p17l2078t225r2151b288],
6	soluble	JJ	O	soluble	amod	8	SENT_250	[p17l9t328r242b391],
7	guanylate	NN	O	guanylate	nn	8	SENT_250	[p17l261t328r580b412],
8	cyclase	NN	O	cyclase	prep_of	4	SENT_250	[p17l600t328r830b412],
9	acting	VBG	O	act	partmod	8	SENT_250	[p17l851t334r1055b412],
10	independently	RB	O	independently	advmod	9	SENT_250	[p17l1072t328r1557b412],
11	of	IN	O	of	_	0	SENT_250	[p17l1574t328r1646b391],
12	nitric	JJ	O	nitric	amod	13	SENT_250	[p17l1655t334r1836b391],
13	oxide	NN	O	oxide	prep_of	9	SENT_250	[p17l1855t328r2051b391],
14	.	.	O	.	_	0	SENT_250	[p17l1855t328r2051b391],

1	In	IN	O	in	_	0	SENT_251	[p17l2074t333r2143b390],
2	a	DT	O	a	det	4	SENT_251	[p17l9t454r43b494],
3	placebo-controlled	JJ	O	placebo-controlled	amod	4	SENT_251	[p17l59t431r687b514],
4	trial	NN	O	trial	prep_in	14	SENT_251	[p17l704t431r840b494],
5	including	VBG	O	include	_	0	SENT_251	[p17l858t431r1175b515],
6	139	CD	NUMBER	139	num	7	SENT_251	[p17l1198t438r1308b494],
7	patients	NNS	O	patient	prep_including	4	SENT_251	[p17l1327t437r1587b514],
8	with	IN	O	with	_	0	SENT_251	[p17l1605t431r1753b494],
9	AHF	NN	ORGANIZATION	ahf	prep_with	7	SENT_251	[p17l1771t435r1944b503],
10	,	,	O	,	_	0	SENT_251	[p17l1771t435r1944b503],
11	treatment	NN	O	treatment	nsubj	14	SENT_251	[p17l1963t443r2140b494, p17l8t546r186b597],
12	with	IN	O	with	_	0	SENT_251	[p17l205t534r359b597],
13	cinaciguat	NN	O	cinaciguat	prep_with	11	SENT_251	[p17l382t540r734b618],
14	showed	VBD	O	show	_	0	SENT_251	[p17l756t534r1015b597],
15	beneﬁcial	JJ	O	beneﬁcial	amod	17	SENT_251	[p17l1034t534r1366b597],
16	hemodynamic	JJ	O	hemodynamic	amod	17	SENT_251	[p17l1387t534r1885b618],
17	effects	NNS	O	effect	dobj	14	SENT_251	[p17l1908t534r2138b597],
18	.	.	O	.	_	0	SENT_251	[p17l1908t534r2138b597],

1	However	RB	O	however	advmod	5	SENT_252	[p17l9t642r338b709],
2	,	,	O	,	_	0	SENT_252	[p17l9t642r338b709],
3	the	DT	O	the	det	4	SENT_252	[p17l364t637r473b700],
4	trial	NN	O	trial	nsubj	5	SENT_252	[p17l498t637r643b700],
5	had	VBD	O	have	_	0	SENT_252	[p17l667t637r798b700],
6	to	TO	O	to	aux	8	SENT_252	[p17l821t649r889b700],
7	be	VB	O	be	auxpass	8	SENT_252	[p17l913t637r995b700],
8	stopped	VBN	O	stop	xcomp	5	SENT_252	[p17l1021t637r1299b720],
9	prematurely	RB	O	prematurely	advmod	8	SENT_252	[p17l1322t637r1755b721],
10	because	IN	O	because	_	0	SENT_252	[p17l1775t637r2051b700],
11	of	IN	O	of	_	0	SENT_252	[p17l2077t637r2152b700],
12	an	DT	O	a	det	14	SENT_252	[p17l9t763r90b803],
13	increased	VBN	O	increase	amod	14	SENT_252	[p17l113t740r443b803],
14	incidence	NN	O	incidence	prep_because_of	8	SENT_252	[p17l464t740r797b803],
15	of	IN	O	of	_	0	SENT_252	[p17l821t740r896b803],
16	treatment-emergent	JJ	O	treatment-emergent	amod	17	SENT_252	[p17l908t752r1608b824],
17	hypotension	NN	O	hypotension	prep_of	14	SENT_252	[p17l1628t740r2060b824],
18	at	IN	O	at	_	0	SENT_252	[p17l2083t752r2143b803],
19	higher	JJR	O	higher	amod	20	SENT_252	[p17l7t842r223b926],
20	doses	NNS	O	dose	prep_at	17	SENT_252	[p17l241t834r499b905],
21	.5	CD	NUMBER	.5	number	22	SENT_252	[p17l241t834r499b905],
22	°	CD	NUMBER	°	num	20	SENT_252	[p17l241t834r499b905],
23	The	DT	O	the	det	26	SENT_252	[p17l518t842r640b905],
24	COMPOSE	NN	O	compose	nn	26	SENT_252	[p17l660t846r1044b905],
25	study	NN	O	study	nn	26	SENT_252	[p17l1063t842r1243b926],
26	program	NN	O	program	nsubjpass	47	SENT_252	[p17l1257t864r1562b926],
27	,	,	O	,	_	0	SENT_252	[p17l1257t864r1562b926],
28	comprising	VBG	O	comprise	partmod	26	SENT_252	[p17l1583t848r1957b926],
29	three	CD	NUMBER	three	dobj	28	SENT_252	[p17l1973t842r2142b905],
30	randomized	VBN	O	randomize	partmod	29	SENT_252	[p17l9t945r447b1017],
31	,	,	O	,	_	0	SENT_252	[p17l9t945r447b1017],
32	placebo-controlled	JJ	O	placebo-controlled	amod	33	SENT_252	[p17l470t945r1130b1028],
33	studies	NNS	O	study	nsubj	35	SENT_252	[p17l1153t945r1391b1008],
34	(	RB	O	(	advmod	35	SENT_252	[p17l1419t946r1849b1021],
35	COMPOSE	VB	O	compose	ccomp	30	SENT_252	[p17l1419t946r1849b1021],
36	EARLY	NN	O	early	dobj	35	SENT_252	[p17l1872t949r2139b1017],
37	,	,	O	,	_	0	SENT_252	[p17l1872t949r2139b1017],
38	COMPOSE	VB	O	compose	ccomp	30	SENT_252	[p17l10t1052r415b1111],
39	1	CD	NUMBER	1	dobj	38	SENT_252	[p17l446t1055r497b1120],
40	,	,	O	,	_	0	SENT_252	[p17l446t1055r497b1120],
41	and	CC	O	and	_	0	SENT_252	[p17l524t1048r653b1111],
42	COMPOSE	VB	O	compose	ccomp	30	SENT_252	[p17l678t1052r1083b1111],
43	2	CD	NUMBER	2	number	44	SENT_252	[p17l1109t1049r1196b1125],
44	)	CD	NUMBER	)	dobj	42	SENT_252	[p17l1109t1049r1196b1125],
45	,	,	O	,	_	0	SENT_252	[p17l1109t1049r1196b1125],
46	was	VBD	O	be	auxpass	47	SENT_252	[p17l1221t1071r1350b1111],
47	designed	VBN	O	design	rcmod	14	SENT_252	[p17l1376t1048r1689b1132],
48	to	TO	O	to	aux	49	SENT_252	[p17l1711t1060r1779b1111],
49	assess	VB	O	assess	xcomp	47	SENT_252	[p17l1806t1071r2007b1111],
50	the	DT	O	the	det	51	SENT_252	[p17l2031t1048r2141b1111],
51	safety	NN	O	safety	dobj	49	SENT_252	[p17l9t1151r205b1235],
52	and	CC	O	and	_	0	SENT_252	[p17l224t1151r350b1214],
53	eﬂicacy	NN	O	eﬂicacy	dobj	49	SENT_252	[p17l372t1151r629b1235],
54	of	IN	O	of	_	0	SENT_252	[p17l649t1151r722b1214],
55	lower	JJR	O	lower	amod	56	SENT_252	[p17l733t1151r924b1214],
56	doses	NNS	O	dose	prep_of	51	SENT_252	[p17l945t1151r1131b1214],
57	of	IN	O	of	_	0	SENT_252	[p17l1154t1151r1228b1214],
58	cinaciguat	NN	O	cinaciguat	prep_of	56	SENT_252	[p17l1241t1157r1591b1235],
59	in	IN	O	in	_	0	SENT_252	[p17l1612t1157r1678b1213],
60	patients	NNS	O	patient	prep_in	49	SENT_252	[p17l1699t1157r1967b1234],
61	with	IN	O	with	prep	49	SENT_252	[p17l1988t1151r2141b1214],

1	VOLUME	NN	O	volume	nn	3	SENT_253	[p17l535t1369r759b1411],
2	94	CD	NUMBER	94	num	3	SENT_253	[p17l776t1370r835b1411],
3	NUMBER	NN	O	number	_	0	SENT_253	[p17l854t1369r1077b1411],
4	4	CD	NUMBER	4	number	5	SENT_253	[p17l1092t1365r1145b1426],
5	|	CD	NUMBER	|	dep	3	SENT_253	[p17l1092t1365r1145b1426],
6	OCTOBER	NNP	DATE	OCTOBER	dep	5	SENT_253	[p17l1165t1369r1412b1411],
7	2013	CD	DATE	2013	num	6	SENT_253	[p17l1430t1370r1548b1411],
8	|	CD	NUMBER	|	num	9	SENT_253	[p17l1569t1365r1574b1426],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_253	[p17l1592t1369r2142b1423],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_254	[p17l1948t1501r2138b1538],

1	AHF	NN	O	ahf	_	0	SENT_255	[p17l7t1714r180b1773],
2	.	.	O	.	_	0	SENT_255	[p17l7t1714r180b1773],

1	However	RB	O	however	advmod	5	SENT_256	[p17l203t1715r517b1782],
2	,	,	O	,	_	0	SENT_256	[p17l203t1715r517b1782],
3	this	DT	O	this	det	4	SENT_256	[p17l537t1710r659b1773],
4	program	NN	O	program	nsubj	5	SENT_256	[p17l678t1732r971b1794],
5	had	VBD	O	have	_	0	SENT_256	[p17l989t1710r1115b1773],
6	to	TO	O	to	aux	8	SENT_256	[p17l1132t1722r1197b1773],
7	be	VB	O	be	auxpass	8	SENT_256	[p17l1216t1710r1294b1773],
8	terminated	VBN	O	terminate	xcomp	5	SENT_256	[p17l1313t1710r1686b1773],
9	early	RB	O	early	advmod	8	SENT_256	[p17l1705t1710r1868b1794],
10	because	IN	O	because	_	0	SENT_256	[p17l1882t1710r2145b1773],
11	of	IN	O	of	_	0	SENT_256	[p17l8t1813r81b1876],
12	an	DT	O	a	det	13	SENT_256	[p17l92t1836r171b1876],
13	excess	NN	O	excess	prep_because_of	8	SENT_256	[p17l191t1836r396b1876],
14	of	IN	O	of	_	0	SENT_256	[p17l417t1813r490b1876],
15	hypotension	NN	O	hypotension	nn	18	SENT_256	[p17l499t1813r917b1897],
16	and	CC	O	and	_	0	SENT_256	[p17l937t1813r1062b1876],
17	recruitment	NN	O	recruitment	conj_and	15	SENT_256	[p17l1080t1819r1483b1876],
18	diﬂiculties	NNS	O	diﬂiculties	prep_of	13	SENT_256	[p17l1502t1813r1868b1876],
19	.	.	O	.	_	0	SENT_256	[p17l1502t1813r1868b1876],

1	In	IN	O	in	_	0	SENT_257	[p17l1891t1818r1962b1875],
2	sum	NN	O	sum	prep_in	7	SENT_257	[p17l1982t1836r2141b1885],
3	,	,	O	,	_	0	SENT_257	[p17l1982t1836r2141b1885],
4	cinaciguat	NN	O	cinaciguat	nsubj	7	SENT_257	[p17l8t1922r355b2000],
5	is	VBZ	O	be	cop	7	SENT_257	[p17l374t1922r424b1979],
6	not	RB	O	not	neg	7	SENT_257	[p17l445t1928r558b1979],
7	suitable	JJ	O	suitable	_	0	SENT_257	[p17l579t1916r836b1979],
8	as	IN	O	as	_	0	SENT_257	[p17l858t1939r922b1979],
9	an	DT	O	a	det	12	SENT_257	[p17l944t1939r1023b1979],
10	acute	JJ	O	acute	amod	12	SENT_257	[p17l1045t1928r1221b1979],
11	hemodynamic	JJ	O	hemodynamic	amod	12	SENT_257	[p17l1241t1916r1732b2000],
12	agent	NN	O	agent	prep_as	7	SENT_257	[p17l1753t1928r1949b2000],
13	.	.	O	.	_	0	SENT_257	[p17l1753t1928r1949b2000],

1	lsta	NN	O	lsta	nn	3	SENT_258	[p17l10t2131r128b2186],
2	roxime	NN	O	roxime	nn	3	SENT_258	[p17l136t2129r375b2186],
3	Istaroxime	NN	MISC	istaroxime	nsubj	4	SENT_258	[p17l8t2231r374b2289],
4	inhibits	VBZ	O	inhibit	_	0	SENT_258	[p17l396t2226r655b2289],
5	Na/K-ATPase	NN	O	na/k-atpase	dobj	4	SENT_258	[p17l677t2229r1156b2292],
6	and	CC	O	and	_	0	SENT_258	[p17l1179t2226r1307b2289],
7	stimulates	VBZ	O	stimulate	conj_and	4	SENT_258	[p17l1329t2226r1675b2289],
8	sarcoplasmic	JJ	O	sarcoplasmic	amod	10	SENT_258	[p17l1698t2226r2144b2309],
9	reticulum	NN	O	reticulum	nn	10	SENT_258	[p17l8t2329r326b2392],
10	ATPase	NN	O	atpase	dobj	7	SENT_258	[p17l342t2332r604b2392],
11	.	.	O	.	_	0	SENT_258	[p17l342t2332r604b2392],

1	Via	NNP	O	Via	dep	4	SENT_259	[p17l623t2334r735b2392],
2	this	DT	O	this	det	4	SENT_259	[p17l750t2329r868b2392],
3	combined	JJ	O	combined	amod	4	SENT_259	[p17l887t2329r1214b2392],
4	mechanism	NN	O	mechanism	ccomp	7	SENT_259	[p17l1230t2329r1625b2401],
5	,	,	O	,	_	0	SENT_259	[p17l1230t2329r1625b2401],
6	istaroxime	NN	O	istaroxime	nsubj	21	SENT_259	[p17l1644t2335r1985b2392],
7	promotes	VBZ	O	promote	_	0	SENT_259	[p17l2001t2351r2139b2412, p17l7t2444r208b2495],
8	a	DT	O	a	det	11	SENT_259	[p17l230t2455r265b2495],
9	cytosolic	JJ	O	cytosolic	amod	11	SENT_259	[p17l285t2432r580b2516],
10	calcium	NN	O	calcium	nn	11	SENT_259	[p17l601t2432r865b2495],
11	accumulation	NN	O	accumulation	dobj	7	SENT_259	[p17l886t2432r1345b2495],
12	during	IN	O	during	_	0	SENT_259	[p17l1366t2432r1593b2516],
13	systole	NN	O	systole	prep_during	7	SENT_259	[p17l1613t2432r1851b2516],
14	,	,	O	,	_	0	SENT_259	[p17l1613t2432r1851b2516],
15	creating	VBG	O	create	partmod	7	SENT_259	[p17l1874t2438r2144b2516],
16	a	DT	O	a	det	18	SENT_259	[p17l8t2559r43b2599],
17	positive	JJ	O	positive	amod	18	SENT_259	[p17l62t2542r326b2619],
18	inotropy	NN	O	inotropy	dobj	15	SENT_259	[p17l348t2542r650b2620],
19	,	,	O	,	_	0	SENT_259	[p17l348t2542r650b2620],
20	and	CC	O	and	_	0	SENT_259	[p17l674t2536r800b2599],
21	increases	VBZ	O	increase	conj_and	7	SENT_259	[p17l820t2542r1126b2599],
22	sequestration	NN	O	sequestration	dobj	21	SENT_259	[p17l1149t2542r1602b2619],
23	of	IN	O	of	_	0	SENT_259	[p17l1624t2536r1698b2599],
24	calcium	NN	O	calcium	prep_of	22	SENT_259	[p17l1710t2536r1977b2599],
25	during	IN	O	during	_	0	SENT_259	[p17l1998t2536r2141b2599, p17l8t2644r113b2722],
26	diastole	NN	O	diastole	prep_during	21	SENT_259	[p17l131t2638r402b2710],
27	,	,	O	,	_	0	SENT_259	[p17l131t2638r402b2710],
28	leading	VBG	O	lead	conj_and	7	SENT_259	[p17l421t2638r667b2722],
29	to	TO	O	to	_	0	SENT_259	[p17l683t2650r747b2701],
30	positive	JJ	O	positive	amod	32	SENT_259	[p17l766t2644r1026b2721],
31	lusitropy	JJ	O	lusitropy	amod	32	SENT_259	[p17l1043t2630r1408b2722],
32	.51	NN	NUMBER	.51	prep_to	28	SENT_259	[p17l1043t2630r1408b2722],
33	In	IN	O	in	_	0	SENT_259	[p17l1431t2643r1501b2700],
34	the	DT	O	the	det	36	SENT_259	[p17l1519t2638r1623b2701],
35	Hemodynamic	JJ	O	hemodynamic	amod	36	SENT_259	[p17l1642t2638r2144b2722],
36	Effects	NNS	O	effect	prep_in	28	SENT_259	[p17l7t2741r222b2804],
37	of	IN	O	of	_	0	SENT_259	[p17l241t2741r312b2804],
38	Istaroxime	NNP	O	Istaroxime	prep_of	36	SENT_259	[p17l321t2746r667b2804],
39	in	IN	O	in	_	0	SENT_259	[p17l685t2747r749b2803],
40	Patients	NNPS	O	Patients	prep_in	38	SENT_259	[p17l768t2746r1023b2804],
41	With	IN	O	with	_	0	SENT_259	[p17l1040t2741r1206b2804],
42	Worsening	VBG	O	worsen	amod	43	SENT_259	[p17l1223t2746r1583b2825],
43	HF	NN	O	hf	prep_with	28	SENT_259	[p17l1599t2746r1703b2803],
44	and	CC	O	and	_	0	SENT_259	[p17l1722t2741r1844b2804],
45	Reduced	VBN	O	reduce	amod	48	SENT_259	[p17l1861t2741r2146b2804],
46	LV	NN	O	lv	nn	48	SENT_259	[p17l8t2849r109b2907],
47	Systolic	JJ	O	systolic	amod	48	SENT_259	[p17l141t2844r416b2928],
48	FunctionHORIZON	NN	O	functionhorizon	prep_with	28	SENT_259	[p17l448t2847r1339b2907],
49	.	.	O	.	_	0	SENT_259	[p17l448t2847r1339b2907],

1	—	NN	O	—	_	0	SENT_260	[p17l448t2847r1339b2907],
2	.	.	O	.	_	0	SENT_260	[p17l448t2847r1339b2907],

1	HF	NN	ORGANIZATION	hf	nn	2	SENT_261	[p17l448t2847r1339b2907],
2	study	NN	O	study	nsubj	13	SENT_261	[p17l1374t2844r1581b2928],
3	,	,	O	,	_	0	SENT_261	[p17l1374t2844r1581b2928],
4	a	DT	O	a	appos	2	SENT_261	[p17l1616t2867r1651b2907],
5	randomized	VBN	O	randomize	partmod	4	SENT_261	[p17l1683t2844r2141b2916],
6	,	,	O	,	_	0	SENT_261	[p17l1683t2844r2141b2916],
7	placebo-controlled	JJ	O	placebo-controlled	amod	8	SENT_261	[p17l6t2947r641b3030],
8	phase	NN	O	phase	appos	4	SENT_261	[p17l660t2947r851b3030],
9	II	CD	NUMBER	ii	num	10	SENT_261	[p17l873t2952r925b3009],
10	trial	NN	O	trial	dep	8	SENT_261	[p17l947t2947r1100b3019],
11	,	,	O	,	_	0	SENT_261	[p17l947t2947r1100b3019],
12	istaroxime	NN	O	istaroxime	nsubj	13	SENT_261	[p17l1123t2953r1474b3010],
13	improved	VBD	O	improve	ccomp	31	SENT_261	[p17l1496t2947r1819b3030],
14	hemodynamic	JJ	O	hemodynamic	amod	15	SENT_261	[p17l1838t2947r2141b3031, p17l7t3056r221b3113],
15	parameters	NNS	O	parameter	dobj	13	SENT_261	[p17l241t3062r626b3133],
16	without	IN	O	without	_	0	SENT_261	[p17l646t3050r917b3113],
17	raising	VBG	O	raise	prepc_without	13	SENT_261	[p17l937t3056r1171b3134],
18	safety	NN	O	safety	nn	19	SENT_261	[p17l1192t3050r1389b3134],
19	issues	NNS	O	issue	iobj	17	SENT_261	[p17l1407t3042r1686b3113],
20	.15	CD	NUMBER	.15	dobj	17	SENT_261	[p17l1407t3042r1686b3113],
21	However	RB	O	however	advmod	20	SENT_261	[p17l1710t3055r2032b3122],
22	,	,	O	,	_	0	SENT_261	[p17l1710t3055r2032b3122],
23	no	DT	O	no	det	25	SENT_261	[p17l2055t3073r2143b3113],
24	AHF	NN	ORGANIZATION	ahf	nn	25	SENT_261	[p17l7t3157r172b3215],
25	trials	NNS	O	trial	nsubj	31	SENT_261	[p17l193t3153r359b3216],
26	with	IN	O	with	_	0	SENT_261	[p17l378t3153r528b3216],
27	hard	JJ	O	hard	amod	30	SENT_261	[p17l547t3153r702b3216],
28	clinical	JJ	O	clinical	amod	30	SENT_261	[p17l721t3153r960b3216],
29	end	NN	O	end	nn	30	SENT_261	[p17l980t3153r1105b3216],
30	points	NNS	O	point	prep_with	25	SENT_261	[p17l1122t3159r1331b3236],
31	are	VBP	O	be	_	0	SENT_261	[p17l1352t3176r1450b3216],
32	under	IN	O	under	_	0	SENT_261	[p17l1470t3153r1671b3216],
33	way	NN	O	way	prep_under	31	SENT_261	[p17l1688t3176r1829b3237],
34	.	.	O	.	_	0	SENT_261	[p17l1688t3176r1829b3237],

1	Carperitide	NNP	PERSON	Carperitide	nn	2	SENT_262	[p18l8t72r400b144],
2	Carperitide	NNP	PERSON	Carperitide	nsubj	9	SENT_262	[p18l9t168r404b251],
3	is	VBZ	O	be	cop	9	SENT_262	[p18l427t174r478b231],
4	a	DT	O	a	det	9	SENT_262	[p18l502t191r536b231],
5	synthetic	JJ	O	synthetic	amod	9	SENT_262	[p18l559t168r870b252],
6	atrial	JJ	O	atrial	amod	7	SENT_262	[p18l893t168r1069b231],
7	natriuretic	JJ	O	natriuretic	amod	9	SENT_262	[p18l1092t174r1455b231],
8	peptide	NN	O	peptide	nn	9	SENT_262	[p18l1477t168r1735b251],
9	analog	NN	O	analog	_	0	SENT_262	[p18l1759t168r2001b252],
10	.	.	O	.	_	0	SENT_262	[p18l1759t168r2001b252],

1	However	RB	O	however	advmod	4	SENT_263	[p18l8t276r332b343],
2	,	,	O	,	_	0	SENT_263	[p18l8t276r332b343],
3	there	EX	O	there	expl	4	SENT_263	[p18l356t271r532b334],
4	is	VBZ	O	be	_	0	SENT_263	[p18l556t277r606b334],
5	only	RB	O	only	advmod	4	SENT_263	[p18l631t271r784b355],
6	one	CD	NUMBER	one	num	9	SENT_263	[p18l804t294r928b334],
7	small	JJ	O	small	amod	9	SENT_263	[p18l953t271r1136b334],
8	randomized	JJ	O	randomized	amod	9	SENT_263	[p18l1158t271r1580b334],
9	trial	NN	O	trial	nsubj	4	SENT_263	[p18l1601t271r1744b334],
10	comparing	VBG	O	compare	partmod	9	SENT_263	[p18l1767t277r2144b355],
11	carperitide	NN	O	carperitide	dobj	10	SENT_263	[p18l8t374r378b457],
12	with	IN	O	with	_	0	SENT_263	[p18l396t374r548b437],
13	placebo	NN	O	placebo	prep_with	10	SENT_263	[p18l567t374r828b457],
14	in	IN	O	in	_	0	SENT_263	[p18l850t380r916b436],
15	49	CD	NUMBER	49	num	16	SENT_263	[p18l936t381r1014b437],
16	patients	NNS	O	patient	prep_in	13	SENT_263	[p18l1034t380r1319b457],
17	.	.	O	.	_	0	SENT_263	[p18l1034t380r1319b457],

1	Therein	RB	O	therein	advmod	7	SENT_264	[p18l1342t374r1622b446],
2	,	,	O	,	_	0	SENT_264	[p18l1342t374r1622b446],
3	carperitide	NN	O	carperitide	nsubj	7	SENT_264	[p18l1644t374r2014b457],
4	did	VBD	O	do	aux	7	SENT_264	[p18l2036t374r2146b437],
5	not	RB	O	not	neg	7	SENT_264	[p18l7t488r119b539],
6	inﬂuence	NN	O	inﬂuence	nn	7	SENT_264	[p18l138t476r446b539],
7	biomarkers	NNS	O	biomarker	_	0	SENT_264	[p18l465t476r845b539],
8	or	CC	O	or	_	0	SENT_264	[p18l866t499r937b539],
9	renal	JJ	O	renal	amod	10	SENT_264	[p18l956t476r1124b539],
10	function	NN	O	function	conj_or	7	SENT_264	[p18l1143t476r1431b539],
11	after	IN	O	after	_	0	SENT_264	[p18l1451t476r1601b539],
12	72	CD	NUMBER	72	num	13	SENT_264	[p18l1621t483r1695b539],
13	h	NN	O	h	prep_after	7	SENT_264	[p18l1710t476r1753b538],
14	of	IN	O	of	_	0	SENT_264	[p18l1773t476r1846b539],
15	continuous	JJ	O	continuous	prep_of	13	SENT_264	[p18l1856t482r2141b539, p18l8t602r126b642],

1	infusion	NN	O	infusion	nsubj	5	SENT_265	[p18l150t579r459b651],
2	,	,	O	,	_	0	SENT_265	[p18l150t579r459b651],
3	but	CC	O	but	prep	1	SENT_265	[p18l481t579r597b642],
4	it	PRP	O	it	dep	3	SENT_265	[p18l620t585r666b642],
5	lowered	VBD	O	lower	_	0	SENT_265	[p18l687t579r965b642],
6	the	DT	O	the	det	9	SENT_265	[p18l987t579r1095b642],
7	composite	JJ	O	composite	amod	9	SENT_265	[p18l1120t585r1477b662],
8	end	NN	O	end	nn	9	SENT_265	[p18l1502t579r1630b642],
9	point	NN	O	point	dobj	5	SENT_265	[p18l1651t585r1839b662],
10	of	IN	O	of	_	0	SENT_265	[p18l1861t579r1936b642],
11	death	NN	O	death	prep_of	9	SENT_265	[p18l1951t579r2143b642],
12	and	CC	O	and	_	0	SENT_265	[p18l8t681r136b744],
13	rehospitalization	NN	O	rehospitalization	prep_of	9	SENT_265	[p18l158t681r740b764],
14	after	IN	O	after	_	0	SENT_265	[p18l764t681r918b744],
15	a	DT	O	a	det	17	SENT_265	[p18l941t704r976b744],
16	follow-up	JJ	O	follow-up	amod	17	SENT_265	[p18l997t681r1332b764],
17	period	NN	O	period	prep_after	5	SENT_265	[p18l1355t681r1585b764],
18	of	IN	O	of	_	0	SENT_265	[p18l1608t681r1682b744],
19	18	CD	DURATION	18	num	20	SENT_265	[p18l1702t688r1774b744],
20	months	NNS	NUMBER	month	prep_of	17	SENT_265	[p18l1799t673r2144b744],
21	.54	CD	NUMBER	.54	tmod	5	SENT_265	[p18l1799t673r2144b744],
22	A	DT	O	a	det	23	SENT_265	[p18l7t788r65b846],
23	larger	JJR	O	larger	nsubjpass	32	SENT_265	[p18l90t784r297b868],
24	randomized	VBN	O	randomize	partmod	23	SENT_265	[p18l323t784r756b847],
25	trial	NN	O	trial	dobj	24	SENT_265	[p18l780t784r928b847],
26	with	IN	O	with	_	0	SENT_265	[p18l953t784r1112b847],
27	hard	JJ	O	hard	amod	30	SENT_265	[p18l1137t784r1301b847],
28	clinical	JJ	O	clinical	amod	30	SENT_265	[p18l1327t784r1585b847],
29	end	NN	O	end	nn	30	SENT_265	[p18l1612t784r1742b847],
30	points	NNS	O	point	prep_with	24	SENT_265	[p18l1767t790r1989b867],
31	was	VBD	O	be	auxpass	32	SENT_265	[p18l2014t807r2145b847],
32	terminated	VBN	O	terminate	rcmod	21	SENT_265	[p18l7t886r386b949],
33	prior	RB	O	prior	_	0	SENT_265	[p18l405t892r579b969],
34	to	TO	O	to	_	0	SENT_265	[p18l599t898r664b949],
35	the	DT	O	the	det	36	SENT_265	[p18l686t886r792b949],
36	enrollment	NN	O	enrollment	prep_prior_to	32	SENT_265	[p18l815t886r1194b949],
37	of	IN	O	of	_	0	SENT_265	[p18l1215t886r1288b949],
38	patients	NNS	O	patient	prep_of	36	SENT_265	[p18l1299t878r1647b969],
39	.51	CD	NUMBER	.51	dep	21	SENT_265	[p18l1299t878r1647b969],

1	Relaxin	NN	O	relaxin	_	0	SENT_266	[p18l10t1099r261b1156],

1	Relaxin	NN	O	relaxin	nsubj	4	SENT_267	[p18l8t1196r275b1259],
2	is	VBZ	O	be	cop	4	SENT_267	[p18l300t1202r351b1259],
3	a	DT	O	a	det	4	SENT_267	[p18l377t1219r412b1259],
4	hormone	NN	O	hormone	_	0	SENT_267	[p18l435t1196r761b1259],
5	secreted	VBN	O	secrete	partmod	4	SENT_267	[p18l787t1196r1076b1259],
6	during	IN	O	during	_	0	SENT_267	[p18l1100t1196r1339b1280],
7	the	DT	O	the	det	9	SENT_267	[p18l1361t1196r1470b1259],
8	late	JJ	O	late	amod	9	SENT_267	[p18l1494t1196r1617b1259],
9	phase	NN	O	phase	prep_during	5	SENT_267	[p18l1640t1196r1842b1279],
10	of	IN	O	of	_	0	SENT_267	[p18l1867t1196r1943b1259],
11	pregnancy	NN	O	pregnancy	prep_of	9	SENT_267	[p18l1957t1218r2140b1280, p18l7t1322r223b1383],
12	that	WDT	O	that	nsubj	13	SENT_267	[p18l243t1299r382b1362],
13	regulates	VBZ	O	regulate	rcmod	4	SENT_267	[p18l406t1299r721b1383],
14	the	DT	O	the	det	15	SENT_267	[p18l745t1299r855b1362],
15	preparation	NN	O	preparation	dobj	13	SENT_267	[p18l879t1305r1296b1382],
16	of	IN	O	of	_	0	SENT_267	[p18l1321t1299r1397b1362],
17	the	DT	O	the	det	19	SENT_267	[p18l1411t1299r1521b1362],
18	birth	NN	O	birth	nn	19	SENT_267	[p18l1544t1299r1721b1362],
19	channel	NN	O	channel	prep_of	15	SENT_267	[p18l1746t1299r2041b1362],
20	.	.	O	.	_	0	SENT_267	[p18l1746t1299r2041b1362],

1	In	IN	O	in	_	0	SENT_268	[p18l2069t1304r2142b1361],
2	addition	NN	O	addition	prep_in	5	SENT_268	[p18l8t1401r321b1473],
3	,	,	O	,	_	0	SENT_268	[p18l8t1401r321b1473],
4	it	PRP	O	it	nsubj	5	SENT_268	[p18l346t1407r393b1465],
5	induces	VBZ	O	induce	_	0	SENT_268	[p18l416t1401r683b1465],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_268	[p18l708t1401r1218b1465],
7	effects	NNS	O	effect	dobj	5	SENT_268	[p18l1241t1401r1458b1465],
8	such	JJ	O	such	_	0	SENT_268	[p18l1483t1401r1641b1465],
9	as	IN	O	as	_	0	SENT_268	[p18l1666t1424r1731b1465],
10	an	DT	O	a	det	11	SENT_268	[p18l1756t1424r1837b1465],
11	increase	NN	O	increase	prep_such_as	7	SENT_268	[p18l1861t1407r2145b1465],
12	in	IN	O	in	_	0	SENT_268	[p18l8t1511r77b1567],
13	cardiac	JJ	O	cardiac	amod	14	SENT_268	[p18l102t1505r357b1568],
14	output	NN	O	output	prep_in	11	SENT_268	[p18l383t1517r636b1588],
15	,	,	O	,	_	0	SENT_268	[p18l383t1517r636b1588],
16	a	DT	O	a	det	17	SENT_268	[p18l664t1528r700b1568],
17	reduction	NN	O	reduction	dobj	5	SENT_268	[p18l724t1505r1070b1568],
18	in	IN	O	in	_	0	SENT_268	[p18l1096t1511r1165b1567],
19	vascular	JJ	O	vascular	amod	20	SENT_268	[p18l1187t1505r1485b1568],
20	resistance	NN	O	resistance	prep_in	17	SENT_268	[p18l1509t1511r1877b1577],
21	,	,	O	,	_	0	SENT_268	[p18l1509t1511r1877b1577],
22	and	CC	O	and	_	0	SENT_268	[p18l1905t1505r2036b1568],
23	an	DT	O	a	det	24	SENT_268	[p18l2061t1528r2143b1568],
24	increase	NN	O	increase	dobj	5	SENT_268	[p18l8t1613r287b1670],
25	in	IN	O	in	_	0	SENT_268	[p18l309t1613r375b1669],
26	glomerular	JJ	O	glomerular	amod	28	SENT_268	[p18l396t1607r780b1691],
27	ﬁltration	NN	O	ﬁltration	nn	28	SENT_268	[p18l800t1607r1101b1670],
28	rate	NN	O	rate	prep_in	24	SENT_268	[p18l1123t1600r1333b1670],
29	.55	CD	NUMBER	.55	dep	28	SENT_268	[p18l1123t1600r1333b1670],
30	These	DT	O	these	det	32	SENT_268	[p18l1356t1607r1551b1670],
31	biological	JJ	O	biological	amod	32	SENT_268	[p18l1570t1607r1908b1691],
32	effects	NNS	O	effect	nsubj	33	SENT_268	[p18l1930t1607r2143b1670],
33	suggest	VBP	O	suggest	rcmod	29	SENT_268	[p18l8t1722r254b1794],
34	that	IN	O	that	complm	41	SENT_268	[p18l273t1710r406b1773],
35	relaxin	NN	O	relaxin	nsubj	41	SENT_268	[p18l425t1710r657b1773],
36	might	MD	O	might	aux	41	SENT_268	[p18l678t1710r879b1794],
37	be	VB	O	be	cop	41	SENT_268	[p18l897t1710r975b1773],
38	an	DT	O	a	det	41	SENT_268	[p18l996t1733r1075b1773],
39	ideal	JJ	O	ideal	amod	41	SENT_268	[p18l1096t1710r1257b1773],
40	therapeutic	JJ	O	therapeutic	amod	41	SENT_268	[p18l1276t1710r1662b1793],
41	agent	NN	O	agent	ccomp	33	SENT_268	[p18l1683t1722r1864b1794],
42	in	IN	O	in	_	0	SENT_268	[p18l1883t1716r1949b1772],
43	AHF	NNP	ORGANIZATION	AHF	prep_in	41	SENT_268	[p18l1968t1714r2144b1782],
44	,	,	O	,	_	0	SENT_268	[p18l1968t1714r2144b1782],
45	in	IN	O	in	_	0	SENT_268	[p18l8t1820r73b1876],
46	which	WDT	O	which	rel	52	SENT_268	[p18l92t1814r298b1877],
47	the	DT	O	the	det	50	SENT_268	[p18l318t1814r423b1877],
48	opposite	JJ	O	opposite	amod	50	SENT_268	[p18l444t1820r730b1897],
49	pathophysiological	JJ	O	pathophysiological	amod	50	SENT_268	[p18l749t1814r1391b1898],
50	changes	NNS	O	change	nsubjpass	52	SENT_268	[p18l1411t1814r1676b1898],
51	are	VBP	O	be	auxpass	52	SENT_268	[p18l1698t1837r1797b1877],
52	observed	VBN	O	observe	rcmod	28	SENT_268	[p18l1818t1814r2139b1877],
53	.	.	O	.	_	0	SENT_268	[p18l1818t1814r2139b1877],

1	Among	IN	O	among	_	0	SENT_269	[p18l7t1921r266b2001],
2	potential	JJ	O	potential	amod	4	SENT_269	[p18l284t1917r592b2000],
3	other	JJ	O	other	amod	4	SENT_269	[p18l613t1917r795b1980],
4	mechanisms	NNS	O	mechanism	prep_among	7	SENT_269	[p18l815t1917r1261b1989],
5	,	,	O	,	_	0	SENT_269	[p18l815t1917r1261b1989],
6	relaxin	NN	O	relaxin	nsubj	7	SENT_269	[p18l1284t1917r1520b1980],
7	acts	VBZ	O	act	_	0	SENT_269	[p18l1542t1929r1670b1980],
8	by	IN	O	by	_	0	SENT_269	[p18l1690t1917r1774b2001],
9	increasing	VBG	O	increase	prepc_by	7	SENT_269	[p18l1792t1923r2146b2001],
10	the	DT	O	the	det	11	SENT_269	[p18l7t2020r116b2083],
11	expression	NN	O	expression	iobj	9	SENT_269	[p18l142t2026r517b2103],
12	of	IN	O	of	_	0	SENT_269	[p18l543t2020r618b2083],
13	endothelin	NN	O	endothelin	prep_of	11	SENT_269	[p18l634t2020r1204b2104],
14	—	CD	NUMBER	—	num	17	SENT_269	[p18l634t2020r1204b2104],
15	type	NN	O	type	nn	17	SENT_269	[p18l634t2020r1204b2104],
16	B	NN	O	b	nn	17	SENT_269	[p18l1229t2025r1275b2082],
17	receptors	NNS	O	receptor	dobj	9	SENT_269	[p18l1301t2032r1627b2103],
18	in	IN	O	in	_	0	SENT_269	[p18l1652t2026r1720b2082],
19	endothelial	JJ	O	endothelial	amod	20	SENT_269	[p18l1746t2020r2144b2083],
20	cells	NNS	O	cell	prep_in	17	SENT_269	[p18l8t2123r173b2186],
21	.	.	O	.	_	0	SENT_269	[p18l8t2123r173b2186],

1	This	DT	O	this	det	2	SENT_270	[p18l200t2123r345b2186],
2	receptor	NN	O	receptor	nsubj	3	SENT_270	[p18l370t2135r660b2206],
3	has	VBZ	O	have	_	0	SENT_270	[p18l682t2123r795b2186],
4	a	DT	O	a	det	6	SENT_270	[p18l821t2146r856b2186],
5	clearance	NN	O	clearance	nn	6	SENT_270	[p18l879t2123r1203b2186],
6	function	NN	O	function	dobj	3	SENT_270	[p18l1228t2123r1527b2186],
7	for	IN	O	for	_	0	SENT_270	[p18l1551t2123r1650b2186],
8	endothelin	NN	O	endothelin	prep_for	6	SENT_270	[p18l1673t2123r2079b2186],
9	-	:	O	-	_	0	SENT_270	[p18l1673t2123r2079b2186],
10	1	CD	DATE	1	dep	6	SENT_270	[p18l2094t2130r2144b2195],
11	,	,	O	,	_	0	SENT_270	[p18l2094t2130r2144b2195],
12	a	DT	O	a	det	14	SENT_270	[p18l8t2249r43b2289],
13	potent	JJ	O	potent	amod	14	SENT_270	[p18l70t2238r306b2309],
14	Vasoconstrictor	NNP	O	Vasoconstrictor	appos	10	SENT_270	[p18l331t2232r912b2289],
15	.	.	O	.	_	0	SENT_270	[p18l331t2232r912b2289],

1	Therefore	RB	O	therefore	advmod	8	SENT_271	[p18l944t2226r1311b2298],
2	,	,	O	,	_	0	SENT_271	[p18l944t2226r1311b2298],
3	relaxin	NN	O	relaxin	nsubj	8	SENT_271	[p18l1342t2226r1592b2289],
4	is	VBZ	O	be	cop	8	SENT_271	[p18l1621t2232r1674b2289],
5	a	DT	O	a	det	8	SENT_271	[p18l1704t2249r1739b2289],
6	functional	JJ	O	functional	amod	8	SENT_271	[p18l1767t2226r2144b2289],
7	endothelin-1	NN	O	endothelin-1	nn	8	SENT_271	[p18l8t2329r466b2392],
8	antagonist	NN	O	antagonist	_	0	SENT_271	[p18l500t2335r890b2413],
9	.	.	O	.	_	0	SENT_271	[p18l500t2335r890b2413],

1	Interestingly	RB	O	interestingly	advmod	8	SENT_272	[p18l920t2329r1387b2413],
2	,	,	O	,	_	0	SENT_272	[p18l920t2329r1387b2413],
3	the	DT	O	the	det	4	SENT_272	[p18l1414t2329r1525b2392],
4	effects	NNS	O	effect	nsubj	8	SENT_272	[p18l1552t2329r1774b2392],
5	of	IN	O	of	_	0	SENT_272	[p18l1802t2329r1879b2392],
6	relaxin	NN	O	relaxin	prep_of	4	SENT_272	[p18l1896t2329r2143b2392],
7	are	VBP	O	be	cop	8	SENT_272	[p18l8t2455r114b2495],
8	selective	JJ	O	selective	_	0	SENT_272	[p18l146t2432r455b2495],
9	to	TO	O	to	aux	10	SENT_272	[p18l484t2444r553b2495],
10	constricted	VBN	O	constrict	xcomp	8	SENT_272	[p18l586t2432r998b2495],
11	vessels	NNS	O	vessel	dobj	10	SENT_272	[p18l1024t2432r1290b2504],
12	,	,	O	,	_	0	SENT_272	[p18l1024t2432r1290b2504],
13	implying	VBG	O	imply	partmod	10	SENT_272	[p18l1323t2432r1650b2516],
14	that	IN	O	that	complm	17	SENT_272	[p18l1678t2432r1821b2495],
15	it	PRP	O	it	nsubj	17	SENT_272	[p18l1850t2438r1899b2495],
16	might	MD	O	might	aux	17	SENT_272	[p18l1928t2432r2144b2516],
17	provide	VB	O	provide	ccomp	13	SENT_272	[p18l6t2535r272b2618],
18	a	DT	O	a	det	20	SENT_272	[p18l296t2558r331b2598],
19	targeted	VBN	O	target	amod	20	SENT_272	[p18l352t2535r636b2619],
20	utilization	NN	O	utilization	dobj	17	SENT_272	[p18l659t2535r1034b2607],
21	,	,	O	,	_	0	SENT_272	[p18l659t2535r1034b2607],
22	e.g.	FW	O	e.g.	appos	20	SENT_272	[p18l1060t2558r1193b2619],
23	,	,	O	,	_	0	SENT_272	[p18l1060t2558r1193b2619],
24	in	IN	O	in	_	0	SENT_272	[p18l1218t2541r1285b2597],
25	patients	NNS	O	patient	prep_in	17	SENT_272	[p18l1308t2541r1582b2618],
26	with	IN	O	with	_	0	SENT_272	[p18l1605t2535r1760b2598],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_272	[p18l1784t2535r2146b2619],
28	hypertension	NN	O	hypertension	prep_with	25	SENT_272	[p18l7t2638r477b2722],
29	or	CC	O	or	_	0	SENT_272	[p18l502t2661r576b2701],
30	pulmonary	JJ	O	pulmonary	amod	31	SENT_272	[p18l599t2638r999b2722],
31	edema	NN	O	edema	conj_or	28	SENT_272	[p18l1021t2638r1271b2701],
32	.	.	O	.	_	0	SENT_272	[p18l1021t2638r1271b2701],

1	In	IN	O	in	_	0	SENT_273	[p18l1299t2643r1372b2700],
2	the	DT	O	the	prep_in	7	SENT_273	[p18l1396t2638r1506b2701],
3	randomized	VBN	O	randomize	partmod	2	SENT_273	[p18l1532t2638r1981b2710],
4	,	,	O	,	_	0	SENT_273	[p18l1532t2638r1981b2710],
5	placebo	NN	O	placebo	nn	6	SENT_273	[p18l2006t2638r2141b2721, p18l8t2740r551b2804],
6	—	NN	O	—	nsubj	7	SENT_273	[p18l2006t2638r2141b2721, p18l8t2740r551b2804],
7	controlled	VBN	O	control	_	0	SENT_273	[p18l2006t2638r2141b2721, p18l8t2740r551b2804],
8	Pre-RELAX	NNP	O	Pre-RELAX	dobj	7	SENT_273	[p18l572t2744r1180b2804],
9	.	.	O	.	_	0	SENT_273	[p18l572t2744r1180b2804],

1	—	NN	O	—	_	0	SENT_274	[p18l572t2744r1180b2804],
2	.	.	O	.	_	0	SENT_274	[p18l572t2744r1180b2804],

1	AHF	NN	ORGANIZATION	ahf	nn	2	SENT_275	[p18l572t2744r1180b2804],
2	trial	NN	O	trial	nsubj	8	SENT_275	[p18l1201t2740r1359b2812],
3	,	,	O	,	_	0	SENT_275	[p18l1201t2740r1359b2812],
4	treatment	NN	O	treatment	nsubj	8	SENT_275	[p18l1381t2752r1716b2804],
5	with	IN	O	with	_	0	SENT_275	[p18l1734t2740r1887b2804],
6	relaxin	NN	O	relaxin	prep_with	4	SENT_275	[p18l1908t2740r2142b2804],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_275	[p18l8t2844r436b2928],
8	reduced	VBD	O	reduce	_	0	SENT_275	[p18l456t2844r736b2907],
9	dyspnea	NN	O	dyspnea	dobj	8	SENT_275	[p18l759t2844r1043b2928],
10	and	CC	O	and	_	0	SENT_275	[p18l1066t2844r1194b2907],
11	the	DT	O	the	det	14	SENT_275	[p18l1216t2844r1324b2907],
12	combined	JJ	O	combined	amod	14	SENT_275	[p18l1349t2844r1696b2907],
13	end	NN	O	end	nn	14	SENT_275	[p18l1720t2844r1847b2907],
14	point	NN	O	point	conj_and	9	SENT_275	[p18l1869t2850r2055b2927],
15	of	IN	O	of	_	0	SENT_275	[p18l2078t2844r2153b2907],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_275	[p18l8t2946r513b3009],
17	death	NN	O	death	prep_of	14	SENT_275	[p18l535t2946r725b3009],
18	or	CC	O	or	_	0	SENT_275	[p18l749t2969r821b3009],
19	admission	NN	O	admission	prep_of	14	SENT_275	[p18l845t2946r1197b3009],
20	due	JJ	O	due	_	0	SENT_275	[p18l1222t2946r1345b3009],
21	to	TO	O	to	_	0	SENT_275	[p18l1368t2958r1434b3009],
22	heart	NN	O	heart	prep_due_to	8	SENT_275	[p18l1458t2946r1637b3009],
23	and	CC	O	and	_	0	SENT_275	[p18l1661t2946r1788b3009],
24	renal	JJ	O	renal	amod	25	SENT_275	[p18l1810t2946r1984b3009],
25	failure	NN	O	failure	conj_and	22	SENT_275	[p18l2007t2946r2141b3009, p18l7t3072r120b3112],

1	at	IN	O	at	_	0	SENT_276	[p18l145t3061r206b3112],
2	day	NN	DURATION	day	pobj	1	SENT_276	[p18l230t3049r354b3133],
3	60	CD	NUMBER	60	num	2	SENT_276	[p18l375t3055r473b3112],
4	.	.	O	.	_	0	SENT_276	[p18l375t3055r473b3112],

1	The	DT	O	the	nsubj	4	SENT_277	[p18l500t3049r628b3112],
2	randomized	VBN	O	randomize	partmod	1	SENT_277	[p18l653t3049r1097b3121],
3	,	,	O	,	_	0	SENT_277	[p18l653t3049r1097b3121],
4	controlled	VBN	O	control	_	0	SENT_277	[p18l1123t3049r1485b3112],
5	phase	NN	O	phase	nn	8	SENT_277	[p18l1507t3049r1707b3132],
6	III	CD	NUMBER	iii	num	8	SENT_277	[p18l1732t3054r1817b3111],
7	RELAXAHF	NN	O	relaxahf	nn	8	SENT_277	[p18l1843t3053r2140b3112, p18l7t3156r173b3214],
8	trial	NN	O	trial	dobj	4	SENT_277	[p18l195t3152r336b3215],
9	compared	VBN	O	compare	partmod	8	SENT_277	[p18l357t3152r700b3235],
10	serelaxin	NN	O	serelaxin	nn	12	SENT_277	[p18l721t3152r1025b3215],
11	(	NN	O	(	nn	12	SENT_277	[p18l1049t3152r1116b3229],
12	n	NN	O	n	nsubj	33	SENT_277	[p18l1049t3152r1116b3229],
13	=	JJ	O	=	dep	33	SENT_277	[p18l1140t3181r1182b3202],
14	581	CD	NUMBER	581	num	15	SENT_277	[p18l1207t3152r1352b3229],
15	)	NN	O	)	dep	22	SENT_277	[p18l1207t3152r1352b3229],
16	with	IN	O	with	_	0	SENT_277	[p18l1375t3152r1528b3215],
17	placebo	NN	O	placebo	prep_with	15	SENT_277	[p18l1548t3152r1811b3235],
18	(	CD	NUMBER	(	num	19	SENT_277	[p18l1837t3153r1904b3228],
19	n	NN	O	n	dep	22	SENT_277	[p18l1837t3153r1904b3228],
20	=	JJ	O	=	quantmod	21	SENT_277	[p18l1928t3181r1970b3202],
21	580	CD	NUMBER	580	num	22	SENT_277	[p18l1995t3152r2140b3229],
22	)	NN	O	)	dep	33	SENT_277	[p18l1995t3152r2140b3229],
23	in	IN	O	in	_	0	SENT_277	[p18l8t3260r76b3316],
24	patients	NNS	O	patient	prep_in	22	SENT_277	[p18l99t3260r378b3337],
25	with	IN	O	with	_	0	SENT_277	[p18l401t3254r558b3317],
26	AHF	NN	O	ahf	prep_with	24	SENT_277	[p18l581t3246r830b3317],
27	.56	CD	NUMBER	.56	num	26	SENT_277	[p18l581t3246r830b3317],
28	The	DT	O	the	det	31	SENT_277	[p18l855t3254r982b3317],
29	primary	JJ	O	primary	amod	31	SENT_277	[p18l1006t3260r1298b3338],
30	end	NN	O	end	nn	31	SENT_277	[p18l1319t3254r1448b3317],
31	point	NN	O	point	nsubj	33	SENT_277	[p18l1471t3260r1659b3337],
32	was	VBD	O	be	cop	33	SENT_277	[p18l1680t3277r1810b3317],
33	dyspnea	NN	O	dyspnea	xcomp	9	SENT_277	[p18l1835t3254r2140b3338],
34	.	.	O	.	_	0	SENT_277	[p18l1835t3254r2140b3338],

1	Secondary	JJ	O	secondary	amod	3	SENT_278	[p18l9t3357r384b3441],
2	end	NN	O	end	nn	3	SENT_278	[p18l405t3357r535b3420],
3	points	NNS	O	point	nsubj	5	SENT_278	[p18l557t3363r777b3440],
4	were	VBD	O	be	cop	5	SENT_278	[p18l801t3380r967b3420],
5	days	NNS	DURATION	day	_	0	SENT_278	[p18l992t3357r1146b3441],
6	survived	VBD	O	survive	rcmod	5	SENT_278	[p18l1172t3357r1476b3420],
7	out	IN	O	out	_	0	SENT_278	[p18l1500t3369r1614b3420],
8	of	IN	O	of	_	0	SENT_278	[p18l1639t3357r1714b3420],
9	the	DT	O	the	det	10	SENT_278	[p18l1728t3357r1838b3420],
10	hospital	NN	O	hospital	prep_out_of	6	SENT_278	[p18l1861t3357r2145b3440],
11	and	CC	O	and	_	0	SENT_278	[p18l8t3460r137b3523],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_278	[p18l161t3460r673b3523],
13	death	NN	O	death	prep_out_of	6	SENT_278	[p18l696t3460r889b3523],
14	or	CC	O	or	_	0	SENT_278	[p18l913t3483r986b3523],
15	rehospitalization	NN	O	rehospitalization	conj_and	10	SENT_278	[p18l1010t3460r1600b3543],
16	due	JJ	O	due	_	0	SENT_278	[p18l1624t3460r1749b3523],
17	to	TO	O	to	_	0	SENT_278	[p18l1773t3472r1840b3523],
18	heart	NN	O	heart	prep_due_to	6	SENT_278	[p18l1864t3460r2047b3523],
19	or	CC	O	or	_	0	SENT_278	[p18l2070t3483r2144b3523],
20	renal	JJ	O	renal	amod	21	SENT_278	[p18l8t3563r181b3626],
21	failure	NN	O	failure	conj_or	18	SENT_278	[p18l204t3563r424b3626],
22	within	IN	O	within	_	0	SENT_278	[p18l446t3563r672b3626],
23	60	CD	DURATION	60	num	24	SENT_278	[p18l695t3569r773b3626],
24	days	NNS	NUMBER	day	prep_within	6	SENT_278	[p18l799t3563r967b3647],
25	.	.	O	.	_	0	SENT_278	[p18l799t3563r967b3647],

1	Within	IN	O	within	_	0	SENT_279	[p18l992t3563r1238b3626],
2	the	DT	O	the	det	3	SENT_279	[p18l1261t3563r1368b3626],
3	ﬁrst	NN	O	ﬁrst	prep_within	10	SENT_279	[p18l1392t3563r1526b3626],
4	5	CD	DURATION	5	num	5	SENT_279	[p18l1550t3571r1584b3626],
5	days	NNS	NUMBER	day	tmod	3	SENT_279	[p18l1611t3563r1780b3647],
6	,	,	O	,	_	0	SENT_279	[p18l1611t3563r1780b3647],
7	treatment	NN	O	treatment	nsubj	10	SENT_279	[p18l1804t3575r2144b3626],
8	with	IN	O	with	_	0	SENT_279	[p18l6t3666r159b3729],
9	serelaxin	NN	O	serelaxin	prep_with	7	SENT_279	[p18l180t3666r485b3729],
10	improved	VBD	O	improve	_	0	SENT_279	[p18l506t3666r836b3749],
11	dyspnea	NN	O	dyspnea	dobj	10	SENT_279	[p18l856t3666r1136b3750],
12	by	IN	O	by	_	0	SENT_279	[p18l1154t3666r1238b3750],
13	19.4	CD	PERCENT	19.4	num	14	SENT_279	[p18l1262t3671r1478b3731],
14	%	NN	PERCENT	%	prep_by	10	SENT_279	[p18l1262t3671r1478b3731],
15	.	.	O	.	_	0	SENT_279	[p18l1262t3671r1478b3731],

1	The	DT	O	the	det	4	SENT_280	[p18l1502t3666r1627b3729],
2	secondary	JJ	O	secondary	amod	4	SENT_280	[p18l1649t3666r2003b3750],
3	end	NN	O	end	nn	4	SENT_280	[p18l2021t3666r2146b3729],
4	points	NNS	O	point	nsubj	6	SENT_280	[p19l6t22r230b99],
5	remained	VBD	O	remain	cop	6	SENT_280	[p19l258t16r599b79],
6	unchanged	JJ	O	unchanged	_	0	SENT_280	[p19l625t16r1038b100],
7	.	.	O	.	_	0	SENT_280	[p19l625t16r1038b100],

1	Interestingly	RB	O	interestingly	advmod	4	SENT_281	[p19l1069t16r1537b100],
2	,	,	O	,	_	0	SENT_281	[p19l1069t16r1537b100],
3	there	EX	O	there	expl	4	SENT_281	[p19l1564t16r1747b79],
4	was	VBD	O	be	_	0	SENT_281	[p19l1772t39r1904b79],
5	a	DT	O	a	det	8	SENT_281	[p19l1932t39r1967b79],
6	37	CD	PERCENT	37	num	8	SENT_281	[p19l1994t21r2141b81],
7	%	NN	PERCENT	%	nn	8	SENT_281	[p19l1994t21r2141b81],
8	reduction	NN	O	reduction	nsubj	4	SENT_281	[p19l8t119r344b182],
9	in	IN	O	in	_	0	SENT_281	[p19l366t125r433b181],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_281	[p19l456t119r960b182],
11	mortality	NN	O	mortality	prep_in	8	SENT_281	[p19l982t119r1307b203],
12	after	IN	O	after	_	0	SENT_281	[p19l1327t119r1481b182],
13	a	DT	O	a	det	15	SENT_281	[p19l1503t142r1538b182],
14	follow-up	JJ	O	follow-up	amod	15	SENT_281	[p19l1558t119r1893b202],
15	period	NN	O	period	prep_after	11	SENT_281	[p19l1915t119r2145b202],
16	of	IN	O	of	_	0	SENT_281	[p19l8t221r84b284],
17	180	CD	DURATION	180	num	18	SENT_281	[p19l105t228r222b284],
18	days	NNS	NUMBER	day	prep_of	15	SENT_281	[p19l248t221r402b305],
19	(	CD	NUMBER	(	num	21	SENT_281	[p19l430t222r699b304],
20	Figure	NN	O	figure	nn	21	SENT_281	[p19l430t222r699b304],
21	3a	NN	O	3a	tmod	15	SENT_281	[p19l723t214r990b298],
22	,	,	O	,	_	0	SENT_281	[p19l723t214r990b298],
23	b	NN	O	b	appos	21	SENT_281	[p19l723t214r990b298],
24	)	CD	NUMBER	)	number	25	SENT_281	[p19l723t214r990b298],
25	.57	CD	NUMBER	.57	num	27	SENT_281	[p19l723t214r990b298],
26	The	DT	O	the	det	27	SENT_281	[p19l1014t221r1142b284],
27	reduction	NN	O	reduction	nsubj	38	SENT_281	[p19l1166t221r1511b284],
28	of	IN	O	of	_	0	SENT_281	[p19l1536t221r1612b285],
29	cardiovascular	JJ	O	cardiovascular	amod	30	SENT_281	[p19l1627t221r2145b284],
30	mortality	NN	O	mortality	prep_of	27	SENT_281	[p19l7t324r343b408],
31	was	VBD	O	be	aux	36	SENT_281	[p19l362t347r493b387],
32	not	RB	O	not	neg	36	SENT_281	[p19l518t336r636b387],
33	a	DT	O	a	det	36	SENT_281	[p19l660t347r696b387],
34	predeﬁned	JJ	O	predeﬁned	amod	36	SENT_281	[p19l718t324r1102b407],
35	end	NN	O	end	nn	36	SENT_281	[p19l1126t324r1257b387],
36	point	NN	O	point	rcmod	23	SENT_281	[p19l1279t330r1470b407],
37	but	CC	O	but	_	0	SENT_281	[p19l1491t324r1609b387],
38	was	VBD	O	be	conj_but	36	SENT_281	[p19l1631t347r1761b387],
39	consistent	JJ	O	consistent	amod	11	SENT_281	[p19l1787t330r2146b387],
40	a	DT	O	a	dep	39	SENT_281	[p19l18t424r62b473],

1	E	NN	O	e	dep	10	SENT_282	[p19l27t546r77b600],
2	35	CD	NUMBER	35	num	1	SENT_282	[p19l126t523r181b561],
3	I	PRP	O	I	dep	1	SENT_282	[p19l256t530r307b564],
4	Serelaxin	NN	O	serelaxin	nn	6	SENT_282	[p19l331t530r543b570],
5	(	NN	O	(	nn	6	SENT_282	[p19l563t530r608b580],
6	n	NN	O	n	dep	3	SENT_282	[p19l563t530r608b580],
7	=	JJ	O	=	dep	10	SENT_282	[p19l623t548r650b563],
8	581	CD	NUMBER	581	number	9	SENT_282	[p19l667t530r767b580],
9	)	CD	NUMBER	)	num	10	SENT_282	[p19l667t530r767b580],
10	AUC	NN	ORGANIZATION	auc	dep	53	SENT_282	[p19l809t530r914b570],
11	with	IN	O	with	_	0	SENT_282	[p19l931t531r1020b570],
12	serelaxin	NN	O	serelaxin	prep_with	10	SENT_282	[p19l1039t531r1256b577],
13	,	,	O	,	_	0	SENT_282	[p19l1039t531r1256b577],
14	2756	CD	DATE	2756	dep	21	SENT_282	[p19l1275t532r1389b570],
15	(	CD	NUMBER	(	num	16	SENT_282	[p19l1408t530r1624b580],
16	SD2588	NN	O	sd2588	dep	14	SENT_282	[p19l1408t530r1624b580],
17	)	CD	NUMBER	)	num	18	SENT_282	[p19l1408t530r1624b580],
18	mm	NN	O	mm	dep	21	SENT_282	[p19l1644t540r1726b569],
19	x	NN	O	x	nn	21	SENT_282	[p19l1743t541r1771b569],
20	h	NN	O	h	nn	21	SENT_282	[p19l1789t531r1812b569],
21	E	NN	O	e	dep	25	SENT_282	[p19l37t606r66b644],
22	30	CD	NUMBER	30	num	23	SENT_282	[p19l126t614r181b653],
23	‘	NN	O	‘	dep	21	SENT_282	[p19l225t580r227b589],
24	I	PRP	O	I	nsubj	25	SENT_282	[p19l257t588r307b617],
25	Placebo	VBP	O	placebo	dep	53	SENT_282	[p19l333t582r516b621],
26	(	CD	NUMBER	(	num	27	SENT_282	[p19l534t581r579b631],
27	n	NN	O	n	nsubj	28	SENT_282	[p19l534t581r579b631],
28	=	JJ	O	=	ccomp	25	SENT_282	[p19l594t599r621b614],
29	580	CD	NUMBER	580	number	30	SENT_282	[p19l638t581r738b631],
30	)	CD	NUMBER	)	num	31	SENT_282	[p19l638t581r738b631],
31	AUC	NN	ORGANIZATION	auc	dobj	28	SENT_282	[p19l809t581r914b621],
32	with	IN	O	with	_	0	SENT_282	[p19l931t582r1020b621],
33	placebo	NN	O	placebo	prep_with	31	SENT_282	[p19l1040t582r1228b631],
34	,	,	O	,	_	0	SENT_282	[p19l1040t582r1228b631],
35	2308	CD	DATE	2308	num	36	SENT_282	[p19l1247t583r1361b621],
36	(	CD	NUMBER	(	dep	46	SENT_282	[p19l1380t581r1596b631],
37	SD3082	NN	O	sd3082	nn	40	SENT_282	[p19l1380t581r1596b631],
38	)	CD	NUMBER	)	num	40	SENT_282	[p19l1380t581r1596b631],
39	mm	NN	O	mm	nn	40	SENT_282	[p19l1616t591r1698b620],
40	x	NN	O	x	dep	36	SENT_282	[p19l1715t592r1742b620],
41	h	NN	O	h	nn	42	SENT_282	[p19l1761t582r1784b620],
42	B	NN	O	b	dep	40	SENT_282	[p19l27t649r77b706],
43	’	CD	NUMBER	’	num	44	SENT_282	[p19l27t649r77b706],
44	P	NN	O	p	dep	46	SENT_282	[p19l627t648r662b686],
45	=	JJ	O	=	amod	46	SENT_282	[p19l674t665r701b680],
46	0.007	CD	NUMBER	0.007	dep	53	SENT_282	[p19l718t649r846b687],
47	g	NN	O	g	nn	49	SENT_282	[p19l28t710r66b756],
48	25	CD	NUMBER	25	num	49	SENT_282	[p19l125t707r181b745],
49	G.	NNP	O	G.	dep	46	SENT_282	[p19l37t761r67b786],
50	)	CD	NUMBER	)	number	51	SENT_282	[p19l37t761r67b786],
51	8	CD	NUMBER	8	dep	49	SENT_282	[p19l37t790r67b842],
52	20	CD	NUMBER	20	num	53	SENT_282	[p19l125t798r181b837],
53	»	NN	O	»	_	0	SENT_282	[p19l208t815r223b824],
54	.	.	O	.	_	0	SENT_282	[p19l28t845r67b869],

1	Q	NNP	O	Q	nn	2	SENT_283	[p19l28t845r67b869],
2	E	NNP	O	E	_	0	SENT_283	[p19l37t890r66b927],
3	15	CD	NUMBER	15	number	4	SENT_283	[p19l129t891r181b929],
4	—	CD	NUMBER	—	num	5	SENT_283	[p19l209t912r223b915],
5	9	CD	NUMBER	9	dep	2	SENT_283	[p19l37t931r67b972],
6	"	``	O	"	punct	5	SENT_283	[p19l28t976r67b1032],
7	5	CD	NUMBER	5	number	8	SENT_283	[p19l28t976r67b1032],
8	10	CD	NUMBER	10	dep	5	SENT_283	[p19l129t982r181b1021],
9	—	NN	O	—	dep	8	SENT_283	[p19l209t998r223b999],
10	8	CD	NUMBER	8	number	11	SENT_283	[p19l37t1036r78b1089],
11	’	CD	NUMBER	’	dep	2	SENT_283	[p19l37t1036r78b1089],
12	cu	NN	O	cu	dep	11	SENT_283	[p19l37t1093r67b1119],
13	5	CD	NUMBER	5	num	12	SENT_283	[p19l155t1075r181b1113],
14	.	.	O	.	_	0	SENT_283	[p19l225t1119r227b1123],

1	.	.	O	.	_	0	SENT_284	[p19l28t1124r66b1147],

1	C	NN	O	c	nn	6	SENT_285	[p19l28t1124r66b1147],
2	o	NN	O	o	nn	6	SENT_285	[p19l27t1152r67b1185],
3	o	NN	O	o	nn	6	SENT_285	[p19l155t1167r181b1205],
4	—	NN	O	—	nn	6	SENT_285	[p19l208t1173r239b1193],
5	'	''	O	'	_	0	SENT_285	[p19l208t1173r239b1193],
6	KT	NN	O	kt	_	0	SENT_285	[p19l300t1184r339b1208],
7	*	NN	O	*	dep	6	SENT_285	[p19l300t1184r339b1208],
8	=	JJ	O	=	amod	7	SENT_285	[p19l415t1184r427b1192],
9	`	``	O	`	_	0	SENT_285	[p19l572t1184r1351b1209],
10	ILT	NNP	O	ILT	nn	12	SENT_285	[p19l572t1184r1351b1209],
11	*	CD	NUMBER	*	num	12	SENT_285	[p19l572t1184r1351b1209],
12	eeee	NN	O	eeee	dep	7	SENT_285	[p19l1680t1184r1703b1185],
13	in	IN	O	in	prep	12	SENT_285	[p19l1715t1184r2069b1191],
14	e	SYM	O	e	dep	13	SENT_285	[p19l2070t1194r2076b1195],

1	o	NN	O	o	dep	13	SENT_286	[p19l218t1235r243b1273],
2	6	CD	DATE	6	number	3	SENT_286	[p19l309t1235r335b1273],
3	12	CD	DATE	12	num	7	SENT_286	[p19l364t1235r415b1272],
4	h	NN	DATE	h	nn	7	SENT_286	[p19l434t1234r458b1272],
5	Day	NN	DATE	day	nn	7	SENT_286	[p19l532t1234r619b1283],
6	1	CD	DATE	1	num	7	SENT_286	[p19l639t1235r653b1272],
7	Day	NN	DATE	day	dep	1	SENT_286	[p19l902t1234r988b1283],
8	2	CD	DATE	2	num	9	SENT_286	[p19l1004t1235r1030b1272],
9	Day	NN	DATE	day	dep	7	SENT_286	[p19l1273t1234r1359b1283],
10	3	CD	DATE	3	num	11	SENT_286	[p19l1375t1235r1401b1273],
11	Day	NN	DATE	day	dep	13	SENT_286	[p19l1646t1234r1733b1283],
12	4	CD	DATE	4	num	13	SENT_286	[p19l1748t1235r1776b1272],
13	Day	NN	DATE	day	_	0	SENT_286	[p19l2010t1234r2097b1283],
14	5	CD	DATE	5	dep	13	SENT_286	[p19l2113t1236r2139b1273],

1	Follow-up	JJ	O	follow-up	amod	2	SENT_287	[p19l1045t1327r1262b1376],
2	b	NN	O	b	_	0	SENT_287	[p19l21t1412r67b1475],

1	14	CD	NUMBER	14	_	0	SENT_288	[p19l190t1487r241b1524],
2	i	FW	O	i	nn	4	SENT_288	[p19l288t1507r291b1511],
3	—	FW	O	—	nn	4	SENT_288	[p19l328t1499r408b1507],
4	Placebo	NN	O	placebo	dep	1	SENT_288	[p19l438t1482r633b1521],
5	:	:	O	:	_	0	SENT_288	[p19l438t1482r633b1521],
6	75	CD	NUMBER	75	num	7	SENT_288	[p19l730t1483r784b1521],
7	events	NNS	O	event	npadvmod	8	SENT_288	[p19l803t1484r950b1521],
8	(	JJ	O	(	amod	10	SENT_288	[p19l969t1481r1145b1530],
9	13.0	CD	PERCENT	13.0	num	10	SENT_288	[p19l969t1481r1145b1530],
10	%	NN	PERCENT	%	dep	1	SENT_288	[p19l969t1481r1145b1530],
11	)	CD	NUMBER	)	number	12	SENT_288	[p19l969t1481r1145b1530],
12	—	CD	NUMBER	—	num	13	SENT_288	[p19l325t1553r412b1561],
13	Serelaxin	NN	O	serelaxin	dep	10	SENT_288	[p19l436t1535r662b1575],
14	:	:	O	:	_	0	SENT_288	[p19l436t1535r662b1575],
15	76	CD	NUMBER	76	num	16	SENT_288	[p19l730t1537r785b1575],
16	events	NNS	O	event	dep	1	SENT_288	[p19l803t1538r950b1575],
17	(	JJ	O	(	dep	19	SENT_288	[p19l969t1535r1145b1585],
18	13.2	CD	PERCENT	13.2	number	19	SENT_288	[p19l969t1535r1145b1585],
19	%	NN	PERCENT	%	amod	16	SENT_288	[p19l969t1535r1145b1585],
20	)	CD	NUMBER	)	dep	1	SENT_288	[p19l969t1535r1145b1585],

1	HR	NN	DURATION	hr	dep	9	SENT_289	[p19l627t1637r697b1675],
2	1.02	CD	PERCENT	1.02	number	3	SENT_289	[p19l717t1638r812b1676],
3	(	CD	PERCENT	(	dep	1	SENT_289	[p19l832t1636r948b1686],
4	95	CD	PERCENT	95	num	5	SENT_289	[p19l832t1636r948b1686],
5	%	NN	PERCENT	%	dep	3	SENT_289	[p19l832t1636r948b1686],
6	CI	NN	O	ci	dep	9	SENT_289	[p19l966t1636r1010b1676],
7	0.74-1	CD	NUMBER	0.74-1	num	6	SENT_289	[p19l1029t1636r1273b1686],
8	.41	CD	NUMBER	.41	num	9	SENT_289	[p19l1029t1636r1273b1686],
9	)	NN	O	)	dep	15	SENT_289	[p19l1029t1636r1273b1686],
10	—	CD	NUMBER	—	num	11	SENT_289	[p19l1897t1657r1946b1659],
11	P	NN	O	p	dep	9	SENT_289	[p19l627t1706r817b1746],
12	=	JJ	O	=	amod	11	SENT_289	[p19l627t1706r817b1746],
13	089	CD	NUMBER	089	number	14	SENT_289	[p19l627t1706r817b1746],
14	““	CD	NUMBER	““	dep	12	SENT_289	[p19l1770t1700r1829b1702],
15	““	NN	O	““	dep	18	SENT_289	[p19l1770t1700r1829b1702],
16	““	CD	NUMBER	““	num	15	SENT_289	[p19l1770t1700r1829b1702],
17	“	CD	NUMBER	“	num	18	SENT_289	[p19l1770t1700r1829b1702],
18	“	NN	O	“	_	0	SENT_289	[p19l1830t1700r1839b1702],

1	.	.	O	.	_	0	SENT_290	[p19l190t1696r204b1733],

1	—	NN	O	—	_	0	SENT_291	[p19l190t1696r204b1733],
2	.	.	O	.	_	0	SENT_291	[p19l190t1696r204b1733],

1	L	NN	O	l	nn	2	SENT_292	[p19l190t1696r204b1733],
2	R	NN	O	r	_	0	SENT_292	[p19l215t1696r240b1733],
3	)	CD	NUMBER	)	dep	2	SENT_292	[p19l215t1696r240b1733],

1	“	NN	O	“	nn	2	SENT_293	[p19l1643t1914r1700b1950],
2	l	NN	O	l	_	0	SENT_293	[p19l1643t1914r1700b1950],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_294	[p19l31t2317r71b2660],
2	death	NN	O	death	_	0	SENT_294	[p19l32t2176r71b2301],
3	or	CC	O	or	_	0	SENT_294	[p19l41t2111r71b2156],
4	readmission	NN	O	readmission	conj_or	2	SENT_294	[p19l32t1820r71b2094],
5	to	TO	O	to	_	0	SENT_294	[p19l96t2718r133b2760],
6	hospital	NN	O	hospital	prep_to	2	SENT_294	[p19l94t2526r143b2699],
7	for	IN	O	for	_	0	SENT_294	[p19l93t2449r133b2508],
8	heart	NN	O	heart	nn	9	SENT_294	[p19l94t2315r133b2432],
9	failure	NN	O	failure	prep_for	6	SENT_294	[p19l93t2161r133b2299],
10	or	CC	O	or	_	0	SENT_294	[p19l103t2099r133b2144],
11	renal	JJ	O	renal	amod	12	SENT_294	[p19l94t1972r133b2081],
12	failure	NN	O	failure	prep_for	6	SENT_294	[p19l93t1816r133b1954],
13	(	CD	PERCENT	(	num	14	SENT_294	[p19l93t1722r143b1796],
14	%	NN	PERCENT	%	dep	2	SENT_294	[p19l93t1722r143b1796],
15	)	CD	NUMBER	)	dep	14	SENT_294	[p19l93t1722r143b1796],

1	Time	NNP	O	Time	_	0	SENT_295	[p19l745t3109r859b3148],
2	since	IN	O	since	dep	1	SENT_295	[p19l877t3109r995b3148],
3	randomization	NN	O	randomization	pobj	2	SENT_295	[p19l1015t3109r1335b3148],
4	(	CD	NUMBER	(	num	5	SENT_295	[p19l1356t3108r1492b3158],
5	days	NNS	NUMBER	day	tmod	3	SENT_295	[p19l1356t3108r1492b3158],
6	)	IN	O	)	dep	1	SENT_295	[p19l1356t3108r1492b3158],

1	Figure	NNP	O	Figure	_	0	SENT_296	[p19l10t3273r197b3335],
2	3	CD	NUMBER	3	num	3	SENT_296	[p19l213t3276r244b3322],
3	Results	NNS	O	result	dep	1	SENT_296	[p19l286t3273r476b3322],
4	of	IN	O	of	_	0	SENT_296	[p19l493t3272r550b3322],
5	the	DT	O	the	det	6	SENT_296	[p19l560t3273r651b3322],
6	Relaxin	NNP	O	Relaxin	prep_of	3	SENT_296	[p19l670t3273r862b3322],
7	for	IN	O	for	_	0	SENT_296	[p19l880t3272r956b3322],
8	the	DT	O	the	det	9	SENT_296	[p19l969t3273r1060b3322],
9	treatment	NN	O	treatment	prep_for	6	SENT_296	[p19l1075t3280r1352b3322],
10	of	IN	O	of	_	0	SENT_296	[p19l1368t3272r1425b3322],
11	patients	NNS	O	patient	prep_of	9	SENT_296	[p19l1439t3275r1659b3334],
12	with	IN	O	with	_	0	SENT_296	[p19l1675t3273r1794b3322],
13	acute	JJ	O	acute	amod	14	SENT_296	[p19l1812t3280r1963b3322],
14	heart	NN	O	heart	prep_with	11	SENT_296	[p19l10t3359r153b3409],
15	failure	NN	O	failure	nn	17	SENT_296	[p19l167t3358r339b3409],
16	(	CD	NUMBER	(	num	17	SENT_296	[p19l358t3360r703b3417],
17	RELAX	NNP	O	RELAX	dep	3	SENT_296	[p19l358t3360r703b3417],
18	.	.	O	.	_	0	SENT_296	[p19l358t3360r703b3417],

1	—	NN	O	—	_	0	SENT_297	[p19l358t3360r703b3417],
2	.	.	O	.	_	0	SENT_297	[p19l358t3360r703b3417],

1	AHF	NN	ORGANIZATION	ahf	nn	4	SENT_298	[p19l358t3360r703b3417],
2	)	CD	NUMBER	)	num	4	SENT_298	[p19l358t3360r703b3417],
3	tria	NN	O	trium	nn	4	SENT_298	[p19l720t3352r877b3409],
4	|	NN	O	|	nsubj	22	SENT_298	[p19l720t3352r877b3409],
5	57	CD	NUMBER	57	nsubj	9	SENT_298	[p19l720t3352r877b3409],
6	showing	VBG	O	show	partmod	5	SENT_298	[p19l893t3359r1127b3422],
7	(	CD	NUMBER	(	dobj	6	SENT_298	[p19l1147t3360r1212b3417],
8	a	DT	O	a	det	9	SENT_298	[p19l1147t3360r1212b3417],
9	)	NN	O	)	rcmod	4	SENT_298	[p19l1147t3360r1212b3417],
10	the	DT	O	the	det	12	SENT_298	[p19l1229t3359r1319b3409],
11	significant	JJ	O	significant	amod	12	SENT_298	[p19l1336t3358r1621b3422],
12	improvement	NN	O	improvement	dobj	9	SENT_298	[p19l1638t3361r2014b3422],
13	of	IN	O	of	_	0	SENT_298	[p19l2029t3358r2087b3409],
14	dyspnea	NN	O	dyspnea	prep_of	12	SENT_298	[p19l8t3445r239b3508],
15	in	IN	O	in	_	0	SENT_298	[p19l259t3448r304b3494],
16	the	DT	O	the	det	18	SENT_298	[p19l321t3445r411b3495],
17	serelaxin	NN	O	serelaxin	nn	18	SENT_298	[p19l428t3445r668b3495],
18	group	NN	O	group	prep_in	9	SENT_298	[p19l686t3460r853b3508],
19	and	CC	O	and	_	0	SENT_298	[p19l869t3445r970b3495],
20	(	NN	O	(	nn	21	SENT_298	[p19l991t3445r1061b3502],
21	b	NN	O	b	prep_in	9	SENT_298	[p19l991t3445r1061b3502],
22	)	VBD	O	)	_	0	SENT_298	[p19l991t3445r1061b3502],
23	the	DT	O	the	det	25	SENT_298	[p19l1078t3445r1168b3495],
24	neutral	JJ	O	neutral	amod	25	SENT_298	[p19l1186t3445r1377b3495],
25	effect	NN	O	effect	dobj	22	SENT_298	[p19l1396t3445r1551b3495],
26	on	IN	O	on	_	0	SENT_298	[p19l1566t3460r1634b3495],
27	the	DT	O	the	det	30	SENT_298	[p19l1651t3445r1742b3495],
28	secondary	JJ	O	secondary	amod	30	SENT_298	[p19l1759t3445r2045b3508],
29	end	NN	O	end	nn	30	SENT_298	[p19l8t3532r110b3581],
30	point	NN	O	point	prep_on	22	SENT_298	[p19l131t3534r276b3593],
31	of	IN	O	of	_	0	SENT_298	[p19l291t3531r349b3581],
32	cardiovascular	JJ	O	cardiovascular	amod	33	SENT_298	[p19l360t3532r757b3581],
33	death	NN	O	death	prep_of	30	SENT_298	[p19l772t3532r929b3581],
34	or	CC	O	or	_	0	SENT_298	[p19l948t3546r1004b3581],
35	rehospitalization	NN	O	rehospitalization	conj_or	33	SENT_298	[p19l1021t3532r1479b3593],
36	due	JJ	O	due	_	0	SENT_298	[p19l1497t3532r1602b3581],
37	to	TO	O	to	_	0	SENT_298	[p19l1617t3539r1673b3581],
38	heart	NN	O	heart	prep_due_to	22	SENT_298	[p19l1692t3532r1835b3581],
39	or	CC	O	or	_	0	SENT_298	[p19l1850t3546r1907b3581],
40	renal	JJ	O	renal	amod	41	SENT_298	[p19l1923t3532r2055b3581],
41	failure	NN	O	failure	prep_due_to	22	SENT_298	[p19l7t3616r191b3666],
42	.	.	O	.	_	0	SENT_298	[p19l7t3616r191b3666],

1	AUC	NN	O	auc	_	0	SENT_299	[p19l207t3619r339b3674],
2	,	,	O	,	_	0	SENT_299	[p19l207t3619r339b3674],
3	area	NN	O	area	appos	1	SENT_299	[p19l355t3631r469b3666],
4	under	IN	O	under	_	0	SENT_299	[p19l489t3617r652b3666],
5	the	DT	O	the	det	6	SENT_299	[p19l665t3617r756b3666],
6	curve	NN	O	curve	prep_under	3	SENT_299	[p19l772t3631r937b3666],
7	.	.	O	.	_	0	SENT_299	[p19l772t3631r937b3666],

1	with	IN	O	with	_	0	SENT_300	[p20l7t83r161b147],
2	the	DT	O	the	det	3	SENT_300	[p20l183t83r291b147],
3	results	NNS	O	result	pobj	1	SENT_300	[p20l315t83r538b147],
4	of	IN	O	of	_	0	SENT_300	[p20l562t83r637b147],
5	the	DT	O	the	det	6	SENT_300	[p20l650t83r757b147],
6	Pre	NNP	O	Pre	prep_of	3	SENT_300	[p20l782t87r1398b147],
7	.	.	O	.	_	0	SENT_300	[p20l782t87r1398b147],

1	—	NN	O	—	_	0	SENT_301	[p20l782t87r1398b147],
2	.	.	O	.	_	0	SENT_301	[p20l782t87r1398b147],

1	RELAX	NN	O	relax	_	0	SENT_302	[p20l782t87r1398b147],
2	.	.	O	.	_	0	SENT_302	[p20l782t87r1398b147],

1	—	NN	O	—	_	0	SENT_303	[p20l782t87r1398b147],
2	.	.	O	.	_	0	SENT_303	[p20l782t87r1398b147],

1	AHF	NN	ORGANIZATION	ahf	_	0	SENT_304	[p20l782t87r1398b147],
2	trial	NN	O	trial	dep	1	SENT_304	[p20l1422t83r1580b147],
3	.	.	O	.	_	0	SENT_304	[p20l1422t83r1580b147],

1	Therefore	RB	O	therefore	advmod	9	SENT_305	[p20l1607t83r1958b155],
2	,	,	O	,	_	0	SENT_305	[p20l1607t83r1958b155],
3	serelaxin	NN	O	serelaxin	nsubj	9	SENT_305	[p20l1984t106r2146b147, p20l7t187r183b250],
4	might	MD	O	might	aux	9	SENT_305	[p20l208t187r419b271],
5	be	VB	O	be	cop	9	SENT_305	[p20l441t187r523b250],
6	a	DT	O	a	det	9	SENT_305	[p20l549t210r584b250],
7	promising	JJ	O	promising	amod	9	SENT_305	[p20l607t193r975b271],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_305	[p20l997t187r1404b270],
9	option	NN	O	option	_	0	SENT_305	[p20l1430t193r1662b270],
10	leading	VBG	O	lead	partmod	9	SENT_305	[p20l1686t187r1949b271],
11	to	TO	O	to	_	0	SENT_305	[p20l1971t199r2039b250],
12	an	DT	O	a	det	14	SENT_305	[p20l2066t210r2149b250],
13	improved	JJ	O	improved	amod	14	SENT_305	[p20l8t290r343b373],
14	survival	NN	O	survival	prep_to	10	SENT_305	[p20l367t290r643b353],
15	in	IN	O	in	_	0	SENT_305	[p20l666t296r733b352],
16	patients	NNS	O	patient	prep_in	14	SENT_305	[p20l756t296r1030b373],
17	with	IN	O	with	_	0	SENT_305	[p20l1053t290r1208b353],
18	AHF	NN	O	ahf	prep_with	16	SENT_305	[p20l1231t294r1409b353],
19	.	.	O	.	_	0	SENT_305	[p20l1231t294r1409b353],

1	To	TO	O	to	aux	2	SENT_306	[p20l1436t293r1521b353],
2	answer	VB	O	answer	dep	6	SENT_306	[p20l1546t313r1790b353],
3	this	DT	O	this	det	4	SENT_306	[p20l1811t290r1938b353],
4	question	NN	O	question	dobj	2	SENT_306	[p20l1963t313r2147b373, p20l7t398r164b464],
5	,	,	O	,	_	0	SENT_306	[p20l1963t313r2147b373, p20l7t398r164b464],
6	another	DT	O	another	nsubj	9	SENT_306	[p20l188t392r456b456],
7	randomized	VBN	O	randomize	partmod	6	SENT_306	[p20l477t392r912b464],
8	,	,	O	,	_	0	SENT_306	[p20l477t392r912b464],
9	controlled	VBN	O	control	_	0	SENT_306	[p20l936t392r1290b456],
10	trial	NN	O	trial	dobj	9	SENT_306	[p20l1309t392r1451b456],
11	with	IN	O	with	_	0	SENT_306	[p20l1470t392r1624b456],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_306	[p20l1646t392r2150b456],
13	mortality	NN	O	mortality	prep_with	9	SENT_306	[p20l8t496r334b580],
14	as	IN	O	as	mark	20	SENT_306	[p20l354t519r418b559],
15	the	DT	O	the	det	18	SENT_306	[p20l441t496r548b559],
16	predeﬁned	JJ	O	predeﬁned	amod	18	SENT_306	[p20l570t496r943b579],
17	end	NN	O	end	nn	18	SENT_306	[p20l965t496r1092b559],
18	point	NN	O	point	nsubjpass	20	SENT_306	[p20l1113t502r1298b579],
19	is	VBZ	O	be	auxpass	20	SENT_306	[p20l1319t502r1370b559],
20	planned	VBN	O	plan	advcl	9	SENT_306	[p20l1391t496r1690b579],
21	.	.	O	.	_	0	SENT_306	[p20l1391t496r1690b579],

1	Omecamtiv	NNP	O	Omecamtiv	nn	3	SENT_307	[p20l9t709r409b766],
2	mecarbil	NN	O	mecarbil	nn	3	SENT_307	[p20l426t709r725b766],
3	Omecamtiv	NNP	O	Omecamtiv	nsubj	8	SENT_307	[p20l10t810r410b869],
4	mecarbil	NN	O	mecarbil	dep	3	SENT_307	[p20l427t806r723b869],
5	is	VBZ	O	be	cop	8	SENT_307	[p20l743t812r793b869],
6	an	DT	O	a	det	8	SENT_307	[p20l815t829r895b869],
7	inotrope-like	JJ	O	inotrope-like	amod	8	SENT_307	[p20l916t806r1357b889],
8	agent	NN	O	agent	_	0	SENT_307	[p20l1379t818r1560b890],
9	that	WDT	O	that	nsubj	10	SENT_307	[p20l1579t806r1711b869],
10	acts	VBZ	O	act	rcmod	8	SENT_307	[p20l1732t818r1858b869],
11	as	IN	O	as	_	0	SENT_307	[p20l1880t829r1944b869],
12	a	DT	O	a	det	15	SENT_307	[p20l1967t829r2001b869],
13	cardiac	JJ	O	cardiac	amod	15	SENT_307	[p20l2021t829r2146b869, p20l9t909r143b972],
14	myosin	NN	O	myosin	nn	15	SENT_307	[p20l160t915r402b993],
15	activator	NN	O	activator	prep_as	10	SENT_307	[p20l420t915r713b972],
16	.	.	O	.	_	0	SENT_307	[p20l420t915r713b972],

1	It	PRP	O	it	nsubj	2	SENT_308	[p20l735t914r782b972],
2	increases	VBZ	O	increase	_	0	SENT_308	[p20l798t915r1094b972],
3	myocardial	JJ	O	myocardial	amod	4	SENT_308	[p20l1112t909r1480b993],
4	contraction	NN	O	contraction	dobj	2	SENT_308	[p20l1498t915r1876b972],
5	without	IN	O	without	_	0	SENT_308	[p20l1892t909r2150b972],
6	increasing	VBG	O	increase	amod	8	SENT_308	[p20l8t1018r342b1096],
7	oxygen	NN	O	oxygen	nn	8	SENT_308	[p20l357t1035r589b1096],
8	consumption	NN	O	consumption	prep_without	2	SENT_308	[p20l607t1018r1053b1095],
9	.	.	O	.	_	0	SENT_308	[p20l607t1018r1053b1095],

1	In	IN	O	in	_	0	SENT_309	[p20l1073t1017r1142b1074],
2	patients	NNS	O	patient	prep_in	10	SENT_309	[p20l1157t1018r1412b1095],
3	with	IN	O	with	_	0	SENT_309	[p20l1428t1012r1574b1075],
4	stable	JJ	O	stable	amod	5	SENT_309	[p20l1592t1012r1774b1075],
5	CHF	NN	MISC	chf	prep_with	2	SENT_309	[p20l1792t1016r1958b1084],
6	,	,	O	,	_	0	SENT_309	[p20l1792t1016r1958b1084],
7	omecamtiv	NN	O	omecamtiv	nn	8	SENT_309	[p20l1977t1035r2146b1075, p20l9t1121r237b1178],
8	mecarbil	NN	O	mecarbil	nsubj	10	SENT_309	[p20l254t1115r548b1178],
9	dose-dependently	RB	O	dose-dependently	advmod	10	SENT_309	[p20l569t1115r1174b1199],
10	increased	VBD	O	increase	_	0	SENT_309	[p20l1192t1115r1511b1178],
11	stroke	NN	O	stroke	nn	12	SENT_309	[p20l1531t1115r1734b1178],
12	volume	NN	O	volume	nsubj	40	SENT_309	[p20l1752t1115r2004b1178],
13	and	CC	O	and	_	0	SENT_309	[p20l2026t1115r2151b1178],
14	cardiac	JJ	O	cardiac	amod	15	SENT_309	[p20l9t1218r243b1281],
15	output	NN	O	output	conj_and	12	SENT_309	[p20l261t1230r478b1301],
16	assessed	VBN	O	assess	partmod	15	SENT_309	[p20l495t1218r764b1281],
17	by	IN	O	by	_	0	SENT_309	[p20l778t1218r860b1302],
18	echocardiography	NN	O	echocardiography	agent	16	SENT_309	[p20l875t1218r1468b1302],
19	without	IN	O	without	_	0	SENT_309	[p20l1480t1218r1737b1281],
20	major	JJ	O	major	amod	22	SENT_309	[p20l1753t1224r1948b1302],
21	safety	NN	O	safety	nn	22	SENT_309	[p20l1966t1218r2153b1302],
22	issues	NNS	O	issue	prep_without	18	SENT_309	[p20l8t1313r277b1385],
23	.58	CD	NUMBER	.58	dobj	16	SENT_309	[p20l8t1313r277b1385],
24	A	DT	O	a	dep	23	SENT_309	[p20l297t1325r355b1384],
25	randomized	VBN	O	randomize	partmod	15	SENT_309	[p20l375t1321r780b1385],
26	controlled	JJ	O	controlled	amod	31	SENT_309	[p20l800t1321r1140b1385],
27	phase	NN	O	phase	nn	31	SENT_309	[p20l1158t1321r1349b1405],
28	II	CD	NUMBER	ii	num	31	SENT_309	[p20l1370t1327r1422b1384],
29	trial	NN	O	trial	nn	31	SENT_309	[p20l1442t1321r1579b1385],
30	(	CD	NUMBER	(	num	31	SENT_309	[p20l1602t1322r2144b1399],
31	NCT01300013	NN	O	nct01300013	nsubj	32	SENT_309	[p20l1602t1322r2144b1399],
32	)	CD	NUMBER	)	xcomp	25	SENT_309	[p20l1602t1322r2144b1399],
33	including	VBG	O	include	_	0	SENT_309	[p20l8t1425r330b1509],
34	600	CD	NUMBER	600	num	35	SENT_309	[p20l349t1431r467b1488],
35	patients	NNS	O	patient	prep_including	32	SENT_309	[p20l488t1431r752b1508],
36	with	IN	O	with	_	0	SENT_309	[p20l771t1425r923b1488],
37	AHF	NN	O	ahf	nn	39	SENT_309	[p20l942t1429r1109b1487],
38	(	CD	NUMBER	(	num	39	SENT_309	[p20l1135t1426r1250b1501],
39	EF	NN	O	ef	prep_with	35	SENT_309	[p20l1135t1426r1250b1501],
40	<	JJR	O	<	xcomp	10	SENT_309	[p20l1274t1430r1480b1497],
41	40	CD	PERCENT	40	num	42	SENT_309	[p20l1274t1430r1480b1497],
42	%	NN	PERCENT	%	nsubj	49	SENT_309	[p20l1274t1430r1480b1497],
43	,	,	O	,	_	0	SENT_309	[p20l1274t1430r1480b1497],
44	elevated	JJ	O	elevated	amod	46	SENT_309	[p20l1503t1425r1775b1488],
45	natriuretic	JJ	O	natriuretic	amod	46	SENT_309	[p20l1795t1431r2149b1488],
46	peptides	NNS	O	peptide	appos	42	SENT_309	[p20l7t1528r321b1611],
47	)	CD	NUMBER	)	dep	46	SENT_309	[p20l7t1528r321b1611],
48	will	MD	O	will	aux	49	SENT_309	[p20l345t1528r471b1591],
49	assess	VB	O	assess	ccomp	40	SENT_309	[p20l493t1551r689b1591],
50	the	DT	O	the	det	51	SENT_309	[p20l710t1528r817b1591],
51	effects	NNS	O	effect	dobj	49	SENT_309	[p20l839t1528r1051b1591],
52	of	IN	O	of	_	0	SENT_309	[p20l1074t1528r1148b1591],
53	omecamtiv	NN	O	omecamtiv	nn	54	SENT_309	[p20l1160t1534r1544b1591],
54	mecarbil	NN	O	mecarbil	prep_of	51	SENT_309	[p20l1562t1528r1862b1591],
55	as	IN	O	as	_	0	SENT_309	[p20l1883t1551r1948b1591],
56	compared	VBN	O	compare	prepc_as	40	SENT_309	[p20l1971t1551r2146b1591, p20l7t1631r197b1714],
57	with	IN	O	with	pcomp	56	SENT_309	[p20l214t1631r363b1694],
58	placebo	NN	O	placebo	pobj	57	SENT_309	[p20l380t1631r636b1714],
59	in	IN	O	in	_	0	SENT_309	[p20l656t1637r722b1693],
60	terms	NNS	O	term	prep_in	58	SENT_309	[p20l739t1643r928b1694],
61	of	IN	O	of	_	0	SENT_309	[p20l949t1631r1021b1694],
62	clinical	JJ	O	clinical	amod	63	SENT_309	[p20l1031t1631r1268b1694],
63	symptoms	NNS	O	symptom	nn	66	SENT_309	[p20l1287t1643r1629b1715],
64	(	JJ	O	(	amod	66	SENT_309	[p20l1652t1631r1993b1715],
65	dyspnea	NN	O	dyspnea	nn	66	SENT_309	[p20l1652t1631r1993b1715],
66	)	NN	O	)	prep_of	60	SENT_309	[p20l1652t1631r1993b1715],
67	.	.	O	.	_	0	SENT_309	[p20l1652t1631r1993b1715],

1	Ularitide	NNP	O	Ularitide	nn	2	SENT_310	[p20l11t1844r312b1901],
2	Ularitide	NNP	O	Ularitide	nsubj	6	SENT_310	[p20l9t1941r325b2004],
3	is	VBZ	O	be	cop	6	SENT_310	[p20l351t1947r402b2004],
4	a	DT	O	a	det	6	SENT_310	[p20l429t1964r464b2004],
5	synthetic	JJ	O	synthetic	amod	6	SENT_310	[p20l489t1941r810b2025],
6	form	NN	O	form	_	0	SENT_310	[p20l834t1941r1007b2004],
7	of	IN	O	of	_	0	SENT_310	[p20l1033t1941r1109b2004],
8	urodilatin	NN	O	urodilatin	prep_of	6	SENT_310	[p20l1124t1941r1499b2013],
9	,	,	O	,	_	0	SENT_310	[p20l1124t1941r1499b2013],
10	a	DT	O	a	det	12	SENT_310	[p20l1527t1964r1562b2004],
11	natriuretic	JJ	O	natriuretic	amod	12	SENT_310	[p20l1586t1947r1961b2004],
12	peptide	NN	O	peptide	appos	8	SENT_310	[p20l1985t1963r2143b2024, p20l7t2043r141b2107],
13	secreted	VBN	O	secrete	partmod	12	SENT_310	[p20l166t2043r454b2107],
14	by	IN	O	by	_	0	SENT_310	[p20l475t2043r561b2128],
15	renal	JJ	O	renal	amod	18	SENT_310	[p20l581t2043r758b2107],
16	distal	JJ	O	distal	amod	18	SENT_310	[p20l782t2043r972b2107],
17	tubular	JJ	O	tubular	amod	18	SENT_310	[p20l994t2043r1252b2107],
18	cells	NNS	O	cell	agent	13	SENT_310	[p20l1276t2035r1508b2107],
19	.59	CD	NUMBER	.59	nsubj	27	SENT_310	[p20l1276t2035r1508b2107],
20	After	IN	O	after	_	0	SENT_310	[p20l1532t2043r1713b2107],
21	secretion	NN	O	secretion	prep_after	19	SENT_310	[p20l1737t2050r2056b2107],
22	in	IN	O	in	_	0	SENT_310	[p20l2081t2050r2149b2106],
23	the	DT	O	the	det	24	SENT_310	[p20l7t2147r117b2210],
24	lumen	NN	O	luman	prep_in	21	SENT_310	[p20l141t2147r386b2219],
25	,	,	O	,	_	0	SENT_310	[p20l141t2147r386b2219],
26	urodilatin	NN	O	urodilatin	appos	24	SENT_310	[p20l412t2147r769b2210],
27	binds	VBZ	O	bind	rcmod	18	SENT_310	[p20l791t2147r986b2210],
28	to	TO	O	to	_	0	SENT_310	[p20l1010t2159r1078b2210],
29	the	DT	O	the	det	35	SENT_310	[p20l1103t2147r1213b2210],
30	natriuretic	JJ	O	natriuretic	amod	35	SENT_310	[p20l1238t2153r1614b2210],
31	peptide	NN	O	peptide	nn	35	SENT_310	[p20l1637t2147r1903b2230],
32	receptor	NN	O	receptor	nn	35	SENT_310	[p20l1928t2169r2147b2230, p20l7t2261r109b2313],
33	(	NN	O	(	nn	35	SENT_310	[p20l136t2250r447b2327],
34	NPR-A	NN	O	npr-a	nn	35	SENT_310	[p20l136t2250r447b2327],
35	)	NN	O	)	prep_to	27	SENT_310	[p20l136t2250r447b2327],
36	of	IN	O	of	_	0	SENT_310	[p20l476t2249r552b2313],
37	the	DT	O	the	det	39	SENT_310	[p20l566t2249r675b2313],
38	collecting	VBG	O	collect	amod	39	SENT_310	[p20l701t2249r1045b2334],
39	duct	NN	O	duct	prep_of	35	SENT_310	[p20l1068t2241r1308b2322],
40	,6	CD	NUMBER	,6	num	41	SENT_310	[p20l1068t2241r1308b2322],
41	°	CD	NUMBER	°	dep	12	SENT_310	[p20l1068t2241r1308b2322],
42	leading	VBG	O	lead	partmod	41	SENT_310	[p20l1331t2249r1591b2334],
43	to	TO	O	to	_	0	SENT_310	[p20l1613t2261r1681b2313],
44	an	DT	O	a	det	46	SENT_310	[p20l1707t2272r1789b2313],
45	increased	VBN	O	increase	amod	46	SENT_310	[p20l1814t2249r2150b2313],
46	sodium	NN	O	sodium	prep_to	42	SENT_310	[p20l9t2353r271b2416],
47	and	CC	O	and	_	0	SENT_310	[p20l295t2353r423b2416],
48	water	NN	O	water	nn	49	SENT_310	[p20l443t2365r636b2416],
49	excretion	NN	O	excretion	conj_and	46	SENT_310	[p20l659t2359r998b2416],
50	.	.	O	.	_	0	SENT_310	[p20l659t2359r998b2416],

1	Randomized	VBN	O	randomize	_	0	SENT_311	[p20l1025t2353r1471b2416],
2	phase	NN	O	phase	dobj	1	SENT_311	[p20l1492t2353r1690b2436],
3	II	CD	NUMBER	ii	num	4	SENT_311	[p20l1714t2358r1768b2415],
4	trials	NNS	O	trial	nsubj	5	SENT_311	[p20l1792t2353r1966b2416],
5	have	VBP	O	have	rcmod	2	SENT_311	[p20l1989t2353r2147b2416],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_312	[p20l21t2501r140b2522],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_312	[p20l149t2501r374b2522],
3	&	CC	O	&	_	0	SENT_312	[p20l381t2501r601b2522],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_312	[p20l381t2501r601b2522],
5	|	CD	NUMBER	|	num	6	SENT_312	[p20l381t2501r601b2522],
6	CS	NNP	O	CS	conj_and	2	SENT_312	[p20l381t2501r601b2522],
7	|	NNP	O	|	nn	8	SENT_312	[p20l611t2499r613b2529],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_312	[p20l621t2501r729b2522],
9	94	CD	NUMBER	94	num	10	SENT_312	[p20l737t2501r765b2522],
10	NUMBER	NN	O	number	dep	12	SENT_312	[p20l774t2501r882b2522],
11	4	CD	NUMBER	4	num	12	SENT_312	[p20l889t2499r915b2529],
12	]	CD	NUMBER	]	dep	15	SENT_312	[p20l889t2499r915b2529],
13	OCTOBER	NNP	DATE	OCTOBER	dep	12	SENT_312	[p20l924t2501r1044b2522],
14	2013	CD	DATE	2013	num	15	SENT_312	[p20l1052t2501r1109b2522],
15	505	CD	NUMBER	505	_	0	SENT_312	[p20l2093t2501r2139b2522],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_313	[p20l19t2604r209b2641],

1	shown	VBN	O	show	partmod	48	SENT_314	[p20l8t2813r231b2876],
2	an	DT	O	a	det	3	SENT_314	[p20l254t2836r334b2876],
3	improvement	NN	O	improvement	dobj	1	SENT_314	[p20l356t2819r821b2896],
4	in	IN	O	in	_	0	SENT_314	[p20l841t2819r908b2875],
5	hemodynamic	JJ	O	hemodynamic	amod	6	SENT_314	[p20l929t2813r1426b2897],
6	parameters	NNS	O	parameter	prep_in	3	SENT_314	[p20l1447t2825r1849b2896],
7	,	,	O	,	_	0	SENT_314	[p20l1447t2825r1849b2896],
8	a	DT	O	a	det	9	SENT_314	[p20l1873t2836r1908b2876],
9	reduction	NN	O	reduction	dobj	1	SENT_314	[p20l1929t2813r2148b2876, p20l7t2922r141b2979],
10	of	IN	O	of	_	0	SENT_314	[p20l161t2916r234b2979],
11	NT-pro-BNP	NN	O	nt-pro-bnp	prep_of	9	SENT_314	[p20l243t2919r694b2999],
12	,	,	O	,	_	0	SENT_314	[p20l243t2919r694b2999],
13	and	CC	O	and	_	0	SENT_314	[p20l715t2916r839b2979],
14	an	DT	O	a	det	15	SENT_314	[p20l859t2939r937b2979],
15	improvement	NN	O	improvement	dobj	1	SENT_314	[p20l957t2922r1410b2999],
16	of	IN	O	of	_	0	SENT_314	[p20l1429t2916r1501b2979],
17	dyspnea	NN	O	dyspnea	prep_of	15	SENT_314	[p20l1512t2916r1785b3000],
18	in	IN	O	in	_	0	SENT_314	[p20l1804t2922r1869b2978],
19	patients	NNS	O	patient	prep_in	1	SENT_314	[p20l1888t2922r2151b2999],
20	treated	VBN	O	treat	partmod	19	SENT_314	[p20l7t3019r261b3082],
21	with	IN	O	with	_	0	SENT_314	[p20l288t3019r450b3082],
22	urodilatin	NN	O	urodilatin	prep_with	20	SENT_314	[p20l480t3019r847b3082],
23	as	IN	O	as	prep	20	SENT_314	[p20l878t3042r945b3082],
24	compared	VBN	O	compare	_	0	SENT_314	[p20l977t3019r1339b3102],
25	with	IN	O	with	prepc_compared_with	20	SENT_314	[p20l1366t3019r1528b3082],
26	placebo	NN	O	placebo	pobj	20	SENT_314	[p20l1557t3019r1836b3102],
27	without	IN	O	without	_	0	SENT_314	[p20l1866t3019r2151b3082],
28	adversely	RB	O	adversely	advmod	29	SENT_314	[p20l8t3121r331b3206],
29	affecting	VBG	O	affect	prepc_without	20	SENT_314	[p20l351t3121r648b3206],
30	renal	JJ	O	renal	amod	31	SENT_314	[p20l669t3121r843b3185],
31	function	NN	O	function	dobj	29	SENT_314	[p20l865t3113r1318b3185],
32	.59	CD	NUMBER	.59	number	33	SENT_314	[p20l865t3113r1318b3185],
33	’61	CD	NUMBER	’61	num	34	SENT_314	[p20l865t3113r1318b3185],
34	A	DT	O	a	dep	31	SENT_314	[p20l1344t3125r1402b3184],
35	randomized	VBN	O	randomize	partmod	31	SENT_314	[p20l1424t3121r1860b3194],
36	,	,	O	,	_	0	SENT_314	[p20l1424t3121r1860b3194],
37	doubleblind	NN	O	doubleblind	nn	43	SENT_314	[p20l1886t3121r2148b3185, p20l6t3225r200b3297],
38	,	,	O	,	_	0	SENT_314	[p20l1886t3121r2148b3185, p20l6t3225r200b3297],
39	phase	NN	O	phase	dep	43	SENT_314	[p20l221t3225r414b3308],
40	III	CD	NUMBER	iii	num	43	SENT_314	[p20l435t3230r517b3287],
41	trial	NN	O	trial	nn	43	SENT_314	[p20l537t3225r677b3288],
42	(	CD	NUMBER	(	num	43	SENT_314	[p20l700t3226r1146b3301],
43	TRUE-AHF	NN	O	true-ahf	nsubj	48	SENT_314	[p20l700t3226r1146b3301],
44	,	,	O	,	_	0	SENT_314	[p20l700t3226r1146b3301],
45	NCTO1661634	NN	O	ncto1661634	nsubj	48	SENT_314	[p20l1167t3226r1692b3302],
46	)	CD	NUMBER	)	num	45	SENT_314	[p20l1167t3226r1692b3302],
47	will	MD	O	will	aux	48	SENT_314	[p20l1714t3225r1839b3288],
48	compare	VB	O	compare	_	0	SENT_314	[p20l1859t3247r2151b3308],
49	the	DT	O	the	det	50	SENT_314	[p20l7t3328r114b3391],
50	effects	NNS	O	effect	dobj	48	SENT_314	[p20l138t3328r352b3391],
51	of	IN	O	of	_	0	SENT_314	[p20l376t3328r451b3391],
52	ularitide	NN	O	ularitide	prep_of	50	SENT_314	[p20l464t3328r756b3391],
53	with	IN	O	with	_	0	SENT_314	[p20l777t3328r932b3391],
54	those	DT	O	those	prep_with	48	SENT_314	[p20l953t3328r1138b3391],
55	of	IN	O	of	_	0	SENT_314	[p20l1162t3328r1236b3391],
56	placebo	NN	O	placebo	prep_of	54	SENT_314	[p20l1249t3328r1514b3411],
57	in	IN	O	in	_	0	SENT_314	[p20l1539t3334r1606b3390],
58	terms	NNS	O	term	prep_in	48	SENT_314	[p20l1628t3340r1823b3391],
59	of	IN	O	of	_	0	SENT_314	[p20l1848t3328r1922b3391],
60	symptoms	NNS	O	symptom	prep_of	58	SENT_314	[p20l1936t3350r2148b3412, p20l7t3443r194b3503],
61	,	,	O	,	_	0	SENT_314	[p20l1936t3350r2148b3412, p20l7t3443r194b3503],
62	all-cause	JJ	O	all-cause	amod	63	SENT_314	[p20l219t3431r518b3494],
63	mortality	NN	O	mortality	conj_and	60	SENT_314	[p20l541t3431r874b3515],
64	,	,	O	,	_	0	SENT_314	[p20l541t3431r874b3515],
65	and	CC	O	and	_	0	SENT_314	[p20l899t3431r1027b3494],
66	cardiovascular	JJ	O	cardiovascular	amod	67	SENT_314	[p20l1049t3431r1552b3494],
67	rehospitalization	NN	O	rehospitalization	conj_and	60	SENT_314	[p20l1574t3431r2153b3514],
68	in	IN	O	in	_	0	SENT_314	[p20l8t3540r74b3596],
69	AHF	NN	ORGANIZATION	ahf	nn	70	SENT_314	[p20l95t3538r263b3596],
70	patients	NNS	O	patient	prep_in	67	SENT_314	[p20l285t3540r573b3617],
71	.	.	O	.	_	0	SENT_314	[p20l285t3540r573b3617],

1	The	DT	O	the	det	2	SENT_315	[p20l597t3534r723b3597],
2	results	NNS	O	result	nsubjpass	4	SENT_315	[p20l744t3534r965b3597],
3	are	VBP	O	be	auxpass	4	SENT_315	[p20l988t3557r1088b3597],
4	expected	VBN	O	expect	_	0	SENT_315	[p20l1111t3534r1415b3617],
5	in	IN	O	in	_	0	SENT_315	[p20l1436t3540r1503b3596],
6	2015	CD	DATE	2015	prep_in	4	SENT_315	[p20l1525t3541r1704b3597],
7	.	.	O	.	_	0	SENT_315	[p20l1525t3541r1704b3597],

1	Renin	NN	O	renin	nn	2	SENT_316	[p20l10t3748r203b3805],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_316	[p20l225t3748r561b3805],

1	Blockade	NN	O	blockade	nsubj	25	SENT_317	[p21l8t32r318b95],
2	of	IN	O	of	_	0	SENT_317	[p21l338t32r412b95],
3	the	DT	O	the	det	9	SENT_317	[p21l421t32r527b95],
4	renin	NN	O	renin	nn	9	SENT_317	[p21l547t32r1613b116],
5	—	NN	O	—	nn	9	SENT_317	[p21l547t32r1613b116],
6	angiotensin	NN	O	angiotensin	nn	9	SENT_317	[p21l547t32r1613b116],
7	—	CD	NUMBER	—	num	9	SENT_317	[p21l547t32r1613b116],
8	aldosterone	NN	O	aldosterone	nn	9	SENT_317	[p21l547t32r1613b116],
9	system	NN	O	system	prep_of	1	SENT_317	[p21l1634t44r1864b116],
10	(	CD	NUMBER	(	num	12	SENT_317	[p21l1887t32r2148b109],
11	RAAS	NN	O	raa	nn	12	SENT_317	[p21l1887t32r2148b109],
12	)	NN	O	)	dep	9	SENT_317	[p21l1887t32r2148b109],
13	with	IN	O	with	_	0	SENT_317	[p21l6t135r164b198],
14	ACE	NN	O	ace	nn	15	SENT_317	[p21l190t139r356b198],
15	inhibitors	NNS	O	inhibitor	prep_with	12	SENT_317	[p21l384t135r731b198],
16	(	CD	NUMBER	(	dep	15	SENT_317	[p21l762t136r865b211],
17	or	CC	O	or	_	0	SENT_317	[p21l762t136r865b211],
18	angiotensin-receptor	JJ	O	angiotensin-receptor	amod	19	SENT_317	[p21l891t141r1640b219],
19	blockers	NNS	O	blocker	conj_or	15	SENT_317	[p21l1663t135r1990b211],
20	)	NN	O	)	nn	23	SENT_317	[p21l1663t135r1990b211],
21	and	CC	O	and	_	0	SENT_317	[p21l2022t135r2152b198],
22	mineralocorticoid-receptor	NN	O	mineralocorticoid-receptor	nn	23	SENT_317	[p21l7t238r980b321],
23	antagonists	NNS	O	antagonist	dep	19	SENT_317	[p21l1005t244r1401b322],
24	is	VBZ	O	be	cop	25	SENT_317	[p21l1427t244r1478b301],
25	one	CD	NUMBER	one	_	0	SENT_317	[p21l1505t261r1630b301],
26	of	IN	O	of	_	0	SENT_317	[p21l1656t238r1732b301],
27	the	DT	O	the	det	29	SENT_317	[p21l1746t238r1855b301],
28	key	JJ	O	key	amod	29	SENT_317	[p21l1879t238r2003b322],
29	elements	NNS	O	element	prep_of	25	SENT_317	[p21l2025t238r2147b301, p21l7t353r213b404],
30	in	IN	O	in	_	0	SENT_317	[p21l234t347r300b403],
31	the	DT	O	the	det	32	SENT_317	[p21l319t341r426b404],
32	treatment	NN	O	treatment	prep_in	29	SENT_317	[p21l445t353r779b404],
33	of	IN	O	of	_	0	SENT_317	[p21l798t341r872b404],
34	CHF	NN	O	chf	prep_of	32	SENT_317	[p21l884t345r1055b404],
35	.	.	O	.	_	0	SENT_317	[p21l884t345r1055b404],

1	However	RB	O	however	advmod	7	SENT_318	[p21l1079t346r1396b413],
2	,	,	O	,	_	0	SENT_318	[p21l1079t346r1396b413],
3	these	DT	O	these	det	4	SENT_318	[p21l1417t341r1592b404],
4	agents	NNS	O	agent	nsubj	7	SENT_318	[p21l1613t353r1824b425],
5	only	RB	O	only	advmod	7	SENT_318	[p21l1846t341r1996b425],
6	partially	RB	O	partially	advmod	7	SENT_318	[p21l2011t363r2148b424, p21l7t444r183b528],
7	block	VB	O	block	_	0	SENT_318	[p21l201t444r396b507],
8	the	DT	O	the	det	9	SENT_318	[p21l415t444r524b507],
9	RAAS	NN	O	raa	dobj	7	SENT_318	[p21l548t448r761b507],
10	and	CC	O	and	_	0	SENT_318	[p21l787t444r916b507],
11	lead	VB	O	lead	conj_and	7	SENT_318	[p21l937t444r1081b507],
12	to	TO	O	to	_	0	SENT_318	[p21l1103t456r1170b507],
13	a	DT	O	a	det	15	SENT_318	[p21l1195t467r1230b507],
14	compensatory	JJ	O	compensatory	amod	15	SENT_318	[p21l1254t456r1754b528],
15	increase	NN	O	increase	prep_to	11	SENT_318	[p21l1774t450r2058b507],
16	in	IN	O	in	_	0	SENT_318	[p21l2082t450r2150b506],
17	renin	NN	O	renin	nn	18	SENT_318	[p21l8t553r188b610],
18	concentrations	NNS	O	concentration	prep_in	15	SENT_318	[p21l209t553r712b610],
19	and	CC	O	and	_	0	SENT_318	[p21l733t547r859b610],
20	other	JJ	O	other	amod	22	SENT_318	[p21l878t547r1058b610],
21	downstream	JJ	O	downstream	amod	22	SENT_318	[p21l1078t547r1500b610],
22	mediators	NNS	O	mediator	nsubj	23	SENT_318	[p21l1519t547r1858b610],
23	(	VBP	O	(	conj_and	7	SENT_318	[p21l1882t547r2150b624],
24	“	CD	NUMBER	“	num	25	SENT_318	[p21l1882t547r2150b624],
25	RAAS	NNS	O	raa	nsubj	26	SENT_318	[p21l1882t547r2150b624],
26	escape	VBP	O	escape	ccomp	23	SENT_318	[p21l8t650r307b733],
27	”	CD	NUMBER	”	number	28	SENT_318	[p21l8t650r307b733],
28	)	CD	NUMBER	)	dobj	26	SENT_318	[p21l8t650r307b733],
29	.	.	O	.	_	0	SENT_318	[p21l8t650r307b733],

1	Therefore	RB	O	therefore	advmod	6	SENT_319	[p21l332t650r681b722],
2	,	,	O	,	_	0	SENT_319	[p21l332t650r681b722],
3	it	PRP	O	it	nsubj	6	SENT_319	[p21l705t656r751b713],
4	might	MD	O	might	aux	6	SENT_319	[p21l772t650r978b734],
5	be	VB	O	be	cop	6	SENT_319	[p21l997t650r1077b713],
6	beneﬁcial	JJ	O	beneﬁcial	_	0	SENT_319	[p21l1097t650r1430b713],
7	to	TO	O	to	aux	8	SENT_319	[p21l1451t662r1518b713],
8	add	VB	O	add	xcomp	6	SENT_319	[p21l1542t650r1669b713],
9	a	DT	O	a	det	12	SENT_319	[p21l1691t673r1726b713],
10	direct	JJ	O	direct	amod	12	SENT_319	[p21l1748t650r1946b713],
11	renin	NN	O	renin	nn	12	SENT_319	[p21l1967t656r2150b713],
12	inhibitor	NN	O	inhibitor	dobj	8	SENT_319	[p21l8t753r308b816],
13	to	TO	O	to	_	0	SENT_319	[p21l326t765r392b816],
14	the	DT	O	the	det	16	SENT_319	[p21l412t753r518b816],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_319	[p21l537t753r924b836],
16	regimen	NN	O	regimen	prep_to	8	SENT_319	[p21l944t759r1241b837],
17	.	.	O	.	_	0	SENT_319	[p21l944t759r1241b837],

1	This	DT	O	this	det	2	SENT_320	[p21l1264t753r1406b816],
2	hypothesis	NN	O	hypothesis	nsubjpass	4	SENT_320	[p21l1426t753r1789b837],
3	was	VBD	O	be	auxpass	4	SENT_320	[p21l1808t776r1933b816],
4	tested	VBN	O	test	_	0	SENT_320	[p21l1953t753r2152b816],
5	in	IN	O	in	_	0	SENT_320	[p21l8t862r76b918],
6	the	DT	O	the	det	10	SENT_320	[p21l99t855r208b919],
7	recently	RB	DATE	recently	advmod	10	SENT_320	[p21l233t855r515b940],
8	published	VBN	O	publish	amod	10	SENT_320	[p21l534t855r880b939],
9	ASTRONAUT	NN	O	astronaut	nn	10	SENT_320	[p21l902t858r1415b919],
10	trial	NN	O	trial	prep_in	4	SENT_320	[p21l1438t847r1666b919],
11	.62	CD	NUMBER	.62	nsubj	17	SENT_320	[p21l1438t847r1666b919],
12	In	IN	O	in	_	0	SENT_320	[p21l1692t861r1765b918],
13	that	DT	O	that	det	14	SENT_320	[p21l1788t855r1925b919],
14	study	NN	O	study	prep_in	11	SENT_320	[p21l1949t855r2149b940],
15	,	,	O	,	_	0	SENT_320	[p21l1949t855r2149b940],
16	1,639	CD	NUMBER	1,639	appos	14	SENT_320	[p21l14t965r186b1031],
17	stabilized	VBD	O	stabilize	rcmod	10	SENT_320	[p21l208t959r526b1022],
18	HF	NN	O	hf	nn	19	SENT_320	[p21l545t964r651b1021],
19	patients	NNS	O	patient	nsubj	22	SENT_320	[p21l671t965r936b1042],
20	(	CD	NUMBER	(	num	21	SENT_320	[p21l960t960r1076b1035],
21	EF	NN	O	ef	npadvmod	22	SENT_320	[p21l960t960r1076b1035],
22	<	JJR	O	<	xcomp	17	SENT_320	[p21l1099t964r1305b1031],
23	40	CD	PERCENT	40	number	24	SENT_320	[p21l1099t964r1305b1031],
24	%	NN	PERCENT	%	amod	10	SENT_320	[p21l1099t964r1305b1031],
25	,	,	O	,	_	0	SENT_320	[p21l1099t964r1305b1031],
26	elevated	JJ	O	elevated	amod	29	SENT_320	[p21l1327t959r1601b1022],
27	natriuretic	JJ	O	natriuretic	amod	29	SENT_320	[p21l1619t965r1976b1022],
28	peptide	NN	O	peptide	nn	29	SENT_320	[p21l1994t981r2146b1042, p21l7t1062r161b1138],
29	)	NN	O	)	nsubj	30	SENT_320	[p21l1994t981r2146b1042, p21l7t1062r161b1138],
30	admitted	VBD	O	admit	conj_and	4	SENT_320	[p21l188t1062r495b1125],
31	to	TO	O	to	_	0	SENT_320	[p21l514t1074r580b1125],
32	the	DT	O	the	det	33	SENT_320	[p21l603t1062r709b1125],
33	hospital	NN	O	hospital	prep_to	30	SENT_320	[p21l730t1062r1002b1145],
34	with	IN	O	with	_	0	SENT_320	[p21l1021t1062r1174b1125],
35	signs	NNS	O	sign	prep_with	30	SENT_320	[p21l1197t1068r1365b1146],
36	and	CC	O	and	_	0	SENT_320	[p21l1389t1062r1515b1125],
37	symptoms	NNS	O	symptom	nsubjpass	42	SENT_320	[p21l1537t1074r1887b1146],
38	of	IN	O	of	_	0	SENT_320	[p21l1910t1062r1984b1125],
39	ﬂuid	JJ	O	ﬂuid	amod	40	SENT_320	[p21l1996t1062r2153b1125],
40	overload	NN	O	overload	prep_of	37	SENT_320	[p21l8t1165r300b1228],
41	were	VBD	O	be	auxpass	42	SENT_320	[p21l316t1188r474b1228],
42	randomized	VBN	O	randomize	conj_and	4	SENT_320	[p21l494t1165r902b1228],
43	to	TO	O	to	_	0	SENT_320	[p21l919t1177r984b1228],
44	either	CC	O	either	preconj	45	SENT_320	[p21l1005t1165r1199b1228],
45	aliskiren	NN	O	aliskiren	prep_to	42	SENT_320	[p21l1218t1165r1503b1228],
46	or	CC	O	or	_	0	SENT_320	[p21l1523t1188r1594b1228],
47	placebo	NN	O	placebo	prep_to	42	SENT_320	[p21l1611t1165r1869b1248],
48	in	IN	O	in	_	0	SENT_320	[p21l1889t1171r1955b1227],
49	addition	NN	O	addition	prep_in	42	SENT_320	[p21l1975t1165r2147b1228, p21l7t1274r147b1331],
50	to	TO	O	to	_	0	SENT_320	[p21l168t1280r235b1331],
51	standard	JJ	O	standard	amod	52	SENT_320	[p21l260t1268r564b1331],
52	treatment	NN	O	treatment	prep_to	42	SENT_320	[p21l585t1280r943b1331],
53	.	.	O	.	_	0	SENT_320	[p21l585t1280r943b1331],

1	In	IN	O	in	_	0	SENT_321	[p21l969t1273r1042b1330],
2	these	DT	O	these	det	3	SENT_321	[p21l1063t1268r1242b1331],
3	patients	NNS	O	patient	prep_in	8	SENT_321	[p21l1264t1274r1557b1351],
4	,	,	O	,	_	0	SENT_321	[p21l1264t1274r1557b1351],
5	aliskiren	NN	O	aliskiren	nsubj	32	SENT_321	[p21l1582t1268r1879b1331],
6	did	VBD	O	do	aux	8	SENT_321	[p21l1903t1268r2016b1331],
7	not	RB	O	not	neg	8	SENT_321	[p21l2037t1280r2153b1331],
8	reduce	VB	O	reduce	_	0	SENT_321	[p21l8t1371r233b1434],
9	the	DT	O	the	det	13	SENT_321	[p21l252t1371r357b1434],
10	combined	JJ	O	combined	amod	13	SENT_321	[p21l377t1371r716b1434],
11	primary	JJ	O	primary	amod	13	SENT_321	[p21l733t1377r1012b1455],
12	end	NN	O	end	nn	13	SENT_321	[p21l1029t1371r1154b1434],
13	point	NN	O	point	dobj	8	SENT_321	[p21l1171t1377r1352b1454],
14	of	IN	O	of	_	0	SENT_321	[p21l1371t1371r1444b1434],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_321	[p21l1455t1371r1946b1434],
16	death	NN	O	death	prep_of	13	SENT_321	[p21l1965t1371r2151b1434],
17	or	CC	O	or	_	0	SENT_321	[p21l8t1497r78b1537],
18	hospitalization	NN	O	hospitalization	prep_of	13	SENT_321	[p21l94t1474r584b1557],
19	for	IN	O	for	_	0	SENT_321	[p21l603t1474r697b1537],
20	HF	NNS	O	hf	prep_for	8	SENT_321	[p21l715t1479r819b1536],
21	at	IN	O	at	_	0	SENT_321	[p21l839t1486r897b1537],
22	6	CD	NUMBER	6	nn	25	SENT_321	[p21l915t1480r951b1537],
23	or	CC	O	or	_	0	SENT_321	[p21l971t1497r1041b1537],
24	12	CD	DURATION	12	conj_or	22	SENT_321	[p21l1065t1481r1133b1536],
25	months	NNS	NUMBER	month	prep_at	20	SENT_321	[p21l1154t1474r1404b1537],
26	after	IN	O	after	_	0	SENT_321	[p21l1425t1474r1572b1537],
27	discharge	NN	O	discharge	prep_after	25	SENT_321	[p21l1591t1474r1903b1558],
28	despite	IN	O	despite	_	0	SENT_321	[p21l1922t1474r2152b1557],
29	signiﬁcantly	NN	O	signiﬁcantly	prep_despite	8	SENT_321	[p21l8t1577r424b1661],
30	and	CC	O	and	_	0	SENT_321	[p21l442t1577r568b1640],
31	sustainably	RB	O	sustainably	advmod	32	SENT_321	[p21l588t1577r969b1661],
32	reducing	VBG	O	reduce	conj_and	8	SENT_321	[p21l986t1577r1287b1661],
33	NT-pro-BNP	NN	O	nt-pro-bnp	nn	34	SENT_321	[p21l1305t1580r1756b1660],
34	levels	NNS	O	level	dobj	32	SENT_321	[p21l1777t1577r1977b1640],
35	.	.	O	.	_	0	SENT_321	[p21l1777t1577r1977b1640],

1	AFTER	IN	O	after	_	0	SENT_322	[p21l7t1793r237b1847],
2	STABILIZATION	NNP	O	STABILIZATION	pobj	1	SENT_322	[p21l256t1792r1054b1848],
3	:	:	O	:	_	0	SENT_322	[p21l256t1792r1054b1848],
4	WHAT	WDT	O	what	nsubj	6	SENT_322	[p21l256t1792r1054b1848],
5	TO	TO	O	to	aux	6	SENT_322	[p21l1067t1792r1163b1848],
6	DO	NNP	O	DO	infmod	2	SENT_322	[p21l1185t1792r1291b1848],
7	AT	IN	O	at	_	0	SENT_322	[p21l1309t1793r1397b1847],
8	DISCHARGE	NNP	O	DISCHARGE	prep_at	6	SENT_322	[p21l1417t1792r1874b1848],
9	?	.	O	?	_	0	SENT_322	[p21l1417t1792r1874b1848],

1	During	IN	O	during	_	0	SENT_323	[p21l8t1893r267b1972],
2	hospitalization	NN	O	hospitalization	prep_during	18	SENT_323	[p21l289t1888r818b1971],
3	for	IN	O	for	_	0	SENT_323	[p21l843t1888r944b1951],
4	AHF	NNP	ORGANIZATION	AHF	prep_for	2	SENT_323	[p21l967t1892r1150b1960],
5	,	,	O	,	_	0	SENT_323	[p21l967t1892r1150b1960],
6	a	DT	O	a	det	8	SENT_323	[p21l1178t1911r1213b1951],
7	preexisting	VBG	O	preexist	amod	8	SENT_323	[p21l1235t1894r1631b1972],
8	[	NN	O	[	appos	4	SENT_323	[p21l1658t1888r1996b1972],
9	3	CD	NUMBER	3	num	11	SENT_323	[p21l1658t1888r1996b1972],
10	—	NN	O	—	nn	11	SENT_323	[p21l1658t1888r1996b1972],
11	blocker	NN	O	blocker	nsubjpass	18	SENT_323	[p21l1658t1888r1996b1972],
12	and	CC	O	and	_	0	SENT_323	[p21l2021t1888r2151b1951],
13	ACE	NN	O	ace	nn	15	SENT_323	[p21l7t1995r170b2054],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_323	[p21l193t1991r502b2054],
15	therapy	NN	O	therapy	conj_and	11	SENT_323	[p21l523t1991r790b2075],
16	should	MD	O	should	aux	18	SENT_323	[p21l811t1991r1046b2054],
17	be	VB	O	be	auxpass	18	SENT_323	[p21l1066t1991r1146b2054],
18	continued	VBN	O	continue	_	0	SENT_323	[p21l1170t1991r1523b2054],
19	as	RB	O	as	advmod	20	SENT_323	[p21l1546t2014r1611b2054],
20	long	RB	O	long	advmod	18	SENT_323	[p21l1633t1991r1787b2075],
21	as	IN	O	as	mark	23	SENT_323	[p21l1810t2014r1875b2054],
22	there	EX	O	there	expl	23	SENT_323	[p21l1898t1991r2075b2054],
23	is	VBZ	O	be	ccomp	20	SENT_323	[p21l2099t1997r2149b2054],
24	no	DT	O	no	det	26	SENT_323	[p21l7t2117r95b2157],
25	hemodynamic	JJ	O	hemodynamic	amod	26	SENT_323	[p21l118t2094r623b2178],
26	instability	NN	O	instability	nsubj	23	SENT_323	[p21l647t2094r1003b2178],
27	.	.	O	.	_	0	SENT_323	[p21l647t2094r1003b2178],

1	In	IN	O	in	_	0	SENT_324	[p21l1030t2099r1102b2156],
2	a	DT	O	a	det	4	SENT_324	[p21l1126t2117r1161b2157],
3	retrospective	JJ	O	retrospective	amod	4	SENT_324	[p21l1183t2100r1635b2177],
4	analysis	NN	O	analysis	prep_in	19	SENT_324	[p21l1660t2094r1930b2178],
5	of	IN	O	of	_	0	SENT_324	[p21l1955t2094r2030b2157],
6	the	DT	O	the	det	8	SENT_324	[p21l2042t2094r2151b2157],
7	SURVIVE	NNP	O	SURVIVE	nn	8	SENT_324	[p21l9t2201r357b2260],
8	trial	NN	O	trial	prep_of	4	SENT_324	[p21l378t2197r536b2269],
9	,	,	O	,	_	0	SENT_324	[p21l378t2197r536b2269],
10	patients	NNS	O	patient	conj_and	10	SENT_324	[p21l558t2203r828b2280],
11	on	IN	O	on	_	0	SENT_324	[p21l850t2220r936b2260],
12	B-blocker	NN	O	b-blocker	nn	13	SENT_324	[p21l961t2197r1288b2281],
13	treatment	NN	O	treatment	prep_on	10	SENT_324	[p21l1307t2209r1644b2260],
14	at	IN	O	at	_	0	SENT_324	[p21l1664t2209r1724b2260],
15	entry	NN	O	entry	prep_at	13	SENT_324	[p21l1744t2209r1927b2281],
16	and	CC	O	and	_	0	SENT_324	[p21l1946t2197r2072b2260],
17	at	IN	O	at	_	0	SENT_324	[p21l2093t2209r2152b2260],
18	discharge	NN	O	discharge	prep_at	10	SENT_324	[p21l8t2300r323b2384],
19	had	VBD	O	have	_	0	SENT_324	[p21l341t2300r467b2363],
20	a	DT	O	a	det	22	SENT_324	[p21l485t2323r520b2363],
21	better	JJR	O	better	amod	22	SENT_324	[p21l536t2300r731b2363],
22	outcome	NN	O	outcome	dobj	19	SENT_324	[p21l750t2312r1039b2363],
23	than	IN	O	than	mark	24	SENT_324	[p21l1058t2300r1208b2363],
24	did	VBD	O	do	advcl	19	SENT_324	[p21l1229t2300r1336b2363],
25	those	DT	O	those	dobj	24	SENT_324	[p21l1354t2300r1532b2363],
26	without	IN	O	without	_	0	SENT_324	[p21l1550t2300r1811b2363],
27	[	CD	NUMBER	[	num	29	SENT_324	[p21l1833t2300r2150b2384],
28	3-blocker	NN	O	3-blocker	nn	29	SENT_324	[p21l1833t2300r2150b2384],
29	treatment	NN	O	treatment	prep_without	24	SENT_324	[p21l7t2394r423b2466],
30	.63	CD	NUMBER	.63	tmod	24	SENT_324	[p21l7t2394r423b2466],
31	These	DT	O	these	det	32	SENT_324	[p21l445t2402r639b2466],
32	results	NNS	O	result	nsubj	34	SENT_324	[p21l661t2402r881b2466],
33	strongly	RB	O	strongly	advmod	34	SENT_324	[p21l903t2402r1183b2487],
34	suggest	VBP	O	suggest	dep	24	SENT_324	[p21l1202t2414r1451b2487],
35	that	IN	O	that	complm	49	SENT_324	[p21l1470t2402r1603b2466],
36	in	IN	O	in	_	0	SENT_324	[p21l1623t2409r1690b2465],
37	patients	NNS	O	patient	prep_in	49	SENT_324	[p21l1709t2409r1979b2486],
38	with	IN	O	with	_	0	SENT_324	[p21l1999t2402r2152b2466],
39	acute	JJ	O	acute	amod	41	SENT_324	[p21l8t2518r190b2569],
40	decompensated	JJ	O	decompensated	amod	41	SENT_324	[p21l215t2506r763b2589],
41	HF	NN	O	hf	prep_with	37	SENT_324	[p21l786t2511r904b2578],
42	,	,	O	,	_	0	SENT_324	[p21l786t2511r904b2578],
43	a	DT	O	a	det	45	SENT_324	[p21l931t2529r966b2569],
44	preexisting	VBG	O	preexist	amod	45	SENT_324	[p21l987t2512r1377b2590],
45	[	NN	O	[	appos	41	SENT_324	[p21l1402t2506r1788b2590],
46	3-blockade	NN	O	3-blockade	nsubjpass	49	SENT_324	[p21l1402t2506r1788b2590],
47	should	MD	O	should	aux	49	SENT_324	[p21l1813t2506r2049b2569],
48	be	VB	O	be	auxpass	49	SENT_324	[p21l2069t2506r2150b2569],
49	continued	VBN	O	continue	ccomp	34	SENT_324	[p21l8t2609r358b2672],
50	after	IN	O	after	_	0	SENT_324	[p21l381t2609r535b2672],
51	stabilization	NN	O	stabilization	prep_after	49	SENT_324	[p21l558t2609r996b2672],
52	.	.	O	.	_	0	SENT_324	[p21l558t2609r996b2672],

1	For	IN	O	for	_	0	SENT_325	[p21l1023t2614r1140b2672],
2	HFpEF	NN	O	hfpef	nn	3	SENT_325	[p21l1162t2614r1410b2692],
3	patients	NNS	O	patient	prep_for	9	SENT_325	[p21l1433t2615r1724b2692],
4	,	,	O	,	_	0	SENT_325	[p21l1433t2615r1724b2692],
5	the	DT	O	the	det	6	SENT_325	[p21l1748t2609r1856b2672],
6	data	NNS	O	datum	nsubj	9	SENT_325	[p21l1880t2609r2025b2672],
7	are	VBP	O	be	cop	9	SENT_325	[p21l2048t2632r2149b2672],
8	less	RBR	O	less	advmod	9	SENT_325	[p21l6t2712r126b2775],
9	clear	JJ	O	clear	_	0	SENT_325	[p21l151t2712r325b2775],
10	.	.	O	.	_	0	SENT_325	[p21l151t2712r325b2775],

1	In	IN	O	in	dep	107	SENT_326	[p21l352t2717r424b2774],
2	the	DT	O	the	dep	107	SENT_326	[p21l445t2712r553b2775],
3	OPTIMIZE-HF	NN	MISC	optimize-hf	dep	107	SENT_326	[p21l578t2715r1125b2775],
4	registry	NN	O	registry	dep	107	SENT_326	[p21l1150t2718r1426b2796],
5	,	,	O	,	_	0	SENT_326	[p21l1150t2718r1426b2796],
6	the	DT	O	the	dep	107	SENT_326	[p21l1450t2712r1557b2775],
7	beneﬁcial	JJ	O	beneﬁcial	dep	107	SENT_326	[p21l1579t2712r1914b2775],
8	effects	NNS	O	effect	dep	107	SENT_326	[p21l1937t2712r2152b2775],
9	of	IN	O	of	dep	107	SENT_326	[p21l8t2815r82b2878],
10	discharge	NN	O	discharge	dep	107	SENT_326	[p21l94t2815r418b2899],
11	use	NN	O	use	dep	107	SENT_326	[p21l439t2838r550b2878],
12	of	IN	O	of	dep	107	SENT_326	[p21l571t2815r645b2878],
13	[	CD	NUMBER	[	dep	107	SENT_326	[p21l660t2815r1016b2899],
14	3	CD	NUMBER	3	dep	107	SENT_326	[p21l660t2815r1016b2899],
15	—	NN	O	—	dep	107	SENT_326	[p21l660t2815r1016b2899],
16	blocl	NN	O	blocl	dep	107	SENT_326	[p21l660t2815r1016b2899],
17	<	JJR	O	<	dep	107	SENT_326	[p21l660t2815r1016b2899],
18	ers	NNPS	O	ers	dep	107	SENT_326	[p21l660t2815r1016b2899],
19	observed	VBN	O	observe	dep	107	SENT_326	[p21l1038t2815r1349b2878],
20	in	IN	O	in	dep	107	SENT_326	[p21l1369t2821r1435b2877],
21	patients	NNS	O	patient	dep	107	SENT_326	[p21l1455t2821r1725b2898],
22	with	IN	O	with	dep	107	SENT_326	[p21l1744t2815r1898b2878],
23	HFrEF	NN	O	hfref	dep	107	SENT_326	[p21l1918t2820r2151b2877],
24	were	VBD	O	be	dep	107	SENT_326	[p21l6t2941r164b2982],
25	not	RB	O	not	dep	107	SENT_326	[p21l184t2930r296b2982],
26	evident	JJ	O	evident	dep	107	SENT_326	[p21l315t2918r563b2982],
27	in	IN	O	in	dep	107	SENT_326	[p21l581t2925r647b2981],
28	HFpEF	NN	O	hfpef	dep	107	SENT_326	[p21l667t2924r908b3002],
29	patients	NNS	O	patient	dep	107	SENT_326	[p21l928t2910r1273b3002],
30	.64	CD	NUMBER	.64	dep	107	SENT_326	[p21l928t2910r1273b3002],
31	Patients	NNS	O	patient	dep	107	SENT_326	[p21l1293t2924r1557b2982],
32	should	MD	O	should	dep	107	SENT_326	[p21l1578t2918r1805b2982],
33	be	VB	O	be	dep	107	SENT_326	[p21l1822t2918r1900b2982],
34	treated	VBN	O	treat	dep	107	SENT_326	[p21l1919t2918r2153b2982],
35	according	VBG	O	accord	dep	107	SENT_326	[p21l8t3022r344b3106],
36	to	TO	O	to	dep	107	SENT_326	[p21l361t3034r426b3085],
37	the	DT	O	the	dep	107	SENT_326	[p21l447t3022r553b3085],
38	guidelines	NNS	O	guideline	dep	107	SENT_326	[p21l573t3022r918b3106],
39	at	IN	O	at	dep	107	SENT_326	[p21l939t3034r998b3085],
40	discharge	NN	O	discharge	dep	107	SENT_326	[p21l1018t3022r1338b3106],
41	because	IN	O	because	dep	107	SENT_326	[p21l1357t3022r1623b3085],
42	doing	VBG	O	do	dep	107	SENT_326	[p21l1644t3022r1838b3106],
43	so	RB	O	so	dep	107	SENT_326	[p21l1858t3045r1928b3085],
44	might	MD	O	might	dep	107	SENT_326	[p21l1949t3022r2151b3106],
45	reduce	VB	O	reduce	dep	107	SENT_326	[p21l8t3124r243b3188],
46	the	DT	O	the	dep	107	SENT_326	[p21l266t3124r376b3188],
47	rehospitalization	NN	O	rehospitalization	dep	107	SENT_326	[p21l401t3124r996b3208],
48	rate	NN	O	rate	dep	107	SENT_326	[p21l1020t3136r1151b3188],
49	and	CC	O	and	dep	107	SENT_326	[p21l1177t3124r1306b3188],
50	the	DT	O	the	dep	107	SENT_326	[p21l1329t3124r1438b3188],
51	risk	NN	O	risk	dep	107	SENT_326	[p21l1463t3124r1597b3188],
52	for	IN	O	for	dep	107	SENT_326	[p21l1617t3124r1718b3188],
53	mortality	NN	O	mortality	dep	107	SENT_326	[p21l1740t3116r2150b3209],
54	.65	CD	NUMBER	.65	dep	107	SENT_326	[p21l1740t3116r2150b3209],
55	This	DT	O	this	dep	107	SENT_326	[p21l7t3228r156b3291],
56	means	VBZ	O	mean	dep	107	SENT_326	[p21l184t3251r433b3300],
57	,	,	O	,	_	0	SENT_326	[p21l184t3251r433b3300],
58	in	IN	O	in	dep	107	SENT_326	[p21l462t3234r531b3290],
59	patients	NNS	O	patient	dep	107	SENT_326	[p21l557t3234r841b3311],
60	with	IN	O	with	dep	107	SENT_326	[p21l867t3228r1027b3291],
61	reduced	VBN	O	reduce	dep	107	SENT_326	[p21l1055t3228r1343b3291],
62	EF	NN	MISC	ef	dep	107	SENT_326	[p21l1369t3233r1474b3300],
63	,	,	O	,	_	0	SENT_326	[p21l1369t3233r1474b3300],
64	treatment	NN	O	treatment	dep	107	SENT_326	[p21l1502t3240r1855b3291],
65	with	IN	O	with	dep	107	SENT_326	[p21l1879t3228r2039b3291],
66	an	DT	O	a	dep	107	SENT_326	[p21l2067t3251r2150b3291],
67	ACE	NN	O	ace	dep	107	SENT_326	[p21l7t3335r166b3394],
68	inhibitor	NN	O	inhibitor	dep	107	SENT_326	[p21l186t3331r484b3394],
69	(	NN	O	(	dep	107	SENT_326	[p21l507t3332r604b3408],
70	or	CC	O	or	dep	107	SENT_326	[p21l507t3332r604b3408],
71	angiotensin-receptor	JJ	O	angiotensin-receptor	dep	107	SENT_326	[p21l624t3337r1330b3415],
72	blocker	NN	O	blocker	dep	107	SENT_326	[p21l1347t3331r1646b3408],
73	)	NN	O	)	dep	107	SENT_326	[p21l1347t3331r1646b3408],
74	,	,	O	,	_	0	SENT_326	[p21l1347t3331r1646b3408],
75	[	CD	NUMBER	[	dep	107	SENT_326	[p21l1671t3331r2003b3415],
76	3-blocker	NN	O	3-blocker	dep	107	SENT_326	[p21l1671t3331r2003b3415],
77	,	,	O	,	_	0	SENT_326	[p21l1671t3331r2003b3415],
78	and	CC	O	and	dep	107	SENT_326	[p21l2026t3331r2150b3394],
79	mineralocorticoid-receptor	JJ	O	mineralocorticoid-receptor	dep	107	SENT_326	[p21l7t3434r927b3517],
80	antagonist	NN	O	antagonist	dep	107	SENT_326	[p21l946t3440r1293b3518],
81	should	MD	O	should	dep	107	SENT_326	[p21l1312t3434r1538b3497],
82	be	VB	O	be	dep	107	SENT_326	[p21l1555t3434r1632b3497],
83	initiated	VBN	O	initiate	dep	107	SENT_326	[p21l1653t3434r1931b3497],
84	at	IN	O	at	dep	107	SENT_326	[p21l1951t3446r2008b3497],
85	discharge	NN	O	discharge	dep	107	SENT_326	[p21l2028t3434r2148b3497, p21l8t3537r252b3621],
86	,	,	O	,	_	0	SENT_326	[p21l2028t3434r2148b3497, p21l8t3537r252b3621],
87	unless	IN	O	unless	dep	107	SENT_326	[p21l277t3537r492b3600],
88	there	EX	O	there	dep	107	SENT_326	[p21l515t3537r692b3600],
89	are	VBP	O	be	dep	107	SENT_326	[p21l716t3560r818b3600],
90	no	DT	O	no	dep	107	SENT_326	[p21l841t3560r928b3600],
91	contraindications	NNS	O	contraindication	dep	107	SENT_326	[p21l954t3537r1564b3600],
92	(	VBN	O	(	dep	107	SENT_326	[p21l1591t3537r1820b3613],
93	blood	NN	O	blood	dep	107	SENT_326	[p21l1591t3537r1820b3613],
94	pressure	NN	O	pressure	dep	107	SENT_326	[p21l1840t3559r2149b3620],
95	,	,	O	,	_	0	SENT_326	[p21l1840t3559r2149b3620],
96	heart	NN	O	heart	dep	107	SENT_326	[p21l7t3640r186b3703],
97	rate	NN	O	rate	dep	107	SENT_326	[p21l208t3652r353b3712],
98	,	,	O	,	_	0	SENT_326	[p21l208t3652r353b3712],
99	renal	JJ	O	renal	dep	107	SENT_326	[p21l379t3640r551b3703],
100	function	NN	O	function	dep	107	SENT_326	[p21l574t3640r887b3712],
101	,	,	O	,	_	0	SENT_326	[p21l574t3640r887b3712],
102	and	CC	O	and	dep	107	SENT_326	[p21l912t3640r1040b3703],
103	serum	NN	O	serum	dep	107	SENT_326	[p21l1062t3663r1278b3703],
104	potassium	NN	O	potassium	dep	107	SENT_326	[p21l1300t3646r1656b3723],
105	levels	NNS	O	level	dep	107	SENT_326	[p21l1678t3640r1865b3703],
106	permitting	VBG	O	permit	dep	107	SENT_326	[p21l1887t3646r2149b3723, p21l7t3744r189b3827],
107	)	NN	O	)	_	0	SENT_326	[p21l1887t3646r2149b3723, p21l7t3744r189b3827],
108	.	.	O	.	_	0	SENT_326	[p21l1887t3646r2149b3723, p21l7t3744r189b3827],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_327	[p21l215t3743r678b3815],
2	,	,	O	,	_	0	SENT_327	[p21l215t3743r678b3815],
3	the	DT	O	the	det	4	SENT_327	[p21l702t3743r809b3806],
4	guidelines	NNS	O	guideline	nsubj	5	SENT_327	[p21l832t3743r1183b3827],
5	recommend	VBP	O	recommend	_	0	SENT_327	[p21l1207t3743r1626b3806],
6	a	DT	O	a	det	7	SENT_327	[p21l1648t3766r1683b3806],
7	restriction	NN	O	restriction	dobj	5	SENT_327	[p21l1705t3749r2063b3806],
8	in	IN	O	in	_	0	SENT_327	[p21l2086t3749r2153b3805],
9	sodium	NN	O	sodium	nn	10	SENT_327	[p22l8t22r259b85],
10	(	NN	O	(	dep	11	SENT_327	[p22l282t23r389b98],
11	<	JJR	O	<	prep_in	7	SENT_327	[p22l282t23r389b98],
12	2	CD	NUMBER	2	num	13	SENT_327	[p22l282t23r389b98],
13	g	NN	O	g	dep	11	SENT_327	[p22l405t26r468b106],
14	/	:	O	/	punct	15	SENT_327	[p22l405t26r468b106],
15	day	NN	DURATION	day	dep	13	SENT_327	[p22l473t22r612b106],
16	)	CD	NUMBER	)	num	15	SENT_327	[p22l473t22r612b106],
17	and	CC	O	and	_	0	SENT_327	[p22l636t22r760b85],
18	ﬂuid	JJ	O	ﬂuid	amod	20	SENT_327	[p22l778t22r931b85],
19	intake	NN	O	intake	nn	20	SENT_327	[p22l950t22r1153b85],
20	(	NN	O	(	dep	21	SENT_327	[p22l1176t23r1242b98],
21	<	JJR	O	<	dep	13	SENT_327	[p22l1176t23r1242b98],
22	1.5-2	CD	NUMBER	1.5-2	num	23	SENT_327	[p22l1255t29r1487b85],
23	.0	NN	NUMBER	.0	dep	21	SENT_327	[p22l1255t29r1487b85],
24	1	CD	NUMBER	1	dep	15	SENT_327	[p22l1506t22r1552b88],
25	/	:	O	/	punct	15	SENT_327	[p22l1506t22r1552b88],
26	day	NN	DURATION	day	dep	13	SENT_327	[p22l1557t22r1718b106],
27	)	CD	NUMBER	)	num	26	SENT_327	[p22l1557t22r1718b106],
28	,	,	O	,	_	0	SENT_327	[p22l1557t22r1718b106],
29	even	RB	O	even	advmod	32	SENT_327	[p22l1739t45r1892b85],
30	though	IN	O	though	dep	32	SENT_327	[p22l1910t22r2151b106],
31	there	EX	O	there	expl	32	SENT_327	[p22l7t124r181b188],
32	is	VBZ	O	be	dep	5	SENT_327	[p22l203t131r253b188],
33	no	DT	O	no	det	35	SENT_327	[p22l276t147r362b188],
34	hard	JJ	O	hard	amod	35	SENT_327	[p22l384t124r542b188],
35	evidence	NN	O	evidence	nsubj	32	SENT_327	[p22l563t124r863b188],
36	supporting	VBG	O	support	partmod	35	SENT_327	[p22l886t131r1264b209],
37	these	DT	O	these	det	38	SENT_327	[p22l1283t124r1459b188],
38	measures	NNS	O	measure	dobj	36	SENT_327	[p22l1481t116r1848b188],
39	}	IN	O	}	prep	36	SENT_327	[p22l1481t116r1848b188],

1	SUMMARY	NN	O	summary	nn	2	SENT_328	[p22l9t341r390b396],
2	AHF	NN	O	ahf	nsubj	6	SENT_328	[p22l7t440r180b498],
3	is	VBZ	O	be	cop	6	SENT_328	[p22l212t442r264b499],
4	a	DT	O	a	det	6	SENT_328	[p22l295t459r330b499],
5	disease	NN	O	disease	nn	6	SENT_328	[p22l360t436r612b499],
6	entity	NN	O	entity	_	0	SENT_328	[p22l643t442r850b520],
7	with	IN	O	with	_	0	SENT_328	[p22l874t436r1034b499],
8	high	JJ	O	high	amod	9	SENT_328	[p22l1063t436r1224b520],
9	morbidity	NN	O	morbidity	prep_with	6	SENT_328	[p22l1253t436r1616b520],
10	and	CC	O	and	_	0	SENT_328	[p22l1642t436r1774b499],
11	mortality	NN	O	mortality	conj_and	9	SENT_328	[p22l1803t436r2149b520],
12	.	.	O	.	_	0	SENT_328	[p22l1803t436r2149b520],

1	Currently	RB	DATE	currently	advmod	8	SENT_329	[p22l9t539r338b623],
2	,	,	O	,	_	0	SENT_329	[p22l9t539r338b623],
3	most	RBS	O	most	advmod	4	SENT_329	[p22l357t551r522b602],
4	recommendations	NNS	O	recommendation	nsubj	8	SENT_329	[p22l539t539r1140b602],
5	in	IN	O	in	_	0	SENT_329	[p22l1158t545r1223b601],
6	guidelines	NNS	O	guideline	prep_in	8	SENT_329	[p22l1240t539r1575b623],
7	are	VBP	O	be	cop	8	SENT_329	[p22l1594t562r1691b602],
8	weak	JJ	O	weak	_	0	SENT_329	[p22l1707t539r1881b602],
9	because	IN	O	because	mark	19	SENT_329	[p22l1893t539r2152b602],
10	of	IN	O	of	_	0	SENT_329	[p22l8t642r81b705],
11	the	DT	O	the	det	13	SENT_329	[p22l90t642r195b705],
12	relevant	JJ	O	relevant	amod	13	SENT_329	[p22l215t642r481b705],
13	lack	NN	O	lack	prep_of	19	SENT_329	[p22l499t642r635b705],
14	of	IN	O	of	_	0	SENT_329	[p22l653t642r725b705],
15	prospective	JJ	O	prospective	prep_of	13	SENT_329	[p22l735t648r1134b725],
16	,	,	O	,	_	0	SENT_329	[p22l735t648r1134b725],
17	well	RB	O	well	advmod	18	SENT_329	[p22l1154t642r1609b725],
18	—	CD	NUMBER	—	nsubj	19	SENT_329	[p22l1154t642r1609b725],
19	powered	VBD	O	power	ccomp	8	SENT_329	[p22l1154t642r1609b725],
20	evidence	NN	O	evidence	dobj	19	SENT_329	[p22l1629t642r1935b705],
21	.	.	O	.	_	0	SENT_329	[p22l1629t642r1935b705],

1	There	EX	O	there	expl	6	SENT_330	[p22l1959t642r2149b705],
2	have	VBP	O	have	aux	6	SENT_330	[p22l7t745r164b808],
3	been	VBN	O	be	cop	6	SENT_330	[p22l185t745r351b808],
4	only	RB	O	only	quantmod	6	SENT_330	[p22l376t745r528b829],
5	a	DT	O	a	quantmod	6	SENT_330	[p22l549t768r584b808],
6	few	JJ	O	few	_	0	SENT_330	[p22l606t745r728b808],
7	adequately	RB	O	adequately	advmod	8	SENT_330	[p22l749t745r1122b829],
8	designed	VBN	O	design	partmod	6	SENT_330	[p22l1142t745r1466b829],
9	,	,	O	,	_	0	SENT_330	[p22l1142t745r1466b829],
10	well-controlled	JJ	O	well-controlled	amod	11	SENT_330	[p22l1489t745r2017b808],
11	trials	NNS	O	trial	ccomp	6	SENT_330	[p22l2038t751r2146b808, p22l8t847r100b911],
12	in	IN	O	in	dep	11	SENT_330	[p22l132t853r201b910],
13	AHF	NNP	ORGANIZATION	AHF	pobj	12	SENT_330	[p22l232t851r417b919],
14	,	,	O	,	_	0	SENT_330	[p22l232t851r417b919],
15	and	CC	O	and	_	0	SENT_330	[p22l451t847r582b911],
16	most	JJS	O	most	nsubj	18	SENT_330	[p22l613t859r791b911],
17	have	VBP	O	have	aux	18	SENT_330	[p22l820t847r982b911],
18	failed	VBN	O	fail	conj_and	6	SENT_330	[p22l1014t847r1214b911],
19	to	TO	O	to	aux	20	SENT_330	[p22l1243t859r1311b911],
20	show	VB	O	show	xcomp	18	SENT_330	[p22l1345t847r1531b911],
21	a	DT	O	a	det	22	SENT_330	[p22l1560t870r1595b911],
22	benefit	NN	O	benefit	dobj	20	SENT_330	[p22l1623t847r1876b911],
23	of	IN	O	of	_	0	SENT_330	[p22l1907t847r1984b911],
24	new	JJ	O	new	prep_of	22	SENT_330	[p22l2005t870r2154b911],

1	506	CD	NUMBER	506	num	3	SENT_331	[p22l8t1067r105b1109],
2	pharmacological	JJ	O	pharmacological	amod	3	SENT_331	[p22l7t1149r566b1233],
3	agents	NNS	O	agent	_	0	SENT_331	[p22l586t1161r793b1233],
4	on	IN	O	on	_	0	SENT_331	[p22l815t1172r900b1212],
5	clinical	JJ	O	clinical	amod	6	SENT_331	[p22l921t1149r1158b1212],
6	outcomes	NNS	O	outcome	prep_on	3	SENT_331	[p22l1178t1161r1498b1212],
7	of	IN	O	of	_	0	SENT_331	[p22l1519t1149r1592b1212],
8	the	DT	O	the	det	9	SENT_331	[p22l1601t1149r1706b1212],
9	patients	NNS	O	patient	prep_of	3	SENT_331	[p22l1725t1155r2002b1232],
10	.	.	O	.	_	0	SENT_331	[p22l1725t1155r2002b1232],

1	The	DT	O	the	det	3	SENT_332	[p22l2026t1149r2150b1212],
2	key	JJ	O	key	amod	3	SENT_332	[p22l7t1252r122b1336],
3	drugs	NNS	O	drug	nsubj	10	SENT_332	[p22l136t1252r318b1336],
4	for	IN	O	for	_	0	SENT_332	[p22l335t1252r428b1315],
5	the	DT	O	the	det	6	SENT_332	[p22l442t1252r544b1315],
6	treatment	NN	O	treatment	prep_for	3	SENT_332	[p22l560t1264r877b1315],
7	of	IN	O	of	_	0	SENT_332	[p22l893t1252r964b1315],
8	AHF	NNP	ORGANIZATION	AHF	prep_of	6	SENT_332	[p22l971t1256r1132b1314],
9	are	VBP	O	be	cop	10	SENT_332	[p22l1151t1275r1246b1315],
10	oxygen	NN	O	oxygen	_	0	SENT_332	[p22l1264t1275r1510b1336],
11	,	,	O	,	_	0	SENT_332	[p22l1264t1275r1510b1336],
12	diuretics	NNS	O	diuretic	conj_and	10	SENT_332	[p22l1530t1252r1823b1324],
13	,	,	O	,	_	0	SENT_332	[p22l1530t1252r1823b1324],
14	and	CC	O	and	_	0	SENT_332	[p22l1842t1252r1963b1315],
15	vasodilators	NNS	O	vasodilator	conj_and	10	SENT_332	[p22l1976t1275r2149b1315, p22l9t1355r264b1418],
16	.	.	O	.	_	0	SENT_332	[p22l1976t1275r2149b1315, p22l9t1355r264b1418],

1	The	DT	O	the	det	2	SENT_333	[p22l285t1355r406b1418],
2	use	NN	O	use	nsubj	9	SENT_333	[p22l424t1378r530b1418],
3	of	IN	O	of	_	0	SENT_333	[p22l548t1355r619b1418],
4	inotropes	NNS	O	inotrope	prep_of	2	SENT_333	[p22l627t1361r934b1438],
5	and	CC	O	and	_	0	SENT_333	[p22l953t1355r1074b1418],
6	vasopressors	NNS	O	vasopressor	prep_of	2	SENT_333	[p22l1087t1377r1498b1438],
7	should	MD	O	should	aux	9	SENT_333	[p22l1517t1355r1736b1418],
8	be	VB	O	be	cop	9	SENT_333	[p22l1751t1355r1827b1418],
9	restricted	JJ	O	restricted	_	0	SENT_333	[p22l1845t1355r2151b1418],
10	to	TO	O	to	_	0	SENT_333	[p22l7t1470r71b1521],
11	hemodynamically	RB	O	hemodynamically	advmod	12	SENT_333	[p22l88t1458r678b1542],
12	unstable	JJ	O	unstable	amod	13	SENT_333	[p22l691t1458r962b1521],
13	patients	NNS	O	patient	prep_to	9	SENT_333	[p22l979t1464r1233b1541],
14	because	IN	O	because	mark	17	SENT_333	[p22l1249t1458r1504b1521],
15	they	PRP	O	they	nsubj	17	SENT_333	[p22l1520t1458r1664b1542],
16	might	MD	O	might	aux	17	SENT_333	[p22l1677t1458r1872b1542],
17	increase	VB	O	increase	advcl	9	SENT_333	[p22l1888t1464r2150b1521],
18	mortality	NN	O	mortality	dobj	17	SENT_333	[p22l8t1561r326b1645],
19	.	.	O	.	_	0	SENT_333	[p22l8t1561r326b1645],

1	Promising	JJ	O	promising	amod	4	SENT_334	[p22l349t1566r695b1645],
2	new	JJ	O	new	amod	4	SENT_334	[p22l711t1584r852b1624],
3	pharmacological	JJ	O	pharmacological	amod	4	SENT_334	[p22l867t1561r1425b1645],
4	agents	NNS	O	agent	nsubjpass	11	SENT_334	[p22l1443t1573r1650b1645],
5	such	JJ	O	such	_	0	SENT_334	[p22l1670t1561r1822b1624],
6	as	IN	O	as	_	0	SENT_334	[p22l1841t1584r1904b1624],
7	relaxin	NN	O	relaxin	prep_such_as	4	SENT_334	[p22l1924t1561r2152b1624],
8	are	VBP	O	be	aux	11	SENT_334	[p22l9t1687r105b1727],
9	currently	RB	DATE	currently	advmod	11	SENT_334	[p22l124t1664r426b1748],
10	being	VBG	O	be	auxpass	11	SENT_334	[p22l437t1664r622b1748],
11	developed	VBN	O	develop	_	0	SENT_334	[p22l638t1664r973b1747],
12	and	CC	O	and	_	0	SENT_334	[p22l990t1664r1113b1727],
13	tested	VBN	O	test	conj_and	11	SENT_334	[p22l1128t1664r1320b1727],
14	in	IN	O	in	_	0	SENT_334	[p22l1337t1670r1401b1726],
15	clinical	JJ	O	clinical	amod	17	SENT_334	[p22l1419t1664r1652b1727],
16	outcome	NN	O	outcome	nn	17	SENT_334	[p22l1669t1676r1954b1727],
17	trials	NNS	O	trial	prep_in	11	SENT_334	[p22l1971t1664r2149b1727],
18	.	.	O	.	_	0	SENT_334	[p22l1971t1664r2149b1727],

1	CONFLICT	NN	O	conflict	nsubj	6	SENT_335	[p22l9t1838r322b1887],
2	OF	IN	O	of	_	0	SENT_335	[p22l337t1838r420b1887],
3	INTEREST	NN	O	interest	nn	4	SENT_335	[p22l439t1838r738b1887],
4	M.B.	NNP	O	M.B.	prep_of	1	SENT_335	[p22l10t1925r124b1974],
5	has	VBZ	O	have	aux	6	SENT_335	[p22l142t1923r234b1974],
6	received	VBN	O	receive	_	0	SENT_335	[p22l252t1923r485b1974],
7	speaker	NN	O	speaker	nn	8	SENT_335	[p22l504t1923r724b1987],
8	honoraria	NN	O	honorarium	dobj	6	SENT_335	[p22l740t1923r1011b1974],
9	from	IN	O	from	_	0	SENT_335	[p22l1027t1922r1159b1974],
10	Servier	NNP	ORGANIZATION	Servier	prep_from	6	SENT_335	[p22l1177t1924r1381b1981],
11	,	,	O	,	_	0	SENT_335	[p22l1177t1924r1381b1981],
12	Boehringer	NNP	PERSON	Boehringer	nn	13	SENT_335	[p22l1400t1923r1714b1987],
13	Ingelheim	NNP	PERSON	Ingelheim	prep_from	6	SENT_335	[p22l1731t1923r2028b1987],
14	,	,	O	,	_	0	SENT_335	[p22l1731t1923r2028b1987],
15	Medtronic	NNP	ORGANIZATION	Medtronic	prep_from	6	SENT_335	[p22l10t2009r314b2068],
16	,	,	O	,	_	0	SENT_335	[p22l10t2009r314b2068],
17	St.	NNP	ORGANIZATION	St.	nn	19	SENT_335	[p22l330t2011r395b2060],
18	Jude	NNP	ORGANIZATION	Jude	nn	19	SENT_335	[p22l409t2009r543b2060],
19	Medical	NNP	ORGANIZATION	Medical	conj_and	10	SENT_335	[p22l560t2009r793b2068],
20	,	,	O	,	_	0	SENT_335	[p22l560t2009r793b2068],
21	and	CC	O	and	_	0	SENT_335	[p22l808t2009r912b2060],
22	Bayer	NNP	ORGANIZATION	Bayer	conj_and	10	SENT_335	[p22l933t2011r1095b2074],
23	.	.	O	.	_	0	SENT_335	[p22l933t2011r1095b2074],

1	The	DT	O	the	det	3	SENT_336	[p22l1105t2009r1209b2060],
2	other	JJ	O	other	amod	3	SENT_336	[p22l1225t2009r1378b2060],
3	authors	NNS	O	author	nsubj	4	SENT_336	[p22l1392t2009r1607b2060],
4	declared	VBD	O	declare	_	0	SENT_336	[p22l1623t2009r1865b2060],
5	no	DT	O	no	det	6	SENT_336	[p22l1884t2024r1954b2060],
6	conflict	NN	O	conflict	dobj	4	SENT_336	[p22l8t2094r217b2145],
7	of	IN	O	of	_	0	SENT_336	[p22l232t2094r291b2145],
8	interest	NN	O	interest	prep_of	6	SENT_336	[p22l303t2097r527b2145],
9	.	.	O	.	_	0	SENT_336	[p22l303t2097r527b2145],

1	©	RB	O	©	dep	2	SENT_337	[p22l8t2278r48b2319],
2	2013	CD	DATE	2013	dep	4	SENT_337	[p22l63t2277r191b2321],
3	American	NNP	ORGANIZATION	American	nn	4	SENT_337	[p22l207t2276r462b2321],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_337	[p22l480t2276r675b2334],
5	for	IN	O	for	_	0	SENT_337	[p22l687t2273r760b2321],
6	Clinical	JJ	O	clinical	amod	7	SENT_337	[p22l774t2274r963b2321],
7	Pharmacology	NN	O	pharmacology	prep_for	4	SENT_337	[p22l984t2274r1370b2334],
8	and	CC	O	and	_	0	SENT_337	[p22l1384t2274r1482b2321],
9	Therapeutics	NNS	O	therapeutics	prep_for	4	SENT_337	[p22l1494t2274r1843b2333],

1	1	LS	NUMBER	1	_	0	SENT_338	[p22l13t2495r50b2540],
2	.	.	O	.	_	0	SENT_338	[p22l13t2495r50b2540],

1	McMurray	NNP	PERSON	McMurray	nn	3	SENT_339	[p22l131t2493r405b2554],
2	,	,	O	,	_	0	SENT_339	[p22l131t2493r405b2554],
3	J.J.	NNP	PERSON	J.J.	_	0	SENT_339	[p22l417t2493r487b2541],
4	et	FW	O	et	nn	5	SENT_339	[p22l501t2498r550b2540],
5	al.	FW	O	al.	dep	3	SENT_339	[p22l559t2491r628b2548],
6	;	:	O	;	_	0	SENT_339	[p22l559t2491r628b2548],
7	ESC	NNP	ORGANIZATION	ESC	nn	8	SENT_339	[p22l645t2493r738b2541],
8	Committee	NNP	ORGANIZATION	Committee	dep	3	SENT_339	[p22l753t2492r1047b2541],
9	for	IN	ORGANIZATION	for	_	0	SENT_339	[p22l1060t2490r1132b2540],
10	Practice	NNP	ORGANIZATION	Practice	nn	11	SENT_339	[p22l1148t2493r1350b2541],
11	Guidelines	NNS	ORGANIZATION	guideline	prep_for	8	SENT_339	[p22l1365t2491r1654b2541],
12	.	.	O	.	_	0	SENT_339	[p22l1365t2491r1654b2541],

1	ESC	NNP	O	ESC	nn	2	SENT_340	[p22l1671t2492r1765b2541],
2	Guidelines	NNS	O	guideline	_	0	SENT_340	[p22l1779t2491r2056b2541],
3	for	IN	O	for	_	0	SENT_340	[p22l130t2568r202b2619],
4	the	DT	O	the	det	5	SENT_340	[p22l214t2569r299b2619],
5	diagnosis	NN	O	diagnosis	prep_for	2	SENT_340	[p22l314t2569r562b2632],
6	and	CC	O	and	_	0	SENT_340	[p22l576t2569r673b2619],
7	treatment	NN	O	treatment	prep_for	2	SENT_340	[p22l688t2576r952b2619],
8	of	IN	O	of	_	0	SENT_340	[p22l965t2568r1020b2619],
9	acute	JJ	O	acute	prep_of	5	SENT_340	[p22l1029t2576r1173b2619],
10	and	CC	O	and	_	0	SENT_340	[p22l1187t2569r1283b2619],
11	chronic	JJ	O	chronic	amod	13	SENT_340	[p22l1300t2569r1494b2619],
12	heart	NN	O	heart	nn	13	SENT_340	[p22l1510t2569r1646b2619],
13	failure	NN	O	failure	prep_for	2	SENT_340	[p22l1658t2568r1822b2619],
14	2012	CD	DATE	2012	dep	13	SENT_340	[p22l1836t2569r2082b2619],
15	:	:	O	:	_	0	SENT_340	[p22l1836t2569r2082b2619],
16	The	DT	O	the	det	18	SENT_340	[p22l1836t2569r2082b2619],
17	Task	NNP	O	Task	nn	18	SENT_340	[p22l129t2646r243b2696],
18	Force	NNP	O	Force	dep	2	SENT_340	[p22l257t2648r395b2696],
19	for	IN	O	for	_	0	SENT_340	[p22l408t2645r480b2696],
20	the	DT	O	the	det	21	SENT_340	[p22l492t2646r578b2696],
21	Diagnosis	NN	O	diagnosis	prep_for	18	SENT_340	[p22l595t2648r847b2709],
22	and	CC	O	and	_	0	SENT_340	[p22l861t2646r958b2696],
23	Treatment	NN	O	treatment	prep_for	18	SENT_340	[p22l969t2648r1242b2696],
24	of	IN	O	of	_	0	SENT_340	[p22l1256t2645r1310b2696],
25	Acute	JJ	O	acute	amod	29	SENT_340	[p22l1319t2648r1470b2696],
26	and	CC	O	and	_	0	SENT_340	[p22l1484t2646r1581b2696],
27	Chronic	JJ	O	chronic	conj_and	25	SENT_340	[p22l1597t2646r1800b2696],
28	Heart	NNP	O	Heart	nn	29	SENT_340	[p22l1816t2648r1958b2696],
29	Failure	NN	O	failure	prep_of	21	SENT_340	[p22l1975t2646r2144b2696],
30	2012	CD	DATE	2012	dep	29	SENT_340	[p22l132t2727r257b2774],
31	of	IN	O	of	_	0	SENT_340	[p22l272t2723r327b2774],
32	the	DT	O	the	det	34	SENT_340	[p22l335t2724r421b2774],
33	European	JJ	ORGANIZATION	european	amod	34	SENT_340	[p22l437t2726r684b2786],
34	Society	NNP	ORGANIZATION	Society	prep_of	30	SENT_340	[p22l702t2726r893b2788],
35	of	IN	ORGANIZATION	of	_	0	SENT_340	[p22l905t2723r959b2774],
36	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	34	SENT_340	[p22l969t2724r1264b2788],
37	.	.	O	.	_	0	SENT_340	[p22l969t2724r1264b2788],

1	Developed	VBN	O	develop	_	0	SENT_341	[p22l1281t2724r1563b2786],
2	in	IN	O	in	_	0	SENT_341	[p22l1582t2726r1624b2773],
3	collaboration	NN	O	collaboration	prep_in	1	SENT_341	[p22l1641t2724r1986b2774],
4	with	IN	O	with	_	0	SENT_341	[p22l2002t2724r2115b2774],
5	the	DT	O	the	det	10	SENT_341	[p22l130t2801r216b2850],
6	Heart	NNP	ORGANIZATION	Heart	nn	10	SENT_341	[p22l232t2803r374b2850],
7	Failure	NN	ORGANIZATION	failure	nn	10	SENT_341	[p22l390t2801r559b2850],
8	Association	NNP	ORGANIZATION	Association	nn	10	SENT_341	[p22l574t2803r872b2850],
9	(	CD	NUMBER	(	num	10	SENT_341	[p22l890t2802r1025b2858],
10	HFA	NNP	O	HFA	prep_with	1	SENT_341	[p22l890t2802r1025b2858],
11	)	CD	NUMBER	)	num	13	SENT_341	[p22l890t2802r1025b2858],
12	ofthe	NN	O	ofthe	nn	13	SENT_341	[p22l1041t2800r1189b2850],
13	ESC	NN	O	esc	dep	10	SENT_341	[p22l1206t2803r1313b2850],
14	.	.	O	.	_	0	SENT_341	[p22l1206t2803r1313b2850],

1	Eur	NNP	O	Eur	_	0	SENT_342	[p22l1327t2803r1415b2850],
2	.	.	O	.	_	0	SENT_342	[p22l1327t2803r1415b2850],

1	HeartJ	NN	O	heartj	_	0	SENT_343	[p22l1430t2803r1616b2850],
2	.	.	O	.	_	0	SENT_343	[p22l1430t2803r1616b2850],

1	33	CD	NUMBER	33	_	0	SENT_344	[p22l1630t2804r1709b2858],
2	,	,	O	,	_	0	SENT_344	[p22l1630t2804r1709b2858],
3	1787-1847	CD	DATE	1787-1847	number	4	SENT_344	[p22l1728t2804r2013b2850],
4	(	CD	NUMBER	(	appos	1	SENT_344	[p22l133t2879r307b2935],
5	2012	CD	DATE	2012	num	6	SENT_344	[p22l133t2879r307b2935],
6	)	NN	O	)	dep	4	SENT_344	[p22l133t2879r307b2935],
7	.	.	O	.	_	0	SENT_344	[p22l133t2879r307b2935],

1	2	LS	NUMBER	2	_	0	SENT_345	[p22l8t2959r50b3006],
2	.	.	O	.	_	0	SENT_345	[p22l8t2959r50b3006],

1	Cleland	NNP	PERSON	Cleland	nn	4	SENT_346	[p22l130t2956r339b3013],
2	,	,	O	,	_	0	SENT_346	[p22l130t2956r339b3013],
3	J.G.	NNP	O	J.G.	appos	4	SENT_346	[p22l351t2958r439b3006],
4	etal.	NNP	O	etal.	_	0	SENT_346	[p22l453t2956r581b3013],
5	;	:	O	;	_	0	SENT_346	[p22l453t2956r581b3013],
6	Study	NNP	ORGANIZATION	Study	nn	7	SENT_346	[p22l595t2956r746b3020],
7	Group	NNP	ORGANIZATION	Group	dep	4	SENT_346	[p22l759t2958r923b3018],
8	on	IN	O	on	_	0	SENT_346	[p22l937t2971r1002b3006],
9	Diagnosis	NN	O	diagnosis	prep_on	7	SENT_346	[p22l1020t2958r1273b3019],
10	of	IN	O	of	_	0	SENT_346	[p22l1287t2955r1342b3006],
11	the	DT	O	the	det	13	SENT_346	[p22l1350t2956r1436b3006],
12	Working	NNP	O	Working	nn	13	SENT_346	[p22l1447t2956r1667b3019],
13	Group	NNP	O	Group	prep_of	9	SENT_346	[p22l1683t2958r1847b3018],
14	on	IN	O	on	_	0	SENT_346	[p22l1861t2971r1926b3006],
15	Heart	NNP	ORGANIZATION	Heart	nn	16	SENT_346	[p22l1945t2958r2087b3006],
16	Failure	NN	ORGANIZATION	failure	prep_on	13	SENT_346	[p22l133t3034r303b3084],
17	of	IN	ORGANIZATION	of	_	0	SENT_346	[p22l317t3033r372b3084],
18	the	DT	ORGANIZATION	the	det	20	SENT_346	[p22l380t3034r466b3084],
19	European	JJ	ORGANIZATION	european	amod	20	SENT_346	[p22l482t3036r729b3096],
20	Society	NNP	ORGANIZATION	Society	prep_of	7	SENT_346	[p22l746t3036r937b3098],
21	of	IN	ORGANIZATION	of	_	0	SENT_346	[p22l950t3033r1004b3084],
22	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	20	SENT_346	[p22l1014t3034r1309b3098],
23	.	.	O	.	_	0	SENT_346	[p22l1014t3034r1309b3098],

1	The	DT	O	the	det	5	SENT_347	[p22l1318t3034r1416b3084],
2	EuroHeart	NNP	O	EuroHeart	nn	5	SENT_347	[p22l1432t3036r1696b3084],
3	Failure	NN	O	failure	nn	5	SENT_347	[p22l1711t3034r1881b3084],
4	survey	NN	O	survey	nn	5	SENT_347	[p22l1895t3049r2068b3098],
5	programme	NN	O	programme	nsubj	6	SENT_347	[p22l133t3127r506b3175],
6	—	VBD	O	—	_	0	SENT_347	[p22l133t3127r506b3175],
7	a	DT	O	a	det	8	SENT_347	[p22l133t3127r506b3175],
8	survey	NN	O	survey	dobj	6	SENT_347	[p22l522t3127r695b3176],
9	on	IN	O	on	_	0	SENT_347	[p22l707t3127r772b3162],
10	the	DT	O	the	det	11	SENT_347	[p22l787t3112r873b3162],
11	quality	NN	O	quality	prep_on	6	SENT_347	[p22l887t3112r1068b3176],
12	of	IN	O	of	_	0	SENT_347	[p22l1081t3111r1135b3162],
13	care	NN	O	care	prep_of	11	SENT_347	[p22l1145t3127r1252b3162],
14	among	IN	O	among	_	0	SENT_347	[p22l1266t3127r1450b3175],
15	patients	NNS	O	patient	prep_among	6	SENT_347	[p22l1469t3114r1678b3174],
16	with	IN	O	with	_	0	SENT_347	[p22l1692t3112r1805b3162],
17	heart	NN	O	heart	nn	18	SENT_347	[p22l1824t3112r1960b3162],
18	failure	NN	O	failure	prep_with	15	SENT_347	[p22l130t3189r293b3240],
19	in	IN	O	in	_	0	SENT_347	[p22l309t3192r352b3239],
20	Europe	NNP	LOCATION	Europe	prep_in	18	SENT_347	[p22l370t3192r566b3252],
21	.	.	O	.	_	0	SENT_347	[p22l370t3192r566b3252],

1	Part	NNP	O	Part	_	0	SENT_348	[p22l583t3192r683b3240],
2	1	CD	NUMBER	1	num	1	SENT_348	[p22l701t3194r716b3239],
3	:	:	O	:	_	0	SENT_348	[p22l731t3207r739b3240],
4	patient	NN	O	patient	nn	5	SENT_348	[p22l755t3192r941b3253],
5	characteristics	NNS	O	characteristic	dep	1	SENT_348	[p22l954t3190r1328b3240],
6	and	CC	O	and	_	0	SENT_348	[p22l1342t3190r1439b3240],
7	diagnosis	NN	O	diagnosis	conj_and	5	SENT_348	[p22l1455t3190r1716b3253],
8	.	.	O	.	_	0	SENT_348	[p22l1455t3190r1716b3253],

1	Eur	NNP	O	Eur	_	0	SENT_349	[p22l1730t3192r1818b3240],
2	.	.	O	.	_	0	SENT_349	[p22l1730t3192r1818b3240],

1	HeartJ	NN	O	heartj	_	0	SENT_350	[p22l1833t3192r2019b3240],
2	.	.	O	.	_	0	SENT_350	[p22l1833t3192r2019b3240],

1	24	CD	NUMBER	24	_	0	SENT_351	[p22l2033t3193r2112b3248],
2	,	,	O	,	_	0	SENT_351	[p22l2033t3193r2112b3248],
3	442-463	CD	NUMBER	442-463	number	4	SENT_351	[p22l130t3270r353b3316],
4	(	CD	NUMBER	(	appos	1	SENT_351	[p22l371t3268r545b3324],
5	2003	CD	DATE	2003	num	6	SENT_351	[p22l371t3268r545b3324],
6	)	NN	O	)	dep	4	SENT_351	[p22l371t3268r545b3324],
7	.	.	O	.	_	0	SENT_351	[p22l371t3268r545b3324],

1	3	LS	NUMBER	3	_	0	SENT_352	[p22l8t3348r50b3395],
2	.	.	O	.	_	0	SENT_352	[p22l8t3348r50b3395],

1	Voors	NNP	O	Voors	nn	6	SENT_353	[p22l128t3347r287b3402],
2	,	,	O	,	_	0	SENT_353	[p22l128t3347r287b3402],
3	A.A.	NNP	ORGANIZATION	A.A.	nn	6	SENT_353	[p22l301t3347r402b3395],
4	&	CC	ORGANIZATION	&	_	0	SENT_353	[p22l416t3347r453b3395],
5	van	NNP	PERSON	van	conj_and	1	SENT_353	[p22l464t3360r556b3395],
6	Veldhuisen	NNP	PERSON	Veldhuisen	_	0	SENT_353	[p22l568t3345r873b3402],
7	,	,	O	,	_	0	SENT_353	[p22l568t3345r873b3402],
8	D.J.	NNP	O	D.J.	appos	6	SENT_353	[p22l890t3347r973b3395],
9	Why	WRB	O	why	advmod	10	SENT_353	[p22l984t3345r1101b3409],
10	do	VBP	O	do	rcmod	8	SENT_353	[p22l1114t3345r1181b3395],
11	drugs	NNS	O	drug	nsubj	16	SENT_353	[p22l1195t3345r1344b3408],
12	for	IN	O	for	_	0	SENT_353	[p22l1357t3344r1429b3395],
13	acute	JJ	O	acute	amod	15	SENT_353	[p22l1442t3353r1585b3395],
14	heart	NN	O	heart	nn	15	SENT_353	[p22l1602t3345r1738b3395],
15	failure	NN	O	failure	prep_for	11	SENT_353	[p22l1751t3344r1914b3395],
16	fail	VB	O	fail	ccomp	10	SENT_353	[p22l1927t3344r2028b3395],
17	?	.	O	?	_	0	SENT_353	[p22l1927t3344r2028b3395],

1	Eur	NNP	O	Eur	_	0	SENT_354	[p22l2043t3347r2131b3395],
2	.	.	O	.	_	0	SENT_354	[p22l2043t3347r2131b3395],

1	J.	NNP	O	J.	nn	2	SENT_355	[p22l127t3424r161b3471],
2	Heart	NNP	O	Heart	_	0	SENT_355	[p22l176t3424r320b3471],
3	Fail	NN	O	fail	dep	2	SENT_355	[p22l329t3422r427b3471],
4	.	.	O	.	_	0	SENT_355	[p22l329t3422r427b3471],

1	14	CD	NUMBER	14	_	0	SENT_356	[p22l445t3426r522b3479],
2	,	,	O	,	_	0	SENT_356	[p22l445t3426r522b3479],
3	955-956	CD	NUMBER	955-956	number	4	SENT_356	[p22l536t3425r760b3471],
4	(	CD	NUMBER	(	appos	1	SENT_356	[p22l776t3423r950b3478],
5	2012	CD	DATE	2012	num	6	SENT_356	[p22l776t3423r950b3478],
6	)	NN	O	)	dep	4	SENT_356	[p22l776t3423r950b3478],
7	.	.	O	.	_	0	SENT_356	[p22l776t3423r950b3478],

1	4	LS	NUMBER	4	_	0	SENT_357	[p22l6t3504r50b3550],
2	.	.	O	.	_	0	SENT_357	[p22l6t3504r50b3550],

1	Lavall	NNP	PERSON	Lavall	_	0	SENT_358	[p22l132t3500r291b3558],
2	,	,	O	,	_	0	SENT_358	[p22l132t3500r291b3558],
3	D.	NNP	O	D.	conj_and	1	SENT_358	[p22l308t3502r369b3558],
4	,	,	O	,	_	0	SENT_358	[p22l308t3502r369b3558],
5	Reil	NNP	PERSON	Reil	conj_and	1	SENT_358	[p22l387t3500r490b3558],
6	,	,	O	,	_	0	SENT_358	[p22l387t3500r490b3558],
7	J.C.	NNP	ORGANIZATION	J.C.	conj_and	1	SENT_358	[p22l503t3502r588b3550],
8	&	CC	ORGANIZATION	&	_	0	SENT_358	[p22l603t3502r639b3550],
9	Bohm	NNP	ORGANIZATION	Bohm	conj_and	1	SENT_358	[p22l655t3500r822b3557],
10	,	,	O	,	_	0	SENT_358	[p22l655t3500r822b3557],
11	M.	NNP	PERSON	M.	nn	13	SENT_358	[p22l838t3502r898b3550],
12	Intracardiac	NNP	PERSON	Intracardiac	nn	13	SENT_358	[p22l915t3500r1225b3550],
13	ﬁstula	NN	O	ﬁstula	appos	1	SENT_358	[p22l1238t3499r1396b3550],
14	due	JJ	O	due	_	0	SENT_358	[p22l1412t3500r1512b3550],
15	to	TO	O	to	_	0	SENT_358	[p22l1526t3508r1579b3550],
16	prosthetic	JJ	O	prosthetic	amod	19	SENT_358	[p22l1597t3500r1863b3562],
17	aortic	JJ	O	aortic	amod	19	SENT_358	[p22l1878t3502r2028b3550],
18	valve	NN	O	valve	nn	19	SENT_358	[p22l130t3578r266b3628],
19	abscess	NN	O	abscess	prep_due_to	13	SENT_358	[p22l281t3578r481b3628],
20	causing	VBG	O	cause	partmod	19	SENT_358	[p22l497t3580r698b3641],
21	acute	JJ	O	acute	amod	23	SENT_358	[p22l715t3586r859b3628],
22	heart	NN	O	heart	nn	23	SENT_358	[p22l877t3578r1014b3628],
23	failure	NN	O	failure	dobj	20	SENT_358	[p22l1027t3577r1205b3628],
24	.	.	O	.	_	0	SENT_358	[p22l1027t3577r1205b3628],

1	Clin	NNP	O	Clin	_	0	SENT_359	[p22l1221t3578r1327b3628],
2	.	.	O	.	_	0	SENT_359	[p22l1221t3578r1327b3628],

1	Res	NNP	O	Res	_	0	SENT_360	[p22l1342t3580r1436b3628],
2	.	.	O	.	_	0	SENT_360	[p22l1342t3580r1436b3628],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_361	[p22l1452t3578r1646b3628],
2	.	.	O	.	_	0	SENT_361	[p22l1452t3578r1646b3628],

1	102	CD	NUMBER	102	_	0	SENT_362	[p22l1664t3581r1777b3635],
2	,	,	O	,	_	0	SENT_362	[p22l1664t3581r1777b3635],
3	543-545	CD	NUMBER	543-545	number	4	SENT_362	[p22l1793t3581r2017b3628],
4	(	CD	NUMBER	(	appos	1	SENT_362	[p22l133t3656r308b3711],
5	2013	CD	DATE	2013	num	6	SENT_362	[p22l133t3656r308b3711],
6	)	NN	O	)	dep	4	SENT_362	[p22l133t3656r308b3711],
7	.	.	O	.	_	0	SENT_362	[p22l133t3656r308b3711],

1	5	CD	NUMBER	5	_	0	SENT_363	[p22l8t3737r50b3783],
2	.	.	O	.	_	0	SENT_363	[p22l8t3737r50b3783],

1	Moller	NNP	PERSON	Moller	_	0	SENT_364	[p22l131t3733r304b3790],
2	,	,	O	,	_	0	SENT_364	[p22l131t3733r304b3790],
3	M.	NNP	O	M.	nn	4	SENT_364	[p22l320t3735r379b3783],
4	etal	NNP	O	etal	appos	1	SENT_364	[p22l393t3733r505b3783],
5	.	.	O	.	_	0	SENT_364	[p22l393t3733r505b3783],

1	Cardiogenic	JJ	O	cardiogenic	amod	2	SENT_365	[p22l522t3733r838b3796],
2	shock	NN	O	shock	dep	3	SENT_365	[p22l852t3733r1004b3783],
3	due	JJ	O	due	_	0	SENT_365	[p22l1016t3733r1115b3783],
4	to	TO	O	to	_	0	SENT_365	[p22l1129t3741r1181b3783],
5	dynamic	JJ	O	dynamic	amod	9	SENT_365	[p22l1196t3733r1421b3797],
6	left	JJ	O	left	amod	9	SENT_365	[p22l1437t3732r1519b3783],
7	ventricular	JJ	O	ventricular	amod	9	SENT_365	[p22l1531t3733r1814b3783],
8	outﬂow	NN	O	outﬂow	nn	9	SENT_365	[p22l1827t3732r2030b3783],
9	ll	NN	O	ll	prep_to	3	SENT_365	[p23l12t1496r82b1542],
10	.	.	O	.	_	0	SENT_365	[p23l12t1496r82b1542],

1	tract	NN	O	tract	nn	2	SENT_366	[p23l130t22r250b64],
2	obstruction	NN	O	obstruction	_	0	SENT_366	[p23l264t14r567b64],
3	in	IN	O	in	_	0	SENT_366	[p23l585t16r627b63],
4	acute	JJ	O	acute	amod	6	SENT_366	[p23l643t22r787b64],
5	myocardial	JJ	O	myocardial	amod	6	SENT_366	[p23l803t14r1087b78],
6	infarction	NN	O	infarction	prep_in	2	SENT_366	[p23l1106t13r1368b64],
7	.	.	O	.	_	0	SENT_366	[p23l1106t13r1368b64],

1	Clin	NNP	O	Clin	_	0	SENT_367	[p23l1383t14r1488b64],
2	.	.	O	.	_	0	SENT_367	[p23l1383t14r1488b64],

1	Res	NNP	O	Res	_	0	SENT_368	[p23l1503t16r1595b64],
2	.	.	O	.	_	0	SENT_368	[p23l1503t16r1595b64],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_369	[p23l1611t14r1803b64],
2	.	.	O	.	_	0	SENT_369	[p23l1611t14r1803b64],

1	100	CD	NUMBER	100	_	0	SENT_370	[p23l1820t17r1932b71],
2	,	,	O	,	_	0	SENT_370	[p23l1820t17r1932b71],
3	621-625	CD	NUMBER	621-625	num	4	SENT_370	[p23l131t94r353b140],
4	(	NN	O	(	appos	1	SENT_370	[p23l371t92r472b147],
5	201	CD	NUMBER	201	number	6	SENT_370	[p23l371t92r472b147],
6	1	CD	NUMBER	1	num	7	SENT_370	[p23l490t92r545b147],
7	)	NN	O	)	dep	4	SENT_370	[p23l490t92r545b147],
8	.	.	O	.	_	0	SENT_370	[p23l490t92r545b147],

1	Yusuf	NNP	PERSON	Yusuf	nn	4	SENT_371	[p23l128t168r281b226],
2	,	,	O	,	_	0	SENT_371	[p23l128t168r281b226],
3	S.	NNP	O	S.	appos	4	SENT_371	[p23l296t171r336b219],
4	etal.	NNP	O	etal.	_	0	SENT_371	[p23l350t169r478b226],
5	;	:	O	;	_	0	SENT_371	[p23l350t169r478b226],
6	CHARM	NNP	O	CHARM	nn	7	SENT_371	[p23l492t171r690b219],
7	Investigators	NNS	O	investigator	dep	4	SENT_371	[p23l708t171r1042b232],
8	and	CC	O	and	_	0	SENT_371	[p23l1057t169r1153b219],
9	Committees	NNS	O	committee	dep	4	SENT_371	[p23l1169t171r1501b219],
10	.	.	O	.	_	0	SENT_371	[p23l1169t171r1501b219],

1	Effects	NNS	O	effect	_	0	SENT_372	[p23l1518t168r1687b219],
2	of	IN	O	of	_	0	SENT_372	[p23l1701t168r1756b219],
3	candesartan	NN	O	candesartan	prep_of	1	SENT_372	[p23l1765t169r2087b219],
4	in	IN	O	in	_	0	SENT_372	[p23l132t249r175b296],
5	patients	NNS	O	patient	prep_in	3	SENT_372	[p23l193t249r403b309],
6	with	IN	O	with	_	0	SENT_372	[p23l416t247r530b297],
7	chronic	JJ	O	chronic	amod	9	SENT_372	[p23l546t247r741b297],
8	heart	NN	O	heart	nn	9	SENT_372	[p23l757t247r893b297],
9	failure	NN	O	failure	prep_with	5	SENT_372	[p23l905t246r1068b297],
10	and	CC	O	and	_	0	SENT_372	[p23l1083t247r1179b297],
11	preserved	JJ	O	preserved	amod	16	SENT_372	[p23l1197t247r1455b309],
12	|	NN	O	|	nn	16	SENT_372	[p23l1474t246r1858b297],
13	eft	NN	O	eft	nn	16	SENT_372	[p23l1474t246r1858b297],
14	—	CD	NUMBER	—	num	16	SENT_372	[p23l1474t246r1858b297],
15	ventricu	NN	O	ventricu	nn	16	SENT_372	[p23l1474t246r1858b297],
16	|	NN	O	|	conj_and	5	SENT_372	[p23l1474t246r1858b297],
17	ar	NN	O	ar	nn	19	SENT_372	[p23l1474t246r1858b297],
18	ejection	NN	O	ejection	nn	19	SENT_372	[p23l1871t249r2080b310],
19	fraction	NN	O	fraction	dep	16	SENT_372	[p23l129t323r345b373],
20	:	:	O	:	_	0	SENT_372	[p23l129t323r345b373],
21	the	DT	O	the	det	22	SENT_372	[p23l358t324r444b373],
22	CHARM	NN	O	charm	dep	1	SENT_372	[p23l458t324r937b373],
23	.	.	O	.	_	0	SENT_372	[p23l458t324r937b373],

1	—	NN	O	—	_	0	SENT_373	[p23l458t324r937b373],
2	.	.	O	.	_	0	SENT_373	[p23l458t324r937b373],

1	Preserved	VBN	O	preserve	_	0	SENT_374	[p23l458t324r937b373],
2	Trial	NN	O	trial	dobj	1	SENT_374	[p23l949t324r1070b373],
3	.	.	O	.	_	0	SENT_374	[p23l949t324r1070b373],

1	Lancet	NNP	O	Lancet	_	0	SENT_375	[p23l1084t326r1254b373],
2	362	CD	NUMBER	362	num	1	SENT_375	[p23l1265t327r1380b381],
3	,	,	O	,	_	0	SENT_375	[p23l1265t327r1380b381],
4	777-781	CD	NUMBER	777-781	num	1	SENT_375	[p23l1396t327r1609b373],
5	(	CD	NUMBER	(	num	7	SENT_375	[p23l1635t325r1809b380],
6	2003	CD	DATE	2003	num	7	SENT_375	[p23l1635t325r1809b380],
7	)	NN	O	)	dep	1	SENT_375	[p23l1635t325r1809b380],
8	.	.	O	.	_	0	SENT_375	[p23l1635t325r1809b380],

1	Cleland	NNP	PERSON	Cleland	nn	23	SENT_376	[p23l129t402r338b460],
2	,	,	O	,	_	0	SENT_376	[p23l129t402r338b460],
3	J.G.	NNP	PERSON	J.G.	conj_and	1	SENT_376	[p23l351t402r686b460],
4	,	,	O	,	_	0	SENT_376	[p23l351t402r686b460],
5	Tendera	NNP	LOCATION	Tendera	conj_and	1	SENT_376	[p23l351t402r686b460],
6	,	,	O	,	_	0	SENT_376	[p23l351t402r686b460],
7	M.	NNP	O	M.	conj_and	1	SENT_376	[p23l702t405r774b460],
8	,	,	O	,	_	0	SENT_376	[p23l702t405r774b460],
9	Adamus	NNP	O	Adamus	conj_and	1	SENT_376	[p23l788t402r1016b460],
10	,	,	O	,	_	0	SENT_376	[p23l788t402r1016b460],
11	J.	NNP	O	J.	conj_and	1	SENT_376	[p23l1028t405r1075b460],
12	,	,	O	,	_	0	SENT_376	[p23l1028t405r1075b460],
13	Freemantle	NNP	PERSON	Freemantle	conj_and	1	SENT_376	[p23l1092t402r1398b460],
14	,	,	O	,	_	0	SENT_376	[p23l1092t402r1398b460],
15	N.	NNP	O	N.	nn	23	SENT_376	[p23l1415t405r1476b460],
16	,	,	O	,	_	0	SENT_376	[p23l1415t405r1476b460],
17	Polonski	NNP	PERSON	Polonski	nn	23	SENT_376	[p23l1493t402r1723b460],
18	,	,	O	,	_	0	SENT_376	[p23l1493t402r1723b460],
19	L.	NNP	ORGANIZATION	L.	nn	23	SENT_376	[p23l1740t405r1777b452],
20	&	CC	ORGANIZATION	&	_	0	SENT_376	[p23l1791t402r2002b466],
21	Taylor	NNP	ORGANIZATION	Taylor	nn	23	SENT_376	[p23l1791t402r2002b466],
22	,	,	O	,	_	0	SENT_376	[p23l1791t402r2002b466],
23	J.	NNP	O	J.	_	0	SENT_376	[p23l2014t405r2062b460],
24	;	:	O	;	_	0	SENT_376	[p23l2014t405r2062b460],
25	PEP	NN	O	pep	dep	23	SENT_376	[p23l133t482r354b530],
26	.	.	O	.	_	0	SENT_376	[p23l133t482r354b530],

1	—	NN	O	—	_	0	SENT_377	[p23l133t482r354b530],
2	.	.	O	.	_	0	SENT_377	[p23l133t482r354b530],

1	CHF	NNP	O	CHF	_	0	SENT_378	[p23l133t482r354b530],
2	Investigators	NNS	O	investigator	dep	1	SENT_378	[p23l372t483r718b543],
3	.	.	O	.	_	0	SENT_378	[p23l372t483r718b543],

1	The	DT	O	the	det	2	SENT_379	[p23l728t480r825b530],
2	perindopril	NN	O	perindopril	_	0	SENT_379	[p23l841t480r1130b543],
3	in	IN	O	in	_	0	SENT_379	[p23l1149t483r1191b529],
4	elderly	JJ	O	elderly	amod	5	SENT_379	[p23l1208t480r1386b544],
5	people	NNS	O	people	prep_in	2	SENT_379	[p23l1401t480r1581b543],
6	with	IN	O	with	_	0	SENT_379	[p23l1594t480r1707b530],
7	chronic	JJ	O	chronic	amod	11	SENT_379	[p23l1724t480r1918b530],
8	heart	NN	O	heart	nn	11	SENT_379	[p23l1935t480r2071b530],
9	failure	NN	O	failure	nn	11	SENT_379	[p23l129t558r293b608],
10	(	CD	NUMBER	(	num	11	SENT_379	[p23l309t559r516b616],
11	PEP	NN	O	pep	prep_with	2	SENT_379	[p23l309t559r516b616],
12	.	.	O	.	_	0	SENT_379	[p23l309t559r516b616],

1	—	NN	O	—	_	0	SENT_380	[p23l309t559r516b616],
2	.	.	O	.	_	0	SENT_380	[p23l309t559r516b616],

1	CH	NN	O	ch	nn	2	SENT_381	[p23l309t559r516b616],
2	F	NN	O	f	_	0	SENT_381	[p23l525t559r565b616],
3	)	CD	NUMBER	)	num	4	SENT_381	[p23l525t559r565b616],
4	study	NN	O	study	dep	2	SENT_381	[p23l582t558r735b622],
5	.	.	O	.	_	0	SENT_381	[p23l582t558r735b622],

1	Eur	NNP	O	Eur	_	0	SENT_382	[p23l750t561r838b608],
2	.	.	O	.	_	0	SENT_382	[p23l750t561r838b608],

1	Heart	NNP	O	Heart	_	0	SENT_383	[p23l853t561r1038b608],
2	]	NN	O	]	dep	1	SENT_383	[p23l853t561r1038b608],
3	.	.	O	.	_	0	SENT_383	[p23l853t561r1038b608],

1	27	CD	NUMBER	27	_	0	SENT_384	[p23l1053t562r1132b616],
2	,	,	O	,	_	0	SENT_384	[p23l1053t562r1132b616],
3	2338-2345	CD	DATE	2338-2345	number	4	SENT_384	[p23l1147t561r1434b608],
4	(	CD	NUMBER	(	appos	1	SENT_384	[p23l1453t559r1626b616],
5	2006	CD	DATE	2006	num	6	SENT_384	[p23l1453t559r1626b616],
6	)	NN	O	)	dep	4	SENT_384	[p23l1453t559r1626b616],
7	.	.	O	.	_	0	SENT_384	[p23l1453t559r1626b616],

1	Massie	NNP	PERSON	Massie	nn	4	SENT_385	[p23l131t639r317b694],
2	,	,	O	,	_	0	SENT_385	[p23l131t639r317b694],
3	B.M.	NNP	O	B.M.	appos	4	SENT_385	[p23l334t638r439b686],
4	etal.	NNP	O	etal.	_	0	SENT_385	[p23l453t636r580b694],
5	;	:	O	;	_	0	SENT_385	[p23l453t636r580b694],
6	|	NN	O	|	dep	4	SENT_385	[p23l597t638r890b686],
7	.	.	O	.	_	0	SENT_385	[p23l597t638r890b686],

1	—	NN	O	—	_	0	SENT_386	[p23l597t638r890b686],
2	.	.	O	.	_	0	SENT_386	[p23l597t638r890b686],

1	PRESERVE	VB	O	preserve	_	0	SENT_387	[p23l597t638r890b686],
2	Investigators	NNS	O	investigator	dobj	1	SENT_387	[p23l906t639r1253b699],
3	.	.	O	.	_	0	SENT_387	[p23l906t639r1253b699],

1	Irbesartan	NNP	O	Irbesartan	_	0	SENT_388	[p23l1270t636r1531b686],
2	in	IN	O	in	_	0	SENT_388	[p23l1550t639r1592b685],
3	patients	NNS	O	patient	prep_in	1	SENT_388	[p23l1611t639r1820b699],
4	with	IN	O	with	_	0	SENT_388	[p23l1834t636r1947b686],
5	heart	NN	O	heart	nn	6	SENT_388	[p23l1966t636r2102b686],
6	failure	NN	O	failure	prep_with	1	SENT_388	[p23l129t714r293b764],
7	and	CC	O	and	_	0	SENT_388	[p23l307t714r403b764],
8	preserved	JJ	O	preserved	amod	10	SENT_388	[p23l422t714r679b777],
9	ejection	NN	O	ejection	nn	10	SENT_388	[p23l696t717r904b777],
10	fraction	NN	O	fraction	conj_and	6	SENT_388	[p23l919t714r1135b764],
11	.	.	O	.	_	0	SENT_388	[p23l919t714r1135b764],

1	N.	NNP	O	N.	nn	2	SENT_389	[p23l1150t717r1197b764],
2	Engl	NNP	O	Engl	_	0	SENT_389	[p23l1212t714r1330b777],
3	.	.	O	.	_	0	SENT_389	[p23l1212t714r1330b777],

1	J.	NNP	O	J.	nn	2	SENT_390	[p23l1341t717r1376b764],
2	Med	NNP	O	Med	_	0	SENT_390	[p23l1389t714r1512b764],
3	.	.	O	.	_	0	SENT_390	[p23l1389t714r1512b764],

1	359	CD	NUMBER	359	_	0	SENT_391	[p23l1527t717r1642b772],
2	,	,	O	,	_	0	SENT_391	[p23l1527t717r1642b772],
3	2456-2467	CD	DATE	2456-2467	number	4	SENT_391	[p23l1656t717r1945b764],
4	(	CD	NUMBER	(	appos	1	SENT_391	[p23l1961t715r2136b772],
5	2008	CD	DATE	2008	num	6	SENT_391	[p23l1961t715r2136b772],
6	)	NN	O	)	dep	4	SENT_391	[p23l1961t715r2136b772],
7	.	.	O	.	_	0	SENT_391	[p23l1961t715r2136b772],

1	Edelmann	NNP	PERSON	Edelmann	nn	4	SENT_392	[p23l132t792r407b850],
2	,	,	O	,	_	0	SENT_392	[p23l132t792r407b850],
3	F.	NNP	O	F.	appos	4	SENT_392	[p23l424t795r455b842],
4	etal.	NNP	O	etal.	_	0	SENT_392	[p23l469t792r597b850],
5	;	:	O	;	_	0	SENT_392	[p23l469t792r597b850],
6	A	DT	O	a	det	7	SENT_392	[p23l610t792r867b842],
7	|	NN	O	|	nsubj	8	SENT_392	[p23l610t792r867b842],
8	do	VBP	O	do	dep	4	SENT_392	[p23l610t792r867b842],
9	.	.	O	.	_	0	SENT_392	[p23l610t792r867b842],

1	—	NN	O	—	_	0	SENT_393	[p23l610t792r867b842],
2	.	.	O	.	_	0	SENT_393	[p23l610t792r867b842],

1	DHF	NNP	ORGANIZATION	DHF	_	0	SENT_394	[p23l610t792r867b842],
2	Investigators	NNS	O	investigator	dep	1	SENT_394	[p23l884t795r1231b855],
3	.	.	O	.	_	0	SENT_394	[p23l884t795r1231b855],

1	Effect	NN	O	effect	_	0	SENT_395	[p23l1248t792r1392b842],
2	of	IN	O	of	_	0	SENT_395	[p23l1406t792r1460b842],
3	spironolactone	NN	O	spironolactone	prep_of	1	SENT_395	[p23l1470t792r1865b855],
4	on	IN	O	on	_	0	SENT_395	[p23l1880t807r1944b842],
5	diastolic	JJ	O	diastolic	amod	6	SENT_395	[p23l131t870r347b920],
6	function	NN	O	function	prep_on	1	SENT_395	[p23l360t870r580b920],
7	and	CC	O	and	_	0	SENT_395	[p23l596t870r693b920],
8	exercise	NN	O	exercise	nn	9	SENT_395	[p23l709t873r918b920],
9	capacity	NN	O	capacity	prep_on	1	SENT_395	[p23l932t873r1151b934],
10	in	IN	O	in	_	0	SENT_395	[p23l1165t873r1208b919],
11	patients	NNS	O	patient	prep_in	6	SENT_395	[p23l1227t873r1436b933],
12	with	IN	O	with	_	0	SENT_395	[p23l1449t870r1563b920],
13	heart	NN	O	heart	nn	14	SENT_395	[p23l1581t870r1717b920],
14	failure	NN	O	failure	prep_with	11	SENT_395	[p23l1730t870r1893b920],
15	with	IN	O	with	_	0	SENT_395	[p23l1906t870r2020b920],
16	preserved	JJ	O	preserved	amod	18	SENT_395	[p23l133t948r390b1011],
17	ejection	NN	O	ejection	nn	18	SENT_395	[p23l407t951r615b1011],
18	fraction	NN	O	fraction	prep_with	14	SENT_395	[p23l630t948r846b998],
19	:	:	O	:	_	0	SENT_395	[p23l630t948r846b998],
20	the	DT	O	the	det	22	SENT_395	[p23l859t948r945b998],
21	A	NN	O	a	nn	22	SENT_395	[p23l959t948r1215b998],
22	|	NN	O	|	nsubj	23	SENT_395	[p23l959t948r1215b998],
23	do	VBP	O	do	dep	1	SENT_395	[p23l959t948r1215b998],
24	.	.	O	.	_	0	SENT_395	[p23l959t948r1215b998],

1	—	NN	O	—	_	0	SENT_396	[p23l959t948r1215b998],
2	.	.	O	.	_	0	SENT_396	[p23l959t948r1215b998],

1	DHF	NN	ORGANIZATION	dhf	nsubj	2	SENT_397	[p23l959t948r1215b998],
2	randomized	VBD	O	randomize	_	0	SENT_397	[p23l1232t948r1544b998],
3	controlled	JJ	O	controlled	amod	5	SENT_397	[p23l1561t948r1827b998],
4	tria	NN	O	trium	nn	5	SENT_397	[p23l1842t948r2108b998],
5	|	NN	O	|	dobj	2	SENT_397	[p23l1842t948r2108b998],
6	.	.	O	.	_	0	SENT_397	[p23l1842t948r2108b998],

1	JAMA	NN	O	jama	_	0	SENT_398	[p23l1842t948r2108b998],
2	309	CD	NUMBER	309	num	1	SENT_398	[p23l131t1028r246b1082],
3	,	,	O	,	_	0	SENT_398	[p23l131t1028r246b1082],
4	781-791	CD	NUMBER	781-791	number	5	SENT_398	[p23l262t1028r475b1074],
5	(	CD	NUMBER	(	appos	1	SENT_398	[p23l501t1026r675b1082],
6	2013	CD	DATE	2013	num	7	SENT_398	[p23l501t1026r675b1082],
7	)	NN	O	)	dep	5	SENT_398	[p23l501t1026r675b1082],
8	.	.	O	.	_	0	SENT_398	[p23l501t1026r675b1082],

1	Task	NNP	O	Task	nn	2	SENT_399	[p23l127t1103r241b1153],
2	Force	NNP	O	Force	_	0	SENT_399	[p23l255t1106r393b1153],
3	on	IN	O	on	_	0	SENT_399	[p23l408t1118r472b1153],
4	Myocardial	JJ	O	myocardial	amod	5	SENT_399	[p23l490t1103r774b1167],
5	Revascularization	NN	O	revascularization	prep_on	2	SENT_399	[p23l793t1103r1246b1153],
6	of	IN	O	of	_	0	SENT_399	[p23l1263t1103r1317b1153],
7	the	DT	O	the	det	14	SENT_399	[p23l1326t1103r1411b1153],
8	European	JJ	ORGANIZATION	european	amod	14	SENT_399	[p23l1428t1106r1675b1166],
9	Society	NNP	ORGANIZATION	Society	dep	8	SENT_399	[p23l1692t1105r1883b1167],
10	of	IN	ORGANIZATION	of	_	0	SENT_399	[p23l1896t1103r1950b1153],
11	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	9	SENT_399	[p23l131t1181r417b1245],
12	(	CD	NUMBER	(	num	11	SENT_399	[p23l431t1182r560b1239],
13	ESC	NNP	ORGANIZATION	ESC	nn	14	SENT_399	[p23l431t1182r560b1239],
14	)	NN	O	)	prep_of	2	SENT_399	[p23l431t1182r560b1239],
15	and	CC	O	and	_	0	SENT_399	[p23l577t1181r673b1231],
16	the	DT	O	the	det	18	SENT_399	[p23l688t1181r774b1231],
17	European	NNP	ORGANIZATION	European	nn	18	SENT_399	[p23l791t1184r1038b1244],
18	Association	NNP	ORGANIZATION	Association	prep_of	2	SENT_399	[p23l1054t1184r1352b1231],
19	for	IN	ORGANIZATION	for	_	0	SENT_399	[p23l1367t1181r1440b1231],
20	Cardio	NNP	ORGANIZATION	Cardio	prep_for	18	SENT_399	[p23l1453t1181r1864b1231],
21	.	.	O	.	_	0	SENT_399	[p23l1453t1181r1864b1231],

1	—	NN	O	—	_	0	SENT_400	[p23l1453t1181r1864b1231],
2	.	.	O	.	_	0	SENT_400	[p23l1453t1181r1864b1231],

1	Thoracic	JJ	O	thoracic	amod	4	SENT_401	[p23l1453t1181r1864b1231],
2	Surgery	NN	O	surgery	nn	4	SENT_401	[p23l1878t1183r2082b1245],
3	(	CD	NUMBER	(	num	4	SENT_401	[p23l132t1260r347b1317],
4	EACTS	NNS	O	eact	_	0	SENT_401	[p23l132t1260r347b1317],
5	)	CD	NUMBER	)	dep	4	SENT_401	[p23l132t1260r347b1317],
6	,	,	O	,	_	0	SENT_401	[p23l132t1260r347b1317],
7	European	NNP	ORGANIZATION	European	nn	8	SENT_401	[p23l363t1262r610b1322],
8	Association	NNP	ORGANIZATION	Association	appos	5	SENT_401	[p23l626t1262r925b1309],
9	for	IN	ORGANIZATION	for	_	0	SENT_401	[p23l940t1259r1012b1309],
10	Percutaneous	NNP	ORGANIZATION	Percutaneous	nn	12	SENT_401	[p23l1028t1261r1383b1309],
11	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	12	SENT_401	[p23l1398t1259r1784b1309],
12	Interventions	NNPS	ORGANIZATION	Interventions	prep_for	8	SENT_401	[p23l1799t1262r2147b1309],
13	(	CD	NUMBER	(	num	15	SENT_401	[p23l132t1338r332b1395],
14	EAPCI	NN	O	eapcus	nn	15	SENT_401	[p23l132t1338r332b1395],
15	)	NN	O	)	dep	4	SENT_401	[p23l132t1338r332b1395],
16	;	:	O	;	_	0	SENT_401	[p23l132t1338r332b1395],
17	Wijns	NNP	O	Wijns	nn	18	SENT_401	[p23l343t1340r483b1400],
18	W.	NNP	O	W.	dep	15	SENT_401	[p23l495t1340r556b1387],
19	et	FW	O	et	nn	20	SENT_401	[p23l570t1345r619b1387],
20	al.	FW	O	al.	dep	18	SENT_401	[p23l628t1337r682b1387],
21	.	.	O	.	_	0	SENT_401	[p23l628t1337r682b1387],

1	Guidelines	NNS	O	guideline	_	0	SENT_402	[p23l698t1337r975b1387],
2	on	IN	O	on	_	0	SENT_402	[p23l990t1352r1054b1387],
3	myocardial	JJ	O	myocardial	amod	4	SENT_402	[p23l1073t1337r1357b1401],
4	revascularization	NN	O	revascularization	prep_on	1	SENT_402	[p23l1376t1337r1830b1387],
5	.	.	O	.	_	0	SENT_402	[p23l1376t1337r1830b1387],

1	Eur	NNP	O	Eur	_	0	SENT_403	[p23l1844t1340r1932b1387],
2	.	.	O	.	_	0	SENT_403	[p23l1844t1340r1932b1387],

1	Heart	NNP	O	Heart	_	0	SENT_404	[p23l1947t1340r2132b1387],
2	]	NN	O	]	dep	1	SENT_404	[p23l1947t1340r2132b1387],
3	.	.	O	.	_	0	SENT_404	[p23l1947t1340r2132b1387],

1	31	CD	NUMBER	31	num	2	SENT_405	[p23l131t1415r228b1471],
2	)	NN	O	)	_	0	SENT_405	[p23l131t1415r228b1471],
3	,	,	O	,	_	0	SENT_405	[p23l131t1415r228b1471],
4	2501-2555	CD	DATE	2501-2555	number	5	SENT_405	[p23l243t1417r530b1463],
5	(	CD	NUMBER	(	appos	2	SENT_405	[p23l549t1415r723b1471],
6	2010	CD	DATE	2010	num	7	SENT_405	[p23l549t1415r723b1471],
7	)	NN	O	)	dep	5	SENT_405	[p23l549t1415r723b1471],
8	.	.	O	.	_	0	SENT_405	[p23l549t1415r723b1471],

1	Hunt	NNP	O	Hunt	_	0	SENT_406	[p23l132t1495r271b1550],
2	,	,	O	,	_	0	SENT_406	[p23l132t1495r271b1550],
3	S.A.	NNP	O	S.A.	nn	4	SENT_406	[p23l286t1494r378b1542],
4	etal	NN	O	etal	appos	1	SENT_406	[p23l392t1492r504b1542],
5	.	.	O	.	_	0	SENT_406	[p23l392t1492r504b1542],

1	2009	CD	DATE	2009	nsubj	2	SENT_407	[p23l521t1495r648b1542],
2	focused	VBD	O	focus	_	0	SENT_407	[p23l660t1492r865b1542],
3	update	VB	O	update	ccomp	2	SENT_407	[p23l884t1492r1068b1555],
4	incorporated	VBN	O	incorporate	dep	3	SENT_407	[p23l1084t1492r1422b1555],
5	into	IN	O	into	_	0	SENT_407	[p23l1439t1495r1539b1542],
6	the	DT	O	the	det	9	SENT_407	[p23l1553t1492r1639b1542],
7	ACC/AHA	NNP	O	ACC/AHA	nn	9	SENT_407	[p23l1653t1494r1902b1544],
8	2005	CD	DATE	2005	num	9	SENT_407	[p23l1916t1495r2041b1542],
9	Guidelines	NNS	O	guideline	prep_into	4	SENT_407	[p23l131t1570r407b1620],
10	for	IN	O	for	_	0	SENT_407	[p23l420t1570r493b1620],
11	the	DT	O	the	det	12	SENT_407	[p23l505t1570r591b1620],
12	Diagnosis	NN	O	diagnosis	prep_for	9	SENT_407	[p23l607t1572r859b1633],
13	and	CC	O	and	_	0	SENT_407	[p23l874t1570r970b1620],
14	Management	NN	O	management	conj_and	12	SENT_407	[p23l988t1573r1341b1633],
15	of	IN	O	of	_	0	SENT_407	[p23l1355t1570r1409b1620],
16	Heart	NNP	O	Heart	nn	17	SENT_407	[p23l1421t1573r1563b1620],
17	Failure	NN	O	failure	prep_of	12	SENT_407	[p23l1579t1570r1749b1620],
18	in	IN	O	in	_	0	SENT_407	[p23l1764t1573r1807b1619],
19	Adults	NNS	O	adult	nsubj	38	SENT_407	[p23l1823t1570r2003b1620],
20	:	:	O	:	_	0	SENT_407	[p23l1823t1570r2003b1620],
21	a	DT	O	a	det	22	SENT_407	[p23l2017t1585r2043b1620],
22	report	NN	O	report	dep	19	SENT_407	[p23l133t1656r294b1711],
23	of	IN	O	of	_	0	SENT_407	[p23l308t1648r362b1698],
24	the	DT	O	the	det	26	SENT_407	[p23l370t1648r456b1698],
25	American	NNP	ORGANIZATION	American	nn	26	SENT_407	[p23l470t1651r719b1698],
26	College	NNP	ORGANIZATION	College	prep_of	22	SENT_407	[p23l735t1648r932b1711],
27	of	IN	ORGANIZATION	of	_	0	SENT_407	[p23l947t1648r1001b1698],
28	Cardiology	NNP	ORGANIZATION	Cardiology	nn	33	SENT_407	[p23l1011t1648r1297b1712],
29	Foundation/American	NNP	ORGANIZATION	Foundation/American	nn	33	SENT_407	[p23l1312t1648r1886b1700],
30	Heart	NNP	ORGANIZATION	Heart	nn	33	SENT_407	[p23l1906t1651r2048b1698],
31	Association	NNP	ORGANIZATION	Association	nn	33	SENT_407	[p23l130t1729r428b1776],
32	Task	NNP	ORGANIZATION	Task	nn	33	SENT_407	[p23l440t1726r554b1776],
33	Force	NNP	ORGANIZATION	Force	prep_of	26	SENT_407	[p23l568t1729r706b1776],
34	on	IN	O	on	_	0	SENT_407	[p23l721t1741r785b1776],
35	Practice	NNP	O	Practice	nn	36	SENT_407	[p23l804t1728r1007b1776],
36	Guidelines	NNS	O	guideline	prep_on	33	SENT_407	[p23l1021t1726r1311b1776],
37	:	:	O	:	_	0	SENT_407	[p23l1021t1726r1311b1776],
38	developed	VBN	O	develop	prepc_in	4	SENT_407	[p23l1326t1726r1603b1789],
39	in	IN	O	in	_	0	SENT_407	[p23l1622t1729r1665b1775],
40	collaboration	NN	O	collaboration	prep_in	38	SENT_407	[p23l1681t1726r2027b1776],
41	with	IN	O	with	_	0	SENT_407	[p23l130t1804r243b1854],
42	the	DT	O	the	det	44	SENT_407	[p23l258t1804r344b1854],
43	International	NNP	ORGANIZATION	International	nn	44	SENT_407	[p23l360t1804r694b1854],
44	Society	NNP	ORGANIZATION	Society	prep_with	38	SENT_407	[p23l711t1806r902b1868],
45	for	IN	ORGANIZATION	for	_	0	SENT_407	[p23l913t1804r985b1854],
46	Heart	NNP	ORGANIZATION	Heart	prep_for	44	SENT_407	[p23l1001t1807r1143b1854],
47	and	CC	O	and	_	0	SENT_407	[p23l1156t1804r1252b1854],
48	Lung	NN	O	lung	conj_and	38	SENT_407	[p23l1272t1807r1398b1867],
49	Transplantation	NN	O	transplantation	dep	48	SENT_407	[p23l1410t1804r1836b1867],
50	.	.	O	.	_	0	SENT_407	[p23l1410t1804r1836b1867],

1	Circulation	NN	O	circulation	_	0	SENT_408	[p23l1852t1804r2125b1854],
2	119	CD	NUMBER	119	num	1	SENT_408	[p23l134t1884r246b1938],
3	,	,	O	,	_	0	SENT_408	[p23l134t1884r246b1938],
4	e391	NN	O	e391	appos	1	SENT_408	[p23l260t1884r376b1930],
5	-	:	O	-	_	0	SENT_408	[p23l390t1884r549b1930],
6	e479	NN	O	e479	dep	1	SENT_408	[p23l390t1884r549b1930],
7	(	CD	NUMBER	(	num	6	SENT_408	[p23l565t1882r740b1938],
8	2009	CD	DATE	2009	num	9	SENT_408	[p23l565t1882r740b1938],
9	)	NN	O	)	dep	6	SENT_408	[p23l565t1882r740b1938],
10	.	.	O	.	_	0	SENT_408	[p23l565t1882r740b1938],

1	Pitt	NNP	PERSON	Pitt	nn	4	SENT_409	[p23l131t1961r227b2017],
2	,	,	O	,	_	0	SENT_409	[p23l131t1961r227b2017],
3	B.	NNP	O	B.	appos	4	SENT_409	[p23l244t1961r285b2009],
4	etal.	NNP	O	etal.	_	0	SENT_409	[p23l299t1959r426b2017],
5	;	:	O	;	_	0	SENT_409	[p23l299t1959r426b2017],
6	Eplerenone	NNP	ORGANIZATION	Eplerenone	nn	7	SENT_409	[p23l443t1959r741b2022],
7	Post	NNP	ORGANIZATION	Post	dep	4	SENT_409	[p23l758t1962r1038b2009],
8	.	.	O	.	_	0	SENT_409	[p23l758t1962r1038b2009],

1	—	NN	O	—	_	0	SENT_410	[p23l758t1962r1038b2009],
2	.	.	O	.	_	0	SENT_410	[p23l758t1962r1038b2009],

1	Acute	JJ	O	acute	amod	3	SENT_411	[p23l758t1962r1038b2009],
2	Myocardial	JJ	O	myocardial	amod	3	SENT_411	[p23l1054t1959r1338b2023],
3	Infarction	NN	O	infarction	_	0	SENT_411	[p23l1357t1959r1604b2009],
4	Heart	NNP	O	Heart	nn	6	SENT_411	[p23l1623t1962r1765b2009],
5	Failure	NN	O	failure	nn	6	SENT_411	[p23l1781t1959r1951b2009],
6	Efﬁcacy	NN	O	efﬁcacy	dep	3	SENT_411	[p23l133t2037r330b2101],
7	and	CC	O	and	_	0	SENT_411	[p23l343t2037r439b2087],
8	Survival	NNP	O	Survival	nn	10	SENT_411	[p23l457t2037r660b2087],
9	Study	NNP	O	Study	nn	10	SENT_411	[p23l677t2037r828b2101],
10	Investigators	NNS	O	investigator	dep	3	SENT_411	[p23l843t2040r1189b2101],
11	.	.	O	.	_	0	SENT_411	[p23l843t2040r1189b2101],

1	Eplerenone	NNP	O	Eplerenone	_	0	SENT_412	[p23l1206t2037r1516b2100],
2	,	,	O	,	_	0	SENT_412	[p23l1206t2037r1516b2100],
3	a	DT	O	a	det	6	SENT_412	[p23l1531t2052r1556b2087],
4	selective	JJ	O	selective	amod	6	SENT_412	[p23l1572t2037r1799b2087],
5	aldosterone	NN	O	aldosterone	nn	6	SENT_412	[p23l1813t2037r2126b2087],
6	blocker	NN	O	blocker	appos	1	SENT_412	[p23l132t2115r333b2173],
7	,	,	O	,	_	0	SENT_412	[p23l132t2115r333b2173],
8	in	IN	O	in	_	0	SENT_412	[p23l349t2118r392b2165],
9	patients	NNS	O	patient	prep_in	1	SENT_412	[p23l411t2118r620b2178],
10	with	IN	O	with	_	0	SENT_412	[p23l634t2115r747b2165],
11	left	JJ	O	left	amod	13	SENT_412	[p23l765t2115r847b2165],
12	ventricular	JJ	O	ventricular	amod	13	SENT_412	[p23l859t2115r1142b2165],
13	dysfunction	NN	O	dysfunction	prep_with	9	SENT_412	[p23l1155t2115r1464b2179],
14	after	IN	O	after	_	0	SENT_412	[p23l1481t2115r1601b2165],
15	myocardial	JJ	O	myocardial	amod	16	SENT_412	[p23l1616t2115r1901b2179],
16	infarction	NN	O	infarction	prep_after	13	SENT_412	[p23l132t2193r394b2243],
17	.	.	O	.	_	0	SENT_412	[p23l132t2193r394b2243],

1	N.	NNP	O	N.	nn	2	SENT_413	[p23l408t2196r456b2243],
2	Engl	NNP	O	Engl	_	0	SENT_413	[p23l471t2193r589b2257],
3	.	.	O	.	_	0	SENT_413	[p23l471t2193r589b2257],

1	J.	NNP	O	J.	nn	2	SENT_414	[p23l601t2196r634b2243],
2	Med	NNP	O	Med	_	0	SENT_414	[p23l648t2193r771b2243],
3	.	.	O	.	_	0	SENT_414	[p23l648t2193r771b2243],

1	348	CD	NUMBER	348	_	0	SENT_415	[p23l786t2197r901b2251],
2	,	,	O	,	_	0	SENT_415	[p23l786t2197r901b2251],
3	1309-1321	CD	DATE	1309-1321	number	4	SENT_415	[p23l920t2197r1195b2243],
4	(	CD	NUMBER	(	appos	1	SENT_415	[p23l1221t2194r1395b2251],
5	2003	CD	DATE	2003	num	6	SENT_415	[p23l1221t2194r1395b2251],
6	)	NN	O	)	dep	4	SENT_415	[p23l1221t2194r1395b2251],
7	.	.	O	.	_	0	SENT_415	[p23l1221t2194r1395b2251],

1	Flather	NNP	PERSON	Flather	_	0	SENT_416	[p23l131t2271r319b2329],
2	,	,	O	,	_	0	SENT_416	[p23l131t2271r319b2329],
3	M.D.	NNP	O	M.D.	nn	4	SENT_416	[p23l335t2274r447b2321],
4	etal	NNP	O	etal	appos	1	SENT_416	[p23l461t2271r573b2321],
5	.	.	O	.	_	0	SENT_416	[p23l461t2271r573b2321],

1	Long	JJ	O	long	amod	4	SENT_417	[p23l592t2274r865b2335],
2	—	NN	O	—	nn	4	SENT_417	[p23l592t2274r865b2335],
3	term	NN	O	term	nn	4	SENT_417	[p23l592t2274r865b2335],
4	ACE	NN	O	ace	_	0	SENT_417	[p23l881t2271r1449b2335],
5	—	CD	NUMBER	—	num	6	SENT_417	[p23l881t2271r1449b2335],
6	inhibitortherapy	NN	O	inhibitortherapy	dep	4	SENT_417	[p23l881t2271r1449b2335],
7	in	IN	O	in	_	0	SENT_417	[p23l1463t2274r1506b2321],
8	patients	NNS	O	patient	prep_in	6	SENT_417	[p23l1524t2274r1733b2334],
9	with	IN	O	with	_	0	SENT_417	[p23l1747t2271r1860b2321],
10	heart	NN	O	heart	nn	11	SENT_417	[p23l1879t2271r2015b2321],
11	failure	NN	O	failure	prep_with	8	SENT_417	[p23l129t2349r293b2399],
12	or	CC	O	or	_	0	SENT_417	[p23l307t2364r360b2399],
13	|	NN	O	|	conj_or	11	SENT_417	[p23l375t2349r760b2399],
14	eft	NN	O	eft	nn	17	SENT_417	[p23l375t2349r760b2399],
15	—	CD	NUMBER	—	num	17	SENT_417	[p23l375t2349r760b2399],
16	ventricu	NN	O	ventricu	nn	17	SENT_417	[p23l375t2349r760b2399],
17	|	NN	O	|	dep	4	SENT_417	[p23l375t2349r760b2399],
18	ar	NN	O	ar	nn	19	SENT_417	[p23l375t2349r760b2399],
19	dysfunction	NN	O	dysfunction	dep	17	SENT_417	[p23l773t2349r1097b2413],
20	:	:	O	:	_	0	SENT_417	[p23l773t2349r1097b2413],
21	a	DT	O	a	det	23	SENT_417	[p23l1111t2364r1137b2399],
22	systematic	JJ	O	systematic	amod	23	SENT_417	[p23l1153t2352r1430b2413],
23	overview	NN	O	overview	dep	17	SENT_417	[p23l1444t2352r1684b2399],
24	of	IN	O	of	_	0	SENT_417	[p23l1698t2349r1752b2399],
25	data	NNS	O	datum	prep_of	23	SENT_417	[p23l1762t2349r1874b2399],
26	from	IN	O	from	_	0	SENT_417	[p23l1889t2349r2011b2399],
27	individual	JJ	O	individual	amod	28	SENT_417	[p23l132t2427r387b2477],
28	patients	NNS	O	patient	prep_from	25	SENT_417	[p23l406t2430r628b2490],
29	.	.	O	.	_	0	SENT_417	[p23l406t2430r628b2490],

1	ACE	NN	O	ace	nn	4	SENT_418	[p23l642t2427r994b2477],
2	—	CD	NUMBER	—	num	4	SENT_418	[p23l642t2427r994b2477],
3	|	NN	O	|	nn	4	SENT_418	[p23l642t2427r994b2477],
4	nhibitor	NN	O	nhibitor	_	0	SENT_418	[p23l642t2427r994b2477],
5	Myocardial	JJ	O	myocardial	amod	8	SENT_418	[p23l1008t2427r1293b2491],
6	Infarction	NN	O	infarction	nn	8	SENT_418	[p23l1312t2427r1559b2477],
7	Collaborative	NNP	O	Collaborative	nn	8	SENT_418	[p23l1576t2427r1923b2477],
8	Group	NNP	O	Group	dep	4	SENT_418	[p23l1938t2429r2113b2490],
9	.	.	O	.	_	0	SENT_418	[p23l1938t2429r2113b2490],

1	Lancet355	NN	O	lancet355	_	0	SENT_419	[p23l130t2507r426b2561],
2	,	,	O	,	_	0	SENT_419	[p23l130t2507r426b2561],
3	1575-1581	CD	DATE	1575-1581	number	4	SENT_419	[p23l445t2508r720b2554],
4	(	CD	NUMBER	(	appos	1	SENT_419	[p23l746t2505r921b2561],
5	2000	CD	DATE	2000	num	6	SENT_419	[p23l746t2505r921b2561],
6	)	NN	O	)	dep	4	SENT_419	[p23l746t2505r921b2561],
7	.	.	O	.	_	0	SENT_419	[p23l746t2505r921b2561],

1	Dargie	NNP	PERSON	Dargie	nsubj	23	SENT_420	[p23l131t2584r313b2646],
2	,	,	O	,	_	0	SENT_420	[p23l131t2584r313b2646],
3	H.J.	NNP	O	H.J.	nn	4	SENT_420	[p23l330t2585r413b2632],
4	Effect	NN	O	effect	appos	1	SENT_420	[p23l430t2582r575b2632],
5	of	IN	O	of	_	0	SENT_420	[p23l588t2582r643b2632],
6	carvedilol	NN	O	carvedilol	prep_of	4	SENT_420	[p23l653t2582r905b2632],
7	on	IN	O	on	_	0	SENT_420	[p23l922t2597r986b2632],
8	outcome	NN	O	outcome	prep_on	6	SENT_420	[p23l1003t2590r1238b2632],
9	after	IN	O	after	_	0	SENT_420	[p23l1253t2582r1373b2632],
10	myocardial	JJ	O	myocardial	amod	11	SENT_420	[p23l1388t2582r1672b2646],
11	infarction	NN	O	infarction	prep_after	8	SENT_420	[p23l1691t2582r1938b2632],
12	in	IN	O	in	_	0	SENT_420	[p23l1956t2585r1999b2631],
13	patients	NNS	O	patient	prep_in	11	SENT_420	[p23l132t2663r342b2723],
14	with	IN	O	with	_	0	SENT_420	[p23l356t2660r469b2710],
15	|	NN	O	|	nn	16	SENT_420	[p23l487t2660r872b2710],
16	eft	NN	O	eft	prep_with	13	SENT_420	[p23l487t2660r872b2710],
17	—	CD	NUMBER	—	num	19	SENT_420	[p23l487t2660r872b2710],
18	ventricular	JJ	O	ventricular	amod	19	SENT_420	[p23l487t2660r872b2710],
19	dysfunction	NN	O	dysfunction	dep	16	SENT_420	[p23l885t2660r1209b2724],
20	:	:	O	:	_	0	SENT_420	[p23l885t2660r1209b2724],
21	the	DT	O	the	det	22	SENT_420	[p23l1223t2660r1308b2710],
22	CAPRICORN	NNP	O	CAPRICORN	dep	16	SENT_420	[p23l1323t2662r1632b2710],
23	randomised	VBD	O	randomise	_	0	SENT_420	[p23l1651t2660r1961b2710],
24	trial	NN	O	trial	dobj	23	SENT_420	[p23l1977t2660r2089b2710],
25	.	.	O	.	_	0	SENT_420	[p23l1977t2660r2089b2710],

1	Lancet	NNP	O	Lancet	_	0	SENT_421	[p23l130t2740r301b2787],
2	357	CD	NUMBER	357	num	1	SENT_421	[p23l311t2741r426b2794],
3	,	,	O	,	_	0	SENT_421	[p23l311t2741r426b2794],
4	1385-1390	CD	DATE	1385-1390	num	1	SENT_421	[p23l445t2741r730b2787],
5	(	CD	NUMBER	(	num	7	SENT_421	[p23l746t2738r921b2794],
6	2001	CD	DATE	2001	num	7	SENT_421	[p23l746t2738r921b2794],
7	)	NN	O	)	dep	1	SENT_421	[p23l746t2738r921b2794],
8	.	.	O	.	_	0	SENT_421	[p23l746t2738r921b2794],

1	Shah	NNP	PERSON	Shah	nn	4	SENT_422	[p23l130t2815r271b2873],
2	,	,	O	,	_	0	SENT_422	[p23l130t2815r271b2873],
3	S.J.	NNP	O	S.J.	appos	4	SENT_422	[p23l286t2817r362b2865],
4	etal.	NNP	O	etal.	_	0	SENT_422	[p23l376t2815r503b2873],
5	;	:	O	;	_	0	SENT_422	[p23l376t2815r503b2873],
6	HOR	NNP	O	HOR	nn	8	SENT_422	[p23l519t2817r859b2865],
7	|	NNP	O	|	nn	8	SENT_422	[p23l519t2817r859b2865],
8	ZON	NNP	O	ZON	dep	4	SENT_422	[p23l519t2817r859b2865],
9	.	.	O	.	_	0	SENT_422	[p23l519t2817r859b2865],

1	—	NN	O	—	_	0	SENT_423	[p23l519t2817r859b2865],
2	.	.	O	.	_	0	SENT_423	[p23l519t2817r859b2865],

1	HF	NN	O	hf	nn	2	SENT_424	[p23l519t2817r859b2865],
2	Investigators	NNS	O	investigator	_	0	SENT_424	[p23l877t2818r1224b2879],
3	.	.	O	.	_	0	SENT_424	[p23l877t2818r1224b2879],

1	Effects	NNS	O	effect	_	0	SENT_425	[p23l1240t2815r1409b2865],
2	of	IN	O	of	_	0	SENT_425	[p23l1424t2815r1478b2865],
3	istaroxime	NN	O	istaroxime	prep_of	1	SENT_425	[p23l1489t2818r1759b2865],
4	on	IN	O	on	_	0	SENT_425	[p23l1774t2830r1838b2865],
5	diastolic	JJ	O	diastolic	amod	6	SENT_425	[p23l1855t2815r2071b2865],
6	stiffness	NN	O	stiffness	prep_on	3	SENT_425	[p23l131t2893r342b2943],
7	in	IN	O	in	_	0	SENT_425	[p23l358t2896r401b2942],
8	acute	JJ	O	acute	amod	11	SENT_425	[p23l417t2901r560b2943],
9	heart	NN	O	heart	nn	11	SENT_425	[p23l577t2893r713b2943],
10	failure	NN	O	failure	nn	11	SENT_425	[p23l725t2893r888b2943],
11	syndromes	NNS	O	syndrome	prep_in	6	SENT_425	[p23l903t2893r1204b2957],
12	:	:	O	:	_	0	SENT_425	[p23l903t2893r1204b2957],
13	results	NNS	O	result	dep	1	SENT_425	[p23l1221t2893r1388b2943],
14	from	IN	O	from	_	0	SENT_425	[p23l1401t2893r1523b2943],
15	the	DT	O	the	det	16	SENT_425	[p23l1538t2893r1624b2943],
16	Hemodynamic	JJ	O	hemodynamic	prep_from	13	SENT_425	[p23l1641t2893r2038b2957],
17	,	,	O	,	_	0	SENT_425	[p23l1641t2893r2038b2957],
18	Echocardiographic	JJ	MISC	echocardiographic	appos	16	SENT_425	[p23l133t2971r635b3035],
19	,	,	O	,	_	0	SENT_425	[p23l133t2971r635b3035],
20	and	CC	O	and	_	0	SENT_425	[p23l649t2971r746b3021],
21	Neurohormonal	NNP	MISC	Neurohormonal	nn	22	SENT_425	[p23l764t2971r1180b3021],
22	Effects	NNS	MISC	effect	conj_and	18	SENT_425	[p23l1200t2971r1369b3021],
23	of	IN	MISC	of	_	0	SENT_425	[p23l1383t2971r1437b3021],
24	Istaroxime	NNP	MISC	Istaroxime	prep_of	18	SENT_425	[p23l1450t2974r1731b3029],
25	,	,	O	,	_	0	SENT_425	[p23l1450t2974r1731b3029],
26	a	DT	O	a	det	28	SENT_425	[p23l1745t2986r1771b3021],
27	Novel	JJ	MISC	novel	amod	28	SENT_425	[p23l1789t2971r1933b3021],
28	Intravenous	JJ	MISC	intravenous	conj_and	18	SENT_425	[p23l133t3052r441b3099],
29	Inotropic	JJ	MISC	inotropic	amod	28	SENT_425	[p23l458t3052r694b3112],
30	and	CC	O	and	_	0	SENT_425	[p23l708t3049r804b3099],
31	Lusitropic	JJ	MISC	lusitropic	amod	32	SENT_425	[p23l823t3052r1077b3112],
32	Agent	NNP	MISC	Agent	conj_and	18	SENT_425	[p23l1090t3052r1262b3113],
33	:	:	O	:	_	0	SENT_425	[p23l1090t3052r1262b3113],
34	a	DT	O	a	det	37	SENT_425	[p23l1276t3064r1302b3099],
35	Randomized	NNP	O	Randomized	nn	37	SENT_425	[p23l1320t3049r1647b3099],
36	Controlled	NNP	O	Controlled	nn	37	SENT_425	[p23l1663t3049r1937b3099],
37	Trial	NNP	O	Trial	dep	18	SENT_425	[p23l1949t3049r2055b3099],
38	in	IN	O	in	prep	37	SENT_425	[p23l2074t3052r2116b3099],

1	VOLUME	NN	O	volume	nn	3	SENT_426	[p23l538t3263r762b3305],
2	94	CD	NUMBER	94	num	3	SENT_426	[p23l780t3264r839b3305],
3	NUMBER	NN	O	number	_	0	SENT_426	[p23l858t3263r1082b3305],
4	4	CD	NUMBER	4	number	5	SENT_426	[p23l1097t3259r1150b3320],
5	|	CD	NUMBER	|	dep	3	SENT_426	[p23l1097t3259r1150b3320],
6	OCTOBER	NNP	DATE	OCTOBER	dep	5	SENT_426	[p23l1170t3263r1419b3305],
7	2013	CD	DATE	2013	num	6	SENT_426	[p23l1437t3264r1555b3305],
8	|	CD	NUMBER	|	num	9	SENT_426	[p23l1577t3259r1581b3320],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_426	[p23l1600t3263r2152b3316],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_427	[p23l1948t3395r2138b3432],

1	Patients	NNS	O	patient	nsubj	2	SENT_428	[p23l132t3606r337b3653],
2	Hospitalized	VBN	O	hospitalize	_	0	SENT_428	[p23l354t3604r674b3665],
3	with	IN	O	with	_	0	SENT_428	[p23l690t3604r803b3653],
4	Heart	NNP	O	Heart	nn	5	SENT_428	[p23l822t3606r964b3653],
5	Failure	NN	O	failure	prep_with	2	SENT_428	[p23l980t3604r1149b3653],
6	(	CD	NUMBER	(	num	5	SENT_428	[p23l1165t3605r1541b3660],
7	HOR	NNP	O	HOR	nn	9	SENT_428	[p23l1165t3605r1541b3660],
8	|	NNP	O	|	nn	9	SENT_428	[p23l1165t3605r1541b3660],
9	ZON	NNP	O	ZON	dep	5	SENT_428	[p23l1165t3605r1541b3660],
10	.	.	O	.	_	0	SENT_428	[p23l1165t3605r1541b3660],

1	—	NN	O	—	_	0	SENT_429	[p23l1165t3605r1541b3660],
2	.	.	O	.	_	0	SENT_429	[p23l1165t3605r1541b3660],

1	HF	NN	O	hf	_	0	SENT_430	[p23l1165t3605r1541b3660],
2	)	CD	NUMBER	)	num	3	SENT_430	[p23l1165t3605r1541b3660],
3	trial	NN	O	trial	dep	1	SENT_430	[p23l1556t3604r1778b3653],
4	.	.	O	.	_	0	SENT_430	[p23l1556t3604r1778b3653],

1	Am	NNP	O	Am	_	0	SENT_431	[p23l1556t3604r1778b3653],
2	.	.	O	.	_	0	SENT_431	[p23l1556t3604r1778b3653],

1	Heart	NNP	O	Heart	_	0	SENT_432	[p23l1792t3606r1978b3653],
2	]	NN	O	]	dep	1	SENT_432	[p23l1792t3606r1978b3653],
3	.	.	O	.	_	0	SENT_432	[p23l1792t3606r1978b3653],

1	157	CD	NUMBER	157	_	0	SENT_433	[p23l1995t3608r2107b3660],
2	,	,	O	,	_	0	SENT_433	[p23l1995t3608r2107b3660],
3	1035-1041	CD	DATE	1035-1041	number	4	SENT_433	[p23l134t3684r409b3730],
4	(	CD	NUMBER	(	appos	1	SENT_433	[p23l435t3682r609b3737],
5	2009	CD	DATE	2009	num	6	SENT_433	[p23l435t3682r609b3737],
6	)	NN	O	)	dep	4	SENT_433	[p23l435t3682r609b3737],
7	.	.	O	.	_	0	SENT_433	[p23l435t3682r609b3737],

1	Cleland	NNP	PERSON	Cleland	nsubj	22	SENT_434	[p24l128t18r337b75],
2	,	,	O	,	_	0	SENT_434	[p24l128t18r337b75],
3	J.G.	NNP	LOCATION	J.G.	nsubj	22	SENT_434	[p24l350t20r451b75],
4	,	,	O	,	_	0	SENT_434	[p24l350t20r451b75],
5	Coletta	NNP	PERSON	Coletta	conj_and	1	SENT_434	[p24l465t18r665b75],
6	,	,	O	,	_	0	SENT_434	[p24l465t18r665b75],
7	A.	NNP	ORGANIZATION	A.	conj_and	1	SENT_434	[p24l679t20r727b67],
8	&	CC	ORGANIZATION	&	_	0	SENT_434	[p24l741t19r939b75],
9	Witte	NNP	ORGANIZATION	Witte	conj_and	1	SENT_434	[p24l741t19r939b75],
10	,	,	O	,	_	0	SENT_434	[p24l741t19r939b75],
11	K.	NNP	O	K.	nn	13	SENT_434	[p24l955t20r998b67],
12	Practical	NNP	O	Practical	nn	13	SENT_434	[p24l1014t18r1229b67],
13	applications	NNS	O	application	appos	1	SENT_434	[p24l1246t18r1565b80],
14	of	IN	O	of	_	0	SENT_434	[p24l1579t17r1634b67],
15	intravenous	JJ	O	intravenous	amod	17	SENT_434	[p24l1645t20r1953b67],
16	diuretic	JJ	O	diuretic	amod	17	SENT_434	[p24l129t96r328b145],
17	therapy	NN	O	therapy	prep_of	13	SENT_434	[p24l340t96r545b159],
18	in	IN	O	in	_	0	SENT_434	[p24l559t98r602b145],
19	decompensated	JJ	O	decompensated	amod	21	SENT_434	[p24l618t96r1044b158],
20	heart	NN	O	heart	nn	21	SENT_434	[p24l1063t96r1199b145],
21	fai	NNS	O	faus	prep_in	17	SENT_434	[p24l1211t95r1497b145],
22	|	VBP	O	|	_	0	SENT_434	[p24l1211t95r1497b145],
23	ure	NN	O	ure	dobj	22	SENT_434	[p24l1211t95r1497b145],
24	.	.	O	.	_	0	SENT_434	[p24l1211t95r1497b145],

1	Am	NNP	O	Am	_	0	SENT_435	[p24l1211t95r1497b145],
2	.	.	O	.	_	0	SENT_435	[p24l1211t95r1497b145],

1	J.	NNP	O	J.	nn	2	SENT_436	[p24l1508t98r1542b145],
2	Med	NNP	O	Med	_	0	SENT_436	[p24l1556t96r1679b145],
3	.	.	O	.	_	0	SENT_436	[p24l1556t96r1679b145],

1	1	CD	NUMBER	1	num	2	SENT_437	[p24l1696t100r1716b145],
2	19	CD	NUMBER	19	_	0	SENT_437	[p24l1731t99r1808b153],
3	,	,	O	,	_	0	SENT_437	[p24l1731t99r1808b153],
4	526-536	CD	NUMBER	526-536	number	5	SENT_437	[p24l1823t97r2044b145],
5	(	CD	NUMBER	(	appos	2	SENT_437	[p24l131t174r305b229],
6	2006	CD	DATE	2006	num	7	SENT_437	[p24l131t174r305b229],
7	)	NN	O	)	dep	5	SENT_437	[p24l131t174r305b229],
8	.	.	O	.	_	0	SENT_437	[p24l131t174r305b229],

1	Felker	NNP	PERSON	Felker	_	0	SENT_438	[p24l130t250r292b306],
2	,	,	O	,	_	0	SENT_438	[p24l130t250r292b306],
3	GM	NNP	ORGANIZATION	GM	appos	1	SENT_438	[p24l306t252r421b299],
4	.	.	O	.	_	0	SENT_438	[p24l306t252r421b299],

1	etal.	NN	O	etal.	_	0	SENT_439	[p24l435t250r562b306],
2	;	:	O	;	_	0	SENT_439	[p24l435t250r562b306],
3	NHLBI	NNP	ORGANIZATION	NHLBI	nn	5	SENT_439	[p24l579t252r733b299],
4	Heart	NNP	ORGANIZATION	Heart	nn	5	SENT_439	[p24l753t252r895b299],
5	Failure	NN	ORGANIZATION	failure	dep	1	SENT_439	[p24l911t250r1080b299],
6	Clinical	JJ	ORGANIZATION	clinical	amod	8	SENT_439	[p24l1094t250r1279b299],
7	Research	NN	ORGANIZATION	research	nn	8	SENT_439	[p24l1299t250r1528b299],
8	Network	NNP	ORGANIZATION	Network	dep	5	SENT_439	[p24l1547t250r1782b299],
9	.	.	O	.	_	0	SENT_439	[p24l1547t250r1782b299],

1	Diuretic	JJ	O	diuretic	amod	2	SENT_440	[p24l1800t252r2002b299],
2	strategies	NNS	O	strategy	_	0	SENT_440	[p24l130t330r381b391],
3	in	IN	O	in	_	0	SENT_440	[p24l398t330r441b377],
4	patients	NNS	O	patient	prep_in	2	SENT_440	[p24l459t330r669b390],
5	with	IN	O	with	_	0	SENT_440	[p24l682t328r795b377],
6	acute	JJ	O	acute	amod	7	SENT_440	[p24l812t335r955b377],
7	decompensated	JJ	O	decompensated	amod	9	SENT_440	[p24l969t328r1395b390],
8	heart	NN	O	heart	nn	9	SENT_440	[p24l1414t328r1550b377],
9	failure	NN	O	failure	prep_with	2	SENT_440	[p24l1562t327r1738b377],
10	.	.	O	.	_	0	SENT_440	[p24l1562t327r1738b377],

1	N.	NNP	O	N.	nn	2	SENT_441	[p24l1752t330r1800b377],
2	Engl	NNP	O	Engl	_	0	SENT_441	[p24l1814t328r1978b391],
3	.	.	O	.	_	0	SENT_441	[p24l1814t328r1978b391],

1	}	NN	O	}	_	0	SENT_442	[p24l1814t328r1978b391],
2	.	.	O	.	_	0	SENT_442	[p24l1814t328r1978b391],

1	Med	NNP	O	Med	_	0	SENT_443	[p24l1992t328r2115b377],
2	.	.	O	.	_	0	SENT_443	[p24l1992t328r2115b377],

1	364	CD	NUMBER	364	_	0	SENT_444	[p24l130t408r245b461],
2	,	,	O	,	_	0	SENT_444	[p24l130t408r245b461],
3	797-805	CD	NUMBER	797-805	num	4	SENT_444	[p24l260t408r481b454],
4	(	NN	O	(	appos	1	SENT_444	[p24l499t406r600b461],
5	201	CD	NUMBER	201	number	6	SENT_444	[p24l499t406r600b461],
6	1	CD	NUMBER	1	num	7	SENT_444	[p24l618t406r673b461],
7	)	NN	O	)	dep	4	SENT_444	[p24l618t406r673b461],
8	.	.	O	.	_	0	SENT_444	[p24l618t406r673b461],

1	Channer	NNP	PERSON	Channer	_	0	SENT_445	[p24l128t482r360b538],
2	,	,	O	,	_	0	SENT_445	[p24l128t482r360b538],
3	K.S.	NNP	PERSON	K.S.	nn	9	SENT_445	[p24l377t483r476b538],
4	,	,	O	,	_	0	SENT_445	[p24l377t483r476b538],
5	McLean	NNP	PERSON	McLean	appos	9	SENT_445	[p24l492t484r707b538],
6	,	,	O	,	_	0	SENT_445	[p24l492t484r707b538],
7	K.A.	NNP	PERSON	K.A.	appos	9	SENT_445	[p24l724t484r831b538],
8	,	,	O	,	_	0	SENT_445	[p24l724t484r831b538],
9	Lawson	NNP	PERSON	Lawson	appos	1	SENT_445	[p24l849t482r1313b538],
10	.	.	O	.	_	0	SENT_445	[p24l849t482r1313b538],

1	—	NN	O	—	_	0	SENT_446	[p24l849t482r1313b538],
2	.	.	O	.	_	0	SENT_446	[p24l849t482r1313b538],

1	Matthew	NNP	PERSON	Matthew	_	0	SENT_447	[p24l849t482r1313b538],
2	,	,	O	,	_	0	SENT_447	[p24l849t482r1313b538],
3	P.	NNP	ORGANIZATION	P.	conj_and	1	SENT_447	[p24l1330t484r1361b531],
4	&	CC	ORGANIZATION	&	_	0	SENT_447	[p24l1376t483r1413b531],
5	Richardson	NNP	ORGANIZATION	Richardson	conj_and	1	SENT_447	[p24l1428t482r1730b538],
6	,	,	O	,	_	0	SENT_447	[p24l1428t482r1730b538],
7	M.	NNP	O	M.	nn	10	SENT_447	[p24l1746t484r1805b531],
8	Combination	NNP	O	Combination	nn	10	SENT_447	[p24l129t559r471b608],
9	diuretic	JJ	O	diuretic	amod	10	SENT_447	[p24l487t559r686b608],
10	treatment	NN	O	treatment	appos	1	SENT_447	[p24l699t566r962b608],
11	in	IN	O	in	_	0	SENT_447	[p24l978t561r1020b607],
12	severe	JJ	O	severe	amod	14	SENT_447	[p24l1037t573r1204b608],
13	heart	NN	O	heart	nn	14	SENT_447	[p24l1221t559r1356b608],
14	failure	NN	O	failure	prep_in	10	SENT_447	[p24l1368t558r1545b608],
15	:	:	O	:	_	0	SENT_447	[p24l1368t558r1545b608],
16	a	DT	O	a	det	19	SENT_447	[p24l1559t573r1585b608],
17	randomised	JJ	O	randomised	amod	19	SENT_447	[p24l1603t559r1914b608],
18	controlled	JJ	O	controlled	amod	19	SENT_447	[p24l129t636r395b685],
19	trial	NN	O	trial	dep	1	SENT_447	[p24l410t636r522b685],
20	.	.	O	.	_	0	SENT_447	[p24l410t636r522b685],

1	Br	NN	O	br	_	0	SENT_448	[p24l536t638r595b685],
2	.	.	O	.	_	0	SENT_448	[p24l536t638r595b685],

1	Heart	NNP	O	Heart	_	0	SENT_449	[p24l610t638r795b685],
2	}	NN	O	}	dep	1	SENT_449	[p24l610t638r795b685],
3	.	.	O	.	_	0	SENT_449	[p24l610t638r795b685],

1	71	CD	NUMBER	71	_	0	SENT_450	[p24l810t640r889b692],
2	,	,	O	,	_	0	SENT_450	[p24l810t640r889b692],
3	146-1	CD	NUMBER	146-1	num	5	SENT_450	[p24l908t639r1052b685],
4	50	CD	NUMBER	50	num	5	SENT_450	[p24l1067t639r1128b685],
5	(	NN	O	(	appos	1	SENT_450	[p24l1144t637r1179b692],
6	1	CD	NUMBER	1	number	7	SENT_450	[p24l1144t637r1179b692],
7	994	CD	NUMBER	994	num	8	SENT_450	[p24l1193t637r1318b692],
8	)	NN	O	)	dep	5	SENT_450	[p24l1193t637r1318b692],
9	.	.	O	.	_	0	SENT_450	[p24l1193t637r1318b692],

1	Metra	NNP	ORGANIZATION	Metra	nn	14	SENT_451	[p24l129t716r293b771],
2	,	,	O	,	_	0	SENT_451	[p24l129t716r293b771],
3	M.	NNP	O	M.	conj_and	14	SENT_451	[p24l308t716r381b771],
4	,	,	O	,	_	0	SENT_451	[p24l308t716r381b771],
5	Cotter	NNP	PERSON	Cotter	conj_and	14	SENT_451	[p24l395t715r566b771],
6	,	,	O	,	_	0	SENT_451	[p24l395t715r566b771],
7	G.	NNP	O	G.	conj_and	14	SENT_451	[p24l581t716r644b771],
8	,	,	O	,	_	0	SENT_451	[p24l581t716r644b771],
9	Gheorghiade	NNP	O	Gheorghiade	conj_and	14	SENT_451	[p24l658t714r1015b777],
10	,	,	O	,	_	0	SENT_451	[p24l658t714r1015b777],
11	M.	NNP	O	M.	conj_and	14	SENT_451	[p24l1031t716r1103b771],
12	,	,	O	,	_	0	SENT_451	[p24l1031t716r1103b771],
13	Dei	NNP	LOCATION	Dei	conj_and	14	SENT_451	[p24l1120t716r1201b763],
14	Cas	NNP	LOCATION	Cas	_	0	SENT_451	[p24l1217t715r1318b771],
15	,	,	O	,	_	0	SENT_451	[p24l1217t715r1318b771],
16	L.	NNP	ORGANIZATION	L.	conj_and	14	SENT_451	[p24l1335t716r1372b763],
17	&	CC	ORGANIZATION	&	_	0	SENT_451	[p24l1386t715r1591b771],
18	Voors	NNP	ORGANIZATION	Voors	conj_and	14	SENT_451	[p24l1386t715r1591b771],
19	,	,	O	,	_	0	SENT_451	[p24l1386t715r1591b771],
20	A.A.	NNP	PERSON	A.A.	appos	14	SENT_451	[p24l1605t716r1705b763],
21	.	.	O	.	_	0	SENT_451	[p24l1605t716r1705b763],

1	The	DT	O	the	det	2	SENT_452	[p24l1715t714r1812b763],
2	role	NN	O	role	_	0	SENT_452	[p24l1829t714r1924b763],
3	of	IN	O	of	_	0	SENT_452	[p24l1939t713r1993b763],
4	the	DT	O	the	det	5	SENT_452	[p24l2002t714r2087b763],
5	kidney	NN	O	kidney	prep_of	2	SENT_452	[p24l131t792r306b855],
6	in	IN	O	in	_	0	SENT_452	[p24l320t794r363b841],
7	heartfai	NN	O	heartfaus	nn	9	SENT_452	[p24l382t791r808b842],
8	|	NN	O	|	nn	9	SENT_452	[p24l382t791r808b842],
9	ure	NN	O	ure	prep_in	2	SENT_452	[p24l382t791r808b842],
10	.	.	O	.	_	0	SENT_452	[p24l382t791r808b842],

1	Eur	NNP	O	Eur	_	0	SENT_453	[p24l382t791r808b842],
2	.	.	O	.	_	0	SENT_453	[p24l382t791r808b842],

1	HeartJ	NN	O	heartj	_	0	SENT_454	[p24l823t794r1008b842],
2	.	.	O	.	_	0	SENT_454	[p24l823t794r1008b842],

1	33	CD	NUMBER	33	_	0	SENT_455	[p24l1023t795r1102b849],
2	,	,	O	,	_	0	SENT_455	[p24l1023t795r1102b849],
3	2135-2142	CD	DATE	2135-2142	number	4	SENT_455	[p24l1117t795r1405b842],
4	(	CD	NUMBER	(	appos	1	SENT_455	[p24l1422t793r1596b849],
5	2012	CD	DATE	2012	num	6	SENT_455	[p24l1422t793r1596b849],
6	)	NN	O	)	dep	4	SENT_455	[p24l1422t793r1596b849],
7	.	.	O	.	_	0	SENT_455	[p24l1422t793r1596b849],

1	Massie	NNP	PERSON	Massie	nn	3	SENT_456	[p24l129t872r316b927],
2	,	,	O	,	_	0	SENT_456	[p24l129t872r316b927],
3	B.M.	NNP	O	B.M.	_	0	SENT_456	[p24l332t872r437b919],
4	et	FW	O	et	nn	5	SENT_456	[p24l451t878r500b919],
5	al.	FW	O	al.	dep	3	SENT_456	[p24l509t870r579b927],
6	;	:	O	;	_	0	SENT_456	[p24l509t870r579b927],
7	PROTECT	NNP	O	PROTECT	nn	8	SENT_456	[p24l595t871r835b920],
8	Investigators	NNS	O	investigator	dep	3	SENT_456	[p24l850t872r1184b933],
9	and	CC	O	and	_	0	SENT_456	[p24l1199t870r1295b920],
10	Committees	NNS	O	committee	dep	3	SENT_456	[p24l1311t872r1643b919],
11	.	.	O	.	_	0	SENT_456	[p24l1311t872r1643b919],

1	Rolofylline	NNP	O	Rolofylline	_	0	SENT_457	[p24l1660t869r1946b934],
2	,	,	O	,	_	0	SENT_457	[p24l1660t869r1946b934],
3	an	DT	O	a	det	5	SENT_457	[p24l1959t885r2020b919],
4	adenosine	NN	O	adenosine	nn	5	SENT_457	[p24l129t948r401b998],
5	A1	NN	O	a1	appos	1	SENT_457	[p24l415t950r474b997],
6	-	:	O	-	_	0	SENT_457	[p24l487t955r729b1010],
7	receptor	NN	O	receptor	nn	8	SENT_457	[p24l487t955r729b1010],
8	antagonist	NN	O	antagonist	dep	1	SENT_457	[p24l742t950r1035b1011],
9	,	,	O	,	_	0	SENT_457	[p24l742t950r1035b1011],
10	in	IN	O	in	dep	1	SENT_457	[p24l1052t950r1094b997],
11	acute	JJ	O	acute	amod	13	SENT_457	[p24l1110t955r1253b998],
12	heart	NN	O	heart	nn	13	SENT_457	[p24l1270t948r1406b998],
13	failure	NN	O	failure	pobj	10	SENT_457	[p24l1418t947r1594b998],
14	.	.	O	.	_	0	SENT_457	[p24l1418t947r1594b998],

1	N.	NNP	O	N.	nn	2	SENT_458	[p24l1608t950r1656b998],
2	Engl	NNP	O	Engl	_	0	SENT_458	[p24l1671t948r1789b1011],
3	.	.	O	.	_	0	SENT_458	[p24l1671t948r1789b1011],

1	J.	NNP	O	J.	nn	2	SENT_459	[p24l1800t950r1834b998],
2	Med	NNP	O	Med	_	0	SENT_459	[p24l1848t948r1971b998],
3	.	.	O	.	_	0	SENT_459	[p24l1848t948r1971b998],

1	363	CD	NUMBER	363	_	0	SENT_460	[p24l1985t951r2100b1005],
2	,	,	O	,	_	0	SENT_460	[p24l1985t951r2100b1005],
3	1419-1428	CD	DATE	1419-1428	number	4	SENT_460	[p24l133t1028r418b1074],
4	(	CD	NUMBER	(	appos	1	SENT_460	[p24l435t1026r609b1081],
5	2010	CD	DATE	2010	num	6	SENT_460	[p24l435t1026r609b1081],
6	)	NN	O	)	dep	4	SENT_460	[p24l435t1026r609b1081],
7	.	.	O	.	_	0	SENT_460	[p24l435t1026r609b1081],

1	Cotter	NNP	PERSON	Cotter	_	0	SENT_461	[p24l128t1105r299b1160],
2	,	,	O	,	_	0	SENT_461	[p24l128t1105r299b1160],
3	G.	NNP	O	G.	nn	4	SENT_461	[p24l313t1105r363b1153],
4	etal	NN	O	etal	appos	1	SENT_461	[p24l378t1103r489b1153],
5	.	.	O	.	_	0	SENT_461	[p24l378t1103r489b1153],

1	Randomised	JJ	O	randomised	amod	2	SENT_462	[p24l509t1103r833b1153],
2	trial	NN	O	trial	_	0	SENT_462	[p24l849t1103r946b1153],
3	of	IN	O	of	_	0	SENT_462	[p24l963t1102r1017b1153],
4	high	JJ	O	high	amod	8	SENT_462	[p24l1029t1103r1293b1166],
5	—	NN	O	—	nn	8	SENT_462	[p24l1029t1103r1293b1166],
6	dose	NN	O	dose	nn	8	SENT_462	[p24l1029t1103r1293b1166],
7	isosorbide	NN	O	isosorbide	nn	8	SENT_462	[p24l1309t1103r1578b1153],
8	dinitrate	NN	O	dinitrate	prep_of	2	SENT_462	[p24l1593t1103r1814b1153],
9	plus	CC	O	plus	prep	8	SENT_462	[p24l1830t1103r1936b1165],
10	lowdose	NN	O	lowdose	nn	11	SENT_462	[p24l1953t1103r2063b1153, p24l129t1181r253b1231],
11	furosemide	NN	O	furosemide	dep	9	SENT_462	[p24l266t1180r565b1231],
12	versus	CC	O	versus	prep	2	SENT_462	[p24l579t1196r744b1231],
13	high	JJ	O	high	amod	16	SENT_462	[p24l761t1181r1024b1244],
14	—	NN	O	—	nn	16	SENT_462	[p24l761t1181r1024b1244],
15	dose	NN	O	dose	nn	16	SENT_462	[p24l761t1181r1024b1244],
16	furosemide	NN	O	furosemide	dep	12	SENT_462	[p24l1037t1180r1337b1231],
17	plus	CC	O	plus	prep	16	SENT_462	[p24l1353t1181r1458b1243],
18	low-dose	JJ	O	low-dose	amod	20	SENT_462	[p24l1475t1181r1714b1231],
19	isosorbide	NN	O	isosorbide	nn	20	SENT_462	[p24l1730t1181r1999b1231],
20	dinitrate	NN	O	dinitrate	dep	17	SENT_462	[p24l129t1259r350b1309],
21	in	IN	O	in	_	0	SENT_462	[p24l366t1261r409b1308],
22	severe	JJ	O	severe	amod	24	SENT_462	[p24l426t1274r593b1309],
23	pulmonary	JJ	O	pulmonary	amod	24	SENT_462	[p24l609t1259r898b1322],
24	oedema	NN	O	oedema	prep_in	20	SENT_462	[p24l910t1259r1138b1309],
25	.	.	O	.	_	0	SENT_462	[p24l910t1259r1138b1309],

1	Lancet351	NN	O	lancet351	_	0	SENT_463	[p24l1153t1261r1449b1316],
2	,	,	O	,	_	0	SENT_463	[p24l1153t1261r1449b1316],
3	389-393	CD	NUMBER	389-393	number	4	SENT_463	[p24l1464t1262r1685b1309],
4	(	CD	NUMBER	(	appos	1	SENT_463	[p24l1704t1260r1877b1316],
5	1998	CD	DATE	1998	num	6	SENT_463	[p24l1704t1260r1877b1316],
6	)	NN	O	)	dep	4	SENT_463	[p24l1704t1260r1877b1316],
7	.	.	O	.	_	0	SENT_463	[p24l1704t1260r1877b1316],

1	Cohn	NNP	PERSON	Cohn	_	0	SENT_464	[p24l128t1337r279b1394],
2	,	,	O	,	_	0	SENT_464	[p24l128t1337r279b1394],
3	J.N.	NNP	O	J.N.	nn	4	SENT_464	[p24l291t1339r380b1387],
4	etal	NN	O	etal	appos	1	SENT_464	[p24l394t1337r506b1387],
5	.	.	O	.	_	0	SENT_464	[p24l394t1337r506b1387],

1	Effect	NN	O	effect	_	0	SENT_465	[p24l525t1336r670b1387],
2	of	IN	O	of	_	0	SENT_465	[p24l683t1336r738b1387],
3	short	JJ	O	short	amod	6	SENT_465	[p24l748t1337r1026b1387],
4	—	JJ	O	—	amod	6	SENT_465	[p24l748t1337r1026b1387],
5	term	NN	O	term	nn	6	SENT_465	[p24l748t1337r1026b1387],
6	infusion	NN	O	infusion	prep_of	1	SENT_465	[p24l1044t1336r1251b1387],
7	of	IN	O	of	_	0	SENT_465	[p24l1267t1336r1322b1387],
8	sodium	NN	O	sodium	nn	9	SENT_465	[p24l1331t1337r1525b1387],
9	nitroprusside	NN	O	nitroprusside	prep_of	6	SENT_465	[p24l1543t1337r1888b1399],
10	on	IN	O	on	_	0	SENT_465	[p24l1903t1352r1967b1387],
11	mortality	NN	O	mortality	nn	12	SENT_465	[p24l131t1415r370b1478],
12	rate	NN	O	rate	prep_on	9	SENT_465	[p24l385t1422r482b1464],
13	in	IN	O	in	_	0	SENT_465	[p24l499t1417r541b1464],
14	acute	JJ	O	acute	amod	16	SENT_465	[p24l557t1422r700b1465],
15	myocardial	JJ	O	myocardial	amod	16	SENT_465	[p24l717t1415r1001b1478],
16	infarction	NN	O	infarction	prep_in	12	SENT_465	[p24l1019t1414r1267b1465],
17	complicated	VBN	O	complicate	partmod	16	SENT_465	[p24l1283t1415r1607b1477],
18	by	IN	O	by	_	0	SENT_465	[p24l1626t1415r1687b1478],
19	left	JJ	O	left	amod	21	SENT_465	[p24l1702t1414r1784b1464],
20	ventricular	JJ	O	ventricular	amod	21	SENT_465	[p24l1796t1415r2078b1465],
21	failure	NN	O	failure	agent	17	SENT_465	[p24l128t1492r304b1543],
22	:	:	O	:	_	0	SENT_465	[p24l128t1492r304b1543],
23	results	NNS	O	result	dep	1	SENT_465	[p24l320t1493r487b1543],
24	of	IN	O	of	_	0	SENT_465	[p24l502t1492r556b1543],
25	a	DT	O	a	det	29	SENT_465	[p24l566t1508r592b1543],
26	Veterans	NNP	O	Veterans	nn	29	SENT_465	[p24l603t1495r831b1543],
27	Administration	NNP	O	Administration	nn	29	SENT_465	[p24l845t1493r1235b1543],
28	cooperative	JJ	O	cooperative	amod	29	SENT_465	[p24l1251t1495r1562b1555],
29	study	NN	O	study	prep_of	23	SENT_465	[p24l1577t1493r1730b1556],
30	.	.	O	.	_	0	SENT_465	[p24l1577t1493r1730b1556],

1	N.	NNP	O	N.	nn	4	SENT_466	[p24l1745t1495r1793b1543],
2	Engl	NNP	O	Engl	nn	4	SENT_466	[p24l1807t1493r1971b1556],
3	.	.	O	.	_	0	SENT_466	[p24l1807t1493r1971b1556],
4	]	NN	O	]	_	0	SENT_466	[p24l1807t1493r1971b1556],

1	.	.	O	.	_	0	SENT_467	[p24l1807t1493r1971b1556],

1	Med	NNP	O	Med	_	0	SENT_468	[p24l1985t1493r2107b1543],
2	.	.	O	.	_	0	SENT_468	[p24l1985t1493r2107b1543],

1	306	CD	NUMBER	306	_	0	SENT_469	[p24l129t1573r244b1626],
2	,	,	O	,	_	0	SENT_469	[p24l129t1573r244b1626],
3	1	CD	NUMBER	1	num	4	SENT_469	[p24l263t1574r278b1618],
4	129-1	CD	NUMBER	129-1	appos	1	SENT_469	[p24l296t1573r440b1619],
5	135	CD	NUMBER	135	number	6	SENT_469	[p24l458t1573r546b1619],
6	(	CD	NUMBER	(	dep	4	SENT_469	[p24l564t1571r738b1626],
7	1982	CD	DATE	1982	num	8	SENT_469	[p24l564t1571r738b1626],
8	)	NN	O	)	dep	6	SENT_469	[p24l564t1571r738b1626],
9	.	.	O	.	_	0	SENT_469	[p24l564t1571r738b1626],

1	Adams	NNP	PERSON	Adams	nn	4	SENT_470	[p24l127t1648r319b1705],
2	,	,	O	,	_	0	SENT_470	[p24l127t1648r319b1705],
3	K.F.	NNP	PERSON	K.F.	appos	4	SENT_470	[p24l336t1650r416b1697],
4	Jr	NNP	PERSON	Jr	_	0	SENT_470	[p24l429t1650r473b1698],
5	et	FW	O	et	nn	6	SENT_470	[p24l485t1655r534b1697],
6	al.	FW	O	al.	dep	4	SENT_470	[p24l543t1648r613b1705],
7	;	:	O	;	_	0	SENT_470	[p24l543t1648r613b1705],
8	ADHERE	VB	O	adhere	dep	4	SENT_470	[p24l626t1650r843b1697],
9	Scientiﬁc	NN	ORGANIZATION	scientiﬁc	nn	11	SENT_470	[p24l858t1647r1094b1697],
10	Advisory	NNP	ORGANIZATION	Advisory	nn	11	SENT_470	[p24l1107t1648r1337b1711],
11	Committee	NNP	ORGANIZATION	Committee	dobj	8	SENT_470	[p24l1350t1650r1645b1698],
12	and	CC	O	and	_	0	SENT_470	[p24l1659t1648r1755b1697],
13	Investigators	NNS	O	investigator	dobj	8	SENT_470	[p24l1774t1650r2121b1711],
14	.	.	O	.	_	0	SENT_470	[p24l1774t1650r2121b1711],

1	Characteristics	NNS	O	characteristic	nsubj	6	SENT_471	[p24l129t1726r511b1776],
2	and	CC	O	and	_	0	SENT_471	[p24l526t1726r622b1776],
3	outcomes	NNS	O	outcome	nsubj	6	SENT_471	[p24l638t1733r898b1776],
4	of	IN	O	of	_	0	SENT_471	[p24l913t1725r968b1776],
5	patients	NNS	O	patient	prep_of	1	SENT_471	[p24l979t1728r1189b1788],
6	hospitalized	VBN	O	hospitalize	_	0	SENT_471	[p24l1205t1726r1520b1788],
7	for	IN	O	for	_	0	SENT_471	[p24l1535t1725r1607b1776],
8	heart	NN	O	heart	nn	9	SENT_471	[p24l1623t1726r1758b1776],
9	failure	NN	O	failure	prep_for	6	SENT_471	[p24l1770t1725r1934b1776],
10	in	IN	O	in	_	0	SENT_471	[p24l1950t1728r1993b1775],
11	the	DT	O	the	det	13	SENT_471	[p24l2008t1726r2094b1776],
12	United	NNP	LOCATION	United	nn	13	SENT_471	[p24l131t1804r303b1854],
13	States	NNPS	LOCATION	States	prep_in	9	SENT_471	[p24l320t1805r489b1854],
14	:	:	O	:	_	0	SENT_471	[p24l320t1805r489b1854],
15	rationale	NN	O	rationale	conj_and	9	SENT_471	[p24l505t1804r746b1861],
16	,	,	O	,	_	0	SENT_471	[p24l505t1804r746b1861],
17	design	NN	O	design	appos	15	SENT_471	[p24l760t1804r948b1867],
18	,	,	O	,	_	0	SENT_471	[p24l760t1804r948b1867],
19	and	CC	O	and	_	0	SENT_471	[p24l962t1804r1058b1853],
20	preliminary	JJ	O	preliminary	amod	21	SENT_471	[p24l1077t1804r1377b1868],
21	observations	NNS	O	observation	conj_and	9	SENT_471	[p24l1390t1804r1728b1854],
22	from	IN	O	from	_	0	SENT_471	[p24l1742t1803r1864b1853],
23	the	DT	O	the	det	24	SENT_471	[p24l1879t1804r1965b1853],
24	ﬁrst	NN	O	ﬁrst	prep_from	21	SENT_471	[p24l1978t1803r2076b1854],
25	100,000	CD	NUMBER	100,000	num	26	SENT_471	[p24l133t1885r334b1939],
26	cases	NNS	O	case	dobj	6	SENT_471	[p24l349t1896r486b1931],
27	in	IN	O	in	_	0	SENT_471	[p24l502t1884r545b1931],
28	the	DT	O	the	det	32	SENT_471	[p24l560t1882r646b1931],
29	Acute	JJ	O	acute	amod	32	SENT_471	[p24l660t1884r810b1931],
30	Decompensated	JJ	O	decompensated	amod	32	SENT_471	[p24l828t1882r1258b1944],
31	Heart	NNP	O	Heart	nn	32	SENT_471	[p24l1277t1884r1419b1931],
32	Failure	NN	O	failure	prep_in	26	SENT_471	[p24l1435t1882r1604b1931],
33	National	NNP	O	National	nn	35	SENT_471	[p24l1621t1882r1836b1931],
34	Registry	NNP	O	Registry	nn	35	SENT_471	[p24l1856t1884r2066b1945],
35	(	NNP	O	(	nsubj	36	SENT_471	[p24l131t1960r393b2015],
36	ADHERE	VBP	O	adhere	rcmod	32	SENT_471	[p24l131t1960r393b2015],
37	)	NN	O	)	dobj	36	SENT_471	[p24l131t1960r393b2015],
38	.	.	O	.	_	0	SENT_471	[p24l131t1960r393b2015],

1	Am	NNP	O	Am	_	0	SENT_472	[p24l404t1961r503b2008],
2	.	.	O	.	_	0	SENT_472	[p24l404t1961r503b2008],

1	Heart	NNP	O	Heart	_	0	SENT_473	[p24l518t1961r703b2008],
2	]	NN	O	]	dep	1	SENT_473	[p24l518t1961r703b2008],
3	.	.	O	.	_	0	SENT_473	[p24l518t1961r703b2008],

1	149	CD	NUMBER	149	_	0	SENT_474	[p24l721t1962r833b2015],
2	,	,	O	,	_	0	SENT_474	[p24l721t1962r833b2015],
3	209-216	CD	NUMBER	209-216	number	4	SENT_474	[p24l848t1962r1072b2008],
4	(	CD	NUMBER	(	appos	1	SENT_474	[p24l1088t1960r1262b2015],
5	2005	CD	DATE	2005	num	6	SENT_474	[p24l1088t1960r1262b2015],
6	)	NN	O	)	dep	4	SENT_474	[p24l1088t1960r1262b2015],
7	.	.	O	.	_	0	SENT_474	[p24l1088t1960r1262b2015],

1	Mebazaa	NNP	PERSON	Mebazaa	nn	4	SENT_475	[p24l129t2037r376b2094],
2	,	,	O	,	_	0	SENT_475	[p24l129t2037r376b2094],
3	A.	NNP	O	A.	appos	4	SENT_475	[p24l390t2039r438b2087],
4	etal.	NNP	O	etal.	_	0	SENT_475	[p24l453t2037r580b2094],
5	;	:	O	;	_	0	SENT_475	[p24l453t2037r580b2094],
6	SURVIVE	NNP	O	SURVIVE	nn	7	SENT_475	[p24l595t2038r816b2087],
7	Investigators	NNS	O	investigator	dep	4	SENT_475	[p24l833t2039r1179b2100],
8	.	.	O	.	_	0	SENT_475	[p24l833t2039r1179b2100],

1	Levosimendan	NNP	O	Levosimendan	_	0	SENT_476	[p24l1196t2037r1576b2087],
2	vs	CC	O	vs	_	0	SENT_476	[p24l1591t2052r1644b2087],
3	dobutamine	NN	O	dobutamine	conj_vs	1	SENT_476	[p24l1659t2037r1984b2087],
4	for	IN	O	for	_	0	SENT_476	[p24l1997t2036r2070b2087],
5	patients	NNS	O	patient	prep_for	3	SENT_476	[p24l131t2117r340b2177],
6	with	IN	O	with	_	0	SENT_476	[p24l354t2115r467b2165],
7	acute	JJ	O	acute	amod	8	SENT_476	[p24l484t2122r627b2165],
8	decompensated	JJ	O	decompensated	amod	10	SENT_476	[p24l641t2115r1067b2177],
9	heart	NN	O	heart	nn	10	SENT_476	[p24l1086t2115r1222b2165],
10	failure	NN	O	failure	prep_with	5	SENT_476	[p24l1234t2114r1410b2165],
11	:	:	O	:	_	0	SENT_476	[p24l1234t2114r1410b2165],
12	the	DT	O	the	det	16	SENT_476	[p24l1424t2115r1509b2165],
13	SURVIVE	NNP	O	SURVIVE	nn	16	SENT_476	[p24l1524t2116r1746b2165],
14	Randomized	NNP	O	Randomized	nn	16	SENT_476	[p24l1762t2115r2089b2165],
15	Tria	NNP	O	Tria	nn	16	SENT_476	[p24l127t2192r402b2241],
16	|	NN	O	|	dep	1	SENT_476	[p24l127t2192r402b2241],
17	.	.	O	.	_	0	SENT_476	[p24l127t2192r402b2241],

1	JAMA	NN	O	jama	_	0	SENT_477	[p24l127t2192r402b2241],
2	297	CD	NUMBER	297	num	1	SENT_477	[p24l418t2195r533b2248],
3	,	,	O	,	_	0	SENT_477	[p24l418t2195r533b2248],
4	1883-1891	CD	DATE	1883-1891	number	5	SENT_477	[p24l552t2195r827b2241],
5	(	CD	NUMBER	(	appos	1	SENT_477	[p24l853t2193r1027b2248],
6	2007	CD	DATE	2007	num	7	SENT_477	[p24l853t2193r1027b2248],
7	)	NN	O	)	dep	5	SENT_477	[p24l853t2193r1027b2248],
8	.	.	O	.	_	0	SENT_477	[p24l853t2193r1027b2248],

1	O'Connor	NNP	PERSON	O'Connor	_	0	SENT_478	[p24l127t2271r387b2327],
2	,	,	O	,	_	0	SENT_478	[p24l127t2271r387b2327],
3	C.M.	NNP	PERSON	C.M.	nn	4	SENT_478	[p24l401t2271r512b2320],
4	etal	NNP	O	etal	appos	1	SENT_478	[p24l526t2270r638b2320],
5	.	.	O	.	_	0	SENT_478	[p24l526t2270r638b2320],

1	Effect	NN	O	effect	_	0	SENT_479	[p24l657t2269r801b2320],
2	of	IN	O	of	_	0	SENT_479	[p24l815t2269r870b2320],
3	nesiritide	NN	O	nesiritide	prep_of	1	SENT_479	[p24l881t2270r1122b2320],
4	in	IN	O	in	_	0	SENT_479	[p24l1138t2272r1180b2319],
5	patients	NNS	O	patient	prep_in	1	SENT_479	[p24l1199t2272r1408b2332],
6	with	IN	O	with	_	0	SENT_479	[p24l1422t2270r1535b2320],
7	acute	JJ	O	acute	amod	8	SENT_479	[p24l1552t2277r1695b2320],
8	decompensated	JJ	O	decompensated	amod	10	SENT_479	[p24l1709t2270r2135b2332],
9	heart	NN	O	heart	nn	10	SENT_479	[p24l131t2347r267b2397],
10	failure	NN	O	failure	prep_with	5	SENT_479	[p24l279t2346r455b2397],
11	.	.	O	.	_	0	SENT_479	[p24l279t2346r455b2397],

1	N.	NNP	O	N.	nn	2	SENT_480	[p24l469t2349r517b2397],
2	Engl	NNP	O	Engl	_	0	SENT_480	[p24l532t2347r650b2410],
3	.	.	O	.	_	0	SENT_480	[p24l532t2347r650b2410],

1	J.	NNP	O	J.	nn	2	SENT_481	[p24l661t2349r695b2397],
2	Med	NNP	O	Med	_	0	SENT_481	[p24l709t2347r832b2397],
3	.	.	O	.	_	0	SENT_481	[p24l709t2347r832b2397],

1	365	CD	NUMBER	365	_	0	SENT_482	[p24l846t2350r961b2405],
2	,	,	O	,	_	0	SENT_482	[p24l846t2350r961b2405],
3	32-43	CD	NUMBER	32-43	num	4	SENT_482	[p24l977t2350r1133b2397],
4	(	NN	O	(	appos	1	SENT_482	[p24l1151t2348r1251b2404],
5	201	CD	NUMBER	201	number	6	SENT_482	[p24l1151t2348r1251b2404],
6	1	CD	NUMBER	1	num	7	SENT_482	[p24l1269t2348r1325b2404],
7	)	NN	O	)	dep	4	SENT_482	[p24l1269t2348r1325b2404],
8	.	.	O	.	_	0	SENT_482	[p24l1269t2348r1325b2404],

1	Packer	NNP	PERSON	Packer	_	0	SENT_483	[p24l130t2425r307b2483],
2	,	,	O	,	_	0	SENT_483	[p24l130t2425r307b2483],
3	M.	NNP	O	M.	nn	4	SENT_483	[p24l323t2427r382b2475],
4	etal	NNP	O	etal	appos	1	SENT_483	[p24l396t2425r508b2475],
5	.	.	O	.	_	0	SENT_483	[p24l396t2425r508b2475],

1	Effect	NN	O	effect	nsubj	12	SENT_484	[p24l527t2424r672b2475],
2	of	IN	O	of	_	0	SENT_484	[p24l685t2424r740b2475],
3	oral	JJ	O	oral	amod	4	SENT_484	[p24l749t2425r844b2475],
4	milrinone	NN	O	milrinone	prep_of	1	SENT_484	[p24l863t2425r1113b2475],
5	on	IN	O	on	_	0	SENT_484	[p24l1128t2440r1192b2475],
6	mortality	NN	O	mortality	prep_on	4	SENT_484	[p24l1210t2425r1450b2489],
7	in	IN	O	in	_	0	SENT_484	[p24l1464t2427r1507b2474],
8	severe	JJ	O	severe	amod	11	SENT_484	[p24l1524t2440r1691b2475],
9	chronic	JJ	O	chronic	amod	11	SENT_484	[p24l1705t2425r1899b2475],
10	heart	NN	O	heart	nn	11	SENT_484	[p24l1915t2425r2051b2475],
11	fai	NNS	O	faus	prep_in	6	SENT_484	[p24l127t2502r409b2553],
12	|	VBP	O	|	_	0	SENT_484	[p24l127t2502r409b2553],
13	ure	NN	O	ure	dobj	12	SENT_484	[p24l127t2502r409b2553],
14	.	.	O	.	_	0	SENT_484	[p24l127t2502r409b2553],

1	The	DT	O	the	det	3	SENT_485	[p24l127t2502r409b2553],
2	PROMISE	NNP	O	PROMISE	nn	3	SENT_485	[p24l427t2505r662b2553],
3	Study	NNP	O	Study	_	0	SENT_485	[p24l677t2503r827b2567],
4	Research	NNP	O	Research	nn	5	SENT_485	[p24l842t2503r1072b2553],
5	Group	NNP	O	Group	dep	3	SENT_485	[p24l1088t2505r1264b2565],
6	.	.	O	.	_	0	SENT_485	[p24l1088t2505r1264b2565],

1	N.	NNP	MISC	N.	nn	2	SENT_486	[p24l1278t2505r1326b2553],
2	EngI	NNP	MISC	EngI	_	0	SENT_486	[p24l1341t2503r1504b2566],
3	.	.	O	.	_	0	SENT_486	[p24l1341t2503r1504b2566],

1	J.	NNP	O	J.	nn	2	SENT_487	[p24l1341t2503r1504b2566],
2	Med	NNP	O	Med	_	0	SENT_487	[p24l1518t2503r1641b2553],
3	.	.	O	.	_	0	SENT_487	[p24l1518t2503r1641b2553],

1	325	CD	NUMBER	325	_	0	SENT_488	[p24l1655t2506r1770b2560],
2	,	,	O	,	_	0	SENT_488	[p24l1655t2506r1770b2560],
3	1468-1475	CD	DATE	1468-1475	number	4	SENT_488	[p24l1789t2506r2072b2553],
4	(	CD	NUMBER	(	appos	1	SENT_488	[p24l131t2581r304b2637],
5	1991	CD	DATE	1991	num	6	SENT_488	[p24l131t2581r304b2637],
6	)	NN	O	)	dep	4	SENT_488	[p24l131t2581r304b2637],
7	.	.	O	.	_	0	SENT_488	[p24l131t2581r304b2637],

1	O'Connor	NNP	PERSON	O'Connor	nn	3	SENT_489	[p24l127t2658r386b2714],
2	,	,	O	,	_	0	SENT_489	[p24l127t2658r386b2714],
3	C.M.	NNP	O	C.M.	_	0	SENT_489	[p24l401t2659r512b2706],
4	et	FW	O	et	nn	5	SENT_489	[p24l526t2665r575b2706],
5	al.	FW	O	al.	dep	3	SENT_489	[p24l584t2657r638b2706],
6	.	.	O	.	_	0	SENT_489	[p24l584t2657r638b2706],

1	Continuous	JJ	O	continuous	amod	3	SENT_490	[p24l654t2659r958b2706],
2	intravenous	JJ	O	intravenous	amod	3	SENT_490	[p24l975t2659r1283b2706],
3	dobutamine	NN	O	dobutamine	nsubjpass	5	SENT_490	[p24l1298t2657r1623b2706],
4	is	VBZ	O	be	auxpass	5	SENT_490	[p24l1639t2659r1673b2706],
5	associated	VBN	O	associate	_	0	SENT_490	[p24l1688t2657r1960b2706],
6	with	IN	O	with	_	0	SENT_490	[p24l1976t2657r2089b2706],
7	an	DT	O	a	det	9	SENT_490	[p24l129t2750r189b2785],
8	increased	VBN	O	increase	amod	9	SENT_490	[p24l207t2735r454b2785],
9	risk	NN	O	risk	prep_with	5	SENT_490	[p24l472t2735r559b2785],
10	of	IN	O	of	_	0	SENT_490	[p24l572t2734r626b2785],
11	death	NN	O	death	prep_of	9	SENT_490	[p24l636t2735r784b2785],
12	in	IN	O	in	_	0	SENT_490	[p24l803t2737r845b2784],
13	patients	NNS	O	patient	prep_in	11	SENT_490	[p24l864t2737r1073b2797],
14	with	IN	O	with	_	0	SENT_490	[p24l1087t2735r1200b2785],
15	advanced	JJ	O	advanced	amod	17	SENT_490	[p24l1216t2735r1470b2785],
16	heart	NN	O	heart	nn	17	SENT_490	[p24l1488t2735r1624b2785],
17	failure	NN	O	failure	prep_with	13	SENT_490	[p24l1636t2734r1813b2785],
18	:	:	O	:	_	0	SENT_490	[p24l1636t2734r1813b2785],
19	insights	NNS	O	insight	dep	31	SENT_490	[p24l1829t2735r2030b2798],
20	from	IN	O	from	_	0	SENT_490	[p24l127t2811r250b2861],
21	the	DT	O	the	det	23	SENT_490	[p24l265t2812r351b2861],
22	Flolan	NNP	O	Flolan	nn	23	SENT_490	[p24l367t2812r520b2861],
23	International	NNP	O	International	prep_from	19	SENT_490	[p24l539t2812r872b2861],
24	Randomized	NNP	O	Randomized	nn	31	SENT_490	[p24l891t2812r1218b2861],
25	Survival	NNP	O	Survival	nn	31	SENT_490	[p24l1234t2812r1438b2861],
26	Trial	NNP	O	Trial	nn	31	SENT_490	[p24l1450t2812r1556b2861],
27	(	CD	NUMBER	(	num	31	SENT_490	[p24l1575t2813r1875b2868],
28	F	NN	O	f	nn	31	SENT_490	[p24l1575t2813r1875b2868],
29	|	CD	NUMBER	|	num	31	SENT_490	[p24l1575t2813r1875b2868],
30	RST	NN	O	rst	nn	31	SENT_490	[p24l1575t2813r1875b2868],
31	)	NN	O	)	parataxis	5	SENT_490	[p24l1575t2813r1875b2868],
32	.	.	O	.	_	0	SENT_490	[p24l1575t2813r1875b2868],

1	Am	NNP	O	Am	_	0	SENT_491	[p24l1575t2813r1875b2868],
2	.	.	O	.	_	0	SENT_491	[p24l1575t2813r1875b2868],

1	HeartJ	NN	O	heartj	_	0	SENT_492	[p24l1890t2814r2075b2861],
2	.	.	O	.	_	0	SENT_492	[p24l1890t2814r2075b2861],

1	138	CD	NUMBER	138	num	2	SENT_493	[p24l132t2890r272b2945],
2	(	NN	O	(	_	0	SENT_493	[p24l132t2890r272b2945],
3	1	CD	NUMBER	1	num	4	SENT_493	[p24l132t2890r272b2945],
4	Pt	NN	O	pt	dep	2	SENT_493	[p24l299t2891r348b2938],
5	1	CD	NUMBER	1	num	6	SENT_493	[p24l366t2890r422b2946],
6	)	NN	O	)	dep	2	SENT_493	[p24l366t2890r422b2946],
7	,	,	O	,	_	0	SENT_493	[p24l366t2890r422b2946],
8	78-86	CD	NUMBER	78-86	number	9	SENT_493	[p24l437t2892r595b2938],
9	(	CD	NUMBER	(	appos	6	SENT_493	[p24l611t2890r785b2945],
10	1999	CD	DATE	1999	num	11	SENT_493	[p24l611t2890r785b2945],
11	)	NN	O	)	dep	9	SENT_493	[p24l611t2890r785b2945],
12	.	.	O	.	_	0	SENT_493	[p24l611t2890r785b2945],

1	Haikala	NNP	PERSON	Haikala	nn	21	SENT_494	[p24l130t2967r331b3024],
2	,	,	O	,	_	0	SENT_494	[p24l130t2967r331b3024],
3	H.	NNP	O	H.	appos	21	SENT_494	[p24l347t2969r409b3025],
4	,	,	O	,	_	0	SENT_494	[p24l347t2969r409b3025],
5	Kaivola	NNP	LOCATION	Kaivola	appos	21	SENT_494	[p24l426t2967r624b3024],
6	,	,	O	,	_	0	SENT_494	[p24l426t2967r624b3024],
7	J.	NNP	O	J.	appos	21	SENT_494	[p24l636t2969r683b3024],
8	,	,	O	,	_	0	SENT_494	[p24l636t2969r683b3024],
9	Nissinen	NNP	PERSON	Nissinen	appos	21	SENT_494	[p24l700t2969r932b3025],
10	,	,	O	,	_	0	SENT_494	[p24l700t2969r932b3025],
11	E.	NNP	O	E.	appos	21	SENT_494	[p24l949t2969r1000b3024],
12	,	,	O	,	_	0	SENT_494	[p24l949t2969r1000b3024],
13	Wall	NNP	O	Wall	appos	21	SENT_494	[p24l1010t2967r1132b3024],
14	,	,	O	,	_	0	SENT_494	[p24l1010t2967r1132b3024],
15	P.	NNP	O	P.	appos	21	SENT_494	[p24l1150t2969r1194b3024],
16	,	,	O	,	_	0	SENT_494	[p24l1150t2969r1194b3024],
17	Levijoki	NNP	PERSON	Levijoki	appos	21	SENT_494	[p24l1211t2967r1420b3030],
18	,	,	O	,	_	0	SENT_494	[p24l1211t2967r1420b3030],
19	J.	NNP	O	J.	appos	21	SENT_494	[p24l1433t2969r1479b3024],
20	,	,	O	,	_	0	SENT_494	[p24l1433t2969r1479b3024],
21	Linden	NNP	PERSON	Linden	_	0	SENT_494	[p24l1496t2967r1686b3024],
22	,	,	O	,	_	0	SENT_494	[p24l1496t2967r1686b3024],
23	|	CD	NUMBER	|	appos	21	SENT_494	[p24l1703t2969r1772b3017],
24	.	.	O	.	_	0	SENT_494	[p24l1703t2969r1772b3017],

1	B.	NNP	O	B.	nn	4	SENT_495	[p24l1703t2969r1772b3017],
2	Cardiac	JJ	O	cardiac	amod	4	SENT_495	[p24l1786t2967r1980b3017],
3	troponin	NN	O	troponin	nn	4	SENT_495	[p24l128t3047r355b3107],
4	C	NN	O	c	_	0	SENT_495	[p24l372t3047r405b3095],
5	as	IN	O	as	_	0	SENT_495	[p24l419t3060r472b3095],
6	a	DT	O	a	det	8	SENT_495	[p24l486t3060r511b3095],
7	target	NN	O	target	nn	8	SENT_495	[p24l526t3053r685b3108],
8	protein	NN	O	protein	prep_as	4	SENT_495	[p24l700t3047r886b3107],
9	for	IN	O	for	_	0	SENT_495	[p24l902t3044r974b3095],
10	a	DT	O	a	det	12	SENT_495	[p24l987t3060r1012b3095],
11	novel	JJ	O	novel	amod	12	SENT_495	[p24l1030t3045r1169b3095],
12	calcium	NN	O	calcium	prep_for	8	SENT_495	[p24l1185t3045r1385b3095],
13	sensitizing	VBG	O	sensitize	partmod	4	SENT_495	[p24l1402t3047r1677b3108],
14	drug	NN	O	drug	nn	17	SENT_495	[p24l1693t3045r1829b3108],
15	,	,	O	,	_	0	SENT_495	[p24l1693t3045r1829b3108],
16	|	NN	O	|	dep	17	SENT_495	[p24l131t3122r557b3171],
17	evosimendan	NN	O	evosimendan	dobj	13	SENT_495	[p24l131t3122r557b3171],
18	.	.	O	.	_	0	SENT_495	[p24l131t3122r557b3171],

1	J.	NNP	O	J.	nn	2	SENT_496	[p24l131t3122r557b3171],
2	Mol	NNP	O	Mol	_	0	SENT_496	[p24l570t3122r676b3171],
3	.	.	O	.	_	0	SENT_496	[p24l570t3122r676b3171],

1	Cell	NN	O	cell	_	0	SENT_497	[p24l691t3122r783b3171],
2	Cardiol	NN	O	cardiol	dep	1	SENT_497	[p24l793t3122r985b3171],
3	.	.	O	.	_	0	SENT_497	[p24l793t3122r985b3171],

1	27	CD	NUMBER	27	_	0	SENT_498	[p24l1000t3125r1079b3179],
2	,	,	O	,	_	0	SENT_498	[p24l1000t3125r1079b3179],
3	1859-1866	CD	DATE	1859-1866	number	4	SENT_498	[p24l1098t3125r1383b3171],
4	(	CD	NUMBER	(	appos	1	SENT_498	[p24l1399t3123r1573b3179],
5	1995	CD	DATE	1995	num	6	SENT_498	[p24l1399t3123r1573b3179],
6	)	NN	O	)	dep	4	SENT_498	[p24l1399t3123r1573b3179],
7	.	.	O	.	_	0	SENT_498	[p24l1399t3123r1573b3179],

1	Pollesello	NNP	O	Pollesello	_	0	SENT_499	[p24l130t3200r385b3257],
2	,	,	O	,	_	0	SENT_499	[p24l130t3200r385b3257],
3	P.	NNP	O	P.	nn	4	SENT_499	[p24l402t3202r434b3250],
4	etal	NN	O	etal	appos	1	SENT_499	[p24l448t3200r560b3250],
5	.	.	O	.	_	0	SENT_499	[p24l448t3200r560b3250],

1	Binding	NN	O	binding	_	0	SENT_500	[p24l579t3200r777b3263],
2	of	IN	O	of	_	0	SENT_500	[p24l793t3199r848b3250],
3	a	DT	O	a	det	5	SENT_500	[p24l858t3215r883b3250],
4	new	JJ	O	new	amod	5	SENT_500	[p24l901t3215r1011b3250],
5	Ca2	NN	O	ca2	prep_of	1	SENT_500	[p24l1024t3202r1158b3250],
6	+	CC	O	+	_	0	SENT_500	[p24l1024t3202r1158b3250],
7	sensitizer	NN	O	sensitizer	conj_+	1	SENT_500	[p24l1173t3202r1426b3257],
8	,	,	O	,	_	0	SENT_500	[p24l1173t3202r1426b3257],
9	Ievosimendan	NN	LOCATION	ievosimendan	appos	7	SENT_500	[p24l1442t3200r1824b3257],
10	,	,	O	,	_	0	SENT_500	[p24l1442t3200r1824b3257],
11	to	TO	O	to	conj_+	1	SENT_500	[p24l1836t3208r1890b3250],
12	recombinant	JJ	O	recombinant	amod	17	SENT_500	[p24l131t3278r467b3328],
13	human	JJ	O	human	amod	17	SENT_500	[p24l483t3278r665b3328],
14	cardiac	JJ	O	cardiac	amod	17	SENT_500	[p24l681t3278r867b3328],
15	troponin	NN	O	troponin	nn	17	SENT_500	[p24l880t3280r1108b3340],
16	C.	NNP	O	C.	nn	17	SENT_500	[p24l1124t3280r1171b3328],
17	A	NNP	O	A	pobj	11	SENT_500	[p24l1185t3280r1221b3327],
18	molecular	JJ	O	molecular	amod	19	SENT_500	[p24l1237t3278r1497b3328],
19	modelling	NN	O	modelling	dep	1	SENT_500	[p24l1512t3278r1790b3341],
20	,	,	O	,	_	0	SENT_500	[p24l1512t3278r1790b3341],
21	ﬂuorescence	NN	O	ﬂuorescence	nn	22	SENT_500	[p24l1803t3277r2137b3328],
22	probe	NN	O	probe	conj_and	19	SENT_500	[p24l131t3356r297b3419],
23	,	,	O	,	_	0	SENT_500	[p24l131t3356r297b3419],
24	and	CC	O	and	_	0	SENT_500	[p24l311t3356r407b3406],
25	proton	NN	O	proton	nn	29	SENT_500	[p24l426t3364r600b3418],
26	nuclear	JJ	O	nuclear	amod	29	SENT_500	[p24l618t3356r811b3406],
27	magnetic	JJ	O	magnetic	amod	29	SENT_500	[p24l826t3358r1072b3419],
28	resonance	NN	O	resonance	nn	29	SENT_500	[p24l1088t3371r1355b3406],
29	study	NN	O	study	conj_and	19	SENT_500	[p24l1370t3356r1524b3420],
30	.	.	O	.	_	0	SENT_500	[p24l1370t3356r1524b3420],

1	J.	NNP	O	J.	nn	2	SENT_501	[p24l1534t3358r1568b3406],
2	Biol	NNP	O	Biol	_	0	SENT_501	[p24l1583t3356r1685b3406],
3	.	.	O	.	_	0	SENT_501	[p24l1583t3356r1685b3406],

1	Chem	NNP	O	Chem	_	0	SENT_502	[p24l1701t3356r1859b3406],
2	.	.	O	.	_	0	SENT_502	[p24l1701t3356r1859b3406],

1	269	CD	NUMBER	269	_	0	SENT_503	[p24l1874t3359r1989b3413],
2	,	,	O	,	_	0	SENT_503	[p24l1874t3359r1989b3413],
3	28584-28590	CD	NUMBER	28584-28590	number	4	SENT_503	[p24l129t3436r483b3482],
4	(	CD	NUMBER	(	appos	1	SENT_503	[p24l500t3434r674b3489],
5	1994	CD	DATE	1994	num	6	SENT_503	[p24l500t3434r674b3489],
6	)	NN	O	)	dep	4	SENT_503	[p24l500t3434r674b3489],
7	.	.	O	.	_	0	SENT_503	[p24l500t3434r674b3489],

1	30	CD	NUMBER	30	_	0	SENT_504	[p25l6t20r80b67],
2	.	.	O	.	_	0	SENT_504	[p25l6t20r80b67],

1	Yokoshiki	NNP	PERSON	Yokoshiki	nsubj	24	SENT_505	[p25l126t17r387b75],
2	,	,	O	,	_	0	SENT_505	[p25l126t17r387b75],
3	H.	NNP	O	H.	nsubj	24	SENT_505	[p25l404t19r465b75],
4	,	,	O	,	_	0	SENT_505	[p25l404t19r465b75],
5	Katsube	NNP	PERSON	Katsube	nsubj	24	SENT_505	[p25l482t17r765b75],
6	,	,	O	,	_	0	SENT_505	[p25l482t17r765b75],
7	Y.	NNP	O	Y.	nsubj	24	SENT_505	[p25l482t17r765b75],
8	,	,	O	,	_	0	SENT_505	[p25l482t17r765b75],
9	Sunagawa	NNP	PERSON	Sunagawa	nsubj	24	SENT_505	[p25l780t19r1065b80],
10	,	,	O	,	_	0	SENT_505	[p25l780t19r1065b80],
11	M.	NNP	ORGANIZATION	M.	nsubj	24	SENT_505	[p25l1080t19r1140b67],
12	&	CC	ORGANIZATION	&	_	0	SENT_505	[p25l1154t19r1190b67],
13	Sperelakis	NNP	ORGANIZATION	Sperelakis	nsubj	24	SENT_505	[p25l1204t17r1479b79],
14	,	,	O	,	_	0	SENT_505	[p25l1204t17r1479b79],
15	N.	NNP	PERSON	N.	nn	16	SENT_505	[p25l1497t19r1545b67],
16	Levosimendan	NNP	PERSON	Levosimendan	appos	1	SENT_505	[p25l1562t17r1957b75],
17	,	,	O	,	_	0	SENT_505	[p25l1562t17r1957b75],
18	a	DT	O	a	det	20	SENT_505	[p25l1972t32r1997b67],
19	novel	JJ	O	novel	amod	20	SENT_505	[p25l131t95r269b145],
20	Ca2	NN	O	ca2	appos	1	SENT_505	[p25l286t97r420b145],
21	+	CC	O	+	_	0	SENT_505	[p25l286t97r420b145],
22	sensitizer	NN	O	sensitizer	appos	1	SENT_505	[p25l435t97r687b152],
23	,	,	O	,	_	0	SENT_505	[p25l435t97r687b152],
24	activates	VBZ	O	activate	_	0	SENT_505	[p25l702t97r932b145],
25	the	DT	O	the	det	31	SENT_505	[p25l945t95r1031b145],
26	g	NN	O	g	nn	31	SENT_505	[p25l1046t95r1672b158],
27	|	NN	O	|	nn	31	SENT_505	[p25l1046t95r1672b158],
28	ibenc	NN	O	ibenc	nn	31	SENT_505	[p25l1046t95r1672b158],
29	|	NN	O	|	nn	31	SENT_505	[p25l1046t95r1672b158],
30	amide	NN	O	amide	nn	31	SENT_505	[p25l1046t95r1672b158],
31	—	NN	O	—	dobj	24	SENT_505	[p25l1046t95r1672b158],
32	sensitive	JJ	O	sensitive	amod	33	SENT_505	[p25l1046t95r1672b158],
33	K	NN	O	k	dep	31	SENT_505	[p25l1688t97r1755b144],
34	+	CC	O	+	_	0	SENT_505	[p25l1688t97r1755b144],
35	channel	NN	O	channel	conj_+	31	SENT_505	[p25l1769t95r1975b145],
36	in	IN	O	in	_	0	SENT_505	[p25l1994t97r2036b144],
37	rat	NN	O	rat	nn	39	SENT_505	[p25l2055t103r2121b145],
38	arterial	JJ	O	arterial	amod	39	SENT_505	[p25l129t173r309b223],
39	myocytes	NNS	O	myocyte	prep_in	35	SENT_505	[p25l328t181r588b237],
40	.	.	O	.	_	0	SENT_505	[p25l328t181r588b237],

1	Eur	NNP	O	Eur	_	0	SENT_506	[p25l603t175r691b223],
2	.	.	O	.	_	0	SENT_506	[p25l603t175r691b223],

1	J.	NNP	PERSON	J.	nn	2	SENT_507	[p25l702t175r736b223],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_507	[p25l751t173r1039b223],
3	.	.	O	.	_	0	SENT_507	[p25l751t173r1039b223],

1	333	CD	NUMBER	333	_	0	SENT_508	[p25l1053t176r1169b230],
2	,	,	O	,	_	0	SENT_508	[p25l1053t176r1169b230],
3	249-259	CD	NUMBER	249-259	num	4	SENT_508	[p25l1183t176r1407b223],
4	(	NN	O	(	appos	1	SENT_508	[p25l1423t174r1458b230],
5	1	CD	NUMBER	1	number	6	SENT_508	[p25l1423t174r1458b230],
6	997	CD	NUMBER	997	num	7	SENT_508	[p25l1473t174r1597b230],
7	)	NN	O	)	dep	4	SENT_508	[p25l1473t174r1597b230],
8	.	.	O	.	_	0	SENT_508	[p25l1473t174r1597b230],

1	Kersten	NNP	PERSON	Kersten	nn	14	SENT_509	[p25l130t253r336b308],
2	,	,	O	,	_	0	SENT_509	[p25l130t253r336b308],
3	J.R.	NNP	PERSON	J.R.	conj_and	1	SENT_509	[p25l349t253r443b308],
4	,	,	O	,	_	0	SENT_509	[p25l349t253r443b308],
5	Montgomery	NNP	LOCATION	Montgomery	nn	14	SENT_509	[p25l459t253r815b315],
6	,	,	O	,	_	0	SENT_509	[p25l459t253r815b315],
7	M.W.	NNP	LOCATION	M.W.	nn	14	SENT_509	[p25l831t253r966b309],
8	,	,	O	,	_	0	SENT_509	[p25l831t253r966b309],
9	Pagel	NNP	PERSON	Pagel	nn	14	SENT_509	[p25l983t251r1135b314],
10	,	,	O	,	_	0	SENT_509	[p25l983t251r1135b314],
11	P.S.	NNP	O	P.S.	conj_and	1	SENT_509	[p25l1152t253r1227b301],
12	&	CC	O	&	_	0	SENT_509	[p25l1241t251r1501b308],
13	War	NNP	O	War	conj_and	1	SENT_509	[p25l1241t251r1501b308],
14	|	NNP	O	|	tmod	26	SENT_509	[p25l1241t251r1501b308],
15	tier	NN	O	tier	dep	14	SENT_509	[p25l1241t251r1501b308],
16	,	,	O	,	_	0	SENT_509	[p25l1241t251r1501b308],
17	D.C.	NNP	LOCATION	D.C.	nn	18	SENT_509	[p25l1518t253r1615b301],
18	Levosimendan	NNP	LOCATION	Levosimendan	nsubj	26	SENT_509	[p25l1632t251r2027b308],
19	,	,	O	,	_	0	SENT_509	[p25l1632t251r2027b308],
20	a	DT	O	a	det	24	SENT_509	[p25l2041t266r2067b301],
21	new	JJ	O	new	amod	24	SENT_509	[p25l131t344r240b379],
22	positive	JJ	O	positive	amod	23	SENT_509	[p25l256t331r458b391],
23	inotropic	JJ	O	inotropic	amod	24	SENT_509	[p25l474t331r710b391],
24	drug	NN	O	drug	appos	18	SENT_509	[p25l724t329r860b392],
25	,	,	O	,	_	0	SENT_509	[p25l724t329r860b392],
26	decreases	VBZ	O	decrease	_	0	SENT_509	[p25l874t329r1131b379],
27	myocardial	JJ	O	myocardial	amod	29	SENT_509	[p25l1148t329r1432b393],
28	infarct	NN	O	infarct	nn	29	SENT_509	[p25l1451t328r1616b379],
29	size	NN	O	size	nsubj	37	SENT_509	[p25l1630t331r1724b379],
30	via	IN	O	via	_	0	SENT_509	[p25l1737t331r1809b379],
31	activation	NN	O	activation	prep_via	29	SENT_509	[p25l1825t331r2081b379],
32	of	IN	O	of	_	0	SENT_509	[p25l2098t328r2153b379],
33	K	NNP	O	K	prep_of	31	SENT_509	[p25l131t408r292b465],
34	(	CD	NUMBER	(	num	33	SENT_509	[p25l131t408r292b465],
35	ATP	NN	ORGANIZATION	atp	nn	37	SENT_509	[p25l131t408r292b465],
36	)	NN	O	)	nn	37	SENT_509	[p25l131t408r292b465],
37	channe	NN	O	channe	xcomp	26	SENT_509	[p25l309t407r929b470],
38	|	CD	NUMBER	|	num	40	SENT_509	[p25l309t407r929b470],
39	s.	NN	O	s.	nn	40	SENT_509	[p25l309t407r929b470],
40	Anesth	NNP	O	Anesth	dep	37	SENT_509	[p25l309t407r929b470],
41	.	.	O	.	_	0	SENT_509	[p25l309t407r929b470],

1	AnaIg	NN	O	anaig	_	0	SENT_510	[p25l309t407r929b470],
2	.	.	O	.	_	0	SENT_510	[p25l309t407r929b470],

1	90	CD	NUMBER	90	_	0	SENT_511	[p25l943t411r1023b465],
2	,	,	O	,	_	0	SENT_511	[p25l943t411r1023b465],
3	5-1	CD	NUMBER	5-1	appos	1	SENT_511	[p25l1038t411r1121b457],
4	1	CD	NUMBER	1	number	5	SENT_511	[p25l1139t411r1154b456],
5	(	CD	NUMBER	(	dep	3	SENT_511	[p25l1180t408r1354b465],
6	2000	CD	DATE	2000	num	7	SENT_511	[p25l1180t408r1354b465],
7	)	NN	O	)	dep	5	SENT_511	[p25l1180t408r1354b465],
8	.	.	O	.	_	0	SENT_511	[p25l1180t408r1354b465],

1	Moiseyev	NNP	PERSON	Moiseyev	nn	4	SENT_512	[p25l129t488r384b549],
2	,	,	O	,	_	0	SENT_512	[p25l129t488r384b549],
3	V.S.	NNP	O	V.S.	appos	4	SENT_512	[p25l394t487r482b535],
4	etal.	NNP	O	etal.	_	0	SENT_512	[p25l496t485r623b543],
5	;	:	O	;	_	0	SENT_512	[p25l496t485r623b543],
6	RUSSLAN	NNP	O	RUSSLAN	nn	8	SENT_512	[p25l640t487r880b535],
7	Study	NNP	O	Study	nn	8	SENT_512	[p25l898t485r1049b549],
8	Investigators	NNS	O	investigator	dep	4	SENT_512	[p25l1064t488r1410b548],
9	.	.	O	.	_	0	SENT_512	[p25l1064t488r1410b548],

1	Safety	NN	O	safety	_	0	SENT_513	[p25l1425t485r1586b549],
2	and	CC	O	and	_	0	SENT_513	[p25l1599t485r1695b535],
3	efﬁcacy	NN	O	efﬁcacy	conj_and	1	SENT_513	[p25l1711t485r1912b549],
4	of	IN	O	of	_	0	SENT_513	[p25l1925t485r1979b535],
5	a	DT	O	a	det	8	SENT_513	[p25l1989t500r2014b535],
6	novel	JJ	O	novel	amod	8	SENT_513	[p25l131t563r269b613],
7	calcium	NN	O	calcium	nn	8	SENT_513	[p25l286t563r485b613],
8	sensitizer	NN	O	sensitizer	prep_of	1	SENT_513	[p25l503t566r755b621],
9	,	,	O	,	_	0	SENT_513	[p25l503t566r755b621],
10	levosimendan	NN	O	levosimendan	appos	8	SENT_513	[p25l772t563r1153b621],
11	,	,	O	,	_	0	SENT_513	[p25l772t563r1153b621],
12	in	IN	O	in	_	0	SENT_513	[p25l1169t566r1212b612],
13	patients	NNS	O	patient	prep_in	1	SENT_513	[p25l1230t566r1440b626],
14	with	IN	O	with	_	0	SENT_513	[p25l1453t563r1567b613],
15	left	JJ	O	left	amod	17	SENT_513	[p25l1585t563r1667b613],
16	ventricular	JJ	O	ventricular	amod	17	SENT_513	[p25l1679t563r1962b613],
17	failure	NN	O	failure	prep_with	13	SENT_513	[p25l1974t563r2137b613],
18	due	JJ	O	due	_	0	SENT_513	[p25l129t641r228b691],
19	to	TO	O	to	_	0	SENT_513	[p25l241t649r294b691],
20	an	DT	O	a	det	23	SENT_513	[p25l308t656r368b691],
21	acute	JJ	O	acute	amod	23	SENT_513	[p25l385t649r528b691],
22	myocardial	JJ	O	myocardial	amod	23	SENT_513	[p25l544t641r828b705],
23	infarction	NN	O	infarction	prep_due_to	1	SENT_513	[p25l847t641r1109b691],
24	.	.	O	.	_	0	SENT_513	[p25l847t641r1109b691],

1	A	DT	O	a	nsubj	6	SENT_514	[p25l1123t644r1159b690],
2	randomized	VBN	O	randomize	amod	1	SENT_514	[p25l1175t641r1502b699],
3	,	,	O	,	_	0	SENT_514	[p25l1175t641r1502b699],
4	placebo	NN	O	placebo	nn	5	SENT_514	[p25l1518t641r2031b704],
5	—	NN	O	—	nsubj	6	SENT_514	[p25l1518t641r2031b704],
6	controlled	VBN	O	control	partmod	14	SENT_514	[p25l1518t641r2031b704],
7	,	,	O	,	_	0	SENT_514	[p25l1518t641r2031b704],
8	double	JJ	O	double	amod	11	SENT_514	[p25l129t719r470b769],
9	—	RB	O	—	advmod	10	SENT_514	[p25l129t719r470b769],
10	blind	JJ	O	blind	amod	11	SENT_514	[p25l129t719r470b769],
11	study	NN	O	study	nsubj	14	SENT_514	[p25l487t719r631b783],
12	(	CD	NUMBER	(	amod	11	SENT_514	[p25l646t720r939b777],
13	RUSSLAN	NNP	O	RUSSLAN	dep	14	SENT_514	[p25l646t720r939b777],
14	)	CD	NUMBER	)	_	0	SENT_514	[p25l646t720r939b777],
15	.	.	O	.	_	0	SENT_514	[p25l646t720r939b777],

1	Eur	NNP	O	Eur	_	0	SENT_515	[p25l953t722r1041b769],
2	.	.	O	.	_	0	SENT_515	[p25l953t722r1041b769],

1	Heart	NNP	O	Heart	_	0	SENT_516	[p25l1056t722r1242b769],
2	}	NN	O	}	dep	1	SENT_516	[p25l1056t722r1242b769],
3	.	.	O	.	_	0	SENT_516	[p25l1056t722r1242b769],

1	23	CD	NUMBER	23	_	0	SENT_517	[p25l1256t722r1335b777],
2	,	,	O	,	_	0	SENT_517	[p25l1256t722r1335b777],
3	1422-1432	CD	DATE	1422-1432	number	4	SENT_517	[p25l1355t722r1639b769],
4	(	CD	NUMBER	(	appos	1	SENT_517	[p25l1656t720r1830b777],
5	2002	CD	DATE	2002	num	6	SENT_517	[p25l1656t720r1830b777],
6	)	NN	O	)	dep	4	SENT_517	[p25l1656t720r1830b777],
7	.	.	O	.	_	0	SENT_517	[p25l1656t720r1830b777],

1	Nieminen	NNP	PERSON	Nieminen	_	0	SENT_518	[p25l129t800r396b855],
2	,	,	O	,	_	0	SENT_518	[p25l129t800r396b855],
3	M.S.	NNP	LOCATION	M.S.	nn	4	SENT_518	[p25l412t799r516b847],
4	etal	NNP	O	etal	appos	1	SENT_518	[p25l530t797r642b847],
5	.	.	O	.	_	0	SENT_518	[p25l530t797r642b847],

1	Hemodynamic	JJ	O	hemodynamic	amod	4	SENT_519	[p25l660t797r1045b861],
2	and	CC	O	and	_	0	SENT_519	[p25l1059t797r1155b847],
3	neurohumoral	JJ	O	neurohumoral	conj_and	1	SENT_519	[p25l1174t797r1548b847],
4	effects	NNS	O	effect	_	0	SENT_519	[p25l1565t797r1736b847],
5	of	IN	O	of	_	0	SENT_519	[p25l1751t797r1805b847],
6	continuous	JJ	O	continuous	amod	7	SENT_519	[p25l1815t800r2110b847],
7	infusion	NN	O	infusion	prep_of	4	SENT_519	[p25l130t875r336b925],
8	of	IN	O	of	_	0	SENT_519	[p25l353t875r407b925],
9	levosimendan	NN	O	levosimendan	prep_of	4	SENT_519	[p25l419t875r785b925],
10	in	IN	O	in	_	0	SENT_519	[p25l804t878r846b924],
11	patients	NNS	O	patient	prep_in	4	SENT_519	[p25l864t878r1074b938],
12	with	IN	O	with	_	0	SENT_519	[p25l1088t875r1201b925],
13	congestive	JJ	O	congestive	amod	15	SENT_519	[p25l1217t878r1502b938],
14	heart	NN	O	heart	nn	15	SENT_519	[p25l1519t875r1655b925],
15	failure	NN	O	failure	prep_with	11	SENT_519	[p25l1667t875r1843b925],
16	.	.	O	.	_	0	SENT_519	[p25l1667t875r1843b925],

1	J.	NNP	O	J.	nn	2	SENT_520	[p25l1853t878r1998b925],
2	Am	NNP	O	Am	_	0	SENT_520	[p25l1853t878r1998b925],
3	.	.	O	.	_	0	SENT_520	[p25l1853t878r1998b925],

1	Coll	NNP	PERSON	Coll	_	0	SENT_521	[p25l2014t875r2117b925],
2	.	.	O	.	_	0	SENT_521	[p25l2014t875r2117b925],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_522	[p25l129t952r321b1001],
2	.	.	O	.	_	0	SENT_522	[p25l129t952r321b1001],

1	36	CD	NUMBER	36	_	0	SENT_523	[p25l336t955r415b1009],
2	,	,	O	,	_	0	SENT_523	[p25l336t955r415b1009],
3	1903-1912	CD	DATE	1903-1912	number	4	SENT_523	[p25l434t955r718b1001],
4	(	CD	NUMBER	(	appos	1	SENT_523	[p25l735t953r909b1009],
5	2000	CD	DATE	2000	num	6	SENT_523	[p25l735t953r909b1009],
6	)	NN	O	)	dep	4	SENT_523	[p25l735t953r909b1009],
7	.	.	O	.	_	0	SENT_523	[p25l735t953r909b1009],

1	Slawsky	NNP	PERSON	Slawsky	_	0	SENT_524	[p25l127t1030r343b1094],
2	,	,	O	,	_	0	SENT_524	[p25l127t1030r343b1094],
3	M.T.	NNP	O	M.T.	nn	4	SENT_524	[p25l358t1033r458b1080],
4	etal	NNP	O	etal	appos	1	SENT_524	[p25l473t1030r584b1080],
5	.	.	O	.	_	0	SENT_524	[p25l473t1030r584b1080],

1	Acute	JJ	O	acute	amod	2	SENT_525	[p25l600t1033r751b1080],
2	hemodynamic	JJ	O	hemodynamic	_	0	SENT_525	[p25l768t1030r1147b1094],
3	and	CC	O	and	_	0	SENT_525	[p25l1160t1030r1257b1080],
4	clinical	JJ	O	clinical	amod	5	SENT_525	[p25l1274t1030r1449b1080],
5	effects	NNS	O	effect	conj_and	2	SENT_525	[p25l1466t1030r1638b1080],
6	of	IN	O	of	_	0	SENT_525	[p25l1653t1030r1707b1080],
7	levosimendan	NN	O	levosimendan	prep_of	2	SENT_525	[p25l1718t1030r2085b1080],
8	in	IN	O	in	_	0	SENT_525	[p25l130t1111r173b1157],
9	patients	NNS	O	patient	prep_in	2	SENT_525	[p25l191t1111r401b1171],
10	with	IN	O	with	_	0	SENT_525	[p25l414t1108r527b1158],
11	severe	JJ	O	severe	amod	13	SENT_525	[p25l544t1123r711b1158],
12	heart	NN	O	heart	nn	13	SENT_525	[p25l728t1108r864b1158],
13	failure	NN	O	failure	prep_with	9	SENT_525	[p25l876t1108r1051b1158],
14	.	.	O	.	_	0	SENT_525	[p25l876t1108r1051b1158],

1	Study	NNP	O	Study	_	0	SENT_526	[p25l1066t1108r1217b1172],
2	Investigators	NNS	O	investigator	dep	1	SENT_526	[p25l1232t1111r1579b1171],
3	.	.	O	.	_	0	SENT_526	[p25l1232t1111r1579b1171],

1	Circulation	NN	O	circulation	_	0	SENT_527	[p25l1594t1108r1868b1158],
2	102	CD	NUMBER	102	num	1	SENT_527	[p25l1886t1111r1998b1166],
3	,	,	O	,	_	0	SENT_527	[p25l1886t1111r1998b1166],
4	2222-2227	CD	DATE	2222-2227	number	5	SENT_527	[p25l129t1188r417b1234],
5	(	CD	NUMBER	(	appos	1	SENT_527	[p25l434t1186r608b1242],
6	2000	CD	DATE	2000	num	7	SENT_527	[p25l434t1186r608b1242],
7	)	NN	O	)	dep	5	SENT_527	[p25l434t1186r608b1242],
8	.	.	O	.	_	0	SENT_527	[p25l434t1186r608b1242],

1	Follath	NNP	PERSON	Follath	nn	4	SENT_528	[p25l129t1263r316b1321],
2	,	,	O	,	_	0	SENT_528	[p25l129t1263r316b1321],
3	F.	NNP	O	F.	appos	4	SENT_528	[p25l333t1266r365b1313],
4	etal.	NNP	O	etal.	_	0	SENT_528	[p25l379t1263r507b1321],
5	;	:	O	;	_	0	SENT_528	[p25l379t1263r507b1321],
6	Steering	NNP	ORGANIZATION	Steering	nn	7	SENT_528	[p25l521t1265r737b1326],
7	Committee	NNP	ORGANIZATION	Committee	dep	4	SENT_528	[p25l754t1265r1048b1313],
8	and	CC	O	and	_	0	SENT_528	[p25l1062t1263r1158b1313],
9	Investigators	NNS	O	investigator	dep	4	SENT_528	[p25l1177t1266r1511b1326],
10	of	IN	O	of	_	0	SENT_528	[p25l1526t1263r1580b1313],
11	the	DT	O	the	det	13	SENT_528	[p25l1588t1263r1674b1313],
12	Levosimendan	NNP	O	Levosimendan	nn	13	SENT_528	[p25l1691t1263r2071b1313],
13	Infusion	NNP	O	Infusion	prep_of	9	SENT_528	[p25l131t1341r337b1391],
14	versus	CC	O	versus	_	0	SENT_528	[p25l353t1356r518b1391],
15	Dobutamine	NNP	O	Dobutamine	conj_versus	13	SENT_528	[p25l535t1341r865b1391],
16	(	CD	NUMBER	(	num	19	SENT_528	[p25l881t1342r1041b1399],
17	LIDO	NNP	ORGANIZATION	LIDO	nn	19	SENT_528	[p25l881t1342r1041b1399],
18	)	CD	NUMBER	)	num	19	SENT_528	[p25l881t1342r1041b1399],
19	Study	NNP	O	Study	dep	9	SENT_528	[p25l1057t1341r1217b1405],
20	.	.	O	.	_	0	SENT_528	[p25l1057t1341r1217b1405],

1	Efﬁcacy	NN	O	efﬁcacy	nsubj	18	SENT_529	[p25l1234t1341r1431b1405],
2	and	CC	O	and	_	0	SENT_529	[p25l1444t1341r1540b1391],
3	safety	NN	O	safety	conj_and	1	SENT_529	[p25l1557t1341r1711b1405],
4	of	IN	O	of	_	0	SENT_529	[p25l1724t1341r1779b1391],
5	intravenous	JJ	O	intravenous	amod	6	SENT_529	[p25l1790t1344r2098b1391],
6	levosimendan	NN	O	levosimendan	prep_of	1	SENT_529	[p25l131t1419r497b1469],
7	compared	VBN	O	compare	_	0	SENT_529	[p25l513t1419r778b1482],
8	with	IN	O	with	prepc_compared_with	6	SENT_529	[p25l794t1419r907b1469],
9	dobutamine	NN	O	dobutamine	pobj	6	SENT_529	[p25l924t1419r1249b1469],
10	in	IN	O	in	_	0	SENT_529	[p25l1265t1422r1308b1468],
11	severe	JJ	O	severe	amod	17	SENT_529	[p25l1325t1434r1492b1469],
12	|	NN	O	|	nn	17	SENT_529	[p25l1508t1419r1803b1482],
13	ow	NN	O	ow	nn	17	SENT_529	[p25l1508t1419r1803b1482],
14	—	NN	O	—	nn	17	SENT_529	[p25l1508t1419r1803b1482],
15	output	NN	O	output	nn	17	SENT_529	[p25l1508t1419r1803b1482],
16	heart	NN	O	heart	nn	17	SENT_529	[p25l1819t1419r1955b1469],
17	failure	NN	O	failure	prep_in	9	SENT_529	[p25l1967t1419r2131b1469],
18	(	VBD	O	(	_	0	SENT_529	[p25l130t1497r231b1555],
19	the	DT	O	the	det	21	SENT_529	[p25l130t1497r231b1555],
20	LIDO	NNP	ORGANIZATION	LIDO	nn	21	SENT_529	[p25l248t1499r373b1547],
21	study	NN	O	study	dobj	18	SENT_529	[p25l388t1497r562b1561],
22	)	CD	NUMBER	)	num	21	SENT_529	[p25l388t1497r562b1561],
23	:	:	O	:	_	0	SENT_529	[p25l388t1497r562b1561],
24	a	DT	O	a	det	27	SENT_529	[p25l576t1512r601b1547],
25	randomised	JJ	O	randomised	amod	27	SENT_529	[p25l619t1497r930b1547],
26	double	JJ	O	double	amod	27	SENT_529	[p25l947t1497r1288b1547],
27	—	NN	O	—	dep	21	SENT_529	[p25l947t1497r1288b1547],
28	blind	JJ	O	blind	amod	29	SENT_529	[p25l947t1497r1288b1547],
29	trial	NN	O	trial	dep	27	SENT_529	[p25l1303t1497r1416b1547],
30	.	.	O	.	_	0	SENT_529	[p25l1303t1497r1416b1547],

1	Lancet360	NN	O	lancet360	_	0	SENT_530	[p25l1430t1500r1726b1555],
2	,	,	O	,	_	0	SENT_530	[p25l1430t1500r1726b1555],
3	196-202	CD	NUMBER	196-202	number	4	SENT_530	[p25l1744t1500r1963b1547],
4	(	CD	NUMBER	(	appos	1	SENT_530	[p25l130t1575r304b1631],
5	2002	CD	DATE	2002	num	6	SENT_530	[p25l130t1575r304b1631],
6	)	NN	O	)	dep	4	SENT_530	[p25l130t1575r304b1631],
7	.	.	O	.	_	0	SENT_530	[p25l130t1575r304b1631],

1	Bergh	NNP	PERSON	Bergh	_	0	SENT_531	[p25l129t1652r294b1715],
2	,	,	O	,	_	0	SENT_531	[p25l129t1652r294b1715],
3	C.H.	NNP	PERSON	C.H.	nn	4	SENT_531	[p25l308t1654r409b1702],
4	etal	NNP	O	etal	appos	1	SENT_531	[p25l423t1652r535b1702],
5	.	.	O	.	_	0	SENT_531	[p25l423t1652r535b1702],

1	Intravenous	JJ	O	intravenous	amod	2	SENT_532	[p25l554t1655r862b1702],
2	levosimendan	NN	O	levosimendan	_	0	SENT_532	[p25l880t1652r1246b1702],
3	vs.	CC	O	vs.	prep	2	SENT_532	[p25l1261t1667r1326b1702],
4	dobutamine	NN	O	dobutamine	dep	3	SENT_532	[p25l1340t1652r1666b1702],
5	in	IN	O	in	_	0	SENT_532	[p25l1682t1655r1725b1701],
6	acute	JJ	O	acute	amod	16	SENT_532	[p25l1741t1660r1884b1702],
7	decompensated	JJ	O	decompensated	amod	10	SENT_532	[p25l129t1730r554b1793],
8	heart	NN	O	heart	nn	10	SENT_532	[p25l573t1730r709b1780],
9	failure	NN	O	failure	nn	10	SENT_532	[p25l721t1730r884b1780],
10	patients	NNS	O	patient	dep	6	SENT_532	[p25l901t1733r1110b1793],
11	on	IN	O	on	_	0	SENT_532	[p25l1125t1745r1190b1780],
12	beta	NN	O	beta	nn	15	SENT_532	[p25l1208t1730r1576b1780],
13	—	CD	NUMBER	—	num	15	SENT_532	[p25l1208t1730r1576b1780],
14	b	NN	O	b	nn	15	SENT_532	[p25l1208t1730r1576b1780],
15	|	NN	O	|	prep_on	10	SENT_532	[p25l1208t1730r1576b1780],
16	ockers	NNS	O	ocker	prep_in	2	SENT_532	[p25l1208t1730r1576b1780],
17	.	.	O	.	_	0	SENT_532	[p25l1208t1730r1576b1780],

1	Eur	NNP	O	Eur	_	0	SENT_533	[p25l1590t1733r1678b1780],
2	.	.	O	.	_	0	SENT_533	[p25l1590t1733r1678b1780],

1	J.	NNP	PERSON	J.	nn	2	SENT_534	[p25l1689t1733r1724b1780],
2	HeartFail	NNP	PERSON	HeartFail	_	0	SENT_534	[p25l1739t1730r1990b1780],
3	.	.	O	.	_	0	SENT_534	[p25l1739t1730r1990b1780],

1	12	CD	NUMBER	12	_	0	SENT_535	[p25l2007t1733r2084b1788],
2	,	,	O	,	_	0	SENT_535	[p25l2007t1733r2084b1788],
3	404-410	CD	NUMBER	404-410	number	4	SENT_535	[p25l127t1810r352b1856],
4	(	CD	NUMBER	(	appos	1	SENT_535	[p25l368t1808r543b1864],
5	2010	CD	DATE	2010	num	6	SENT_535	[p25l368t1808r543b1864],
6	)	NN	O	)	dep	4	SENT_535	[p25l368t1808r543b1864],
7	.	.	O	.	_	0	SENT_535	[p25l368t1808r543b1864],

1	Felker	NNP	PERSON	Felker	nn	3	SENT_536	[p25l129t1885r291b1943],
2	,	,	O	,	_	0	SENT_536	[p25l129t1885r291b1943],
3	G.M.	NNP	O	G.M.	_	0	SENT_536	[p25l305t1887r420b1935],
4	et	FW	O	et	nn	5	SENT_536	[p25l434t1893r483b1935],
5	al.	FW	O	al.	dep	3	SENT_536	[p25l492t1885r562b1943],
6	;	:	O	;	_	0	SENT_536	[p25l492t1885r562b1943],
7	OPTIME	NNP	O	OPTIME	dep	3	SENT_536	[p25l576t1887r908b1935],
8	.	.	O	.	_	0	SENT_536	[p25l576t1887r908b1935],

1	—	NN	O	—	_	0	SENT_537	[p25l576t1887r908b1935],
2	.	.	O	.	_	0	SENT_537	[p25l576t1887r908b1935],

1	CHF	NNP	O	CHF	_	0	SENT_538	[p25l576t1887r908b1935],
2	Investigators	NNS	O	investigator	dep	1	SENT_538	[p25l926t1888r1273b1948],
3	.	.	O	.	_	0	SENT_538	[p25l926t1888r1273b1948],

1	Heart	NNP	O	Heart	nn	3	SENT_539	[p25l1289t1888r1431b1935],
2	failure	NN	O	failure	nn	3	SENT_539	[p25l1443t1885r1607b1935],
3	etiology	NN	O	etiology	_	0	SENT_539	[p25l1621t1885r1837b1949],
4	and	CC	O	and	_	0	SENT_539	[p25l1850t1885r1946b1935],
5	response	NN	O	response	conj_and	3	SENT_539	[p25l130t1978r365b2026],
6	to	TO	O	to	_	0	SENT_539	[p25l378t1971r431b2013],
7	milrinone	NN	O	milrinone	prep_to	5	SENT_539	[p25l448t1963r698b2013],
8	in	IN	O	in	_	0	SENT_539	[p25l714t1966r757b2013],
9	decompensated	JJ	O	decompensated	amod	11	SENT_539	[p25l774t1963r1199b2026],
10	heart	NN	O	heart	nn	11	SENT_539	[p25l1218t1963r1354b2013],
11	failure	NN	O	failure	prep_in	7	SENT_539	[p25l1366t1963r1543b2013],
12	:	:	O	:	_	0	SENT_539	[p25l1366t1963r1543b2013],
13	results	NNS	O	result	dep	3	SENT_539	[p25l1559t1963r1726b2013],
14	from	IN	O	from	_	0	SENT_539	[p25l1739t1963r1862b2013],
15	the	DT	O	the	det	16	SENT_539	[p25l1877t1963r1963b2013],
16	OPTIME	NNP	O	OPTIME	prep_from	13	SENT_539	[p25l128t2043r461b2091],
17	.	.	O	.	_	0	SENT_539	[p25l128t2043r461b2091],

1	—	NN	O	—	_	0	SENT_540	[p25l128t2043r461b2091],
2	.	.	O	.	_	0	SENT_540	[p25l128t2043r461b2091],

1	CHF	NN	O	chf	_	0	SENT_541	[p25l128t2043r461b2091],
2	study	NN	O	study	dep	1	SENT_541	[p25l477t2041r630b2105],
3	.	.	O	.	_	0	SENT_541	[p25l477t2041r630b2105],

1	J.	NNP	O	J.	nn	2	SENT_542	[p25l640t2044r675b2091],
2	Am	NNP	O	Am	_	0	SENT_542	[p25l686t2044r785b2091],
3	.	.	O	.	_	0	SENT_542	[p25l686t2044r785b2091],

1	Coll	NNP	PERSON	Coll	_	0	SENT_543	[p25l801t2041r904b2091],
2	.	.	O	.	_	0	SENT_543	[p25l801t2041r904b2091],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_544	[p25l919t2041r1111b2091],
2	.	.	O	.	_	0	SENT_544	[p25l919t2041r1111b2091],

1	41	CD	NUMBER	41	_	0	SENT_545	[p25l1125t2045r1205b2099],
2	,	,	O	,	_	0	SENT_545	[p25l1125t2045r1205b2099],
3	997-1003	CD	NUMBER	997-1003	number	4	SENT_545	[p25l1220t2045r1475b2091],
4	(	CD	NUMBER	(	appos	1	SENT_545	[p25l1493t2042r1667b2099],
5	2003	CD	DATE	2003	num	6	SENT_545	[p25l1493t2042r1667b2099],
6	)	NN	O	)	dep	4	SENT_545	[p25l1493t2042r1667b2099],
7	.	.	O	.	_	0	SENT_545	[p25l1493t2042r1667b2099],

1	Werdan	NNP	PERSON	Werdan	nn	3	SENT_546	[p25l129t2119r346b2177],
2	,	,	O	,	_	0	SENT_546	[p25l129t2119r346b2177],
3	K.	NNP	O	K.	_	0	SENT_546	[p25l363t2122r418b2177],
4	,	,	O	,	_	0	SENT_546	[p25l363t2122r418b2177],
5	Rul3	NN	O	rul3	appos	3	SENT_546	[p25l435t2119r545b2177],
6	,	,	O	,	_	0	SENT_546	[p25l435t2119r545b2177],
7	M.	NNP	O	M.	nn	13	SENT_546	[p25l561t2122r633b2177],
8	,	,	O	,	_	0	SENT_546	[p25l561t2122r633b2177],
9	Buerke	NNP	PERSON	Buerke	appos	13	SENT_546	[p25l650t2119r840b2177],
10	,	,	O	,	_	0	SENT_546	[p25l650t2119r840b2177],
11	M.	NNP	O	M.	appos	13	SENT_546	[p25l856t2122r928b2177],
12	,	,	O	,	_	0	SENT_546	[p25l856t2122r928b2177],
13	Del	NNP	O	Del	appos	5	SENT_546	[p25l945t2119r1254b2177],
14	|	CD	NUMBER	|	num	13	SENT_546	[p25l945t2119r1254b2177],
15	e	LS	O	e	dep	13	SENT_546	[p25l945t2119r1254b2177],
16	.	.	O	.	_	0	SENT_546	[p25l945t2119r1254b2177],

1	—	NN	O	—	_	0	SENT_547	[p25l945t2119r1254b2177],
2	.	.	O	.	_	0	SENT_547	[p25l945t2119r1254b2177],

1	Karth	NNP	PERSON	Karth	_	0	SENT_548	[p25l945t2119r1254b2177],
2	,	,	O	,	_	0	SENT_548	[p25l945t2119r1254b2177],
3	G.	NNP	O	G.	conj_and	1	SENT_548	[p25l1269t2121r1332b2177],
4	,	,	O	,	_	0	SENT_548	[p25l1269t2121r1332b2177],
5	Geppert	NNP	PERSON	Geppert	conj_and	1	SENT_548	[p25l1347t2121r1577b2182],
6	,	,	O	,	_	0	SENT_548	[p25l1347t2121r1577b2182],
7	A.	NNP	ORGANIZATION	A.	conj_and	1	SENT_548	[p25l1590t2122r1639b2169],
8	&	CC	ORGANIZATION	&	_	0	SENT_548	[p25l1654t2121r1690b2169],
9	Schondube	NNP	ORGANIZATION	Schondube	conj_and	1	SENT_548	[p25l1704t2119r2017b2177],
10	,	,	O	,	_	0	SENT_548	[p25l1704t2119r2017b2177],
11	F.A.	NNP	O	F.A.	appos	1	SENT_548	[p25l2033t2122r2130b2177],
12	;	:	O	;	_	0	SENT_548	[p25l2033t2122r2130b2177],
13	German	JJ	ORGANIZATION	german	amod	15	SENT_548	[p25l132t2199r340b2247],
14	Cardiac	JJ	ORGANIZATION	cardiac	amod	15	SENT_548	[p25l356t2197r550b2247],
15	Society	NN	ORGANIZATION	society	dep	11	SENT_548	[p25l564t2199r769b2261],
16	;	:	O	;	_	0	SENT_548	[p25l564t2199r769b2261],
17	German	NNP	ORGANIZATION	German	nn	18	SENT_548	[p25l783t2199r991b2247],
18	Society	NNP	ORGANIZATION	Society	dep	11	SENT_548	[p25l1008t2199r1199b2261],
19	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l1211t2197r1266b2247],
20	Intensive	NNP	ORGANIZATION	Intensive	nn	21	SENT_548	[p25l1278t2200r1512b2247],
21	Care	NNP	ORGANIZATION	Care	prep_of	18	SENT_548	[p25l1526t2199r1642b2247],
22	and	CC	O	and	_	0	SENT_548	[p25l1656t2197r1752b2247],
23	Emergency	NNP	ORGANIZATION	Emergency	nn	24	SENT_548	[p25l1771t2200r2066b2261],
24	Medicine	NNP	ORGANIZATION	Medicine	prep_of	18	SENT_548	[p25l133t2275r386b2333],
25	;	:	O	;	_	0	SENT_548	[p25l133t2275r386b2333],
26	German	NNP	ORGANIZATION	German	nn	28	SENT_548	[p25l400t2277r608b2325],
27	Society	NNP	ORGANIZATION	Society	nn	28	SENT_548	[p25l626t2277r816b2339],
28	forThoracic	NNP	O	forThoracic	dep	11	SENT_548	[p25l828t2275r1131b2325],
29	and	CC	O	and	_	0	SENT_548	[p25l1145t2275r1241b2325],
30	Cardiovascular	NNP	O	Cardiovascular	nn	31	SENT_548	[p25l1258t2275r1644b2325],
31	Surgery	NNP	O	Surgery	dep	11	SENT_548	[p25l1658t2277r1875b2339],
32	;	:	O	;	_	0	SENT_548	[p25l1658t2277r1875b2339],
33	(	CD	NUMBER	(	num	35	SENT_548	[p25l134t2354r365b2411],
34	Austrian	JJ	O	austrian	amod	35	SENT_548	[p25l134t2354r365b2411],
35	Society	NN	ORGANIZATION	society	dep	11	SENT_548	[p25l382t2355r572b2417],
36	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l585t2353r640b2403],
37	Internal	JJ	ORGANIZATION	internal	prep_of	35	SENT_548	[p25l652t2353r848b2403],
38	and	CC	O	and	_	0	SENT_548	[p25l865t2353r961b2403],
39	General	JJ	ORGANIZATION	general	amod	42	SENT_548	[p25l978t2353r1178b2403],
40	Intensive	NNP	ORGANIZATION	Intensive	nn	42	SENT_548	[p25l1198t2356r1432b2403],
41	Care	NNP	ORGANIZATION	Care	nn	42	SENT_548	[p25l1446t2355r1561b2403],
42	Medicine	NNP	ORGANIZATION	Medicine	prep_of	35	SENT_548	[p25l1577t2353r1830b2411],
43	;	:	O	;	_	0	SENT_548	[p25l1577t2353r1830b2411],
44	German	NNP	ORGANIZATION	German	nn	46	SENT_548	[p25l1844t2355r2052b2403],
45	Interdisciplinary	NNP	ORGANIZATION	Interdisciplinary	nn	46	SENT_548	[p25l134t2431r556b2495],
46	Association	NNP	ORGANIZATION	Association	dep	11	SENT_548	[p25l569t2434r867b2481],
47	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l884t2431r938b2481],
48	Intensive	NNP	ORGANIZATION	Intensive	nn	49	SENT_548	[p25l950t2434r1184b2481],
49	Care	NNP	ORGANIZATION	Care	prep_of	46	SENT_548	[p25l1199t2433r1314b2481],
50	and	CC	O	and	_	0	SENT_548	[p25l1329t2431r1425b2481],
51	Emergency	NNP	ORGANIZATION	Emergency	nn	52	SENT_548	[p25l1443t2434r1738b2495],
52	Medicine	NNP	ORGANIZATION	Medicine	prep_of	46	SENT_548	[p25l1753t2431r2005b2489],
53	;	:	O	;	_	0	SENT_548	[p25l1753t2431r2005b2489],
54	Austrian	JJ	ORGANIZATION	austrian	amod	55	SENT_548	[p25l132t2512r347b2559],
55	Society	NN	ORGANIZATION	society	dep	11	SENT_548	[p25l364t2511r555b2573],
56	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l568t2509r622b2559],
57	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	55	SENT_548	[p25l632t2509r931b2573],
58	;	:	O	;	_	0	SENT_548	[p25l632t2509r931b2573],
59	German	NNP	ORGANIZATION	German	nn	60	SENT_548	[p25l946t2511r1153b2559],
60	Society	NNP	ORGANIZATION	Society	dep	11	SENT_548	[p25l1170t2511r1361b2573],
61	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l1374t2509r1428b2559],
62	Anaesthesiology	NNP	ORGANIZATION	Anaesthesiology	prep_of	60	SENT_548	[p25l1437t2509r1877b2573],
63	and	CC	O	and	_	0	SENT_548	[p25l1889t2509r1985b2559],
64	Intensive	NNP	ORGANIZATION	Intensive	nn	66	SENT_548	[p25l134t2590r369b2637],
65	Care	NNP	ORGANIZATION	Care	nn	66	SENT_548	[p25l383t2589r499b2637],
66	Medicine	NNP	ORGANIZATION	Medicine	prep_of	60	SENT_548	[p25l514t2587r768b2645],
67	;	:	O	;	_	0	SENT_548	[p25l514t2587r768b2645],
68	German	NNP	ORGANIZATION	German	nn	69	SENT_548	[p25l781t2589r989b2637],
69	Society	NNP	ORGANIZATION	Society	dep	11	SENT_548	[p25l1006t2589r1197b2651],
70	of	IN	ORGANIZATION	of	_	0	SENT_548	[p25l1210t2587r1264b2637],
71	Preventive	NNP	ORGANIZATION	Preventive	nn	72	SENT_548	[p25l1277t2590r1550b2637],
72	Medicine	NNP	ORGANIZATION	Medicine	prep_of	69	SENT_548	[p25l1565t2587r1805b2637],
73	and	CC	O	and	_	0	SENT_548	[p25l1819t2587r1916b2637],
74	Rehabilitation	NNP	O	Rehabilitation	conj_and	72	SENT_548	[p25l135t2665r512b2715],
75	.	.	O	.	_	0	SENT_548	[p25l135t2665r512b2715],

1	Cardiogenic	JJ	O	cardiogenic	amod	2	SENT_549	[p25l526t2665r842b2729],
2	shock	NN	O	shock	_	0	SENT_549	[p25l856t2665r1009b2715],
3	due	JJ	O	due	_	0	SENT_549	[p25l1020t2665r1120b2715],
4	to	TO	O	to	_	0	SENT_549	[p25l1133t2673r1186b2715],
5	myocardial	JJ	O	myocardial	amod	6	SENT_549	[p25l1202t2665r1486b2729],
6	infarction	NN	O	infarction	prep_due_to	2	SENT_549	[p25l1505t2665r1767b2715],
7	:	:	O	:	_	0	SENT_549	[p25l1505t2665r1767b2715],
8	diagnosis	NN	O	diagnosis	dep	2	SENT_549	[p25l1782t2665r2042b2729],
9	,	,	O	,	_	0	SENT_549	[p25l1782t2665r2042b2729],
10	monitoring	NN	O	monitoring	conj_and	8	SENT_549	[p25l134t2746r427b2807],
11	and	CC	O	and	_	0	SENT_549	[p25l443t2743r539b2793],
12	treatment	NN	O	treatment	dep	2	SENT_549	[p25l555t2751r831b2793],
13	:	:	O	:	_	0	SENT_549	[p25l555t2751r831b2793],
14	a	DT	O	a	det	15	SENT_549	[p25l845t2758r870b2793],
15	German	JJ	MISC	german	dep	8	SENT_549	[p25l886t2745r1335b2793],
16	.	.	O	.	_	0	SENT_549	[p25l886t2745r1335b2793],

1	—	NN	O	—	_	0	SENT_550	[p25l886t2745r1335b2793],
2	.	.	O	.	_	0	SENT_550	[p25l886t2745r1335b2793],

1	Austrian	JJ	MISC	austrian	amod	2	SENT_551	[p25l886t2745r1335b2793],
2	S3	NN	O	s3	_	0	SENT_551	[p25l1352t2745r1410b2793],
3	Guideline	NN	O	guideline	dep	2	SENT_551	[p25l1426t2743r1690b2793],
4	.	.	O	.	_	0	SENT_551	[p25l1426t2743r1690b2793],

1	Dtsch	NNP	PERSON	Dtsch	_	0	SENT_552	[p25l1705t2743r2061b2793],
2	.	.	O	.	_	0	SENT_552	[p25l1705t2743r2061b2793],

1	Arztebl	NNP	O	Arztebl	_	0	SENT_553	[p25l1705t2743r2061b2793],
2	.	.	O	.	_	0	SENT_553	[p25l1705t2743r2061b2793],

1	Int	NN	O	int	_	0	SENT_554	[p25l132t2823r210b2870],
2	.	.	O	.	_	0	SENT_554	[p25l132t2823r210b2870],

1	109	CD	NUMBER	109	_	0	SENT_555	[p25l227t2824r339b2877],
2	,	,	O	,	_	0	SENT_555	[p25l227t2824r339b2877],
3	343-351	CD	NUMBER	343-351	number	4	SENT_555	[p25l355t2824r568b2870],
4	(	CD	NUMBER	(	appos	1	SENT_555	[p25l594t2821r768b2877],
5	2012	CD	DATE	2012	num	6	SENT_555	[p25l594t2821r768b2877],
6	)	NN	O	)	dep	4	SENT_555	[p25l594t2821r768b2877],
7	.	.	O	.	_	0	SENT_555	[p25l594t2821r768b2877],

1	Elkayam	NNP	PERSON	Elkayam	nn	19	SENT_556	[p25l133t2898r361b2962],
2	,	,	O	,	_	0	SENT_556	[p25l133t2898r361b2962],
3	U.	NNP	O	U.	conj_and	1	SENT_556	[p25l378t2901r437b2956],
4	,	,	O	,	_	0	SENT_556	[p25l378t2901r437b2956],
5	Ng	NNP	O	Ng	conj_and	1	SENT_556	[p25l454t2901r663b2962],
6	,	,	O	,	_	0	SENT_556	[p25l454t2901r663b2962],
7	T.M.	NNP	LOCATION	T.M.	conj_and	1	SENT_556	[p25l454t2901r663b2962],
8	,	,	O	,	_	0	SENT_556	[p25l454t2901r663b2962],
9	Hatamizadeh	NNP	PERSON	Hatamizadeh	conj_and	1	SENT_556	[p25l680t2898r1040b2956],
10	,	,	O	,	_	0	SENT_556	[p25l680t2898r1040b2956],
11	P.	NNP	O	P.	conj_and	1	SENT_556	[p25l1057t2900r1101b2956],
12	,	,	O	,	_	0	SENT_556	[p25l1057t2900r1101b2956],
13	Janmohamed	NNP	O	Janmohamed	nn	19	SENT_556	[p25l1114t2898r1490b2956],
14	,	,	O	,	_	0	SENT_556	[p25l1114t2898r1490b2956],
15	M.	NNP	ORGANIZATION	M.	nn	19	SENT_556	[p25l1505t2901r1565b2948],
16	&	CC	ORGANIZATION	&	_	0	SENT_556	[p25l1579t2900r1615b2948],
17	Mehra	NNP	ORGANIZATION	Mehra	nn	19	SENT_556	[p25l1630t2898r1807b2956],
18	,	,	O	,	_	0	SENT_556	[p25l1630t2898r1807b2956],
19	A.	NNP	O	A.	_	0	SENT_556	[p25l1821t2901r1870b2948],
20	Renal	JJ	O	renal	amod	22	SENT_556	[p25l1887t2898r2026b2948],
21	Vasodilatory	NNP	O	Vasodilatory	nn	22	SENT_556	[p25l130t2976r458b3040],
22	Action	NNP	O	Action	dep	19	SENT_556	[p25l470t2979r638b3026],
23	of	IN	O	of	_	0	SENT_556	[p25l655t2976r709b3026],
24	Dopamine	NN	O	dopamine	prep_of	22	SENT_556	[p25l722t2978r996b3039],
25	in	IN	O	in	_	0	SENT_556	[p25l1011t2979r1054b3025],
26	Patients	NNS	O	patient	prep_in	24	SENT_556	[p25l1073t2978r1278b3026],
27	With	IN	O	with	_	0	SENT_556	[p25l1289t2976r1408b3026],
28	Heart	NNP	O	Heart	nn	29	SENT_556	[p25l1428t2979r1570b3026],
29	Failure	NN	O	failure	prep_with	26	SENT_556	[p25l1586t2976r1768b3026],
30	:	:	O	:	_	0	SENT_556	[p25l1586t2976r1768b3026],
31	Magnitude	NN	O	magnitude	dep	19	SENT_556	[p25l1783t2976r2070b3040],
32	of	IN	O	of	_	0	SENT_556	[p25l2085t2976r2139b3026],
33	Effect	NN	O	effect	prep_of	31	SENT_556	[p25l134t3053r279b3103],
34	and	CC	O	and	_	0	SENT_556	[p25l292t3053r388b3103],
35	Site	NN	O	site	prep_of	31	SENT_556	[p25l406t3055r500b3103],
36	of	IN	O	of	_	0	SENT_556	[p25l514t3053r569b3103],
37	Action	NNP	O	Action	prep_of	31	SENT_556	[p25l578t3056r761b3103],
38	.	.	O	.	_	0	SENT_556	[p25l578t3056r761b3103],

1	Circulation	NN	O	circulation	_	0	SENT_557	[p25l777t3053r1050b3103],
2	1	CD	NUMBER	1	number	3	SENT_557	[p25l1068t3057r1088b3102],
3	17	CD	NUMBER	17	dep	1	SENT_557	[p25l1104t3057r1180b3110],
4	,	,	O	,	_	0	SENT_557	[p25l1104t3057r1180b3110],
5	200-205	CD	NUMBER	200-205	number	6	SENT_557	[p25l1195t3057r1417b3103],
6	(	CD	NUMBER	(	appos	1	SENT_557	[p25l1435t3054r1609b3110],
7	2008	CD	DATE	2008	num	8	SENT_557	[p25l1435t3054r1609b3110],
8	)	NN	O	)	dep	6	SENT_557	[p25l1435t3054r1609b3110],
9	.	.	O	.	_	0	SENT_557	[p25l1435t3054r1609b3110],

1	Ungar	NNP	PERSON	Ungar	_	0	SENT_558	[p25l133t3134r300b3195],
2	,	,	O	,	_	0	SENT_558	[p25l133t3134r300b3195],
3	A.	NNP	O	A.	nn	4	SENT_558	[p25l314t3134r362b3181],
4	etal	NNP	O	etal	appos	1	SENT_558	[p25l377t3131r488b3181],
5	.	.	O	.	_	0	SENT_558	[p25l377t3131r488b3181],

1	Renal	JJ	O	renal	dep	12	SENT_559	[p25l508t3131r661b3189],
2	,	,	O	,	_	0	SENT_559	[p25l508t3131r661b3189],
3	but	CC	O	but	_	0	SENT_559	[p25l678t3131r765b3181],
4	not	RB	O	not	_	0	SENT_559	[p25l781t3139r867b3181],
5	systemic	JJ	O	systemic	conj_negcc	1	SENT_559	[p25l881t3134r1118b3195],
6	,	,	O	,	_	0	SENT_559	[p25l881t3134r1118b3195],
7	hemodynamic	JJ	O	hemodynamic	amod	8	SENT_559	[p25l1135t3131r1513b3195],
8	effects	NNS	O	effect	nsubjpass	12	SENT_559	[p25l1528t3131r1699b3181],
9	of	IN	O	of	_	0	SENT_559	[p25l1713t3131r1768b3181],
10	dopamine	NN	O	dopamine	prep_of	8	SENT_559	[p25l1778t3131r2047b3194],
11	are	VBP	O	be	auxpass	12	SENT_559	[p25l132t3224r211b3259],
12	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_559	[p25l227t3209r501b3259],
13	by	IN	O	by	_	0	SENT_559	[p25l520t3209r581b3273],
14	the	DT	O	the	det	15	SENT_559	[p25l593t3209r678b3259],
15	severity	NN	O	severity	agent	12	SENT_559	[p25l693t3212r897b3273],
16	of	IN	O	of	_	0	SENT_559	[p25l910t3209r964b3259],
17	congestive	JJ	O	congestive	amod	19	SENT_559	[p25l974t3212r1259b3273],
18	heart	NN	O	heart	nn	19	SENT_559	[p25l1276t3209r1411b3259],
19	failure	NN	O	failure	prep_of	15	SENT_559	[p25l1424t3209r1599b3259],
20	.	.	O	.	_	0	SENT_559	[p25l1424t3209r1599b3259],

1	Crit	NNP	O	Crit	_	0	SENT_560	[p25l1614t3211r1710b3259],
2	.	.	O	.	_	0	SENT_560	[p25l1614t3211r1710b3259],

1	Care	NNP	O	Care	nn	2	SENT_561	[p25l1727t3211r1840b3259],
2	Med	NNP	O	Med	_	0	SENT_561	[p25l1850t3209r1973b3259],
3	.	.	O	.	_	0	SENT_561	[p25l1850t3209r1973b3259],

1	32	CD	NUMBER	32	_	0	SENT_562	[p25l1987t3213r2067b3267],
2	,	,	O	,	_	0	SENT_562	[p25l1987t3213r2067b3267],
3	1125-1	CD	NUMBER	1125-1	num	4	SENT_562	[p25l136t3290r313b3336],
4	129	CD	NUMBER	129	appos	1	SENT_562	[p25l332t3290r422b3336],
5	(	CD	NUMBER	(	num	7	SENT_562	[p25l437t3287r611b3343],
6	2004	CD	DATE	2004	num	7	SENT_562	[p25l437t3287r611b3343],
7	)	NN	O	)	dep	4	SENT_562	[p25l437t3287r611b3343],
8	.	.	O	.	_	0	SENT_562	[p25l437t3287r611b3343],

1	Giamouzis	NNP	PERSON	Giamouzis	_	0	SENT_563	[p26l130t19r416b75],
2	,	,	O	,	_	0	SENT_563	[p26l130t19r416b75],
3	G.	NNP	O	G.	nn	4	SENT_563	[p26l430t19r481b67],
4	etal	NN	O	etal	appos	1	SENT_563	[p26l495t17r607b67],
5	.	.	O	.	_	0	SENT_563	[p26l495t17r607b67],

1	Impact	NN	O	impact	_	0	SENT_564	[p26l626t20r807b80],
2	of	IN	O	of	_	0	SENT_564	[p26l820t17r875b67],
3	dopamine	NN	O	dopamine	nn	4	SENT_564	[p26l885t17r1154b80],
4	infusion	NN	O	infusion	prep_of	1	SENT_564	[p26l1170t17r1376b67],
5	on	IN	O	on	_	0	SENT_564	[p26l1393t32r1457b67],
6	renal	JJ	O	renal	amod	7	SENT_564	[p26l1476t17r1601b67],
7	function	NN	O	function	prep_on	4	SENT_564	[p26l1616t17r1836b67],
8	in	IN	O	in	_	0	SENT_564	[p26l1854t20r1897b67],
9	hospitalized	VBN	O	hospitalize	amod	12	SENT_564	[p26l134t95r448b158],
10	heart	NN	O	heart	nn	12	SENT_564	[p26l467t95r603b145],
11	failure	NN	O	failure	nn	12	SENT_564	[p26l615t95r779b145],
12	patients	NNS	O	patient	prep_in	7	SENT_564	[p26l795t98r1018b158],
13	:	:	O	:	_	0	SENT_564	[p26l795t98r1018b158],
14	results	NNS	O	result	dep	1	SENT_564	[p26l1034t95r1202b145],
15	of	IN	O	of	_	0	SENT_564	[p26l1216t95r1271b145],
16	the	DT	O	the	det	17	SENT_564	[p26l1279t95r1365b145],
17	Dopamine	NN	O	dopamine	prep_of	14	SENT_564	[p26l1381t98r1655b158],
18	in	IN	O	in	_	0	SENT_564	[p26l1672t98r1714b145],
19	Acute	JJ	O	acute	amod	24	SENT_564	[p26l1730t98r1881b145],
20	Decompensated	JJ	O	decompensated	amod	24	SENT_564	[p26l134t173r565b236],
21	Heart	NNP	O	Heart	nn	24	SENT_564	[p26l584t176r726b223],
22	Failure	NN	O	failure	nn	24	SENT_564	[p26l741t173r911b223],
23	(	CD	NUMBER	(	num	24	SENT_564	[p26l927t174r1122b231],
24	DAD	NN	O	dad	prep_in	17	SENT_564	[p26l927t174r1122b231],
25	.	.	O	.	_	0	SENT_564	[p26l927t174r1122b231],

1	—	NN	O	—	_	0	SENT_565	[p26l927t174r1122b231],
2	.	.	O	.	_	0	SENT_565	[p26l927t174r1122b231],

1	H	NN	O	h	nn	2	SENT_566	[p26l927t174r1122b231],
2	F	NN	O	f	_	0	SENT_566	[p26l1131t174r1172b231],
3	)	CD	NUMBER	)	num	5	SENT_566	[p26l1131t174r1172b231],
4	Tria	NNP	O	Tria	nn	5	SENT_566	[p26l1183t173r1349b223],
5	|	NN	O	|	dep	2	SENT_566	[p26l1183t173r1349b223],
6	.	.	O	.	_	0	SENT_566	[p26l1183t173r1349b223],

1	J.	NNP	O	J.	nn	2	SENT_567	[p26l1183t173r1349b223],
2	Card	NNP	O	Card	_	0	SENT_567	[p26l1364t173r1491b223],
3	.	.	O	.	_	0	SENT_567	[p26l1364t173r1491b223],

1	Fail	NN	O	fail	_	0	SENT_568	[p26l1506t173r1605b223],
2	.	.	O	.	_	0	SENT_568	[p26l1506t173r1605b223],

1	16	CD	NUMBER	16	_	0	SENT_569	[p26l1622t177r1699b231],
2	,	,	O	,	_	0	SENT_569	[p26l1622t177r1699b231],
3	922-930	CD	NUMBER	922-930	number	4	SENT_569	[p26l1713t177r1937b223],
4	(	CD	NUMBER	(	appos	1	SENT_569	[p26l1954t174r2127b231],
5	2010	CD	DATE	2010	num	6	SENT_569	[p26l1954t174r2127b231],
6	)	NN	O	)	dep	4	SENT_569	[p26l1954t174r2127b231],
7	.	.	O	.	_	0	SENT_569	[p26l1954t174r2127b231],

1	van	NNP	O	van	nn	3	SENT_570	[p26l129t266r221b301],
2	de	NNP	O	de	nn	3	SENT_570	[p26l237t251r301b301],
3	Borne	NNP	O	Borne	nsubj	15	SENT_570	[p26l318t253r482b309],
4	,	,	O	,	_	0	SENT_570	[p26l318t253r482b309],
5	P.	NNP	O	P.	conj_and	3	SENT_570	[p26l499t253r544b309],
6	,	,	O	,	_	0	SENT_570	[p26l499t253r544b309],
7	Oren	NNP	PERSON	Oren	conj_and	3	SENT_570	[p26l558t253r699b309],
8	,	,	O	,	_	0	SENT_570	[p26l558t253r699b309],
9	R.	NNP	ORGANIZATION	R.	conj_and	3	SENT_570	[p26l715t253r757b301],
10	&	CC	ORGANIZATION	&	_	0	SENT_570	[p26l771t253r807b301],
11	Somers	NNP	ORGANIZATION	Somers	conj_and	3	SENT_570	[p26l821t253r1129b309],
12	,	,	O	,	_	0	SENT_570	[p26l821t253r1129b309],
13	V.K.	NNP	PERSON	V.K.	nn	14	SENT_570	[p26l821t253r1129b309],
14	Dopamine	NN	PERSON	dopamine	appos	3	SENT_570	[p26l1145t253r1419b314],
15	depresses	VBZ	O	depress	_	0	SENT_570	[p26l1434t251r1693b314],
16	minute	JJ	DURATION	minute	amod	17	SENT_570	[p26l1710t254r1895b301],
17	ventilation	NN	O	ventilation	dobj	15	SENT_570	[p26l131t330r410b379],
18	in	IN	O	in	_	0	SENT_570	[p26l428t332r471b379],
19	patients	NNS	O	patient	prep_in	15	SENT_570	[p26l489t332r699b392],
20	with	IN	O	with	_	0	SENT_570	[p26l712t330r826b379],
21	heart	NN	O	heart	nn	22	SENT_570	[p26l844t330r980b379],
22	failure	NN	O	failure	prep_with	19	SENT_570	[p26l992t329r1168b379],
23	.	.	O	.	_	0	SENT_570	[p26l992t329r1168b379],

1	Circulation	NN	O	circulation	_	0	SENT_571	[p26l1183t330r1457b379],
2	98	CD	NUMBER	98	num	1	SENT_571	[p26l1472t333r1552b387],
3	,	,	O	,	_	0	SENT_571	[p26l1472t333r1552b387],
4	126-131	CD	NUMBER	126-131	number	5	SENT_571	[p26l1571t333r1781b379],
5	(	CD	NUMBER	(	appos	1	SENT_571	[p26l1807t331r1981b387],
6	1998	CD	DATE	1998	num	7	SENT_571	[p26l1807t331r1981b387],
7	)	NN	O	)	dep	5	SENT_571	[p26l1807t331r1981b387],
8	.	.	O	.	_	0	SENT_571	[p26l1807t331r1981b387],

1	Gheorghiade	NNP	O	Gheorghiade	nn	5	SENT_572	[p26l130t408r487b471],
2	,	,	O	,	_	0	SENT_572	[p26l130t408r487b471],
3	M.	NNP	O	M.	appos	5	SENT_572	[p26l503t410r562b457],
4	et	NNP	O	et	nn	5	SENT_572	[p26l576t415r625b457],
5	aI.	NNP	O	aI.	_	0	SENT_572	[p26l634t408r970b470],
6	;	:	O	;	_	0	SENT_572	[p26l634t408r970b470],
7	To	TO	O	to	aux	8	SENT_572	[p26l634t408r970b470],
8	|	VB	O	|	infmod	5	SENT_572	[p26l634t408r970b470],
9	vaptan	NN	O	vaptan	nn	10	SENT_572	[p26l634t408r970b470],
10	Investigators	NNS	O	investigator	dobj	8	SENT_572	[p26l989t410r1655b471],
11	.	.	O	.	_	0	SENT_572	[p26l989t410r1655b471],

1	Vasopressin	NNP	O	Vasopressin	nn	2	SENT_573	[p26l989t410r1655b471],
2	V2	NNP	O	V2	_	0	SENT_573	[p26l1667t410r1979b470],
3	—	NN	O	—	nn	5	SENT_573	[p26l1667t410r1979b470],
4	receptor	NN	O	receptor	nn	5	SENT_573	[p26l1667t410r1979b470],
5	blockade	NN	O	blockade	dep	2	SENT_573	[p26l134t486r372b535],
6	with	IN	O	with	_	0	SENT_573	[p26l386t486r499b535],
7	tolvaptan	NN	O	tolvaptan	prep_with	5	SENT_573	[p26l514t486r764b548],
8	in	IN	O	in	_	0	SENT_573	[p26l782t488r825b535],
9	patients	NNS	O	patient	prep_in	7	SENT_573	[p26l843t488r1053b548],
10	with	IN	O	with	_	0	SENT_573	[p26l1066t486r1180b535],
11	chronic	JJ	O	chronic	amod	13	SENT_573	[p26l1196t486r1391b535],
12	heart	NN	O	heart	nn	13	SENT_573	[p26l1407t486r1543b535],
13	failure	NN	O	failure	prep_with	9	SENT_573	[p26l1555t485r1731b535],
14	:	:	O	:	_	0	SENT_573	[p26l1555t485r1731b535],
15	results	NNS	O	result	dep	2	SENT_573	[p26l1748t486r1915b535],
16	from	IN	O	from	_	0	SENT_573	[p26l1928t485r2051b535],
17	a	DT	O	a	det	19	SENT_573	[p26l2067t500r2093b535],
18	double	JJ	O	double	amod	19	SENT_573	[p26l132t563r488b619],
19	—	NN	O	—	prep_from	15	SENT_573	[p26l132t563r488b619],
20	blind	JJ	O	blind	amod	23	SENT_573	[p26l132t563r488b619],
21	,	,	O	,	_	0	SENT_573	[p26l132t563r488b619],
22	randomized	JJ	O	randomized	amod	23	SENT_573	[p26l504t563r817b612],
23	trial	NN	O	trial	dep	15	SENT_573	[p26l832t563r944b612],
24	.	.	O	.	_	0	SENT_573	[p26l832t563r944b612],

1	Circulation	NN	O	circulation	_	0	SENT_574	[p26l959t563r1232b612],
2	107	CD	NUMBER	107	num	1	SENT_574	[p26l1251t566r1363b619],
3	,	,	O	,	_	0	SENT_574	[p26l1251t566r1363b619],
4	2690-2696	CD	DATE	2690-2696	number	5	SENT_574	[p26l1378t566r1667b612],
5	(	CD	NUMBER	(	appos	1	SENT_574	[p26l1683t564r1857b619],
6	2003	CD	DATE	2003	num	7	SENT_574	[p26l1683t564r1857b619],
7	)	NN	O	)	dep	5	SENT_574	[p26l1683t564r1857b619],
8	.	.	O	.	_	0	SENT_574	[p26l1683t564r1857b619],

1	Gheorghiade	NNP	PERSON	Gheorghiade	nn	4	SENT_575	[p26l130t641r487b704],
2	,	,	O	,	_	0	SENT_575	[p26l130t641r487b704],
3	M.	NNP	O	M.	appos	4	SENT_575	[p26l502t643r562b690],
4	etal.	NNP	O	etal.	_	0	SENT_575	[p26l576t641r703b698],
5	;	:	O	;	_	0	SENT_575	[p26l576t641r703b698],
6	Acute	JJ	O	acute	amod	10	SENT_575	[p26l717t643r868b690],
7	and	CC	O	and	_	0	SENT_575	[p26l882t641r978b690],
8	Chronic	JJ	O	chronic	amod	10	SENT_575	[p26l995t641r1198b690],
9	Therapeutic	JJ	O	therapeutic	amod	10	SENT_575	[p26l1207t641r1523b703],
10	Impact	NN	O	impact	dep	4	SENT_575	[p26l1539t643r1720b703],
11	of	IN	O	of	_	0	SENT_575	[p26l1734t640r1788b690],
12	a	DT	O	a	det	14	SENT_575	[p26l1798t655r1823b690],
13	Vasopressin	NNP	O	Vasopressin	nn	14	SENT_575	[p26l1835t643r2144b703],
14	Antagonist	NNP	O	Antagonist	prep_of	10	SENT_575	[p26l131t721r421b782],
15	in	IN	O	in	_	0	SENT_575	[p26l436t721r479b768],
16	Congestive	JJ	O	congestive	amod	18	SENT_575	[p26l495t720r789b782],
17	Heart	NNP	O	Heart	nn	18	SENT_575	[p26l806t721r948b768],
18	Failure	NN	O	failure	prep_in	14	SENT_575	[p26l963t719r1133b768],
19	(	CD	NUMBER	(	num	20	SENT_575	[p26l1149t720r1322b776],
20	ACTIV	NN	O	activ	dep	18	SENT_575	[p26l1149t720r1322b776],
21	in	IN	O	in	_	0	SENT_575	[p26l1336t721r1378b768],
22	CH	NN	MISC	ch	nn	23	SENT_575	[p26l1395t720r1467b768],
23	F	NN	MISC	f	prep_in	20	SENT_575	[p26l1476t720r1517b776],
24	)	CD	NUMBER	)	num	25	SENT_575	[p26l1476t720r1517b776],
25	Investigators	NNS	O	investigator	dep	20	SENT_575	[p26l1535t721r1882b782],
26	.	.	O	.	_	0	SENT_575	[p26l1535t721r1882b782],

1	Effects	NNS	O	effect	nsubj	11	SENT_576	[p26l1899t718r2068b768],
2	of	IN	O	of	_	0	SENT_576	[p26l2082t718r2137b768],
3	tolvaptan	NN	O	tolvaptan	prep_of	1	SENT_576	[p26l130t797r396b859],
4	,	,	O	,	_	0	SENT_576	[p26l130t797r396b859],
5	a	DT	O	a	det	7	SENT_576	[p26l410t811r435b846],
6	vasopressin	NN	O	vasopressin	nn	7	SENT_576	[p26l450t799r755b859],
7	antagonist	NN	O	antagonist	appos	3	SENT_576	[p26l772t799r1065b860],
8	,	,	O	,	_	0	SENT_576	[p26l772t799r1065b860],
9	in	IN	O	in	_	0	SENT_576	[p26l1081t799r1124b846],
10	patients	NNS	O	patient	prep_in	3	SENT_576	[p26l1142t799r1352b859],
11	hospitalized	VBN	O	hospitalize	_	0	SENT_576	[p26l1369t797r1683b859],
12	with	IN	O	with	_	0	SENT_576	[p26l1699t797r1812b846],
13	worsening	VBG	O	worsen	amod	15	SENT_576	[p26l1827t799r2103b860],
14	heart	NN	O	heart	nn	15	SENT_576	[p26l134t874r270b923],
15	failure	NN	O	failure	prep_with	11	SENT_576	[p26l282t873r458b923],
16	:	:	O	:	_	0	SENT_576	[p26l282t873r458b923],
17	a	DT	O	a	nsubj	18	SENT_576	[p26l473t888r498b923],
18	randomized	VBN	O	randomize	parataxis	11	SENT_576	[p26l516t874r828b923],
19	controlled	JJ	O	controlled	amod	20	SENT_576	[p26l845t874r1111b923],
20	trial	NN	O	trial	dobj	18	SENT_576	[p26l1126t874r1393b923],
21	.	.	O	.	_	0	SENT_576	[p26l1126t874r1393b923],

1	JAMA	NN	O	jama	_	0	SENT_577	[p26l1126t874r1393b923],
2	291	CD	NUMBER	291	num	1	SENT_577	[p26l1409t877r1523b930],
3	,	,	O	,	_	0	SENT_577	[p26l1409t877r1523b930],
4	1963-1971	CD	DATE	1963-1971	number	5	SENT_577	[p26l1542t877r1817b923],
5	(	CD	NUMBER	(	appos	1	SENT_577	[p26l1843t875r2018b930],
6	2004	CD	DATE	2004	num	7	SENT_577	[p26l1843t875r2018b930],
7	)	NN	O	)	dep	5	SENT_577	[p26l1843t875r2018b930],
8	.	.	O	.	_	0	SENT_577	[p26l1843t875r2018b930],

1	Gheorghiade	NNP	PERSON	Gheorghiade	nn	4	SENT_578	[p26l130t952r487b1015],
2	,	,	O	,	_	0	SENT_578	[p26l130t952r487b1015],
3	M.	NNP	O	M.	appos	4	SENT_578	[p26l502t954r562b1001],
4	etal.	NNP	O	etal.	_	0	SENT_578	[p26l576t952r703b1009],
5	;	:	O	;	_	0	SENT_578	[p26l576t952r703b1009],
6	Efﬁcacy	NNP	O	Efﬁcacy	nn	8	SENT_578	[p26l720t951r917b1015],
7	ofVasopressin	NNP	O	ofVasopressin	nn	8	SENT_578	[p26l930t951r1299b1014],
8	Antagonism	NNP	O	Antagonism	dep	4	SENT_578	[p26l1315t954r1634b1015],
9	in	IN	O	in	_	0	SENT_578	[p26l1653t954r1695b1001],
10	Heart	NNP	O	Heart	nn	13	SENT_578	[p26l1714t954r1856b1001],
11	Failure	NN	O	failure	nn	13	SENT_578	[p26l1872t952r2041b1001],
12	Outcome	NNP	O	Outcome	nn	13	SENT_578	[p26l132t1031r376b1079],
13	Study	NNP	O	Study	prep_in	8	SENT_578	[p26l391t1030r542b1093],
14	With	IN	O	with	_	0	SENT_578	[p26l551t1030r670b1079],
15	Tolvaptan	NNP	O	Tolvaptan	nn	19	SENT_578	[p26l682t1030r940b1092],
16	(	CD	NUMBER	(	num	19	SENT_578	[p26l958t1031r1218b1087],
17	EVEREST	NNP	O	EVEREST	nn	19	SENT_578	[p26l958t1031r1218b1087],
18	)	NNP	O	)	nn	19	SENT_578	[p26l958t1031r1218b1087],
19	Investigators	NNS	O	investigator	prep_with	13	SENT_578	[p26l1236t1032r1583b1093],
20	.	.	O	.	_	0	SENT_578	[p26l1236t1032r1583b1093],

1	Short	JJ	O	short	amod	5	SENT_579	[p26l1598t1030r1882b1079],
2	—	NN	O	—	nn	5	SENT_579	[p26l1598t1030r1882b1079],
3	term	NN	O	term	nn	5	SENT_579	[p26l1598t1030r1882b1079],
4	clinical	JJ	O	clinical	amod	5	SENT_579	[p26l1899t1030r2075b1079],
5	effects	NNS	O	effect	nsubj	27	SENT_579	[p26l132t1107r303b1157],
6	of	IN	O	of	_	0	SENT_579	[p26l318t1107r372b1157],
7	tolvaptan	NN	O	tolvaptan	prep_of	5	SENT_579	[p26l381t1108r646b1170],
8	,	,	O	,	_	0	SENT_579	[p26l381t1108r646b1170],
9	an	DT	O	a	det	12	SENT_579	[p26l660t1122r721b1157],
10	oral	JJ	O	oral	amod	12	SENT_579	[p26l737t1108r832b1157],
11	vasopressin	NN	O	vasopressin	nn	12	SENT_579	[p26l847t1110r1153b1170],
12	antagonist	NN	O	antagonist	appos	7	SENT_579	[p26l1169t1110r1463b1171],
13	,	,	O	,	_	0	SENT_579	[p26l1169t1110r1463b1171],
14	in	IN	O	in	_	0	SENT_579	[p26l1479t1110r1521b1157],
15	patients	NNS	O	patient	prep_in	7	SENT_579	[p26l1539t1110r1749b1170],
16	hospitalized	VBN	O	hospitalize	partmod	15	SENT_579	[p26l1766t1108r2080b1170],
17	for	IN	O	for	_	0	SENT_579	[p26l130t1184r203b1234],
18	heart	NN	O	heart	nn	19	SENT_579	[p26l218t1185r354b1234],
19	failure	NN	O	failure	prep_for	16	SENT_579	[p26l366t1184r543b1234],
20	:	:	O	:	_	0	SENT_579	[p26l366t1184r543b1234],
21	the	DT	O	the	det	22	SENT_579	[p26l556t1185r641b1234],
22	EVEREST	NNP	O	EVEREST	dep	7	SENT_579	[p26l658t1186r882b1234],
23	Clinical	JJ	O	clinical	amod	26	SENT_579	[p26l894t1185r1078b1234],
24	Status	NNP	O	Status	nn	26	SENT_579	[p26l1096t1186r1255b1234],
25	Tria	NNP	O	Tria	nn	26	SENT_579	[p26l1264t1185r1565b1234],
26	|	NNP	O	|	dep	22	SENT_579	[p26l1264t1185r1565b1234],
27	s.	VBD	O	s.	_	0	SENT_579	[p26l1264t1185r1565b1234],
28	JAMA	NN	O	jama	dobj	27	SENT_579	[p26l1264t1185r1565b1234],
29	297	CD	NUMBER	297	num	28	SENT_579	[p26l1581t1188r1696b1241],
30	,	,	O	,	_	0	SENT_579	[p26l1581t1188r1696b1241],
31	1332-1343	CD	DATE	1332-1343	number	32	SENT_579	[p26l1715t1188r1998b1234],
32	(	CD	NUMBER	(	appos	28	SENT_579	[p26l133t1263r307b1318],
33	2007	CD	DATE	2007	num	34	SENT_579	[p26l133t1263r307b1318],
34	)	NN	O	)	dep	32	SENT_579	[p26l133t1263r307b1318],
35	.	.	O	.	_	0	SENT_579	[p26l133t1263r307b1318],

1	Metra	NNP	ORGANIZATION	Metra	_	0	SENT_580	[p26l132t1342r295b1397],
2	,	,	O	,	_	0	SENT_580	[p26l132t1342r295b1397],
3	M.	NNP	O	M.	nn	4	SENT_580	[p26l311t1342r370b1389],
4	etal	NNP	O	etal	appos	1	SENT_580	[p26l384t1340r496b1389],
5	.	.	O	.	_	0	SENT_580	[p26l384t1340r496b1389],

1	Early	RB	O	early	advmod	3	SENT_581	[p26l515t1340r638b1403],
2	dyspnoea	JJ	O	dyspnoea	amod	3	SENT_581	[p26l651t1340r905b1403],
3	relief	NN	O	relief	_	0	SENT_581	[p26l924t1339r1055b1389],
4	in	IN	O	in	_	0	SENT_581	[p26l1066t1342r1108b1389],
5	acute	JJ	O	acute	amod	7	SENT_581	[p26l1125t1347r1268b1389],
6	heart	NN	O	heart	nn	7	SENT_581	[p26l1285t1340r1421b1389],
7	failure	NN	O	failure	prep_in	3	SENT_581	[p26l1433t1339r1609b1389],
8	:	:	O	:	_	0	SENT_581	[p26l1433t1339r1609b1389],
9	prevalence	NN	O	prevalence	conj_and	3	SENT_581	[p26l1626t1340r1924b1402],
10	,	,	O	,	_	0	SENT_581	[p26l1626t1340r1924b1402],
11	association	NN	O	association	appos	9	SENT_581	[p26l132t1420r421b1467],
12	with	IN	O	with	_	0	SENT_581	[p26l437t1418r550b1467],
13	mortality	NN	O	mortality	prep_with	11	SENT_581	[p26l569t1418r817b1481],
14	,	,	O	,	_	0	SENT_581	[p26l569t1418r817b1481],
15	and	CC	O	and	_	0	SENT_581	[p26l831t1418r927b1467],
16	effect	NN	O	effect	conj_and	3	SENT_581	[p26l944t1417r1091b1467],
17	of	IN	O	of	_	0	SENT_581	[p26l1105t1417r1159b1467],
18	rolofylline	NN	O	rolofylline	prep_of	16	SENT_581	[p26l1171t1417r1430b1481],
19	in	IN	O	in	_	0	SENT_581	[p26l1446t1420r1489b1467],
20	the	DT	O	the	det	22	SENT_581	[p26l1504t1418r1590b1467],
21	PROTECT	NNP	O	PROTECT	nn	22	SENT_581	[p26l1607t1419r1847b1467],
22	Study	NNP	O	Study	prep_in	18	SENT_581	[p26l1859t1418r2019b1481],
23	.	.	O	.	_	0	SENT_581	[p26l1859t1418r2019b1481],

1	Eur	NNP	O	Eur	_	0	SENT_582	[p26l2033t1420r2122b1467],
2	.	.	O	.	_	0	SENT_582	[p26l2033t1420r2122b1467],

1	HeartJ	NN	O	heartj	_	0	SENT_583	[p26l131t1496r905b1551],
2	.32,1519	CD	NUMBER	.32,1519	num	1	SENT_583	[p26l131t1496r905b1551],
3	—	CD	NUMBER	—	number	4	SENT_583	[p26l131t1496r905b1551],
4	1534	CD	DATE	1534	dep	1	SENT_583	[p26l131t1496r905b1551],
5	(	CD	DATE	(	num	7	SENT_583	[p26l131t1496r905b1551],
6	2011	CD	DATE	2011	num	7	SENT_583	[p26l131t1496r905b1551],
7	)	NN	O	)	dep	4	SENT_583	[p26l131t1496r905b1551],
8	.	.	O	.	_	0	SENT_583	[p26l131t1496r905b1551],

1	Va	NNP	O	Va	nsubj	2	SENT_584	[p26l128t1573r370b1630],
2	|	VBD	O	|	_	0	SENT_584	[p26l128t1573r370b1630],
3	|	CD	NUMBER	|	dobj	2	SENT_584	[p26l128t1573r370b1630],
4	on	IN	O	on	prep	2	SENT_584	[p26l128t1573r370b1630],
5	,	,	O	,	_	0	SENT_584	[p26l128t1573r370b1630],
6	V.	NNP	O	V.	dobj	2	SENT_584	[p26l128t1573r370b1630],
7	,	,	O	,	_	0	SENT_584	[p26l128t1573r370b1630],
8	Miihlbauer	NNP	O	Miihlbauer	dobj	2	SENT_584	[p26l385t1573r682b1630],
9	,	,	O	,	_	0	SENT_584	[p26l385t1573r682b1630],
10	B.	NNP	ORGANIZATION	B.	dobj	2	SENT_584	[p26l699t1575r739b1622],
11	&	CC	ORGANIZATION	&	_	0	SENT_584	[p26l753t1574r790b1622],
12	Osswald	NNP	ORGANIZATION	Osswald	dobj	2	SENT_584	[p26l803t1573r1034b1630],
13	,	,	O	,	_	0	SENT_584	[p26l803t1573r1034b1630],
14	H.	NNP	LOCATION	H.	nn	15	SENT_584	[p26l1051t1575r1099b1622],
15	Adenosine	NNP	LOCATION	Adenosine	conj_and	6	SENT_584	[p26l1113t1573r1393b1622],
16	and	CC	O	and	_	0	SENT_584	[p26l1408t1573r1504b1622],
17	kidney	NN	O	kidney	nn	18	SENT_584	[p26l1523t1573r1697b1636],
18	function	NN	O	function	conj_and	6	SENT_584	[p26l1708t1572r1944b1622],
19	.	.	O	.	_	0	SENT_584	[p26l1708t1572r1944b1622],

1	Physiol	NNP	O	Physiol	_	0	SENT_585	[p26l1957t1573r2143b1636],
2	.	.	O	.	_	0	SENT_585	[p26l1957t1573r2143b1636],

1	Rev.	NNP	O	Rev.	_	0	SENT_586	[p26l131t1652r232b1699],
2	86	CD	NUMBER	86	num	1	SENT_586	[p26l246t1653r326b1706],
3	,	,	O	,	_	0	SENT_586	[p26l246t1653r326b1706],
4	901	CD	NUMBER	901	num	1	SENT_586	[p26l341t1653r425b1699],
5	-940	CD	NUMBER	-940	number	6	SENT_586	[p26l438t1653r565b1699],
6	(	CD	NUMBER	(	dep	1	SENT_586	[p26l581t1651r755b1706],
7	2006	CD	DATE	2006	num	8	SENT_586	[p26l581t1651r755b1706],
8	)	NN	O	)	dep	6	SENT_586	[p26l581t1651r755b1706],
9	.	.	O	.	_	0	SENT_586	[p26l581t1651r755b1706],

1	Va	NNP	O	Va	nsubj	2	SENT_587	[p26l128t1728r370b1785],
2	|	VBD	O	|	_	0	SENT_587	[p26l128t1728r370b1785],
3	|	CD	NUMBER	|	dobj	2	SENT_587	[p26l128t1728r370b1785],
4	on	IN	O	on	prep	2	SENT_587	[p26l128t1728r370b1785],
5	,	,	O	,	_	0	SENT_587	[p26l128t1728r370b1785],
6	V.	NNP	O	V.	dobj	2	SENT_587	[p26l128t1728r370b1785],
7	,	,	O	,	_	0	SENT_587	[p26l128t1728r370b1785],
8	Miracle	NNP	O	Miracle	dobj	2	SENT_587	[p26l385t1728r586b1785],
9	,	,	O	,	_	0	SENT_587	[p26l385t1728r586b1785],
10	C.	NNP	ORGANIZATION	C.	dobj	2	SENT_587	[p26l600t1729r647b1777],
11	&	CC	ORGANIZATION	&	_	0	SENT_587	[p26l660t1728r967b1785],
12	Thomson	NNP	ORGANIZATION	Thomson	dobj	2	SENT_587	[p26l660t1728r967b1785],
13	,	,	O	,	_	0	SENT_587	[p26l660t1728r967b1785],
14	S.	NNP	LOCATION	S.	nn	15	SENT_587	[p26l982t1729r1022b1777],
15	Adenosine	NNP	LOCATION	Adenosine	conj_and	6	SENT_587	[p26l1036t1728r1317b1777],
16	and	CC	O	and	_	0	SENT_587	[p26l1331t1728r1427b1777],
17	kidney	NN	O	kidney	nn	18	SENT_587	[p26l1446t1728r1620b1791],
18	function	NN	O	function	conj_and	6	SENT_587	[p26l1632t1727r1867b1777],
19	:	:	O	:	_	0	SENT_587	[p26l1632t1727r1867b1777],
20	potential	JJ	O	potential	amod	21	SENT_587	[p26l1883t1728r2115b1790],
21	implications	NNS	O	implication	dep	6	SENT_587	[p26l133t1806r451b1868],
22	in	IN	O	in	_	0	SENT_587	[p26l468t1808r510b1855],
23	patients	NNS	O	patient	prep_in	21	SENT_587	[p26l529t1808r738b1868],
24	with	IN	O	with	_	0	SENT_587	[p26l752t1806r865b1855],
25	heart	NN	O	heart	nn	26	SENT_587	[p26l884t1806r1020b1855],
26	failure	NN	O	failure	prep_with	23	SENT_587	[p26l1032t1805r1208b1855],
27	.	.	O	.	_	0	SENT_587	[p26l1032t1805r1208b1855],

1	Eur	NNP	O	Eur	_	0	SENT_588	[p26l1222t1808r1310b1855],
2	.	.	O	.	_	0	SENT_588	[p26l1222t1808r1310b1855],

1	J.	NNP	O	J.	nn	2	SENT_589	[p26l1321t1808r1356b1855],
2	HeartFaiI	NNP	O	HeartFaiI	_	0	SENT_589	[p26l1370t1806r1622b1855],
3	.	.	O	.	_	0	SENT_589	[p26l1370t1806r1622b1855],

1	10	CD	NUMBER	10	_	0	SENT_590	[p26l1639t1809r1716b1863],
2	,	,	O	,	_	0	SENT_590	[p26l1639t1809r1716b1863],
3	176-187	CD	NUMBER	176-187	number	4	SENT_590	[p26l1735t1809r1954b1855],
4	(	CD	NUMBER	(	appos	1	SENT_590	[p26l1971t1807r2145b1863],
5	2008	CD	DATE	2008	num	6	SENT_590	[p26l1971t1807r2145b1863],
6	)	NN	O	)	dep	4	SENT_590	[p26l1971t1807r2145b1863],
7	.	.	O	.	_	0	SENT_590	[p26l1971t1807r2145b1863],

1	Cotter	NNP	PERSON	Cotter	nn	4	SENT_591	[p26l130t1885r301b1941],
2	,	,	O	,	_	0	SENT_591	[p26l130t1885r301b1941],
3	G.	NNP	O	G.	appos	4	SENT_591	[p26l315t1886r366b1934],
4	etal.	NNP	O	etal.	_	0	SENT_591	[p26l380t1884r508b1941],
5	;	:	O	;	_	0	SENT_591	[p26l380t1884r508b1941],
6	Protect	NNP	ORGANIZATION	Protect	nn	8	SENT_591	[p26l524t1886r709b1934],
7	Steering	NNP	ORGANIZATION	Steering	nn	8	SENT_591	[p26l724t1885r940b1947],
8	Committee	NNP	ORGANIZATION	Committee	dep	4	SENT_591	[p26l956t1885r1263b1941],
9	,	,	O	,	_	0	SENT_591	[p26l956t1885r1263b1941],
10	Investigators	NNS	O	investigator	conj_and	8	SENT_591	[p26l1279t1886r1626b1947],
11	,	,	O	,	_	0	SENT_591	[p26l1279t1886r1626b1947],
12	and	CC	O	and	_	0	SENT_591	[p26l1640t1884r1736b1934],
13	Coordinators	NNS	O	coordinator	conj_and	8	SENT_591	[p26l1753t1884r2106b1934],
14	.	.	O	.	_	0	SENT_591	[p26l1753t1884r2106b1934],

1	The	DT	O	the	det	4	SENT_592	[p26l129t1962r226b2011],
2	PROTECT	NNP	O	PROTECT	nn	4	SENT_592	[p26l243t1963r483b2012],
3	pilot	NN	O	pilot	nn	4	SENT_592	[p26l497t1962r614b2024],
4	study	NN	O	study	_	0	SENT_592	[p26l628t1962r785b2025],
5	:	:	O	:	_	0	SENT_592	[p26l628t1962r785b2025],
6	a	DT	O	a	dep	4	SENT_592	[p26l800t1977r825b2011],
7	randomized	VBN	O	randomize	partmod	6	SENT_592	[p26l843t1962r1170b2019],
8	,	,	O	,	_	0	SENT_592	[p26l843t1962r1170b2019],
9	placebo-controlled	JJ	O	placebo-controlled	amod	12	SENT_592	[p26l1186t1962r1700b2024],
10	,	,	O	,	_	0	SENT_592	[p26l1186t1962r1700b2024],
11	dose-ﬁnding	JJ	O	dose-ﬁnding	amod	12	SENT_592	[p26l1714t1961r2048b2025],
12	study	NN	O	study	appos	6	SENT_592	[p26l132t2040r276b2103],
13	of	IN	O	of	_	0	SENT_592	[p26l289t2039r344b2090],
14	the	DT	O	the	det	19	SENT_592	[p26l352t2040r438b2090],
15	adenosine	NN	O	adenosine	nn	19	SENT_592	[p26l452t2040r725b2090],
16	A1	NN	O	a1	nn	19	SENT_592	[p26l738t2042r797b2089],
17	receptor	NN	O	receptor	nn	19	SENT_592	[p26l823t2047r1043b2102],
18	antagonist	NN	O	antagonist	nn	19	SENT_592	[p26l1056t2042r1338b2103],
19	rolofylline	NN	O	rolofylline	prep_of	12	SENT_592	[p26l1353t2039r1613b2103],
20	in	IN	O	in	_	0	SENT_592	[p26l1629t2042r1671b2089],
21	patients	NNS	O	patient	prep_in	19	SENT_592	[p26l1690t2042r1899b2102],
22	with	IN	O	with	_	0	SENT_592	[p26l1913t2040r2026b2090],
23	acute	JJ	O	acute	amod	25	SENT_592	[p26l131t2125r275b2168],
24	heart	NN	O	heart	nn	25	SENT_592	[p26l291t2118r427b2168],
25	failure	NN	O	failure	prep_with	21	SENT_592	[p26l439t2117r603b2168],
26	and	CC	O	and	_	0	SENT_592	[p26l617t2118r713b2168],
27	renal	JJ	O	renal	amod	28	SENT_592	[p26l732t2118r856b2168],
28	impairment	NN	O	impairment	conj_and	25	SENT_592	[p26l875t2120r1195b2180],
29	.	.	O	.	_	0	SENT_592	[p26l875t2120r1195b2180],

1	J.	NNP	O	J.	nn	2	SENT_593	[p26l1205t2120r1239b2168],
2	Card	NNP	O	Card	_	0	SENT_593	[p26l1255t2118r1381b2168],
3	.	.	O	.	_	0	SENT_593	[p26l1255t2118r1381b2168],

1	Fail	NN	O	fail	_	0	SENT_594	[p26l1397t2118r1495b2168],
2	.	.	O	.	_	0	SENT_594	[p26l1397t2118r1495b2168],

1	14	CD	NUMBER	14	_	0	SENT_595	[p26l1512t2122r1590b2175],
2	,	,	O	,	_	0	SENT_595	[p26l1512t2122r1590b2175],
3	631-640	CD	NUMBER	631-640	number	4	SENT_595	[p26l1603t2121r1828b2168],
4	(	CD	NUMBER	(	appos	1	SENT_595	[p26l1844t2119r2018b2175],
5	2008	CD	DATE	2008	num	6	SENT_595	[p26l1844t2119r2018b2175],
6	)	NN	O	)	dep	4	SENT_595	[p26l1844t2119r2018b2175],
7	.	.	O	.	_	0	SENT_595	[p26l1844t2119r2018b2175],

1	Erdmann	NNP	PERSON	Erdmann	nn	3	SENT_596	[p26l132t2196r381b2253],
2	,	,	O	,	_	0	SENT_596	[p26l132t2196r381b2253],
3	E.	NNP	O	E.	_	0	SENT_596	[p26l398t2198r436b2245],
4	et	FW	O	et	nn	5	SENT_596	[p26l450t2203r499b2245],
5	al.	FW	O	al.	dep	3	SENT_596	[p26l508t2196r562b2245],
6	.	.	O	.	_	0	SENT_596	[p26l508t2196r562b2245],

1	Cinaciguat	NNP	O	Cinaciguat	nsubj	9	SENT_597	[p26l579t2197r871b2259],
2	,	,	O	,	_	0	SENT_597	[p26l579t2197r871b2259],
3	a	DT	O	a	det	7	SENT_597	[p26l885t2211r910b2245],
4	soluble	JJ	O	soluble	amod	7	SENT_597	[p26l927t2196r1116b2245],
5	guanylate	NN	O	guanylate	nn	7	SENT_597	[p26l1130t2196r1390b2259],
6	cyclase	NN	O	cyclase	nn	7	SENT_597	[p26l1405t2196r1591b2259],
7	activator	NN	O	activator	appos	1	SENT_597	[p26l1605t2198r1844b2253],
8	,	,	O	,	_	0	SENT_597	[p26l1605t2198r1844b2253],
9	unloads	VBZ	O	unload	_	0	SENT_597	[p26l1860t2196r2066b2245],
10	the	DT	O	the	det	11	SENT_597	[p26l130t2274r216b2323],
11	heart	NN	O	heart	dobj	9	SENT_597	[p26l232t2274r369b2323],
12	but	CC	O	but	_	0	SENT_597	[p26l384t2274r472b2323],
13	also	RB	O	also	advmod	14	SENT_597	[p26l485t2274r587b2323],
14	causes	VBZ	O	cause	conj_but	9	SENT_597	[p26l602t2289r774b2324],
15	hypotension	NN	O	hypotension	dobj	14	SENT_597	[p26l791t2274r1117b2337],
16	in	IN	O	in	_	0	SENT_597	[p26l1135t2276r1177b2323],
17	acute	JJ	O	acute	amod	20	SENT_597	[p26l1194t2281r1337b2324],
18	decompensated	JJ	O	decompensated	amod	20	SENT_597	[p26l1351t2274r1777b2336],
19	heart	NN	O	heart	nn	20	SENT_597	[p26l1796t2274r1932b2323],
20	failure	NN	O	failure	prep_in	14	SENT_597	[p26l1944t2273r2120b2323],
21	.	.	O	.	_	0	SENT_597	[p26l1944t2273r2120b2323],

1	Eur	NNP	O	Eur	_	0	SENT_598	[p26l131t2353r220b2400],
2	.	.	O	.	_	0	SENT_598	[p26l131t2353r220b2400],

1	Heart	NNP	O	Heart	_	0	SENT_599	[p26l234t2353r420b2400],
2	]	NN	O	]	dep	1	SENT_599	[p26l234t2353r420b2400],
3	.	.	O	.	_	0	SENT_599	[p26l234t2353r420b2400],

1	34	CD	NUMBER	34	_	0	SENT_600	[p26l434t2354r514b2407],
2	,	,	O	,	_	0	SENT_600	[p26l434t2354r514b2407],
3	57-67	CD	NUMBER	57-67	number	4	SENT_600	[p26l529t2354r686b2400],
4	(	CD	NUMBER	(	appos	1	SENT_600	[p26l703t2352r877b2407],
5	2013	CD	DATE	2013	num	6	SENT_600	[p26l703t2352r877b2407],
6	)	NN	O	)	dep	4	SENT_600	[p26l703t2352r877b2407],
7	.	.	O	.	_	0	SENT_600	[p26l703t2352r877b2407],

1	Ezekowitz	NNP	PERSON	Ezekowitz	nn	3	SENT_601	[p26l132t2429r404b2486],
2	,	,	O	,	_	0	SENT_601	[p26l132t2429r404b2486],
3	J.A.	NNP	O	J.A.	_	0	SENT_601	[p26l416t2431r502b2479],
4	Novel	JJ	O	novel	amod	6	SENT_601	[p26l519t2429r663b2479],
5	pharmacologic	JJ	O	pharmacologic	amod	6	SENT_601	[p26l682t2429r1076b2492],
6	therapies	NNS	O	therapy	dep	3	SENT_601	[p26l1088t2429r1333b2491],
7	in	IN	O	in	_	0	SENT_601	[p26l1350t2431r1392b2478],
8	development	NN	O	development	prep_in	6	SENT_601	[p26l1408t2429r1763b2491],
9	for	IN	O	for	_	0	SENT_601	[p26l1775t2428r1847b2479],
10	acute	JJ	O	acute	amod	11	SENT_601	[p26l1860t2436r2003b2479],
11	decompensated	JJ	O	decompensated	amod	13	SENT_601	[p26l132t2507r557b2569],
12	heart	NN	O	heart	nn	13	SENT_601	[p26l576t2507r712b2557],
13	failure	NN	O	failure	prep_for	8	SENT_601	[p26l724t2506r900b2557],
14	.	.	O	.	_	0	SENT_601	[p26l724t2506r900b2557],

1	Curr	NN	O	curr	_	0	SENT_602	[p26l915t2509r1028b2557],
2	.	.	O	.	_	0	SENT_602	[p26l915t2509r1028b2557],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_603	[p26l1044t2507r1232b2557],
2	.	.	O	.	_	0	SENT_603	[p26l1044t2507r1232b2557],

1	Rep.	NNP	O	Rep.	_	0	SENT_604	[p26l1248t2509r1352b2569],
2	15	CD	NUMBER	15	num	1	SENT_604	[p26l1370t2511r1447b2564],
3	,	,	O	,	_	0	SENT_604	[p26l1370t2511r1447b2564],
4	329	CD	NUMBER	329	number	5	SENT_604	[p26l1462t2510r1555b2557],
5	(	CD	NUMBER	(	appos	1	SENT_604	[p26l1572t2508r1746b2564],
6	2013	CD	DATE	2013	num	7	SENT_604	[p26l1572t2508r1746b2564],
7	)	NN	O	)	dep	5	SENT_604	[p26l1572t2508r1746b2564],
8	.	.	O	.	_	0	SENT_604	[p26l1572t2508r1746b2564],

1	Nomura	NNP	ORGANIZATION	Nomura	_	0	SENT_605	[p26l132t2587r356b2642],
2	,	,	O	,	_	0	SENT_605	[p26l132t2587r356b2642],
3	F.	NNP	O	F.	nn	4	SENT_605	[p26l372t2587r404b2635],
4	etal	NNP	O	etal	appos	1	SENT_605	[p26l418t2585r530b2635],
5	.	.	O	.	_	0	SENT_605	[p26l418t2585r530b2635],

1	Multicenter	JJ	O	multicenter	amod	3	SENT_606	[p26l548t2585r850b2635],
2	prospective	JJ	O	prospective	amod	3	SENT_606	[p26l865t2587r1171b2647],
3	investigation	NN	O	investigation	_	0	SENT_606	[p26l1187t2587r1523b2648],
4	on	IN	O	on	_	0	SENT_606	[p26l1540t2600r1604b2635],
5	efficacy	NN	O	efficacy	prep_on	3	SENT_606	[p26l1621t2584r1821b2648],
6	and	CC	O	and	_	0	SENT_606	[p26l1834t2585r1930b2635],
7	safety	NN	O	safety	prep_on	3	SENT_606	[p26l132t2662r286b2726],
8	of	IN	O	of	_	0	SENT_606	[p26l299t2662r353b2712],
9	carperitide	NN	O	carperitide	prep_of	3	SENT_606	[p26l363t2663r647b2725],
10	as	IN	O	as	_	0	SENT_606	[p26l661t2678r713b2713],
11	a	DT	O	a	det	13	SENT_606	[p26l727t2678r753b2712],
12	ﬁrst-line	JJ	O	ﬁrst-line	amod	13	SENT_606	[p26l767t2662r981b2713],
13	drug	NN	O	drug	prep_as	9	SENT_606	[p26l996t2663r1117b2726],
14	for	IN	O	for	_	0	SENT_606	[p26l1132t2662r1204b2712],
15	acute	JJ	O	acute	amod	18	SENT_606	[p26l1217t2670r1361b2713],
16	heart	NN	O	heart	nn	18	SENT_606	[p26l1377t2663r1513b2713],
17	failure	NN	O	failure	nn	18	SENT_606	[p26l1526t2662r1689b2712],
18	syndrome	NN	O	syndrome	prep_for	13	SENT_606	[p26l1704t2663r1966b2727],
19	with	IN	O	with	_	0	SENT_606	[p26l1980t2663r2093b2712],
20	preserved	JJ	O	preserved	amod	22	SENT_606	[p26l133t2741r391b2803],
21	blood	NN	O	blood	nn	22	SENT_606	[p26l409t2741r558b2791],
22	pressure	NN	O	pressure	prep_with	18	SENT_606	[p26l577t2756r810b2803],
23	:	:	O	:	_	0	SENT_606	[p26l577t2756r810b2803],
24	COMPASS	NNS	O	compass	dep	3	SENT_606	[p26l824t2742r1095b2791],
25	:	:	O	:	_	0	SENT_606	[p26l824t2742r1095b2791],
26	Carperitide	NNP	O	Carperitide	nn	28	SENT_606	[p26l1109t2741r1401b2803],
27	Effects	NNPS	O	Effects	nn	28	SENT_606	[p26l1418t2740r1587b2791],
28	Observed	NNP	O	Observed	nsubj	30	SENT_606	[p26l1601t2741r1853b2791],
29	Through	IN	O	through	prep	28	SENT_606	[p26l1864t2741r2089b2804],
30	Monitoring	VBG	O	monitor	rcmod	24	SENT_606	[p26l133t2821r425b2882],
31	Dyspnea	NNP	O	Dyspnea	dobj	30	SENT_606	[p26l443t2821r668b2882],
32	in	IN	O	in	_	0	SENT_606	[p26l686t2821r728b2868],
33	Acute	JJ	O	acute	amod	37	SENT_606	[p26l744t2821r896b2868],
34	Decompensated	JJ	O	decompensated	amod	37	SENT_606	[p26l912t2819r1343b2881],
35	Heart	NNP	O	Heart	nn	37	SENT_606	[p26l1361t2821r1503b2868],
36	Failure	NN	O	failure	nn	37	SENT_606	[p26l1520t2819r1689b2868],
37	Study	NN	O	study	prep_in	31	SENT_606	[p26l1704t2819r1863b2883],
38	.	.	O	.	_	0	SENT_606	[p26l1704t2819r1863b2883],

1	Circ	NNP	O	Circ	_	0	SENT_607	[p26l1879t2821r1980b2868],
2	.	.	O	.	_	0	SENT_607	[p26l1879t2821r1980b2868],

1	J.	NNP	O	J.	_	0	SENT_608	[p26l1991t2821r2028b2868],
2	72	CD	NUMBER	72	num	1	SENT_608	[p26l2043t2822r2122b2876],
3	,	,	O	,	_	0	SENT_608	[p26l2043t2822r2122b2876],
4	1777-1786	CD	DATE	1777-1786	num	1	SENT_608	[p26l136t2899r421b2945],
5	(	CD	NUMBER	(	num	7	SENT_608	[p26l437t2897r611b2952],
6	2008	CD	DATE	2008	num	7	SENT_608	[p26l437t2897r611b2952],
7	)	NN	O	)	dep	1	SENT_608	[p26l437t2897r611b2952],
8	.	.	O	.	_	0	SENT_608	[p26l437t2897r611b2952],

1	Sato	NNP	PERSON	Sato	nn	4	SENT_609	[p26l130t2976r255b3031],
2	,	,	O	,	_	0	SENT_609	[p26l130t2976r255b3031],
3	N.	NNP	O	N.	appos	4	SENT_609	[p26l272t2976r321b3024],
4	etal.	NNP	O	etal.	_	0	SENT_609	[p26l335t2974r462b3031],
5	;	:	O	;	_	0	SENT_609	[p26l335t2974r462b3031],
6	ATTEND	NNP	O	ATTEND	nn	7	SENT_609	[p26l476t2976r688b3023],
7	Investigators	NNS	O	investigator	dep	4	SENT_609	[p26l705t2976r1051b3037],
8	.	.	O	.	_	0	SENT_609	[p26l705t2976r1051b3037],

1	Acute	JJ	O	acute	amod	5	SENT_610	[p26l1065t2976r1217b3024],
2	decompensated	JJ	O	decompensated	amod	5	SENT_610	[p26l1231t2974r1657b3036],
3	heart	NN	O	heart	nn	5	SENT_610	[p26l1676t2974r1812b3024],
4	failure	NN	O	failure	nn	5	SENT_610	[p26l1824t2973r1987b3024],
5	syndromes	NNS	O	syndrome	nsubj	6	SENT_610	[p26l132t3052r419b3116],
6	(	VBP	O	(	_	0	SENT_610	[p26l435t3053r678b3109],
7	ATTEND	NN	O	attend	nn	9	SENT_610	[p26l435t3053r678b3109],
8	)	NN	O	)	nn	9	SENT_610	[p26l435t3053r678b3109],
9	registry	NN	O	registry	dobj	6	SENT_610	[p26l697t3054r902b3115],
10	.	.	O	.	_	0	SENT_610	[p26l697t3054r902b3115],

1	A	DT	O	a	det	6	SENT_611	[p26l915t3054r952b3101],
2	prospective	JJ	O	prospective	amod	6	SENT_611	[p26l967t3054r1273b3114],
3	observational	JJ	O	observational	amod	6	SENT_611	[p26l1287t3052r1644b3101],
4	multicenter	NN	O	multicenter	nn	6	SENT_611	[p26l1663t3052r1966b3101],
5	cohort	NN	O	cohort	nn	6	SENT_611	[p26l1979t3052r2152b3101],
6	study	NN	O	study	_	0	SENT_611	[p26l132t3130r289b3193],
7	:	:	O	:	_	0	SENT_611	[p26l132t3130r289b3193],
8	rationale	NN	O	rationale	dep	6	SENT_611	[p26l306t3130r547b3187],
9	,	,	O	,	_	0	SENT_611	[p26l306t3130r547b3187],
10	design	NN	O	design	dep	6	SENT_611	[p26l561t3130r749b3193],
11	,	,	O	,	_	0	SENT_611	[p26l561t3130r749b3193],
12	and	CC	O	and	_	0	SENT_611	[p26l762t3130r859b3179],
13	preliminary	JJ	O	preliminary	amod	14	SENT_611	[p26l878t3130r1177b3194],
14	data	NNS	O	datum	dep	6	SENT_611	[p26l1190t3130r1318b3179],
15	.	.	O	.	_	0	SENT_611	[p26l1190t3130r1318b3179],

1	Am	NNP	O	Am	_	0	SENT_612	[p26l1328t3132r1427b3179],
2	.	.	O	.	_	0	SENT_612	[p26l1328t3132r1427b3179],

1	Heart	NNP	O	Heart	_	0	SENT_613	[p26l1442t3132r1628b3179],
2	]	NN	O	]	dep	1	SENT_613	[p26l1442t3132r1628b3179],
3	.	.	O	.	_	0	SENT_613	[p26l1442t3132r1628b3179],

1	159	CD	NUMBER	159	_	0	SENT_614	[p26l1645t3133r1757b3187],
2	,	,	O	,	_	0	SENT_614	[p26l1645t3133r1757b3187],
3	949	CD	NUMBER	949	num	4	SENT_614	[p26l1772t3133r2064b3180],
4	—	NN	O	—	appos	1	SENT_614	[p26l1772t3133r2064b3180],
5	955	CD	NUMBER	955	dep	4	SENT_614	[p26l1772t3133r2064b3180],
6	.	.	O	.	_	0	SENT_614	[p26l1772t3133r2064b3180],

1	e1	NN	O	e1	_	0	SENT_615	[p26l1772t3133r2064b3180],
2	(	CD	NUMBER	(	num	1	SENT_615	[p26l133t3208r307b3263],
3	2010	CD	DATE	2010	num	4	SENT_615	[p26l133t3208r307b3263],
4	)	NN	O	)	dep	1	SENT_615	[p26l133t3208r307b3263],
5	.	.	O	.	_	0	SENT_615	[p26l133t3208r307b3263],

1	54	CD	NUMBER	54	_	0	SENT_616	[p27l9t22r82b68],
2	.	.	O	.	_	0	SENT_616	[p27l9t22r82b68],

1	Hata	NNP	PERSON	Hata	_	0	SENT_617	[p27l132t20r263b75],
2	,	,	O	,	_	0	SENT_617	[p27l132t20r263b75],
3	N.	NNP	O	N.	nn	4	SENT_617	[p27l280t20r328b68],
4	etal	NN	O	etal	appos	1	SENT_617	[p27l342t18r454b68],
5	.	.	O	.	_	0	SENT_617	[p27l342t18r454b68],

1	Effects	NNS	O	effect	_	0	SENT_618	[p27l473t17r642b68],
2	of	IN	O	of	_	0	SENT_618	[p27l657t17r711b68],
3	carperitide	NN	O	carperitide	prep_of	1	SENT_618	[p27l721t18r1004b80],
4	on	IN	O	on	_	0	SENT_618	[p27l1019t33r1083b68],
5	the	DT	O	the	det	7	SENT_618	[p27l1099t18r1184b68],
6	long-term	JJ	O	long-term	amod	7	SENT_618	[p27l1201t18r1460b81],
7	prognosis	NN	O	prognosis	prep_on	1	SENT_618	[p27l1479t20r1734b81],
8	of	IN	O	of	_	0	SENT_618	[p27l1749t17r1803b68],
9	patients	NNS	O	patient	prep_of	7	SENT_618	[p27l1815t20r2025b80],
10	with	IN	O	with	_	0	SENT_618	[p27l130t96r243b146],
11	acute	JJ	O	acute	amod	12	SENT_618	[p27l260t103r403b146],
12	decompensated	JJ	O	decompensated	amod	15	SENT_618	[p27l417t96r843b158],
13	chronic	JJ	O	chronic	amod	15	SENT_618	[p27l860t96r1054b146],
14	heart	NN	O	heart	nn	15	SENT_618	[p27l1070t96r1206b146],
15	failure	NN	O	failure	prep_with	9	SENT_618	[p27l1218t95r1395b146],
16	:	:	O	:	_	0	SENT_618	[p27l1218t95r1395b146],
17	the	DT	O	the	det	19	SENT_618	[p27l1408t96r1494b146],
18	PROTECT	NNP	O	PROTECT	nn	19	SENT_618	[p27l1511t97r1751b146],
19	multicenter	NN	O	multicenter	nsubj	20	SENT_618	[p27l1765t96r2068b146],
20	randomized	VBD	O	randomize	dep	1	SENT_618	[p27l133t173r446b223],
21	controlled	JJ	O	controlled	amod	22	SENT_618	[p27l462t173r728b223],
22	study	NN	O	study	dobj	20	SENT_618	[p27l745t173r898b237],
23	.	.	O	.	_	0	SENT_618	[p27l745t173r898b237],

1	Circ	NNP	O	Circ	_	0	SENT_619	[p27l913t175r1016b223],
2	.	.	O	.	_	0	SENT_619	[p27l913t175r1016b223],

1	J.	NNP	O	J.	_	0	SENT_620	[p27l1027t175r1063b223],
2	72	CD	NUMBER	72	num	1	SENT_620	[p27l1078t176r1157b230],
3	,	,	O	,	_	0	SENT_620	[p27l1078t176r1157b230],
4	1787-1793	CD	DATE	1787-1793	num	1	SENT_620	[p27l1176t176r1459b223],
5	(	CD	NUMBER	(	num	7	SENT_620	[p27l1478t174r1651b230],
6	2008	CD	DATE	2008	num	7	SENT_620	[p27l1478t174r1651b230],
7	)	NN	O	)	dep	1	SENT_620	[p27l1478t174r1651b230],
8	.	.	O	.	_	0	SENT_620	[p27l1478t174r1651b230],

1	55	CD	NUMBER	55	_	0	SENT_621	[p27l9t255r82b301],
2	.	.	O	.	_	0	SENT_621	[p27l9t255r82b301],

1	Conrad	NNP	PERSON	Conrad	_	0	SENT_622	[p27l130t251r332b308],
2	,	,	O	,	_	0	SENT_622	[p27l130t251r332b308],
3	K.P.	NNP	O	K.P.	nn	5	SENT_622	[p27l349t253r429b301],
4	Maternal	NNP	O	Maternal	nn	5	SENT_622	[p27l445t251r674b301],
5	vasodilation	NN	O	vasodilation	appos	1	SENT_622	[p27l689t251r1008b301],
6	in	IN	O	in	_	0	SENT_622	[p27l1026t253r1069b300],
7	pregnancy	NN	O	pregnancy	prep_in	5	SENT_622	[p27l1087t266r1381b315],
8	:	:	O	:	_	0	SENT_622	[p27l1087t266r1381b315],
9	the	DT	O	the	det	11	SENT_622	[p27l1394t251r1479b301],
10	emerging	VBG	O	emerge	amod	11	SENT_622	[p27l1494t253r1746b314],
11	role	NN	O	role	dep	1	SENT_622	[p27l1765t251r1861b301],
12	of	IN	O	of	_	0	SENT_622	[p27l1876t250r1930b301],
13	relaxin	NN	O	relaxin	prep_of	11	SENT_622	[p27l1941t251r2125b301],
14	.	.	O	.	_	0	SENT_622	[p27l1941t251r2125b301],

1	Am	NNP	O	Am	_	0	SENT_623	[p27l128t331r227b379],
2	.	.	O	.	_	0	SENT_623	[p27l128t331r227b379],

1	J.	NNP	PERSON	J.	nn	2	SENT_624	[p27l237t331r272b379],
2	Physiol	NNP	PERSON	Physiol	_	0	SENT_624	[p27l287t329r473b393],
3	.	.	O	.	_	0	SENT_624	[p27l287t329r473b393],

1	Regul	NN	O	regul	_	0	SENT_625	[p27l488t329r637b392],
2	.	.	O	.	_	0	SENT_625	[p27l488t329r637b392],

1	Integr	NNP	O	Integr	_	0	SENT_626	[p27l653t331r808b392],
2	.	.	O	.	_	0	SENT_626	[p27l653t331r808b392],

1	Comp	NN	O	comp	_	0	SENT_627	[p27l824t331r982b391],
2	.	.	O	.	_	0	SENT_627	[p27l824t331r982b391],

1	Physiol	NNP	O	Physiol	_	0	SENT_628	[p27l998t329r1186b393],
2	.	.	O	.	_	0	SENT_628	[p27l998t329r1186b393],

1	301	CD	NUMBER	301	_	0	SENT_629	[p27l1201t332r1316b387],
2	,	,	O	,	_	0	SENT_629	[p27l1201t332r1316b387],
3	R267	NN	O	r267	appos	1	SENT_629	[p27l1333t331r1621b379],
4	.	.	O	.	_	0	SENT_629	[p27l1333t331r1621b379],

1	—	NN	O	—	_	0	SENT_630	[p27l1333t331r1621b379],
2	.	.	O	.	_	0	SENT_630	[p27l1333t331r1621b379],

1	R275	NN	O	r275	nn	2	SENT_631	[p27l1333t331r1621b379],
2	(	NN	O	(	_	0	SENT_631	[p27l1639t330r1740b386],
3	201	CD	NUMBER	201	number	4	SENT_631	[p27l1639t330r1740b386],
4	1	CD	NUMBER	1	dep	2	SENT_631	[p27l1758t330r1814b386],
5	)	NN	O	)	dep	4	SENT_631	[p27l1758t330r1814b386],
6	.	.	O	.	_	0	SENT_631	[p27l1758t330r1814b386],

1	56	CD	NUMBER	56	_	0	SENT_632	[p27l9t410r82b457],
2	.	.	O	.	_	0	SENT_632	[p27l9t410r82b457],

1	Teerlink	NNP	PERSON	Teerlink	_	0	SENT_633	[p27l127t407r347b464],
2	,	,	O	,	_	0	SENT_633	[p27l127t407r347b464],
3	J.R.	NNP	PERSON	J.R.	nn	4	SENT_633	[p27l359t409r440b457],
4	etal	NNP	O	etal	appos	1	SENT_633	[p27l454t407r566b457],
5	.	.	O	.	_	0	SENT_633	[p27l454t407r566b457],

1	Relaxin	NN	O	relaxin	_	0	SENT_634	[p27l585t407r769b457],
2	for	IN	O	for	_	0	SENT_634	[p27l783t406r856b457],
3	the	DT	O	the	det	4	SENT_634	[p27l867t407r953b457],
4	treatment	NN	O	treatment	prep_for	1	SENT_634	[p27l966t415r1230b457],
5	of	IN	O	of	_	0	SENT_634	[p27l1244t406r1298b457],
6	patients	NNS	O	patient	prep_of	1	SENT_634	[p27l1310t409r1520b469],
7	with	IN	O	with	_	0	SENT_634	[p27l1533t407r1646b457],
8	acute	JJ	O	acute	amod	10	SENT_634	[p27l1663t415r1806b457],
9	heart	NN	O	heart	nn	10	SENT_634	[p27l1823t407r1958b457],
10	failure	NN	O	failure	prep_with	6	SENT_634	[p27l1971t406r2134b457],

1	(	NN	O	(	_	0	SENT_635	[p27l133t486r582b542],
2	Pre	NN	O	pre	dep	1	SENT_635	[p27l133t486r582b542],
3	.	.	O	.	_	0	SENT_635	[p27l133t486r582b542],

1	—	NN	O	—	_	0	SENT_636	[p27l133t486r582b542],
2	.	.	O	.	_	0	SENT_636	[p27l133t486r582b542],

1	RELAX	NN	O	relax	_	0	SENT_637	[p27l133t486r582b542],
2	.	.	O	.	_	0	SENT_637	[p27l133t486r582b542],

1	—	NN	O	—	_	0	SENT_638	[p27l133t486r582b542],
2	.	.	O	.	_	0	SENT_638	[p27l133t486r582b542],

1	AHF	NN	O	ahf	dep	16	SENT_639	[p27l133t486r582b542],
2	)	CD	NUMBER	)	num	1	SENT_639	[p27l133t486r582b542],
3	:	:	O	:	_	0	SENT_639	[p27l133t486r582b542],
4	a	DT	O	a	det	15	SENT_639	[p27l596t500r622b535],
5	multicentre	JJ	O	multicentre	amod	7	SENT_639	[p27l640t485r953b542],
6	,	,	O	,	_	0	SENT_639	[p27l640t485r953b542],
7	randomised	JJ	O	randomised	amod	15	SENT_639	[p27l970t485r1295b542],
8	,	,	O	,	_	0	SENT_639	[p27l970t485r1295b542],
9	p	NN	O	p	nn	12	SENT_639	[p27l1311t485r1824b547],
10	|	CD	NUMBER	|	num	12	SENT_639	[p27l1311t485r1824b547],
11	acebo	NN	O	acebo	nn	12	SENT_639	[p27l1311t485r1824b547],
12	—	NN	O	—	dep	7	SENT_639	[p27l1311t485r1824b547],
13	contro	NN	O	contro	dep	12	SENT_639	[p27l1311t485r1824b547],
14	|	CD	NUMBER	|	num	13	SENT_639	[p27l1311t485r1824b547],
15	|	NN	O	|	nsubj	16	SENT_639	[p27l1311t485r1824b547],
16	ed	VBD	O	ed	_	0	SENT_639	[p27l1311t485r1824b547],
17	,	,	O	,	_	0	SENT_639	[p27l1311t485r1824b547],
18	parallelgroup	NN	O	parallelgroup	nn	21	SENT_639	[p27l1840t485r2049b547, p27l131t578r301b626],
19	,	,	O	,	_	0	SENT_639	[p27l1840t485r2049b547, p27l131t578r301b626],
20	dose	NN	O	dose	dep	21	SENT_639	[p27l315t562r649b626],
21	—	NN	O	—	nsubj	22	SENT_639	[p27l315t562r649b626],
22	ﬁnding	VBG	O	ﬁnding	dep	16	SENT_639	[p27l315t562r649b626],
23	phase	NN	O	phase	nn	25	SENT_639	[p27l667t563r821b625],
24	llb	NN	O	llb	nn	25	SENT_639	[p27l837t563r899b613],
25	study	NN	O	study	dobj	22	SENT_639	[p27l913t563r1067b627],
26	.	.	O	.	_	0	SENT_639	[p27l913t563r1067b627],

1	Lancet373	NN	O	lancet373	_	0	SENT_640	[p27l1081t565r1377b620],
2	,	,	O	,	_	0	SENT_640	[p27l1081t565r1377b620],
3	1429-1439	CD	DATE	1429-1439	number	4	SENT_640	[p27l1396t566r1681b613],
4	(	CD	NUMBER	(	appos	1	SENT_640	[p27l1697t564r1871b620],
5	2009	CD	DATE	2009	num	6	SENT_640	[p27l1697t564r1871b620],
6	)	NN	O	)	dep	4	SENT_640	[p27l1697t564r1871b620],
7	.	.	O	.	_	0	SENT_640	[p27l1697t564r1871b620],

1	57	CD	NUMBER	57	_	0	SENT_641	[p27l9t644r82b689],
2	.	.	O	.	_	0	SENT_641	[p27l9t644r82b689],

1	Teerlink	NNP	PERSON	Teerlink	_	0	SENT_642	[p27l127t640r346b697],
2	,	,	O	,	_	0	SENT_642	[p27l127t640r346b697],
3	J.R.	NNP	PERSON	J.R.	nn	4	SENT_642	[p27l359t642r440b689],
4	etal	NNP	O	etal	appos	1	SENT_642	[p27l454t640r566b689],
5	.	.	O	.	_	0	SENT_642	[p27l454t640r566b689],

1	Serelaxin	NNP	O	Serelaxin	_	0	SENT_643	[p27l583t640r832b697],
2	,	,	O	,	_	0	SENT_643	[p27l583t640r832b697],
3	recombinant	JJ	O	recombinant	amod	6	SENT_643	[p27l849t640r1185b689],
4	human	JJ	O	human	amod	6	SENT_643	[p27l1202t640r1383b689],
5	re	NN	O	re	nn	6	SENT_643	[p27l1402t640r1638b697],
6	|	NN	O	|	nn	7	SENT_643	[p27l1402t640r1638b697],
7	axin	NN	O	axin	appos	1	SENT_643	[p27l1402t640r1638b697],
8	—	NN	O	—	dep	7	SENT_643	[p27l1402t640r1638b697],
9	2	CD	NUMBER	2	num	8	SENT_643	[p27l1402t640r1638b697],
10	,	,	O	,	_	0	SENT_643	[p27l1402t640r1638b697],
11	fortreatment	NN	O	fortreatment	appos	1	SENT_643	[p27l1651t639r1999b689],
12	of	IN	O	of	_	0	SENT_643	[p27l131t717r185b768],
13	acute	JJ	O	acute	amod	15	SENT_643	[p27l195t726r338b768],
14	heart	NN	O	heart	nn	15	SENT_643	[p27l355t718r491b768],
15	failure	NN	O	failure	prep_of	11	SENT_643	[p27l503t717r667b768],
16	(	CD	NUMBER	(	dep	1	SENT_643	[p27l683t719r1026b775],
17	RELAX	NNP	O	RELAX	dep	16	SENT_643	[p27l683t719r1026b775],
18	.	.	O	.	_	0	SENT_643	[p27l683t719r1026b775],

1	—	NN	O	—	_	0	SENT_644	[p27l683t719r1026b775],
2	.	.	O	.	_	0	SENT_644	[p27l683t719r1026b775],

1	AHF	NN	O	ahf	_	0	SENT_645	[p27l683t719r1026b775],
2	)	CD	NUMBER	)	num	1	SENT_645	[p27l683t719r1026b775],
3	:	:	O	:	_	0	SENT_645	[p27l683t719r1026b775],
4	a	DT	O	a	dep	1	SENT_645	[p27l1040t733r1065b768],
5	randomised	VBN	O	randomise	partmod	4	SENT_645	[p27l1083t718r1408b775],
6	,	,	O	,	_	0	SENT_645	[p27l1083t718r1408b775],
7	placebo	NN	O	placebo	nn	8	SENT_645	[p27l1425t718r1923b780],
8	—	NN	O	—	dobj	5	SENT_645	[p27l1425t718r1923b780],
9	controlled	VBN	O	control	partmod	8	SENT_645	[p27l1425t718r1923b780],
10	trial	NN	O	trial	dobj	9	SENT_645	[p27l1938t718r2051b768],
11	.	.	O	.	_	0	SENT_645	[p27l1938t718r2051b768],

1	Lancet	NNP	O	Lancet	nn	3	SENT_646	[p27l131t797r301b844],
2	381	CD	NUMBER	381	num	3	SENT_646	[p27l312t798r405b844],
3	)	NN	O	)	_	0	SENT_646	[p27l417t796r445b852],
4	,	,	O	,	_	0	SENT_646	[p27l417t796r445b852],
5	29-39	CD	NUMBER	29-39	num	6	SENT_646	[p27l460t798r618b844],
6	(	NN	O	(	appos	3	SENT_646	[p27l634t796r735b851],
7	201	CD	NUMBER	201	number	8	SENT_646	[p27l634t796r735b851],
8	3	CD	NUMBER	3	num	9	SENT_646	[p27l749t796r808b852],
9	)	NN	O	)	dep	6	SENT_646	[p27l749t796r808b852],
10	.	.	O	.	_	0	SENT_646	[p27l749t796r808b852],

1	58	CD	NUMBER	58	_	0	SENT_647	[p27l9t876r82b923],
2	.	.	O	.	_	0	SENT_647	[p27l9t876r82b923],

1	Cleland	NNP	PERSON	Cleland	_	0	SENT_648	[p27l130t873r339b931],
2	,	,	O	,	_	0	SENT_648	[p27l130t873r339b931],
3	J.G.	NNP	PERSON	J.G.	nn	4	SENT_648	[p27l351t875r439b923],
4	etal	NNP	O	etal	appos	1	SENT_648	[p27l454t873r565b923],
5	.	.	O	.	_	0	SENT_648	[p27l454t873r565b923],

1	The	DT	O	the	det	2	SENT_649	[p27l577t873r674b923],
2	effects	NNS	O	effect	_	0	SENT_649	[p27l688t872r860b923],
3	of	IN	O	of	_	0	SENT_649	[p27l875t872r929b923],
4	the	DT	O	the	det	7	SENT_649	[p27l937t873r1023b923],
5	cardiac	JJ	O	cardiac	amod	7	SENT_649	[p27l1038t873r1224b923],
6	myosin	NN	O	myosin	nn	7	SENT_649	[p27l1239t875r1424b937],
7	activator	NN	O	activator	prep_of	2	SENT_649	[p27l1440t875r1679b930],
8	,	,	O	,	_	0	SENT_649	[p27l1440t875r1679b930],
9	omecamtiv	NN	O	omecamtiv	nn	10	SENT_649	[p27l1693t875r1990b923],
10	mecarbil	NN	O	mecarbil	appos	2	SENT_649	[p27l133t951r371b1008],
11	,	,	O	,	_	0	SENT_649	[p27l133t951r371b1008],
12	on	IN	O	on	_	0	SENT_649	[p27l385t966r450b1001],
13	cardiac	JJ	O	cardiac	amod	14	SENT_649	[p27l466t951r652b1001],
14	function	NN	O	function	prep_on	10	SENT_649	[p27l664t950r884b1001],
15	in	IN	O	in	_	0	SENT_649	[p27l903t953r945b1000],
16	systolic	JJ	O	systolic	amod	18	SENT_649	[p27l962t951r1152b1015],
17	heart	NN	O	heart	nn	18	SENT_649	[p27l1168t951r1304b1001],
18	failure	NN	O	failure	prep_in	14	SENT_649	[p27l1316t950r1493b1001],
19	:	:	O	:	_	0	SENT_649	[p27l1316t950r1493b1001],
20	a	DT	O	a	det	22	SENT_649	[p27l1507t966r1532b1001],
21	double	JJ	O	double	amod	22	SENT_649	[p27l1549t951r1904b1008],
22	—	NN	O	—	dep	2	SENT_649	[p27l1549t951r1904b1008],
23	blind	JJ	O	blind	amod	25	SENT_649	[p27l1549t951r1904b1008],
24	,	,	O	,	_	0	SENT_649	[p27l1549t951r1904b1008],
25	placebocontrolled	JJ	O	placebocontrolled	amod	22	SENT_649	[p27l1921t951r2149b1014, p27l131t1029r411b1086],
26	,	,	O	,	_	0	SENT_649	[p27l1921t951r2149b1014, p27l131t1029r411b1086],
27	crossover	NN	O	crossover	appos	2	SENT_649	[p27l426t1044r683b1087],
28	,	,	O	,	_	0	SENT_649	[p27l426t1044r683b1087],
29	dose	NN	O	dose	nn	30	SENT_649	[p27l697t1029r1048b1092],
30	—	NN	O	—	appos	2	SENT_649	[p27l697t1029r1048b1092],
31	ranging	VBG	O	range	partmod	30	SENT_649	[p27l697t1029r1048b1092],
32	phase	NN	O	phase	nn	34	SENT_649	[p27l1066t1029r1220b1091],
33	2	CD	NUMBER	2	num	34	SENT_649	[p27l1235t1032r1262b1078],
34	trial	NN	O	trial	dobj	31	SENT_649	[p27l1277t1029r1388b1079],
35	.	.	O	.	_	0	SENT_649	[p27l1277t1029r1388b1079],

1	Lancet	NNP	O	Lancet	_	0	SENT_650	[p27l1403t1031r1573b1079],
2	378	CD	NUMBER	378	num	1	SENT_650	[p27l1584t1032r1699b1086],
3	,	,	O	,	_	0	SENT_650	[p27l1584t1032r1699b1086],
4	676-683	CD	NUMBER	676-683	num	1	SENT_650	[p27l1713t1032r1935b1079],
5	(	NN	O	(	dep	1	SENT_650	[p27l1954t1030r2054b1086],
6	201	CD	NUMBER	201	number	7	SENT_650	[p27l1954t1030r2054b1086],
7	1	CD	NUMBER	1	num	8	SENT_650	[p27l2072t1030r2128b1086],
8	)	NN	O	)	dep	5	SENT_650	[p27l2072t1030r2128b1086],
9	.	.	O	.	_	0	SENT_650	[p27l2072t1030r2128b1086],

1	59	CD	NUMBER	59	_	0	SENT_651	[p27l9t1110r82b1157],
2	.	.	O	.	_	0	SENT_651	[p27l9t1110r82b1157],

1	Mitrovic	NNP	PERSON	Mitrovic	_	0	SENT_652	[p27l131t1109r355b1164],
2	,	,	O	,	_	0	SENT_652	[p27l131t1109r355b1164],
3	V.	NNP	O	V.	nn	4	SENT_652	[p27l365t1109r408b1157],
4	etal	NN	O	etal	appos	1	SENT_652	[p27l422t1107r534b1157],
5	.	.	O	.	_	0	SENT_652	[p27l422t1107r534b1157],

1	Haemodynamic	JJ	PERSON	haemodynamic	amod	4	SENT_653	[p27l553t1107r968b1171],
2	and	CC	O	and	_	0	SENT_653	[p27l982t1107r1078b1157],
3	clinical	JJ	O	clinical	conj_and	1	SENT_653	[p27l1095t1107r1271b1157],
4	effects	NNS	O	effect	_	0	SENT_653	[p27l1287t1106r1459b1157],
5	of	IN	O	of	_	0	SENT_653	[p27l1474t1106r1528b1157],
6	ularitide	NN	O	ularitide	prep_of	4	SENT_653	[p27l1540t1107r1754b1157],
7	in	IN	O	in	_	0	SENT_653	[p27l1770t1109r1813b1156],
8	decompensated	JJ	O	decompensated	amod	10	SENT_653	[p27l131t1185r557b1247],
9	heart	NN	O	heart	nn	10	SENT_653	[p27l576t1185r711b1235],
10	failure	NN	O	failure	prep_in	4	SENT_653	[p27l724t1184r900b1235],
11	.	.	O	.	_	0	SENT_653	[p27l724t1184r900b1235],

1	Eur	NNP	O	Eur	_	0	SENT_654	[p27l914t1187r1002b1235],
2	.	.	O	.	_	0	SENT_654	[p27l914t1187r1002b1235],

1	Heart	NNP	O	Heart	_	0	SENT_655	[p27l1017t1187r1202b1235],
2	]	NN	O	]	dep	1	SENT_655	[p27l1017t1187r1202b1235],
3	.	.	O	.	_	0	SENT_655	[p27l1017t1187r1202b1235],

1	27	CD	NUMBER	27	_	0	SENT_656	[p27l1217t1188r1297b1242],
2	,	,	O	,	_	0	SENT_656	[p27l1217t1188r1297b1242],
3	2823-2832	CD	DATE	2823-2832	number	4	SENT_656	[p27l1311t1188r1599b1235],
4	(	CD	NUMBER	(	appos	1	SENT_656	[p27l1616t1186r1791b1242],
5	2006	CD	DATE	2006	num	6	SENT_656	[p27l1616t1186r1791b1242],
6	)	NN	O	)	dep	4	SENT_656	[p27l1616t1186r1791b1242],
7	.	.	O	.	_	0	SENT_656	[p27l1616t1186r1791b1242],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_657	[p27l20t1325r139b1346],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_657	[p27l148t1325r373b1346],
3	&	CC	O	&	_	0	SENT_657	[p27l380t1325r600b1346],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_657	[p27l380t1325r600b1346],
5	|	CD	NUMBER	|	num	6	SENT_657	[p27l380t1325r600b1346],
6	CS	NNP	O	CS	conj_and	2	SENT_657	[p27l380t1325r600b1346],
7	|	NNP	O	|	nn	8	SENT_657	[p27l610t1323r612b1353],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_657	[p27l620t1325r728b1346],
9	94	CD	NUMBER	94	num	10	SENT_657	[p27l736t1325r765b1346],
10	NUMBER	NN	O	number	dep	12	SENT_657	[p27l773t1325r881b1346],
11	4	CD	NUMBER	4	num	12	SENT_657	[p27l888t1323r914b1353],
12	|	CD	NUMBER	|	dep	15	SENT_657	[p27l888t1323r914b1353],
13	OCTOBER	NNP	DATE	OCTOBER	dep	12	SENT_657	[p27l924t1325r1043b1346],
14	2013	CD	DATE	2013	num	15	SENT_657	[p27l1051t1325r1108b1346],
15	507	CD	NUMBER	507	_	0	SENT_657	[p27l2093t1325r2139b1346],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_658	[p27l19t1428r209b1465],

1	60	CD	NUMBER	60	_	0	SENT_659	[p27l7t1643r83b1690],
2	.	.	O	.	_	0	SENT_659	[p27l7t1643r83b1690],

1	Forssmann	NNP	PERSON	Forssmann	_	0	SENT_660	[p27l133t1642r522b1698],
2	,	,	O	,	_	0	SENT_660	[p27l133t1642r522b1698],
3	W.	NNP	O	W.	conj_and	1	SENT_660	[p27l133t1642r522b1698],
4	,	,	O	,	_	0	SENT_660	[p27l133t1642r522b1698],
5	Meyer	NNP	PERSON	Meyer	conj_and	1	SENT_660	[p27l539t1642r712b1704],
6	,	,	O	,	_	0	SENT_660	[p27l539t1642r712b1704],
7	M.	NNP	ORGANIZATION	M.	conj_and	1	SENT_660	[p27l728t1642r788b1690],
8	&	CC	ORGANIZATION	&	_	0	SENT_660	[p27l802t1641r840b1690],
9	Forssmann	NNP	ORGANIZATION	Forssmann	conj_and	1	SENT_660	[p27l855t1642r1158b1698],
10	,	,	O	,	_	0	SENT_660	[p27l855t1642r1158b1698],
11	K.	NNP	O	K.	nn	15	SENT_660	[p27l1175t1642r1218b1690],
12	The	NNP	O	The	nn	15	SENT_660	[p27l1228t1640r1327b1690],
13	renal	JJ	O	renal	amod	15	SENT_660	[p27l1344t1640r1470b1690],
14	urodilatin	NN	O	urodilatin	nn	15	SENT_660	[p27l1490t1640r1744b1690],
15	system	NN	O	system	appos	1	SENT_660	[p27l1761t1647r1959b1704],
16	:	:	O	:	_	0	SENT_660	[p27l1761t1647r1959b1704],
17	clinical	JJ	O	clinical	amod	18	SENT_660	[p27l1974t1640r2153b1690],
18	implications	NNS	O	implication	dep	1	SENT_660	[p27l134t1719r472b1782],
19	.	.	O	.	_	0	SENT_660	[p27l134t1719r472b1782],

1	Cardiovasc	NNP	O	Cardiovasc	_	0	SENT_661	[p27l487t1719r779b1769],
2	.	.	O	.	_	0	SENT_661	[p27l487t1719r779b1769],

1	Res	NNP	O	Res	_	0	SENT_662	[p27l794t1721r891b1769],
2	.	.	O	.	_	0	SENT_662	[p27l794t1721r891b1769],

1	51	CD	NUMBER	51	_	0	SENT_663	[p27l906t1723r987b1777],
2	,	,	O	,	_	0	SENT_663	[p27l906t1723r987b1777],
3	450-462	CD	NUMBER	450-462	number	4	SENT_663	[p27l1000t1722r1229b1769],
4	(	CD	NUMBER	(	appos	1	SENT_663	[p27l1247t1720r1424b1777],
5	2001	CD	DATE	2001	num	6	SENT_663	[p27l1247t1720r1424b1777],
6	)	NN	O	)	dep	4	SENT_663	[p27l1247t1720r1424b1777],
7	.	.	O	.	_	0	SENT_663	[p27l1247t1720r1424b1777],

1	61	CD	NUMBER	61	_	0	SENT_664	[p27l7t1801r83b1848],
2	.	.	O	.	_	0	SENT_664	[p27l7t1801r83b1848],

1	Luss	NNP	O	Luss	_	0	SENT_665	[p27l133t1800r257b1856],
2	,	,	O	,	_	0	SENT_665	[p27l133t1800r257b1856],
3	H.	NNP	O	H.	nn	4	SENT_665	[p27l273t1800r323b1848],
4	etal	NN	O	etal	appos	1	SENT_665	[p27l337t1798r451b1848],
5	.	.	O	.	_	0	SENT_665	[p27l337t1798r451b1848],

1	Renal	JJ	O	renal	amod	2	SENT_666	[p27l471t1798r612b1848],
2	effects	NNS	O	effect	nsubj	11	SENT_666	[p27l629t1797r804b1848],
3	of	IN	O	of	_	0	SENT_666	[p27l819t1797r875b1848],
4	ularitide	NN	O	ularitide	prep_of	2	SENT_666	[p27l887t1798r1105b1848],
5	in	IN	O	in	_	0	SENT_666	[p27l1121t1800r1165b1847],
6	patients	NNS	O	patient	prep_in	4	SENT_666	[p27l1183t1800r1397b1861],
7	with	IN	O	with	_	0	SENT_666	[p27l1411t1798r1527b1848],
8	decompensated	JJ	O	decompensated	amod	10	SENT_666	[p27l1543t1798r1977b1861],
9	heart	NN	O	heart	nn	10	SENT_666	[p27l1997t1798r2135b1848],
10	fai	NNS	O	faus	prep_with	6	SENT_666	[p27l131t1875r1420b1933],
11	|	VBP	O	|	_	0	SENT_666	[p27l131t1875r1420b1933],
12	ure.Am.HeartJ.155,1012.e1-1012	NN	O	ure.am.heartj.155,1012.e1-1012	dobj	11	SENT_666	[p27l131t1875r1420b1933],
13	.	.	O	.	_	0	SENT_666	[p27l131t1875r1420b1933],

1	e8	NN	O	e8	_	0	SENT_667	[p27l131t1875r1420b1933],
2	(	CD	NUMBER	(	num	1	SENT_667	[p27l131t1875r1420b1933],
3	2008	CD	DATE	2008	num	4	SENT_667	[p27l131t1875r1420b1933],
4	)	NN	O	)	dep	1	SENT_667	[p27l131t1875r1420b1933],
5	.	.	O	.	_	0	SENT_667	[p27l131t1875r1420b1933],

1	62	CD	NUMBER	62	_	0	SENT_668	[p27l7t1958r83b2005],
2	.	.	O	.	_	0	SENT_668	[p27l7t1958r83b2005],

1	Gheorghiade	NNP	O	Gheorghiade	nn	5	SENT_669	[p27l131t1955r494b2019],
2	,	,	O	,	_	0	SENT_669	[p27l131t1955r494b2019],
3	M.	NNP	O	M.	appos	5	SENT_669	[p27l510t1957r571b2005],
4	et	NNP	O	et	nn	5	SENT_669	[p27l585t1962r635b2005],
5	aI.	NNP	O	aI.	_	0	SENT_669	[p27l644t1955r715b2013],
6	;	:	O	;	_	0	SENT_669	[p27l644t1955r715b2013],
7	ASTRONAUT	NNP	O	ASTRONAUT	nn	8	SENT_669	[p27l729t1956r1068b2005],
8	Investigators	NNS	O	investigator	dep	5	SENT_669	[p27l1082t1957r1423b2019],
9	and	CC	O	and	_	0	SENT_669	[p27l1437t1955r1535b2005],
10	Coordinators	NNS	O	coordinator	dep	5	SENT_669	[p27l1552t1955r1912b2005],
11	.	.	O	.	_	0	SENT_669	[p27l1552t1955r1912b2005],

1	Effect	NN	O	effect	nsubj	13	SENT_670	[p27l1929t1954r2076b2005],
2	of	IN	O	of	_	0	SENT_670	[p27l2090t1954r2146b2005],
3	aliskiren	NN	O	aliskiren	prep_of	1	SENT_670	[p27l132t2034r349b2084],
4	on	IN	O	on	_	0	SENT_670	[p27l366t2049r432b2084],
5	postdischarge	NN	O	postdischarge	nn	6	SENT_670	[p27l451t2034r827b2098],
6	mortality	NN	O	mortality	prep_on	3	SENT_670	[p27l844t2034r1088b2098],
7	and	CC	O	and	_	0	SENT_670	[p27l1101t2034r1199b2084],
8	heart	NN	O	heart	nn	10	SENT_670	[p27l1218t2034r1356b2084],
9	failure	NN	O	failure	nn	10	SENT_670	[p27l1369t2033r1535b2084],
10	readmissions	NNS	O	readmission	prep_on	3	SENT_670	[p27l1552t2034r1900b2084],
11	among	IN	O	among	_	0	SENT_670	[p27l1915t2049r2103b2098],
12	patients	NNS	O	patient	prep_among	3	SENT_670	[p27l134t2115r348b2176],
13	hospitalized	VBN	O	hospitalize	_	0	SENT_670	[p27l366t2113r686b2176],
14	for	IN	O	for	_	0	SENT_670	[p27l701t2112r775b2163],
15	heart	NN	O	heart	nn	16	SENT_670	[p27l790t2113r929b2163],
16	failure	NN	O	failure	prep_for	13	SENT_670	[p27l941t2112r1121b2163],
17	:	:	O	:	_	0	SENT_670	[p27l941t2112r1121b2163],
18	the	DT	O	the	det	19	SENT_670	[p27l1135t2113r1222b2163],
19	ASTRONAUT	NNP	O	ASTRONAUT	nsubj	20	SENT_670	[p27l1236t2114r1575b2163],
20	randomized	VBD	O	randomize	parataxis	13	SENT_670	[p27l1589t2113r1907b2163],
21	trial	NN	O	trial	dobj	20	SENT_670	[p27l1922t2113r2037b2163],
22	.	.	O	.	_	0	SENT_670	[p27l1922t2113r2037b2163],

1	JAMA	NN	O	jama	_	0	SENT_671	[p27l128t2194r275b2242],
2	309	CD	NUMBER	309	num	1	SENT_671	[p27l291t2195r409b2249],
3	,	,	O	,	_	0	SENT_671	[p27l291t2195r409b2249],
4	1125-1	CD	NUMBER	1125-1	number	5	SENT_671	[p27l428t2195r608b2242],
5	135	CD	NUMBER	135	appos	1	SENT_671	[p27l627t2195r716b2242],
6	(	CD	NUMBER	(	num	8	SENT_671	[p27l735t2193r913b2249],
7	2013	CD	DATE	2013	num	8	SENT_671	[p27l735t2193r913b2249],
8	)	NN	O	)	dep	5	SENT_671	[p27l735t2193r913b2249],
9	.	.	O	.	_	0	SENT_671	[p27l735t2193r913b2249],

1	63	CD	NUMBER	63	_	0	SENT_672	[p27l7t2273r83b2320],
2	.	.	O	.	_	0	SENT_672	[p27l7t2273r83b2320],

1	Bohm	NNP	PERSON	Bohm	_	0	SENT_673	[p27l133t2270r302b2328],
2	,	,	O	,	_	0	SENT_673	[p27l133t2270r302b2328],
3	M.	NNP	O	M.	nn	4	SENT_673	[p27l318t2272r379b2320],
4	etal	NNP	O	etal	appos	1	SENT_673	[p27l393t2270r507b2320],
5	.	.	O	.	_	0	SENT_673	[p27l393t2270r507b2320],

1	Beneﬁcial	JJ	O	beneﬁcial	amod	2	SENT_674	[p27l526t2269r779b2320],
2	association	NN	O	association	_	0	SENT_674	[p27l796t2272r1091b2320],
3	of	IN	O	of	_	0	SENT_674	[p27l1108t2269r1164b2320],
4	B	NN	O	b	nn	8	SENT_674	[p27l1176t2269r1649b2334],
5	—	CD	NUMBER	—	num	8	SENT_674	[p27l1176t2269r1649b2334],
6	b	NN	O	b	nn	8	SENT_674	[p27l1176t2269r1649b2334],
7	|	NN	O	|	nn	8	SENT_674	[p27l1176t2269r1649b2334],
8	ockertherapy	NN	O	ockertherapy	prep_of	2	SENT_674	[p27l1176t2269r1649b2334],
9	on	IN	O	on	_	0	SENT_674	[p27l1661t2285r1727b2320],
10	recovery	NN	O	recovery	prep_on	2	SENT_674	[p27l1746t2285r1975b2334],
11	from	IN	O	from	_	0	SENT_674	[p27l1986t2269r2112b2320],
12	severe	JJ	O	severe	amod	16	SENT_674	[p27l133t2364r303b2399],
13	acute	JJ	O	acute	amod	16	SENT_674	[p27l318t2356r463b2399],
14	heart	NN	O	heart	nn	16	SENT_674	[p27l480t2349r619b2399],
15	failure	NN	O	failure	nn	16	SENT_674	[p27l631t2348r798b2399],
16	treatment	NN	O	treatment	prep_from	10	SENT_674	[p27l812t2356r1093b2399],
17	:	:	O	:	_	0	SENT_674	[p27l812t2356r1093b2399],
18	data	NNS	O	datum	dep	2	SENT_674	[p27l1108t2349r1222b2399],
19	from	IN	O	from	_	0	SENT_674	[p27l1237t2348r1362b2399],
20	the	DT	O	the	det	21	SENT_674	[p27l1378t2349r1465b2399],
21	Survival	NN	O	survival	prep_from	18	SENT_674	[p27l1480t2349r1687b2399],
22	of	IN	O	of	dep	2	SENT_674	[p27l1705t2348r1760b2399],
23	Patients	NNS	O	patient	pobj	22	SENT_674	[p27l1773t2351r1981b2399],
24	With	IN	O	with	dep	2	SENT_674	[p27l1993t2349r2115b2399],

1	Acute	JJ	O	acute	amod	3	SENT_675	[p27l129t2631r280b2679],
2	Heart	NNP	O	Heart	nn	3	SENT_675	[p27l297t2631r439b2679],
3	Failure	NN	O	failure	_	0	SENT_675	[p27l455t2629r625b2678],
4	in	IN	O	in	_	0	SENT_675	[p27l641t2631r683b2678],
5	Need	NN	MISC	need	prep_in	3	SENT_675	[p27l702t2629r836b2679],
6	of	IN	MISC	of	_	0	SENT_675	[p27l853t2628r907b2678],
7	Intravenous	JJ	MISC	intravenous	amod	10	SENT_675	[p27l919t2631r1228b2679],
8	Inotropic	JJ	MISC	inotropic	amod	10	SENT_675	[p27l1245t2631r1481b2691],
9	Support	NN	MISC	support	nn	10	SENT_675	[p27l1496t2630r1710b2691],
10	trial	NN	O	trial	prep_of	3	SENT_675	[p27l1722t2629r1834b2679],
11	.	.	O	.	_	0	SENT_675	[p27l1722t2629r1834b2679],

1	Crit	NNP	O	Crit	_	0	SENT_676	[p27l1849t2630r1946b2678],
2	.	.	O	.	_	0	SENT_676	[p27l1849t2630r1946b2678],

1	Care	NNP	O	Care	nn	2	SENT_677	[p27l1962t2630r2075b2678],
2	Med	NNP	O	Med	_	0	SENT_677	[p27l128t2706r250b2755],
3	.	.	O	.	_	0	SENT_677	[p27l128t2706r250b2755],

1	39	CD	NUMBER	39	_	0	SENT_678	[p27l266t2709r345b2762],
2	,	,	O	,	_	0	SENT_678	[p27l266t2709r345b2762],
3	940-944	CD	NUMBER	940-944	num	4	SENT_678	[p27l360t2709r585b2755],
4	(	NN	O	(	appos	1	SENT_678	[p27l600t2707r701b2762],
5	201	CD	NUMBER	201	number	6	SENT_678	[p27l600t2707r701b2762],
6	1	CD	NUMBER	1	num	7	SENT_678	[p27l719t2707r774b2762],
7	)	NN	O	)	dep	4	SENT_678	[p27l719t2707r774b2762],
8	.	.	O	.	_	0	SENT_678	[p27l719t2707r774b2762],

1	64	CD	NUMBER	64	_	0	SENT_679	[p27l6t2786r83b2832],
2	.	.	O	.	_	0	SENT_679	[p27l6t2786r83b2832],

1	Hernandez	NNP	PERSON	Hernandez	_	0	SENT_680	[p27l130t2783r440b2839],
2	,	,	O	,	_	0	SENT_680	[p27l130t2783r440b2839],
3	A.F.	NNP	LOCATION	A.F.	nn	15	SENT_680	[p27l456t2785r561b2839],
4	,	,	O	,	_	0	SENT_680	[p27l456t2785r561b2839],
5	Hammill	NNP	PERSON	Hammill	appos	15	SENT_680	[p27l581t2783r820b2839],
6	,	,	O	,	_	0	SENT_680	[p27l581t2783r820b2839],
7	B.G.	NNP	LOCATION	B.G.	appos	15	SENT_680	[p27l839t2785r952b2839],
8	,	,	O	,	_	0	SENT_680	[p27l839t2785r952b2839],
9	O'Connor	NNP	PERSON	O'Connor	appos	15	SENT_680	[p27l969t2784r1239b2839],
10	,	,	O	,	_	0	SENT_680	[p27l969t2784r1239b2839],
11	C.M.	NNP	PERSON	C.M.	appos	15	SENT_680	[p27l1256t2784r1385b2839],
12	,	,	O	,	_	0	SENT_680	[p27l1256t2784r1385b2839],
13	Schulman	NNP	PERSON	Schulman	appos	15	SENT_680	[p27l1403t2783r1687b2839],
14	,	,	O	,	_	0	SENT_680	[p27l1403t2783r1687b2839],
15	K.A.	NNP	PERSON	K.A.	appos	1	SENT_680	[p27l1706t2785r1819b2839],
16	,	,	O	,	_	0	SENT_680	[p27l1706t2785r1819b2839],

1	Curtis	NNP	PERSON	Curtis	_	0	SENT_681	[p27l129t2861r300b2916],
2	,	,	O	,	_	0	SENT_681	[p27l129t2861r300b2916],
3	L.H.	NNP	ORGANIZATION	L.H.	conj_and	1	SENT_681	[p27l320t2862r415b2909],
4	&	CC	ORGANIZATION	&	_	0	SENT_681	[p27l431t2861r468b2909],
5	Fonarow	NNP	ORGANIZATION	Fonarow	conj_and	1	SENT_681	[p27l486t2862r731b2916],
6	,	,	O	,	_	0	SENT_681	[p27l486t2862r731b2916],
7	G.C.	NNP	O	G.C.	nn	9	SENT_681	[p27l749t2861r853b2909],
8	Clinical	JJ	O	clinical	amod	9	SENT_681	[p27l870t2860r1064b2909],
9	effectiveness	NN	O	effectiveness	appos	1	SENT_681	[p27l1083t2859r1438b2909],
10	of	IN	O	of	_	0	SENT_681	[p27l1456t2859r1512b2909],
11	beta	NN	O	beta	nn	13	SENT_681	[p27l1526t2860r1897b2909],
12	—	CD	NUMBER	—	num	13	SENT_681	[p27l1526t2860r1897b2909],
13	blockers	NNS	O	blocker	prep_of	9	SENT_681	[p27l1526t2860r1897b2909],
14	in	IN	O	in	_	0	SENT_681	[p27l131t2940r175b2987],
15	heart	NN	O	heart	nn	16	SENT_681	[p27l196t2938r337b2987],
16	failure	NN	O	failure	prep_in	9	SENT_681	[p27l352t2937r538b2987],
17	:	:	O	:	_	0	SENT_681	[p27l352t2937r538b2987],
18	ﬁndings	NNS	O	ﬁndings	dep	1	SENT_681	[p27l553t2937r775b3001],
19	from	IN	O	from	_	0	SENT_681	[p27l790t2937r917b2987],
20	the	DT	O	the	det	36	SENT_681	[p27l934t2938r1023b2987],
21	OPTIMIZE-HF	NN	O	optimize-hf	amod	36	SENT_681	[p27l1040t2939r1399b2987],
22	(	CD	NUMBER	(	num	21	SENT_681	[p27l1418t2938r1715b3001],
23	Organized	NNP	O	Organized	nn	24	SENT_681	[p27l1418t2938r1715b3001],
24	Program	NNP	O	Program	dep	21	SENT_681	[p27l132t3018r359b3079],
25	to	TO	O	to	aux	26	SENT_681	[p27l377t3023r431b3066],
26	Initiate	VB	O	initiate	infmod	24	SENT_681	[p27l450t3018r638b3066],
27	Lifesaving	NNP	O	Lifesaving	nn	28	SENT_681	[p27l658t3015r927b3079],
28	Treatment	NN	O	treatment	dobj	26	SENT_681	[p27l941t3018r1225b3066],
29	in	IN	O	in	_	0	SENT_681	[p27l1243t3018r1286b3065],
30	Hospitalized	VBN	O	hospitalize	prepc_in	26	SENT_681	[p27l1308t3016r1643b3078],
31	Patients	NNS	O	patient	dobj	30	SENT_681	[p27l1665t3018r1879b3066],
32	with	IN	O	with	_	0	SENT_681	[p27l128t3094r245b3144],
33	Heart	NNP	O	Heart	nn	34	SENT_681	[p27l267t3096r414b3144],
34	Failure	NN	O	failure	prep_with	30	SENT_681	[p27l433t3094r628b3151],
35	)	NN	O	)	nn	36	SENT_681	[p27l433t3094r628b3151],
36	Registry	NN	O	registry	prep_from	18	SENT_681	[p27l649t3096r878b3157],
37	.	.	O	.	_	0	SENT_681	[p27l649t3096r878b3157],

1	J.	NNP	O	J.	nn	2	SENT_682	[p27l891t3096r927b3144],
2	Am	NNP	O	Am	_	0	SENT_682	[p27l941t3096r1043b3144],
3	.	.	O	.	_	0	SENT_682	[p27l941t3096r1043b3144],

1	Coll	NNP	PERSON	Coll	_	0	SENT_683	[p27l1062t3094r1169b3144],
2	.	.	O	.	_	0	SENT_683	[p27l1062t3094r1169b3144],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_684	[p27l1188t3094r1389b3144],
2	.	.	O	.	_	0	SENT_684	[p27l1188t3094r1389b3144],

1	53	CD	NUMBER	53	_	0	SENT_685	[p27l1406t3097r1489b3151],
2	,	,	O	,	_	0	SENT_685	[p27l1406t3097r1489b3151],
3	184-192	CD	NUMBER	184-192	number	4	SENT_685	[p27l1510t3097r1737b3144],
4	(	CD	NUMBER	(	appos	1	SENT_685	[p27l131t3172r313b3227],
5	2009	CD	DATE	2009	num	6	SENT_685	[p27l131t3172r313b3227],
6	)	NN	O	)	dep	4	SENT_685	[p27l131t3172r313b3227],
7	.	.	O	.	_	0	SENT_685	[p27l131t3172r313b3227],

1	65	CD	NUMBER	65	_	0	SENT_686	[p27l6t3251r80b3297],
2	.	.	O	.	_	0	SENT_686	[p27l6t3251r80b3297],

1	How	WRB	O	how	advmod	3	SENT_687	[p27l130t3248r449b3304],
2	|	JJ	O	|	amod	3	SENT_687	[p27l130t3248r449b3304],
3	ett	NN	O	ett	dep	11	SENT_687	[p27l130t3248r449b3304],
4	,	,	O	,	_	0	SENT_687	[p27l130t3248r449b3304],
5	J.G.	NNP	O	J.G.	nn	8	SENT_687	[p27l130t3248r449b3304],
6	Acute	JJ	O	acute	amod	8	SENT_687	[p27l464t3250r614b3297],
7	heart	NN	O	heart	nn	8	SENT_687	[p27l632t3248r768b3297],
8	failure	NN	O	failure	nsubj	11	SENT_687	[p27l780t3247r956b3297],
9	:	:	O	:	_	0	SENT_687	[p27l780t3247r956b3297],
10	lessons	NNS	O	lesson	dep	8	SENT_687	[p27l973t3248r1160b3297],
11	learned	VBD	O	learn	_	0	SENT_687	[p27l1177t3248r1370b3297],
12	so	RB	O	so	advmod	13	SENT_687	[p27l1387t3262r1443b3297],
13	far	RB	O	far	advmod	11	SENT_687	[p27l1456t3247r1533b3297],
14	.	.	O	.	_	0	SENT_687	[p27l1456t3247r1533b3297],

1	Can	MD	O	can	_	0	SENT_688	[p27l1549t3250r1658b3297],
2	.	.	O	.	_	0	SENT_688	[p27l1549t3250r1658b3297],

1	J.	NNP	PERSON	J.	nn	2	SENT_689	[p27l1669t3250r1703b3297],
2	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_689	[p27l1719t3248r1911b3297],
3	.	.	O	.	_	0	SENT_689	[p27l1719t3248r1911b3297],

1	27	CD	NUMBER	27	_	0	SENT_690	[p27l1925t3251r2005b3304],
2	,	,	O	,	_	0	SENT_690	[p27l1925t3251r2005b3304],

1	VOLUME	NN	O	volume	nn	3	SENT_691	[p27l536t3542r761b3585],
2	94	CD	NUMBER	94	num	3	SENT_691	[p27l779t3543r838b3585],
3	NUMBER	NN	O	number	_	0	SENT_691	[p27l857t3542r1081b3585],
4	4	CD	NUMBER	4	number	5	SENT_691	[p27l1097t3538r1150b3600],
5	|	CD	NUMBER	|	dep	3	SENT_691	[p27l1097t3538r1150b3600],
6	OCTOBER	NNP	DATE	OCTOBER	dep	5	SENT_691	[p27l1170t3542r1419b3585],
7	2013	CD	DATE	2013	num	6	SENT_691	[p27l1437t3543r1555b3585],
8	|	CD	NUMBER	|	num	9	SENT_691	[p27l1577t3538r2153b3600],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_691	[p27l1577t3538r2153b3600],

